data_6mpo_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6mpo _Structure_validation_residue.Date_analyzed 2019-02-15 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.678 0 N-CA-C 112.17 -0.372 . . . . 0.0 112.17 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 26.4 m -152.21 98.93 2.47 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.497 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 2.2 mp -116.67 -176.66 3.01 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.615 -172.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 87.6 m -134.01 154.77 50.92 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.418 -176.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 41.1 t -93.87 107.26 19.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.421 ' HB2' ' HG1' ' A' ' 252' ' ' THR . 26.3 tptp -90.49 -31.19 16.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.025 0.44 . . . . 0.0 111.194 -172.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 19.2 p -128.71 -168.45 1.92 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.194 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.422 ' HB3' HG22 ' A' ' 333' ' ' VAL . 64.9 mt-30 -108.08 122.02 41.96 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-O 120.887 0.375 . . . . 0.0 110.617 -171.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.77 106.78 2.32 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 123.014 2.476 . . . . 0.0 113.264 -176.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.433 ' O ' HG21 ' A' ' 236' ' ' VAL . 10.2 t -155.33 127.93 7.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.964 0.411 . . . . 0.0 111.911 176.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.585 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -155.3 173.96 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.308 172.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' THR . . . . . 0.489 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 57.1 m -20.38 112.04 0.02 OUTLIER 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.535 1.534 . . . . 0.0 114.207 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -115.61 100.85 8.35 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.087 174.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -135.61 131.52 35.94 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.129 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -98.82 -47.82 5.15 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.168 -170.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.68 -23.8 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.437 0.637 . . . . 0.0 110.078 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -100.61 1.07 40.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.296 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 51.0 50.61 18.78 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.324 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 14.7 m -122.31 101.08 7.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.336 -175.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -128.58 112.55 14.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.941 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . 0.452 ' HB2' HG12 ' A' ' 236' ' ' VAL . 50.6 mt-30 -138.75 164.62 29.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 175.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.585 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 36.8 p90 -147.02 134.64 21.01 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.244 171.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 38.6 m -100.34 137.79 38.29 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.68 143.96 22.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.317 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 18.3 m -91.22 113.37 25.61 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 160.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 309' ' ' VAL . 5.1 mp -101.77 167.29 10.18 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -177.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.421 ' HG1' ' HB2' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -118.57 141.07 48.94 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.236 177.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -141.62 -143.37 4.23 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 121.227 -0.511 . . . . 0.0 111.937 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -112.15 -174.44 2.46 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -175.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.539 HG21 ' H ' ' A' ' 256' ' ' ALA . 3.0 m -67.86 173.55 4.35 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.417 -172.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.539 ' H ' HG21 ' A' ' 255' ' ' THR . . . -60.48 -176.17 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.818 0.847 . . . . 0.0 112.535 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 15.3 t 81.05 6.3 1.34 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.125 0.97 . . . . 0.0 110.619 -176.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 91.6 t -123.74 90.37 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 170.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.4 m -75.54 93.43 3.01 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.345 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 75.74 97.16 0.14 Allowed Glycine 0 N--CA 1.44 -1.068 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.068 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.466 ' HB3' HD12 ' A' ' 262' ' ' LEU . 28.5 m-85 -46.2 -58.75 3.38 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.652 0.739 . . . . 0.0 109.737 172.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.476 ' N ' HD23 ' A' ' 262' ' ' LEU . 0.0 OUTLIER -151.88 171.32 17.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.807 177.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 37.9 mtmm -136.28 -166.84 1.95 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.696 0.284 . . . . 0.0 111.765 -174.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -53.46 118.87 4.19 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.397 0.618 . . . . 0.0 111.69 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 106.31 -12.15 43.82 Favored Glycine 0 C--N 1.316 -0.557 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.118 176.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . 0.437 ' CB ' ' HB2' ' A' ' 262' ' ' LEU . 40.9 m-20 -84.47 133.23 34.48 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -94.36 147.62 23.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.326 0.584 . . . . 0.0 111.149 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.5 OUTLIER -120.48 179.59 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.4 174.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 269' ' ' LYS . 12.8 tmtt? -134.51 102.55 5.35 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 174.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -112.51 143.77 43.11 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.534 -174.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.602 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 84.8 m -127.78 89.54 2.96 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.649 0.737 . . . . 0.0 110.297 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.449 ' HA ' ' CB ' ' A' ' 337' ' ' ASP . 2.4 t-20 . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.562 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.575 0.226 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -142.71 -135.81 0.1 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.512 -169.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 48.7 m -70.49 130.87 43.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.13 0.491 . . . . 0.0 112.031 -173.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -130.11 -169.49 2.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.029 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 54.5 m -139.85 132.63 29.09 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.431 HG12 HG21 ' A' ' 311' ' ' VAL . 64.4 t -82.16 139.89 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.33 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.38 9.64 13.4 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.493 -169.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -171.82 -172.28 0.99 Allowed 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 120.568 0.223 . . . . 0.0 111.509 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.98 123.42 18.03 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.397 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.548 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -111.81 110.02 20.15 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.528 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -80.0 132.29 35.98 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -166.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.517 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 12.8 t -106.75 95.97 6.12 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 164.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.63 -178.63 3.78 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.261 -175.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 23.3 t -60.76 -34.8 75.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.971 0.415 . . . . 0.0 111.368 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -81.9 -3.12 90.68 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.687 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 65.0 41.17 97.44 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.704 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.32 125.84 54.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.385 0.612 . . . . 0.0 109.852 175.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 251' ' ' LEU . 2.0 p -127.07 94.08 2.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.946 -175.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 53.5 m -98.79 127.01 44.58 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.003 -0.435 . . . . 0.0 111.676 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.431 HG21 HG12 ' A' ' 297' ' ' VAL . 11.8 p -161.95 151.02 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 175.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 49.2 m -93.22 146.03 23.99 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.079 0.466 . . . . 0.0 110.339 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.476 ' HB2' ' CE2' ' A' ' 247' ' ' PHE . 5.7 mp -117.46 151.21 37.54 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.62 -175.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 C--N 1.319 -0.752 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.589 173.657 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.422 HG22 ' HB3' ' A' ' 233' ' ' GLN . 9.5 m . . . . . 0 N--CA 1.451 -0.386 0 CA-C-O 120.757 0.313 . . . . 0.0 110.76 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -137.52 148.17 45.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.085 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -97.71 172.75 7.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.049 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 112.73 11.64 14.19 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.444 176.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.602 ' HB3' ' O ' ' A' ' 271' ' ' THR . 4.3 m-20 -104.36 -170.77 1.82 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -176.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -114.32 157.17 23.15 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.155 0.503 . . . . 0.0 111.926 -172.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 39.0 t -134.42 145.8 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.28 -176.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 35.9 t -142.62 176.45 9.03 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 50.9 t -119.04 126.58 75.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.966 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 CA--C 1.535 0.373 0 CA-C-O 121.499 0.666 . . . . 0.0 110.979 176.875 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.604 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 23.6 m -124.32 132.03 53.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.177 0.513 . . . . 0.0 110.18 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.498 HD22 HG12 ' A' ' 309' ' ' VAL . 5.5 mt -131.3 173.36 11.14 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.576 -175.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 31.6 m -141.9 156.08 45.5 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -174.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 54.7 t -117.14 127.96 74.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 122.418 -0.177 . . . . 0.0 110.964 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.462 ' NZ ' HG23 ' A' ' 252' ' ' THR . 31.1 mtmm -112.38 -14.9 13.23 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -177.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 75.2 p -120.44 -174.09 2.72 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.23 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -106.59 106.33 57.39 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -170.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.53 ' C ' ' HB2' ' A' ' 247' ' ' PHE . 55.5 Cg_endo -69.83 103.75 1.22 Allowed 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.567 2.178 . . . . 0.0 113.6 -174.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 236' ' ' VAL . 15.1 t -157.93 129.32 6.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.714 170.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.59 ' N ' ' HA ' ' A' ' 247' ' ' PHE . 2.9 t -155.94 114.49 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 C-N-CA 122.827 0.451 . . . . 0.0 110.69 172.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' THR . . . . . 0.623 ' O ' ' HA ' ' A' ' 245' ' ' TYR . 23.7 m 64.57 93.65 0.06 Allowed 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.228 0.537 . . . . 0.0 111.649 176.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -109.55 84.44 1.92 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -132.52 129.06 38.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.218 -175.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.22 -35.01 7.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.78 -173.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 61.5 t -62.81 -29.56 47.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.497 0.665 . . . . 0.0 109.62 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.457 ' HA ' ' HE2' ' A' ' 242' ' ' LYS . 9.8 mmpt? -96.81 -12.46 23.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.881 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 60.7 59.92 2.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.001 -1.454 . . . . 0.0 110.55 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 36.8 m -143.93 106.27 4.4 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.151 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . 0.623 ' HA ' ' O ' ' A' ' 237' ' ' THR . 59.0 m-85 -129.07 118.17 22.07 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 236' ' ' VAL . 45.0 mt-30 -130.54 -179.16 5.12 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.59 ' HA ' ' N ' ' A' ' 236' ' ' VAL . 13.0 p90 -160.26 136.8 8.89 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.238 165.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.503 ' OG1' HG22 ' A' ' 236' ' ' VAL . 32.8 m -102.66 138.41 39.6 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.438 ' HB ' ' CD1' ' A' ' 251' ' ' LEU . 0.1 OUTLIER -144.92 151.15 15.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.712 -0.795 . . . . 0.0 112.11 -178.336 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.597 HG23 ' OG1' ' A' ' 310' ' ' THR . 91.7 m -103.14 104.85 15.04 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 168.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.497 ' HB2' ' O ' ' A' ' 309' ' ' VAL . 5.1 mp -102.7 167.78 9.68 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -169.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.462 HG23 ' NZ ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -114.68 151.37 33.71 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.91 172.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -150.97 -142.67 3.57 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 121.197 -0.525 . . . . 0.0 111.907 -173.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.576 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -107.42 -174.59 2.57 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.549 HG23 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -69.48 -177.8 1.26 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.41 -172.043 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.549 ' H ' HG23 ' A' ' 255' ' ' THR . . . -64.39 -175.98 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.825 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 49.8 m 80.24 9.05 1.36 Allowed 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.489 0.716 . . . . 0.0 111.287 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 28.6 t -126.85 90.07 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 171.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.9 m -70.9 93.76 1.01 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.892 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 73.62 98.0 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.217 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.463 ' CE1' HD23 ' A' ' 228' ' ' LEU . 6.3 m-85 -44.99 -58.67 3.02 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.816 0.817 . . . . 0.0 109.824 171.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.479 ' HB3' ' HB2' ' A' ' 266' ' ' ASP . 77.8 mt -140.78 169.15 18.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.31 -1.314 . . . . 0.0 109.051 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -133.25 -167.33 1.91 Allowed 'General case' 0 C--N 1.323 -0.554 0 O-C-N 123.079 0.237 . . . . 0.0 110.502 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -59.93 116.28 4.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.286 0.565 . . . . 0.0 111.171 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 111.7 -14.37 27.09 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.547 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . 0.479 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 37.3 m-20 -81.0 128.23 33.46 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.938 0.399 . . . . 0.0 110.292 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.97 150.93 22.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.449 0.642 . . . . 0.0 111.759 -173.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.42 HG11 HG21 ' A' ' 341' ' ' VAL . 1.3 m -131.38 171.71 17.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.276 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.475 ' HD2' HG12 ' A' ' 342' ' ' VAL . 0.0 OUTLIER -143.77 129.21 18.99 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.2 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -130.4 158.51 39.67 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.128 -174.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.67 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 93.2 m -108.7 86.89 2.37 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.163 -173.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 . . . . . 0 C--N 1.326 -0.424 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.975 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -145.29 154.25 42.15 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.07 0.462 . . . . 0.0 110.439 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 86.7 m -89.31 134.75 33.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.87 -172.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -129.03 -174.19 3.19 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 177.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 80.0 m -142.48 135.36 28.34 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.476 HG13 HG22 ' A' ' 311' ' ' VAL . 58.2 t -78.31 140.53 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.832 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 4.0 m -116.31 1.57 13.09 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -161.56 176.96 10.48 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.908 -0.495 . . . . 0.0 111.517 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.93 104.96 0.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.23 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -93.22 103.42 15.69 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.797 -174.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -61.0 135.07 57.68 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -171.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.07 97.49 6.25 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 162.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.4 174.11 6.85 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.715 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 42.5 m -57.05 -33.74 67.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -77.74 -3.05 83.1 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.449 -176.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 72.73 41.26 50.68 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.246 -178.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -113.37 146.25 39.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.687 0.743 . . . . 0.0 110.909 174.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.498 HG12 HD22 ' A' ' 228' ' ' LEU . 2.2 p -145.56 102.19 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.414 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.597 ' OG1' HG23 ' A' ' 250' ' ' THR . 91.0 m -102.42 124.17 47.5 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.514 -0.741 . . . . 0.0 111.032 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.476 HG22 HG13 ' A' ' 297' ' ' VAL . 14.8 p -160.15 154.31 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.134 0.493 . . . . 0.0 110.213 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 47.0 m -97.87 152.39 19.24 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.65 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.442 HD13 ' CE1' ' A' ' 247' ' ' PHE . 5.7 mp -119.89 135.19 54.98 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.632 -177.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 27.7 p . . . . . 0 C--N 1.325 -0.492 0 CA-C-O 120.807 0.337 . . . . 0.0 111.598 -175.683 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.401 HG22 ' N ' ' A' ' 334' ' ' GLU . 13.1 p . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . 0.401 ' N ' HG22 ' A' ' 333' ' ' VAL . 10.4 tp10 -119.87 147.81 44.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.978 0.418 . . . . 0.0 110.485 -175.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -85.85 173.5 9.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.213 -176.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 112.58 11.5 14.8 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.417 173.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.67 ' HB2' ' O ' ' A' ' 271' ' ' THR . 4.9 p-10 -91.05 179.87 5.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.998 0.428 . . . . 0.0 111.52 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -118.04 137.63 52.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.442 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 55.9 t -116.48 150.78 18.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.458 -172.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 41.9 m -146.73 173.22 12.57 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 172.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.42 HG21 HG11 ' A' ' 268' ' ' VAL . 86.1 t -117.85 132.99 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -171.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.475 HG12 ' HD2' ' A' ' 269' ' ' LYS . 32.6 m . . . . . 0 N--CA 1.465 0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 111.561 174.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 0.143 0 CA-C-O 120.899 0.166 . . . . 0.0 113.167 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 21.2 m -107.53 142.66 37.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.04 0.448 . . . . 0.0 110.72 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.465 HD21 ' CZ ' ' A' ' 261' ' ' PHE . 20.4 mt -143.03 175.93 9.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.269 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.56 ' O ' ' HB3' ' A' ' 251' ' ' LEU . 43.6 m -131.7 152.69 50.7 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.414 0.149 . . . . 0.0 110.615 -176.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.448 HG23 ' CG2' ' A' ' 339' ' ' VAL . 12.2 t -100.03 127.9 52.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 176.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -110.96 -29.1 8.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.373 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.45 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 72.7 p -119.87 -169.33 1.76 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.688 0.28 . . . . 0.0 110.732 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.578 ' HB3' ' HB ' ' A' ' 333' ' ' VAL . 85.1 mt-30 -112.76 125.68 29.52 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -172.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 248' ' ' THR . 10.0 Cg_endo -92.71 106.39 0.19 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.337 2.691 . . . . 0.0 115.728 -168.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.491 ' O ' HG22 ' A' ' 236' ' ' VAL . 1.2 m -157.52 133.23 9.22 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 165.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.665 ' N ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -158.24 139.6 4.92 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.807 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 176.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 97.7 m 69.12 108.51 0.05 Allowed 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.494 0.718 . . . . 0.0 112.635 170.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -116.31 99.81 7.46 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.437 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.53 88.31 2.79 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -83.63 -44.32 14.69 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.773 -163.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 22.8 t -66.47 -23.18 31.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.629 0.728 . . . . 0.0 109.145 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -99.87 -3.75 31.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.888 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 36.1 t70 57.39 68.85 0.8 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.35 -1.296 . . . . 0.0 111.729 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 24.4 t -152.9 119.76 5.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.513 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -129.6 128.51 42.83 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -121.8 -174.74 2.94 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.665 ' HA ' ' N ' ' A' ' 236' ' ' VAL . 1.8 p90 -156.71 125.74 5.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 174.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 52.9 m -95.41 142.29 27.96 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.07 137.92 24.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 119.786 -0.766 . . . . 0.0 112.391 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.45 ' HB ' ' CG2' ' A' ' 232' ' ' THR . 92.2 m -98.43 113.36 25.32 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 168.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.58 ' HB2' HG13 ' A' ' 309' ' ' VAL . 1.4 mp -107.85 168.68 9.1 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -175.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.76 139.4 41.24 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.187 172.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -141.86 -149.41 5.19 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.275 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -96.25 -174.23 3.01 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 256' ' ' ALA . 2.8 m -77.01 175.73 9.31 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.021 -170.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.559 ' H ' HG22 ' A' ' 255' ' ' THR . . . -65.03 -176.39 0.28 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.446 0.698 . . . . 0.0 112.275 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 24.8 t 80.2 6.97 1.62 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.834 0.854 . . . . 0.0 110.517 -176.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 24.0 t -123.37 90.71 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 170.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 5.6 m -73.44 92.45 1.86 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.654 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 80.77 94.2 0.43 Allowed Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.958 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.465 ' CZ ' HD21 ' A' ' 228' ' ' LEU . 4.1 m-85 -43.5 -55.35 4.28 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 169.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.8 pp -165.51 173.85 10.55 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.568 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 60.3 mttp -143.23 -166.32 2.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.997 0.427 . . . . 0.0 111.836 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -53.54 122.74 10.38 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.162 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 109.92 -16.01 30.89 Favored Glycine 0 C--N 1.313 -0.718 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.7 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -84.35 139.43 32.28 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' GLN . . . . . 0.424 ' HB2' HG12 ' A' ' 342' ' ' VAL . 27.5 mt-30 -107.91 151.92 25.13 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.389 0.614 . . . . 0.0 110.765 -178.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.4 OUTLIER -132.4 176.18 9.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.397 -179.24 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -123.64 143.24 50.37 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 172.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . 0.463 ' CE2' ' HB2' ' A' ' 295' ' ' ALA . 17.2 p90 -136.68 142.5 43.16 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 173.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 25.7 p -150.17 109.69 4.01 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.876 -174.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.496 HD21 ' HG3' ' A' ' 334' ' ' GLU . 24.1 p-10 . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 121.555 0.693 . . . . 0.0 111.802 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 120.196 0.046 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -161.71 -144.16 0.09 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 -168.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 56.0 m -74.77 137.04 41.71 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -175.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . 0.463 ' HB2' ' CE2' ' A' ' 270' ' ' PHE . . . -124.92 172.4 9.41 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 173.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 87.1 m -134.21 129.54 35.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.473 0.654 . . . . 0.0 112.474 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.47 HG13 ' H ' ' A' ' 299' ' ' ALA . 93.3 t -89.87 140.69 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.047 -177.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 1.9 m -125.06 23.86 7.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.009 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -156.29 -177.25 6.45 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -76.83 165.57 24.52 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.775 -174.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.605 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -147.5 155.61 42.05 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.688 -175.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -128.99 133.1 47.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.263 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.8 OUTLIER -111.51 95.45 5.51 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 164.141 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.15 169.37 8.48 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.554 -0.459 . . . . 0.0 110.444 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 67.0 m -57.95 -30.3 65.87 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -76.85 7.51 34.17 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.622 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 59.89 41.88 97.94 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.219 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -121.78 117.98 27.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.316 0.558 . . . . 0.0 111.242 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.58 HG13 ' HB2' ' A' ' 251' ' ' LEU . 2.6 p -125.42 125.42 68.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.982 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 86.2 m -120.21 135.67 54.9 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 121.729 -0.607 . . . . 0.0 111.249 -177.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.576 ' CG1' ' HB3' ' A' ' 301' ' ' ALA . 6.6 m -146.76 165.21 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.143 0.497 . . . . 0.0 110.445 175.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 28.3 m -121.95 136.32 54.92 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.691 173.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 4.2 mp -112.8 158.93 19.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.999 -173.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 14.3 m . . . . . 0 C--N 1.322 -0.626 0 CA-C-O 120.863 0.363 . . . . 0.0 111.561 -176.455 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.578 ' HB ' ' HB3' ' A' ' 233' ' ' GLN . 28.8 m . . . . . 0 C--O 1.235 0.311 0 CA-C-O 121.991 0.901 . . . . 0.0 112.962 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . 0.496 ' HG3' HD21 ' A' ' 272' ' ' ASN . 1.0 OUTLIER -109.19 145.74 35.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.402 -178.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -99.97 156.29 17.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.653 174.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 106.86 8.89 31.32 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.487 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.443 ' HB3' ' CG2' ' A' ' 230' ' ' VAL . 10.6 t70 -66.01 150.45 48.65 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.781 0.324 . . . . 0.0 110.854 178.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -98.52 112.64 24.61 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.448 ' CG2' HG23 ' A' ' 230' ' ' VAL . 57.4 t -97.09 148.85 5.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.387 0.613 . . . . 0.0 111.654 -170.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 65.5 m -143.67 171.58 13.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.762 173.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 24.1 t -119.25 141.85 37.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.424 HG12 ' HB2' ' A' ' 267' ' ' GLN . 8.4 p . . . . . 0 N--CA 1.464 0.241 0 CA-C-O 121.085 0.469 . . . . 0.0 110.555 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.793 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 20.8 m -152.36 96.22 2.14 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 175.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.465 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 4.0 mp -122.73 -179.25 4.17 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.889 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 48.3 m -134.34 162.72 31.41 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.529 -175.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 94.4 t -108.24 130.88 60.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.401 ' HB2' HG23 ' A' ' 252' ' ' THR . 27.2 tptp -108.53 -15.21 14.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.874 0.369 . . . . 0.0 111.482 -173.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 20.6 p -138.44 -169.54 2.62 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.206 -173.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.433 ' HB3' ' HB ' ' A' ' 333' ' ' VAL . 74.7 mt-30 -105.02 118.24 56.6 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.248 -172.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.42 ' HA ' HG21 ' A' ' 249' ' ' VAL . 44.3 Cg_endo -68.78 106.15 1.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.716 2.277 . . . . 0.0 111.997 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.454 ' O ' HG21 ' A' ' 236' ' ' VAL . 10.9 t -154.88 124.06 6.33 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.575 -0.45 . . . . 0.0 112.095 -178.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.565 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 1.1 t -154.05 168.89 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.606 171.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' THR . . . . . 0.482 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 74.6 m -14.73 112.96 0.02 OUTLIER 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.725 1.61 . . . . 0.0 114.472 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -106.41 88.57 2.81 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 172.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -125.89 139.32 53.56 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.366 0.603 . . . . 0.0 110.236 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.468 ' CB ' ' HH ' ' A' ' 245' ' ' TYR . . . -106.22 -44.58 4.52 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.558 -173.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 63.1 t -61.04 -36.71 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.263 0.554 . . . . 0.0 110.167 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -88.14 -5.48 58.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.316 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 22.4 t70 50.91 67.45 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.036 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.5 m -144.75 100.89 3.58 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.589 -175.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . 0.468 ' HH ' ' CB ' ' A' ' 240' ' ' ALA . 47.0 m-85 -121.49 100.89 7.28 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . 0.487 ' HB2' ' CG1' ' A' ' 236' ' ' VAL . 80.0 mt-30 -127.6 178.97 5.76 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.629 -171.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.565 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 2.1 p90 -156.64 125.63 5.97 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 19.5 m -95.4 134.53 38.1 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.446 ' HB ' ' CD1' ' A' ' 251' ' ' LEU . 0.2 OUTLIER -141.95 146.71 22.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.676 -178.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.464 HG22 ' OG1' ' A' ' 310' ' ' THR . 95.2 m -96.69 112.79 24.4 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 164.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.481 ' HB2' HG11 ' A' ' 309' ' ' VAL . 5.3 mp -102.46 169.16 8.84 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -176.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.401 HG23 ' HB2' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -127.57 108.69 11.0 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.68 0.276 . . . . 0.0 111.628 -177.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.541 ' N ' HG12 ' A' ' 309' ' ' VAL . . . -147.39 135.81 5.8 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 177.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -108.34 93.98 4.82 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -172.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.482 ' HB ' ' OG ' ' A' ' 303' ' ' SER . 10.1 m -126.29 118.97 26.21 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 170.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -73.04 136.82 45.05 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 70.8 m 59.89 55.58 3.8 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.119 174.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 94.6 t -131.74 95.37 2.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.25 0.548 . . . . 0.0 109.858 174.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 27.4 m -74.15 97.63 2.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.143 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 71.23 99.7 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.844 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.523 ' CE2' ' HB2' ' A' ' 303' ' ' SER . 11.6 m-85 -48.02 -59.18 3.56 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.324 0.583 . . . . 0.0 110.34 170.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 61.3 mt -143.57 173.52 11.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.537 -173.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -130.7 -169.86 2.23 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.818 0.342 . . . . 0.0 111.172 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -57.95 114.05 2.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.563 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 111.14 -1.6 28.33 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.846 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -87.59 145.32 26.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.704 0.252 . . . . 0.0 110.556 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -102.23 149.23 24.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.48 0.657 . . . . 0.0 111.124 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.483 HG22 ' HB2' ' A' ' 295' ' ' ALA . 0.1 OUTLIER -132.22 174.33 13.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.542 178.357 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 293' ' ' PHE . 5.6 mptp? -110.23 135.83 50.38 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 172.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . 0.682 ' O ' ' HA ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -142.65 105.87 4.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.806 0.812 . . . . 0.0 110.566 178.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.567 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 31.4 m -81.15 86.06 6.24 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 . . . . . 0 C--N 1.319 -0.744 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.93 -170.068 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.138 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . 0.682 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 2.2 p90 -109.77 88.36 2.73 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -166.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 92.3 m -151.63 112.03 4.15 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 122.061 -0.4 . . . . 0.0 110.975 175.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . 0.511 ' HB3' ' CD2' ' A' ' 270' ' ' PHE . . . -131.35 -177.1 4.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.555 0.217 . . . . 0.0 111.197 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 7.5 m -143.39 131.56 21.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.876 0.846 . . . . 0.0 113.061 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.48 HG13 ' CG2' ' A' ' 311' ' ' VAL . 63.2 t -76.75 141.55 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 113.551 -1.658 . . . . 0.0 111.135 -178.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 15.1 m -110.35 -14.23 14.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -176.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -162.03 -175.63 4.74 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 122.158 -0.339 . . . . 0.0 111.266 -177.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -59.15 113.99 2.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.029 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -94.87 101.5 13.3 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.476 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' A' ' 309' ' ' VAL . 5.1 m-20 -58.55 127.3 31.49 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.708 -174.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.523 ' HB2' ' CE2' ' A' ' 261' ' ' PHE . 30.2 t -114.97 113.39 24.06 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 120.73 0.3 . . . . 0.0 111.267 172.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -127.16 152.21 47.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 170.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 10.8 t -74.72 -4.31 36.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.712 -172.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -68.63 -11.46 62.56 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 172.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 92.55 37.12 5.93 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.067 -0.567 . . . . 0.0 113.384 176.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -125.81 141.9 51.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 117.225 0.513 . . . . 0.0 111.407 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 302' ' ' ASN . 1.6 p -152.24 100.37 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.16 174.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.464 ' OG1' HG22 ' A' ' 250' ' ' THR . 63.8 m -93.15 129.83 39.02 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.521 -0.737 . . . . 0.0 110.824 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.48 ' CG2' HG13 ' A' ' 297' ' ' VAL . 2.1 p -157.61 141.92 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 54.7 m -94.48 147.67 23.02 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.047 0.451 . . . . 0.0 110.122 175.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.427 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.0 mp -131.54 170.82 14.19 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.717 -174.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 29.8 p . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.066 176.998 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.471 HG11 ' H ' ' A' ' 334' ' ' GLU . 2.9 t . . . . . 0 CA--C 1.529 0.165 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . 0.471 ' H ' HG11 ' A' ' 333' ' ' VAL . 33.7 tt0 -115.11 134.83 54.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.683 0.277 . . . . 0.0 111.118 -174.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -97.85 173.06 7.27 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.674 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 117.73 1.97 17.14 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.432 -0.89 . . . . 0.0 113.879 170.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' A' ' 271' ' ' THR . 10.7 p-10 -79.47 173.01 13.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.079 0.439 . . . . 0.0 111.484 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -110.84 148.7 31.85 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.255 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.465 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 73.9 t -127.28 150.74 33.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.841 0.353 . . . . 0.0 111.82 -169.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.504 ' HB3' ' HB2' ' A' ' 269' ' ' LYS . 31.0 t -151.74 178.03 9.79 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 175.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 58.9 t -119.19 144.03 28.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 122.338 -0.226 . . . . 0.0 110.971 -176.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 50.7 t . . . . . 0 CA--C 1.523 -0.073 0 CA-C-O 121.061 0.457 . . . . 0.0 110.037 174.355 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.109 0 N-CA-C 112.618 -0.193 . . . . 0.0 112.618 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 23.7 m -136.34 136.56 39.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.978 0.418 . . . . 0.0 110.705 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.495 ' HB2' ' CG1' ' A' ' 339' ' ' VAL . 1.2 mp -139.51 175.75 9.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.752 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 24.7 m -130.63 160.24 34.81 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.482 HG21 ' CG2' ' A' ' 339' ' ' VAL . 73.8 t -118.42 147.01 22.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 122.304 -0.248 . . . . 0.0 110.692 174.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -117.6 -19.02 9.56 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.406 ' HG1' ' CB ' ' A' ' 250' ' ' THR . 39.6 p -124.7 -167.61 1.69 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -112.7 131.01 22.9 Favored Pre-proline 0 C--N 1.316 -0.881 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -173.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.459 ' HA ' HG21 ' A' ' 249' ' ' VAL . 35.2 Cg_endo -66.95 104.04 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.06 1.84 . . . . 0.0 111.545 177.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 5.0 t -154.91 116.86 4.16 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.416 0.627 . . . . 0.0 111.778 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.636 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.5 174.42 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 168.404 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' THR . . . . . 0.458 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 66.9 m -37.62 110.03 0.11 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -174.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -112.18 83.96 1.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.042 170.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -110.96 132.86 53.85 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.39 -39.91 5.75 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.733 -170.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.45 -27.21 42.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.471 0.653 . . . . 0.0 109.938 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -96.33 -13.93 22.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.837 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 60.45 68.46 0.76 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.471 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 41.7 m -149.08 100.86 3.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.36 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -116.84 109.74 17.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.551 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.41 161.44 32.44 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 172.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.636 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 0.7 OUTLIER -160.12 133.67 7.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.471 0.176 . . . . 0.0 111.109 179.056 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 48.2 m -108.47 143.1 37.89 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 122.35 -0.218 . . . . 0.0 110.506 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.501 HG23 ' CD2' ' A' ' 313' ' ' LEU . 0.4 OUTLIER -146.09 148.36 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.923 178.612 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.58 HG21 ' OG1' ' A' ' 310' ' ' THR . 28.2 m -97.68 114.47 26.44 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 169.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 309' ' ' VAL . 4.9 mp -109.81 164.79 12.24 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 -175.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.83 140.42 52.95 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -135.22 -143.32 4.73 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.388 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.498 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -108.75 -176.5 3.06 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.981 0.419 . . . . 0.0 112.102 -177.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.556 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.6 OUTLIER -68.94 -179.54 1.51 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.146 -171.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.556 ' H ' HG22 ' A' ' 255' ' ' THR . . . -60.49 -177.39 0.07 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.233 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 46.9 m 79.48 6.19 2.01 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.734 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 10.9 t -124.29 89.51 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.799 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 171.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 11.6 m -73.22 98.38 2.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.831 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 61.84 98.82 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.842 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -43.1 -56.36 3.41 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.827 0.346 . . . . 0.0 111.139 173.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.54 167.08 23.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.928 -177.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.418 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 48.6 mtmt -137.25 -166.34 1.91 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -176.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -46.68 116.09 1.23 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.983 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 117.5 -10.53 14.45 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.092 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -101.96 138.6 38.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.951 0.405 . . . . 0.0 110.829 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -107.24 153.43 22.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.32 0.581 . . . . 0.0 110.191 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.489 HG21 ' HB2' ' A' ' 295' ' ' ALA . 1.7 m -133.97 168.2 24.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 176.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.32 135.27 32.03 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.067 170.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . 0.575 ' HB3' ' HA ' ' A' ' 339' ' ' VAL . 35.1 p90 -147.64 167.39 24.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.83 -0.168 . . . . 0.0 111.21 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.416 ' HB ' ' HA ' ' A' ' 292' ' ' SER . 1.8 t -158.24 119.06 3.4 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.379 0.609 . . . . 0.0 112.19 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.548 ' HB2' ' CA ' ' A' ' 337' ' ' ASP . 51.0 t30 . . . . . 0 C--N 1.324 -0.509 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 160.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' SER . . . . . 0.416 ' HA ' ' HB ' ' A' ' 271' ' ' THR . 30.4 p . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -127.11 137.19 52.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.099 0.476 . . . . 0.0 110.101 175.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 85.7 m -82.45 136.32 34.95 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.886 -174.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . 0.489 ' HB2' HG21 ' A' ' 268' ' ' VAL . . . -114.85 177.04 4.79 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.877 176.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 7.2 m -141.02 114.14 8.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.457 0.646 . . . . 0.0 111.398 177.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 67.3 t -75.51 131.77 34.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.013 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 8.4 p -123.31 24.35 8.76 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.101 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -152.4 164.39 37.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.027 0.442 . . . . 0.0 111.983 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.418 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 2.3 m-20 -60.41 112.47 1.97 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.974 176.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -92.66 175.54 6.78 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.032 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.556 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 64.2 t30 -149.46 122.34 8.74 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -168.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.4 94.87 5.32 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 163.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -96.23 -178.53 4.35 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.005 -174.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 25.5 m -58.66 -33.06 69.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.871 0.367 . . . . 0.0 111.647 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -82.03 -5.8 89.41 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.146 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 67.47 42.46 89.04 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.114 -176.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -116.62 132.27 56.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.78 0.79 . . . . 0.0 111.343 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.556 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.5 OUTLIER -135.06 102.58 3.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.945 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.58 ' OG1' HG21 ' A' ' 250' ' ' THR . 95.3 m -107.66 113.89 27.49 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.774 -0.579 . . . . 0.0 110.533 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 27.5 m -143.06 157.6 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-O 121.545 0.688 . . . . 0.0 110.698 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 26.3 m -109.02 148.24 31.08 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.224 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.562 HD23 ' N ' ' A' ' 313' ' ' LEU . 0.8 OUTLIER -112.23 135.01 53.43 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.237 -176.145 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 41.5 m . . . . . 0 C--N 1.316 -0.875 0 C-N-CA 119.738 -0.785 . . . . 0.0 112.621 -171.794 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.761 0.315 . . . . 0.0 110.964 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -115.41 152.14 33.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.566 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -90.61 126.04 35.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.24 -175.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 230' ' ' VAL . . . 129.38 13.13 2.39 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.083 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.548 ' CA ' ' HB2' ' A' ' 272' ' ' ASN . 3.0 m-20 -49.03 134.65 16.97 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.92 105.67 3.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.302 168.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.575 ' HA ' ' HB3' ' A' ' 270' ' ' PHE . 75.7 t -95.04 139.16 19.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.399 0.619 . . . . 0.0 111.888 -173.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 41.2 m -147.82 157.28 43.46 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.059 172.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 20.8 t -87.76 151.24 3.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.566 -176.01 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.514 0 N-CA-C 112.719 -0.153 . . . . 0.0 112.719 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 8.3 m -79.15 140.03 37.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.811 0.338 . . . . 0.0 110.493 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.485 HD21 ' HA3' ' A' ' 253' ' ' GLY . 1.8 mp -132.7 177.41 7.64 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 252' ' ' THR . 82.0 m -128.75 159.95 34.06 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.636 0.255 . . . . 0.0 110.853 -174.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 41.8 t -110.05 138.39 38.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 43.3 tttm -111.34 -34.62 6.08 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.388 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 76.3 p -119.91 -169.46 1.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.523 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -112.37 120.8 40.62 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 120.512 0.196 . . . . 0.0 111.235 -167.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.657 ' HB3' ' CD1' ' A' ' 247' ' ' PHE . 88.9 Cg_exo -51.1 102.68 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.172 2.581 . . . . 0.0 113.313 175.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.54 ' O ' HG21 ' A' ' 236' ' ' VAL . 8.7 t -158.38 113.98 2.67 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 174.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.54 HG21 ' O ' ' A' ' 235' ' ' THR . 7.9 t -154.01 125.05 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 120.915 0.388 . . . . 0.0 110.889 169.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 26.5 m 48.15 89.53 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 123.82 0.848 . . . . 0.0 111.906 177.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -99.05 89.09 4.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.332 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -111.07 114.91 28.54 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 175.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -94.78 -50.39 5.17 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -168.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 49.0 t -65.45 -23.27 32.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.306 0.574 . . . . 0.0 110.129 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -96.02 -8.43 33.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.231 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 14.9 t70 55.41 69.61 0.72 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.955 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 17.8 m -145.2 105.11 4.02 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.819 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -129.84 122.43 28.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.847 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . 0.426 ' HB2' HG11 ' A' ' 236' ' ' VAL . 0.3 OUTLIER -120.73 -176.9 3.34 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 172.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.657 ' CD1' ' HB3' ' A' ' 234' ' ' PRO . 1.2 p90 -166.41 126.81 1.66 Allowed 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 119.969 -0.692 . . . . 0.0 112.793 174.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 37.2 m -99.75 131.25 45.85 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.405 HG21 ' HA ' ' A' ' 234' ' ' PRO . 19.4 t -138.67 141.9 35.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 119.609 -0.836 . . . . 0.0 112.111 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.431 HG21 ' OG1' ' A' ' 310' ' ' THR . 98.3 m -94.08 115.83 28.19 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 309' ' ' VAL . 5.2 mp -104.18 166.27 10.51 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -177.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.484 ' O ' ' HB ' ' A' ' 229' ' ' THR . 0.7 OUTLIER -134.88 99.81 4.41 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.802 0.334 . . . . 0.0 111.34 -176.203 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.485 ' HA3' HD21 ' A' ' 228' ' ' LEU . . . -137.59 140.26 11.14 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.304 -0.719 . . . . 0.0 111.304 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -110.93 92.75 4.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.092 0.472 . . . . 0.0 112.081 -172.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 38.7 m -125.82 106.77 9.92 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.273 171.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 305' ' ' SER . . . -63.16 141.47 58.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -175.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 6.0 t 61.72 53.32 3.24 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.92 171.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 49.0 t -137.45 103.84 2.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.164 0.507 . . . . 0.0 110.009 174.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 36.2 m -79.11 87.75 4.86 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.401 0.619 . . . . 0.0 110.299 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.562 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 94.4 92.98 1.64 Allowed Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.384 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.745 ' CE1' ' HB3' ' A' ' 303' ' ' SER . 3.0 m-85 -45.2 -59.26 2.73 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.324 0.583 . . . . 0.0 111.557 172.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.484 HD12 ' HB2' ' A' ' 266' ' ' ASP . 2.8 tm? -166.8 140.51 3.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.679 -166.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -125.94 -171.2 2.33 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -51.89 131.49 31.06 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.084 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 122.32 -32.23 4.59 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.513 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . 0.484 ' HB2' HD12 ' A' ' 262' ' ' LEU . 9.5 m-20 -108.07 154.49 21.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.005 0.431 . . . . 0.0 110.449 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' GLN . . . . . 0.411 ' HB2' HG12 ' A' ' 342' ' ' VAL . 10.7 mt-30 -115.04 161.97 17.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.43 0.633 . . . . 0.0 111.44 -173.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 295' ' ' ALA . 0.4 OUTLIER -126.18 -175.46 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.205 178.297 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.463 ' HD2' ' C ' ' A' ' 269' ' ' LYS . 2.5 tmmm? -148.54 134.71 19.31 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -146.66 148.1 31.7 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 118.779 -1.169 . . . . 0.0 112.258 176.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 81.0 p -95.83 111.44 23.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.569 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.478 ' HA ' ' OD1' ' A' ' 337' ' ' ASP . 25.7 p-10 . . . . . 0 C--N 1.323 -0.58 0 CA-C-O 121.027 0.442 . . . . 0.0 110.877 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 32.2 m . . . . . 0 N--CA 1.448 -0.574 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -161.05 162.29 31.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.472 0.653 . . . . 0.0 111.443 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 98.1 m -88.86 127.15 35.62 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.607 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . 0.451 ' HB2' HG22 ' A' ' 268' ' ' VAL . . . -108.47 175.91 5.3 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 45.0 m -135.32 123.35 22.77 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.553 HG12 HG23 ' A' ' 311' ' ' VAL . 91.0 t -77.72 124.97 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.872 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 312' ' ' THR . 15.0 t -132.77 17.95 4.24 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.303 -170.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.401 ' HB3' HG21 ' A' ' 311' ' ' VAL . . . -152.78 -173.32 4.53 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.146 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -70.94 139.68 50.73 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.186 0.517 . . . . 0.0 109.717 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.562 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -136.17 167.6 20.96 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.742 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -140.25 157.6 45.32 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.091 -177.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.745 ' HB3' ' CE1' ' A' ' 261' ' ' PHE . 0.0 OUTLIER -139.18 96.01 3.04 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.422 174.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -108.7 153.65 23.14 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 171.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' SER . . . . . 0.417 ' HB3' ' HB1' ' A' ' 256' ' ' ALA . 0.1 OUTLIER -68.65 -7.61 34.79 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -171.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -75.31 -4.68 74.67 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 175.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 86.46 42.85 6.38 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.933 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -125.21 137.05 54.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.69 0.745 . . . . 0.0 112.119 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 251' ' ' LEU . 1.2 p -154.97 106.33 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.175 174.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.431 ' OG1' HG21 ' A' ' 250' ' ' THR . 54.5 m -106.44 130.28 54.27 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 121.16 -0.962 . . . . 0.0 111.431 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.553 HG23 HG12 ' A' ' 297' ' ' VAL . 7.1 p -159.55 147.43 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.131 0.491 . . . . 0.0 110.549 174.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 52.8 m -86.31 150.1 24.58 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.06 174.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.512 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.2 mp -126.05 164.83 19.99 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.284 -177.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.754 179.57 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 6.8 p . . . . . 0 CA--C 1.533 0.299 0 CA-C-O 120.569 0.224 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -118.59 144.41 46.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.685 -174.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -100.58 151.98 20.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.401 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 112.45 12.08 14.0 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.391 173.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.478 ' OD1' ' HA ' ' A' ' 272' ' ' ASN . 10.8 m-20 -71.73 168.92 16.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.056 0.455 . . . . 0.0 111.463 -177.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -98.97 122.36 42.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.535 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 49.6 t -100.79 145.36 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.248 0.547 . . . . 0.0 111.773 -172.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 53.7 m -151.22 179.07 8.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.186 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 29.6 t -111.96 143.69 21.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.411 HG12 ' HB2' ' A' ' 267' ' ' GLN . 9.7 p . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 120.976 0.417 . . . . 0.0 110.88 -175.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 112.857 -0.097 . . . . 0.0 112.857 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 87.2 m -129.38 131.28 46.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 2.4 mp -136.87 -178.36 5.16 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 60.9 m -128.4 153.78 46.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.765 0.317 . . . . 0.0 111.532 -171.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.458 ' CG2' HG22 ' A' ' 339' ' ' VAL . 22.0 t -110.53 133.0 57.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.487 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -125.22 12.09 8.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.824 0.345 . . . . 0.0 111.591 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.4 p -144.61 -172.0 3.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.596 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.706 ' OE1' ' HB3' ' A' ' 335' ' ' ALA . 1.3 mm100 -114.03 134.39 22.17 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -174.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.479 ' HB3' ' CG ' ' A' ' 247' ' ' PHE . 28.4 Cg_exo -61.95 104.97 0.35 Allowed 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.224 1.95 . . . . 0.0 111.454 173.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.42 ' O ' HG22 ' A' ' 236' ' ' VAL . 5.8 t -156.02 103.86 2.24 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.607 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.75 173.41 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.139 0.575 . . . . 0.0 110.561 170.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' THR . . . . . 0.464 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 45.5 m -23.13 115.76 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.467 1.507 . . . . 0.0 114.521 -174.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -111.91 83.58 1.81 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.759 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.475 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 4.5 t30 -103.34 99.65 9.5 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -175.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -86.5 -47.94 8.83 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -163.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 37.7 t -65.88 -23.26 31.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.7 0.762 . . . . 0.0 109.313 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.475 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 28.0 mmmt -93.75 -7.47 43.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.16 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 54.83 58.98 4.35 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.424 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 19.8 m -136.83 102.86 5.01 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.62 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -120.73 116.62 25.62 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . 0.427 ' HG2' ' HA ' ' A' ' 314' ' ' SER . 22.5 mt-30 -133.61 158.74 42.43 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 177.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.607 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 3.6 p90 -140.83 138.66 34.17 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.101 172.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.519 ' OG1' HG21 ' A' ' 236' ' ' VAL . 54.3 m -97.25 135.89 38.54 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 42.3 t -142.43 141.61 27.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.715 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.472 HG22 ' OG1' ' A' ' 310' ' ' THR . 90.8 m -88.08 113.83 24.1 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 168.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 309' ' ' VAL . 4.9 mp -104.34 163.95 12.07 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -176.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.9 140.87 52.53 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -139.3 -143.07 4.35 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.289 -175.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -106.02 -174.51 2.55 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -174.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.565 HG21 ' H ' ' A' ' 256' ' ' ALA . 0.6 OUTLIER -71.51 -178.54 2.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.733 -172.088 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.565 ' H ' HG21 ' A' ' 255' ' ' THR . . . -62.41 -176.9 0.12 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.123 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 15.6 t 80.77 7.5 1.32 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.991 0.917 . . . . 0.0 110.559 -175.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 21.2 t -126.25 89.52 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-O 121.562 0.696 . . . . 0.0 109.216 170.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 31.2 m -74.37 99.66 3.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.426 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 67.16 94.48 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.455 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 303' ' ' SER . 8.8 m-85 -43.42 -59.32 2.18 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 111.427 174.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 266' ' ' ASP . 95.9 mt -148.49 162.68 39.13 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.503 ' HB3' ' HZ2' ' A' ' 263' ' ' LYS . 9.6 mtpm? -137.22 -167.26 2.07 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.625 0.231 . . . . 0.0 111.625 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -53.33 113.32 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.273 0.558 . . . . 0.0 111.86 -175.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 109.93 -17.74 29.57 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.553 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 30.2 m-20 -77.52 144.81 37.38 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' GLN . . . . . 0.465 ' HB2' HG12 ' A' ' 342' ' ' VAL . 35.4 mt-30 -111.98 154.57 25.1 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.619 0.723 . . . . 0.0 111.192 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.411 HG23 ' HB3' ' A' ' 295' ' ' ALA . 0.0 OUTLIER -121.98 -176.65 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.623 178.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.5 ' HA ' ' HD3' ' A' ' 269' ' ' LYS . 16.8 tppt? -125.29 89.02 2.98 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.719 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . 0.453 ' HB3' ' CE1' ' A' ' 293' ' ' PHE . 6.8 t80 -81.73 128.33 33.87 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -171.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 85.7 m -119.25 87.4 2.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.046 0.45 . . . . 0.0 109.855 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.469 ' HA ' ' HB2' ' A' ' 337' ' ' ASP . 22.6 t-20 . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.222 -175.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 120.922 0.391 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . 0.453 ' CE1' ' HB3' ' A' ' 270' ' ' PHE . 13.0 p90 -140.69 161.0 38.81 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 46.4 m -88.48 111.41 21.79 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.831 0.348 . . . . 0.0 110.551 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . 0.411 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -97.6 -178.16 4.04 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 313' ' ' LEU . 93.2 m -136.96 131.85 33.56 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -174.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.448 HG12 HG22 ' A' ' 311' ' ' VAL . 67.3 t -78.5 131.49 34.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.703 174.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.463 HG21 ' O ' ' A' ' 312' ' ' THR . 6.9 t -111.41 2.35 17.5 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.757 -0.777 . . . . 0.0 112.723 -167.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -170.55 -166.49 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.776 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.92 144.54 27.89 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.508 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -137.59 173.58 11.51 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.854 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.646 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 6.9 t30 -146.34 128.7 15.86 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -169.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.437 ' HB2' ' HB ' ' A' ' 258' ' ' VAL . 0.3 OUTLIER -117.87 95.12 4.78 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 165.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . 0.498 ' HB3' HD22 ' A' ' 302' ' ' ASN . 4.6 p-10 -104.04 -177.21 3.3 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.925 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 39.1 m -60.88 -30.98 70.48 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.708 0.289 . . . . 0.0 111.425 -177.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -77.61 0.94 68.54 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.207 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 56.32 41.58 87.52 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.408 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -116.38 127.89 55.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.696 0.748 . . . . 0.0 111.005 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.646 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.4 OUTLIER -135.34 104.45 4.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.344 -179.398 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.472 ' OG1' HG22 ' A' ' 250' ' ' THR . 94.6 m -105.35 121.09 43.16 Favored 'General case' 0 C--N 1.316 -0.858 0 O-C-N 121.865 -0.522 . . . . 0.0 110.776 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.448 HG22 HG12 ' A' ' 297' ' ' VAL . 7.7 p -157.65 150.26 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 121.089 0.471 . . . . 0.0 110.006 176.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 58.1 m -85.54 151.95 23.54 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.265 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.556 ' HA ' ' O ' ' A' ' 296' ' ' THR . 5.9 mp -114.53 135.47 54.09 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.747 -177.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' SER . . . . . 0.427 ' HA ' ' HG2' ' A' ' 246' ' ' GLN . 14.1 p . . . . . 0 C--N 1.324 -0.505 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -174.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 13.2 t . . . . . 0 CA--C 1.537 0.471 0 CA-C-O 121.012 0.434 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -97.25 144.54 26.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.493 -165.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.706 ' HB3' ' OE1' ' A' ' 233' ' ' GLN . . . -98.84 172.24 7.56 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.878 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 96.71 9.92 55.9 Favored Glycine 0 CA--C 1.511 -0.205 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.086 171.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.469 ' HB2' ' HA ' ' A' ' 272' ' ' ASN . 12.5 p-10 -88.43 -176.11 5.21 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.831 0.348 . . . . 0.0 110.854 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -120.16 145.76 46.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.438 0.637 . . . . 0.0 111.803 -171.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 79.4 t -108.63 150.23 11.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.973 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.488 ' HB2' ' HB3' ' A' ' 269' ' ' LYS . 69.3 m -144.89 176.7 9.27 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 174.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 44.6 t -117.94 140.39 41.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' A' ' 267' ' ' GLN . 5.3 p . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.83 0.348 . . . . 0.0 110.692 -175.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.412 0 N-CA-C 112.341 -0.304 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 19.3 m -75.04 143.86 43.29 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.958 0.408 . . . . 0.0 111.031 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.1 mp -135.21 -178.74 5.24 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 70.8 m -130.24 150.43 51.49 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.885 0.374 . . . . 0.0 111.894 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.81 106.68 19.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -93.09 -16.92 24.42 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.972 0.415 . . . . 0.0 111.207 -173.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 32.1 p -130.84 -169.15 2.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.757 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.426 ' HB3' HG21 ' A' ' 333' ' ' VAL . 70.6 mt-30 -105.61 120.49 49.15 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.048 -170.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.485 ' HA ' HG22 ' A' ' 249' ' ' VAL . 15.0 Cg_exo -66.5 105.61 0.93 Allowed 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.378 2.052 . . . . 0.0 111.618 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 8.0 t -154.67 121.84 5.61 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.587 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -155.14 174.02 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 166.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' THR . . . . . 0.488 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 62.9 m -23.78 110.07 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.88 1.272 . . . . 0.0 114.226 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -103.69 108.87 20.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.487 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.417 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 5.3 t30 -122.79 94.82 4.4 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -83.45 -50.12 8.62 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.08 -162.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 40.3 t -62.49 -23.1 31.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.662 0.744 . . . . 0.0 109.688 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.417 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 13.9 mmmm -96.18 -7.44 35.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.033 -178.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 60.28 57.5 2.89 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.684 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 11.7 t -139.95 112.9 8.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.907 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -129.52 110.12 11.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.591 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . 0.463 ' HB2' HG13 ' A' ' 236' ' ' VAL . 0.7 OUTLIER -114.65 165.93 12.26 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 173.618 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.587 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 1.7 p90 -157.65 125.98 5.53 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 51.9 m -94.17 133.07 38.07 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.485 HG22 ' HA ' ' A' ' 234' ' ' PRO . 0.8 OUTLIER -141.12 142.92 28.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 119.182 -1.007 . . . . 0.0 112.231 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.513 HG23 ' OG1' ' A' ' 310' ' ' THR . 21.9 m -93.79 111.97 23.75 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 165.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.542 ' HB2' ' O ' ' A' ' 309' ' ' VAL . 5.2 mp -102.92 167.81 9.61 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -176.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.24 140.51 51.07 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -141.64 -143.1 4.19 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.329 -174.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -109.42 -173.93 2.38 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -174.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.562 HG22 ' H ' ' A' ' 256' ' ' ALA . 3.3 m -66.58 174.76 2.64 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.369 -172.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.562 ' H ' HG22 ' A' ' 255' ' ' THR . . . -59.52 -175.38 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.047 0.939 . . . . 0.0 113.012 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 69.8 m 81.18 10.88 0.87 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.992 0.917 . . . . 0.0 111.556 -177.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 22.3 t -128.73 89.79 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 167.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 7.2 m -71.72 97.17 1.71 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.384 -177.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 69.01 98.89 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.021 -172.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -44.34 -60.25 2.02 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 117.108 0.454 . . . . 0.0 110.933 172.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.504 ' HB3' ' CB ' ' A' ' 266' ' ' ASP . 94.4 mt -148.21 166.08 29.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.545 -174.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 97.6 mttt -141.36 -166.68 2.24 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -52.04 113.6 1.06 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.362 0.601 . . . . 0.0 112.058 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 110.92 -17.31 27.44 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.054 177.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . 0.504 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 18.0 m-20 -82.58 146.15 29.33 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.42 145.55 45.13 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.607 0.718 . . . . 0.0 111.641 -174.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.441 HG23 ' HB2' ' A' ' 295' ' ' ALA . 0.2 OUTLIER -121.75 -178.97 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.038 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.51 ' HD3' ' C ' ' A' ' 269' ' ' LYS . 1.0 OUTLIER -126.77 139.36 53.18 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . 0.499 ' CE1' ' HB3' ' A' ' 295' ' ' ALA . 8.1 p90 -146.48 157.46 43.75 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.644 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.539 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 5.6 t -137.38 95.89 3.16 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.955 176.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.42 ' HA ' ' CG ' ' A' ' 337' ' ' ASP . 4.0 m120 . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.551 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 25.9 p . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -165.34 -171.05 2.04 Favored 'General case' 0 C--O 1.23 0.079 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.912 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 91.3 m -88.76 134.65 33.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.914 -173.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . 0.499 ' HB3' ' CE1' ' A' ' 270' ' ' PHE . . . -117.5 176.0 5.37 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 54.5 m -130.82 125.44 33.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.597 0.713 . . . . 0.0 112.877 -176.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.495 HG13 HG22 ' A' ' 311' ' ' VAL . 60.7 t -75.33 130.5 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.714 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 3.5 m -115.78 -1.59 12.6 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.276 -169.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -160.13 -166.33 1.67 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.085 -0.384 . . . . 0.0 111.138 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.412 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 3.3 m-20 -66.32 157.62 31.25 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.468 0.651 . . . . 0.0 110.229 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.444 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -149.23 177.44 9.64 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.595 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -144.62 137.09 26.45 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.211 -0.196 . . . . 0.0 111.297 -171.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.8 OUTLIER -118.99 95.08 4.67 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 163.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.95 177.46 4.85 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.946 -174.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 11.6 t -59.58 -32.41 70.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.898 0.38 . . . . 0.0 111.004 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -78.9 4.23 62.16 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.252 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 59.94 42.33 98.22 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.631 176.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -114.55 131.1 56.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.454 0.627 . . . . 0.0 110.528 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.542 ' O ' ' HB2' ' A' ' 251' ' ' LEU . 2.1 p -132.45 95.01 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.501 0.667 . . . . 0.0 111.062 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.513 ' OG1' HG23 ' A' ' 250' ' ' THR . 76.7 m -101.42 128.41 47.63 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 122.011 -0.431 . . . . 0.0 111.827 -176.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.495 HG22 HG13 ' A' ' 297' ' ' VAL . 7.3 p -162.21 150.72 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.981 174.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 52.0 m -86.87 146.41 26.21 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.989 0.423 . . . . 0.0 110.584 177.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.469 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.4 mp -120.99 159.04 26.44 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.58 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 17.5 m . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.179 -178.507 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.426 HG21 ' HB3' ' A' ' 233' ' ' GLN . 6.1 m . . . . . 0 N--CA 1.456 -0.168 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.16 162.65 14.07 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.412 0.625 . . . . 0.0 111.627 -176.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -99.04 170.0 9.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.977 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 110.64 10.75 20.89 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.473 172.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.539 ' HB3' ' O ' ' A' ' 271' ' ' THR . 13.6 m-20 -96.27 -177.26 3.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.846 0.323 . . . . 0.0 111.778 -176.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -109.08 153.3 23.87 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -169.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 76.1 t -135.98 157.31 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.676 -175.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 5.6 t -156.97 179.73 9.02 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 172.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 69.2 t -115.88 133.08 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.126 0.489 . . . . 0.0 111.946 -175.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 71.8 t . . . . . 0 CA--C 1.529 0.171 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.887 176.114 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.547 0 N-CA-C 111.859 -0.497 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 10.3 m -135.38 136.01 41.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.782 0.325 . . . . 0.0 110.378 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.511 HD21 ' CE1' ' A' ' 261' ' ' PHE . 8.2 mt -147.88 174.68 11.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.267 -177.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 57.2 m -134.59 161.98 33.57 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 12.2 t -116.11 139.61 41.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.425 ' HD2' ' CG2' ' A' ' 252' ' ' THR . 38.0 tttt -120.17 -1.58 10.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.044 0.45 . . . . 0.0 111.117 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.452 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 19.8 p -139.33 -168.23 2.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.932 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -113.67 102.52 54.89 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -174.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 248' ' ' THR . 35.9 Cg_endo -66.99 105.72 1.02 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.216 1.944 . . . . 0.0 112.176 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.435 ' O ' ' HB2' ' A' ' 247' ' ' PHE . 12.0 t -113.03 144.51 42.48 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.319 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.468 ' HA ' ' HB3' ' A' ' 247' ' ' PHE . 28.9 t -80.81 122.99 36.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.03 -171.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 94.0 m -97.95 124.59 42.47 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.104 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -93.77 124.1 37.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.188 0.518 . . . . 0.0 110.987 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.46 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 20.5 t30 -127.04 70.85 1.3 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -86.06 -28.38 24.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.757 -161.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.46 -22.97 30.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 172.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.46 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 19.6 mmtp -101.05 -0.72 35.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.135 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 23.1 t70 50.82 52.66 14.49 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 113.999 -1.455 . . . . 0.0 111.3 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 24.2 m -140.25 128.96 23.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.423 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -109.47 110.84 22.07 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -118.37 176.65 5.14 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.111 -174.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.468 ' HB3' ' HA ' ' A' ' 236' ' ' VAL . 15.7 p90 -160.58 148.87 16.41 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.366 171.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 55.4 m -112.11 145.07 40.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.786 -168.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 9.9 p -154.08 142.8 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.452 ' HB ' ' CG2' ' A' ' 232' ' ' THR . 19.2 m -103.93 109.93 21.87 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 166.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.69 171.33 7.42 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.287 0.565 . . . . 0.0 109.695 -175.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.425 ' CG2' ' HD2' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -125.77 139.14 53.76 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.066 175.01 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -136.08 -143.72 4.73 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.025 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.521 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -101.75 -174.58 2.62 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.607 HG23 ' H ' ' A' ' 256' ' ' ALA . 2.1 m -73.69 -178.2 3.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.426 -173.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.607 ' H ' HG23 ' A' ' 255' ' ' THR . . . -59.19 -177.19 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.697 0.799 . . . . 0.0 112.868 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' SER . . . . . 0.426 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 33.8 t 80.89 7.63 1.26 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.077 0.951 . . . . 0.0 111.109 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.516 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 59.1 t -128.01 89.7 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 121.538 0.685 . . . . 0.0 109.512 171.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 87.0 m -76.94 98.75 5.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.48 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 68.23 89.64 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.493 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.511 ' CE1' HD21 ' A' ' 228' ' ' LEU . 8.2 m-85 -46.12 -59.58 2.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.538 0.685 . . . . 0.0 109.897 170.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.49 HD23 ' HB3' ' A' ' 261' ' ' PHE . 1.4 mm? -123.31 156.21 35.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.286 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -132.81 -167.6 1.93 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 171.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -54.41 114.23 1.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.212 0.53 . . . . 0.0 111.386 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 106.57 -12.86 42.93 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.527 175.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . 0.441 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 8.7 m-20 -78.32 136.67 37.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.827 0.346 . . . . 0.0 110.32 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -110.95 141.69 44.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.715 0.769 . . . . 0.0 112.133 -171.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 2.4 m -118.58 169.94 8.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.43 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.32 135.11 19.96 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . 0.459 ' CB ' ' HA ' ' A' ' 339' ' ' VAL . 31.0 p90 -147.03 159.96 42.95 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.06 -1.056 . . . . 0.0 112.664 -173.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.506 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 82.7 p -99.69 96.06 7.36 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.943 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 . . . . . 0 C--N 1.323 -0.545 0 CA-C-O 121.372 0.606 . . . . 0.0 110.877 -176.289 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 C--O 1.234 0.251 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -134.56 145.3 48.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.032 0.444 . . . . 0.0 110.328 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 91.2 m -90.32 131.17 36.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.157 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -123.19 173.95 7.57 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.403 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 90.2 m -134.4 128.23 33.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.277 0.56 . . . . 0.0 112.456 -175.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.534 HG13 ' H ' ' A' ' 299' ' ' ALA . 40.2 t -86.42 139.6 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.812 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 15.0 t -111.5 11.44 21.35 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.534 ' H ' HG13 ' A' ' 297' ' ' VAL . . . -153.23 177.56 10.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.847 0.356 . . . . 0.0 111.504 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.95 114.55 6.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.3 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.438 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -93.33 100.1 12.5 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.893 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.709 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 13.6 m120 -68.15 126.85 30.83 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -171.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.516 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 18.8 t -104.75 94.82 5.49 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 161.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.1 178.31 5.58 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.718 -175.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 6.3 t -61.18 -33.63 73.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.815 0.341 . . . . 0.0 111.198 -176.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -82.44 7.19 65.48 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.08 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 61.38 42.35 99.75 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.099 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -117.79 134.54 54.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 117.232 0.516 . . . . 0.0 111.082 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.709 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.1 OUTLIER -141.13 106.03 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.957 -178.003 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.446 ' OG1' HG23 ' A' ' 250' ' ' THR . 47.0 m -112.7 122.8 48.73 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.695 -0.628 . . . . 0.0 110.837 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 17.6 m -147.73 161.55 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-O 121.227 0.537 . . . . 0.0 110.895 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 15.5 m -113.73 138.24 50.51 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.478 172.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 4.8 mp -103.26 149.28 24.86 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.609 -175.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--N 1.319 -0.726 0 CA-C-O 121.05 0.452 . . . . 0.0 111.845 -173.561 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 18.7 m . . . . . 0 C--O 1.234 0.254 0 CA-C-O 121.171 0.51 . . . . 0.0 111.902 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -123.87 147.04 47.98 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.798 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -69.14 139.31 54.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.841 -0.163 . . . . 0.0 111.111 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.63 -2.1 6.48 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.932 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 271' ' ' THR . 7.3 p-10 -75.66 168.66 19.6 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.256 0.55 . . . . 0.0 111.292 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -104.36 131.11 52.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.516 -171.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.459 ' HA ' ' CB ' ' A' ' 270' ' ' PHE . 73.8 t -108.44 146.9 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.131 -176.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -143.98 165.09 28.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.277 173.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 48.3 t -109.41 142.4 22.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.235 -176.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 53.2 t . . . . . 0 C--N 1.331 -0.221 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 175.334 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 112.208 -0.357 . . . . 0.0 112.208 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 41.5 m -136.75 101.5 4.62 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.974 0.416 . . . . 0.0 109.948 -177.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.4 mp -119.4 176.2 5.46 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 63.9 m -138.55 158.34 44.45 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 -174.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 89.6 t -110.11 106.66 21.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 250' ' ' THR . 17.1 ptmt -93.27 -12.65 29.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.968 0.414 . . . . 0.0 111.02 -174.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.424 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 31.8 p -123.79 -166.95 1.55 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.32 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -112.6 121.06 39.71 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.145 -172.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -70.76 113.35 3.51 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.976 2.451 . . . . 0.0 111.849 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 10.1 t -147.23 109.06 4.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.782 0.801 . . . . 0.0 112.784 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.622 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.48 174.39 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 164.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' THR . . . . . 0.458 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 54.3 m -40.94 119.03 1.07 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -173.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -112.71 82.64 1.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 171.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -115.24 136.75 52.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -174.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.68 -45.12 4.29 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.566 -171.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.89 -27.94 43.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.31 0.576 . . . . 0.0 110.035 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -94.55 -7.37 41.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.832 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 56.53 61.48 2.66 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.309 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.8 t -144.43 95.62 2.74 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.575 0.702 . . . . 0.0 110.073 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -108.71 101.53 10.65 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.908 175.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . 0.485 ' HB2' HG13 ' A' ' 236' ' ' VAL . 71.6 mt-30 -130.04 156.36 44.62 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.622 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 15.6 p90 -157.47 136.88 11.99 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.588 0.232 . . . . 0.0 111.615 177.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.413 HG21 ' OG1' ' A' ' 312' ' ' THR . 32.8 m -101.02 133.5 45.42 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.419 ' HB ' ' CD1' ' A' ' 251' ' ' LEU . 0.3 OUTLIER -142.18 148.05 20.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.906 -176.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.537 HG23 ' OG1' ' A' ' 310' ' ' THR . 41.3 m -99.07 111.92 24.19 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.419 ' CD1' ' HB ' ' A' ' 249' ' ' VAL . 5.4 mp -106.15 167.83 9.54 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -172.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.41 148.63 37.42 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.839 174.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -144.94 -142.35 3.84 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -175.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.518 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -110.2 -174.19 2.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.537 HG23 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -68.59 -178.34 1.13 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.676 -170.436 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.537 ' H ' HG23 ' A' ' 255' ' ' THR . . . -67.5 -176.3 0.59 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.849 -177.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 22.7 t 81.03 7.99 1.17 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.491 0.716 . . . . 0.0 111.033 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 39.1 t -124.16 90.81 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 173.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 18.4 m -69.62 98.22 1.14 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.691 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 66.98 95.67 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.717 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -41.91 -56.43 2.75 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 172.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.3 pp -165.08 161.58 19.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.979 -0.1 . . . . 0.0 110.905 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.43 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 92.6 mttt -141.29 -165.91 2.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.722 0.296 . . . . 0.0 111.764 -175.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -49.46 117.95 2.48 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.769 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 113.84 -20.07 17.82 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.689 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -89.15 142.28 27.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.888 0.375 . . . . 0.0 110.191 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -112.02 153.25 27.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.343 0.592 . . . . 0.0 110.881 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -131.43 165.93 30.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.401 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 341' ' ' VAL . 0.0 OUTLIER -119.3 150.37 40.24 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 169.537 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -149.06 143.27 25.95 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.25 168.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.427 ' HB ' ' OG ' ' A' ' 292' ' ' SER . 3.7 t -93.69 105.02 17.09 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.143 176.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.607 ' HA ' ' OD2' ' A' ' 337' ' ' ASP . 2.8 t-20 . . . . . 0 C--N 1.32 -0.683 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.321 -174.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' SER . . . . . 0.427 ' OG ' ' HB ' ' A' ' 271' ' ' THR . 51.5 m . . . . . 0 C--O 1.233 0.236 0 CA-C-O 120.591 0.234 . . . . 0.0 110.415 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -150.04 166.74 28.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.869 0.366 . . . . 0.0 110.719 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 99.7 m -100.19 135.79 41.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.488 -173.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -126.77 177.61 6.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.185 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 87.4 m -134.26 134.69 42.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.29 0.567 . . . . 0.0 112.203 -176.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 84.4 t -93.84 144.54 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.282 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 4.2 m -131.4 25.32 4.82 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.985 0.422 . . . . 0.0 111.803 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -147.46 171.06 16.11 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.838 -0.539 . . . . 0.0 112.157 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.43 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 28.7 m-20 -63.62 157.18 24.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.721 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.431 ' HB2' ' CG1' ' A' ' 311' ' ' VAL . . . -141.77 168.82 18.84 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.953 -175.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.495 ' OD1' ' HB3' ' A' ' 304' ' ' ASP . 28.1 t-20 -143.85 131.98 21.8 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.869 -174.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.4 ' HB2' ' HB ' ' A' ' 258' ' ' VAL . 0.5 OUTLIER -115.58 94.53 4.74 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 163.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . 0.495 ' HB3' ' OD1' ' A' ' 302' ' ' ASN . 0.8 OUTLIER -94.92 176.31 6.3 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.763 -177.117 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 15.5 m -58.22 -32.87 68.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.027 0.441 . . . . 0.0 111.533 -177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -77.42 -7.59 87.03 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.085 -178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 73.19 43.29 39.88 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.498 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -115.83 138.07 51.5 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 117.963 0.881 . . . . 0.0 111.488 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.9 OUTLIER -141.34 111.01 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.805 179.455 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.537 ' OG1' HG23 ' A' ' 250' ' ' THR . 88.9 m -100.49 122.54 43.38 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.602 -0.686 . . . . 0.0 111.01 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.431 ' CG1' ' HB2' ' A' ' 301' ' ' ALA . 9.6 m -145.0 155.72 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.545 0.688 . . . . 0.0 111.409 177.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.413 ' OG1' HG21 ' A' ' 248' ' ' THR . 20.7 m -112.3 140.19 47.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.547 177.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.51 HD11 ' CE2' ' A' ' 247' ' ' PHE . 5.1 mp -113.86 138.1 50.75 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.853 -174.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 C--N 1.32 -0.698 0 CA-C-O 120.786 0.327 . . . . 0.0 110.466 -179.764 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 18.7 m . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 121.799 0.809 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -164.44 132.25 3.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.81 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -99.41 158.05 16.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.69 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.36 -22.1 5.35 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.878 175.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.607 ' OD2' ' HA ' ' A' ' 272' ' ' ASN . 65.3 m-20 -56.34 141.14 42.88 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 117.226 0.513 . . . . 0.0 111.479 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -99.41 139.76 34.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.571 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 53.7 t -117.37 148.01 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -169.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 36.3 t -142.36 175.59 9.66 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 173.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.447 ' O ' ' HE2' ' A' ' 269' ' ' LYS . 40.0 t -118.66 146.07 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 O-C-N 122.265 -0.272 . . . . 0.0 110.602 -174.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.463 0.201 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.709 -179.364 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 112.078 -0.409 . . . . 0.0 112.078 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.8 m -94.71 134.9 36.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.916 0.388 . . . . 0.0 109.978 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 1.1 mp -134.02 176.04 8.94 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.404 ' HB ' ' OG1' ' A' ' 252' ' ' THR . 35.4 m -122.33 154.79 37.16 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.667 0.27 . . . . 0.0 110.728 -175.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.49 HG22 ' OD2' ' A' ' 337' ' ' ASP . 99.2 t -97.91 133.15 41.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.172 -177.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.452 ' HD2' HG21 ' A' ' 252' ' ' THR . 33.2 mtpt -109.37 -38.19 5.55 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 171.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.703 ' O ' HG11 ' A' ' 249' ' ' VAL . 70.9 p -141.0 160.87 39.15 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 172.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.53 ' CD ' ' HD2' ' A' ' 234' ' ' PRO . 6.0 mm100 -116.12 163.74 20.42 Favored Pre-proline 0 C--N 1.318 -0.772 0 C-N-CA 123.369 0.667 . . . . 0.0 110.075 -176.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.601 ' HB3' ' CD2' ' A' ' 247' ' ' PHE . 5.6 Cg_exo -38.47 109.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 124.824 3.683 . . . . 0.0 115.126 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.44 ' O ' HG23 ' A' ' 236' ' ' VAL . 9.0 t -155.25 92.42 1.42 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.368 0.604 . . . . 0.0 111.596 173.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.649 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -157.75 175.17 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.983 171.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' THR . . . . . 0.504 ' H ' HG11 ' A' ' 236' ' ' VAL . 60.7 m -37.28 119.14 0.67 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.811 1.244 . . . . 0.0 114.093 -171.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -108.11 83.91 1.86 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 174.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.56 115.82 28.07 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -175.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -101.18 -42.76 6.23 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -166.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.11 -24.19 33.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.624 0.726 . . . . 0.0 109.405 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -98.32 -8.89 26.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.014 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 16.1 t70 53.1 57.23 6.51 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.442 -175.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.7 m -129.47 96.94 4.41 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.1 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -115.91 109.25 17.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.659 -173.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -126.92 153.47 45.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.649 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 35.2 p90 -148.33 140.73 24.3 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.541 -0.463 . . . . 0.0 111.187 174.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 85.2 m -97.85 143.82 28.06 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 122.19 -0.319 . . . . 0.0 110.287 -178.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.703 HG11 ' O ' ' A' ' 232' ' ' THR . 41.6 t -140.64 125.14 18.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.862 177.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.539 HG21 ' OG1' ' A' ' 310' ' ' THR . 41.5 m -90.85 129.62 36.89 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 173.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.47 HD21 HG13 ' A' ' 339' ' ' VAL . 4.4 mp -120.3 165.39 14.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.585 0.707 . . . . 0.0 110.438 -176.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.452 HG21 ' HD2' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -120.75 136.98 54.73 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.375 -0.83 . . . . 0.0 108.973 169.57 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -127.58 -143.53 5.75 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.011 -176.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -112.99 -173.23 2.21 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.481 HG23 ' H ' ' A' ' 256' ' ' ALA . 1.4 m -56.5 168.82 0.51 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.581 -171.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.481 ' H ' HG23 ' A' ' 255' ' ' THR . . . -66.48 -176.77 0.49 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.294 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 10.9 t 79.6 16.76 0.83 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.009 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 45.1 t -128.96 90.45 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.784 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 172.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 23.2 m -73.68 95.82 2.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.147 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 75.43 93.8 0.16 Allowed Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.358 -0.837 . . . . 0.0 113.067 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -42.63 -56.14 3.25 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 171.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -161.79 164.82 28.64 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -140.02 -166.96 2.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -50.48 123.38 8.61 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.752 0.787 . . . . 0.0 111.903 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 109.39 -21.97 25.43 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.737 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -87.52 139.54 30.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.879 0.371 . . . . 0.0 110.16 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -111.74 143.45 42.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.159 0.504 . . . . 0.0 111.197 -175.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.2 OUTLIER -116.26 179.62 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.277 174.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.561 ' HD2' ' C ' ' A' ' 269' ' ' LYS . 3.0 tmmm? -138.35 128.57 25.84 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -116.4 157.66 24.74 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.783 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.515 ' HA ' ' OG ' ' A' ' 292' ' ' SER . 41.4 p -136.92 98.23 3.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.507 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.452 ' HA ' ' CG ' ' A' ' 337' ' ' ASP . 25.5 p-10 . . . . . 0 C--N 1.321 -0.649 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.81 -173.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' SER . . . . . 0.515 ' OG ' ' HA ' ' A' ' 271' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . 0.437 ' HB2' ' H ' ' A' ' 294' ' ' THR . 24.8 p90 -142.81 -150.47 0.31 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -172.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 35.1 m -74.93 144.97 43.0 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -168.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -126.86 159.28 34.39 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 165.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 93.1 m -122.77 119.43 30.61 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.801 -0.759 . . . . 0.0 112.381 -175.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 64.9 t -78.81 133.99 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.614 -177.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 3.4 m -129.38 24.65 5.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.307 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -151.07 166.85 29.5 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.208 0.527 . . . . 0.0 112.134 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -65.86 115.82 6.37 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.244 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.506 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -93.29 170.25 9.76 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.629 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.61 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 9.5 t30 -149.02 131.75 15.97 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.59 -171.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -113.85 95.52 5.36 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 169.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . 0.535 ' HB3' HD22 ' A' ' 302' ' ' ASN . 0.8 OUTLIER -96.35 178.52 5.34 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.007 -176.652 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 23.2 t -59.9 -34.38 73.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.938 0.399 . . . . 0.0 111.207 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -83.88 4.01 83.9 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.857 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 64.35 43.17 97.23 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.797 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -113.18 133.9 54.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 118.116 0.958 . . . . 0.0 111.634 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.61 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.1 OUTLIER -137.84 119.55 18.08 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.974 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.009 178.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.539 ' OG1' HG21 ' A' ' 250' ' ' THR . 76.6 m -120.51 126.11 49.55 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.379 -0.826 . . . . 0.0 110.979 -178.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 30.7 m -138.2 163.47 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.638 0.732 . . . . 0.0 111.485 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 31.4 m -123.25 138.58 54.6 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.1 173.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 313' ' ' LEU . 1.3 mm? -106.68 124.46 49.64 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.014 -169.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 C--N 1.325 -0.494 0 CA-C-O 121.147 0.499 . . . . 0.0 111.813 -171.689 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.506 ' HB ' ' CB ' ' A' ' 233' ' ' GLN . 14.7 m . . . . . 0 C--O 1.238 0.474 0 CA-C-O 120.67 0.271 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.93 129.8 55.43 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -163.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -100.26 115.82 30.81 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.003 -0.436 . . . . 0.0 111.975 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 129.05 12.06 2.7 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 119.554 -1.308 . . . . 0.0 114.82 170.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.49 ' OD2' HG22 ' A' ' 230' ' ' VAL . 3.9 p-10 -92.82 -148.74 0.25 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 117.548 0.674 . . . . 0.0 111.322 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -121.54 147.28 46.01 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -168.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.47 HG13 HD21 ' A' ' 251' ' ' LEU . 68.0 t -121.85 149.4 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.145 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 25.4 m -147.42 178.62 8.28 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 46.6 t -112.27 153.34 13.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 74.1 t . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 118.012 0.369 . . . . 0.0 110.52 -179.973 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.544 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 11.3 m -143.33 139.3 30.02 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.429 HD21 HG12 ' A' ' 309' ' ' VAL . 18.4 mt -142.0 176.26 9.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' A' ' 251' ' ' LEU . 8.3 t -140.5 166.39 24.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.738 0.304 . . . . 0.0 110.335 -178.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 15.1 t -117.88 134.26 62.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.4 -168.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -128.6 11.87 6.3 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.86 0.362 . . . . 0.0 111.528 176.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.425 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 17.4 p -141.06 -174.46 4.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.221 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -114.24 116.23 44.52 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -176.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.524 ' HB2' ' CD1' ' A' ' 247' ' ' PHE . 73.4 Cg_endo -78.28 106.7 2.18 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.455 2.103 . . . . 0.0 113.361 -176.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.48 ' O ' HG22 ' A' ' 236' ' ' VAL . 9.1 t -155.98 127.1 7.03 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.179 174.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.743 ' O ' ' HB2' ' A' ' 246' ' ' GLN . 47.7 t -154.35 81.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.384 0.674 . . . . 0.0 109.623 170.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 236' ' ' VAL . 33.1 m 83.14 94.89 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.939 175.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -111.67 90.22 3.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.925 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -122.91 135.86 54.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -103.64 -49.79 3.59 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.876 -170.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 75.9 t -60.36 -31.39 48.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.504 0.668 . . . . 0.0 110.071 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -91.05 -6.51 53.74 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.575 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 36.0 t70 54.55 63.98 1.97 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.435 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.7 m -143.27 99.82 3.51 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.622 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -120.78 112.92 19.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.033 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . 0.743 ' HB2' ' O ' ' A' ' 236' ' ' VAL . 69.7 mt-30 -135.48 170.33 16.12 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.666 ' HA ' ' N ' ' A' ' 236' ' ' VAL . 26.5 p90 -166.8 142.17 4.3 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 176.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 34.0 m -104.5 142.9 33.8 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.96 139.67 27.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.769 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.509 HG21 ' OG1' ' A' ' 310' ' ' THR . 53.0 m -103.61 105.45 15.69 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 170.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.522 ' HB2' HG13 ' A' ' 309' ' ' VAL . 0.4 OUTLIER -106.4 171.36 7.4 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.553 0.692 . . . . 0.0 109.651 -174.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 307' ' ' GLY . 0.0 OUTLIER -121.81 144.37 48.86 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.703 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -144.73 -142.6 3.89 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.362 -172.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.525 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -95.58 -176.8 3.86 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -172.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.519 HG23 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -81.66 -177.16 6.42 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.867 -171.342 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.519 ' H ' HG23 ' A' ' 255' ' ' THR . . . -61.7 -177.61 0.11 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.668 -177.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 95.6 p 66.9 17.89 10.57 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.086 1.354 . . . . 0.0 110.895 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.427 HG13 ' CE2' ' A' ' 261' ' ' PHE . 12.9 t -129.06 88.83 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 31.6 m -87.79 92.56 9.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.347 -177.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 86.76 86.46 1.08 Allowed Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.533 178.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.427 ' CE2' HG13 ' A' ' 258' ' ' VAL . 0.8 OUTLIER -48.63 -45.06 37.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.093 0.473 . . . . 0.0 110.04 170.405 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.477 ' HB2' ' CB ' ' A' ' 266' ' ' ASP . 2.1 pt? -162.42 168.55 21.88 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.055 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.428 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 97.2 mttt -137.78 -167.53 2.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.634 0.254 . . . . 0.0 111.584 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -56.64 118.97 5.38 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.363 0.602 . . . . 0.0 110.969 178.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 110.73 -16.49 28.5 Favored Glycine 0 C--N 1.313 -0.742 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.541 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . 0.477 ' CB ' ' HB2' ' A' ' 262' ' ' LEU . 37.0 m-20 -91.68 140.5 29.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.038 0.447 . . . . 0.0 110.09 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' GLN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 296' ' ' THR . 2.2 mp0 -95.55 168.7 10.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.552 -178.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.1 OUTLIER -126.54 171.83 14.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.514 173.079 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.487 ' HA ' ' HD2' ' A' ' 269' ' ' LYS . 16.6 tptm -134.47 89.11 2.51 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.379 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -114.2 159.81 19.7 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 119.189 -1.005 . . . . 0.0 111.098 -172.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 271' ' ' THR . 10.1 t -132.57 99.89 4.79 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.853 0.835 . . . . 0.0 110.246 -177.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.642 178.647 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 43.8 p . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -134.65 171.8 13.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.535 0.683 . . . . 0.0 112.368 -175.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 87.7 m -102.53 127.89 49.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.623 -1.172 . . . . 0.0 111.5 -172.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -127.37 -172.46 2.67 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 267' ' ' GLN . 73.7 m -134.35 135.84 42.99 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -175.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.502 HG13 ' H ' ' A' ' 299' ' ' ALA . 87.0 t -95.9 142.72 13.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.98 176.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 8.9 t -114.84 24.1 12.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.857 0.36 . . . . 0.0 111.742 -174.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.502 ' H ' HG13 ' A' ' 297' ' ' VAL . . . -160.42 170.15 21.58 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.125 0.488 . . . . 0.0 112.029 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.428 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 5.2 m-20 -62.85 111.98 2.36 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.042 177.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.476 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -92.42 114.25 26.75 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.206 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.634 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 27.3 m-80 -88.46 138.02 31.81 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -170.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 57.7 m -124.24 99.97 6.47 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.827 157.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -98.99 -175.06 2.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.447 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 49.3 m -57.21 -32.46 66.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.705 0.288 . . . . 0.0 111.758 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -79.57 2.56 72.17 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.741 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 58.17 42.25 95.18 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.284 -177.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -114.75 142.06 47.02 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 117.727 0.764 . . . . 0.0 111.259 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.634 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 1.6 p -149.3 104.13 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.74 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.509 ' OG1' HG21 ' A' ' 250' ' ' THR . 55.4 m -113.28 124.78 53.3 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 121.576 -0.703 . . . . 0.0 110.916 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 22.0 m -147.48 164.27 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.1 0.476 . . . . 0.0 110.568 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 31.4 m -116.47 145.54 43.22 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.055 0.455 . . . . 0.0 110.196 176.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.457 HD13 ' CE1' ' A' ' 247' ' ' PHE . 5.2 mp -120.99 152.18 38.87 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.093 -174.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 25.6 m . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.438 179.776 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 120.742 0.306 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -137.96 163.56 31.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.921 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -86.29 159.73 19.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.855 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 110.01 8.35 25.88 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.655 -0.783 . . . . 0.0 114.09 173.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 271' ' ' THR . 14.9 m-20 -93.77 -172.85 2.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.437 0.618 . . . . 0.0 111.713 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -115.56 149.22 38.55 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.816 -172.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.458 HG22 HD21 ' A' ' 251' ' ' LEU . 55.6 t -128.9 147.29 33.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.866 -177.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.477 ' HB2' ' HB3' ' A' ' 269' ' ' LYS . 37.3 m -137.96 178.27 7.25 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 21.1 t -118.0 147.79 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 120.942 0.401 . . . . 0.0 111.751 -171.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.408 HG11 ' O ' ' A' ' 342' ' ' VAL . 47.0 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 122.359 1.076 . . . . 0.0 108.353 173.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.658 0 CA-C-O 121.061 0.256 . . . . 0.0 113.169 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 6.1 m -82.16 144.97 30.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.915 0.388 . . . . 0.0 111.08 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.444 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.0 mp -136.14 -177.25 4.62 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 172.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 41.4 m -131.72 153.79 49.69 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.885 0.374 . . . . 0.0 110.961 -173.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 14.3 t -101.09 130.71 50.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -111.99 -28.13 8.14 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.16 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 32.8 p -123.82 -167.82 1.69 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.991 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.411 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 45.6 mt-30 -109.59 121.63 41.72 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -175.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.601 ' O ' HG13 ' A' ' 333' ' ' VAL . 14.6 Cg_exo -68.1 105.39 1.18 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.556 2.17 . . . . 0.0 111.633 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.456 ' O ' HG23 ' A' ' 236' ' ' VAL . 9.8 t -154.26 123.47 6.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.727 0.775 . . . . 0.0 112.868 -177.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.599 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 2.1 t -154.18 175.23 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 170.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' THR . . . . . 0.515 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 87.4 m -39.93 116.12 0.61 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -108.36 83.5 1.79 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 172.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -110.29 138.54 46.54 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.96 -41.5 5.17 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.588 -172.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 44.4 t -61.71 -31.62 51.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.435 0.636 . . . . 0.0 109.732 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -95.14 -5.77 43.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.667 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 30.6 t70 53.01 51.11 16.47 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.367 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 22.5 m -127.9 97.56 4.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.474 -173.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -113.69 105.36 13.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.95 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . 0.468 ' HB2' HG13 ' A' ' 236' ' ' VAL . 86.8 mt-30 -129.71 152.99 48.61 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.882 -178.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.599 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 2.8 p90 -154.8 129.8 9.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.776 0.322 . . . . 0.0 111.842 176.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 37.0 m -103.26 141.83 35.23 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.48 ' HB ' ' CD1' ' A' ' 251' ' ' LEU . 0.2 OUTLIER -142.84 146.45 21.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 119.911 -0.716 . . . . 0.0 112.129 179.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.549 HG21 ' OG1' ' A' ' 310' ' ' THR . 57.8 m -101.22 111.43 23.64 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 163.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.543 ' HB2' HG11 ' A' ' 309' ' ' VAL . 3.3 mp -114.04 168.57 9.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -172.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.7 138.56 46.93 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.74 0.305 . . . . 0.0 110.517 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -133.05 -142.74 4.88 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -175.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.475 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -106.34 -177.73 3.45 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.332 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.548 HG23 ' H ' ' A' ' 256' ' ' ALA . 0.3 OUTLIER -70.82 -177.32 1.56 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.39 -175.635 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.548 ' H ' HG23 ' A' ' 255' ' ' THR . . . -63.34 -176.65 0.16 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 122.999 0.52 . . . . 0.0 111.672 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 11.7 t 79.63 12.81 1.12 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.073 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 90.9 t -133.02 89.56 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-O 121.621 0.724 . . . . 0.0 109.565 171.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 12.4 m -79.45 97.46 6.4 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.624 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 79.78 93.45 0.37 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.744 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.667 ' CE1' ' HB2' ' A' ' 303' ' ' SER . 7.0 m-85 -53.37 -43.07 67.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.217 0.532 . . . . 0.0 110.469 169.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.474 ' HB2' ' CB ' ' A' ' 266' ' ' ASP . 4.1 pp -161.34 172.96 15.66 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.97 -176.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -129.84 -166.92 1.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.989 0.423 . . . . 0.0 111.48 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -60.93 118.19 6.4 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.193 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 109.83 -15.86 31.2 Favored Glycine 0 C--N 1.316 -0.543 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.444 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . 0.474 ' CB ' ' HB2' ' A' ' 262' ' ' LEU . 14.3 m-20 -75.29 134.88 40.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -97.96 151.78 19.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.74 0.781 . . . . 0.0 111.668 -176.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 1.7 m -125.38 172.31 13.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.795 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.16 133.17 21.36 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 169.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' A' ' 338' ' ' ALA . 47.2 p90 -143.81 167.87 21.28 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.456 -174.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.603 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 13.9 t -133.67 123.92 25.83 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.329 0.585 . . . . 0.0 111.561 -175.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.249 173.525 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' SER . . . . . 0.436 ' HB3' ' HB ' ' A' ' 271' ' ' THR . 16.0 p . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -152.26 159.7 43.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.936 0.398 . . . . 0.0 111.085 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 96.4 m -90.88 129.36 36.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.054 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -119.97 -178.66 3.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.164 -178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 96.9 m -142.63 128.41 19.35 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.476 0.655 . . . . 0.0 112.503 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 299' ' ' ALA . 39.2 t -94.41 147.54 5.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.019 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 15.1 t -110.15 17.27 21.15 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -173.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.475 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -165.95 176.95 7.41 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.422 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 4.5 m-20 -60.91 120.76 10.81 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.58 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.429 ' HA ' ' CG1' ' A' ' 311' ' ' VAL . . . -93.38 115.02 27.58 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.263 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -79.72 130.17 35.11 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -169.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.667 ' HB2' ' CE1' ' A' ' 261' ' ' PHE . 32.7 t -114.06 94.91 5.03 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 162.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -109.66 177.6 4.68 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.152 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 17.2 t -54.78 -33.17 61.08 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -77.05 6.11 44.54 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.625 -176.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 56.24 40.49 84.55 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.927 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -120.17 124.29 45.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.861 0.363 . . . . 0.0 110.544 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.543 HG11 ' HB2' ' A' ' 251' ' ' LEU . 2.6 p -125.05 94.48 2.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.643 0.735 . . . . 0.0 110.359 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.549 ' OG1' HG21 ' A' ' 250' ' ' THR . 56.7 m -102.44 117.26 34.34 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.064 -176.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.429 ' CG1' ' HA ' ' A' ' 301' ' ' ALA . 5.4 m -148.55 160.09 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.306 0.574 . . . . 0.0 110.717 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 26.5 m -110.36 141.62 43.15 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.389 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.468 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.0 mp -109.59 122.39 47.33 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.551 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 23.6 p . . . . . 0 C--N 1.316 -0.871 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.945 -170.951 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.601 HG13 ' O ' ' A' ' 234' ' ' PRO . 21.8 m . . . . . 0 N--CA 1.449 -0.504 0 CA-C-O 121.595 0.712 . . . . 0.0 112.871 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -140.12 153.89 46.83 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.649 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -91.87 141.67 28.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.653 -0.248 . . . . 0.0 111.065 -175.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 115.87 9.3 12.48 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.672 175.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.603 ' HB3' ' O ' ' A' ' 271' ' ' THR . 49.6 m-20 -87.45 -169.14 2.48 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.349 0.574 . . . . 0.0 112.215 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 270' ' ' PHE . . . -110.94 148.06 33.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.605 -174.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 54.3 t -124.12 151.74 29.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.816 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 24.0 m -150.36 163.25 38.82 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 48.8 t -117.34 138.41 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.611 0.243 . . . . 0.0 110.694 -176.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 71.3 t . . . . . 0 C--N 1.332 -0.181 0 CA-C-O 121.117 0.484 . . . . 0.0 109.953 177.39 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.613 ' O ' ' HA ' ' A' ' 340' ' ' SER . . . . . . . . 0 C--O 1.227 -0.325 0 N-CA-C 112.343 -0.303 . . . . 0.0 112.343 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 17.8 m -92.87 132.11 37.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.907 0.384 . . . . 0.0 111.536 -175.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.449 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.3 mp -138.46 -177.21 4.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 96.8 m -138.45 156.02 47.93 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.321 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.419 HG23 HG23 ' A' ' 339' ' ' VAL . 69.9 t -103.1 126.38 57.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -109.7 -11.69 14.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.048 0.452 . . . . 0.0 110.951 -173.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.5 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 36.5 p -131.22 -167.04 1.79 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.375 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.506 HE21 ' HB2' ' A' ' 335' ' ' ALA . 1.3 mp0 -111.85 115.27 51.12 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -173.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 248' ' ' THR . 65.0 Cg_endo -78.54 105.01 1.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.216 1.944 . . . . 0.0 111.975 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 15.3 t -107.42 136.13 47.73 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.34 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.475 ' HA ' ' HB3' ' A' ' 247' ' ' PHE . 39.2 t -82.58 121.74 36.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.391 0.615 . . . . 0.0 111.788 -175.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 52.7 m -87.38 105.24 17.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.558 175.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -86.46 125.65 33.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.055 0.455 . . . . 0.0 110.801 -178.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.401 ' OD1' ' HG3' ' A' ' 242' ' ' LYS . 0.2 OUTLIER -138.75 77.68 1.64 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.476 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -83.04 -36.18 25.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.03 -163.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 39.5 t -68.15 -23.4 28.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.401 ' HG3' ' OD1' ' A' ' 239' ' ' ASN . 11.3 mmpt? -97.56 -2.8 40.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.432 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 56.18 46.14 21.97 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.119 -1.401 . . . . 0.0 112.143 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 35.3 t -132.55 125.45 30.56 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.416 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -128.88 102.17 6.41 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -130.8 159.1 38.31 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.475 ' HB3' ' HA ' ' A' ' 236' ' ' VAL . 8.1 p90 -137.58 137.54 38.64 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.873 178.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 85.2 m -105.18 143.55 33.19 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 -171.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.516 HG11 ' CD1' ' A' ' 251' ' ' LEU . 4.2 p -148.5 142.79 18.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.581 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.5 ' HB ' ' CG2' ' A' ' 232' ' ' THR . 57.4 m -99.11 126.88 44.96 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 167.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.516 ' CD1' HG11 ' A' ' 249' ' ' VAL . 4.8 mp -111.59 172.56 6.82 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.968 -173.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.52 145.74 47.65 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 169.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -145.39 -142.83 3.87 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.862 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.534 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -113.47 -174.41 2.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.853 0.358 . . . . 0.0 111.725 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.583 HG23 ' H ' ' A' ' 256' ' ' ALA . 0.7 OUTLIER -70.43 -179.82 2.21 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.561 -170.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.583 ' H ' HG23 ' A' ' 255' ' ' THR . . . -63.93 -174.93 0.12 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.678 0.791 . . . . 0.0 112.256 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 34.5 t 81.94 7.4 1.01 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.819 0.847 . . . . 0.0 111.172 -177.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 42.4 t -128.45 89.04 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.619 0 CA-C-O 121.615 0.721 . . . . 0.0 109.377 170.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 26.4 m -81.86 88.42 6.34 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.105 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 96.31 81.69 1.59 Allowed Glycine 0 N--CA 1.439 -1.115 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.347 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -47.05 -59.7 2.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.382 0.61 . . . . 0.0 110.194 168.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 300' ' ' ASP . 88.1 mt -137.65 169.63 17.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.907 -174.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -135.78 -167.64 2.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.641 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.61 114.29 3.86 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.792 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 116.06 -5.64 19.96 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.989 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -87.06 127.47 35.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.951 0.405 . . . . 0.0 110.696 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -86.84 149.36 24.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.103 0.478 . . . . 0.0 110.748 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 1.1 m -120.9 172.54 7.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.261 174.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.58 ' HD3' ' C ' ' A' ' 269' ' ' LYS . 0.7 OUTLIER -131.62 124.84 30.77 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.307 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -146.78 160.41 42.29 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.052 176.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 14.9 t -122.4 134.01 54.62 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.708 -178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.726 ' HA ' ' OD1' ' A' ' 337' ' ' ASP . 4.5 t-20 . . . . . 0 C--N 1.32 -0.711 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.805 -174.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -151.97 167.09 29.5 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.23 0.538 . . . . 0.0 111.697 -177.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 94.6 m -97.93 129.75 44.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.992 -176.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -121.95 -171.68 2.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.298 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 23.4 m -141.17 129.11 21.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.471 HG13 ' H ' ' A' ' 299' ' ' ALA . 50.4 t -86.47 138.59 18.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.678 176.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.475 HG21 ' O ' ' A' ' 312' ' ' THR . 6.0 t -112.59 14.91 20.2 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.895 0.379 . . . . 0.0 111.988 -174.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.471 ' H ' HG13 ' A' ' 297' ' ' VAL . . . -165.95 -178.56 4.77 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.849 0.357 . . . . 0.0 111.743 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.504 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 4.3 m-20 -68.13 145.87 53.97 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.514 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.466 ' HB3' HG13 ' A' ' 311' ' ' VAL . . . -121.44 127.62 51.31 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.818 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.572 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 63.7 t30 -90.06 123.17 33.7 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -171.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.544 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 8.9 t -100.73 95.09 6.42 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 163.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . 0.472 ' HB3' ' ND2' ' A' ' 302' ' ' ASN . 0.3 OUTLIER -96.64 175.03 6.53 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.888 -174.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 8.3 t -59.84 -33.34 71.64 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.698 0.285 . . . . 0.0 111.57 -176.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -80.68 -3.94 90.26 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.15 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 71.54 41.56 57.4 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.238 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -121.99 133.63 54.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.365 0.582 . . . . 0.0 111.247 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.572 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.2 OUTLIER -128.24 155.5 39.92 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.046 179.039 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.444 ' OG1' HG21 ' A' ' 250' ' ' THR . 55.1 m -147.98 125.74 11.89 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.584 -0.698 . . . . 0.0 110.932 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.466 HG13 ' HB3' ' A' ' 301' ' ' ALA . 18.7 m -148.1 159.31 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.592 0.711 . . . . 0.0 111.25 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.475 ' O ' HG21 ' A' ' 298' ' ' THR . 16.4 m -108.94 140.21 42.74 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.488 174.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 5.3 mp -105.27 122.45 45.97 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.719 -174.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 16.6 p . . . . . 0 C--N 1.319 -0.753 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.94 -176.915 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.493 ' HB ' ' HG2' ' A' ' 233' ' ' GLN . 15.5 m . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 120.805 0.336 . . . . 0.0 111.362 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 334' ' ' GLU . 0.5 OUTLIER -140.8 112.88 7.79 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.178 0.513 . . . . 0.0 111.257 179.748 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.506 ' HB2' HE21 ' A' ' 233' ' ' GLN . . . -100.66 138.85 37.16 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.93 -0.481 . . . . 0.0 112.029 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.42 -10.25 6.49 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.667 171.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.726 ' OD1' ' HA ' ' A' ' 272' ' ' ASN . 2.9 m-20 -54.33 150.75 8.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.388 0.613 . . . . 0.0 112.642 -178.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -102.41 134.93 44.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.012 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 57.8 t -114.82 147.23 18.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.32 0.581 . . . . 0.0 112.248 -169.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 226' ' ' GLY . 9.0 t -144.44 172.36 13.06 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.882 172.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 95.3 t -119.76 127.13 75.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.644 0.259 . . . . 0.0 111.655 -173.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 85.6 t . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 120.99 0.424 . . . . 0.0 110.367 175.764 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 N-CA-C 112.054 -0.418 . . . . 0.0 112.054 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 26.4 m -119.38 134.24 55.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.014 0.435 . . . . 0.0 109.964 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.488 HD21 ' CA ' ' A' ' 253' ' ' GLY . 9.7 mt -140.32 171.66 13.83 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.292 -174.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 62.6 m -136.68 165.94 24.73 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.477 ' CG2' ' HB2' ' A' ' 337' ' ' ASP . 70.9 t -117.22 132.24 67.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 O-C-N 122.078 -0.389 . . . . 0.0 110.287 176.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.407 ' HE3' HG22 ' A' ' 252' ' ' THR . 34.8 ttmt -120.62 11.88 11.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.51 0.671 . . . . 0.0 110.32 -177.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.434 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 7.5 p -139.33 -170.49 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.323 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.502 HE21 ' HA ' ' A' ' 334' ' ' GLU . 34.7 mt-30 -114.79 111.22 45.86 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -177.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.94 105.71 1.87 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.382 2.055 . . . . 0.0 113.048 -176.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 4.6 t -155.81 130.82 9.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.122 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.584 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -154.71 171.84 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 171.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' THR . . . . . 0.469 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 38.5 m -12.36 113.37 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.75 1.62 . . . . 0.0 114.798 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.469 ' HD1' ' CD2' ' A' ' 245' ' ' TYR . 95.7 m-85 -115.45 84.04 2.03 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.332 173.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -122.97 133.21 54.38 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.15 -33.47 7.84 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -170.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.94 -28.82 45.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.581 0.705 . . . . 0.0 109.512 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.453 ' HA ' ' HE2' ' A' ' 242' ' ' LYS . 8.2 mmpt? -98.44 -9.14 25.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.06 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 61.48 40.51 13.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.234 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.9 m -113.03 95.73 5.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.026 -175.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . 0.469 ' CD2' ' HD1' ' A' ' 238' ' ' TYR . 4.8 m-85 -126.93 109.66 12.18 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 176.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . 0.408 ' HB2' HG11 ' A' ' 236' ' ' VAL . 70.6 mt-30 -136.94 173.16 12.0 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.584 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 4.7 p90 -154.14 134.8 13.59 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.369 -0.533 . . . . 0.0 112.374 176.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 59.3 m -99.34 139.17 35.38 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.458 HG13 ' HG ' ' A' ' 251' ' ' LEU . 5.5 p -142.75 142.3 26.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.501 -176.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 310' ' ' THR . 38.9 m -99.36 103.97 15.82 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 166.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.458 ' HG ' HG13 ' A' ' 249' ' ' VAL . 0.4 OUTLIER -87.18 171.01 10.99 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.407 HG22 ' HE3' ' A' ' 231' ' ' LYS . 0.2 OUTLIER -128.53 141.46 51.37 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.025 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.488 ' CA ' HD21 ' A' ' 228' ' ' LEU . . . -146.76 -142.45 3.72 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.433 -174.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -106.28 -173.64 2.34 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.549 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -67.37 -179.31 1.0 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.408 -168.48 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.549 ' H ' HG22 ' A' ' 255' ' ' THR . . . -65.99 -175.33 0.3 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.352 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 49.2 m 80.2 17.31 0.68 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.908 0.883 . . . . 0.0 111.362 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 49.5 t -133.43 90.9 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 170.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 31.2 m -68.1 100.72 1.04 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.493 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 70.73 92.32 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.934 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -41.96 -59.69 1.64 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 169.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.413 ' H ' ' HB3' ' A' ' 301' ' ' ALA . 91.7 mt -146.68 163.21 36.64 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.673 0.273 . . . . 0.0 111.106 -174.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 49.4 mtmt -134.89 -167.88 2.07 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.632 177.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.58 120.78 12.4 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.353 0.597 . . . . 0.0 111.234 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 106.62 -3.95 36.82 Favored Glycine 0 C--N 1.316 -0.553 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.162 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -92.59 134.94 34.51 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -103.12 152.31 21.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.566 0.698 . . . . 0.0 111.869 -174.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.77 153.67 39.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.745 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 340' ' ' SER . 0.8 OUTLIER -86.2 94.9 9.42 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 166.576 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . 0.54 ' O ' ' HA ' ' A' ' 293' ' ' PHE . 76.7 t80 -115.15 106.94 14.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.582 -165.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 292' ' ' SER . 89.4 m -88.29 94.96 10.0 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.922 -178.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.704 ' HA ' ' OD1' ' A' ' 337' ' ' ASP . 3.0 t-20 . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 121.448 0.642 . . . . 0.0 109.521 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 271' ' ' THR . 15.0 m . . . . . 0 C--O 1.226 -0.138 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . 0.54 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 0.8 OUTLIER -162.54 86.03 0.57 Allowed 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 21.3 m -160.79 124.28 3.4 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.027 -0.42 . . . . 0.0 111.003 175.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -152.85 179.88 8.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.323 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 90.8 m -140.31 132.39 27.92 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.595 0.712 . . . . 0.0 112.304 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.406 HG11 ' H ' ' A' ' 299' ' ' ALA . 59.2 t -79.54 136.52 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 114.35 -1.296 . . . . 0.0 110.339 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 4.4 m -124.86 25.01 7.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.13 0.49 . . . . 0.0 111.086 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -166.62 178.26 6.11 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -66.96 165.88 14.69 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.563 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.573 ' HB1' ' CG1' ' A' ' 311' ' ' VAL . . . -144.87 171.27 14.67 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.82 -177.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.654 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 16.6 m120 -142.29 126.27 17.26 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 119.687 -0.197 . . . . 0.0 110.964 -173.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.7 OUTLIER -107.88 96.88 6.69 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 168.253 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.16 178.71 4.53 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.023 -176.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 10.8 t -61.76 -33.17 73.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.991 0.424 . . . . 0.0 111.044 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -81.7 1.76 85.09 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.897 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 61.51 42.01 99.68 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 121.016 -0.612 . . . . 0.0 113.704 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.83 132.67 55.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 118.06 0.93 . . . . 0.0 110.454 175.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.654 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.1 OUTLIER -138.23 109.44 5.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.807 -177.308 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 250' ' ' THR . 54.0 m -101.5 135.22 43.38 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.962 -0.461 . . . . 0.0 111.712 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.573 ' CG1' ' HB1' ' A' ' 301' ' ' ALA . 26.8 m -145.71 165.36 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 173.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 46.4 m -117.02 138.9 51.27 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 171.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 4.9 mp -112.25 141.59 45.77 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.736 -173.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.321 -0.65 0 CA-C-O 121.327 0.584 . . . . 0.0 109.851 178.385 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 C--O 1.235 0.307 0 CA-C-O 121.341 0.591 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . 0.502 ' HA ' HE21 ' A' ' 233' ' ' GLN . 0.8 OUTLIER -112.66 -166.82 1.11 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.477 176.363 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -81.56 155.11 25.88 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.041 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 129.59 -8.35 6.18 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.054 -1.07 . . . . 0.0 113.444 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.704 ' OD1' ' HA ' ' A' ' 272' ' ' ASN . 4.1 m-20 -52.12 140.62 20.41 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.978 0.389 . . . . 0.0 110.784 174.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -100.56 132.65 45.84 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.476 ' CG1' ' HB2' ' A' ' 228' ' ' LEU . 93.2 t -120.69 140.18 45.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.479 0.657 . . . . 0.0 112.029 -171.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 269' ' ' LYS . 22.7 m -141.09 167.6 21.79 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 47.8 t -116.24 140.62 37.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.693 0.282 . . . . 0.0 111.122 -175.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 76.8 t . . . . . 0 C--O 1.23 0.072 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.265 175.791 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.407 0 CA-C-O 121.023 0.235 . . . . 0.0 113.438 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 6.8 m -65.48 132.31 48.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.763 0.316 . . . . 0.0 111.246 -177.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.437 ' HB3' ' HA2' ' A' ' 253' ' ' GLY . 29.2 mt -137.16 -175.95 4.22 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -177.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 84.9 m -104.26 148.87 25.85 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -171.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 60.3 t -99.41 133.23 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.482 175.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.46 ' HE3' HG23 ' A' ' 252' ' ' THR . 22.9 mmtp -102.92 -41.29 6.19 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 121.138 -0.225 . . . . 0.0 110.906 175.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.451 ' O ' HG13 ' A' ' 249' ' ' VAL . 40.2 p -136.55 175.76 9.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.925 0.393 . . . . 0.0 110.781 177.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.504 ' HG3' ' HD2' ' A' ' 234' ' ' PRO . 0.4 OUTLIER -115.68 156.19 46.55 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.986 -170.72 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.504 ' HD2' ' HG3' ' A' ' 233' ' ' GLN . 3.9 Cg_endo -45.48 107.43 0.11 Allowed 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 124.127 3.218 . . . . 0.0 113.473 175.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 65.2 m -152.77 94.77 1.92 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.069 0.461 . . . . 0.0 111.34 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.631 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -157.85 173.97 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 123.874 0.87 . . . . 0.0 109.1 168.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' THR . . . . . 0.49 ' H ' HG11 ' A' ' 236' ' ' VAL . 27.2 m -29.8 109.16 0.05 OUTLIER 'General case' 0 C--O 1.236 0.373 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -172.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.451 ' HH ' ' HB3' ' A' ' 247' ' ' PHE . 72.2 m-85 -112.95 87.74 2.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.945 171.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -128.43 133.8 48.63 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -177.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -105.22 -42.85 5.16 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -169.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.93 -27.51 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.318 0.58 . . . . 0.0 109.963 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' A' ' 242' ' ' LYS . 27.9 mmmt -90.72 -12.63 36.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.805 178.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 60.84 66.67 0.89 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.131 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 55.6 m -150.76 99.03 2.68 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.571 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -120.13 102.21 8.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.949 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -135.42 160.25 39.03 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.631 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 27.2 p90 -148.17 139.84 23.76 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.07 174.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 53.5 m -99.81 136.7 39.33 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' ' 232' ' ' THR . 99.2 t -137.92 141.39 38.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.841 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.535 HG21 ' OG1' ' A' ' 310' ' ' THR . 84.8 m -95.87 119.26 34.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 170.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 309' ' ' VAL . 3.6 mp -115.33 163.02 16.3 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -176.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.46 HG23 ' HE3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -126.77 111.12 13.85 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 121.014 -0.275 . . . . 0.0 110.566 175.662 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.437 ' HA2' ' HB3' ' A' ' 228' ' ' LEU . . . -95.17 -147.27 22.36 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.034 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -109.46 -173.72 2.33 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.467 HG23 ' H ' ' A' ' 256' ' ' ALA . 3.1 m -58.84 167.31 1.61 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.801 -1.091 . . . . 0.0 113.476 -169.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.467 ' H ' HG23 ' A' ' 255' ' ' THR . . . -62.43 -176.56 0.11 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.819 -176.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 42.6 m 79.47 12.2 1.23 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.68 -176.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 23.8 t -125.44 94.78 2.87 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.2 m -77.3 94.2 4.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.099 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 74.02 93.15 0.13 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.491 178.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.656 ' CE1' ' HB3' ' A' ' 303' ' ' SER . 4.1 m-85 -44.4 -42.11 6.69 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 169.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 266' ' ' ASP . 1.0 OUTLIER -166.51 173.63 9.65 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.287 -173.005 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 63.8 mttm -142.65 -165.91 2.15 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.04 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -57.84 114.41 2.3 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.54 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 114.5 -16.21 19.49 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.932 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . 0.425 ' HB2' ' HB2' ' A' ' 262' ' ' LEU . 14.3 m-20 -78.83 126.42 30.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -93.29 150.01 20.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.711 0.767 . . . . 0.0 111.954 -176.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 341' ' ' VAL . 2.9 m -127.02 170.6 16.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.453 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.04 144.62 43.3 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 167.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . 0.651 ' O ' ' HA ' ' A' ' 292' ' ' SER . 56.8 m-85 -110.99 129.34 55.92 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.332 -175.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.477 ' OG1' ' HB3' ' A' ' 338' ' ' ALA . 81.3 p -95.16 88.16 5.1 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 166.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.524 ' HA ' ' CG ' ' A' ' 337' ' ' ASP . 3.2 p-10 . . . . . 0 C--N 1.319 -0.757 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.355 -170.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 71.2 m . . . . . 0 CA--C 1.53 0.19 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -155.15 145.67 22.14 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 173.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 99.0 m -91.63 123.26 34.9 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.237 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -120.61 -176.18 3.18 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 121.173 -0.211 . . . . 0.0 110.625 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 94.1 m -141.32 130.06 22.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.327 0.584 . . . . 0.0 112.287 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.433 HG12 ' H ' ' A' ' 299' ' ' ALA . 59.6 t -83.63 145.79 7.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.752 177.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 2.3 m -123.46 24.02 8.76 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -173.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -167.71 -176.94 3.29 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 178.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.57 159.0 25.61 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.38 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.506 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -139.92 166.25 25.14 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.45 -177.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.517 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 18.2 m120 -136.51 122.22 19.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -174.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.656 ' HB3' ' CE1' ' A' ' 261' ' ' PHE . 0.0 OUTLIER -108.6 94.76 5.23 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 165.013 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.96 -170.56 1.86 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.022 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 10.1 t -60.03 -33.85 72.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.359 . . . . 0.0 111.418 -175.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -98.36 0.52 58.48 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 59.99 43.17 98.42 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 114.963 0.745 . . . . 0.0 114.963 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -88.34 110.19 20.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 119.557 1.679 . . . . 0.0 109.964 176.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.517 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 1.3 p -124.11 94.71 2.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.473 0.654 . . . . 0.0 111.394 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.535 ' OG1' HG21 ' A' ' 250' ' ' THR . 92.9 m -100.65 118.38 36.67 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.109 -0.369 . . . . 0.0 110.332 177.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 9.6 m -138.6 156.47 29.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.31 0.576 . . . . 0.0 110.795 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 44.9 m -108.32 133.69 52.18 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.137 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.417 ' HB2' ' CE2' ' A' ' 247' ' ' PHE . 5.2 mp -102.24 124.69 48.28 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.432 -174.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--N 1.322 -0.628 0 CA-C-O 120.803 0.335 . . . . 0.0 111.415 -173.945 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.448 ' HB ' ' H ' ' A' ' 233' ' ' GLN . 26.9 m . . . . . 0 CA--C 1.534 0.362 0 CA-C-O 120.822 0.344 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -115.56 111.72 21.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.547 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -79.71 164.0 24.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.799 0.333 . . . . 0.0 110.963 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.87 -16.09 5.86 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.89 176.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.524 ' CG ' ' HA ' ' A' ' 272' ' ' ASN . 70.6 m-20 -81.53 -177.7 6.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.837 0.351 . . . . 0.0 111.089 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . 0.477 ' HB3' ' OG1' ' A' ' 271' ' ' THR . . . -122.77 150.02 43.34 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.316 0.579 . . . . 0.0 111.736 -176.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 53.0 t -103.04 147.53 9.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.386 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 11.6 p -156.85 151.95 26.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.018 0.437 . . . . 0.0 111.21 173.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 268' ' ' VAL . 41.0 t -108.37 147.03 13.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.238 -176.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 54.5 t . . . . . 0 C--O 1.232 0.152 0 CA-C-O 121.216 0.532 . . . . 0.0 110.044 177.432 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.602 ' C ' ' HB3' ' A' ' 340' ' ' SER . . . . . . . . 0 N--CA 1.442 -0.963 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.548 HG22 ' HB ' ' A' ' 339' ' ' VAL . 52.4 m -153.29 135.49 14.88 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.664 -0.315 . . . . 0.0 111.311 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.612 ' H ' ' HA ' ' A' ' 339' ' ' VAL . 3.2 mt -128.36 87.63 2.62 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.959 ' HA ' ' O ' ' A' ' 338' ' ' ALA . 1.2 m -83.64 133.85 34.81 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.345 -174.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.675 ' O ' ' HA2' ' A' ' 336' ' ' GLY . 39.3 t -82.68 158.52 3.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.916 -160.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.404 ' N ' HG13 ' A' ' 230' ' ' VAL . 16.8 ptmt -131.75 -12.26 3.38 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.161 175.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 335' ' ' ALA . 40.6 p -129.32 -166.97 1.72 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.475 0.31 . . . . 0.0 110.829 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 34.1 mt-30 -112.91 118.24 44.94 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -173.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 248' ' ' THR . 1.1 Cg_endo -75.44 107.58 2.51 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.88 2.387 . . . . 0.0 113.007 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 236' ' ' VAL . 19.4 m -155.39 131.07 9.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.408 177.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.601 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -154.93 175.91 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.245 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' THR . . . . . 0.485 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 98.1 m -32.84 124.74 0.35 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.18 1.392 . . . . 0.0 114.578 -173.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -104.13 108.42 19.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.631 172.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.407 HD21 ' HA ' ' A' ' 239' ' ' ASN . 0.4 OUTLIER -114.01 91.45 3.64 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.215 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -88.16 -37.74 15.91 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.773 -161.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 40.0 t -64.69 -22.88 32.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -103.7 -0.67 29.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.14 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 24.6 t70 53.7 48.82 20.65 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.051 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 14.9 m -127.2 113.14 15.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.524 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -128.44 105.97 8.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -174.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -108.28 154.11 22.26 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.601 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 4.6 p90 -149.81 124.72 9.92 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.679 177.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 78.3 m -91.7 140.6 29.56 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.405 HG13 ' CD1' ' A' ' 251' ' ' LEU . 8.2 p -139.97 136.03 38.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 C-N-CA 119.848 -0.741 . . . . 0.0 112.354 -177.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.578 HG23 ' OG1' ' A' ' 310' ' ' THR . 94.0 m -96.99 115.85 28.16 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 168.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.405 ' CD1' HG13 ' A' ' 249' ' ' VAL . 1.0 OUTLIER -113.8 171.55 7.52 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.968 0.889 . . . . 0.0 110.463 -173.108 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 307' ' ' GLY . 0.0 OUTLIER -121.21 94.13 4.24 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.094 169.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.511 ' HA3' HD23 ' A' ' 228' ' ' LEU . . . -120.52 135.12 10.7 Favored Glycine 0 CA--C 1.505 -0.58 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.705 -176.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -115.6 93.42 4.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -165.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 93.5 m -128.23 103.91 7.45 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.119 165.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.579 ' HA ' ' CB ' ' A' ' 305' ' ' SER . . . -50.57 130.69 24.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 35.9 m 57.76 58.56 3.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.64 -1.164 . . . . 0.0 113.108 168.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.427 ' HB ' ' OG ' ' A' ' 303' ' ' SER . 60.2 t -140.2 101.29 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-O 121.022 0.439 . . . . 0.0 110.249 174.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 33.6 m -71.44 86.99 0.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.407 0.623 . . . . 0.0 109.855 177.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 78.81 111.44 0.21 Allowed Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.569 -174.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.705 ' CE2' ' HB3' ' A' ' 303' ' ' SER . 57.3 m-85 -49.91 -61.27 2.23 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 121.85 0.833 . . . . 0.0 109.168 173.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 261' ' ' PHE . 73.6 mt -167.38 -179.93 4.7 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.336 -1.756 . . . . 0.0 106.603 -175.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -108.92 -169.8 1.55 Allowed 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -35.37 114.97 0.27 Allowed 'General case' 0 N--CA 1.464 0.238 0 O-C-N 124.181 0.925 . . . . 0.0 112.516 -177.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 131.92 -14.0 5.23 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.123 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . 0.487 ' OD1' ' HB2' ' A' ' 262' ' ' LEU . 80.8 m-20 -64.05 146.69 53.72 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 120.758 0.314 . . . . 0.0 110.207 175.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.14 174.49 6.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.447 -174.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.905 ' HA ' ' N ' ' A' ' 341' ' ' VAL . 34.8 m -151.89 142.63 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.805 -175.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.698 ' N ' HG22 ' A' ' 341' ' ' VAL . 0.0 OUTLIER -77.6 97.76 5.19 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 157.139 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . 0.491 ' HA ' ' HB1' ' A' ' 338' ' ' ALA . 14.2 t80 -78.75 86.58 4.69 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.67 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 53.7 m -78.9 107.68 11.81 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 C--N 1.319 -0.726 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.237 -178.908 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -141.67 144.0 33.89 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 88.6 m -85.21 125.94 33.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.71 0.291 . . . . 0.0 111.503 -172.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -119.38 -179.5 3.88 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 84.9 m -136.14 138.15 41.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.428 0.632 . . . . 0.0 112.531 -174.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.513 HG13 ' H ' ' A' ' 299' ' ' ALA . 48.9 t -93.66 139.3 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.228 179.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 8.4 t -109.93 24.1 13.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.044 0.449 . . . . 0.0 111.5 -175.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.513 ' H ' HG13 ' A' ' 297' ' ' VAL . . . -156.69 174.99 14.65 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.177 0.513 . . . . 0.0 112.087 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.97 113.13 2.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.709 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.445 ' HA ' ' CG1' ' A' ' 311' ' ' VAL . . . -93.18 106.86 18.77 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.059 -176.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.525 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 65.4 t30 -69.63 147.08 51.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.818 0.342 . . . . 0.0 111.532 -177.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.705 ' HB3' ' CE2' ' A' ' 261' ' ' PHE . 2.5 p -142.01 95.98 2.89 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.151 0.501 . . . . 0.0 110.517 171.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.58 151.87 21.83 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 172.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' SER . . . . . 0.579 ' CB ' ' HA ' ' A' ' 256' ' ' ALA . 0.3 OUTLIER -70.77 -12.31 61.47 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -171.639 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -71.16 -11.62 70.99 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 169.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 252' ' ' THR . . . 75.77 41.36 28.86 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.784 -0.708 . . . . 0.0 113.869 174.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -125.55 111.18 14.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.034 0.917 . . . . 0.0 111.602 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.525 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.6 OUTLIER -132.59 138.79 51.32 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.103 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.578 ' OG1' HG23 ' A' ' 250' ' ' THR . 94.7 m -123.17 126.34 46.82 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.129 -0.357 . . . . 0.0 110.305 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.445 ' CG1' ' HA ' ' A' ' 301' ' ' ALA . 15.4 m -146.47 164.89 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.944 0.402 . . . . 0.0 110.156 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 56.8 m -114.3 139.43 49.44 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.128 0.489 . . . . 0.0 110.573 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 4.8 mp -105.28 150.34 25.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.853 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 34.1 t . . . . . 0 C--N 1.323 -0.548 0 CA-C-O 121.16 0.505 . . . . 0.0 112.047 -174.65 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.453 ' CG1' ' HD2' ' A' ' 234' ' ' PRO . 23.5 t . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.785 0.326 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.66 129.25 34.31 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -168.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 232' ' ' THR . . . -99.59 114.26 27.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.901 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . 0.675 ' HA2' ' O ' ' A' ' 230' ' ' VAL . . . 128.8 13.34 2.5 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 119.179 -1.486 . . . . 0.0 115.82 163.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.67 ' HB3' ' O ' ' A' ' 271' ' ' THR . 3.6 t0 -108.83 -67.34 0.98 Allowed 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -171.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . 0.959 ' O ' ' HA ' ' A' ' 229' ' ' THR . . . -51.11 178.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 116.917 2.191 . . . . 0.0 116.917 -156.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.612 ' HA ' ' H ' ' A' ' 228' ' ' LEU . 3.1 m -149.42 -164.77 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 CA-C-O 117.855 -1.069 . . . . 0.0 108.833 -168.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.611 ' HB2' ' HG ' ' A' ' 228' ' ' LEU . 29.1 t -119.63 152.35 37.21 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 121.247 1.839 . . . . 0.0 114.404 -168.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.905 ' N ' ' HA ' ' A' ' 268' ' ' VAL . 53.3 t -124.83 58.03 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.827 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 164.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.429 HG21 ' OG ' ' A' ' 340' ' ' SER . 3.5 t . . . . . 0 C--N 1.318 -0.793 0 CA-C-O 122.446 1.117 . . . . 0.0 108.094 175.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 112.208 -0.357 . . . . 0.0 112.208 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 27.5 m -141.43 135.12 30.01 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.452 HD23 ' CE1' ' A' ' 261' ' ' PHE . 8.9 mt -139.31 178.11 7.43 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.705 -176.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.8 m -124.27 154.91 39.53 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.826 0.346 . . . . 0.0 110.735 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 67.2 t -99.63 128.78 51.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.974 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 51.2 tttt -112.47 -28.09 8.0 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.929 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 27.1 p -139.38 -169.97 2.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.696 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -112.64 116.81 47.67 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -174.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.716 ' HA ' ' O ' ' A' ' 248' ' ' THR . 7.4 Cg_exo -72.58 104.81 1.78 Allowed 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.361 2.041 . . . . 0.0 112.722 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.9 t -154.26 131.92 11.44 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.028 0.442 . . . . 0.0 111.782 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.634 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.87 176.47 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 168.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' THR . . . . . 0.485 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 91.6 m -37.17 111.0 0.14 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -176.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -97.45 84.04 3.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.221 173.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.506 ' OD1' ' HB2' ' A' ' 242' ' ' LYS . 0.8 OUTLIER -87.09 121.25 29.29 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -176.091 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -105.99 -56.92 2.11 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -164.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 32.8 t -64.66 -29.7 48.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.388 0.613 . . . . 0.0 109.57 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.506 ' HB2' ' OD1' ' A' ' 239' ' ' ASN . 27.6 mtpt -89.56 -16.92 29.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.754 178.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 68.54 70.67 0.3 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 114.495 -1.229 . . . . 0.0 112.617 174.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.4 t -154.03 96.5 1.97 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.384 0.612 . . . . 0.0 110.298 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 17.1 m-30 -103.85 108.22 19.44 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.32 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -112.84 149.34 33.23 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 173.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.634 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 1.3 p90 -160.17 139.82 11.17 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 121.339 -0.144 . . . . 0.0 110.819 177.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.716 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 52.4 m -109.22 142.53 39.91 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.218 -0.193 . . . . 0.0 111.167 -174.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.97 131.35 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 121.466 0.651 . . . . 0.0 112.727 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 21.3 m -96.94 120.69 37.74 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 165.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.401 ' HB2' HG12 ' A' ' 309' ' ' VAL . 0.4 OUTLIER -116.47 171.54 7.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.242 0.544 . . . . 0.0 109.831 -175.725 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.01 147.68 46.39 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.364 172.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -148.45 -143.75 3.85 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.62 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.465 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -104.76 -174.47 2.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -176.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.583 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.5 OUTLIER -72.31 -177.91 2.32 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.49 -169.628 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.583 ' H ' HG22 ' A' ' 255' ' ' THR . . . -62.83 -176.89 0.13 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.451 0.701 . . . . 0.0 112.506 -178.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 68.3 m 80.32 16.31 0.71 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.838 0.855 . . . . 0.0 111.613 -177.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 61.8 t -135.34 94.76 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 171.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 4.3 m -72.05 92.27 1.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.622 -177.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 76.72 92.86 0.22 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.925 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.493 ' CE1' ' HB3' ' A' ' 303' ' ' SER . 3.2 m-85 -42.92 -53.5 4.67 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.775 0.321 . . . . 0.0 111.66 168.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 18.3 mt -141.29 147.01 37.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.308 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 57.8 mtmt -139.38 -169.39 2.66 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 123.249 0.343 . . . . 0.0 110.886 175.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -53.66 119.39 4.85 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.278 0.561 . . . . 0.0 111.411 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 107.25 -7.87 37.75 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.45 176.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -90.45 130.97 36.45 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -109.23 140.7 42.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.877 0.37 . . . . 0.0 110.686 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.516 HG22 ' HB1' ' A' ' 295' ' ' ALA . 1.0 OUTLIER -122.24 171.41 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 121.305 0.574 . . . . 0.0 111.834 -178.399 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.41 ' HD2' ' C ' ' A' ' 269' ' ' LYS . 0.2 OUTLIER -131.42 129.64 41.51 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.887 179.18 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 292' ' ' SER . 47.5 m-85 -100.04 127.57 46.24 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.129 -0.357 . . . . 0.0 110.261 177.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.507 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 51.7 m -102.73 88.15 3.14 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 173.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.645 ' HA ' ' CB ' ' A' ' 337' ' ' ASP . 4.3 p-10 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.071 -167.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 52.0 m . . . . . 0 C--O 1.233 0.233 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -135.77 150.59 49.54 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 121.018 0.437 . . . . 0.0 111.472 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 98.4 m -95.65 136.51 35.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.755 -173.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . 0.516 ' HB1' HG22 ' A' ' 268' ' ' VAL . . . -121.25 171.07 8.99 Favored 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 122.447 -0.158 . . . . 0.0 110.705 176.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 96.6 m -135.2 121.59 20.43 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.282 0.563 . . . . 0.0 112.168 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 59.5 t -79.36 139.96 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.333 -178.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 0.9 OUTLIER -130.62 24.24 5.07 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.017 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -162.14 179.83 7.64 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.411 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 5.6 m-20 -69.17 163.48 24.79 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.81 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.5 ' HB1' ' CG1' ' A' ' 311' ' ' VAL . . . -149.48 172.86 14.29 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.668 -174.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.627 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 16.8 m120 -138.28 122.71 18.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -175.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.493 ' HB3' ' CE1' ' A' ' 261' ' ' PHE . 0.6 OUTLIER -105.87 93.37 4.6 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 162.622 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.33 178.91 4.46 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.436 -0.505 . . . . 0.0 110.92 -173.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 17.7 m -57.65 -33.1 67.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.851 0.358 . . . . 0.0 111.649 -177.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -82.05 0.89 88.11 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.321 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 62.01 43.11 99.61 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.438 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -121.04 126.65 50.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.717 0.758 . . . . 0.0 110.855 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.627 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.3 OUTLIER -136.67 126.2 38.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.846 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -177.901 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 34.1 m -123.65 132.58 53.89 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.939 -0.475 . . . . 0.0 111.117 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.5 ' CG1' ' HB1' ' A' ' 301' ' ' ALA . 9.2 m -144.71 162.19 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.213 0.53 . . . . 0.0 110.418 176.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 21.0 m -117.01 142.21 47.26 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.48 0.657 . . . . 0.0 109.891 174.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 313' ' ' LEU . 0.5 OUTLIER -107.83 133.27 52.44 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.874 -173.591 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 C--N 1.32 -0.704 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.532 -171.418 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.476 HG11 ' O ' ' A' ' 234' ' ' PRO . 34.3 m . . . . . 0 N--CA 1.45 -0.438 0 CA-C-O 121.606 0.717 . . . . 0.0 111.867 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -146.88 145.72 29.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.967 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -99.29 142.97 30.08 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.676 -174.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 129.09 11.43 2.83 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.569 171.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.645 ' CB ' ' HA ' ' A' ' 272' ' ' ASN . 10.9 p-10 -104.4 -153.32 0.48 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.926 0.363 . . . . 0.0 111.093 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -126.23 139.24 53.49 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 121.207 0.527 . . . . 0.0 111.774 -173.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 75.1 t -103.08 145.44 12.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.657 -177.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 10.5 m -142.97 178.92 7.35 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 268' ' ' VAL . 60.5 t -117.58 141.54 35.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.673 0.273 . . . . 0.0 110.563 -175.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 72.1 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.87 177.034 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.644 0 N-CA-C 111.771 -0.531 . . . . 0.0 111.771 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.9 m -127.9 141.34 51.58 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.821 0.343 . . . . 0.0 110.421 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.438 HD21 ' CE2' ' A' ' 261' ' ' PHE . 12.7 mt -143.08 175.19 10.05 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.985 -177.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 63.3 m -128.65 157.46 41.26 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.219 -176.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.493 HG23 ' OD2' ' A' ' 337' ' ' ASP . 92.6 t -99.13 138.67 22.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 120.622 0.249 . . . . 0.0 110.648 -177.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -117.53 -34.7 4.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.547 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 53.9 p -137.04 -173.67 3.52 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.594 ' HG3' ' N ' ' A' ' 334' ' ' GLU . 24.3 mm-40 -115.57 155.96 46.69 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -168.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.472 ' HB3' ' CD1' ' A' ' 247' ' ' PHE . 28.3 Cg_endo -63.47 105.95 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.176 2.584 . . . . 0.0 111.985 174.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 236' ' ' VAL . 5.1 t -148.27 96.98 2.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.574 0.702 . . . . 0.0 111.741 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.634 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.73 174.01 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 168.217 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' THR . . . . . 0.468 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 44.2 m -29.06 109.54 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -175.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -108.72 87.63 2.54 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 168.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.502 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 4.9 t30 -113.88 102.47 10.24 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.642 -174.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -84.51 -52.14 6.37 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -164.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 26.1 t -67.28 -23.59 30.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.411 0.624 . . . . 0.0 109.578 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.502 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 43.2 mmtt -89.88 -12.77 38.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.566 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 30.0 t70 63.37 69.65 0.56 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.183 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.2 m -149.5 106.86 3.61 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.879 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -125.29 102.76 7.59 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -129.76 160.01 34.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.634 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 7.4 p90 -154.92 132.91 11.58 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.629 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 53.0 m -97.94 131.89 44.0 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 25.3 t -136.86 140.32 43.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.867 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 24.2 m -96.9 121.49 38.83 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 167.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 4.8 mp -110.24 167.37 10.24 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -123.54 140.63 52.81 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.401 ' CA ' HD22 ' A' ' 228' ' ' LEU . . . -142.11 -143.56 4.22 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.709 -174.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -102.63 -174.32 2.53 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.601 HG21 ' H ' ' A' ' 256' ' ' ALA . 0.9 OUTLIER -72.18 -179.43 2.84 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.446 -169.907 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.601 ' H ' HG21 ' A' ' 255' ' ' THR . . . -61.22 -176.44 0.07 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.93 0.892 . . . . 0.0 112.898 -177.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 27.7 t 80.52 6.73 1.51 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.82 0.848 . . . . 0.0 110.922 -178.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 17.3 t -122.07 90.21 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 17.0 m -74.8 88.02 2.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.595 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 83.44 91.48 0.69 Allowed Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.383 -178.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.438 ' CE2' HD21 ' A' ' 228' ' ' LEU . 4.1 m-85 -43.01 -60.09 1.76 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 170.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 63.9 mt -149.02 161.76 41.29 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.12 -172.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 85.6 mttt -142.92 -167.19 2.47 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.119 0.262 . . . . 0.0 111.138 175.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -49.63 116.68 1.87 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.276 0.56 . . . . 0.0 111.686 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 108.36 -5.14 33.39 Favored Glycine 0 C--N 1.316 -0.53 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.299 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -94.96 143.27 26.61 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' GLN . . . . . 0.414 ' O ' HG12 ' A' ' 342' ' ' VAL . 23.0 mt-30 -114.06 152.7 30.63 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.551 0.691 . . . . 0.0 111.455 -176.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.3 OUTLIER -130.09 165.97 28.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.865 177.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 340' ' ' SER . 0.8 OUTLIER -122.64 87.45 2.75 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.1 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 339' ' ' VAL . 5.3 p90 -92.16 132.38 36.67 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.807 -175.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.591 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 77.2 m -98.24 87.14 3.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.36 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 . . . . . 0 C--N 1.32 -0.69 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.006 -177.525 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.45 -0.454 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.96 144.57 50.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.19 0.519 . . . . 0.0 111.014 -176.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 60.3 m -81.53 122.89 28.13 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.275 -176.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -114.48 175.45 5.48 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 63.8 m -135.19 130.58 35.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.573 0.701 . . . . 0.0 112.808 -176.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 62.8 t -80.57 139.39 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.811 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.51 HG21 ' O ' ' A' ' 312' ' ' THR . 13.8 t -121.71 1.8 10.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.782 0.325 . . . . 0.0 111.399 -176.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -142.46 -177.12 5.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -173.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -71.51 164.65 25.43 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.121 -178.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.548 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -149.58 156.08 41.36 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.316 -173.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.511 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 3.9 m-20 -129.17 126.88 40.2 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.624 -175.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.483 ' HB2' ' HB ' ' A' ' 258' ' ' VAL . 0.4 OUTLIER -111.24 95.5 5.56 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 163.966 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -102.16 178.2 4.67 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.646 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 50.4 m -60.21 -32.28 70.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.729 0.299 . . . . 0.0 111.697 -177.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -73.64 -8.83 77.62 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.175 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 70.61 42.39 63.11 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.511 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -118.43 136.01 54.02 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.734 0.767 . . . . 0.0 111.474 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.7 OUTLIER -142.92 110.31 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.804 -178.478 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 25.5 m -105.16 127.4 52.89 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.609 -0.682 . . . . 0.0 111.537 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.499 ' CG1' ' HB1' ' A' ' 301' ' ' ALA . 19.5 m -144.38 148.72 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.296 0.57 . . . . 0.0 111.014 175.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.51 ' O ' HG21 ' A' ' 298' ' ' THR . 50.0 m -97.22 146.78 24.77 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 172.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.47 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.1 mp -117.51 136.73 53.03 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.299 -176.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 38.1 m . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.494 -174.217 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.44 ' HB ' ' OE1' ' A' ' 233' ' ' GLN . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.25 0 CA-C-O 120.24 0.066 . . . . 0.0 110.867 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . 0.594 ' N ' ' HG3' ' A' ' 233' ' ' GLN . 10.8 tp10 -158.67 130.34 6.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.606 0.241 . . . . 0.0 110.7 -173.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -66.22 158.35 29.09 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.295 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 130.07 -1.24 5.8 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.673 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 271' ' ' THR . 10.3 p-10 -89.08 -171.3 3.22 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 122.333 0.253 . . . . 0.0 110.742 176.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -129.04 162.57 27.35 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -171.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 270' ' ' PHE . 98.3 t -128.56 142.62 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.968 -175.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.462 ' HB3' ' HB2' ' A' ' 269' ' ' LYS . 33.7 t -127.63 165.17 20.48 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 170.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 39.5 t -120.76 148.72 23.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 122.328 0.251 . . . . 0.0 110.386 -177.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 267' ' ' GLN . 7.5 p . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 121.025 0.44 . . . . 0.0 110.691 177.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.719 0 N-CA-C 112.283 -0.327 . . . . 0.0 112.283 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 27.1 m -111.05 141.06 45.04 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.468 HD21 ' CE2' ' A' ' 261' ' ' PHE . 8.6 mt -139.34 172.07 13.35 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.575 -173.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 40.3 m -128.0 152.74 47.56 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 -176.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.447 ' HB ' ' H ' ' A' ' 337' ' ' ASP . 61.3 t -94.08 108.16 20.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -95.49 -32.41 12.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.192 0.52 . . . . 0.0 110.888 -174.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.559 ' OG1' ' HB ' ' A' ' 250' ' ' THR . 61.6 p -129.09 -167.44 1.78 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.604 178.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.545 ' HB3' ' CG2' ' A' ' 333' ' ' VAL . 13.1 mt-30 -112.72 128.51 25.48 Favored Pre-proline 0 C--N 1.32 -0.702 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.61 -171.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.28 107.92 2.27 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.682 2.255 . . . . 0.0 112.739 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 13.5 t -112.54 147.47 36.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.007 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.0 t -110.52 136.97 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -166.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 22.5 m -101.91 116.89 33.68 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 168.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -103.16 131.5 50.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.039 0.447 . . . . 0.0 111.87 -176.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.434 HD21 ' HA ' ' A' ' 239' ' ' ASN . 0.2 OUTLIER -142.1 88.66 2.12 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.508 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -88.79 -41.0 12.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.293 -162.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.3 -23.22 32.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.706 0.765 . . . . 0.0 109.037 175.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -94.69 -12.33 27.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.016 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 6.3 t70 60.73 57.93 2.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.713 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 21.4 m -146.5 115.64 6.99 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.929 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -120.29 133.56 55.44 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -143.33 126.72 16.73 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 313' ' ' LEU . 18.7 p90 -130.17 133.33 46.52 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.429 174.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 92.9 m -104.52 142.19 35.06 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.988 -167.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 8.5 p -145.69 133.06 15.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.36 0.6 . . . . 0.0 112.294 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.559 ' HB ' ' OG1' ' A' ' 232' ' ' THR . 52.9 m -97.23 116.81 30.12 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 168.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.44 170.89 7.97 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.486 0.66 . . . . 0.0 109.893 -175.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.54 150.25 35.22 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.486 171.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.41 ' CA ' HD22 ' A' ' 228' ' ' LEU . . . -148.27 -144.12 3.92 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.515 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -106.39 -176.5 3.09 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -175.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.565 HG21 ' H ' ' A' ' 256' ' ' ALA . 1.3 m -68.42 178.99 1.77 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.519 -171.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.565 ' H ' HG21 ' A' ' 255' ' ' THR . . . -61.76 -176.14 0.08 Allowed 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.718 0.807 . . . . 0.0 112.323 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 28.9 t 81.07 6.83 1.28 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.835 0.854 . . . . 0.0 110.894 -178.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 40.1 t -126.03 89.96 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.463 0.649 . . . . 0.0 109.304 172.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 10.8 m -69.37 97.31 0.96 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.376 -178.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 68.21 99.46 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.494 -177.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.468 ' CE2' HD21 ' A' ' 228' ' ' LEU . 11.9 m-85 -43.23 -49.99 6.51 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.742 0.271 . . . . 0.0 111.371 170.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -166.08 166.16 17.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.677 -175.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.425 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 59.0 mtmt -140.79 -165.82 2.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.722 0.296 . . . . 0.0 111.685 -177.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -51.91 118.27 3.31 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.448 0.642 . . . . 0.0 111.877 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 107.02 -10.3 40.24 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.975 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -93.3 136.97 33.06 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -108.31 151.52 25.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.533 0.682 . . . . 0.0 112.313 -172.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 294' ' ' THR . 1.3 m -125.26 163.8 25.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.901 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.13 126.91 29.22 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 169.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -144.71 163.71 33.19 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.909 -0.494 . . . . 0.0 110.906 -174.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.585 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 5.0 t -121.67 101.3 7.51 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.893 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.366 -179.201 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 42.8 m . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.19 145.43 51.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.967 0.413 . . . . 0.0 110.936 -175.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 87.1 m -90.02 131.07 36.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.798 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -129.63 -178.4 4.67 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 89.7 m -141.71 134.15 28.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.392 0.615 . . . . 0.0 112.385 -177.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 94.9 t -86.32 146.01 6.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.719 -178.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 13.6 t -125.57 18.11 8.12 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.572 -175.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.461 ' H ' HG11 ' A' ' 297' ' ' VAL . . . -154.58 -177.86 6.77 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.425 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 2.7 m-20 -69.78 163.0 26.72 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.168 -178.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.505 ' HB2' ' CG1' ' A' ' 311' ' ' VAL . . . -147.28 167.88 23.14 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.973 -178.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.661 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 21.0 m120 -142.59 128.97 20.04 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.469 -174.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.6 OUTLIER -109.48 94.97 5.31 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 163.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -101.62 -176.94 3.28 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.207 -175.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 13.1 t -60.59 -33.03 72.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.792 0.33 . . . . 0.0 111.424 -175.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -82.67 -2.8 90.67 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.696 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 63.5 44.44 96.65 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.203 -178.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -115.02 126.51 54.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 118.0 0.9 . . . . 0.0 111.0 177.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.661 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.2 OUTLIER -134.7 119.65 29.24 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.568 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.843 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.468 ' OG1' HG22 ' A' ' 250' ' ' THR . 53.1 m -113.39 134.98 54.35 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.285 -0.26 . . . . 0.0 110.498 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.505 ' CG1' ' HB2' ' A' ' 301' ' ' ALA . 6.9 m -145.8 164.39 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.361 0.601 . . . . 0.0 110.547 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.444 ' O ' HG21 ' A' ' 298' ' ' THR . 19.7 m -119.99 138.54 53.43 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.421 173.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.505 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 4.1 mp -109.59 169.58 8.61 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.631 -175.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 C--N 1.326 -0.449 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -172.91 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.545 ' CG2' ' HB3' ' A' ' 233' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 121.227 0.537 . . . . 0.0 112.117 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -144.65 147.86 33.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.328 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -98.95 173.18 6.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.767 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 98.99 8.16 54.36 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.818 -0.706 . . . . 0.0 113.05 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.585 ' HB3' ' O ' ' A' ' 271' ' ' THR . 30.6 m-20 -92.81 -172.96 3.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.793 0.33 . . . . 0.0 111.795 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -112.12 142.71 44.24 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.665 -172.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 82.9 t -126.97 149.55 32.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.373 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 50.7 m -147.98 158.86 44.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.921 0.391 . . . . 0.0 110.528 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 48.9 t -102.22 137.04 31.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.797 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 53.1 t . . . . . 0 C--N 1.332 -0.181 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.078 175.957 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.61 0 CA-C-O 121.201 0.334 . . . . 0.0 113.241 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.9 m -91.01 147.61 22.96 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.159 0.504 . . . . 0.0 111.434 -175.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 4.4 mp -138.34 176.01 9.07 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 168.138 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 33.0 m -135.92 161.79 34.64 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.634 0.254 . . . . 0.0 110.893 -170.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 59.3 t -118.09 126.09 74.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 176.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.405 ' HE2' HG23 ' A' ' 252' ' ' THR . 20.4 ttmm -108.67 -11.34 15.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.131 0.491 . . . . 0.0 111.126 -177.657 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.46 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 57.5 p -124.11 -166.83 1.55 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.476 -179.327 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -102.82 112.49 65.75 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -170.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -65.08 103.53 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.503 1.469 . . . . 0.0 111.154 175.399 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.3 t -103.01 120.22 40.25 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.509 0.671 . . . . 0.0 110.532 -177.057 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.414 ' HA ' ' CB ' ' A' ' 247' ' ' PHE . 21.3 t -77.26 123.17 33.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.848 -175.856 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 29.2 m -96.72 105.15 17.21 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.12 178.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -89.84 116.09 27.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.607 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.474 ' OD1' ' HG3' ' A' ' 242' ' ' LYS . 0.8 OUTLIER -122.71 76.14 1.32 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 176.547 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -84.3 -32.28 24.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.126 -160.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 38.8 t -65.39 -22.17 30.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 122.164 0.983 . . . . 0.0 108.529 173.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.474 ' HG3' ' OD1' ' A' ' 239' ' ' ASN . 43.4 mmtt -101.77 0.47 35.87 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.166 179.196 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 51.4 37.67 19.75 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.056 -178.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.9 m -119.17 127.32 53.2 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.009 178.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -125.17 112.11 16.06 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.079 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . 0.422 ' HB3' ' O ' ' A' ' 313' ' ' LEU . 18.2 mt-30 -130.79 -178.87 4.99 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.685 -175.276 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.416 ' CE2' ' HB2' ' A' ' 313' ' ' LEU . 6.9 p90 -156.76 137.83 13.59 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.476 171.611 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 61.4 m -103.15 134.95 45.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.177 -173.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -147.62 149.36 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.563 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.546 HG22 ' OG1' ' A' ' 310' ' ' THR . 38.3 m -99.09 111.4 23.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 164.721 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.488 ' HB2' HG13 ' A' ' 309' ' ' VAL . 4.6 mp -104.3 168.06 9.35 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -172.751 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.405 HG23 ' HE2' ' A' ' 231' ' ' LYS . 0.7 OUTLIER -120.57 130.24 54.11 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.693 0.282 . . . . 0.0 110.367 177.467 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.466 ' N ' HG11 ' A' ' 309' ' ' VAL . . . -124.08 -143.15 6.15 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.944 -171.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -113.5 -171.33 1.86 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -173.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.446 HG23 ' H ' ' A' ' 256' ' ' ALA . 1.8 m -51.12 167.34 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -173.157 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 257' ' ' SER . . . -69.95 -175.78 0.99 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.177 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 257' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 67.6 m 80.6 9.15 1.21 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.794 176.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 94.4 t -119.52 94.5 3.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 170.585 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 22.6 m -74.6 89.56 2.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.42 -178.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 80.1 102.32 0.28 Allowed Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.623 -175.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.462 ' CE1' ' HB2' ' A' ' 303' ' ' SER . 10.6 m-85 -48.17 -59.11 3.66 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.673 0.749 . . . . 0.0 110.392 173.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 266' ' ' ASP . 89.3 mt -141.7 168.4 19.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.009 -175.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -131.63 -169.27 2.16 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.18 0.3 . . . . 0.0 111.006 -179.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -56.82 114.41 2.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.255 0.55 . . . . 0.0 111.652 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 112.75 -6.07 25.97 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.562 177.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . 0.511 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 64.6 m-20 -96.19 138.14 34.24 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 267' ' ' GLN . . . . . 0.416 ' HB2' HG11 ' A' ' 342' ' ' VAL . 30.5 mt-30 -108.94 159.76 16.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.636 0.732 . . . . 0.0 111.779 -173.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.06 -175.48 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.827 -179.29 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.472 ' HB3' ' HB2' ' A' ' 340' ' ' SER . 23.9 tptt -120.9 104.56 9.93 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.834 174.419 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -95.29 120.71 35.99 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 120.942 0.401 . . . . 0.0 110.127 -175.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 54.8 m -110.6 89.25 2.98 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.767 178.352 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 . . . . . 0 C--N 1.323 -0.571 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.611 179.115 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 55.7 p . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -143.45 148.27 35.85 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 66.7 m -74.94 115.99 15.16 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.675 -179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -103.14 -179.95 4.1 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 177.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.596 ' HB ' ' O ' ' A' ' 314' ' ' SER . 90.7 m -139.82 133.8 30.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -175.1 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.486 HG13 HG22 ' A' ' 311' ' ' VAL . 50.7 t -78.64 135.91 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.715 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 5.1 m -108.62 -13.43 14.81 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -173.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -154.38 -178.66 7.29 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.172 -0.33 . . . . 0.0 110.916 -175.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.58 105.58 0.66 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.178 0.513 . . . . 0.0 110.447 178.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -95.41 100.43 12.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.499 -177.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.406 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 65.3 t30 -61.04 149.49 36.74 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -168.569 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.497 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 36.6 t -128.78 95.23 4.04 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 166.374 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -104.9 173.03 6.48 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.89 -179.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 8.5 t -58.25 -32.08 68.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.861 0.362 . . . . 0.0 111.472 -173.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -73.77 3.45 35.25 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.217 -177.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 66.27 41.85 94.46 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.739 178.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -116.84 139.08 51.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.901 0.35 . . . . 0.0 110.694 -178.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.488 HG13 ' HB2' ' A' ' 251' ' ' LEU . 1.8 p -147.7 95.17 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.366 0.603 . . . . 0.0 111.352 179.186 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.546 ' OG1' HG22 ' A' ' 250' ' ' THR . 53.0 m -96.12 130.37 43.18 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 121.597 -0.689 . . . . 0.0 110.896 179.523 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.486 HG22 HG13 ' A' ' 297' ' ' VAL . 14.5 p -165.81 150.24 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.109 0.48 . . . . 0.0 110.424 175.216 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 25.0 m -93.69 145.49 24.52 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.632 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.506 ' HA ' ' O ' ' A' ' 296' ' ' THR . 5.1 mp -110.62 140.95 44.48 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.086 -175.662 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 314' ' ' SER . . . . . 0.596 ' O ' ' HB ' ' A' ' 296' ' ' THR . 39.0 t . . . . . 0 C--N 1.32 -0.709 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.677 -176.14 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.232 0.156 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -127.43 134.83 49.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.92 0.39 . . . . 0.0 110.628 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -66.53 157.16 32.94 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.584 -175.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.38 3.12 5.75 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.401 178.21 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.11 166.85 10.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.222 0.534 . . . . 0.0 111.49 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -116.56 148.05 41.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.993 -179.048 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 70.7 t -130.38 150.59 34.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.809 0.338 . . . . 0.0 111.086 -172.573 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.472 ' HB2' ' HB3' ' A' ' 269' ' ' LYS . 30.0 m -150.05 177.77 9.57 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.318 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 39.3 t -113.56 142.58 25.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' A' ' 267' ' ' GLN . 9.9 p . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 121.053 0.454 . . . . 0.0 111.051 -175.095 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.7 0 CA-C-O 121.047 0.248 . . . . 0.0 112.942 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.1 m -105.94 147.84 28.33 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.975 0.417 . . . . 0.0 111.184 -174.466 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.457 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.9 mp -132.61 -178.66 5.04 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 167.152 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.45 ' HB ' ' OG1' ' A' ' 252' ' ' THR . 23.1 m -127.47 155.82 43.11 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 122.324 -0.235 . . . . 0.0 111.072 -173.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.483 HG21 ' CG2' ' A' ' 339' ' ' VAL . 0.9 OUTLIER -111.22 137.43 43.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.275 177.399 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 59.3 mtmt -109.57 -26.92 9.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.769 174.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.448 ' O ' HG13 ' A' ' 230' ' ' VAL . 58.6 p -137.07 -179.7 5.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.535 ' HB3' ' HB ' ' A' ' 333' ' ' VAL . 17.9 mm-40 -116.57 157.01 46.92 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -166.797 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.464 ' HG3' ' CZ ' ' A' ' 293' ' ' PHE . 73.8 Cg_endo -73.05 104.24 1.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.076 2.517 . . . . 0.0 113.127 178.576 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.449 ' N ' ' HB2' ' A' ' 247' ' ' PHE . 10.1 t -157.11 110.44 2.57 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.659 170.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.766 ' O ' ' HB2' ' A' ' 246' ' ' GLN . 75.7 t -154.74 79.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.34 0.656 . . . . 0.0 109.559 165.814 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 26.0 m 81.44 92.73 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.536 0.684 . . . . 0.0 110.645 174.117 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -106.95 104.96 14.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.341 178.13 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -129.29 126.82 39.87 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -102.61 -43.0 5.74 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.622 -170.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 67.3 t -61.55 -26.9 40.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.39 0.614 . . . . 0.0 109.916 178.085 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -99.05 -4.77 31.66 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.874 -179.425 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 53.3 57.9 5.77 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.059 -177.051 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 23.7 m -138.51 111.14 7.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.458 -177.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -128.57 120.08 26.02 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.321 -177.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . 0.766 ' HB2' ' O ' ' A' ' 236' ' ' VAL . 47.3 mt-30 -128.57 163.36 25.18 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 173.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.529 ' HA ' ' N ' ' A' ' 236' ' ' VAL . 20.9 p90 -168.64 151.43 5.21 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 174.007 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 50.0 m -113.97 138.54 50.21 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 31.6 t -137.91 139.71 42.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.526 -178.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.502 HG22 ' OG1' ' A' ' 310' ' ' THR . 15.8 m -102.09 113.74 27.25 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.565 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.49 ' HB2' HG13 ' A' ' 309' ' ' VAL . 4.9 mp -110.39 170.63 7.96 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.943 0.402 . . . . 0.0 110.027 -171.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.626 HG22 ' O ' ' A' ' 307' ' ' GLY . 0.0 OUTLIER -126.87 120.97 30.5 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.402 176.761 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.441 ' N ' HG11 ' A' ' 309' ' ' VAL . . . -156.78 134.77 4.16 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.81 -0.709 . . . . 0.0 111.404 178.049 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -112.7 93.41 4.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.107 0.48 . . . . 0.0 112.179 -173.293 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 18.3 m -126.16 102.74 7.34 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 169.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -56.0 134.86 52.67 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -175.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 24.5 t 63.31 53.65 2.16 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.901 172.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 84.2 t -132.47 95.97 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.291 0.567 . . . . 0.0 110.377 175.61 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.5 m -75.97 86.31 2.89 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.567 0.698 . . . . 0.0 109.857 177.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 95.62 92.51 1.75 Allowed Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.251 -177.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.554 ' CD1' ' HB2' ' A' ' 303' ' ' SER . 3.6 m-85 -45.34 -58.79 3.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.786 0.803 . . . . 0.0 109.958 169.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.446 ' HB3' ' CB ' ' A' ' 266' ' ' ASP . 75.8 mt -141.53 169.83 16.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.168 -1.378 . . . . 0.0 108.031 -175.63 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 96.0 mttt -137.68 -171.22 2.94 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 121.173 -0.211 . . . . 0.0 110.884 -179.386 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -54.11 113.95 1.43 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.261 0.553 . . . . 0.0 111.413 -179.061 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 113.03 -6.82 25.42 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.77 177.087 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . 0.446 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 22.9 m-20 -90.37 136.03 33.31 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.722 -0.281 . . . . 0.0 110.262 179.049 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -107.15 142.28 37.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.5 0.667 . . . . 0.0 111.981 -174.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.456 HG21 ' HB2' ' A' ' 295' ' ' ALA . 0.7 OUTLIER -126.09 164.04 26.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.569 179.006 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.408 ' HZ3' ' HB3' ' A' ' 340' ' ' SER . 0.0 OUTLIER -135.68 147.99 48.75 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.674 174.221 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -110.95 130.03 55.71 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -174.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 44.0 m -104.25 126.63 51.52 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 . . . . . 0 C--N 1.316 -0.885 0 CA-C-O 121.893 0.854 . . . . 0.0 113.184 -163.208 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 32.8 p . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . 0.464 ' CZ ' ' HG3' ' A' ' 234' ' ' PRO . 35.9 p90 -161.58 177.2 10.23 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.992 0.425 . . . . 0.0 111.403 -176.652 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 53.8 m -124.06 132.67 53.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.508 -178.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . 0.456 ' HB2' HG21 ' A' ' 268' ' ' VAL . . . -114.97 -179.74 3.71 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.802 0.334 . . . . 0.0 111.249 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 96.1 m -143.67 121.64 12.06 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.569 0.699 . . . . 0.0 111.675 178.358 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.495 HG12 HG21 ' A' ' 311' ' ' VAL . 78.0 t -66.86 138.79 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.544 -178.04 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 312' ' ' THR . 6.0 t -121.4 6.54 10.13 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.108 -175.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -163.18 -167.03 1.37 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -72.46 113.8 9.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.246 0.546 . . . . 0.0 110.047 179.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -91.98 101.28 13.83 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.343 178.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -56.36 134.01 53.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.503 -0.772 . . . . 0.0 112.802 -169.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.554 ' HB2' ' CD1' ' A' ' 261' ' ' PHE . 30.5 t -128.23 111.39 13.36 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 120.913 0.387 . . . . 0.0 110.873 173.583 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.49 157.41 41.23 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 3.9 t -71.07 -10.14 59.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.009 -171.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -69.17 -15.05 69.41 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 173.004 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . 0.626 ' O ' HG22 ' A' ' 252' ' ' THR . . . 90.07 41.03 5.68 Favored Glycine 0 C--O 1.223 -0.558 0 C-N-CA 120.925 -0.655 . . . . 0.0 114.379 174.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -126.22 130.73 51.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.151 0.976 . . . . 0.0 111.427 178.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.49 HG13 ' HB2' ' A' ' 251' ' ' LEU . 0.8 OUTLIER -141.93 112.06 2.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.744 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.525 176.018 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.502 ' OG1' HG22 ' A' ' 250' ' ' THR . 99.0 m -110.15 129.47 55.7 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.491 -0.756 . . . . 0.0 110.618 177.375 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.495 HG21 HG12 ' A' ' 297' ' ' VAL . 2.6 p -151.72 144.38 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 121.141 0.496 . . . . 0.0 111.23 178.252 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.517 ' O ' HG22 ' A' ' 298' ' ' THR . 22.6 m -100.34 145.21 28.43 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.679 175.418 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.477 ' N ' HD21 ' A' ' 313' ' ' LEU . 1.3 mm? -121.44 129.81 53.21 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.484 -172.065 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 16.0 p . . . . . 0 C--N 1.316 -0.861 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.932 -174.762 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 233' ' ' GLN . 15.4 m . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -155.92 112.16 3.1 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.483 -174.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -74.64 143.71 44.18 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -171.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 131.51 11.55 2.16 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 120.787 -0.72 . . . . 0.0 114.231 175.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -76.72 174.48 10.4 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 117.498 0.649 . . . . 0.0 112.03 175.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -112.0 132.0 55.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.731 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.483 ' CG2' HG21 ' A' ' 230' ' ' VAL . 54.5 t -102.67 152.91 5.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.668 -169.498 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.408 ' HB3' ' HZ3' ' A' ' 269' ' ' LYS . 23.2 t -157.45 177.16 11.75 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 174.77 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 46.6 t -112.52 138.59 41.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.65 0.262 . . . . 0.0 110.767 -174.04 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 56.5 t . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.78 -179.949 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.233 0 N-CA-C 113.526 0.17 . . . . 0.0 113.526 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 19.1 m -102.66 142.44 33.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.926 0.393 . . . . 0.0 110.886 -178.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.522 HD21 ' CE1' ' A' ' 261' ' ' PHE . 19.2 mt -144.39 176.61 9.24 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 42.7 m -135.97 160.23 39.26 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 122.27 -0.269 . . . . 0.0 110.485 -174.142 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.628 ' HB ' ' OD2' ' A' ' 337' ' ' ASP . 3.4 t -118.63 152.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 177.581 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.475 ' HE2' ' O ' ' A' ' 251' ' ' LEU . 53.1 pttt -130.38 14.43 5.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.857 0.36 . . . . 0.0 111.132 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.527 ' H ' HG13 ' A' ' 230' ' ' VAL . 24.1 p -151.73 -178.55 6.79 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -175.56 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.533 ' HB3' ' CG2' ' A' ' 333' ' ' VAL . 0.3 OUTLIER -115.79 129.46 25.14 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -174.28 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.49 105.79 1.32 Allowed 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.452 2.101 . . . . 0.0 112.243 -179.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 5.8 t -107.0 129.6 54.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.307 178.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 8.1 t -85.61 123.63 39.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.203 -173.054 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 49.2 m -82.17 96.66 7.89 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.048 173.145 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.75 109.07 13.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.511 -178.548 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.405 ' OD1' ' HG3' ' A' ' 242' ' ' LYS . 0.2 OUTLIER -121.0 81.2 1.74 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.419 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -85.11 -36.86 20.85 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.067 -164.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.03 -23.15 32.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.757 0.789 . . . . 0.0 109.162 174.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.405 ' HG3' ' OD1' ' A' ' 239' ' ' ASN . 13.4 mmmm -103.62 -6.76 21.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.262 -176.212 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 58.32 58.95 3.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.57 -177.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 41.7 m -145.53 128.63 16.61 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.372 176.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -129.14 100.4 5.61 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.199 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -133.97 144.18 48.62 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -120.11 136.59 54.54 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.644 -178.083 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 97.9 m -100.95 141.25 34.1 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -173.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.498 HG13 ' CD1' ' A' ' 251' ' ' LEU . 1.4 p -144.48 146.14 20.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.418 -177.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.412 HG22 ' HE3' ' A' ' 231' ' ' LYS . 4.9 m -107.84 124.95 50.84 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 174.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.547 ' HB2' HG21 ' A' ' 309' ' ' VAL . 3.9 mp -115.21 171.74 7.5 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.668 0.747 . . . . 0.0 110.926 -167.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.11 142.28 50.94 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.218 169.151 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -140.98 -144.54 4.45 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.007 -173.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.515 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -101.91 -173.54 2.37 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -176.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.566 HG21 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -70.83 -177.81 1.7 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.337 -171.635 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.566 ' H ' HG21 ' A' ' 255' ' ' THR . . . -67.32 -175.39 0.47 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.266 -178.599 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 257' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 50.7 m 80.59 6.22 1.53 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.002 0.921 . . . . 0.0 111.244 179.46 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.9 88.79 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.505 0.669 . . . . 0.0 109.411 171.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 62.9 m -89.09 103.68 16.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.953 179.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 83.22 79.44 1.03 Allowed Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.068 -176.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.642 ' CE1' ' HB2' ' A' ' 303' ' ' SER . 6.8 m-85 -45.32 -54.59 6.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.788 0.804 . . . . 0.0 109.932 170.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.5 pp -158.11 173.7 16.33 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.288 -1.323 . . . . 0.0 108.677 -175.021 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.544 ' HE2' ' OD2' ' A' ' 300' ' ' ASP . 94.4 mttt -136.29 -167.54 2.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.702 0.287 . . . . 0.0 111.54 -174.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -55.4 116.57 2.93 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.436 0.636 . . . . 0.0 111.446 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 115.08 -14.96 18.84 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.199 177.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -86.06 141.89 29.12 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.254 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -104.86 150.16 25.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.878 0.847 . . . . 0.0 112.668 -172.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.35 173.71 13.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.668 175.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.437 ' HE2' ' CB ' ' A' ' 340' ' ' SER . 0.0 OUTLIER -134.57 149.88 50.67 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 167.091 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . 0.496 ' O ' ' HA ' ' A' ' 292' ' ' SER . 55.4 m-85 -106.5 130.73 54.23 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.494 -175.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 45.6 m -107.16 88.34 2.71 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 171.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 121.424 0.631 . . . . 0.0 111.767 -172.3 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 292' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 17.8 p . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -111.63 147.39 35.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.856 0.36 . . . . 0.0 111.127 -174.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 51.9 m -88.02 127.27 35.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.783 -179.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -120.23 179.13 4.38 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 95.3 m -136.97 130.65 31.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.534 0.683 . . . . 0.0 112.543 -177.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.495 HG11 ' H ' ' A' ' 299' ' ' ALA . 61.1 t -85.1 144.08 10.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.484 -178.359 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 0.6 OUTLIER -119.33 24.74 10.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.821 -174.993 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.495 ' H ' HG11 ' A' ' 297' ' ' VAL . . . -166.83 173.34 9.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.763 0.316 . . . . 0.0 111.668 -177.346 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.544 ' OD2' ' HE2' ' A' ' 263' ' ' LYS . 2.3 m-20 -64.8 116.55 6.42 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.256 176.688 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -93.26 112.75 24.76 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.664 179.023 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.717 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 65.9 t30 -85.55 134.47 34.02 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -171.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.642 ' HB2' ' CE1' ' A' ' 261' ' ' PHE . 7.7 t -113.88 95.72 5.46 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 163.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -98.53 179.25 4.76 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.976 -178.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 20.5 m -57.07 -32.92 66.75 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -173.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -83.39 5.54 76.97 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.468 -176.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 64.49 42.69 97.42 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.864 -178.345 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -120.22 142.91 48.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.367 0.584 . . . . 0.0 111.682 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.717 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.2 OUTLIER -143.89 152.7 15.93 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.616 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.096 176.973 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 95.5 m -149.72 120.04 7.34 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.692 -0.63 . . . . 0.0 110.619 178.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.401 HG21 HD11 ' A' ' 251' ' ' LEU . 35.4 m -145.87 160.88 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.41 0.624 . . . . 0.0 111.23 -177.362 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 23.7 m -114.75 140.93 48.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.582 176.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.52 126.52 54.47 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.367 -171.245 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 7.6 p . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.329 -176.118 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.533 ' CG2' ' HB3' ' A' ' 233' ' ' GLN . 2.6 m . . . . . 0 C--O 1.236 0.393 0 CA-C-O 121.381 0.61 . . . . 0.0 112.113 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -147.22 161.82 40.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.937 -177.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -65.96 173.09 3.18 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.507 0.504 . . . . 0.0 111.358 178.596 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 112.26 13.73 11.64 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -176.086 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.628 ' OD2' ' HB ' ' A' ' 230' ' ' VAL . 0.4 OUTLIER -96.29 146.68 24.51 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.742 0.782 . . . . 0.0 112.617 -173.885 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -144.08 163.56 33.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.779 178.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.468 HG23 HD21 ' A' ' 251' ' ' LEU . 74.7 t -125.24 143.03 40.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.227 0.537 . . . . 0.0 111.285 -169.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.437 ' CB ' ' HE2' ' A' ' 269' ' ' LYS . 20.0 m -147.51 127.21 13.38 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 172.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 19.1 t -76.04 143.12 13.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 120.867 0.365 . . . . 0.0 111.311 -173.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 53.4 t . . . . . 0 C--N 1.333 -0.15 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.471 176.969 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.565 0 CA-C-O 121.533 0.518 . . . . 0.0 114.083 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 5.3 m -67.28 145.35 55.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.435 0.636 . . . . 0.0 112.401 -173.077 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 1.3 mt -133.68 179.13 6.42 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.89 177.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.409 ' O ' ' HB3' ' A' ' 251' ' ' LEU . 48.1 m -139.08 158.84 43.46 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 122.303 -0.248 . . . . 0.0 110.498 -175.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 17.6 t -106.08 133.19 51.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 179.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -104.46 -39.05 6.56 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 178.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 63.5 p -118.77 -169.56 1.75 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.785 0.326 . . . . 0.0 110.489 -177.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.433 ' HB3' HG23 ' A' ' 333' ' ' VAL . 91.2 mt-30 -105.27 126.1 31.83 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.507 -169.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.629 ' HB3' ' CD2' ' A' ' 247' ' ' PHE . 23.7 Cg_exo -62.56 104.73 0.38 Allowed 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.687 2.258 . . . . 0.0 111.861 176.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.8 t -142.55 104.87 4.45 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.661 0.743 . . . . 0.0 112.187 -177.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.595 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.16 175.42 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.879 171.931 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 237' ' ' THR . . . . . 0.507 ' H ' HG12 ' A' ' 236' ' ' VAL . 55.9 m -34.09 114.27 0.2 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -169.648 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -116.04 88.13 2.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.465 173.178 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -113.73 133.16 55.52 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -179.225 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -104.28 -40.39 6.13 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.621 -172.163 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.73 -29.77 46.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.516 0.674 . . . . 0.0 109.74 176.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.486 ' HA ' ' HE2' ' A' ' 242' ' ' LYS . 11.2 mmpt? -100.45 -3.43 30.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.084 -178.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 53.72 51.57 14.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 113.998 -1.456 . . . . 0.0 111.089 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.2 m -126.28 99.16 5.75 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.095 -175.239 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -116.44 108.42 16.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.071 0.462 . . . . 0.0 110.502 -177.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . 0.468 ' HB2' HG13 ' A' ' 236' ' ' VAL . 95.0 mt-30 -129.5 164.16 24.35 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.057 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.629 ' CD2' ' HB3' ' A' ' 234' ' ' PRO . 31.3 p90 -159.79 135.66 8.59 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.565 -0.454 . . . . 0.0 112.143 176.712 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 51.9 m -98.09 138.92 34.66 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.7 150.83 17.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.765 -179.305 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.584 HG23 ' OG1' ' A' ' 310' ' ' THR . 96.2 m -104.38 117.45 34.21 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 167.488 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.513 ' HB2' HG12 ' A' ' 309' ' ' VAL . 4.0 mp -118.49 169.49 9.73 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.209 -170.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.444 HG21 ' O ' ' A' ' 307' ' ' GLY . 0.0 OUTLIER -110.4 141.72 43.09 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.279 176.114 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.407 ' N ' HG13 ' A' ' 309' ' ' VAL . . . -138.34 -143.92 4.57 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.999 -178.653 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -109.96 -173.61 2.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.814 0.34 . . . . 0.0 111.877 -177.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.552 HG23 ' H ' ' A' ' 256' ' ' ALA . 2.2 m -67.04 173.68 3.55 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.388 -0.823 . . . . 0.0 112.877 -170.125 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.552 ' H ' HG23 ' A' ' 255' ' ' THR . . . -62.94 -175.34 0.09 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.861 0.864 . . . . 0.0 112.663 -178.785 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 257' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 31.3 t 81.53 6.4 1.2 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.95 0.9 . . . . 0.0 111.101 -178.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.499 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 64.4 t -125.32 90.54 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.545 0.688 . . . . 0.0 109.571 171.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 22.2 m -75.81 97.86 4.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.735 178.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 80.52 87.82 0.58 Allowed Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.495 -177.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.461 ' CD2' ' HB2' ' A' ' 303' ' ' SER . 2.6 m-85 -44.6 -61.39 1.57 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.666 0.746 . . . . 0.0 110.143 170.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.45 HD23 ' HB3' ' A' ' 261' ' ' PHE . 2.9 mm? -135.22 166.01 24.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.405 -1.27 . . . . 0.0 108.483 179.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -134.74 -170.98 2.67 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 123.164 0.29 . . . . 0.0 110.822 178.022 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -59.51 117.28 4.7 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.112 0.482 . . . . 0.0 110.57 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 115.26 -14.93 18.36 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.514 177.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -86.9 138.48 31.51 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -100.6 154.2 18.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.072 0.463 . . . . 0.0 110.319 -178.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 294' ' ' THR . 1.3 m -135.17 176.33 8.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.314 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.403 ' HE3' HG22 ' A' ' 342' ' ' VAL . 1.7 mptm? -122.8 139.99 53.41 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 171.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -137.68 136.76 37.72 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.803 174.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.628 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 29.7 m -110.14 88.54 2.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.428 -175.79 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.467 ' HA ' ' CG ' ' A' ' 337' ' ' ASP . 3.2 t-20 . . . . . 0 N--CA 1.467 0.384 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.205 176.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 10.3 p . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -153.3 168.87 24.58 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.248 0.547 . . . . 0.0 111.737 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 90.0 m -89.35 133.57 34.44 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.814 -172.614 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -119.15 -170.43 1.92 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.963 175.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 16.9 m -139.01 131.82 29.19 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.58 0.705 . . . . 0.0 112.877 -177.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.491 HG12 HG21 ' A' ' 311' ' ' VAL . 55.1 t -82.42 142.09 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 114.207 -1.361 . . . . 0.0 109.488 179.155 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 41.5 p -129.19 18.44 5.98 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -173.576 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -167.59 177.95 5.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.394 0.14 . . . . 0.0 110.67 179.092 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.41 108.66 2.04 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.846 0.716 . . . . 0.0 109.556 178.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -92.67 100.91 13.33 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.275 0.56 . . . . 0.0 110.241 -177.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.438 ' OD1' ' HB3' ' A' ' 304' ' ' ASP . 9.0 t-20 -63.35 135.06 56.76 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -169.204 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.499 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 27.5 t -115.68 96.52 5.65 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 166.38 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . 0.438 ' HB3' ' OD1' ' A' ' 302' ' ' ASN . 0.4 OUTLIER -106.25 174.7 5.77 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.476 -176.864 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 20.3 m -60.67 -32.24 71.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.749 0.309 . . . . 0.0 111.589 -176.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -74.21 1.05 51.2 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.188 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . 0.444 ' O ' HG21 ' A' ' 252' ' ' THR . . . 63.91 40.68 98.56 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.309 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -114.16 127.77 56.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.695 0.284 . . . . 0.0 110.683 -179.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.513 HG12 ' HB2' ' A' ' 251' ' ' LEU . 2.7 p -131.97 101.06 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.392 0.615 . . . . 0.0 111.134 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.584 ' OG1' HG23 ' A' ' 250' ' ' THR . 54.3 m -104.03 126.63 51.3 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 121.95 -0.469 . . . . 0.0 110.864 -179.009 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.491 HG21 HG12 ' A' ' 297' ' ' VAL . 12.7 p -160.43 151.4 5.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.066 0.46 . . . . 0.0 110.237 175.37 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 48.4 m -92.4 148.9 21.75 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.307 178.449 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.493 ' HB2' ' CE2' ' A' ' 247' ' ' PHE . 5.7 mp -117.23 149.3 40.64 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.795 -179.076 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 36.8 m . . . . . 0 C--N 1.32 -0.713 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.74 -178.461 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 233' ' ' GLN . 22.2 m . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -131.34 153.89 49.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.0 0.429 . . . . 0.0 110.638 -178.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -97.95 165.21 12.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.857 -179.079 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 103.5 12.17 31.46 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.344 175.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.628 ' HB3' ' O ' ' A' ' 271' ' ' THR . 23.8 m-20 -95.19 -178.77 4.57 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.021 0.438 . . . . 0.0 112.126 -178.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -104.73 153.92 20.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.61 -173.444 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.414 HG22 HD21 ' A' ' 251' ' ' LEU . 50.5 t -132.86 150.34 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.791 -176.367 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 31.6 t -144.85 171.34 14.57 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 175.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 32.2 t -118.29 160.28 18.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.403 HG22 ' HE3' ' A' ' 269' ' ' LYS . 94.3 t . . . . . 0 C--O 1.235 0.293 0 CA-C-N 118.212 0.46 . . . . 0.0 110.392 -179.582 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.964 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 20.3 m -129.74 131.49 46.3 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.738 0.304 . . . . 0.0 110.383 -173.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.473 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 2.2 mp -138.47 -177.3 4.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.122 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 95.3 m -143.74 156.14 44.42 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.997 -176.799 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 66.3 t -108.05 122.77 62.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.197 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -106.05 -6.28 18.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.106 0.479 . . . . 0.0 110.716 -175.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 17.5 p -130.25 -168.32 1.95 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.732 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -113.74 113.65 47.39 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -175.347 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.17 106.98 0.51 Allowed 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.894 2.396 . . . . 0.0 112.494 -179.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.0 t -149.37 118.44 6.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.533 0.682 . . . . 0.0 112.269 179.556 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.588 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -155.9 174.72 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.164 171.569 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 237' ' ' THR . . . . . 0.462 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 34.8 m -23.09 100.19 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.609 1.164 . . . . 0.0 113.525 -177.318 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.95 83.42 1.82 Allowed 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.408 174.158 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.41 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 35.7 t-20 -108.79 129.96 55.38 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.016 -178.326 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -102.46 -41.39 6.32 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.68 -170.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.8 -33.77 65.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.43 0.633 . . . . 0.0 109.944 178.1 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 242' ' ' LYS . 10.8 mmpt? -88.77 -11.25 45.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.481 178.835 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 26.5 t70 58.1 69.19 0.75 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.277 -178.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.9 m -146.8 104.84 3.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.159 -177.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -123.33 106.33 10.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.783 -176.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . 0.46 ' HB2' HG11 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -124.03 161.92 24.53 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 171.551 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.588 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 35.2 p90 -149.09 134.82 18.78 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.67 174.818 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 46.5 m -98.8 137.49 37.32 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.41 ' HB ' ' CD1' ' A' ' 251' ' ' LEU . 0.2 OUTLIER -142.29 148.58 20.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.878 -178.946 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.582 HG23 ' OG1' ' A' ' 310' ' ' THR . 41.6 m -99.51 107.84 20.12 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 166.519 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 309' ' ' VAL . 5.2 mp -102.82 167.97 9.53 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -170.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.19 144.13 43.69 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.813 175.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -142.82 -142.48 4.01 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.369 -173.144 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -113.37 -173.66 2.31 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -176.362 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.558 HG22 ' H ' ' A' ' 256' ' ' ALA . 1.8 m -70.9 174.0 6.69 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.185 -171.726 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.558 ' H ' HG22 ' A' ' 255' ' ' THR . . . -62.51 -177.46 0.14 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.495 0.718 . . . . 0.0 112.862 -177.17 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 23.1 t 80.83 10.93 0.95 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.185 0.994 . . . . 0.0 111.155 -176.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 40.4 t -124.33 94.06 2.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 169.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.2 m -67.65 88.89 0.24 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.515 -177.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 69.48 107.42 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.109 -174.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -44.19 -57.35 3.49 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 117.243 0.521 . . . . 0.0 111.091 174.254 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 91.9 mt -147.83 146.81 29.26 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -177.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.511 ' HD2' ' N ' ' A' ' 263' ' ' LYS . 9.5 mptt -112.86 -166.45 1.08 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.033 0.444 . . . . 0.0 111.561 176.53 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -52.79 114.15 1.32 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.66 -175.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 114.2 -16.07 20.26 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.416 171.392 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.54 134.79 35.2 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.83 -177.014 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.19 145.94 24.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.24 -173.592 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.33 165.3 22.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.744 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.513 ' HB3' ' HB2' ' A' ' 340' ' ' SER . 0.8 OUTLIER -97.57 120.3 37.69 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 172.433 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -122.55 120.55 34.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.857 0.361 . . . . 0.0 110.085 -174.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 30.4 m -125.79 113.0 16.69 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.491 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 19.4 m120 . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.031 -177.584 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.449 -0.488 0 CA-C-O 120.739 0.304 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -118.96 174.99 5.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.046 0.45 . . . . 0.0 110.665 -178.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 67.9 m -109.22 117.91 35.35 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.852 178.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -104.24 -175.85 2.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 -176.148 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 91.4 m -141.63 131.16 23.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.384 0.612 . . . . 0.0 112.282 -176.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.509 HG11 HG23 ' A' ' 311' ' ' VAL . 64.3 t -75.13 136.67 24.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.053 176.372 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 2.4 m -111.45 -9.04 14.24 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.97 -167.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -164.45 -168.9 1.63 Allowed 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.912 -0.492 . . . . 0.0 111.676 -177.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.16 151.71 35.1 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.77 0.795 . . . . 0.0 110.762 179.35 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -148.13 -178.38 6.26 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.315 -1.311 . . . . 0.0 109.433 -178.135 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -136.56 135.83 38.77 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -173.482 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.8 OUTLIER -112.94 95.62 5.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 161.618 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -99.88 175.49 5.76 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.662 -176.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 53.5 m -60.91 -31.39 70.9 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -177.027 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -78.55 -2.43 84.85 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.213 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 69.2 42.06 77.36 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.739 179.006 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -114.67 135.52 54.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.92 0.86 . . . . 0.0 110.856 175.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' ' 251' ' ' LEU . 2.3 p -136.51 105.29 4.41 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.507 -179.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.582 ' OG1' HG23 ' A' ' 250' ' ' THR . 90.7 m -102.82 129.84 49.62 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 121.664 -0.648 . . . . 0.0 111.365 -178.31 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.509 HG23 HG11 ' A' ' 297' ' ' VAL . 14.4 p -165.93 155.41 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.033 0.444 . . . . 0.0 110.237 174.303 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 52.4 m -96.64 149.32 21.93 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.453 -179.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.466 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.4 mp -117.21 136.62 52.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.542 -178.422 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.446 -173.915 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 25.9 m . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.873 0.368 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -132.64 144.7 50.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.5 -179.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -67.16 154.01 42.29 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.591 -178.49 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 117.25 6.1 13.98 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.201 -178.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -69.33 159.99 32.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.836 0.35 . . . . 0.0 111.162 -177.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -105.96 138.51 42.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.769 -176.235 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 77.2 t -128.09 145.1 35.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.137 0.494 . . . . 0.0 111.202 -175.436 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.513 ' HB2' ' HB3' ' A' ' 269' ' ' LYS . 36.5 m -145.02 175.54 10.15 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 172.206 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 98.7 t -116.09 122.3 69.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.917 0.389 . . . . 0.0 111.963 -174.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.428 173.563 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.701 0 N-CA-C 111.871 -0.492 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -115.72 140.11 49.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.178 0.513 . . . . 0.0 111.033 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -79.73 -22.23 43.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.26 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 100.76 12.65 36.89 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.4 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -111.74 115.7 3.94 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.17 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 26.4 m -152.21 98.93 2.47 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.497 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 2.2 mp -116.67 -176.66 3.01 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.615 -172.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 87.6 m -134.01 154.77 50.92 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.418 -176.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 41.1 t -93.87 107.26 19.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.421 ' HB2' ' HG1' ' A' ' 252' ' ' THR . 26.3 tptp -90.49 -31.19 16.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.025 0.44 . . . . 0.0 111.194 -172.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 19.2 p -128.71 -168.45 1.92 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.194 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.422 ' HB3' HG22 ' A' ' 333' ' ' VAL . 64.9 mt-30 -108.08 122.02 41.96 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-O 120.887 0.375 . . . . 0.0 110.617 -171.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.77 106.78 2.32 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 123.014 2.476 . . . . 0.0 113.264 -176.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.433 ' O ' HG21 ' A' ' 236' ' ' VAL . 10.2 t -155.33 127.93 7.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.964 0.411 . . . . 0.0 111.911 176.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.585 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -155.3 173.96 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.308 172.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.489 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 57.1 m -20.38 112.04 0.02 OUTLIER 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.535 1.534 . . . . 0.0 114.207 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -115.61 100.85 8.35 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.087 174.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -135.61 131.52 35.94 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.129 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -98.82 -47.82 5.15 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.168 -170.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.68 -23.8 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.437 0.637 . . . . 0.0 110.078 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -100.61 1.07 40.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.296 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 51.0 50.61 18.78 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.324 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 14.7 m -122.31 101.08 7.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.336 -175.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -128.58 112.55 14.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.941 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . 0.452 ' HB2' HG12 ' A' ' 236' ' ' VAL . 50.6 mt-30 -138.75 164.62 29.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 175.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.585 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 36.8 p90 -147.02 134.64 21.01 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.244 171.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 38.6 m -100.34 137.79 38.29 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.68 143.96 22.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.317 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 18.3 m -91.22 113.37 25.61 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 160.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 309' ' ' VAL . 5.1 mp -101.77 167.29 10.18 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -177.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.421 ' HG1' ' HB2' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -118.57 141.07 48.94 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.236 177.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -141.62 -143.37 4.23 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 121.227 -0.511 . . . . 0.0 111.937 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -112.15 -174.44 2.46 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -175.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.539 HG21 ' H ' ' A' ' 256' ' ' ALA . 3.0 m -67.86 173.55 4.35 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.417 -172.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.539 ' H ' HG21 ' A' ' 255' ' ' THR . . . -60.48 -176.17 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.818 0.847 . . . . 0.0 112.535 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 15.3 t 81.05 6.3 1.34 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.125 0.97 . . . . 0.0 110.619 -176.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 91.6 t -123.74 90.37 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 170.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.4 m -75.54 93.43 3.01 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.345 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 75.74 97.16 0.14 Allowed Glycine 0 N--CA 1.44 -1.068 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.068 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.466 ' HB3' HD12 ' A' ' 262' ' ' LEU . 28.5 m-85 -46.2 -58.75 3.38 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.652 0.739 . . . . 0.0 109.737 172.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.476 ' N ' HD23 ' A' ' 262' ' ' LEU . 0.0 OUTLIER -151.88 171.32 17.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.807 177.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 37.9 mtmm -136.28 -166.84 1.95 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.696 0.284 . . . . 0.0 111.765 -174.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -53.46 118.87 4.19 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.397 0.618 . . . . 0.0 111.69 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 106.31 -12.15 43.82 Favored Glycine 0 C--N 1.316 -0.557 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.118 176.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . 0.437 ' CB ' ' HB2' ' A' ' 262' ' ' LEU . 40.9 m-20 -84.47 133.23 34.48 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -94.36 147.62 23.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.326 0.584 . . . . 0.0 111.149 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.5 OUTLIER -120.48 179.59 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.4 174.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 269' ' ' LYS . 12.8 tmtt? -134.51 102.55 5.35 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 174.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -112.51 143.77 43.11 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.534 -174.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.602 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 84.8 m -127.78 89.54 2.96 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.649 0.737 . . . . 0.0 110.297 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.449 ' HA ' ' CB ' ' A' ' 337' ' ' ASP . 2.4 t-20 -102.39 95.13 6.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.562 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' THR . . . . . 0.551 ' HB ' ' OG1' ' A' ' 289' ' ' THR . 68.2 p -88.89 111.7 22.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.772 -171.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -85.21 115.94 23.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.815 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 41.1 t-105 -101.69 14.06 33.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.885 0.85 . . . . 0.0 109.503 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.404 ' N ' HD23 ' A' ' 276' ' ' LEU . 3.5 mm? -81.0 47.08 0.96 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.932 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -101.96 -46.81 4.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.724 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -59.2 -47.65 84.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.247 -173.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -73.54 -33.44 64.71 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.386 -176.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 33.4 p -78.72 -34.0 46.26 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.908 0.385 . . . . 0.0 111.097 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -85.84 -10.08 55.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.497 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 62.43 11.46 4.64 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.822 0.849 . . . . 0.0 111.197 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -177.82 -171.6 0.31 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.57 -1.196 . . . . 0.0 107.953 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 8.6 mp 61.59 71.95 0.53 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -52.54 -36.74 56.24 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.186 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 14.1 m120 65.89 167.16 0.2 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.876 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -143.17 15.5 2.33 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.488 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -136.23 119.39 16.6 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.133 0.492 . . . . 0.0 110.438 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.551 ' OG1' ' HB ' ' A' ' 273' ' ' THR . 10.0 t -90.47 149.0 40.13 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.278 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . 0.445 ' HD2' ' OG1' ' A' ' 289' ' ' THR . 35.0 Cg_exo -35.28 -58.34 0.42 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.332 3.354 . . . . 0.0 114.516 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 289' ' ' THR . 68.9 mt 64.13 95.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.401 0.62 . . . . 0.0 110.737 -176.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.23 177.26 7.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.088 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -142.71 -135.81 0.1 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.512 -169.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 48.7 m -70.49 130.87 43.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.13 0.491 . . . . 0.0 112.031 -173.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -130.11 -169.49 2.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.029 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 54.5 m -139.85 132.63 29.09 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.431 HG12 HG21 ' A' ' 311' ' ' VAL . 64.4 t -82.16 139.89 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.33 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.38 9.64 13.4 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.493 -169.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -171.82 -172.28 0.99 Allowed 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 120.568 0.223 . . . . 0.0 111.509 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.98 123.42 18.03 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.397 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.548 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -111.81 110.02 20.15 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.528 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -80.0 132.29 35.98 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -166.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.517 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 12.8 t -106.75 95.97 6.12 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 164.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.63 -178.63 3.78 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.261 -175.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 23.3 t -60.76 -34.8 75.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.971 0.415 . . . . 0.0 111.368 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -81.9 -3.12 90.68 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.687 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 65.0 41.17 97.44 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.704 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.32 125.84 54.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.385 0.612 . . . . 0.0 109.852 175.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 251' ' ' LEU . 2.0 p -127.07 94.08 2.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.946 -175.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 53.5 m -98.79 127.01 44.58 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.003 -0.435 . . . . 0.0 111.676 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.431 HG21 HG12 ' A' ' 297' ' ' VAL . 11.8 p -161.95 151.02 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 175.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 49.2 m -93.22 146.03 23.99 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.079 0.466 . . . . 0.0 110.339 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.476 ' HB2' ' CE2' ' A' ' 247' ' ' PHE . 5.7 mp -117.46 151.21 37.54 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.62 -175.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 2.8 p -100.32 135.6 41.5 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.589 173.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.462 ' O ' HG13 ' A' ' 316' ' ' VAL . . . 116.89 -171.58 13.86 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -175.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . 0.466 ' O ' HG13 ' A' ' 318' ' ' ILE . 1.5 m -157.71 170.09 9.52 Favored Pre-proline 0 N--CA 1.466 0.358 0 C-N-CA 122.985 0.514 . . . . 0.0 109.844 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.31 92.09 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.458 2.105 . . . . 0.0 110.693 169.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 316' ' ' VAL . 96.3 mt -80.95 146.69 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.528 -171.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 79.7 -13.55 0.94 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.179 0.991 . . . . 0.0 111.103 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -113.21 -62.06 1.65 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.263 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 32.1 p -88.07 52.56 2.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.449 0.642 . . . . 0.0 110.494 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 2.1 m -102.61 5.7 39.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.033 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -113.75 88.75 14.46 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.096 -174.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.42 -44.66 21.64 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 121.577 1.518 . . . . 0.0 111.165 173.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 328' ' ' SER . 13.7 mt-30 72.93 -41.37 0.5 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.753 171.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 75.73 -32.14 0.21 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.642 0.777 . . . . 0.0 112.509 172.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -111.04 -48.87 3.07 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 325' ' ' GLN . 23.1 t -74.57 102.92 4.69 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.532 173.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 34.5 t -49.63 122.58 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.078 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 19.3 m -61.06 150.61 33.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.515 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.28 142.08 57.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.917 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -88.49 149.53 23.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.095 0.474 . . . . 0.0 110.444 -174.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.422 HG22 ' HB3' ' A' ' 233' ' ' GLN . 9.5 m -77.64 150.27 5.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.76 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -137.52 148.17 45.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.085 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -97.71 172.75 7.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.049 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 112.73 11.64 14.19 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.444 176.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.602 ' HB3' ' O ' ' A' ' 271' ' ' THR . 4.3 m-20 -104.36 -170.77 1.82 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -176.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -114.32 157.17 23.15 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.155 0.503 . . . . 0.0 111.926 -172.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 39.0 t -134.42 145.8 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.28 -176.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 35.9 t -142.62 176.45 9.03 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 50.9 t -119.04 126.58 75.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.966 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 9.7 p -112.06 4.75 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 121.499 0.666 . . . . 0.0 110.979 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -81.33 169.05 50.94 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.117 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 18.9 p -120.29 -82.05 0.64 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.07 0.462 . . . . 0.0 111.272 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.898 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.14 -179.793 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.816 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -59.69 121.58 11.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.17 0.509 . . . . 0.0 111.327 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.485 ' HB3' ' HB ' ' A' ' 341' ' ' VAL . 85.0 t80 -82.71 -28.2 30.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.785 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 96.55 -1.96 62.33 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.621 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -89.77 145.14 18.13 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.073 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 23.6 m -124.32 132.03 53.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.177 0.513 . . . . 0.0 110.18 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.498 HD22 HG12 ' A' ' 309' ' ' VAL . 5.5 mt -131.3 173.36 11.14 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.576 -175.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 31.6 m -141.9 156.08 45.5 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -174.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 54.7 t -117.14 127.96 74.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 122.418 -0.177 . . . . 0.0 110.964 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.462 ' NZ ' HG23 ' A' ' 252' ' ' THR . 31.1 mtmm -112.38 -14.9 13.23 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -177.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 75.2 p -120.44 -174.09 2.72 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.23 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -106.59 106.33 57.39 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -170.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.53 ' C ' ' HB2' ' A' ' 247' ' ' PHE . 55.5 Cg_endo -69.83 103.75 1.22 Allowed 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.567 2.178 . . . . 0.0 113.6 -174.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 236' ' ' VAL . 15.1 t -157.93 129.32 6.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.714 170.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.59 ' N ' ' HA ' ' A' ' 247' ' ' PHE . 2.9 t -155.94 114.49 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 C-N-CA 122.827 0.451 . . . . 0.0 110.69 172.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.623 ' O ' ' HA ' ' A' ' 245' ' ' TYR . 23.7 m 64.57 93.65 0.06 Allowed 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.228 0.537 . . . . 0.0 111.649 176.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -109.55 84.44 1.92 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -132.52 129.06 38.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.218 -175.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.22 -35.01 7.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.78 -173.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 61.5 t -62.81 -29.56 47.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.497 0.665 . . . . 0.0 109.62 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.457 ' HA ' ' HE2' ' A' ' 242' ' ' LYS . 9.8 mmpt? -96.81 -12.46 23.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.881 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 60.7 59.92 2.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.001 -1.454 . . . . 0.0 110.55 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 36.8 m -143.93 106.27 4.4 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.151 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . 0.623 ' HA ' ' O ' ' A' ' 237' ' ' THR . 59.0 m-85 -129.07 118.17 22.07 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 236' ' ' VAL . 45.0 mt-30 -130.54 -179.16 5.12 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.59 ' HA ' ' N ' ' A' ' 236' ' ' VAL . 13.0 p90 -160.26 136.8 8.89 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.238 165.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.503 ' OG1' HG22 ' A' ' 236' ' ' VAL . 32.8 m -102.66 138.41 39.6 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.438 ' HB ' ' CD1' ' A' ' 251' ' ' LEU . 0.1 OUTLIER -144.92 151.15 15.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.712 -0.795 . . . . 0.0 112.11 -178.336 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.597 HG23 ' OG1' ' A' ' 310' ' ' THR . 91.7 m -103.14 104.85 15.04 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 168.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.497 ' HB2' ' O ' ' A' ' 309' ' ' VAL . 5.1 mp -102.7 167.78 9.68 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -169.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.462 HG23 ' NZ ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -114.68 151.37 33.71 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.91 172.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -150.97 -142.67 3.57 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 121.197 -0.525 . . . . 0.0 111.907 -173.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.576 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -107.42 -174.59 2.57 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.549 HG23 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -69.48 -177.8 1.26 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.41 -172.043 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.549 ' H ' HG23 ' A' ' 255' ' ' THR . . . -64.39 -175.98 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.825 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 49.8 m 80.24 9.05 1.36 Allowed 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.489 0.716 . . . . 0.0 111.287 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 28.6 t -126.85 90.07 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 171.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.9 m -70.9 93.76 1.01 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.892 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 73.62 98.0 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.217 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.463 ' CE1' HD23 ' A' ' 228' ' ' LEU . 6.3 m-85 -44.99 -58.67 3.02 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.816 0.817 . . . . 0.0 109.824 171.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.479 ' HB3' ' HB2' ' A' ' 266' ' ' ASP . 77.8 mt -140.78 169.15 18.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.31 -1.314 . . . . 0.0 109.051 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -133.25 -167.33 1.91 Allowed 'General case' 0 C--N 1.323 -0.554 0 O-C-N 123.079 0.237 . . . . 0.0 110.502 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -59.93 116.28 4.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.286 0.565 . . . . 0.0 111.171 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 111.7 -14.37 27.09 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.547 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . 0.479 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 37.3 m-20 -81.0 128.23 33.46 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.938 0.399 . . . . 0.0 110.292 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.97 150.93 22.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.449 0.642 . . . . 0.0 111.759 -173.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.42 HG11 HG21 ' A' ' 341' ' ' VAL . 1.3 m -131.38 171.71 17.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.276 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.475 ' HD2' HG12 ' A' ' 342' ' ' VAL . 0.0 OUTLIER -143.77 129.21 18.99 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.2 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -130.4 158.51 39.67 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.128 -174.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.67 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 93.2 m -108.7 86.89 2.37 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.163 -173.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -116.1 89.96 3.23 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 19.6 p -76.62 85.9 3.29 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.531 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -86.64 157.57 19.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.273 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.471 ' HA ' ' HB2' ' A' ' 279' ' ' GLN . 9.3 p-90 -158.23 81.16 0.84 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.047 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.6 ' HB2' ' OD1' ' A' ' 320' ' ' ASP . 2.9 mm? -107.38 -74.93 0.64 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.39 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . 0.524 ' OE1' ' HA ' ' A' ' 321' ' ' THR . 69.4 mt-30 -106.39 -56.1 2.24 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -174.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 320' ' ' ASP . 75.8 mt-30 -74.6 -59.85 2.55 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.546 0.689 . . . . 0.0 110.16 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.471 ' HB2' ' HA ' ' A' ' 275' ' ' TRP . 12.5 mm100 -70.76 9.3 0.69 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.46 -1.246 . . . . 0.0 113.38 -170.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.64 -45.21 8.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.81 0.338 . . . . 0.0 110.445 171.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -92.02 -37.25 12.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.056 0.455 . . . . 0.0 110.489 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 61.72 19.7 10.74 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.445 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.406 ' HB3' HD22 ' A' ' 284' ' ' LEU . . . 67.16 -57.02 0.43 Allowed 'General case' 0 CA--C 1.532 0.253 0 O-C-N 124.589 1.181 . . . . 0.0 112.163 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.406 HD22 ' HB3' ' A' ' 283' ' ' ALA . 1.1 mm? -106.11 -4.7 20.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.726 0.298 . . . . 0.0 110.596 -177.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 60.51 92.31 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.407 -172.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -96.71 -41.28 8.57 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.51 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 102.66 24.16 8.37 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.313 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -149.65 -171.39 3.88 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 120.945 0.402 . . . . 0.0 110.24 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.603 ' OG1' ' HD2' ' A' ' 290' ' ' PRO . 9.3 t -172.11 158.35 4.2 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . 0.603 ' HD2' ' OG1' ' A' ' 289' ' ' THR . 6.6 Cg_endo -49.45 118.34 3.6 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.835 2.357 . . . . 0.0 112.109 177.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 50.0 mm -75.59 -60.6 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.462 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 36.9 m -132.04 143.31 49.96 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.4 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -145.29 154.25 42.15 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.07 0.462 . . . . 0.0 110.439 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 86.7 m -89.31 134.75 33.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.87 -172.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -129.03 -174.19 3.19 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 177.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 80.0 m -142.48 135.36 28.34 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.476 HG13 HG22 ' A' ' 311' ' ' VAL . 58.2 t -78.31 140.53 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.832 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 4.0 m -116.31 1.57 13.09 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -161.56 176.96 10.48 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.908 -0.495 . . . . 0.0 111.517 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.93 104.96 0.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.23 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -93.22 103.42 15.69 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.797 -174.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -61.0 135.07 57.68 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -171.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.07 97.49 6.25 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 162.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.4 174.11 6.85 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.715 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 42.5 m -57.05 -33.74 67.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -77.74 -3.05 83.1 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.449 -176.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 72.73 41.26 50.68 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.246 -178.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -113.37 146.25 39.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.687 0.743 . . . . 0.0 110.909 174.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.498 HG12 HD22 ' A' ' 228' ' ' LEU . 2.2 p -145.56 102.19 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.414 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.597 ' OG1' HG23 ' A' ' 250' ' ' THR . 91.0 m -102.42 124.17 47.5 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.514 -0.741 . . . . 0.0 111.032 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.476 HG22 HG13 ' A' ' 297' ' ' VAL . 14.8 p -160.15 154.31 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.134 0.493 . . . . 0.0 110.213 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 47.0 m -97.87 152.39 19.24 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.65 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.442 HD13 ' CE1' ' A' ' 247' ' ' PHE . 5.7 mp -119.89 135.19 54.98 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.632 -177.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 27.7 p -122.51 151.43 41.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.807 0.337 . . . . 0.0 111.598 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 78.67 50.06 6.24 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.959 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . 0.456 HG21 ' CD2' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -138.37 85.62 17.87 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 121.079 0.466 . . . . 0.0 111.425 -174.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -76.5 78.54 3.27 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.943 2.428 . . . . 0.0 112.444 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 11.0 mm -83.57 128.36 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.382 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -115.69 134.88 54.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.125 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.6 ' OD1' ' HB2' ' A' ' 276' ' ' LEU . 24.3 t70 -172.98 -38.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.358 174.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.524 ' HA ' ' OE1' ' A' ' 277' ' ' GLN . 0.0 OUTLIER -82.75 73.95 9.74 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.449 176.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 4.9 m -80.78 -23.04 39.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.555 0.693 . . . . 0.0 110.087 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -66.4 136.83 95.17 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.37 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.41 20.23 0.43 Allowed 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.81 1.674 . . . . 0.0 113.943 -174.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 74.44 -50.81 0.68 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.648 0.779 . . . . 0.0 112.912 173.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 65.07 22.72 12.38 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.478 0.656 . . . . 0.0 109.6 -174.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -176.87 159.77 1.78 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -173.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 20.4 m -75.85 90.44 2.93 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.398 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 23.7 t 64.85 103.48 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.984 -177.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 19.3 p -98.42 -69.41 0.76 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.182 -176.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -102.29 153.57 19.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.747 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -133.55 -177.33 4.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.321 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.401 HG22 ' N ' ' A' ' 334' ' ' GLU . 13.1 p -88.98 166.03 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . 0.401 ' N ' HG22 ' A' ' 333' ' ' VAL . 10.4 tp10 -119.87 147.81 44.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.978 0.418 . . . . 0.0 110.485 -175.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -85.85 173.5 9.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.213 -176.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 112.58 11.5 14.8 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.417 173.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.67 ' HB2' ' O ' ' A' ' 271' ' ' THR . 4.9 p-10 -91.05 179.87 5.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.998 0.428 . . . . 0.0 111.52 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -118.04 137.63 52.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.442 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 55.9 t -116.48 150.78 18.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.458 -172.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 41.9 m -146.73 173.22 12.57 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 172.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 224' ' ' PHE . 86.1 t -117.85 132.99 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -171.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.475 HG12 ' HD2' ' A' ' 269' ' ' LYS . 32.6 m -117.14 10.4 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 111.561 174.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -97.49 96.41 1.82 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.603 -177.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 8.5 p -127.07 -67.15 0.86 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.287 0.565 . . . . 0.0 109.742 175.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.947 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.955 177.503 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.56 0 N-CA-C 112.184 -0.366 . . . . 0.0 112.184 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -87.21 52.2 2.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.331 0.586 . . . . 0.0 110.631 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -82.46 46.51 1.06 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.779 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 67.12 36.68 90.74 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.054 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -41.23 115.51 0.75 Allowed Glycine 0 C--N 1.338 0.653 0 O-C-N 124.18 0.576 . . . . 0.0 113.167 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 21.2 m -107.53 142.66 37.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.04 0.448 . . . . 0.0 110.72 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.465 HD21 ' CZ ' ' A' ' 261' ' ' PHE . 20.4 mt -143.03 175.93 9.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.269 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.56 ' O ' ' HB3' ' A' ' 251' ' ' LEU . 43.6 m -131.7 152.69 50.7 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.414 0.149 . . . . 0.0 110.615 -176.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.448 HG23 ' CG2' ' A' ' 339' ' ' VAL . 12.2 t -100.03 127.9 52.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 176.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -110.96 -29.1 8.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.373 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.45 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 72.7 p -119.87 -169.33 1.76 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.688 0.28 . . . . 0.0 110.732 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.578 ' HB3' ' HB ' ' A' ' 333' ' ' VAL . 85.1 mt-30 -112.76 125.68 29.52 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -172.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 248' ' ' THR . 10.0 Cg_endo -92.71 106.39 0.19 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.337 2.691 . . . . 0.0 115.728 -168.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.491 ' O ' HG22 ' A' ' 236' ' ' VAL . 1.2 m -157.52 133.23 9.22 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 165.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.665 ' N ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -158.24 139.6 4.92 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.807 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 176.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 97.7 m 69.12 108.51 0.05 Allowed 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.494 0.718 . . . . 0.0 112.635 170.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.411 ' OH ' ' HD2' ' A' ' 319' ' ' TYR . 4.4 m-85 -116.31 99.81 7.46 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.437 175.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.53 88.31 2.79 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -83.63 -44.32 14.69 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.773 -163.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 22.8 t -66.47 -23.18 31.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.629 0.728 . . . . 0.0 109.145 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -99.87 -3.75 31.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.888 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 36.1 t70 57.39 68.85 0.8 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.35 -1.296 . . . . 0.0 111.729 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 24.4 t -152.9 119.76 5.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.513 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -129.6 128.51 42.83 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -121.8 -174.74 2.94 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.665 ' HA ' ' N ' ' A' ' 236' ' ' VAL . 1.8 p90 -156.71 125.74 5.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 174.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 52.9 m -95.41 142.29 27.96 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.07 137.92 24.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 119.786 -0.766 . . . . 0.0 112.391 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.45 ' HB ' ' CG2' ' A' ' 232' ' ' THR . 92.2 m -98.43 113.36 25.32 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 168.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.58 ' HB2' HG13 ' A' ' 309' ' ' VAL . 1.4 mp -107.85 168.68 9.1 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -175.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.76 139.4 41.24 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.187 172.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -141.86 -149.41 5.19 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.275 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -96.25 -174.23 3.01 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 256' ' ' ALA . 2.8 m -77.01 175.73 9.31 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.021 -170.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.559 ' H ' HG22 ' A' ' 255' ' ' THR . . . -65.03 -176.39 0.28 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.446 0.698 . . . . 0.0 112.275 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 24.8 t 80.2 6.97 1.62 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.834 0.854 . . . . 0.0 110.517 -176.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 24.0 t -123.37 90.71 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 170.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 5.6 m -73.44 92.45 1.86 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.654 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 80.77 94.2 0.43 Allowed Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.958 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.465 ' CZ ' HD21 ' A' ' 228' ' ' LEU . 4.1 m-85 -43.5 -55.35 4.28 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 169.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.8 pp -165.51 173.85 10.55 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.568 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 60.3 mttp -143.23 -166.32 2.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.997 0.427 . . . . 0.0 111.836 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -53.54 122.74 10.38 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.162 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 109.92 -16.01 30.89 Favored Glycine 0 C--N 1.313 -0.718 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.7 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -84.35 139.43 32.28 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.424 ' HB2' HG12 ' A' ' 342' ' ' VAL . 27.5 mt-30 -107.91 151.92 25.13 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.389 0.614 . . . . 0.0 110.765 -178.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.4 OUTLIER -132.4 176.18 9.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.397 -179.24 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -123.64 143.24 50.37 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 172.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . 0.463 ' CE2' ' HB2' ' A' ' 295' ' ' ALA . 17.2 p90 -136.68 142.5 43.16 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 173.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 25.7 p -150.17 109.69 4.01 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.876 -174.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.496 HD21 ' HG3' ' A' ' 334' ' ' GLU . 24.1 p-10 -109.19 147.38 32.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.555 0.693 . . . . 0.0 111.802 -176.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 20.3 p -121.79 81.44 1.81 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.495 168.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -146.96 140.33 25.52 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.15 -172.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -86.43 121.73 29.39 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.327 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -78.93 102.46 8.28 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . 0.569 ' O ' ' HG2' ' A' ' 281' ' ' LYS . 96.7 mt-30 -56.49 -29.58 61.94 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -172.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -71.03 -45.15 64.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.125 0.488 . . . . 0.0 110.437 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.405 ' HG2' ' NE2' ' A' ' 332' ' ' GLN . 11.4 mm-40 -72.05 -36.81 69.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.986 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 34.4 p -69.01 -12.15 61.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.674 0.273 . . . . 0.0 111.562 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 277' ' ' GLN . 47.1 mmtm -63.45 -43.91 95.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.369 0.604 . . . . 0.0 109.378 171.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -84.51 -58.81 2.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.907 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 49.46 65.07 1.5 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.187 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -107.81 -40.97 5.12 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.148 176.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -136.39 23.61 3.2 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.904 -175.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -93.57 -54.72 3.54 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.042 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 86.09 -64.55 4.03 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.241 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -162.42 -151.31 0.2 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 6.9 t -77.22 125.55 86.38 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-O 120.959 0.409 . . . . 0.0 110.294 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.69 141.64 24.93 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.521 2.147 . . . . 0.0 111.738 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 41.4 pt -89.08 132.16 34.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.047 0.451 . . . . 0.0 110.582 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.33 -165.85 1.34 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.004 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -161.71 -144.16 0.09 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 -168.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 56.0 m -74.77 137.04 41.71 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -175.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . 0.463 ' HB2' ' CE2' ' A' ' 270' ' ' PHE . . . -124.92 172.4 9.41 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 173.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 87.1 m -134.21 129.54 35.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.473 0.654 . . . . 0.0 112.474 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.47 HG13 ' H ' ' A' ' 299' ' ' ALA . 93.3 t -89.87 140.69 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.047 -177.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 1.9 m -125.06 23.86 7.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.009 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -156.29 -177.25 6.45 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -76.83 165.57 24.52 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.775 -174.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.605 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -147.5 155.61 42.05 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.688 -175.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -128.99 133.1 47.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.263 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.8 OUTLIER -111.51 95.45 5.51 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 164.141 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.15 169.37 8.48 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.554 -0.459 . . . . 0.0 110.444 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 67.0 m -57.95 -30.3 65.87 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -76.85 7.51 34.17 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.622 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 59.89 41.88 97.94 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.219 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -121.78 117.98 27.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.316 0.558 . . . . 0.0 111.242 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.58 HG13 ' HB2' ' A' ' 251' ' ' LEU . 2.6 p -125.42 125.42 68.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.982 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 86.2 m -120.21 135.67 54.9 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 121.729 -0.607 . . . . 0.0 111.249 -177.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.576 ' CG1' ' HB3' ' A' ' 301' ' ' ALA . 6.6 m -146.76 165.21 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.143 0.497 . . . . 0.0 110.445 175.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 28.3 m -121.95 136.32 54.92 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.691 173.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 4.2 mp -112.8 158.93 19.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.999 -173.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 14.3 m -133.15 140.07 47.41 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.863 0.363 . . . . 0.0 111.561 -176.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 101.06 78.77 1.37 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.65 170.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 1.9 m -146.13 129.18 8.15 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 120.618 0.247 . . . . 0.0 110.695 173.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -81.67 48.43 2.85 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.65 2.233 . . . . 0.0 111.376 175.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.513 HG12 ' CD2' ' A' ' 319' ' ' TYR . 20.7 tt -83.97 133.46 29.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.952 -175.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 0.513 ' CD2' HG12 ' A' ' 318' ' ' ILE . 49.0 m-85 73.02 36.05 0.9 Allowed 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.028 176.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -76.05 -58.91 3.0 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.463 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.448 ' HB ' ' H ' ' A' ' 322' ' ' THR . 2.6 p -149.68 -155.22 0.61 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' THR . . . . . 0.448 ' H ' ' HB ' ' A' ' 321' ' ' THR . 23.9 m -99.58 -39.28 8.38 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.422 0.63 . . . . 0.0 109.761 176.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -137.65 68.24 51.96 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.511 -169.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -59.96 -67.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.171 1.914 . . . . 0.0 111.932 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' A' ' 326' ' ' TYR . 26.4 mm-40 -107.38 67.0 0.68 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 325' ' ' GLN . 69.8 m-85 73.25 -39.92 0.46 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.305 -176.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -172.28 114.81 0.32 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 170.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 9.3 m -144.15 111.11 5.75 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.769 -0.582 . . . . 0.0 111.277 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 5.5 t 58.76 42.22 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-O 121.907 0.86 . . . . 0.0 111.186 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 9.6 t -80.14 57.63 2.76 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 173.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -92.32 144.2 25.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.623 -173.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . 0.511 ' HA ' ' HH ' ' A' ' 319' ' ' TYR . 25.9 mp0 -121.85 123.0 40.73 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 168.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.578 ' HB ' ' HB3' ' A' ' 233' ' ' GLN . 28.8 m -44.8 107.34 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.991 0.901 . . . . 0.0 112.962 -168.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . 0.496 ' HG3' HD21 ' A' ' 272' ' ' ASN . 1.0 OUTLIER -109.19 145.74 35.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.402 -178.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -99.97 156.29 17.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.653 174.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 106.86 8.89 31.32 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.487 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.443 ' HB3' ' CG2' ' A' ' 230' ' ' VAL . 10.6 t70 -66.01 150.45 48.65 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.781 0.324 . . . . 0.0 110.854 178.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -98.52 112.64 24.61 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.448 ' CG2' HG23 ' A' ' 230' ' ' VAL . 57.4 t -97.09 148.85 5.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.387 0.613 . . . . 0.0 111.654 -170.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 65.5 m -143.67 171.58 13.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.762 173.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.508 HG13 ' H ' ' A' ' 343' ' ' GLY . 24.1 t -119.25 141.85 37.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.424 HG12 ' HB2' ' A' ' 267' ' ' GLN . 8.4 p -73.91 -28.41 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.085 0.469 . . . . 0.0 110.555 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . 0.508 ' H ' HG13 ' A' ' 341' ' ' VAL . . . 158.88 -174.87 35.92 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 17.6 p -102.17 -75.8 0.59 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.103 0.478 . . . . 0.0 110.55 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.033 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.725 178.051 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.817 0 N-CA-C 112.267 -0.333 . . . . 0.0 112.267 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -117.69 -78.32 0.58 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.505 0.193 . . . . 0.0 110.629 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -99.79 178.0 4.96 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 111.24 3.06 27.85 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.735 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -80.26 122.26 5.69 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.088 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 20.8 m -152.36 96.22 2.14 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 175.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.465 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 4.0 mp -122.73 -179.25 4.17 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.889 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 48.3 m -134.34 162.72 31.41 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.529 -175.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 94.4 t -108.24 130.88 60.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.401 ' HB2' HG23 ' A' ' 252' ' ' THR . 27.2 tptp -108.53 -15.21 14.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.874 0.369 . . . . 0.0 111.482 -173.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 20.6 p -138.44 -169.54 2.62 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.206 -173.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.433 ' HB3' ' HB ' ' A' ' 333' ' ' VAL . 74.7 mt-30 -105.02 118.24 56.6 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.248 -172.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.42 ' HA ' HG21 ' A' ' 249' ' ' VAL . 44.3 Cg_endo -68.78 106.15 1.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.716 2.277 . . . . 0.0 111.997 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.454 ' O ' HG21 ' A' ' 236' ' ' VAL . 10.9 t -154.88 124.06 6.33 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.575 -0.45 . . . . 0.0 112.095 -178.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.565 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 1.1 t -154.05 168.89 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.606 171.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.482 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 74.6 m -14.73 112.96 0.02 OUTLIER 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.725 1.61 . . . . 0.0 114.472 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -106.41 88.57 2.81 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 172.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -125.89 139.32 53.56 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.366 0.603 . . . . 0.0 110.236 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.468 ' CB ' ' HH ' ' A' ' 245' ' ' TYR . . . -106.22 -44.58 4.52 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.558 -173.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 63.1 t -61.04 -36.71 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.263 0.554 . . . . 0.0 110.167 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -88.14 -5.48 58.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.316 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 22.4 t70 50.91 67.45 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.036 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.5 m -144.75 100.89 3.58 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.589 -175.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . 0.468 ' HH ' ' CB ' ' A' ' 240' ' ' ALA . 47.0 m-85 -121.49 100.89 7.28 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . 0.487 ' HB2' ' CG1' ' A' ' 236' ' ' VAL . 80.0 mt-30 -127.6 178.97 5.76 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.629 -171.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.565 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 2.1 p90 -156.64 125.63 5.97 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 19.5 m -95.4 134.53 38.1 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.446 ' HB ' ' CD1' ' A' ' 251' ' ' LEU . 0.2 OUTLIER -141.95 146.71 22.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.676 -178.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.464 HG22 ' OG1' ' A' ' 310' ' ' THR . 95.2 m -96.69 112.79 24.4 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 164.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.481 ' HB2' HG11 ' A' ' 309' ' ' VAL . 5.3 mp -102.46 169.16 8.84 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -176.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.401 HG23 ' HB2' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -127.57 108.69 11.0 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.68 0.276 . . . . 0.0 111.628 -177.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.541 ' N ' HG12 ' A' ' 309' ' ' VAL . . . -147.39 135.81 5.8 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 177.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -108.34 93.98 4.82 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -172.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.482 ' HB ' ' OG ' ' A' ' 303' ' ' SER . 10.1 m -126.29 118.97 26.21 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 170.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -73.04 136.82 45.05 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 70.8 m 59.89 55.58 3.8 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.119 174.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 94.6 t -131.74 95.37 2.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.25 0.548 . . . . 0.0 109.858 174.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 27.4 m -74.15 97.63 2.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.143 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 71.23 99.7 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.844 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.523 ' CE2' ' HB2' ' A' ' 303' ' ' SER . 11.6 m-85 -48.02 -59.18 3.56 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.324 0.583 . . . . 0.0 110.34 170.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 61.3 mt -143.57 173.52 11.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.537 -173.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -130.7 -169.86 2.23 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.818 0.342 . . . . 0.0 111.172 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -57.95 114.05 2.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.563 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 111.14 -1.6 28.33 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.846 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -87.59 145.32 26.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.704 0.252 . . . . 0.0 110.556 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -102.23 149.23 24.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.48 0.657 . . . . 0.0 111.124 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.483 HG22 ' HB2' ' A' ' 295' ' ' ALA . 0.1 OUTLIER -132.22 174.33 13.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.542 178.357 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 293' ' ' PHE . 5.6 mptp? -110.23 135.83 50.38 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 172.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . 0.682 ' O ' ' HA ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -142.65 105.87 4.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.806 0.812 . . . . 0.0 110.566 178.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.567 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 31.4 m -81.15 86.06 6.24 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -108.97 86.5 2.29 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.93 -170.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 22.8 p -114.27 98.42 6.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.198 0.523 . . . . 0.0 112.26 -173.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -165.41 174.33 10.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.6 174.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 35.0 p-90 -144.14 151.91 40.2 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 82.5 mt -108.66 140.27 42.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.132 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -72.46 -10.4 59.74 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.127 0.489 . . . . 0.0 110.619 -178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -86.8 -51.97 5.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.298 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -66.84 -26.7 67.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.712 -174.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 17.7 p -59.96 -34.05 72.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.032 0.444 . . . . 0.0 111.179 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -82.15 -33.3 29.65 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.024 0.44 . . . . 0.0 110.008 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -66.64 -36.39 82.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.022 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.646 ' HB1' ' O ' ' A' ' 286' ' ' ASN . . . -99.33 28.42 4.55 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.359 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 8.3 mp 64.72 63.85 0.7 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.349 171.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 69.75 25.37 5.12 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.289 1.042 . . . . 0.0 110.319 173.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.646 ' O ' ' HB1' ' A' ' 283' ' ' ALA . 2.3 t30 -144.85 138.11 26.79 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.5 -1.682 . . . . 0.0 108.318 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -104.3 -128.54 6.3 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.463 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -167.34 124.9 1.23 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 93.9 m -147.73 116.35 4.2 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.774 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.51 127.54 18.55 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.432 2.088 . . . . 0.0 111.188 174.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 18.5 tt -63.08 -35.98 73.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.378 -172.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.95 -147.76 0.12 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 175.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . 0.682 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 2.2 p90 -109.77 88.36 2.73 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -166.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 92.3 m -151.63 112.03 4.15 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 122.061 -0.4 . . . . 0.0 110.975 175.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . 0.511 ' HB3' ' CD2' ' A' ' 270' ' ' PHE . . . -131.35 -177.1 4.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.555 0.217 . . . . 0.0 111.197 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 7.5 m -143.39 131.56 21.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.876 0.846 . . . . 0.0 113.061 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.48 HG13 ' CG2' ' A' ' 311' ' ' VAL . 63.2 t -76.75 141.55 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 113.551 -1.658 . . . . 0.0 111.135 -178.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 15.1 m -110.35 -14.23 14.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -176.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -162.03 -175.63 4.74 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 122.158 -0.339 . . . . 0.0 111.266 -177.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -59.15 113.99 2.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.029 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -94.87 101.5 13.3 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.476 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' A' ' 309' ' ' VAL . 5.1 m-20 -58.55 127.3 31.49 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.708 -174.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.523 ' HB2' ' CE2' ' A' ' 261' ' ' PHE . 30.2 t -114.97 113.39 24.06 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 120.73 0.3 . . . . 0.0 111.267 172.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -127.16 152.21 47.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 170.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 10.8 t -74.72 -4.31 36.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.712 -172.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -68.63 -11.46 62.56 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 172.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 92.55 37.12 5.93 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.067 -0.567 . . . . 0.0 113.384 176.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -125.81 141.9 51.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 117.225 0.513 . . . . 0.0 111.407 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 302' ' ' ASN . 1.6 p -152.24 100.37 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.16 174.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.464 ' OG1' HG22 ' A' ' 250' ' ' THR . 63.8 m -93.15 129.83 39.02 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.521 -0.737 . . . . 0.0 110.824 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.48 ' CG2' HG13 ' A' ' 297' ' ' VAL . 2.1 p -157.61 141.92 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 54.7 m -94.48 147.67 23.02 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.047 0.451 . . . . 0.0 110.122 175.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.427 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.0 mp -131.54 170.82 14.19 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.717 -174.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 29.8 p -132.91 157.17 45.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.066 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 94.18 72.85 1.19 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.151 -0.547 . . . . 0.0 113.809 171.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . 0.471 HG12 ' CE2' ' A' ' 247' ' ' PHE . 2.6 m -148.44 158.61 40.44 Favored Pre-proline 0 N--CA 1.466 0.342 0 CA-C-N 116.929 0.364 . . . . 0.0 111.462 177.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -96.8 47.01 0.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.086 2.524 . . . . 0.0 110.838 167.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 82.7 mt -118.45 122.38 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.193 -176.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -66.4 153.89 41.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.254 0.55 . . . . 0.0 111.857 -176.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.421 ' HA ' ' OG1' ' A' ' 235' ' ' THR . 13.0 p-10 -86.45 29.71 0.75 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.961 -173.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 20.6 p 45.78 42.05 8.3 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 173.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 7.3 p -118.1 100.41 7.52 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 175.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -150.11 159.36 35.49 Favored Pre-proline 0 C--N 1.312 -1.038 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.146 -169.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.506 ' HB2' ' CE1' ' A' ' 326' ' ' TYR . 84.6 Cg_endo -79.99 103.65 1.58 Allowed 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.297 1.998 . . . . 0.0 111.518 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -58.59 -67.46 0.36 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.791 -1.549 . . . . 0.0 111.271 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . 0.506 ' CE1' ' HB2' ' A' ' 324' ' ' PRO . 17.6 m-85 69.2 -45.96 0.56 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.677 0.791 . . . . 0.0 112.824 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -99.81 -76.87 0.54 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.671 0.272 . . . . 0.0 110.378 -174.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 10.2 p -163.05 -70.16 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.487 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 23.0 t -69.17 126.91 30.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.087 0.47 . . . . 0.0 110.587 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 12.1 m -87.0 160.61 18.58 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.61 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -73.05 111.57 8.29 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 174.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -123.03 153.18 40.18 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.995 0.426 . . . . 0.0 111.132 -169.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.471 HG11 ' H ' ' A' ' 334' ' ' GLU . 2.9 t -88.31 168.99 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.006 177.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . 0.471 ' H ' HG11 ' A' ' 333' ' ' VAL . 33.7 tt0 -115.11 134.83 54.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.683 0.277 . . . . 0.0 111.118 -174.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -97.85 173.06 7.27 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.674 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 117.73 1.97 17.14 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.432 -0.89 . . . . 0.0 113.879 170.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' A' ' 271' ' ' THR . 10.7 p-10 -79.47 173.01 13.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.079 0.439 . . . . 0.0 111.484 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -110.84 148.7 31.85 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.255 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.465 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 73.9 t -127.28 150.74 33.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.841 0.353 . . . . 0.0 111.82 -169.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.504 ' HB3' ' HB2' ' A' ' 269' ' ' LYS . 31.0 t -151.74 178.03 9.79 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 175.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 58.9 t -119.19 144.03 28.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 122.338 -0.226 . . . . 0.0 110.971 -176.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 50.7 t -71.21 -47.01 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.073 0 CA-C-O 121.061 0.457 . . . . 0.0 110.037 174.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 126.38 174.73 13.92 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.008 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 13.2 p -132.85 -74.64 0.5 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.235 0.541 . . . . 0.0 110.288 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.809 177.932 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 63.26 18.98 11.4 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 122.97 0.508 . . . . 0.0 111.931 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.547 ' HD1' ' N ' ' A' ' 225' ' ' GLY . 0.5 OUTLIER -94.58 122.12 36.84 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -178.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.547 ' N ' ' HD1' ' A' ' 224' ' ' PHE . . . 85.59 28.96 28.19 Favored Glycine 0 CA--C 1.501 -0.84 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 176.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -49.9 114.49 2.44 Favored Glycine 0 N--CA 1.454 -0.109 0 CA-C-N 114.52 -0.84 . . . . 0.0 112.618 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 23.7 m -136.34 136.56 39.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.978 0.418 . . . . 0.0 110.705 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.495 ' HB2' ' CG1' ' A' ' 339' ' ' VAL . 1.2 mp -139.51 175.75 9.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.752 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 24.7 m -130.63 160.24 34.81 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.482 HG21 ' CG2' ' A' ' 339' ' ' VAL . 73.8 t -118.42 147.01 22.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 122.304 -0.248 . . . . 0.0 110.692 174.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -117.6 -19.02 9.56 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.406 ' HG1' ' CB ' ' A' ' 250' ' ' THR . 39.6 p -124.7 -167.61 1.69 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -112.7 131.01 22.9 Favored Pre-proline 0 C--N 1.316 -0.881 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -173.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.459 ' HA ' HG21 ' A' ' 249' ' ' VAL . 35.2 Cg_endo -66.95 104.04 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.06 1.84 . . . . 0.0 111.545 177.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 5.0 t -154.91 116.86 4.16 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.416 0.627 . . . . 0.0 111.778 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.636 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.5 174.42 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 168.404 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.458 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 66.9 m -37.62 110.03 0.11 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -174.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -112.18 83.96 1.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.042 170.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -110.96 132.86 53.85 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.39 -39.91 5.75 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.733 -170.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.45 -27.21 42.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.471 0.653 . . . . 0.0 109.938 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -96.33 -13.93 22.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.837 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 60.45 68.46 0.76 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.471 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 41.7 m -149.08 100.86 3.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.36 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -116.84 109.74 17.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.551 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.41 161.44 32.44 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 172.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.636 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 0.7 OUTLIER -160.12 133.67 7.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.471 0.176 . . . . 0.0 111.109 179.056 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 48.2 m -108.47 143.1 37.89 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 122.35 -0.218 . . . . 0.0 110.506 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.501 HG23 ' CD2' ' A' ' 313' ' ' LEU . 0.4 OUTLIER -146.09 148.36 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.923 178.612 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.58 HG21 ' OG1' ' A' ' 310' ' ' THR . 28.2 m -97.68 114.47 26.44 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 169.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 309' ' ' VAL . 4.9 mp -109.81 164.79 12.24 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 -175.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.83 140.42 52.95 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -135.22 -143.32 4.73 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.388 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.498 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -108.75 -176.5 3.06 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.981 0.419 . . . . 0.0 112.102 -177.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.556 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.6 OUTLIER -68.94 -179.54 1.51 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.146 -171.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.556 ' H ' HG22 ' A' ' 255' ' ' THR . . . -60.49 -177.39 0.07 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.233 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 46.9 m 79.48 6.19 2.01 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.734 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 10.9 t -124.29 89.51 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.799 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 171.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 11.6 m -73.22 98.38 2.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.831 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 61.84 98.82 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.842 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -43.1 -56.36 3.41 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.827 0.346 . . . . 0.0 111.139 173.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.54 167.08 23.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.928 -177.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.418 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 48.6 mtmt -137.25 -166.34 1.91 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -176.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -46.68 116.09 1.23 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.983 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.529 ' HA2' ' OH ' ' A' ' 319' ' ' TYR . . . 117.5 -10.53 14.45 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.092 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -101.96 138.6 38.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.951 0.405 . . . . 0.0 110.829 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -107.24 153.43 22.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.32 0.581 . . . . 0.0 110.191 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.489 HG21 ' HB2' ' A' ' 295' ' ' ALA . 1.7 m -133.97 168.2 24.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 176.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.32 135.27 32.03 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.067 170.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . 0.575 ' HB3' ' HA ' ' A' ' 339' ' ' VAL . 35.1 p90 -147.64 167.39 24.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.83 -0.168 . . . . 0.0 111.21 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.416 ' HB ' ' HA ' ' A' ' 292' ' ' SER . 1.8 t -158.24 119.06 3.4 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.379 0.609 . . . . 0.0 112.19 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.548 ' HB2' ' CA ' ' A' ' 337' ' ' ASP . 51.0 t30 -123.47 79.39 1.68 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 160.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 2.0 p -107.48 87.23 2.45 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.394 -173.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -85.79 114.55 22.83 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 175.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 6.1 p90 37.2 53.5 1.24 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 124.273 0.983 . . . . 0.0 112.98 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.37 153.46 29.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.616 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -74.42 -10.19 59.33 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-O 121.124 0.488 . . . . 0.0 110.858 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -88.34 -2.22 58.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.878 -172.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.421 ' OE1' ' HB ' ' A' ' 289' ' ' THR . 46.0 mt-30 -47.92 -67.91 0.23 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.588 176.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 16.6 p -118.85 -82.12 0.64 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.949 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -113.12 -70.97 0.78 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.984 0.421 . . . . 0.0 110.499 174.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -117.49 -24.43 7.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.021 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 53.96 82.21 0.09 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.47 -0.787 . . . . 0.0 112.344 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 6.7 mp -84.55 -39.56 18.64 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.608 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -110.36 101.27 10.01 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.766 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -83.16 147.75 27.87 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.292 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -153.95 -46.13 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -136.63 116.88 13.52 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 173.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.421 ' HB ' ' OE1' ' A' ' 279' ' ' GLN . 1.9 t -122.33 88.51 48.89 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 121.495 0.664 . . . . 0.0 111.267 -173.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -95.89 -157.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.479 2.786 . . . . 0.0 112.499 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 47.5 mm 75.86 120.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.576 0.703 . . . . 0.0 111.634 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' SER . . . . . 0.416 ' HA ' ' HB ' ' A' ' 271' ' ' THR . 30.4 p -105.59 171.66 7.21 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.304 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -127.11 137.19 52.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.099 0.476 . . . . 0.0 110.101 175.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 85.7 m -82.45 136.32 34.95 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.886 -174.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . 0.489 ' HB2' HG21 ' A' ' 268' ' ' VAL . . . -114.85 177.04 4.79 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.877 176.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 7.2 m -141.02 114.14 8.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.457 0.646 . . . . 0.0 111.398 177.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 67.3 t -75.51 131.77 34.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.013 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 8.4 p -123.31 24.35 8.76 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.101 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -152.4 164.39 37.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.027 0.442 . . . . 0.0 111.983 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.418 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 2.3 m-20 -60.41 112.47 1.97 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.974 176.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -92.66 175.54 6.78 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.032 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.556 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 64.2 t30 -149.46 122.34 8.74 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -168.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.4 94.87 5.32 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 163.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -96.23 -178.53 4.35 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.005 -174.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 25.5 m -58.66 -33.06 69.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.871 0.367 . . . . 0.0 111.647 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -82.03 -5.8 89.41 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.146 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 67.47 42.46 89.04 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.114 -176.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -116.62 132.27 56.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.78 0.79 . . . . 0.0 111.343 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.556 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.5 OUTLIER -135.06 102.58 3.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.945 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.58 ' OG1' HG21 ' A' ' 250' ' ' THR . 95.3 m -107.66 113.89 27.49 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.774 -0.579 . . . . 0.0 110.533 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 27.5 m -143.06 157.6 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-O 121.545 0.688 . . . . 0.0 110.698 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 26.3 m -109.02 148.24 31.08 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.224 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.562 HD23 ' N ' ' A' ' 313' ' ' LEU . 0.8 OUTLIER -112.23 135.01 53.43 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.237 -176.145 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 41.5 m -147.02 145.63 29.78 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 119.738 -0.785 . . . . 0.0 112.621 -171.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 132.02 152.28 7.07 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.74 169.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . 0.581 ' HB ' ' HD2' ' A' ' 317' ' ' PRO . 18.0 m -68.36 -179.8 0.55 Allowed Pre-proline 0 CA--C 1.54 0.594 0 CA-C-O 117.406 -1.283 . . . . 0.0 108.648 172.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.581 ' HD2' ' HB ' ' A' ' 316' ' ' VAL . 4.3 Cg_exo -30.71 106.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 123.056 2.504 . . . . 0.0 113.632 -169.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 11.7 pt -82.88 102.89 9.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.739 -164.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 0.529 ' OH ' ' HA2' ' A' ' 265' ' ' GLY . 44.3 m-85 57.39 24.99 10.76 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.535 173.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 52.6 32.31 11.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.563 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 41.1 p -83.98 -3.73 58.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.693 0.758 . . . . 0.0 109.48 174.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 1.2 t -137.37 128.03 26.96 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.883 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.535 ' HB3' ' HD3' ' A' ' 324' ' ' PRO . 4.2 t-20 -167.71 -46.98 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.004 -178.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 323' ' ' ASN . 4.8 Cg_exo -84.32 3.8 7.32 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.329 2.019 . . . . 0.0 110.857 173.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . 0.474 ' CA ' HE21 ' A' ' 325' ' ' GLN . 0.0 OUTLIER -64.9 -55.19 20.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.186 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 54.34 53.49 10.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.859 0.838 . . . . 0.0 108.841 -174.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -119.31 26.34 9.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.854 -172.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 5.8 m -84.12 53.1 2.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.636 0.731 . . . . 0.0 109.671 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 27.9 t -119.84 154.24 22.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.528 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 9.7 t -70.43 77.11 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.572 0.701 . . . . 0.0 109.263 175.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -80.0 144.84 32.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.504 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -89.23 107.64 19.17 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 16.6 m -84.37 137.37 20.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.964 -175.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -115.41 152.14 33.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.566 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -90.61 126.04 35.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.24 -175.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 230' ' ' VAL . . . 129.38 13.13 2.39 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.083 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.548 ' CA ' ' HB2' ' A' ' 272' ' ' ASN . 3.0 m-20 -49.03 134.65 16.97 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.92 105.67 3.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.302 168.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.575 ' HA ' ' HB3' ' A' ' 270' ' ' PHE . 75.7 t -95.04 139.16 19.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.399 0.619 . . . . 0.0 111.888 -173.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 41.2 m -147.82 157.28 43.46 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.059 172.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.405 HG13 ' H ' ' A' ' 343' ' ' GLY . 20.8 t -87.76 151.24 3.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 8.9 p -69.14 -24.45 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.566 -176.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . 0.405 ' H ' HG13 ' A' ' 341' ' ' VAL . . . -141.04 -144.43 4.43 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.082 -0.58 . . . . 0.0 111.684 174.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 7.6 p -111.72 -53.27 2.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.423 0.63 . . . . 0.0 110.539 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.569 176.348 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.738 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -129.16 16.81 6.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.829 0.347 . . . . 0.0 111.498 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -81.42 -30.39 33.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.108 0.48 . . . . 0.0 110.627 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 80.78 26.83 52.75 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.073 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -73.52 159.3 53.09 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.719 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 8.3 m -79.15 140.03 37.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.811 0.338 . . . . 0.0 110.493 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.485 HD21 ' HA3' ' A' ' 253' ' ' GLY . 1.8 mp -132.7 177.41 7.64 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 252' ' ' THR . 82.0 m -128.75 159.95 34.06 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.636 0.255 . . . . 0.0 110.853 -174.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 41.8 t -110.05 138.39 38.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 43.3 tttm -111.34 -34.62 6.08 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.388 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 76.3 p -119.91 -169.46 1.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.523 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -112.37 120.8 40.62 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 120.512 0.196 . . . . 0.0 111.235 -167.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.657 ' HB3' ' CD1' ' A' ' 247' ' ' PHE . 88.9 Cg_exo -51.1 102.68 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.172 2.581 . . . . 0.0 113.313 175.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.54 ' O ' HG21 ' A' ' 236' ' ' VAL . 8.7 t -158.38 113.98 2.67 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 174.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.54 HG21 ' O ' ' A' ' 235' ' ' THR . 7.9 t -154.01 125.05 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 120.915 0.388 . . . . 0.0 110.889 169.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 26.5 m 48.15 89.53 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 123.82 0.848 . . . . 0.0 111.906 177.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -99.05 89.09 4.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.332 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -111.07 114.91 28.54 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 175.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -94.78 -50.39 5.17 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -168.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 49.0 t -65.45 -23.27 32.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.306 0.574 . . . . 0.0 110.129 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -96.02 -8.43 33.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.231 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 14.9 t70 55.41 69.61 0.72 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.955 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 17.8 m -145.2 105.11 4.02 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.819 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -129.84 122.43 28.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.847 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . 0.426 ' HB2' HG11 ' A' ' 236' ' ' VAL . 0.3 OUTLIER -120.73 -176.9 3.34 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 172.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.657 ' CD1' ' HB3' ' A' ' 234' ' ' PRO . 1.2 p90 -166.41 126.81 1.66 Allowed 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 119.969 -0.692 . . . . 0.0 112.793 174.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 37.2 m -99.75 131.25 45.85 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.405 HG21 ' HA ' ' A' ' 234' ' ' PRO . 19.4 t -138.67 141.9 35.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 119.609 -0.836 . . . . 0.0 112.111 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.431 HG21 ' OG1' ' A' ' 310' ' ' THR . 98.3 m -94.08 115.83 28.19 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 309' ' ' VAL . 5.2 mp -104.18 166.27 10.51 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -177.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.484 ' O ' ' HB ' ' A' ' 229' ' ' THR . 0.7 OUTLIER -134.88 99.81 4.41 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.802 0.334 . . . . 0.0 111.34 -176.203 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.485 ' HA3' HD21 ' A' ' 228' ' ' LEU . . . -137.59 140.26 11.14 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.304 -0.719 . . . . 0.0 111.304 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -110.93 92.75 4.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.092 0.472 . . . . 0.0 112.081 -172.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 38.7 m -125.82 106.77 9.92 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.273 171.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 305' ' ' SER . . . -63.16 141.47 58.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -175.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 6.0 t 61.72 53.32 3.24 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.92 171.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 49.0 t -137.45 103.84 2.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.164 0.507 . . . . 0.0 110.009 174.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 36.2 m -79.11 87.75 4.86 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.401 0.619 . . . . 0.0 110.299 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.562 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 94.4 92.98 1.64 Allowed Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.384 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.745 ' CE1' ' HB3' ' A' ' 303' ' ' SER . 3.0 m-85 -45.2 -59.26 2.73 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.324 0.583 . . . . 0.0 111.557 172.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.484 HD12 ' HB2' ' A' ' 266' ' ' ASP . 2.8 tm? -166.8 140.51 3.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.679 -166.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -125.94 -171.2 2.33 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -51.89 131.49 31.06 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.084 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 122.32 -32.23 4.59 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.513 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . 0.484 ' HB2' HD12 ' A' ' 262' ' ' LEU . 9.5 m-20 -108.07 154.49 21.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.005 0.431 . . . . 0.0 110.449 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.411 ' HB2' HG12 ' A' ' 342' ' ' VAL . 10.7 mt-30 -115.04 161.97 17.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.43 0.633 . . . . 0.0 111.44 -173.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 295' ' ' ALA . 0.4 OUTLIER -126.18 -175.46 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.205 178.297 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.463 ' HD2' ' C ' ' A' ' 269' ' ' LYS . 2.5 tmmm? -148.54 134.71 19.31 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -146.66 148.1 31.7 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 118.779 -1.169 . . . . 0.0 112.258 176.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 81.0 p -95.83 111.44 23.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.569 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.478 ' HA ' ' OD1' ' A' ' 337' ' ' ASP . 25.7 p-10 -104.22 153.73 20.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.027 0.442 . . . . 0.0 110.877 -176.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 32.9 p -122.99 159.95 27.29 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.718 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -126.44 113.24 16.58 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 173.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 31.6 p-90 -159.71 36.05 0.19 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.387 0.613 . . . . 0.0 110.404 174.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 92.1 mt -66.92 173.97 3.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.804 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . 0.458 ' O ' ' HG3' ' A' ' 281' ' ' LYS . 18.4 mp0 -55.93 -50.41 70.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.716 0.293 . . . . 0.0 111.186 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -68.25 -46.0 71.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.472 0.653 . . . . 0.0 110.283 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -57.84 -40.32 79.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.242 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 4.1 p -67.48 -26.51 66.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.808 0.337 . . . . 0.0 111.577 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 277' ' ' GLN . 28.2 mtpp -83.07 -31.13 27.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.932 0.396 . . . . 0.0 110.748 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -86.84 -13.84 43.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.573 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.89 148.05 26.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.981 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.412 HD11 ' N ' ' A' ' 284' ' ' LEU . 6.8 mp -100.49 0.15 39.03 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.605 176.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 66.88 104.46 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.928 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -93.75 -26.93 16.77 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.339 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 132.01 -41.57 1.49 Allowed Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.23 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . 0.497 ' O ' ' HD3' ' A' ' 290' ' ' PRO . . . -158.71 154.09 25.78 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 99.0 m -111.52 85.55 5.98 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.917 175.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 288' ' ' ALA . 12.3 Cg_endo -92.24 60.05 0.77 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.351 2.701 . . . . 0.0 112.402 -177.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 49.0 mm -92.6 134.96 28.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.978 0.418 . . . . 0.0 109.949 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 32.2 m -140.05 142.74 36.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.115 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -161.05 162.29 31.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.472 0.653 . . . . 0.0 111.443 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 98.1 m -88.86 127.15 35.62 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.607 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . 0.451 ' HB2' HG22 ' A' ' 268' ' ' VAL . . . -108.47 175.91 5.3 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 45.0 m -135.32 123.35 22.77 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.553 HG12 HG23 ' A' ' 311' ' ' VAL . 91.0 t -77.72 124.97 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.872 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 312' ' ' THR . 15.0 t -132.77 17.95 4.24 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.303 -170.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.401 ' HB3' HG21 ' A' ' 311' ' ' VAL . . . -152.78 -173.32 4.53 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.146 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -70.94 139.68 50.73 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.186 0.517 . . . . 0.0 109.717 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.562 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -136.17 167.6 20.96 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.742 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -140.25 157.6 45.32 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.091 -177.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.745 ' HB3' ' CE1' ' A' ' 261' ' ' PHE . 0.0 OUTLIER -139.18 96.01 3.04 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.422 174.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -108.7 153.65 23.14 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 171.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.417 ' HB3' ' HB1' ' A' ' 256' ' ' ALA . 0.1 OUTLIER -68.65 -7.61 34.79 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -171.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -75.31 -4.68 74.67 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 175.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 86.46 42.85 6.38 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.933 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -125.21 137.05 54.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.69 0.745 . . . . 0.0 112.119 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 251' ' ' LEU . 1.2 p -154.97 106.33 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.175 174.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.431 ' OG1' HG21 ' A' ' 250' ' ' THR . 54.5 m -106.44 130.28 54.27 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 121.16 -0.962 . . . . 0.0 111.431 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.553 HG23 HG12 ' A' ' 297' ' ' VAL . 7.1 p -159.55 147.43 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.131 0.491 . . . . 0.0 110.549 174.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 52.8 m -86.31 150.1 24.58 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.06 174.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.512 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.2 mp -126.05 164.83 19.99 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.284 -177.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 15.9 m -131.03 134.26 46.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.754 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 89.67 104.15 1.12 Allowed Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.978 173.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . 0.621 HG12 ' CE2' ' A' ' 247' ' ' PHE . 0.0 OUTLIER -127.09 143.59 47.52 Favored Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 122.208 0.203 . . . . 0.0 110.851 177.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.92 104.58 1.53 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.048 2.498 . . . . 0.0 111.673 174.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.535 HG23 ' H ' ' A' ' 319' ' ' TYR . 24.1 mm -97.11 178.51 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.845 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 0.535 ' H ' HG23 ' A' ' 318' ' ' ILE . 96.8 m-85 77.38 -46.2 0.47 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.976 0.91 . . . . 0.0 110.786 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 56.08 66.05 1.29 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.612 0.72 . . . . 0.0 110.329 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 23.6 p -99.69 11.18 39.88 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.279 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 23.3 m -101.09 -48.62 4.36 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.678 -175.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.57 ' HB3' ' HD3' ' A' ' 324' ' ' PRO . 31.7 t-20 -74.19 -55.94 2.78 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.749 -176.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 323' ' ' ASN . 3.3 Cg_exo -83.52 -6.87 10.81 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.292 1.994 . . . . 0.0 112.511 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 58.45 -77.63 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.781 0.832 . . . . 0.0 112.581 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -105.86 -17.33 14.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.154 -172.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -110.65 52.69 0.72 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.117 0.484 . . . . 0.0 110.239 -173.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 61.0 m -80.52 66.65 6.11 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.289 -177.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 38.5 t -64.35 138.17 23.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 174.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 16.0 m -56.97 106.16 0.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.175 0.512 . . . . 0.0 110.992 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . 0.532 ' HD2' ' O ' ' A' ' 331' ' ' ARG . 3.8 ppt_? -85.35 154.89 21.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.987 -177.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . 0.405 ' OE1' ' HA ' ' A' ' 332' ' ' GLN . 11.6 mm-40 -94.67 154.38 17.35 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 173.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 6.8 p -77.76 143.73 12.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.718 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -118.59 144.41 46.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.685 -174.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -100.58 151.98 20.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.401 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 112.45 12.08 14.0 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.391 173.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.478 ' OD1' ' HA ' ' A' ' 272' ' ' ASN . 10.8 m-20 -71.73 168.92 16.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.056 0.455 . . . . 0.0 111.463 -177.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -98.97 122.36 42.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.535 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 49.6 t -100.79 145.36 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.248 0.547 . . . . 0.0 111.773 -172.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 53.7 m -151.22 179.07 8.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.186 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.478 HG11 ' H ' ' A' ' 343' ' ' GLY . 29.6 t -111.96 143.69 21.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -175.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.411 HG12 ' HB2' ' A' ' 267' ' ' GLN . 9.7 p -69.57 -24.33 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.976 0.417 . . . . 0.0 110.88 -175.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . 0.478 ' H ' HG11 ' A' ' 341' ' ' VAL . . . -87.46 87.01 1.53 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.768 178.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 70.4 p 61.42 117.33 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.788 1.235 . . . . 0.0 112.803 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -1.009 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.733 179.479 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.563 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -153.52 -81.68 0.09 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.629 0.215 . . . . 0.0 110.656 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.426 ' CG ' ' N ' ' A' ' 225' ' ' GLY . 24.3 t80 54.18 -157.51 0.19 Allowed 'General case' 0 CA--C 1.542 0.642 0 O-C-N 123.266 0.354 . . . . 0.0 110.068 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.426 ' N ' ' CG ' ' A' ' 224' ' ' PHE . . . 121.88 -31.24 5.03 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.239 177.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -118.11 137.24 12.91 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.857 -177.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 87.2 m -129.38 131.28 46.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 2.4 mp -136.87 -178.36 5.16 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 60.9 m -128.4 153.78 46.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.765 0.317 . . . . 0.0 111.532 -171.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.458 ' CG2' HG22 ' A' ' 339' ' ' VAL . 22.0 t -110.53 133.0 57.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.487 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -125.22 12.09 8.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.824 0.345 . . . . 0.0 111.591 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.4 p -144.61 -172.0 3.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.596 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.706 ' OE1' ' HB3' ' A' ' 335' ' ' ALA . 1.3 mm100 -114.03 134.39 22.17 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -174.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.479 ' HB3' ' CG ' ' A' ' 247' ' ' PHE . 28.4 Cg_exo -61.95 104.97 0.35 Allowed 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.224 1.95 . . . . 0.0 111.454 173.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.42 ' O ' HG22 ' A' ' 236' ' ' VAL . 5.8 t -156.02 103.86 2.24 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.607 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.75 173.41 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.139 0.575 . . . . 0.0 110.561 170.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.464 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 45.5 m -23.13 115.76 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.467 1.507 . . . . 0.0 114.521 -174.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -111.91 83.58 1.81 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.759 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.475 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 4.5 t30 -103.34 99.65 9.5 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -175.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -86.5 -47.94 8.83 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -163.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 37.7 t -65.88 -23.26 31.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.7 0.762 . . . . 0.0 109.313 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.475 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 28.0 mmmt -93.75 -7.47 43.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.16 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 54.83 58.98 4.35 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.424 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 19.8 m -136.83 102.86 5.01 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.62 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -120.73 116.62 25.62 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . 0.427 ' HG2' ' HA ' ' A' ' 314' ' ' SER . 22.5 mt-30 -133.61 158.74 42.43 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 177.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.607 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 3.6 p90 -140.83 138.66 34.17 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.101 172.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.519 ' OG1' HG21 ' A' ' 236' ' ' VAL . 54.3 m -97.25 135.89 38.54 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 42.3 t -142.43 141.61 27.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.715 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.472 HG22 ' OG1' ' A' ' 310' ' ' THR . 90.8 m -88.08 113.83 24.1 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 168.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 309' ' ' VAL . 4.9 mp -104.34 163.95 12.07 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -176.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.9 140.87 52.53 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -139.3 -143.07 4.35 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.289 -175.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -106.02 -174.51 2.55 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -174.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.565 HG21 ' H ' ' A' ' 256' ' ' ALA . 0.6 OUTLIER -71.51 -178.54 2.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.733 -172.088 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.565 ' H ' HG21 ' A' ' 255' ' ' THR . . . -62.41 -176.9 0.12 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.123 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 15.6 t 80.77 7.5 1.32 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.991 0.917 . . . . 0.0 110.559 -175.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 21.2 t -126.25 89.52 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-O 121.562 0.696 . . . . 0.0 109.216 170.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 31.2 m -74.37 99.66 3.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.426 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 67.16 94.48 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.455 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 303' ' ' SER . 8.8 m-85 -43.42 -59.32 2.18 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 111.427 174.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 266' ' ' ASP . 95.9 mt -148.49 162.68 39.13 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.503 ' HB3' ' HZ2' ' A' ' 263' ' ' LYS . 9.6 mtpm? -137.22 -167.26 2.07 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.625 0.231 . . . . 0.0 111.625 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -53.33 113.32 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.273 0.558 . . . . 0.0 111.86 -175.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 109.93 -17.74 29.57 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.553 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 30.2 m-20 -77.52 144.81 37.38 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.465 ' HB2' HG12 ' A' ' 342' ' ' VAL . 35.4 mt-30 -111.98 154.57 25.1 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.619 0.723 . . . . 0.0 111.192 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.411 HG23 ' HB3' ' A' ' 295' ' ' ALA . 0.0 OUTLIER -121.98 -176.65 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.623 178.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.5 ' HA ' ' HD3' ' A' ' 269' ' ' LYS . 16.8 tppt? -125.29 89.02 2.98 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.719 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . 0.453 ' HB3' ' CE1' ' A' ' 293' ' ' PHE . 6.8 t80 -81.73 128.33 33.87 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -171.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 291' ' ' ILE . 85.7 m -119.25 87.4 2.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.046 0.45 . . . . 0.0 109.855 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.528 ' O ' ' HA ' ' A' ' 291' ' ' ILE . 22.6 t-20 -93.66 152.51 18.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.222 -175.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 12.4 p -84.83 134.23 34.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.022 0.439 . . . . 0.0 110.711 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -83.27 116.05 22.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.714 0.768 . . . . 0.0 110.839 -174.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 36.0 t90 -147.35 -22.23 0.39 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.367 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 276' ' ' LEU . 2.8 mm? -91.11 23.68 3.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.781 -176.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . 0.49 ' O ' ' HB1' ' A' ' 283' ' ' ALA . 90.2 mt-30 -83.88 -70.77 0.54 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.073 0.463 . . . . 0.0 110.433 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -95.39 -26.8 15.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.339 -174.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 -85.91 13.06 8.0 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.226 -173.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.75 -80.44 0.44 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.87 0.367 . . . . 0.0 111.793 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -111.43 -80.02 0.58 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.015 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -162.94 86.83 0.56 Allowed 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.49 ' HB1' ' O ' ' A' ' 277' ' ' GLN . . . -65.85 -77.29 0.07 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.925 -174.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 53.19 37.48 25.17 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -170.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 63.27 93.42 0.06 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.792 -177.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -146.4 -36.32 0.26 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.746 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -138.15 -130.16 2.77 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . 177.04 -174.9 0.12 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.367 0.604 . . . . 0.0 110.184 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 86.3 m -137.98 102.93 8.28 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 173.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . 0.421 ' O ' ' HB3' ' A' ' 272' ' ' ASN . 69.5 Cg_exo -40.72 104.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 124.163 3.242 . . . . 0.0 114.091 -171.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.528 ' HA ' ' O ' ' A' ' 272' ' ' ASN . 13.4 tt -88.95 -26.81 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.138 -176.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 43.3 t -156.99 95.14 1.48 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.922 0.391 . . . . 0.0 110.001 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . 0.453 ' CE1' ' HB3' ' A' ' 270' ' ' PHE . 13.0 p90 -140.69 161.0 38.81 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 46.4 m -88.48 111.41 21.79 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.831 0.348 . . . . 0.0 110.551 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . 0.411 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -97.6 -178.16 4.04 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 313' ' ' LEU . 93.2 m -136.96 131.85 33.56 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -174.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.448 HG12 HG22 ' A' ' 311' ' ' VAL . 67.3 t -78.5 131.49 34.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.703 174.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.463 HG21 ' O ' ' A' ' 312' ' ' THR . 6.9 t -111.41 2.35 17.5 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.757 -0.777 . . . . 0.0 112.723 -167.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -170.55 -166.49 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.776 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.92 144.54 27.89 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.508 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -137.59 173.58 11.51 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.854 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.646 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 6.9 t30 -146.34 128.7 15.86 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -169.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.437 ' HB2' ' HB ' ' A' ' 258' ' ' VAL . 0.3 OUTLIER -117.87 95.12 4.78 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 165.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . 0.498 ' HB3' HD22 ' A' ' 302' ' ' ASN . 4.6 p-10 -104.04 -177.21 3.3 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.925 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 39.1 m -60.88 -30.98 70.48 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.708 0.289 . . . . 0.0 111.425 -177.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -77.61 0.94 68.54 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.207 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 56.32 41.58 87.52 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.408 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -116.38 127.89 55.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.696 0.748 . . . . 0.0 111.005 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.646 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.4 OUTLIER -135.34 104.45 4.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.344 -179.398 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.472 ' OG1' HG22 ' A' ' 250' ' ' THR . 94.6 m -105.35 121.09 43.16 Favored 'General case' 0 C--N 1.316 -0.858 0 O-C-N 121.865 -0.522 . . . . 0.0 110.776 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.448 HG22 HG12 ' A' ' 297' ' ' VAL . 7.7 p -157.65 150.26 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 121.089 0.471 . . . . 0.0 110.006 176.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 58.1 m -85.54 151.95 23.54 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.265 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.556 ' HA ' ' O ' ' A' ' 296' ' ' THR . 5.9 mp -114.53 135.47 54.09 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.747 -177.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' SER . . . . . 0.427 ' HA ' ' HG2' ' A' ' 246' ' ' GLN . 14.1 p -113.53 154.51 26.98 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -174.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 72.12 40.35 56.51 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.071 176.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 2.6 m -142.89 112.74 5.79 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-O 121.006 0.431 . . . . 0.0 111.637 -170.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -90.31 87.28 0.35 Allowed 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.048 2.499 . . . . 0.0 113.535 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 49.4 mt -128.16 101.6 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 120.791 0.329 . . . . 0.0 111.016 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 0.497 ' HE1' ' O ' ' A' ' 236' ' ' VAL . 1.1 m-85 -150.6 136.91 18.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.317 174.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -109.76 -48.17 3.25 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.711 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 69.4 p 47.74 56.82 6.64 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.159 0.584 . . . . 0.0 111.074 -174.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 10.4 m -89.63 -68.44 0.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.998 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 65.5 t30 29.24 78.61 0.27 Allowed Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.415 ' HB2' ' CD1' ' A' ' 326' ' ' TYR . 7.5 Cg_exo -74.12 -179.01 4.28 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.022 1.814 . . . . 0.0 111.06 175.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -102.04 26.45 7.59 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.86 -168.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . 0.415 ' CD1' ' HB2' ' A' ' 324' ' ' PRO . 81.9 m-85 -63.29 -55.97 20.33 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.249 178.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -139.97 -4.11 1.38 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.274 0.559 . . . . 0.0 110.357 176.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 9.5 t 60.65 52.47 4.46 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.984 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 2.5 t -92.34 17.51 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.615 0.721 . . . . 0.0 110.312 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 8.2 t 58.07 57.54 4.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.338 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -67.77 115.2 7.05 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.296 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -131.51 -165.05 1.52 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -177.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 13.2 t -44.44 154.07 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 O-C-N 123.759 0.662 . . . . 0.0 110.893 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -97.25 144.54 26.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.493 -165.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.706 ' HB3' ' OE1' ' A' ' 233' ' ' GLN . . . -98.84 172.24 7.56 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.878 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 96.71 9.92 55.9 Favored Glycine 0 CA--C 1.511 -0.205 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.086 171.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.469 ' HB2' ' HA ' ' A' ' 272' ' ' ASN . 12.5 p-10 -88.43 -176.11 5.21 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.831 0.348 . . . . 0.0 110.854 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -120.16 145.76 46.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.438 0.637 . . . . 0.0 111.803 -171.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 79.4 t -108.63 150.23 11.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.973 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.488 ' HB2' ' HB3' ' A' ' 269' ' ' LYS . 69.3 m -144.89 176.7 9.27 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 174.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.475 HG13 ' H ' ' A' ' 343' ' ' GLY . 44.6 t -117.94 140.39 41.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' A' ' 267' ' ' GLN . 5.3 p -69.75 -27.42 33.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 CA-C-O 120.83 0.348 . . . . 0.0 110.692 -175.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . 0.475 ' H ' HG13 ' A' ' 341' ' ' VAL . . . 172.67 -122.15 0.91 Allowed Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 3.5 p -142.24 -54.61 0.43 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.036 0.446 . . . . 0.0 110.563 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.931 -179.164 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 N-CA-C 112.035 -0.426 . . . . 0.0 112.035 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -148.42 117.18 6.67 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -89.64 20.87 3.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.757 -174.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 92.07 32.51 8.35 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.422 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -75.86 -141.96 1.06 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.369 -0.443 . . . . 0.0 112.341 177.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 19.3 m -75.04 143.86 43.29 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.958 0.408 . . . . 0.0 111.031 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.1 mp -135.21 -178.74 5.24 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 70.8 m -130.24 150.43 51.49 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.885 0.374 . . . . 0.0 111.894 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.81 106.68 19.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -93.09 -16.92 24.42 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.972 0.415 . . . . 0.0 111.207 -173.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 32.1 p -130.84 -169.15 2.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.757 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.426 ' HB3' HG21 ' A' ' 333' ' ' VAL . 70.6 mt-30 -105.61 120.49 49.15 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.048 -170.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.485 ' HA ' HG22 ' A' ' 249' ' ' VAL . 15.0 Cg_exo -66.5 105.61 0.93 Allowed 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.378 2.052 . . . . 0.0 111.618 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 8.0 t -154.67 121.84 5.61 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.587 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -155.14 174.02 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 166.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.488 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 62.9 m -23.78 110.07 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.88 1.272 . . . . 0.0 114.226 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -103.69 108.87 20.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.487 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.417 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 5.3 t30 -122.79 94.82 4.4 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -83.45 -50.12 8.62 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.08 -162.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 40.3 t -62.49 -23.1 31.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.662 0.744 . . . . 0.0 109.688 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.417 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 13.9 mmmm -96.18 -7.44 35.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.033 -178.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 60.28 57.5 2.89 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.684 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 11.7 t -139.95 112.9 8.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.907 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -129.52 110.12 11.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.591 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . 0.463 ' HB2' HG13 ' A' ' 236' ' ' VAL . 0.7 OUTLIER -114.65 165.93 12.26 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 173.618 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.587 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 1.7 p90 -157.65 125.98 5.53 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 51.9 m -94.17 133.07 38.07 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.485 HG22 ' HA ' ' A' ' 234' ' ' PRO . 0.8 OUTLIER -141.12 142.92 28.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 119.182 -1.007 . . . . 0.0 112.231 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.513 HG23 ' OG1' ' A' ' 310' ' ' THR . 21.9 m -93.79 111.97 23.75 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 165.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.542 ' HB2' ' O ' ' A' ' 309' ' ' VAL . 5.2 mp -102.92 167.81 9.61 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -176.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.24 140.51 51.07 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -141.64 -143.1 4.19 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.329 -174.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -109.42 -173.93 2.38 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -174.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.562 HG22 ' H ' ' A' ' 256' ' ' ALA . 3.3 m -66.58 174.76 2.64 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.369 -172.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.562 ' H ' HG22 ' A' ' 255' ' ' THR . . . -59.52 -175.38 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.047 0.939 . . . . 0.0 113.012 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 69.8 m 81.18 10.88 0.87 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.992 0.917 . . . . 0.0 111.556 -177.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 22.3 t -128.73 89.79 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 167.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 7.2 m -71.72 97.17 1.71 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.384 -177.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 69.01 98.89 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.021 -172.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -44.34 -60.25 2.02 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 117.108 0.454 . . . . 0.0 110.933 172.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.504 ' HB3' ' CB ' ' A' ' 266' ' ' ASP . 94.4 mt -148.21 166.08 29.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.545 -174.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 97.6 mttt -141.36 -166.68 2.24 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -52.04 113.6 1.06 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.362 0.601 . . . . 0.0 112.058 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 110.92 -17.31 27.44 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.054 177.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . 0.504 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 18.0 m-20 -82.58 146.15 29.33 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.42 145.55 45.13 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.607 0.718 . . . . 0.0 111.641 -174.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.441 HG23 ' HB2' ' A' ' 295' ' ' ALA . 0.2 OUTLIER -121.75 -178.97 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.038 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.51 ' HD3' ' C ' ' A' ' 269' ' ' LYS . 1.0 OUTLIER -126.77 139.36 53.18 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . 0.499 ' CE1' ' HB3' ' A' ' 295' ' ' ALA . 8.1 p90 -146.48 157.46 43.75 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.644 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.539 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 5.6 t -137.38 95.89 3.16 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.955 176.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.42 ' HA ' ' CG ' ' A' ' 337' ' ' ASP . 4.0 m120 -95.34 113.73 25.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.551 177.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 19.1 p -91.74 79.88 5.34 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.398 0.618 . . . . 0.0 110.55 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -94.99 123.87 38.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.191 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -82.72 17.9 1.71 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.473 0.654 . . . . 0.0 110.511 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.47 12.39 2.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.701 -178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -107.85 -8.72 15.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.051 172.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . 0.402 HE22 HD21 ' A' ' 284' ' ' LEU . 33.3 mm-40 -69.08 -81.38 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.039 0.447 . . . . 0.0 112.037 -171.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -79.52 -21.47 45.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.09 -173.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 39.4 p -67.54 -44.65 77.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.177 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -95.16 -74.09 0.56 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.0 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -138.73 -102.12 0.17 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -175.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -170.18 116.62 0.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.402 HD21 HE22 ' A' ' 278' ' ' GLN . 8.1 mp -101.74 -33.15 9.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.672 0.272 . . . . 0.0 110.584 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 68.53 -58.73 0.47 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.001 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -107.17 122.88 47.4 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.98 0.419 . . . . 0.0 110.068 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 93.24 123.07 3.42 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.04 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . 0.592 ' O ' ' HB ' ' A' ' 289' ' ' THR . . . -67.1 -41.7 85.84 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.711 0.767 . . . . 0.0 109.484 177.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.592 ' HB ' ' O ' ' A' ' 288' ' ' ALA . 5.6 t 169.8 128.81 0.05 OUTLIER Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 113.487 -1.688 . . . . 0.0 109.99 173.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.96 46.25 2.11 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.763 2.308 . . . . 0.0 112.551 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 36.3 mm -86.11 116.29 28.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.156 0.503 . . . . 0.0 111.208 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 25.9 p -152.74 122.17 6.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.492 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -165.34 -171.05 2.04 Favored 'General case' 0 C--O 1.23 0.079 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.912 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 91.3 m -88.76 134.65 33.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.914 -173.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . 0.499 ' HB3' ' CE1' ' A' ' 270' ' ' PHE . . . -117.5 176.0 5.37 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 54.5 m -130.82 125.44 33.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.597 0.713 . . . . 0.0 112.877 -176.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.495 HG13 HG22 ' A' ' 311' ' ' VAL . 60.7 t -75.33 130.5 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.714 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 3.5 m -115.78 -1.59 12.6 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.276 -169.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -160.13 -166.33 1.67 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.085 -0.384 . . . . 0.0 111.138 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.412 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 3.3 m-20 -66.32 157.62 31.25 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.468 0.651 . . . . 0.0 110.229 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.444 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -149.23 177.44 9.64 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.595 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -144.62 137.09 26.45 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.211 -0.196 . . . . 0.0 111.297 -171.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.8 OUTLIER -118.99 95.08 4.67 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 163.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.95 177.46 4.85 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.946 -174.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 11.6 t -59.58 -32.41 70.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.898 0.38 . . . . 0.0 111.004 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -78.9 4.23 62.16 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.252 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 59.94 42.33 98.22 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.631 176.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -114.55 131.1 56.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.454 0.627 . . . . 0.0 110.528 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.542 ' O ' ' HB2' ' A' ' 251' ' ' LEU . 2.1 p -132.45 95.01 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.501 0.667 . . . . 0.0 111.062 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.513 ' OG1' HG23 ' A' ' 250' ' ' THR . 76.7 m -101.42 128.41 47.63 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 122.011 -0.431 . . . . 0.0 111.827 -176.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.495 HG22 HG13 ' A' ' 297' ' ' VAL . 7.3 p -162.21 150.72 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.981 174.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 52.0 m -86.87 146.41 26.21 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.989 0.423 . . . . 0.0 110.584 177.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.469 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.4 mp -120.99 159.04 26.44 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.58 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 17.5 m -138.48 127.75 24.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.179 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 100.7 94.18 2.16 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.607 -0.806 . . . . 0.0 114.007 172.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -138.64 110.28 8.06 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 172.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.26 62.49 3.44 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.89 2.393 . . . . 0.0 112.377 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 41.0 pt -122.04 147.49 26.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.924 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -116.99 119.43 35.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.974 0.416 . . . . 0.0 111.211 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.502 ' C ' ' HG1' ' A' ' 321' ' ' THR . 8.2 p-10 -93.51 20.87 6.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.744 176.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.502 ' HG1' ' C ' ' A' ' 320' ' ' ASP . 20.3 p 50.57 -107.14 0.27 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.402 -174.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 38.1 m -159.62 -63.95 0.07 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.421 ' CB ' ' HB2' ' A' ' 330' ' ' SER . 43.1 m-80 55.4 64.65 5.36 Favored Pre-proline 0 N--CA 1.469 0.477 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.637 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.597 ' HA ' ' O ' ' A' ' 328' ' ' SER . 71.5 Cg_endo -90.9 -165.8 0.18 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.482 2.122 . . . . 0.0 111.565 -177.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 66.53 -69.91 0.11 Allowed 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.94 0.775 . . . . 0.0 111.707 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -57.57 -47.93 80.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.422 -174.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -136.26 21.54 3.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.799 0.333 . . . . 0.0 110.415 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 324' ' ' PRO . 41.1 m 67.8 -65.99 0.23 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.124 -176.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 10.6 t -136.91 104.65 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 172.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' SER . . . . . 0.421 ' HB2' ' CB ' ' A' ' 323' ' ' ASN . 9.1 m -90.18 58.23 4.02 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.351 0.596 . . . . 0.0 110.947 -173.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -96.37 112.85 24.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.726 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -123.25 109.55 14.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.819 0.342 . . . . 0.0 110.526 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.426 HG21 ' HB3' ' A' ' 233' ' ' GLN . 6.1 m -103.04 132.44 49.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.16 162.65 14.07 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.412 0.625 . . . . 0.0 111.627 -176.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -99.04 170.0 9.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.977 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 110.64 10.75 20.89 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.473 172.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.539 ' HB3' ' O ' ' A' ' 271' ' ' THR . 13.6 m-20 -96.27 -177.26 3.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.846 0.323 . . . . 0.0 111.778 -176.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -109.08 153.3 23.87 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -169.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 76.1 t -135.98 157.31 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.676 -175.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 5.6 t -156.97 179.73 9.02 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 172.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 69.2 t -115.88 133.08 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.126 0.489 . . . . 0.0 111.946 -175.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 71.8 t -96.39 -44.76 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.887 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 113.06 -126.67 7.57 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 111.396 -0.681 . . . . 0.0 111.396 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 4.6 p -134.5 -71.57 0.49 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.313 0.578 . . . . 0.0 110.068 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.881 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.578 176.916 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.655 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 63.23 -81.16 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.352 0.661 . . . . 0.0 112.06 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -88.11 -23.25 23.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.87 0.367 . . . . 0.0 110.66 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 129.78 -38.78 1.93 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.127 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -118.35 121.75 5.15 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.859 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 10.3 m -135.38 136.01 41.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.782 0.325 . . . . 0.0 110.378 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.511 HD21 ' CE1' ' A' ' 261' ' ' PHE . 8.2 mt -147.88 174.68 11.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.267 -177.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 57.2 m -134.59 161.98 33.57 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 12.2 t -116.11 139.61 41.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.425 ' HD2' ' CG2' ' A' ' 252' ' ' THR . 38.0 tttt -120.17 -1.58 10.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.044 0.45 . . . . 0.0 111.117 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.452 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 19.8 p -139.33 -168.23 2.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.932 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -113.67 102.52 54.89 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -174.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 248' ' ' THR . 35.9 Cg_endo -66.99 105.72 1.02 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.216 1.944 . . . . 0.0 112.176 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.435 ' O ' ' HB2' ' A' ' 247' ' ' PHE . 12.0 t -113.03 144.51 42.48 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.319 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.468 ' HA ' ' HB3' ' A' ' 247' ' ' PHE . 28.9 t -80.81 122.99 36.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.03 -171.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 94.0 m -97.95 124.59 42.47 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.104 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -93.77 124.1 37.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.188 0.518 . . . . 0.0 110.987 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.46 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 20.5 t30 -127.04 70.85 1.3 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -86.06 -28.38 24.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.757 -161.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.46 -22.97 30.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 172.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.46 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 19.6 mmtp -101.05 -0.72 35.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.135 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 23.1 t70 50.82 52.66 14.49 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 113.999 -1.455 . . . . 0.0 111.3 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 24.2 m -140.25 128.96 23.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.423 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -109.47 110.84 22.07 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -118.37 176.65 5.14 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.111 -174.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.468 ' HB3' ' HA ' ' A' ' 236' ' ' VAL . 15.7 p90 -160.58 148.87 16.41 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.366 171.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 55.4 m -112.11 145.07 40.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.786 -168.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 9.9 p -154.08 142.8 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.452 ' HB ' ' CG2' ' A' ' 232' ' ' THR . 19.2 m -103.93 109.93 21.87 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 166.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.69 171.33 7.42 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.287 0.565 . . . . 0.0 109.695 -175.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.425 ' CG2' ' HD2' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -125.77 139.14 53.76 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.066 175.01 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -136.08 -143.72 4.73 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.025 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.521 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -101.75 -174.58 2.62 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.607 HG23 ' H ' ' A' ' 256' ' ' ALA . 2.1 m -73.69 -178.2 3.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.426 -173.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.607 ' H ' HG23 ' A' ' 255' ' ' THR . . . -59.19 -177.19 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.697 0.799 . . . . 0.0 112.868 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' SER . . . . . 0.426 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 33.8 t 80.89 7.63 1.26 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.077 0.951 . . . . 0.0 111.109 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.516 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 59.1 t -128.01 89.7 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 121.538 0.685 . . . . 0.0 109.512 171.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 87.0 m -76.94 98.75 5.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.48 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 68.23 89.64 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.493 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.511 ' CE1' HD21 ' A' ' 228' ' ' LEU . 8.2 m-85 -46.12 -59.58 2.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.538 0.685 . . . . 0.0 109.897 170.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.49 HD23 ' HB3' ' A' ' 261' ' ' PHE . 1.4 mm? -123.31 156.21 35.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.286 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -132.81 -167.6 1.93 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 171.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -54.41 114.23 1.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.212 0.53 . . . . 0.0 111.386 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 106.57 -12.86 42.93 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.527 175.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . 0.441 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 8.7 m-20 -78.32 136.67 37.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.827 0.346 . . . . 0.0 110.32 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -110.95 141.69 44.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.715 0.769 . . . . 0.0 112.133 -171.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 2.4 m -118.58 169.94 8.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.43 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.32 135.11 19.96 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . 0.459 ' CB ' ' HA ' ' A' ' 339' ' ' VAL . 31.0 p90 -147.03 159.96 42.95 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.06 -1.056 . . . . 0.0 112.664 -173.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.506 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 82.7 p -99.69 96.06 7.36 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.943 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -77.38 160.52 28.71 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.372 0.606 . . . . 0.0 110.877 -176.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' THR . . . . . 0.459 HG22 ' HB3' ' A' ' 337' ' ' ASP . 1.0 OUTLIER -70.26 123.4 21.59 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.912 -173.505 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -134.58 162.44 32.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.995 170.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.622 ' O ' ' HG3' ' A' ' 278' ' ' GLN . 32.1 t-105 57.84 72.65 0.51 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.717 0.635 . . . . 0.0 109.296 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.02 14.9 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.227 -175.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . 0.459 ' H ' ' C ' ' A' ' 275' ' ' TRP . 41.7 mt-30 -93.02 -14.07 27.86 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 176.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . 0.622 ' HG3' ' O ' ' A' ' 275' ' ' TRP . 63.5 mt-30 -63.49 -51.27 66.27 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.422 0.629 . . . . 0.0 110.208 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -67.12 -27.0 66.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.454 -175.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 1.8 p -91.57 -47.84 7.18 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -176.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -77.94 -32.12 51.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.932 0.396 . . . . 0.0 110.987 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 57.85 18.93 5.29 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.8 0.84 . . . . 0.0 112.072 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -145.88 -164.99 2.08 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.315 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 90.4 mt 67.49 27.79 7.83 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 123.611 0.569 . . . . 0.0 111.199 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 63.84 102.24 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.648 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -158.67 158.15 33.2 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.592 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 156.59 -32.98 0.58 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.63 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -137.64 103.96 5.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.706 0.289 . . . . 0.0 110.929 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 11.7 t -65.38 134.0 95.55 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . 0.584 ' O ' HG12 ' A' ' 291' ' ' ILE . 49.7 Cg_endo -69.77 158.02 58.36 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.56 2.173 . . . . 0.0 112.824 -177.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.584 HG12 ' O ' ' A' ' 290' ' ' PRO . 7.9 pt 59.37 170.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.085 1.354 . . . . 0.0 113.186 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 20.1 m -154.2 164.63 38.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.888 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -134.56 145.3 48.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.032 0.444 . . . . 0.0 110.328 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 91.2 m -90.32 131.17 36.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.157 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -123.19 173.95 7.57 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.403 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 90.2 m -134.4 128.23 33.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.277 0.56 . . . . 0.0 112.456 -175.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.534 HG13 ' H ' ' A' ' 299' ' ' ALA . 40.2 t -86.42 139.6 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.812 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 15.0 t -111.5 11.44 21.35 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.534 ' H ' HG13 ' A' ' 297' ' ' VAL . . . -153.23 177.56 10.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.847 0.356 . . . . 0.0 111.504 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.95 114.55 6.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.3 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.438 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -93.33 100.1 12.5 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.893 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.709 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 13.6 m120 -68.15 126.85 30.83 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -171.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.516 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 18.8 t -104.75 94.82 5.49 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 161.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.1 178.31 5.58 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.718 -175.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 6.3 t -61.18 -33.63 73.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.815 0.341 . . . . 0.0 111.198 -176.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -82.44 7.19 65.48 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.08 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 61.38 42.35 99.75 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.099 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -117.79 134.54 54.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 117.232 0.516 . . . . 0.0 111.082 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.709 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.1 OUTLIER -141.13 106.03 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.957 -178.003 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.446 ' OG1' HG23 ' A' ' 250' ' ' THR . 47.0 m -112.7 122.8 48.73 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.695 -0.628 . . . . 0.0 110.837 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 17.6 m -147.73 161.55 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-O 121.227 0.537 . . . . 0.0 110.895 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 15.5 m -113.73 138.24 50.51 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.478 172.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 4.8 mp -103.26 149.28 24.86 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.609 -175.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 20.3 m -138.48 139.0 38.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.05 0.452 . . . . 0.0 111.845 -173.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 92.92 41.66 4.59 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.509 -0.768 . . . . 0.0 112.43 174.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 4.7 m -127.42 98.96 28.08 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.203 0.525 . . . . 0.0 111.042 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.06 48.83 2.37 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 123.003 2.469 . . . . 0.0 111.817 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.51 122.96 38.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.425 0.631 . . . . 0.0 109.62 -176.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 0.49 ' HB3' ' HB ' ' A' ' 322' ' ' THR . 29.1 m-85 -102.88 73.6 1.27 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.138 0.494 . . . . 0.0 110.533 -175.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.61 -50.04 75.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.628 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 14.5 p -101.79 -7.3 22.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.954 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 319' ' ' TYR . 0.6 OUTLIER -101.02 -1.38 34.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.065 0.46 . . . . 0.0 110.889 -174.163 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.483 ' ND2' ' HB2' ' A' ' 319' ' ' TYR . 39.8 m-20 -124.43 74.36 61.22 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.567 176.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.453 ' HB3' ' HA ' ' A' ' 328' ' ' SER . 38.5 Cg_exo -58.64 -58.03 0.84 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.836 1.691 . . . . 0.0 111.707 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . 0.539 ' HA ' HE21 ' A' ' 325' ' ' GLN . 0.0 OUTLIER 63.67 -79.81 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.934 175.315 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -79.19 -36.95 39.42 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.469 -176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -165.7 147.88 7.41 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -174.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' SER . . . . . 0.453 ' HA ' ' HB3' ' A' ' 324' ' ' PRO . 50.6 m -77.9 76.88 4.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.372 0.606 . . . . 0.0 109.982 176.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . 0.418 ' C ' ' HG ' ' A' ' 330' ' ' SER . 38.8 t -71.59 -49.38 46.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.331 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' SER . . . . . 0.418 ' HG ' ' C ' ' A' ' 329' ' ' VAL . 11.5 p 44.07 55.78 5.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.518 0.675 . . . . 0.0 111.34 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -102.82 154.03 19.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.898 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -107.99 142.07 38.68 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 171.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 18.7 m -58.52 154.98 2.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.902 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -123.87 147.04 47.98 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.798 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -69.14 139.31 54.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.841 -0.163 . . . . 0.0 111.111 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.63 -2.1 6.48 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.932 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 271' ' ' THR . 7.3 p-10 -75.66 168.66 19.6 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.256 0.55 . . . . 0.0 111.292 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -104.36 131.11 52.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.516 -171.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.459 ' HA ' ' CB ' ' A' ' 270' ' ' PHE . 73.8 t -108.44 146.9 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.131 -176.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -143.98 165.09 28.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.277 173.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 48.3 t -109.41 142.4 22.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.235 -176.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 53.2 t -73.16 -46.46 50.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . 0.489 ' C ' ' HG1' ' A' ' 344' ' ' THR . . . 48.81 -123.77 11.2 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.972 176.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.489 ' HG1' ' C ' ' A' ' 343' ' ' GLY . 25.5 p 58.38 -66.33 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.26 1.424 . . . . 0.0 112.92 -178.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 C-N-CA 123.52 0.728 . . . . 0.0 111.288 -177.801 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.83 134.47 34.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.537 0.169 . . . . 0.0 110.681 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 39.8 t80 68.85 -43.88 0.52 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.901 0.88 . . . . 0.0 112.584 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 100.65 6.11 53.08 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -56.3 126.36 40.58 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.128 -0.536 . . . . 0.0 112.208 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 41.5 m -136.75 101.5 4.62 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.974 0.416 . . . . 0.0 109.948 -177.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.4 mp -119.4 176.2 5.46 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 63.9 m -138.55 158.34 44.45 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 -174.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 89.6 t -110.11 106.66 21.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 250' ' ' THR . 17.1 ptmt -93.27 -12.65 29.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.968 0.414 . . . . 0.0 111.02 -174.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.424 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 31.8 p -123.79 -166.95 1.55 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.32 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -112.6 121.06 39.71 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.145 -172.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -70.76 113.35 3.51 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.976 2.451 . . . . 0.0 111.849 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 10.1 t -147.23 109.06 4.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.782 0.801 . . . . 0.0 112.784 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.622 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.48 174.39 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 164.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.458 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 54.3 m -40.94 119.03 1.07 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -173.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -112.71 82.64 1.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 171.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -115.24 136.75 52.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -174.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.68 -45.12 4.29 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.566 -171.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.89 -27.94 43.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.31 0.576 . . . . 0.0 110.035 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -94.55 -7.37 41.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.832 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 56.53 61.48 2.66 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.309 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.8 t -144.43 95.62 2.74 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.575 0.702 . . . . 0.0 110.073 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -108.71 101.53 10.65 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.908 175.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . 0.485 ' HB2' HG13 ' A' ' 236' ' ' VAL . 71.6 mt-30 -130.04 156.36 44.62 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.622 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 15.6 p90 -157.47 136.88 11.99 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.588 0.232 . . . . 0.0 111.615 177.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.413 HG21 ' OG1' ' A' ' 312' ' ' THR . 32.8 m -101.02 133.5 45.42 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.419 ' HB ' ' CD1' ' A' ' 251' ' ' LEU . 0.3 OUTLIER -142.18 148.05 20.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.906 -176.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.537 HG23 ' OG1' ' A' ' 310' ' ' THR . 41.3 m -99.07 111.92 24.19 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.419 ' CD1' ' HB ' ' A' ' 249' ' ' VAL . 5.4 mp -106.15 167.83 9.54 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -172.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.41 148.63 37.42 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.839 174.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -144.94 -142.35 3.84 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -175.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.518 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -110.2 -174.19 2.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.537 HG23 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -68.59 -178.34 1.13 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.676 -170.436 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.537 ' H ' HG23 ' A' ' 255' ' ' THR . . . -67.5 -176.3 0.59 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.849 -177.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 22.7 t 81.03 7.99 1.17 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.491 0.716 . . . . 0.0 111.033 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 39.1 t -124.16 90.81 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 173.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 18.4 m -69.62 98.22 1.14 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.691 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 66.98 95.67 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.717 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -41.91 -56.43 2.75 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 172.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.3 pp -165.08 161.58 19.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.979 -0.1 . . . . 0.0 110.905 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.43 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 92.6 mttt -141.29 -165.91 2.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.722 0.296 . . . . 0.0 111.764 -175.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -49.46 117.95 2.48 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.769 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 113.84 -20.07 17.82 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.689 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -89.15 142.28 27.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.888 0.375 . . . . 0.0 110.191 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.404 HE21 ' HG2' ' A' ' 317' ' ' PRO . 39.8 mt-30 -112.02 153.25 27.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.343 0.592 . . . . 0.0 110.881 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -131.43 165.93 30.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.401 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 341' ' ' VAL . 0.0 OUTLIER -119.3 150.37 40.24 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 169.537 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -149.06 143.27 25.95 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.25 168.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.427 ' HB ' ' OG ' ' A' ' 292' ' ' SER . 3.7 t -93.69 105.02 17.09 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.143 176.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.607 ' HA ' ' OD2' ' A' ' 337' ' ' ASP . 2.8 t-20 -91.26 130.02 37.18 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.321 -174.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 16.0 p -112.16 111.33 22.15 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.713 174.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -87.88 113.0 23.12 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.636 ' O ' ' HB2' ' A' ' 279' ' ' GLN . 18.2 p-90 -157.43 -45.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.558 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 7.3 mp 59.6 174.73 0.08 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.485 0.659 . . . . 0.0 111.298 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -87.08 -10.39 53.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.022 0.439 . . . . 0.0 110.699 -177.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -93.46 -47.43 6.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.136 -175.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.636 ' HB2' ' O ' ' A' ' 275' ' ' TRP . 15.7 mm100 -67.08 -29.45 69.23 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.239 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.701 ' HA ' ' O ' ' A' ' 283' ' ' ALA . 1.2 p -72.71 0.23 11.32 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -176.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -75.22 -36.69 61.34 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -98.07 -44.07 6.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.561 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.701 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -103.42 107.68 18.61 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.953 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 72.0 mt -88.36 9.18 24.25 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -169.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -137.26 -70.14 0.45 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.748 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 62.38 67.46 0.72 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.734 0.646 . . . . 0.0 110.788 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -101.59 9.76 57.33 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.381 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -91.93 9.43 33.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.247 0.546 . . . . 0.0 110.417 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 15.2 t -67.61 145.2 98.13 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.791 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.95 111.63 0.96 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.861 2.374 . . . . 0.0 112.048 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.538 HG21 ' H ' ' A' ' 292' ' ' SER . 3.6 tp -45.2 -68.55 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -170.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' SER . . . . . 0.538 ' H ' HG21 ' A' ' 291' ' ' ILE . 51.5 m -155.71 145.04 20.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 118.198 0.454 . . . . 0.0 110.415 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -150.04 166.74 28.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.869 0.366 . . . . 0.0 110.719 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 99.7 m -100.19 135.79 41.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.488 -173.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . 0.456 ' HA ' ' HD2' ' A' ' 317' ' ' PRO . . . -126.77 177.61 6.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.185 176.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 87.4 m -134.26 134.69 42.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.29 0.567 . . . . 0.0 112.203 -176.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 84.4 t -93.84 144.54 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.282 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 4.2 m -131.4 25.32 4.82 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.985 0.422 . . . . 0.0 111.803 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -147.46 171.06 16.11 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.838 -0.539 . . . . 0.0 112.157 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.43 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 28.7 m-20 -63.62 157.18 24.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.721 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.431 ' HB2' ' CG1' ' A' ' 311' ' ' VAL . . . -141.77 168.82 18.84 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.953 -175.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.495 ' OD1' ' HB3' ' A' ' 304' ' ' ASP . 28.1 t-20 -143.85 131.98 21.8 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.869 -174.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.4 ' HB2' ' HB ' ' A' ' 258' ' ' VAL . 0.5 OUTLIER -115.58 94.53 4.74 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 163.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . 0.495 ' HB3' ' OD1' ' A' ' 302' ' ' ASN . 0.8 OUTLIER -94.92 176.31 6.3 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.763 -177.117 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 15.5 m -58.22 -32.87 68.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.027 0.441 . . . . 0.0 111.533 -177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -77.42 -7.59 87.03 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.085 -178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 73.19 43.29 39.88 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.498 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -115.83 138.07 51.5 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 117.963 0.881 . . . . 0.0 111.488 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.9 OUTLIER -141.34 111.01 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.805 179.455 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.537 ' OG1' HG23 ' A' ' 250' ' ' THR . 88.9 m -100.49 122.54 43.38 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.602 -0.686 . . . . 0.0 111.01 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.431 ' CG1' ' HB2' ' A' ' 301' ' ' ALA . 9.6 m -145.0 155.72 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.545 0.688 . . . . 0.0 111.409 177.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.413 ' OG1' HG21 ' A' ' 248' ' ' THR . 20.7 m -112.3 140.19 47.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.547 177.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.51 HD11 ' CE2' ' A' ' 247' ' ' PHE . 5.1 mp -113.86 138.1 50.75 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.853 -174.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 78.6 p -139.4 116.85 11.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.786 0.327 . . . . 0.0 110.466 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 101.9 136.15 9.12 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 3.9 m -119.3 89.61 40.36 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 121.303 0.573 . . . . 0.0 111.993 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 295' ' ' ALA . 5.4 Cg_exo -76.57 54.52 4.42 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.529 2.82 . . . . 0.0 111.122 173.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 17.2 pt -94.02 155.91 3.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.069 -173.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -103.48 51.9 0.78 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.448 0.642 . . . . 0.0 109.82 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -127.92 60.9 1.44 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.785 -176.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 55.9 p 63.51 110.93 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.683 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 18.8 m -84.05 -27.01 28.61 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -89.56 147.95 39.08 Favored Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.149 173.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.1 61.85 3.26 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.89 1.726 . . . . 0.0 112.61 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . 0.656 ' HA ' HE21 ' A' ' 325' ' ' GLN . 0.0 OUTLIER -90.51 32.03 0.99 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.937 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 66.47 97.31 0.05 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.869 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -154.99 -63.64 0.12 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.066 175.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 20.2 m 54.16 86.5 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.469 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 48.5 t -80.53 130.82 35.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 41.8 m -142.31 102.68 4.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.071 0.462 . . . . 0.0 111.518 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . 0.503 ' CZ ' HD22 ' A' ' 272' ' ' ASN . 3.9 tpm_? -87.11 112.78 22.25 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -91.71 -177.6 4.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 174.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 18.7 m -67.77 106.44 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.799 0.809 . . . . 0.0 111.138 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -164.44 132.25 3.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.81 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -99.41 158.05 16.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.69 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.36 -22.1 5.35 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.878 175.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.607 ' OD2' ' HA ' ' A' ' 272' ' ' ASN . 65.3 m-20 -56.34 141.14 42.88 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 117.226 0.513 . . . . 0.0 111.479 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -99.41 139.76 34.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.571 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 53.7 t -117.37 148.01 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -169.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 36.3 t -142.36 175.59 9.66 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 173.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.447 ' O ' ' HE2' ' A' ' 269' ' ' LYS . 40.0 t -118.66 146.07 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 O-C-N 122.265 -0.272 . . . . 0.0 110.602 -174.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 42.0 t -75.4 -40.79 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.709 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -128.5 -168.16 12.36 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.995 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -73.6 -44.84 56.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.884 0.373 . . . . 0.0 111.522 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.844 179.742 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.554 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -106.73 131.95 53.27 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -62.84 156.38 24.25 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.008 0.432 . . . . 0.0 111.364 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 106.48 17.49 12.27 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -172.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -59.42 121.51 26.98 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.078 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.8 m -94.71 134.9 36.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.916 0.388 . . . . 0.0 109.978 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 1.1 mp -134.02 176.04 8.94 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.404 ' HB ' ' OG1' ' A' ' 252' ' ' THR . 35.4 m -122.33 154.79 37.16 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.667 0.27 . . . . 0.0 110.728 -175.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.49 HG22 ' OD2' ' A' ' 337' ' ' ASP . 99.2 t -97.91 133.15 41.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.172 -177.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.452 ' HD2' HG21 ' A' ' 252' ' ' THR . 33.2 mtpt -109.37 -38.19 5.55 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 171.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.703 ' O ' HG11 ' A' ' 249' ' ' VAL . 70.9 p -141.0 160.87 39.15 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 172.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.53 ' CD ' ' HD2' ' A' ' 234' ' ' PRO . 6.0 mm100 -116.12 163.74 20.42 Favored Pre-proline 0 C--N 1.318 -0.772 0 C-N-CA 123.369 0.667 . . . . 0.0 110.075 -176.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.601 ' HB3' ' CD2' ' A' ' 247' ' ' PHE . 5.6 Cg_exo -38.47 109.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 124.824 3.683 . . . . 0.0 115.126 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.44 ' O ' HG23 ' A' ' 236' ' ' VAL . 9.0 t -155.25 92.42 1.42 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.368 0.604 . . . . 0.0 111.596 173.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.649 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -157.75 175.17 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.983 171.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.504 ' H ' HG11 ' A' ' 236' ' ' VAL . 60.7 m -37.28 119.14 0.67 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.811 1.244 . . . . 0.0 114.093 -171.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -108.11 83.91 1.86 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 174.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.56 115.82 28.07 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -175.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -101.18 -42.76 6.23 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -166.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.11 -24.19 33.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.624 0.726 . . . . 0.0 109.405 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -98.32 -8.89 26.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.014 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 16.1 t70 53.1 57.23 6.51 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.442 -175.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.7 m -129.47 96.94 4.41 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.1 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -115.91 109.25 17.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.659 -173.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -126.92 153.47 45.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.649 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 35.2 p90 -148.33 140.73 24.3 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.541 -0.463 . . . . 0.0 111.187 174.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 85.2 m -97.85 143.82 28.06 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 122.19 -0.319 . . . . 0.0 110.287 -178.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.703 HG11 ' O ' ' A' ' 232' ' ' THR . 41.6 t -140.64 125.14 18.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.862 177.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.539 HG21 ' OG1' ' A' ' 310' ' ' THR . 41.5 m -90.85 129.62 36.89 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 173.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.47 HD21 HG13 ' A' ' 339' ' ' VAL . 4.4 mp -120.3 165.39 14.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.585 0.707 . . . . 0.0 110.438 -176.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.452 HG21 ' HD2' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -120.75 136.98 54.73 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.375 -0.83 . . . . 0.0 108.973 169.57 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -127.58 -143.53 5.75 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.011 -176.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -112.99 -173.23 2.21 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.481 HG23 ' H ' ' A' ' 256' ' ' ALA . 1.4 m -56.5 168.82 0.51 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.581 -171.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.481 ' H ' HG23 ' A' ' 255' ' ' THR . . . -66.48 -176.77 0.49 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.294 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 10.9 t 79.6 16.76 0.83 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.009 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 45.1 t -128.96 90.45 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.784 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 172.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 23.2 m -73.68 95.82 2.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.147 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 75.43 93.8 0.16 Allowed Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.358 -0.837 . . . . 0.0 113.067 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -42.63 -56.14 3.25 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 171.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -161.79 164.82 28.64 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -140.02 -166.96 2.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -50.48 123.38 8.61 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.752 0.787 . . . . 0.0 111.903 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 109.39 -21.97 25.43 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.737 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -87.52 139.54 30.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.879 0.371 . . . . 0.0 110.16 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -111.74 143.45 42.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.159 0.504 . . . . 0.0 111.197 -175.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.2 OUTLIER -116.26 179.62 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.277 174.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.561 ' HD2' ' C ' ' A' ' 269' ' ' LYS . 3.0 tmmm? -138.35 128.57 25.84 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -116.4 157.66 24.74 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.783 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.515 ' HA ' ' OG ' ' A' ' 292' ' ' SER . 41.4 p -136.92 98.23 3.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.507 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.452 ' HA ' ' CG ' ' A' ' 337' ' ' ASP . 25.5 p-10 -91.25 162.29 14.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.81 -173.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 9.7 p -83.78 171.34 13.24 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.464 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.527 ' HB2' ' H ' ' A' ' 289' ' ' THR . 45.5 t80 -79.94 113.73 18.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.417 0.627 . . . . 0.0 109.901 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.96 0.94 0.65 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.258 -177.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 331' ' ' ARG . 3.9 mp -103.9 -163.01 0.94 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.401 -176.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -66.38 -72.13 0.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.956 0.408 . . . . 0.0 110.954 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -115.08 -80.96 0.6 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.0 0.429 . . . . 0.0 109.965 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -117.23 -63.08 1.49 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.91 175.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 18.9 p -110.91 -77.68 0.59 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.534 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -92.71 -78.28 0.42 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.076 -0.249 . . . . 0.0 111.364 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -138.39 -9.71 1.46 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 284' ' ' LEU . . . -132.02 -146.97 0.3 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -170.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 283' ' ' ALA . 52.7 mt 84.59 8.71 0.46 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.621 1.169 . . . . 0.0 111.963 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 71.24 -67.01 0.27 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 169.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -43.93 -47.91 8.49 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.458 0.911 . . . . 0.0 113.458 -167.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 79.86 30.96 41.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.227 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . 0.653 ' O ' ' HD3' ' A' ' 290' ' ' PRO . . . -148.57 137.57 21.65 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.527 ' H ' ' HB2' ' A' ' 274' ' ' TYR . 17.3 m -107.85 86.43 3.03 Favored Pre-proline 0 C--N 1.317 -0.826 0 O-C-N 123.109 0.255 . . . . 0.0 110.624 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . 0.653 ' HD3' ' O ' ' A' ' 288' ' ' ALA . 76.9 Cg_endo -102.62 12.25 0.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.309 2.673 . . . . 0.0 112.913 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 10.4 tp -165.37 145.87 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.047 0.451 . . . . 0.0 111.157 -175.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' SER . . . . . 0.515 ' OG ' ' HA ' ' A' ' 271' ' ' THR . 0.0 OUTLIER -142.73 -162.38 1.42 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.315 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . 0.437 ' HB2' ' H ' ' A' ' 294' ' ' THR . 24.8 p90 -142.81 -150.47 0.31 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -172.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 35.1 m -74.93 144.97 43.0 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -168.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -126.86 159.28 34.39 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 165.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 93.1 m -122.77 119.43 30.61 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.801 -0.759 . . . . 0.0 112.381 -175.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 64.9 t -78.81 133.99 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.614 -177.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 3.4 m -129.38 24.65 5.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.307 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -151.07 166.85 29.5 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.208 0.527 . . . . 0.0 112.134 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -65.86 115.82 6.37 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.244 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.506 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -93.29 170.25 9.76 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.629 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.61 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 9.5 t30 -149.02 131.75 15.97 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.59 -171.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -113.85 95.52 5.36 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 169.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . 0.535 ' HB3' HD22 ' A' ' 302' ' ' ASN . 0.8 OUTLIER -96.35 178.52 5.34 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.007 -176.652 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 23.2 t -59.9 -34.38 73.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.938 0.399 . . . . 0.0 111.207 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -83.88 4.01 83.9 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.857 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 64.35 43.17 97.23 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.797 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -113.18 133.9 54.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 118.116 0.958 . . . . 0.0 111.634 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.61 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.1 OUTLIER -137.84 119.55 18.08 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.974 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.009 178.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.539 ' OG1' HG21 ' A' ' 250' ' ' THR . 76.6 m -120.51 126.11 49.55 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.379 -0.826 . . . . 0.0 110.979 -178.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 30.7 m -138.2 163.47 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.638 0.732 . . . . 0.0 111.485 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 31.4 m -123.25 138.58 54.6 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.1 173.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 313' ' ' LEU . 1.3 mm? -106.68 124.46 49.64 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.014 -169.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 47.6 t -120.53 144.22 48.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.147 0.499 . . . . 0.0 111.813 -171.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 78.37 38.03 26.3 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.936 176.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.62 112.79 5.46 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-O 120.868 0.366 . . . . 0.0 110.842 -174.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.23 72.35 5.95 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.876 2.384 . . . . 0.0 113.598 -175.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.564 ' HB ' ' CE1' ' A' ' 247' ' ' PHE . 8.3 mm -103.5 128.53 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -71.95 113.03 8.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.846 -173.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.401 ' C ' ' HG1' ' A' ' 321' ' ' THR . 1.4 t70 -63.46 -62.71 1.5 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.842 174.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.401 ' HG1' ' C ' ' A' ' 320' ' ' ASP . 38.6 p 45.36 27.26 0.35 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 27.3 m -119.6 -34.63 3.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.05 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.413 ' HB3' ' HD3' ' A' ' 324' ' ' PRO . 7.4 t30 -61.77 -48.15 90.2 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.413 ' HD3' ' HB3' ' A' ' 323' ' ' ASN . 20.0 Cg_exo -69.58 2.09 3.74 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.661 2.241 . . . . 0.0 113.104 -176.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -84.04 78.16 9.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.601 0.715 . . . . 0.0 109.427 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -101.75 -8.7 21.48 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.661 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -164.16 -49.84 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.9 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 13.2 m -85.54 68.52 10.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.847 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 15.2 t -79.62 113.46 19.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.57 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 4.0 p -117.24 -71.06 0.76 Allowed 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.815 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . 0.512 ' HD3' ' H ' ' A' ' 331' ' ' ARG . 0.0 OUTLIER -103.37 145.74 29.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.64 0.257 . . . . 0.0 110.392 178.714 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -142.34 133.14 25.58 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.506 ' HB ' ' CB ' ' A' ' 233' ' ' GLN . 14.7 m -57.82 145.87 8.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 O-C-N 123.334 0.396 . . . . 0.0 110.383 175.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.93 129.8 55.43 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -163.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -100.26 115.82 30.81 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.003 -0.436 . . . . 0.0 111.975 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 129.05 12.06 2.7 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 119.554 -1.308 . . . . 0.0 114.82 170.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.49 ' OD2' HG22 ' A' ' 230' ' ' VAL . 3.9 p-10 -92.82 -148.74 0.25 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 117.548 0.674 . . . . 0.0 111.322 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -121.54 147.28 46.01 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -168.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.47 HG13 HD21 ' A' ' 251' ' ' LEU . 68.0 t -121.85 149.4 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.145 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 25.4 m -147.42 178.62 8.28 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 46.6 t -112.27 153.34 13.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 74.1 t -68.71 -63.38 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 118.012 0.369 . . . . 0.0 110.52 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 69.5 67.03 2.05 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.939 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.38 -45.27 18.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.565 0.698 . . . . 0.0 110.557 176.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.532 179.168 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.815 0 N-CA-C 111.721 -0.552 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 53.76 69.16 0.74 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.168 0.509 . . . . 0.0 110.362 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.43 ' CG ' ' N ' ' A' ' 225' ' ' GLY . 12.6 t80 61.42 -161.25 0.29 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.391 -173.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.43 ' N ' ' CG ' ' A' ' 224' ' ' PHE . . . 131.07 -8.56 5.71 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.674 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -65.3 113.29 5.7 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.23 -0.986 . . . . 0.0 111.454 176.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 11.3 m -143.33 139.3 30.02 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.429 HD21 HG12 ' A' ' 309' ' ' VAL . 18.4 mt -142.0 176.26 9.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' A' ' 251' ' ' LEU . 8.3 t -140.5 166.39 24.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.738 0.304 . . . . 0.0 110.335 -178.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 15.1 t -117.88 134.26 62.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.4 -168.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -128.6 11.87 6.3 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.86 0.362 . . . . 0.0 111.528 176.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.425 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 17.4 p -141.06 -174.46 4.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.221 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -114.24 116.23 44.52 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -176.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.524 ' HB2' ' CD1' ' A' ' 247' ' ' PHE . 73.4 Cg_endo -78.28 106.7 2.18 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.455 2.103 . . . . 0.0 113.361 -176.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.48 ' O ' HG22 ' A' ' 236' ' ' VAL . 9.1 t -155.98 127.1 7.03 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.179 174.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.743 ' O ' ' HB2' ' A' ' 246' ' ' GLN . 47.7 t -154.35 81.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.384 0.674 . . . . 0.0 109.623 170.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 236' ' ' VAL . 33.1 m 83.14 94.89 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.939 175.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -111.67 90.22 3.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.925 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -122.91 135.86 54.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.409 ' HB3' ' OD2' ' A' ' 320' ' ' ASP . . . -103.64 -49.79 3.59 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.876 -170.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 75.9 t -60.36 -31.39 48.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.504 0.668 . . . . 0.0 110.071 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -91.05 -6.51 53.74 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.575 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 36.0 t70 54.55 63.98 1.97 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.435 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.7 m -143.27 99.82 3.51 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.622 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -120.78 112.92 19.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.033 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . 0.743 ' HB2' ' O ' ' A' ' 236' ' ' VAL . 69.7 mt-30 -135.48 170.33 16.12 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.666 ' HA ' ' N ' ' A' ' 236' ' ' VAL . 26.5 p90 -166.8 142.17 4.3 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 176.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 34.0 m -104.5 142.9 33.8 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.96 139.67 27.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.769 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.509 HG21 ' OG1' ' A' ' 310' ' ' THR . 53.0 m -103.61 105.45 15.69 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 170.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.522 ' HB2' HG13 ' A' ' 309' ' ' VAL . 0.4 OUTLIER -106.4 171.36 7.4 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.553 0.692 . . . . 0.0 109.651 -174.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 307' ' ' GLY . 0.0 OUTLIER -121.81 144.37 48.86 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.703 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -144.73 -142.6 3.89 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.362 -172.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.525 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -95.58 -176.8 3.86 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -172.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.519 HG23 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -81.66 -177.16 6.42 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.867 -171.342 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.519 ' H ' HG23 ' A' ' 255' ' ' THR . . . -61.7 -177.61 0.11 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.668 -177.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 95.6 p 66.9 17.89 10.57 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.086 1.354 . . . . 0.0 110.895 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.427 HG13 ' CE2' ' A' ' 261' ' ' PHE . 12.9 t -129.06 88.83 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 31.6 m -87.79 92.56 9.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.347 -177.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 86.76 86.46 1.08 Allowed Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.533 178.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.427 ' CE2' HG13 ' A' ' 258' ' ' VAL . 0.8 OUTLIER -48.63 -45.06 37.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.093 0.473 . . . . 0.0 110.04 170.405 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.477 ' HB2' ' CB ' ' A' ' 266' ' ' ASP . 2.1 pt? -162.42 168.55 21.88 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.055 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.428 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 97.2 mttt -137.78 -167.53 2.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.634 0.254 . . . . 0.0 111.584 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -56.64 118.97 5.38 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.363 0.602 . . . . 0.0 110.969 178.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 110.73 -16.49 28.5 Favored Glycine 0 C--N 1.313 -0.742 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.541 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . 0.477 ' CB ' ' HB2' ' A' ' 262' ' ' LEU . 37.0 m-20 -91.68 140.5 29.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.038 0.447 . . . . 0.0 110.09 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 296' ' ' THR . 2.2 mp0 -95.55 168.7 10.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.552 -178.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.1 OUTLIER -126.54 171.83 14.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.514 173.079 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.487 ' HA ' ' HD2' ' A' ' 269' ' ' LYS . 16.6 tptm -134.47 89.11 2.51 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.379 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -114.2 159.81 19.7 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 119.189 -1.005 . . . . 0.0 111.098 -172.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 271' ' ' THR . 10.1 t -132.57 99.89 4.79 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.853 0.835 . . . . 0.0 110.246 -177.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -94.88 81.29 3.75 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.642 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' THR . . . . . 0.437 ' HB ' ' CB ' ' A' ' 288' ' ' ALA . 48.9 p -67.87 105.91 2.12 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.557 -178.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -82.5 112.97 19.9 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.548 ' O ' ' HG3' ' A' ' 278' ' ' GLN . 15.6 t-105 174.44 71.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -176.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -83.23 25.86 0.68 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -169.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.68 -5.35 58.82 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 172.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 275' ' ' TRP . 39.0 mt-30 -58.14 -41.24 83.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.517 174.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -63.88 -31.39 72.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.482 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 11.9 p -93.52 -22.31 18.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.642 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -89.56 -42.22 11.55 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.262 -0.175 . . . . 0.0 111.147 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 68.19 -37.72 0.35 Allowed 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.597 1.159 . . . . 0.0 113.857 175.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -71.47 -18.67 62.29 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.201 0.524 . . . . 0.0 110.87 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 87.5 mt 61.5 28.18 17.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.798 171.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -76.86 -14.92 59.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.127 0.489 . . . . 0.0 109.807 174.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -83.14 153.54 24.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.505 175.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -103.49 -128.27 6.29 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.416 177.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . 0.437 ' CB ' ' HB ' ' A' ' 273' ' ' THR . . . 176.36 -172.72 0.09 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -175.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.424 ' O ' HG22 ' A' ' 273' ' ' THR . 8.4 t -85.13 117.01 67.89 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.68 175.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.61 53.53 4.77 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.866 2.377 . . . . 0.0 113.238 -174.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 21.1 pt -85.94 114.89 26.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.228 0.537 . . . . 0.0 111.092 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 43.8 p -127.11 116.08 20.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.596 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -134.65 171.8 13.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.535 0.683 . . . . 0.0 112.368 -175.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 87.7 m -102.53 127.89 49.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.623 -1.172 . . . . 0.0 111.5 -172.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -127.37 -172.46 2.67 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 267' ' ' GLN . 73.7 m -134.35 135.84 42.99 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -175.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.502 HG13 ' H ' ' A' ' 299' ' ' ALA . 87.0 t -95.9 142.72 13.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.98 176.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 8.9 t -114.84 24.1 12.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.857 0.36 . . . . 0.0 111.742 -174.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.502 ' H ' HG13 ' A' ' 297' ' ' VAL . . . -160.42 170.15 21.58 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.125 0.488 . . . . 0.0 112.029 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.428 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 5.2 m-20 -62.85 111.98 2.36 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.042 177.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.476 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -92.42 114.25 26.75 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.206 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.634 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 27.3 m-80 -88.46 138.02 31.81 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -170.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 57.7 m -124.24 99.97 6.47 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.827 157.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -98.99 -175.06 2.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.447 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 49.3 m -57.21 -32.46 66.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.705 0.288 . . . . 0.0 111.758 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -79.57 2.56 72.17 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.741 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 58.17 42.25 95.18 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.284 -177.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -114.75 142.06 47.02 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 117.727 0.764 . . . . 0.0 111.259 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.634 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 1.6 p -149.3 104.13 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.74 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.509 ' OG1' HG21 ' A' ' 250' ' ' THR . 55.4 m -113.28 124.78 53.3 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 121.576 -0.703 . . . . 0.0 110.916 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 22.0 m -147.48 164.27 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.1 0.476 . . . . 0.0 110.568 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 31.4 m -116.47 145.54 43.22 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.055 0.455 . . . . 0.0 110.196 176.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.457 HD13 ' CE1' ' A' ' 247' ' ' PHE . 5.2 mp -120.99 152.18 38.87 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.093 -174.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 25.6 m -139.98 119.19 12.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.438 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 98.46 133.11 7.87 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.967 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 30.5 m -136.6 155.35 76.87 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.51 47.55 2.32 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.609 2.206 . . . . 0.0 112.339 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.474 HG23 HH12 ' A' ' 331' ' ' ARG . 80.9 mt -118.01 122.47 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -101.35 140.16 36.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.054 0.454 . . . . 0.0 110.727 -174.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.409 ' OD2' ' HB3' ' A' ' 240' ' ' ALA . 37.1 t70 -87.42 3.27 47.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.601 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 3.6 p -54.71 -60.74 2.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.074 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 8.7 m -102.34 -43.93 5.54 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.591 175.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.449 ' N ' ' HD3' ' A' ' 324' ' ' PRO . 7.5 t-20 44.97 56.06 14.4 Favored Pre-proline 0 N--CA 1.472 0.663 0 O-C-N 123.807 0.692 . . . . 0.0 111.649 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 323' ' ' ASN . 25.5 Cg_endo -98.39 26.36 0.19 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.311 2.674 . . . . 0.0 112.59 -175.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -77.2 77.67 3.74 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.868 -172.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 65.82 -61.54 0.26 Allowed 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.32 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -152.72 -27.18 0.16 Allowed 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.424 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 10.1 t 77.05 -51.71 0.56 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.143 175.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 26.2 t -75.72 -18.45 15.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.401 0.619 . . . . 0.0 110.623 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 15.5 m -110.67 35.54 3.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.175 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . 0.474 HH12 HG23 ' A' ' 318' ' ' ILE . 86.7 mtm180 -92.32 113.75 26.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.573 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -111.72 151.52 28.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.842 0.353 . . . . 0.0 110.285 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 25.6 m -116.51 163.01 14.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.302 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -137.96 163.56 31.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.921 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -86.29 159.73 19.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.855 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 110.01 8.35 25.88 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.655 -0.783 . . . . 0.0 114.09 173.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 271' ' ' THR . 14.9 m-20 -93.77 -172.85 2.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.437 0.618 . . . . 0.0 111.713 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -115.56 149.22 38.55 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.816 -172.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.458 HG22 HD21 ' A' ' 251' ' ' LEU . 55.6 t -128.9 147.29 33.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.866 -177.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.477 ' HB2' ' HB3' ' A' ' 269' ' ' LYS . 37.3 m -137.96 178.27 7.25 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.437 HG13 ' H ' ' A' ' 343' ' ' GLY . 21.1 t -118.0 147.79 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 120.942 0.401 . . . . 0.0 111.751 -171.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.408 HG11 ' O ' ' A' ' 342' ' ' VAL . 47.0 t -128.76 50.62 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 122.359 1.076 . . . . 0.0 108.353 173.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . 0.437 ' H ' HG13 ' A' ' 341' ' ' VAL . . . -53.87 148.27 18.31 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 114.203 -1.362 . . . . 0.0 113.036 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 21.2 p -105.35 -61.05 1.53 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.04 0.447 . . . . 0.0 111.067 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.505 -179.539 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.79 0 N-CA-C 112.218 -0.353 . . . . 0.0 112.218 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.7 91.0 5.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.829 0.347 . . . . 0.0 111.099 -177.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -64.2 -41.83 96.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.214 0.531 . . . . 0.0 110.628 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 77.27 29.55 56.12 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.001 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -90.98 -143.43 11.26 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.169 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 6.1 m -82.16 144.97 30.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.915 0.388 . . . . 0.0 111.08 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.444 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.0 mp -136.14 -177.25 4.62 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 172.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 41.4 m -131.72 153.79 49.69 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.885 0.374 . . . . 0.0 110.961 -173.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 14.3 t -101.09 130.71 50.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -111.99 -28.13 8.14 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.16 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 32.8 p -123.82 -167.82 1.69 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.991 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.411 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 45.6 mt-30 -109.59 121.63 41.72 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -175.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.601 ' O ' HG13 ' A' ' 333' ' ' VAL . 14.6 Cg_exo -68.1 105.39 1.18 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.556 2.17 . . . . 0.0 111.633 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.456 ' O ' HG23 ' A' ' 236' ' ' VAL . 9.8 t -154.26 123.47 6.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.727 0.775 . . . . 0.0 112.868 -177.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.599 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 2.1 t -154.18 175.23 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 170.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.515 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 87.4 m -39.93 116.12 0.61 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -108.36 83.5 1.79 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 172.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -110.29 138.54 46.54 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.96 -41.5 5.17 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.588 -172.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 44.4 t -61.71 -31.62 51.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.435 0.636 . . . . 0.0 109.732 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -95.14 -5.77 43.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.667 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 30.6 t70 53.01 51.11 16.47 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.367 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 22.5 m -127.9 97.56 4.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.474 -173.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -113.69 105.36 13.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.95 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . 0.468 ' HB2' HG13 ' A' ' 236' ' ' VAL . 86.8 mt-30 -129.71 152.99 48.61 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.882 -178.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.599 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 2.8 p90 -154.8 129.8 9.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.776 0.322 . . . . 0.0 111.842 176.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 37.0 m -103.26 141.83 35.23 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.48 ' HB ' ' CD1' ' A' ' 251' ' ' LEU . 0.2 OUTLIER -142.84 146.45 21.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 119.911 -0.716 . . . . 0.0 112.129 179.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.549 HG21 ' OG1' ' A' ' 310' ' ' THR . 57.8 m -101.22 111.43 23.64 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 163.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.543 ' HB2' HG11 ' A' ' 309' ' ' VAL . 3.3 mp -114.04 168.57 9.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -172.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.7 138.56 46.93 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.74 0.305 . . . . 0.0 110.517 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -133.05 -142.74 4.88 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -175.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.475 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -106.34 -177.73 3.45 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.332 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.548 HG23 ' H ' ' A' ' 256' ' ' ALA . 0.3 OUTLIER -70.82 -177.32 1.56 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.39 -175.635 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.548 ' H ' HG23 ' A' ' 255' ' ' THR . . . -63.34 -176.65 0.16 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 122.999 0.52 . . . . 0.0 111.672 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 11.7 t 79.63 12.81 1.12 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.073 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 90.9 t -133.02 89.56 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-O 121.621 0.724 . . . . 0.0 109.565 171.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 12.4 m -79.45 97.46 6.4 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.624 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 79.78 93.45 0.37 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.744 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.667 ' CE1' ' HB2' ' A' ' 303' ' ' SER . 7.0 m-85 -53.37 -43.07 67.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.217 0.532 . . . . 0.0 110.469 169.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.474 ' HB2' ' CB ' ' A' ' 266' ' ' ASP . 4.1 pp -161.34 172.96 15.66 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.97 -176.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -129.84 -166.92 1.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.989 0.423 . . . . 0.0 111.48 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -60.93 118.19 6.4 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.193 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 109.83 -15.86 31.2 Favored Glycine 0 C--N 1.316 -0.543 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.444 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . 0.474 ' CB ' ' HB2' ' A' ' 262' ' ' LEU . 14.3 m-20 -75.29 134.88 40.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -97.96 151.78 19.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.74 0.781 . . . . 0.0 111.668 -176.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 1.7 m -125.38 172.31 13.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.795 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.16 133.17 21.36 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 169.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' A' ' 338' ' ' ALA . 47.2 p90 -143.81 167.87 21.28 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.456 -174.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.603 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 13.9 t -133.67 123.92 25.83 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.329 0.585 . . . . 0.0 111.561 -175.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.537 ' O ' ' HA ' ' A' ' 290' ' ' PRO . 3.2 t-20 -88.45 109.23 19.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.249 173.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 11.5 p -118.26 81.07 1.62 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.434 0.635 . . . . 0.0 111.327 -173.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -142.57 -171.85 3.5 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.738 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 46.8 t-105 -131.56 77.77 1.79 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.129 0.49 . . . . 0.0 109.777 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -89.27 22.75 2.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.667 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . 0.467 ' HA ' ' CG2' ' A' ' 280' ' ' THR . 12.7 mp0 -60.91 -23.71 65.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.753 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -64.84 -29.37 70.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.368 0.604 . . . . 0.0 109.729 175.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -107.8 13.34 26.49 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.118 -176.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.467 ' CG2' ' HA ' ' A' ' 277' ' ' GLN . 35.3 p -80.45 12.85 2.75 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.683 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -76.58 -29.09 56.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.236 0.541 . . . . 0.0 109.555 176.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -79.48 -26.55 41.63 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.394 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -85.82 -173.9 4.85 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.75 172.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.406 HD23 ' N ' ' A' ' 284' ' ' LEU . 2.9 mm? -98.13 34.79 1.87 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.131 0.491 . . . . 0.0 110.112 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 57.26 96.65 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.236 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -128.88 159.09 36.9 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.897 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -123.11 -3.21 8.97 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.338 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -102.57 56.64 0.78 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.931 0.396 . . . . 0.0 110.878 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.455 ' HB ' ' HD3' ' A' ' 290' ' ' PRO . 70.0 m -68.73 -46.4 33.79 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.073 178.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 272' ' ' ASN . 23.4 Cg_exo -66.12 79.46 0.3 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 122.171 1.914 . . . . 0.0 112.437 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 9.7 tp -124.17 149.99 28.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.157 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' SER . . . . . 0.436 ' HB3' ' HB ' ' A' ' 271' ' ' THR . 16.0 p -113.38 138.83 49.5 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 176.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -152.26 159.7 43.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.936 0.398 . . . . 0.0 111.085 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 96.4 m -90.88 129.36 36.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.054 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -119.97 -178.66 3.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.164 -178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 96.9 m -142.63 128.41 19.35 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.476 0.655 . . . . 0.0 112.503 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 299' ' ' ALA . 39.2 t -94.41 147.54 5.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.019 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 15.1 t -110.15 17.27 21.15 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -173.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.475 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -165.95 176.95 7.41 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.422 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 4.5 m-20 -60.91 120.76 10.81 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.58 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.429 ' HA ' ' CG1' ' A' ' 311' ' ' VAL . . . -93.38 115.02 27.58 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.263 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -79.72 130.17 35.11 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -169.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.667 ' HB2' ' CE1' ' A' ' 261' ' ' PHE . 32.7 t -114.06 94.91 5.03 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 162.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -109.66 177.6 4.68 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.152 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 17.2 t -54.78 -33.17 61.08 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -77.05 6.11 44.54 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.625 -176.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 56.24 40.49 84.55 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.927 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -120.17 124.29 45.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.861 0.363 . . . . 0.0 110.544 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.543 HG11 ' HB2' ' A' ' 251' ' ' LEU . 2.6 p -125.05 94.48 2.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.643 0.735 . . . . 0.0 110.359 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.549 ' OG1' HG21 ' A' ' 250' ' ' THR . 56.7 m -102.44 117.26 34.34 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.064 -176.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.429 ' CG1' ' HA ' ' A' ' 301' ' ' ALA . 5.4 m -148.55 160.09 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.306 0.574 . . . . 0.0 110.717 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 26.5 m -110.36 141.62 43.15 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.389 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.468 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.0 mp -109.59 122.39 47.33 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.551 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 23.6 p -144.13 152.46 40.96 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.945 -170.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 82.25 32.52 28.37 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.792 174.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 2.9 m -127.17 84.06 64.42 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 121.189 0.518 . . . . 0.0 111.635 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.73 78.12 3.82 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.217 2.611 . . . . 0.0 110.506 174.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 6.4 tt -82.09 99.15 4.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.28 -172.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -123.14 70.43 1.03 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.026 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.435 ' OD1' ' HB2' ' A' ' 326' ' ' TYR . 14.0 t70 -65.61 -62.01 1.76 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.593 -177.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.412 HG21 HE21 ' A' ' 325' ' ' GLN . 1.1 p -139.03 138.91 37.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.1 0.476 . . . . 0.0 110.596 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.2 -18.44 42.64 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.733 0.778 . . . . 0.0 109.57 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -80.45 159.42 69.78 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.711 172.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.44 34.62 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.351 2.034 . . . . 0.0 113.793 -174.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . 0.412 HE21 HG21 ' A' ' 321' ' ' THR . 25.1 mt-30 -81.12 -63.42 1.41 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 174.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . 0.435 ' HB2' ' OD1' ' A' ' 320' ' ' ASP . 86.8 m-85 -137.75 72.98 1.42 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.534 0.683 . . . . 0.0 109.436 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -106.62 71.23 0.85 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.244 -175.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 16.0 m -73.18 6.43 2.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.174 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 59.4 t -75.66 -37.9 37.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.745 175.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 51.3 m -79.39 52.19 1.33 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.702 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -97.38 142.39 29.29 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.638 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -125.48 108.42 11.61 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.601 HG13 ' O ' ' A' ' 234' ' ' PRO . 21.8 m -73.33 137.52 23.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.871 -167.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -140.12 153.89 46.83 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.649 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -91.87 141.67 28.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.653 -0.248 . . . . 0.0 111.065 -175.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 115.87 9.3 12.48 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.672 175.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.603 ' HB3' ' O ' ' A' ' 271' ' ' THR . 49.6 m-20 -87.45 -169.14 2.48 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.349 0.574 . . . . 0.0 112.215 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 270' ' ' PHE . . . -110.94 148.06 33.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.605 -174.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 54.3 t -124.12 151.74 29.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.816 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 24.0 m -150.36 163.25 38.82 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.452 HG11 ' H ' ' A' ' 343' ' ' GLY . 48.8 t -117.34 138.41 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.611 0.243 . . . . 0.0 110.694 -176.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 71.3 t -69.82 -35.96 67.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.117 0.484 . . . . 0.0 109.953 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . 0.452 ' H ' HG11 ' A' ' 341' ' ' VAL . . . 90.15 -60.64 3.38 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.407 174.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 4.8 p -155.71 123.57 5.69 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.518 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.364 179.869 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.59 0 N-CA-C 111.974 -0.45 . . . . 0.0 111.974 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 68.13 97.71 0.06 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.381 0.61 . . . . 0.0 111.033 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -65.93 -47.93 73.08 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.948 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 85.76 -2.77 87.77 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.996 -176.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.613 ' O ' ' HA ' ' A' ' 340' ' ' SER . . . -55.74 125.65 37.49 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.343 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 17.8 m -92.87 132.11 37.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.907 0.384 . . . . 0.0 111.536 -175.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.449 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.3 mp -138.46 -177.21 4.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 96.8 m -138.45 156.02 47.93 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.321 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.419 HG23 HG23 ' A' ' 339' ' ' VAL . 69.9 t -103.1 126.38 57.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -109.7 -11.69 14.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.048 0.452 . . . . 0.0 110.951 -173.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.5 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 36.5 p -131.22 -167.04 1.79 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.375 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.506 HE21 ' HB2' ' A' ' 335' ' ' ALA . 1.3 mp0 -111.85 115.27 51.12 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -173.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 248' ' ' THR . 65.0 Cg_endo -78.54 105.01 1.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.216 1.944 . . . . 0.0 111.975 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.433 ' OG1' ' HB2' ' A' ' 331' ' ' ARG . 15.3 t -107.42 136.13 47.73 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.34 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.475 ' HA ' ' HB3' ' A' ' 247' ' ' PHE . 39.2 t -82.58 121.74 36.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.391 0.615 . . . . 0.0 111.788 -175.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 52.7 m -87.38 105.24 17.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.558 175.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -86.46 125.65 33.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.055 0.455 . . . . 0.0 110.801 -178.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.401 ' OD1' ' HG3' ' A' ' 242' ' ' LYS . 0.2 OUTLIER -138.75 77.68 1.64 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.476 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -83.04 -36.18 25.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.03 -163.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 39.5 t -68.15 -23.4 28.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.401 ' HG3' ' OD1' ' A' ' 239' ' ' ASN . 11.3 mmpt? -97.56 -2.8 40.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.432 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 56.18 46.14 21.97 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.119 -1.401 . . . . 0.0 112.143 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 35.3 t -132.55 125.45 30.56 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.416 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -128.88 102.17 6.41 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -130.8 159.1 38.31 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.475 ' HB3' ' HA ' ' A' ' 236' ' ' VAL . 8.1 p90 -137.58 137.54 38.64 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.873 178.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 85.2 m -105.18 143.55 33.19 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 -171.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.516 HG11 ' CD1' ' A' ' 251' ' ' LEU . 4.2 p -148.5 142.79 18.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.581 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.5 ' HB ' ' CG2' ' A' ' 232' ' ' THR . 57.4 m -99.11 126.88 44.96 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 167.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.516 ' CD1' HG11 ' A' ' 249' ' ' VAL . 4.8 mp -111.59 172.56 6.82 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.968 -173.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.52 145.74 47.65 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 169.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -145.39 -142.83 3.87 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.862 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.534 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -113.47 -174.41 2.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.853 0.358 . . . . 0.0 111.725 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.583 HG23 ' H ' ' A' ' 256' ' ' ALA . 0.7 OUTLIER -70.43 -179.82 2.21 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.561 -170.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.583 ' H ' HG23 ' A' ' 255' ' ' THR . . . -63.93 -174.93 0.12 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.678 0.791 . . . . 0.0 112.256 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 34.5 t 81.94 7.4 1.01 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.819 0.847 . . . . 0.0 111.172 -177.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 42.4 t -128.45 89.04 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.619 0 CA-C-O 121.615 0.721 . . . . 0.0 109.377 170.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 26.4 m -81.86 88.42 6.34 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.105 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 96.31 81.69 1.59 Allowed Glycine 0 N--CA 1.439 -1.115 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.347 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -47.05 -59.7 2.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.382 0.61 . . . . 0.0 110.194 168.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 300' ' ' ASP . 88.1 mt -137.65 169.63 17.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.907 -174.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -135.78 -167.64 2.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.641 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.61 114.29 3.86 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.792 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 116.06 -5.64 19.96 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.989 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -87.06 127.47 35.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.951 0.405 . . . . 0.0 110.696 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -86.84 149.36 24.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.103 0.478 . . . . 0.0 110.748 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 1.1 m -120.9 172.54 7.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.261 174.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.58 ' HD3' ' C ' ' A' ' 269' ' ' LYS . 0.7 OUTLIER -131.62 124.84 30.77 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.307 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -146.78 160.41 42.29 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.052 176.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 14.9 t -122.4 134.01 54.62 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.708 -178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.726 ' HA ' ' OD1' ' A' ' 337' ' ' ASP . 4.5 t-20 -76.67 83.33 3.31 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.805 -174.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' THR . . . . . 0.442 ' OG1' ' HA ' ' A' ' 337' ' ' ASP . 12.9 p -86.91 77.95 9.13 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.569 0.7 . . . . 0.0 110.042 175.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -166.03 133.26 2.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.301 177.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 23.6 m-90 -91.9 89.9 7.22 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 6.4 mp -68.28 167.98 13.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.405 0.621 . . . . 0.0 111.29 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -73.33 -4.13 31.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.608 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -64.15 -46.84 82.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.003 177.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -66.39 -26.33 67.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.633 -177.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 17.1 p -100.37 -56.85 2.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -173.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -86.27 -31.58 21.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.743 -172.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -101.62 -9.03 21.3 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.909 -0.317 . . . . 0.0 111.472 -173.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -153.06 172.69 16.48 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.974 0.416 . . . . 0.0 111.208 -177.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 93.1 mt -116.21 32.09 6.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.34 175.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -121.93 98.4 5.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.928 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -132.63 172.39 12.59 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.31 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 144.21 -79.34 0.25 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -128.44 -168.89 1.98 Allowed 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.9 t -159.28 77.66 2.99 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-O 121.941 0.877 . . . . 0.0 110.841 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -93.44 38.68 0.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.45 2.766 . . . . 0.0 112.326 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 24.1 mt -77.29 92.65 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.19 -178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 4.4 m -107.84 127.55 53.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.165 -177.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -151.97 167.09 29.5 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.23 0.538 . . . . 0.0 111.697 -177.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 94.6 m -97.93 129.75 44.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.992 -176.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -121.95 -171.68 2.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.298 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 23.4 m -141.17 129.11 21.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.471 HG13 ' H ' ' A' ' 299' ' ' ALA . 50.4 t -86.47 138.59 18.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.678 176.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.475 HG21 ' O ' ' A' ' 312' ' ' THR . 6.0 t -112.59 14.91 20.2 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.895 0.379 . . . . 0.0 111.988 -174.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.471 ' H ' HG13 ' A' ' 297' ' ' VAL . . . -165.95 -178.56 4.77 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.849 0.357 . . . . 0.0 111.743 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.504 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 4.3 m-20 -68.13 145.87 53.97 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.514 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.466 ' HB3' HG13 ' A' ' 311' ' ' VAL . . . -121.44 127.62 51.31 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.818 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.572 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 63.7 t30 -90.06 123.17 33.7 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -171.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.544 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 8.9 t -100.73 95.09 6.42 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 163.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . 0.472 ' HB3' ' ND2' ' A' ' 302' ' ' ASN . 0.3 OUTLIER -96.64 175.03 6.53 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.888 -174.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 8.3 t -59.84 -33.34 71.64 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.698 0.285 . . . . 0.0 111.57 -176.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -80.68 -3.94 90.26 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.15 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 71.54 41.56 57.4 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.238 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -121.99 133.63 54.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.365 0.582 . . . . 0.0 111.247 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.572 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.2 OUTLIER -128.24 155.5 39.92 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.046 179.039 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.444 ' OG1' HG21 ' A' ' 250' ' ' THR . 55.1 m -147.98 125.74 11.89 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.584 -0.698 . . . . 0.0 110.932 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.466 HG13 ' HB3' ' A' ' 301' ' ' ALA . 18.7 m -148.1 159.31 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.592 0.711 . . . . 0.0 111.25 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.475 ' O ' HG21 ' A' ' 298' ' ' THR . 16.4 m -108.94 140.21 42.74 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.488 174.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 5.3 mp -105.27 122.45 45.97 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.719 -174.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 16.6 p -96.79 125.77 41.47 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.94 -176.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 95.67 115.4 2.97 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.648 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 15.6 m -73.39 120.7 82.45 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-O 121.013 0.435 . . . . 0.0 110.541 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.8 47.66 2.39 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.977 2.451 . . . . 0.0 112.509 -177.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 7.5 pt -136.56 131.15 47.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.12 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -119.23 112.58 19.66 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.862 0.363 . . . . 0.0 111.022 -174.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.58 -10.34 17.92 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.171 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 9.3 p -66.49 -60.92 2.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.583 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 22.3 m -94.91 -25.02 16.73 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.313 0.578 . . . . 0.0 110.727 -177.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -99.77 117.79 62.97 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.814 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.5 -13.3 22.66 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 121.134 1.223 . . . . 0.0 111.772 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 69.16 -60.36 0.46 Allowed 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.841 0.856 . . . . 0.0 112.072 176.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 57.04 34.58 25.15 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.747 0.784 . . . . 0.0 109.644 -173.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -171.41 120.03 0.48 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.886 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 35.1 m -66.87 116.26 7.54 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 20.9 t -48.64 116.47 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.134 -177.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 34.0 m -128.78 157.37 41.64 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.4 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . 0.433 ' HB2' ' OG1' ' A' ' 235' ' ' THR . 10.1 ptp180 -69.22 111.83 5.41 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.826 0.346 . . . . 0.0 110.687 -178.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -112.51 153.55 27.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.736 0.303 . . . . 0.0 110.362 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.493 ' HB ' ' HG2' ' A' ' 233' ' ' GLN . 15.5 m -118.63 118.54 58.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.362 176.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 334' ' ' GLU . 0.5 OUTLIER -140.8 112.88 7.79 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.178 0.513 . . . . 0.0 111.257 179.748 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.506 ' HB2' HE21 ' A' ' 233' ' ' GLN . . . -100.66 138.85 37.16 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.93 -0.481 . . . . 0.0 112.029 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.42 -10.25 6.49 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.667 171.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.726 ' OD1' ' HA ' ' A' ' 272' ' ' ASN . 2.9 m-20 -54.33 150.75 8.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.388 0.613 . . . . 0.0 112.642 -178.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -102.41 134.93 44.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.012 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 57.8 t -114.82 147.23 18.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.32 0.581 . . . . 0.0 112.248 -169.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 226' ' ' GLY . 9.0 t -144.44 172.36 13.06 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.882 172.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 95.3 t -119.76 127.13 75.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.644 0.259 . . . . 0.0 111.655 -173.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 85.6 t -91.24 -45.02 14.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.99 0.424 . . . . 0.0 110.367 175.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 93.6 -135.97 12.85 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.771 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 3.7 p -125.68 -69.72 0.77 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.654 0.264 . . . . 0.0 110.82 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.903 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.832 -179.228 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.602 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -109.59 24.74 12.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.999 0.428 . . . . 0.0 111.236 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -73.49 155.28 39.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.593 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 117.96 20.92 4.34 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.612 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -61.67 115.43 7.92 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.054 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 26.4 m -119.38 134.24 55.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.014 0.435 . . . . 0.0 109.964 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.488 HD21 ' CA ' ' A' ' 253' ' ' GLY . 9.7 mt -140.32 171.66 13.83 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.292 -174.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 62.6 m -136.68 165.94 24.73 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.477 ' CG2' ' HB2' ' A' ' 337' ' ' ASP . 70.9 t -117.22 132.24 67.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 O-C-N 122.078 -0.389 . . . . 0.0 110.287 176.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.407 ' HE3' HG22 ' A' ' 252' ' ' THR . 34.8 ttmt -120.62 11.88 11.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.51 0.671 . . . . 0.0 110.32 -177.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.434 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 7.5 p -139.33 -170.49 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.323 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.502 HE21 ' HA ' ' A' ' 334' ' ' GLU . 34.7 mt-30 -114.79 111.22 45.86 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -177.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.94 105.71 1.87 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.382 2.055 . . . . 0.0 113.048 -176.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 4.6 t -155.81 130.82 9.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.122 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.584 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -154.71 171.84 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 171.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.469 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 38.5 m -12.36 113.37 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.75 1.62 . . . . 0.0 114.798 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.532 ' CE1' ' HG2' ' A' ' 317' ' ' PRO . 95.7 m-85 -115.45 84.04 2.03 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.332 173.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -122.97 133.21 54.38 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.15 -33.47 7.84 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -170.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.94 -28.82 45.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.581 0.705 . . . . 0.0 109.512 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.453 ' HA ' ' HE2' ' A' ' 242' ' ' LYS . 8.2 mmpt? -98.44 -9.14 25.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.06 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 61.48 40.51 13.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.234 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.9 m -113.03 95.73 5.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.026 -175.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . 0.469 ' CD2' ' HD1' ' A' ' 238' ' ' TYR . 4.8 m-85 -126.93 109.66 12.18 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 176.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . 0.408 ' HB2' HG11 ' A' ' 236' ' ' VAL . 70.6 mt-30 -136.94 173.16 12.0 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.595 ' CD2' ' HG3' ' A' ' 317' ' ' PRO . 4.7 p90 -154.14 134.8 13.59 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.369 -0.533 . . . . 0.0 112.374 176.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 59.3 m -99.34 139.17 35.38 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.458 HG13 ' HG ' ' A' ' 251' ' ' LEU . 5.5 p -142.75 142.3 26.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.501 -176.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 310' ' ' THR . 38.9 m -99.36 103.97 15.82 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 166.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.458 ' HG ' HG13 ' A' ' 249' ' ' VAL . 0.4 OUTLIER -87.18 171.01 10.99 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.407 HG22 ' HE3' ' A' ' 231' ' ' LYS . 0.2 OUTLIER -128.53 141.46 51.37 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.025 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.488 ' CA ' HD21 ' A' ' 228' ' ' LEU . . . -146.76 -142.45 3.72 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.433 -174.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -106.28 -173.64 2.34 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.549 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -67.37 -179.31 1.0 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.408 -168.48 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.549 ' H ' HG22 ' A' ' 255' ' ' THR . . . -65.99 -175.33 0.3 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.352 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 49.2 m 80.2 17.31 0.68 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.908 0.883 . . . . 0.0 111.362 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 49.5 t -133.43 90.9 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 170.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 31.2 m -68.1 100.72 1.04 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.493 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 70.73 92.32 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.934 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -41.96 -59.69 1.64 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 169.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.413 ' H ' ' HB3' ' A' ' 301' ' ' ALA . 91.7 mt -146.68 163.21 36.64 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.673 0.273 . . . . 0.0 111.106 -174.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 49.4 mtmt -134.89 -167.88 2.07 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.632 177.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.58 120.78 12.4 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.353 0.597 . . . . 0.0 111.234 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 106.62 -3.95 36.82 Favored Glycine 0 C--N 1.316 -0.553 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.162 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -92.59 134.94 34.51 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -103.12 152.31 21.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.566 0.698 . . . . 0.0 111.869 -174.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.77 153.67 39.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.745 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 340' ' ' SER . 0.8 OUTLIER -86.2 94.9 9.42 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 166.576 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . 0.54 ' O ' ' HA ' ' A' ' 293' ' ' PHE . 76.7 t80 -115.15 106.94 14.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.582 -165.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 292' ' ' SER . 89.4 m -88.29 94.96 10.0 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.922 -178.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.704 ' HA ' ' OD1' ' A' ' 337' ' ' ASP . 3.0 t-20 -90.22 84.95 6.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.448 0.642 . . . . 0.0 109.521 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 18.7 p -123.85 157.63 33.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.143 -178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.52 ' CE2' HG22 ' A' ' 321' ' ' THR . 53.0 m-85 -82.98 113.84 20.84 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -126.64 57.34 1.44 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.572 0.701 . . . . 0.0 111.075 -170.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 97.7 mt -59.98 125.65 24.5 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 166.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -61.42 -24.61 66.64 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -161.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' A' ' 282' ' ' GLN . 35.9 mt-30 -115.11 -62.7 1.56 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.928 -174.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -62.13 -17.52 58.09 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -167.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 29.3 p -83.04 -78.1 0.22 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 118.484 0.584 . . . . 0.0 111.965 -176.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -79.19 -32.31 44.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.539 0.685 . . . . 0.0 110.764 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 52.9 mt-30 67.77 16.49 9.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.241 176.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -127.86 107.46 9.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.767 176.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 68.3 mt -81.24 21.79 0.72 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.264 -174.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -110.8 -7.92 14.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.008 -177.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -132.48 78.67 1.81 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.816 0.341 . . . . 0.0 111.126 -175.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -81.7 54.57 4.82 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.301 178.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -146.49 128.63 15.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.78 0.324 . . . . 0.0 110.298 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 16.8 p -112.18 92.49 18.82 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.6 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -90.06 107.04 0.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.661 2.241 . . . . 0.0 112.953 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.44 HG22 ' H ' ' A' ' 292' ' ' SER . 4.7 tp -167.13 -58.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.194 176.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 271' ' ' THR . 15.0 m -127.91 138.57 52.7 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . 0.54 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 0.8 OUTLIER -162.54 86.03 0.57 Allowed 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 21.3 m -160.79 124.28 3.4 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.027 -0.42 . . . . 0.0 111.003 175.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -152.85 179.88 8.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.323 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 90.8 m -140.31 132.39 27.92 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.595 0.712 . . . . 0.0 112.304 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.406 HG11 ' H ' ' A' ' 299' ' ' ALA . 59.2 t -79.54 136.52 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 114.35 -1.296 . . . . 0.0 110.339 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 4.4 m -124.86 25.01 7.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.13 0.49 . . . . 0.0 111.086 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -166.62 178.26 6.11 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -66.96 165.88 14.69 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.563 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.573 ' HB1' ' CG1' ' A' ' 311' ' ' VAL . . . -144.87 171.27 14.67 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.82 -177.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.654 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 16.6 m120 -142.29 126.27 17.26 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 119.687 -0.197 . . . . 0.0 110.964 -173.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.7 OUTLIER -107.88 96.88 6.69 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 168.253 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.16 178.71 4.53 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.023 -176.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 10.8 t -61.76 -33.17 73.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.991 0.424 . . . . 0.0 111.044 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -81.7 1.76 85.09 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.897 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 61.51 42.01 99.68 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 121.016 -0.612 . . . . 0.0 113.704 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.83 132.67 55.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 118.06 0.93 . . . . 0.0 110.454 175.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.654 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.1 OUTLIER -138.23 109.44 5.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.807 -177.308 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 250' ' ' THR . 54.0 m -101.5 135.22 43.38 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.962 -0.461 . . . . 0.0 111.712 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.573 ' CG1' ' HB1' ' A' ' 301' ' ' ALA . 26.8 m -145.71 165.36 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 173.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 46.4 m -117.02 138.9 51.27 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 171.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 4.9 mp -112.25 141.59 45.77 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.736 -173.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 22.9 t -111.01 131.01 55.41 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.327 0.584 . . . . 0.0 109.851 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 132.93 155.97 7.99 Favored Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -174.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 16.1 m -66.98 116.97 41.16 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 120.932 0.396 . . . . 0.0 111.909 -173.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.595 ' HG3' ' CD2' ' A' ' 247' ' ' PHE . 62.2 Cg_exo -57.13 138.91 88.39 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.524 2.149 . . . . 0.0 110.663 171.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.581 ' H ' HD11 ' A' ' 318' ' ' ILE . 0.1 OUTLIER -102.01 111.24 31.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-O 121.374 0.607 . . . . 0.0 110.714 -168.513 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -77.62 115.01 17.03 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.83 -175.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.03 -13.58 62.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.088 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.52 HG22 ' CE2' ' A' ' 274' ' ' TYR . 1.2 p -75.72 52.58 0.68 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.938 176.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 323' ' ' ASN . 0.6 OUTLIER -112.2 87.88 2.68 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.629 0.728 . . . . 0.0 110.378 178.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.594 ' HB3' ' HD3' ' A' ' 324' ' ' PRO . 13.5 t-20 165.88 -53.72 0.0 OUTLIER Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 113.646 -1.616 . . . . 0.0 109.206 -175.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' A' ' 323' ' ' ASN . 23.5 Cg_endo -101.48 112.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 123.463 2.776 . . . . 0.0 111.356 176.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -71.96 -32.13 66.99 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.831 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 70.8 -65.19 0.35 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 124.201 0.938 . . . . 0.0 109.938 -177.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 177.58 -61.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 32.1 t -145.13 -129.67 0.08 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.39 -1.277 . . . . 0.0 107.963 175.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 24.2 t -83.88 119.66 33.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 31.5 m -123.79 -68.32 0.88 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.829 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -91.38 137.54 32.28 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 120.699 0.285 . . . . 0.0 110.748 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -118.24 169.91 9.32 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 26.7 m -76.14 131.86 34.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.341 0.591 . . . . 0.0 111.665 -176.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . 0.502 ' HA ' HE21 ' A' ' 233' ' ' GLN . 0.8 OUTLIER -112.66 -166.82 1.11 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.477 176.363 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -81.56 155.11 25.88 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.041 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 129.59 -8.35 6.18 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.054 -1.07 . . . . 0.0 113.444 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.704 ' OD1' ' HA ' ' A' ' 272' ' ' ASN . 4.1 m-20 -52.12 140.62 20.41 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.978 0.389 . . . . 0.0 110.784 174.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -100.56 132.65 45.84 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.476 ' CG1' ' HB2' ' A' ' 228' ' ' LEU . 93.2 t -120.69 140.18 45.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.479 0.657 . . . . 0.0 112.029 -171.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 269' ' ' LYS . 22.7 m -141.09 167.6 21.79 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 343' ' ' GLY . 47.8 t -116.24 140.62 37.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.693 0.282 . . . . 0.0 111.122 -175.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 76.8 t -81.24 -37.43 15.72 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.265 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . 0.405 ' N ' HG13 ' A' ' 341' ' ' VAL . . . -61.17 129.77 46.33 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.781 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 7.3 p -79.1 -61.15 2.1 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.4 0.619 . . . . 0.0 110.997 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.941 177.639 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 N-CA-C 112.176 -0.369 . . . . 0.0 112.176 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 68.8 -74.7 0.07 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.535 0.734 . . . . 0.0 111.982 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -80.17 132.45 35.9 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.729 0.299 . . . . 0.0 110.361 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.401 ' HA3' ' HB ' ' A' ' 341' ' ' VAL . . . 99.53 35.71 4.57 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -174.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -67.46 -176.7 9.36 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.258 -0.471 . . . . 0.0 113.438 -177.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 6.8 m -65.48 132.31 48.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.763 0.316 . . . . 0.0 111.246 -177.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.437 ' HB3' ' HA2' ' A' ' 253' ' ' GLY . 29.2 mt -137.16 -175.95 4.22 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -177.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 84.9 m -104.26 148.87 25.85 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -171.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 60.3 t -99.41 133.23 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.482 175.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.46 ' HE3' HG23 ' A' ' 252' ' ' THR . 22.9 mmtp -102.92 -41.29 6.19 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 121.138 -0.225 . . . . 0.0 110.906 175.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.451 ' O ' HG13 ' A' ' 249' ' ' VAL . 40.2 p -136.55 175.76 9.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.925 0.393 . . . . 0.0 110.781 177.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.504 ' HG3' ' HD2' ' A' ' 234' ' ' PRO . 0.4 OUTLIER -115.68 156.19 46.55 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.986 -170.72 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.504 ' HD2' ' HG3' ' A' ' 233' ' ' GLN . 3.9 Cg_endo -45.48 107.43 0.11 Allowed 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 124.127 3.218 . . . . 0.0 113.473 175.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 65.2 m -152.77 94.77 1.92 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.069 0.461 . . . . 0.0 111.34 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.631 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -157.85 173.97 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 123.874 0.87 . . . . 0.0 109.1 168.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.49 ' H ' HG11 ' A' ' 236' ' ' VAL . 27.2 m -29.8 109.16 0.05 OUTLIER 'General case' 0 C--O 1.236 0.373 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -172.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.451 ' HH ' ' HB3' ' A' ' 247' ' ' PHE . 72.2 m-85 -112.95 87.74 2.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.945 171.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -128.43 133.8 48.63 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -177.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -105.22 -42.85 5.16 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -169.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.93 -27.51 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.318 0.58 . . . . 0.0 109.963 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' A' ' 242' ' ' LYS . 27.9 mmmt -90.72 -12.63 36.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.805 178.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 60.84 66.67 0.89 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.131 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 55.6 m -150.76 99.03 2.68 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.571 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -120.13 102.21 8.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.949 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -135.42 160.25 39.03 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.631 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 27.2 p90 -148.17 139.84 23.76 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.07 174.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 53.5 m -99.81 136.7 39.33 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' ' 232' ' ' THR . 99.2 t -137.92 141.39 38.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.841 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.535 HG21 ' OG1' ' A' ' 310' ' ' THR . 84.8 m -95.87 119.26 34.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 170.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 309' ' ' VAL . 3.6 mp -115.33 163.02 16.3 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -176.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.46 HG23 ' HE3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -126.77 111.12 13.85 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 121.014 -0.275 . . . . 0.0 110.566 175.662 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.437 ' HA2' ' HB3' ' A' ' 228' ' ' LEU . . . -95.17 -147.27 22.36 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.034 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -109.46 -173.72 2.33 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.467 HG23 ' H ' ' A' ' 256' ' ' ALA . 3.1 m -58.84 167.31 1.61 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.801 -1.091 . . . . 0.0 113.476 -169.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.467 ' H ' HG23 ' A' ' 255' ' ' THR . . . -62.43 -176.56 0.11 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.819 -176.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 42.6 m 79.47 12.2 1.23 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.68 -176.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 23.8 t -125.44 94.78 2.87 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.2 m -77.3 94.2 4.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.099 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 74.02 93.15 0.13 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.491 178.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.656 ' CE1' ' HB3' ' A' ' 303' ' ' SER . 4.1 m-85 -44.4 -42.11 6.69 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 169.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 266' ' ' ASP . 1.0 OUTLIER -166.51 173.63 9.65 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.287 -173.005 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 63.8 mttm -142.65 -165.91 2.15 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.04 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -57.84 114.41 2.3 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.54 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 114.5 -16.21 19.49 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.932 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . 0.425 ' HB2' ' HB2' ' A' ' 262' ' ' LEU . 14.3 m-20 -78.83 126.42 30.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -93.29 150.01 20.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.711 0.767 . . . . 0.0 111.954 -176.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 341' ' ' VAL . 2.9 m -127.02 170.6 16.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.453 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.04 144.62 43.3 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 167.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . 0.651 ' O ' ' HA ' ' A' ' 292' ' ' SER . 56.8 m-85 -110.99 129.34 55.92 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.332 -175.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.477 ' OG1' ' HB3' ' A' ' 338' ' ' ALA . 81.3 p -95.16 88.16 5.1 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 166.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.711 ' O ' ' HA ' ' A' ' 291' ' ' ILE . 3.2 p-10 -122.96 164.22 18.92 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.355 -170.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 1.9 p -117.91 99.21 6.77 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.046 173.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.586 ' O ' HG21 ' A' ' 289' ' ' THR . 26.3 t80 -82.91 114.25 21.07 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -148.84 68.14 1.06 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.878 0.846 . . . . 0.0 109.394 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 8.6 mp -98.85 166.07 11.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.209 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . 0.582 ' O ' ' HG3' ' A' ' 281' ' ' LYS . 73.9 mt-30 -63.96 -16.61 61.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.604 -173.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -55.46 -39.79 70.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.442 0.639 . . . . 0.0 109.896 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -72.47 -48.46 40.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.068 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 29.5 p -71.45 -24.42 62.01 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -171.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.582 ' HG3' ' O ' ' A' ' 277' ' ' GLN . 96.9 mttt -60.98 -54.97 38.43 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.913 0.387 . . . . 0.0 110.798 177.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -84.04 -26.17 29.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.903 -177.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 62.15 22.28 13.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.094 175.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 80.2 mt -88.59 -34.25 17.39 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.977 0.418 . . . . 0.0 110.924 -177.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -124.91 90.28 3.22 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.321 0.581 . . . . 0.0 111.038 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -129.45 -3.72 4.85 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.691 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -85.65 -22.18 51.18 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.592 -176.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -128.2 120.71 27.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.977 0.418 . . . . 0.0 110.357 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.586 HG21 ' O ' ' A' ' 274' ' ' TYR . 17.5 m -99.83 117.72 63.03 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.068 178.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -52.43 115.79 2.43 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.824 2.349 . . . . 0.0 111.647 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.711 ' HA ' ' O ' ' A' ' 272' ' ' ASN . 33.9 pt -110.11 -17.27 8.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -172.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 71.2 m -153.5 139.17 17.88 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.886 -0.726 . . . . 0.0 112.774 -176.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -155.15 145.67 22.14 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 173.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 99.0 m -91.63 123.26 34.9 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.237 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -120.61 -176.18 3.18 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 121.173 -0.211 . . . . 0.0 110.625 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 94.1 m -141.32 130.06 22.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.327 0.584 . . . . 0.0 112.287 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.433 HG12 ' H ' ' A' ' 299' ' ' ALA . 59.6 t -83.63 145.79 7.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.752 177.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 2.3 m -123.46 24.02 8.76 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -173.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -167.71 -176.94 3.29 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 178.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.57 159.0 25.61 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.38 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.506 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -139.92 166.25 25.14 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.45 -177.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.517 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 18.2 m120 -136.51 122.22 19.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -174.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.656 ' HB3' ' CE1' ' A' ' 261' ' ' PHE . 0.0 OUTLIER -108.6 94.76 5.23 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 165.013 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.96 -170.56 1.86 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.022 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 10.1 t -60.03 -33.85 72.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.359 . . . . 0.0 111.418 -175.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -98.36 0.52 58.48 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 59.99 43.17 98.42 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 114.963 0.745 . . . . 0.0 114.963 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -88.34 110.19 20.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 119.557 1.679 . . . . 0.0 109.964 176.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.517 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 1.3 p -124.11 94.71 2.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.473 0.654 . . . . 0.0 111.394 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.535 ' OG1' HG21 ' A' ' 250' ' ' THR . 92.9 m -100.65 118.38 36.67 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.109 -0.369 . . . . 0.0 110.332 177.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 9.6 m -138.6 156.47 29.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.31 0.576 . . . . 0.0 110.795 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 44.9 m -108.32 133.69 52.18 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.137 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.417 ' HB2' ' CE2' ' A' ' 247' ' ' PHE . 5.2 mp -102.24 124.69 48.28 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.432 -174.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 14.6 m -125.72 144.92 50.41 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.803 0.335 . . . . 0.0 111.415 -173.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 77.24 60.65 2.81 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.365 176.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 18.6 m -113.34 136.41 21.87 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.625 0.25 . . . . 0.0 110.942 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -83.32 46.87 2.21 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.749 2.3 . . . . 0.0 112.083 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 83.3 mt -117.24 99.42 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.558 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -107.83 61.16 0.61 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.768 0.794 . . . . 0.0 110.02 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -91.7 -51.02 5.44 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.129 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 3.1 p -83.51 49.1 1.52 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.331 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' THR . . . . . 0.576 ' O ' ' HD3' ' A' ' 324' ' ' PRO . 7.3 m -81.26 1.33 32.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.754 0.788 . . . . 0.0 110.003 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -101.51 94.03 3.86 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.419 178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.576 ' HD3' ' O ' ' A' ' 322' ' ' THR . 5.8 Cg_exo -80.94 -168.49 0.64 Allowed 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.756 1.638 . . . . 0.0 111.541 173.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 69.02 -49.12 0.59 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.792 0.837 . . . . 0.0 112.028 -178.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -84.81 15.57 3.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.144 0.497 . . . . 0.0 111.051 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -109.09 23.7 14.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.05 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 7.1 t -78.59 56.52 1.83 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.152 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 41.0 t 65.81 119.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.613 0.72 . . . . 0.0 111.981 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 12.3 t -173.19 -72.37 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.075 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -102.78 111.11 23.27 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 171.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -99.5 -168.89 1.67 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.448 ' HB ' ' H ' ' A' ' 233' ' ' GLN . 26.9 m -55.31 135.55 18.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.822 0.344 . . . . 0.0 111.059 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -115.56 111.72 21.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.547 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -79.71 164.0 24.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.799 0.333 . . . . 0.0 110.963 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.87 -16.09 5.86 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.89 176.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.524 ' CG ' ' HA ' ' A' ' 272' ' ' ASN . 70.6 m-20 -81.53 -177.7 6.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.837 0.351 . . . . 0.0 111.089 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . 0.477 ' HB3' ' OG1' ' A' ' 271' ' ' THR . . . -122.77 150.02 43.34 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.316 0.579 . . . . 0.0 111.736 -176.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 53.0 t -103.04 147.53 9.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.386 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 11.6 p -156.85 151.95 26.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.018 0.437 . . . . 0.0 111.21 173.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.505 HG13 ' H ' ' A' ' 343' ' ' GLY . 41.0 t -108.37 147.03 13.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.238 -176.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 54.5 t -77.95 -34.06 19.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-O 121.216 0.532 . . . . 0.0 110.044 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . 0.505 ' H ' HG13 ' A' ' 341' ' ' VAL . . . 114.1 -165.32 12.04 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.172 175.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.6 p -88.15 -51.66 5.66 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.337 0.589 . . . . 0.0 110.873 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.353 178.639 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.713 0 N-CA-C 111.819 -0.512 . . . . 0.0 111.819 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -130.38 137.42 49.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.84 0.352 . . . . 0.0 111.027 -176.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.27 -30.56 71.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.179 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 130.24 -45.79 1.12 Allowed Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -174.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.602 ' C ' ' HB3' ' A' ' 340' ' ' SER . . . -104.52 114.59 4.74 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 173.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.548 HG22 ' HB ' ' A' ' 339' ' ' VAL . 52.4 m -153.29 135.49 14.88 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.664 -0.315 . . . . 0.0 111.311 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.612 ' H ' ' HA ' ' A' ' 339' ' ' VAL . 3.2 mt -128.36 87.63 2.62 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.959 ' HA ' ' O ' ' A' ' 338' ' ' ALA . 1.2 m -83.64 133.85 34.81 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.345 -174.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.675 ' O ' ' HA2' ' A' ' 336' ' ' GLY . 39.3 t -82.68 158.52 3.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.916 -160.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.404 ' N ' HG13 ' A' ' 230' ' ' VAL . 16.8 ptmt -131.75 -12.26 3.38 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.161 175.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 335' ' ' ALA . 40.6 p -129.32 -166.97 1.72 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.475 0.31 . . . . 0.0 110.829 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 34.1 mt-30 -112.91 118.24 44.94 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -173.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 248' ' ' THR . 1.1 Cg_endo -75.44 107.58 2.51 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.88 2.387 . . . . 0.0 113.007 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 236' ' ' VAL . 19.4 m -155.39 131.07 9.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.408 177.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.601 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -154.93 175.91 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.245 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.485 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 98.1 m -32.84 124.74 0.35 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.18 1.392 . . . . 0.0 114.578 -173.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -104.13 108.42 19.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.631 172.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.407 HD21 ' HA ' ' A' ' 239' ' ' ASN . 0.4 OUTLIER -114.01 91.45 3.64 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.215 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -88.16 -37.74 15.91 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.773 -161.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 40.0 t -64.69 -22.88 32.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -103.7 -0.67 29.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.14 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 24.6 t70 53.7 48.82 20.65 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.051 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 14.9 m -127.2 113.14 15.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.524 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -128.44 105.97 8.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -174.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -108.28 154.11 22.26 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.601 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 4.6 p90 -149.81 124.72 9.92 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.679 177.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 78.3 m -91.7 140.6 29.56 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.405 HG13 ' CD1' ' A' ' 251' ' ' LEU . 8.2 p -139.97 136.03 38.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 C-N-CA 119.848 -0.741 . . . . 0.0 112.354 -177.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.578 HG23 ' OG1' ' A' ' 310' ' ' THR . 94.0 m -96.99 115.85 28.16 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 168.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.405 ' CD1' HG13 ' A' ' 249' ' ' VAL . 1.0 OUTLIER -113.8 171.55 7.52 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.968 0.889 . . . . 0.0 110.463 -173.108 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 307' ' ' GLY . 0.0 OUTLIER -121.21 94.13 4.24 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.094 169.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.511 ' HA3' HD23 ' A' ' 228' ' ' LEU . . . -120.52 135.12 10.7 Favored Glycine 0 CA--C 1.505 -0.58 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.705 -176.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -115.6 93.42 4.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -165.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 93.5 m -128.23 103.91 7.45 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.119 165.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.579 ' HA ' ' CB ' ' A' ' 305' ' ' SER . . . -50.57 130.69 24.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 35.9 m 57.76 58.56 3.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.64 -1.164 . . . . 0.0 113.108 168.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.427 ' HB ' ' OG ' ' A' ' 303' ' ' SER . 60.2 t -140.2 101.29 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-O 121.022 0.439 . . . . 0.0 110.249 174.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 33.6 m -71.44 86.99 0.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.407 0.623 . . . . 0.0 109.855 177.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 78.81 111.44 0.21 Allowed Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.569 -174.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.705 ' CE2' ' HB3' ' A' ' 303' ' ' SER . 57.3 m-85 -49.91 -61.27 2.23 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 121.85 0.833 . . . . 0.0 109.168 173.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 261' ' ' PHE . 73.6 mt -167.38 -179.93 4.7 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.336 -1.756 . . . . 0.0 106.603 -175.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -108.92 -169.8 1.55 Allowed 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -35.37 114.97 0.27 Allowed 'General case' 0 N--CA 1.464 0.238 0 O-C-N 124.181 0.925 . . . . 0.0 112.516 -177.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 131.92 -14.0 5.23 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.123 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . 0.487 ' OD1' ' HB2' ' A' ' 262' ' ' LEU . 80.8 m-20 -64.05 146.69 53.72 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 120.758 0.314 . . . . 0.0 110.207 175.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.14 174.49 6.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.447 -174.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.905 ' HA ' ' N ' ' A' ' 341' ' ' VAL . 34.8 m -151.89 142.63 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.805 -175.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.698 ' N ' HG22 ' A' ' 341' ' ' VAL . 0.0 OUTLIER -77.6 97.76 5.19 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 157.139 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . 0.491 ' HA ' ' HB1' ' A' ' 338' ' ' ALA . 14.2 t80 -78.75 86.58 4.69 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.67 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 53.7 m -78.9 107.68 11.81 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -124.31 95.38 4.52 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.237 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' THR . . . . . 0.446 ' O ' ' HG2' ' A' ' 334' ' ' GLU . 1.3 p -70.67 93.26 0.92 Allowed 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 166.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.581 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 84.9 t80 -84.03 156.22 22.35 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.581 ' HB2' ' O ' ' A' ' 274' ' ' TYR . 85.2 m95 82.47 39.0 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 O-C-N 124.039 0.837 . . . . 0.0 111.051 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.631 ' HG ' ' CG ' ' A' ' 334' ' ' GLU . 12.2 mt -76.38 155.08 34.37 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.348 177.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -65.71 -77.99 0.06 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.817 0.341 . . . . 0.0 110.664 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -118.62 -82.65 0.64 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.935 0.398 . . . . 0.0 110.747 174.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -119.08 -73.12 0.66 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -176.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 3.2 p -105.1 -19.25 13.88 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -168.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -62.95 -31.5 72.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.783 0.325 . . . . 0.0 111.014 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.512 ' O ' ' HA ' ' A' ' 276' ' ' LEU . 78.7 mt-30 64.25 -68.49 0.1 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.523 1.129 . . . . 0.0 112.043 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -177.86 122.81 0.11 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.31 -173.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 89.1 mt -104.94 -30.41 9.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.04 0.448 . . . . 0.0 110.809 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -123.86 7.13 8.7 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.397 -178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -129.37 168.69 15.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.699 -177.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 160.31 102.88 0.18 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.006 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -154.99 83.58 1.08 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.922 0.392 . . . . 0.0 110.802 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.9 t -135.26 142.21 40.76 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.16 45.1 0.91 Allowed 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.132 2.554 . . . . 0.0 113.496 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 62.8 mt 66.62 -77.08 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.55 0.74 . . . . 0.0 111.997 177.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 8.5 t -163.85 158.93 20.54 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -141.67 144.0 33.89 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 88.6 m -85.21 125.94 33.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.71 0.291 . . . . 0.0 111.503 -172.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -119.38 -179.5 3.88 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 84.9 m -136.14 138.15 41.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.428 0.632 . . . . 0.0 112.531 -174.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.513 HG13 ' H ' ' A' ' 299' ' ' ALA . 48.9 t -93.66 139.3 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.228 179.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 8.4 t -109.93 24.1 13.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.044 0.449 . . . . 0.0 111.5 -175.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.513 ' H ' HG13 ' A' ' 297' ' ' VAL . . . -156.69 174.99 14.65 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.177 0.513 . . . . 0.0 112.087 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.97 113.13 2.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.709 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.445 ' HA ' ' CG1' ' A' ' 311' ' ' VAL . . . -93.18 106.86 18.77 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.059 -176.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.525 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 65.4 t30 -69.63 147.08 51.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.818 0.342 . . . . 0.0 111.532 -177.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.705 ' HB3' ' CE2' ' A' ' 261' ' ' PHE . 2.5 p -142.01 95.98 2.89 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.151 0.501 . . . . 0.0 110.517 171.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.58 151.87 21.83 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 172.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.579 ' CB ' ' HA ' ' A' ' 256' ' ' ALA . 0.3 OUTLIER -70.77 -12.31 61.47 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -171.639 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -71.16 -11.62 70.99 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 169.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 252' ' ' THR . . . 75.77 41.36 28.86 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.784 -0.708 . . . . 0.0 113.869 174.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -125.55 111.18 14.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.034 0.917 . . . . 0.0 111.602 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.525 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.6 OUTLIER -132.59 138.79 51.32 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.103 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.578 ' OG1' HG23 ' A' ' 250' ' ' THR . 94.7 m -123.17 126.34 46.82 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.129 -0.357 . . . . 0.0 110.305 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.445 ' CG1' ' HA ' ' A' ' 301' ' ' ALA . 15.4 m -146.47 164.89 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.944 0.402 . . . . 0.0 110.156 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 56.8 m -114.3 139.43 49.44 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.128 0.489 . . . . 0.0 110.573 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 4.8 mp -105.28 150.34 25.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.853 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 34.1 t -135.87 129.4 32.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.16 0.505 . . . . 0.0 112.047 -174.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 125.04 -43.55 1.37 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.891 167.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 34.0 m -108.11 146.24 33.11 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-O 120.928 0.394 . . . . 0.0 111.963 -172.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -92.47 139.8 1.96 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.119 2.546 . . . . 0.0 113.363 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.535 ' H ' HD11 ' A' ' 318' ' ' ILE . 0.1 OUTLIER -94.22 125.21 46.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 172.212 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -82.81 72.93 9.88 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -167.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -81.28 -8.45 59.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.746 0.784 . . . . 0.0 109.028 170.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 2.4 p -87.93 24.61 1.74 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.375 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 15.1 m -84.89 -15.16 45.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.887 0.851 . . . . 0.0 108.885 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -81.22 147.12 59.91 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.418 174.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.43 ' O ' ' HB2' ' A' ' 325' ' ' GLN . 60.3 Cg_endo -70.63 -19.0 32.53 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.115 1.876 . . . . 0.0 113.242 -174.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . 0.514 ' O ' ' HB ' ' A' ' 329' ' ' VAL . 27.5 mt-30 73.5 -58.75 0.58 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.447 0.699 . . . . 0.0 111.864 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' A' ' 325' ' ' GLN . 47.2 m-85 72.29 -63.64 0.42 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.448 0.699 . . . . 0.0 110.135 -178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -175.94 -60.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.634 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 19.7 m -99.9 -15.93 18.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.849 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . 0.514 ' HB ' ' O ' ' A' ' 325' ' ' GLN . 49.1 t -81.19 134.29 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 62.0 m -148.82 144.89 27.26 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.728 0.299 . . . . 0.0 110.278 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . 0.472 ' HG2' ' OH ' ' A' ' 274' ' ' TYR . 17.9 tpt180 -102.39 149.85 23.94 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.072 178.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -111.49 152.12 27.82 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 173.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.453 ' CG1' ' HD2' ' A' ' 234' ' ' PRO . 23.5 t -68.07 150.44 10.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.203 -178.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . 0.631 ' CG ' ' HG ' ' A' ' 276' ' ' LEU . 0.7 OUTLIER -79.66 129.25 34.31 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -168.166 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 232' ' ' THR . . . -99.59 114.26 27.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.901 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . 0.675 ' HA2' ' O ' ' A' ' 230' ' ' VAL . . . 128.8 13.34 2.5 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 119.179 -1.486 . . . . 0.0 115.82 163.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.67 ' HB3' ' O ' ' A' ' 271' ' ' THR . 3.6 t0 -108.83 -67.34 0.98 Allowed 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -171.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . 0.959 ' O ' ' HA ' ' A' ' 229' ' ' THR . . . -51.11 178.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 116.917 2.191 . . . . 0.0 116.917 -156.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.612 ' HA ' ' H ' ' A' ' 228' ' ' LEU . 3.1 m -149.42 -164.77 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 CA-C-O 117.855 -1.069 . . . . 0.0 108.833 -168.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.611 ' HB2' ' HG ' ' A' ' 228' ' ' LEU . 29.1 t -119.63 152.35 37.21 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 121.247 1.839 . . . . 0.0 114.404 -168.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.905 ' N ' ' HA ' ' A' ' 268' ' ' VAL . 53.3 t -124.83 58.03 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.827 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 164.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.429 HG21 ' OG ' ' A' ' 340' ' ' SER . 3.5 t -119.81 47.37 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 122.446 1.117 . . . . 0.0 108.094 175.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 113.96 129.89 4.97 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 113.758 -1.564 . . . . 0.0 110.417 -170.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 80.6 p 62.05 118.1 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.523 1.129 . . . . 0.0 112.151 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.128 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.642 -176.302 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.793 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.15 -31.71 58.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.58 0.229 . . . . 0.0 110.813 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -60.9 136.15 58.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.145 178.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 93.35 10.19 59.65 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -173.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -89.92 168.76 34.49 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.208 -178.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 27.5 m -141.43 135.12 30.01 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.452 HD23 ' CE1' ' A' ' 261' ' ' PHE . 8.9 mt -139.31 178.11 7.43 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.705 -176.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.8 m -124.27 154.91 39.53 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.826 0.346 . . . . 0.0 110.735 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 67.2 t -99.63 128.78 51.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.974 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 51.2 tttt -112.47 -28.09 8.0 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.929 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 27.1 p -139.38 -169.97 2.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.696 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -112.64 116.81 47.67 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -174.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.716 ' HA ' ' O ' ' A' ' 248' ' ' THR . 7.4 Cg_exo -72.58 104.81 1.78 Allowed 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.361 2.041 . . . . 0.0 112.722 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.9 t -154.26 131.92 11.44 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.028 0.442 . . . . 0.0 111.782 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.634 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.87 176.47 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 168.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.485 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 91.6 m -37.17 111.0 0.14 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -176.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -97.45 84.04 3.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.221 173.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.506 ' OD1' ' HB2' ' A' ' 242' ' ' LYS . 0.8 OUTLIER -87.09 121.25 29.29 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -176.091 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -105.99 -56.92 2.11 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -164.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 32.8 t -64.66 -29.7 48.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.388 0.613 . . . . 0.0 109.57 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.506 ' HB2' ' OD1' ' A' ' 239' ' ' ASN . 27.6 mtpt -89.56 -16.92 29.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.754 178.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 68.54 70.67 0.3 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 114.495 -1.229 . . . . 0.0 112.617 174.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.4 t -154.03 96.5 1.97 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.384 0.612 . . . . 0.0 110.298 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 17.1 m-30 -103.85 108.22 19.44 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.32 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -112.84 149.34 33.23 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 173.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.634 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 1.3 p90 -160.17 139.82 11.17 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 121.339 -0.144 . . . . 0.0 110.819 177.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.716 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 52.4 m -109.22 142.53 39.91 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.218 -0.193 . . . . 0.0 111.167 -174.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.97 131.35 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 121.466 0.651 . . . . 0.0 112.727 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 21.3 m -96.94 120.69 37.74 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 165.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.401 ' HB2' HG12 ' A' ' 309' ' ' VAL . 0.4 OUTLIER -116.47 171.54 7.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.242 0.544 . . . . 0.0 109.831 -175.725 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.01 147.68 46.39 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.364 172.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -148.45 -143.75 3.85 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.62 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.465 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -104.76 -174.47 2.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -176.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.583 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.5 OUTLIER -72.31 -177.91 2.32 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.49 -169.628 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.583 ' H ' HG22 ' A' ' 255' ' ' THR . . . -62.83 -176.89 0.13 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.451 0.701 . . . . 0.0 112.506 -178.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 68.3 m 80.32 16.31 0.71 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.838 0.855 . . . . 0.0 111.613 -177.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 61.8 t -135.34 94.76 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 171.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 4.3 m -72.05 92.27 1.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.622 -177.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 76.72 92.86 0.22 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.925 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.493 ' CE1' ' HB3' ' A' ' 303' ' ' SER . 3.2 m-85 -42.92 -53.5 4.67 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.775 0.321 . . . . 0.0 111.66 168.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 18.3 mt -141.29 147.01 37.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.308 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 57.8 mtmt -139.38 -169.39 2.66 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 123.249 0.343 . . . . 0.0 110.886 175.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -53.66 119.39 4.85 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.278 0.561 . . . . 0.0 111.411 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 107.25 -7.87 37.75 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.45 176.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -90.45 130.97 36.45 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -109.23 140.7 42.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.877 0.37 . . . . 0.0 110.686 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.516 HG22 ' HB1' ' A' ' 295' ' ' ALA . 1.0 OUTLIER -122.24 171.41 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 121.305 0.574 . . . . 0.0 111.834 -178.399 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.41 ' HD2' ' C ' ' A' ' 269' ' ' LYS . 0.2 OUTLIER -131.42 129.64 41.51 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.887 179.18 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 292' ' ' SER . 47.5 m-85 -100.04 127.57 46.24 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.129 -0.357 . . . . 0.0 110.261 177.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.507 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 51.7 m -102.73 88.15 3.14 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 173.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.645 ' HA ' ' CB ' ' A' ' 337' ' ' ASP . 4.3 p-10 -91.08 155.58 18.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.071 -167.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 11.7 p -123.03 169.47 11.15 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.678 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -80.79 115.17 20.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.781 0.801 . . . . 0.0 110.985 -176.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 54.5 m95 -134.51 -22.39 1.71 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.22 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.501 ' HG ' ' OE1' ' A' ' 334' ' ' GLU . 97.0 mt -43.3 99.27 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 O-C-N 123.92 0.763 . . . . 0.0 112.753 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -78.26 -11.54 59.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.243 0.544 . . . . 0.0 109.675 175.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -63.98 -28.59 69.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.052 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.438 ' OE1' ' HB2' ' A' ' 286' ' ' ASN . 15.6 mm100 -67.32 -6.77 20.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.532 -175.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 35.8 p -72.76 -37.53 67.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.097 0.475 . . . . 0.0 110.407 177.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -110.02 -62.45 1.51 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.021 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -95.38 63.89 2.59 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 122.072 0.939 . . . . 0.0 111.039 -172.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -86.21 5.52 33.8 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.088 -1.415 . . . . 0.0 110.524 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 42.0 mt -85.28 -24.82 27.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.166 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -80.7 -57.15 3.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.352 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.438 ' HB2' ' OE1' ' A' ' 279' ' ' GLN . 81.1 m-20 -101.08 134.28 44.33 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.942 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -75.94 -45.36 16.59 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.492 175.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -176.1 159.68 2.14 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.0 t -54.89 142.58 54.85 Favored Pre-proline 0 C--N 1.32 -0.716 0 O-C-N 123.491 0.495 . . . . 0.0 109.731 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.16 -170.0 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.529 2.153 . . . . 0.0 112.833 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 40.6 mm -103.32 -65.4 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.475 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 52.0 m -159.72 129.94 5.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.139 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -135.77 150.59 49.54 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 121.018 0.437 . . . . 0.0 111.472 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 98.4 m -95.65 136.51 35.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.755 -173.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . 0.516 ' HB1' HG22 ' A' ' 268' ' ' VAL . . . -121.25 171.07 8.99 Favored 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 122.447 -0.158 . . . . 0.0 110.705 176.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 96.6 m -135.2 121.59 20.43 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.282 0.563 . . . . 0.0 112.168 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 59.5 t -79.36 139.96 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.333 -178.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 0.9 OUTLIER -130.62 24.24 5.07 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.017 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -162.14 179.83 7.64 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.411 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 5.6 m-20 -69.17 163.48 24.79 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.81 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.5 ' HB1' ' CG1' ' A' ' 311' ' ' VAL . . . -149.48 172.86 14.29 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.668 -174.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.627 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 16.8 m120 -138.28 122.71 18.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -175.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.493 ' HB3' ' CE1' ' A' ' 261' ' ' PHE . 0.6 OUTLIER -105.87 93.37 4.6 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 162.622 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.33 178.91 4.46 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.436 -0.505 . . . . 0.0 110.92 -173.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 17.7 m -57.65 -33.1 67.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.851 0.358 . . . . 0.0 111.649 -177.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -82.05 0.89 88.11 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.321 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 62.01 43.11 99.61 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.438 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -121.04 126.65 50.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.717 0.758 . . . . 0.0 110.855 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.627 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.3 OUTLIER -136.67 126.2 38.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.846 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -177.901 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 34.1 m -123.65 132.58 53.89 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.939 -0.475 . . . . 0.0 111.117 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.5 ' CG1' ' HB1' ' A' ' 301' ' ' ALA . 9.2 m -144.71 162.19 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.213 0.53 . . . . 0.0 110.418 176.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 21.0 m -117.01 142.21 47.26 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.48 0.657 . . . . 0.0 109.891 174.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 313' ' ' LEU . 0.5 OUTLIER -107.83 133.27 52.44 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.874 -173.591 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 46.7 t -137.93 138.37 38.92 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.532 -171.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.45 49.25 71.41 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 114.774 -1.103 . . . . 0.0 113.666 170.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 20.3 m -82.94 123.8 77.41 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 121.077 0.465 . . . . 0.0 110.644 177.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -82.46 64.33 8.2 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.919 2.413 . . . . 0.0 112.006 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 22.9 mm -94.31 99.89 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-O 121.352 0.596 . . . . 0.0 111.296 -176.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -114.53 -63.7 1.42 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.122 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -139.42 33.74 2.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -177.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 3.5 p -52.99 117.3 2.88 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.984 -175.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 2.8 m -95.26 -5.71 43.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.679 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.519 ' HB3' ' HD3' ' A' ' 324' ' ' PRO . 19.2 t-20 -56.81 -47.32 99.24 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.453 173.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 323' ' ' ASN . 1.4 Cg_endo -86.94 -166.41 0.3 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.537 2.158 . . . . 0.0 111.096 173.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -87.98 58.74 4.97 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.542 0.687 . . . . 0.0 110.627 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 59.07 96.84 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 113.705 -1.589 . . . . 0.0 111.026 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . 0.487 HD22 ' HG2' ' A' ' 331' ' ' ARG . 25.7 t-20 -129.37 108.05 9.99 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 22.8 t -113.52 68.61 0.69 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 120.771 0.319 . . . . 0.0 110.596 -174.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 53.6 t 75.07 -42.21 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.634 175.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 16.5 m -66.86 82.02 0.11 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.318 0.58 . . . . 0.0 111.46 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . 0.487 ' HG2' HD22 ' A' ' 327' ' ' ASN . 81.4 mtt180 -103.75 113.02 26.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.277 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -89.19 122.17 32.21 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.476 HG11 ' O ' ' A' ' 234' ' ' PRO . 34.3 m -99.16 123.24 51.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.606 0.717 . . . . 0.0 111.867 -175.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . 0.501 ' OE1' ' HG ' ' A' ' 276' ' ' LEU . 2.6 pt-20 -146.88 145.72 29.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.967 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -99.29 142.97 30.08 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.676 -174.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 129.09 11.43 2.83 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.569 171.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.645 ' CB ' ' HA ' ' A' ' 272' ' ' ASN . 10.9 p-10 -104.4 -153.32 0.48 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.926 0.363 . . . . 0.0 111.093 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -126.23 139.24 53.49 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 121.207 0.527 . . . . 0.0 111.774 -173.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 75.1 t -103.08 145.44 12.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.657 -177.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 10.5 m -142.97 178.92 7.35 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 268' ' ' VAL . 60.5 t -117.58 141.54 35.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.673 0.273 . . . . 0.0 110.563 -175.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 72.1 t -97.02 -44.93 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.87 177.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -179.47 168.41 38.95 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.967 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 19.0 p -124.91 -68.81 0.83 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.396 0.617 . . . . 0.0 110.333 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.189 -0.91 . . . . 0.0 109.365 175.034 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 112.249 -0.34 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.421 ' O ' ' HA3' ' A' ' 343' ' ' GLY . . . -78.04 71.16 4.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.292 0.568 . . . . 0.0 111.183 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -99.08 161.66 13.5 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.567 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 105.11 6.27 39.7 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -176.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -76.49 117.52 5.0 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.771 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.9 m -127.9 141.34 51.58 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.821 0.343 . . . . 0.0 110.421 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.438 HD21 ' CE2' ' A' ' 261' ' ' PHE . 12.7 mt -143.08 175.19 10.05 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.985 -177.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 63.3 m -128.65 157.46 41.26 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.219 -176.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.493 HG23 ' OD2' ' A' ' 337' ' ' ASP . 92.6 t -99.13 138.67 22.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 120.622 0.249 . . . . 0.0 110.648 -177.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -117.53 -34.7 4.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.547 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 53.9 p -137.04 -173.67 3.52 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.594 ' HG3' ' N ' ' A' ' 334' ' ' GLU . 24.3 mm-40 -115.57 155.96 46.69 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -168.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.472 ' HB3' ' CD1' ' A' ' 247' ' ' PHE . 28.3 Cg_endo -63.47 105.95 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.176 2.584 . . . . 0.0 111.985 174.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 236' ' ' VAL . 5.1 t -148.27 96.98 2.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.574 0.702 . . . . 0.0 111.741 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.634 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.73 174.01 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 168.217 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.468 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 44.2 m -29.06 109.54 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -175.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -108.72 87.63 2.54 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 168.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.502 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 4.9 t30 -113.88 102.47 10.24 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.642 -174.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -84.51 -52.14 6.37 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -164.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 26.1 t -67.28 -23.59 30.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.411 0.624 . . . . 0.0 109.578 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.502 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 43.2 mmtt -89.88 -12.77 38.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.566 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 30.0 t70 63.37 69.65 0.56 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.183 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.2 m -149.5 106.86 3.61 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.879 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -125.29 102.76 7.59 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -129.76 160.01 34.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.634 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 7.4 p90 -154.92 132.91 11.58 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.629 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 53.0 m -97.94 131.89 44.0 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 25.3 t -136.86 140.32 43.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.867 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 24.2 m -96.9 121.49 38.83 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 167.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 4.8 mp -110.24 167.37 10.24 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -123.54 140.63 52.81 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.401 ' CA ' HD22 ' A' ' 228' ' ' LEU . . . -142.11 -143.56 4.22 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.709 -174.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -102.63 -174.32 2.53 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.601 HG21 ' H ' ' A' ' 256' ' ' ALA . 0.9 OUTLIER -72.18 -179.43 2.84 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.446 -169.907 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.601 ' H ' HG21 ' A' ' 255' ' ' THR . . . -61.22 -176.44 0.07 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.93 0.892 . . . . 0.0 112.898 -177.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 27.7 t 80.52 6.73 1.51 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.82 0.848 . . . . 0.0 110.922 -178.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 17.3 t -122.07 90.21 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 17.0 m -74.8 88.02 2.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.595 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 83.44 91.48 0.69 Allowed Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.383 -178.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.438 ' CE2' HD21 ' A' ' 228' ' ' LEU . 4.1 m-85 -43.01 -60.09 1.76 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 170.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 63.9 mt -149.02 161.76 41.29 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.12 -172.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 85.6 mttt -142.92 -167.19 2.47 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.119 0.262 . . . . 0.0 111.138 175.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -49.63 116.68 1.87 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.276 0.56 . . . . 0.0 111.686 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 108.36 -5.14 33.39 Favored Glycine 0 C--N 1.316 -0.53 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.299 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -94.96 143.27 26.61 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.414 ' O ' HG12 ' A' ' 342' ' ' VAL . 23.0 mt-30 -114.06 152.7 30.63 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.551 0.691 . . . . 0.0 111.455 -176.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.3 OUTLIER -130.09 165.97 28.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.865 177.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 340' ' ' SER . 0.8 OUTLIER -122.64 87.45 2.75 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.1 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 339' ' ' VAL . 5.3 p90 -92.16 132.38 36.67 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.807 -175.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.591 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 77.2 m -98.24 87.14 3.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.36 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -99.21 101.97 13.47 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.006 -177.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 3.0 p -77.01 80.91 3.54 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.616 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -91.22 113.0 25.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.434 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -174.07 53.62 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.52 HD11 ' O ' ' A' ' 332' ' ' GLN . 25.4 mt -91.11 91.14 8.13 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.587 -170.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -99.62 -71.99 0.68 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.155 -176.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -115.24 -81.34 0.61 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.04 0.448 . . . . 0.0 110.858 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -86.58 -22.95 25.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.308 -176.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 28.1 p -64.35 -17.51 63.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.871 0.367 . . . . 0.0 111.228 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.439 ' HG2' ' HB3' ' A' ' 276' ' ' LEU . 7.3 mtpm? -63.58 -28.34 69.87 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.076 0.465 . . . . 0.0 110.325 176.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -104.5 -9.44 18.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.599 -178.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -130.88 88.94 2.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.906 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.9 -3.2 27.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.253 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -77.87 -18.05 56.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.065 0.46 . . . . 0.0 109.876 177.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -116.95 132.39 56.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.247 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -160.95 -122.63 0.64 Allowed Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.658 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -174.0 39.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.083 0.468 . . . . 0.0 110.07 -177.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.2 t -165.82 88.84 0.91 Allowed Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.682 0.753 . . . . 0.0 110.916 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -89.78 45.82 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.011 2.474 . . . . 0.0 112.65 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 50.2 pt -119.82 171.59 7.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.227 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 8.0 t -135.22 142.04 45.92 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.96 144.57 50.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.19 0.519 . . . . 0.0 111.014 -176.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 60.3 m -81.53 122.89 28.13 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.275 -176.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -114.48 175.45 5.48 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 63.8 m -135.19 130.58 35.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.573 0.701 . . . . 0.0 112.808 -176.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 62.8 t -80.57 139.39 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.811 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.51 HG21 ' O ' ' A' ' 312' ' ' THR . 13.8 t -121.71 1.8 10.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.782 0.325 . . . . 0.0 111.399 -176.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -142.46 -177.12 5.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -173.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -71.51 164.65 25.43 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.121 -178.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.548 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -149.58 156.08 41.36 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.316 -173.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.511 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 3.9 m-20 -129.17 126.88 40.2 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.624 -175.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.483 ' HB2' ' HB ' ' A' ' 258' ' ' VAL . 0.4 OUTLIER -111.24 95.5 5.56 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 163.966 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -102.16 178.2 4.67 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.646 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 50.4 m -60.21 -32.28 70.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.729 0.299 . . . . 0.0 111.697 -177.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -73.64 -8.83 77.62 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.175 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 70.61 42.39 63.11 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.511 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -118.43 136.01 54.02 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.734 0.767 . . . . 0.0 111.474 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.7 OUTLIER -142.92 110.31 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.804 -178.478 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 25.5 m -105.16 127.4 52.89 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.609 -0.682 . . . . 0.0 111.537 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.499 ' CG1' ' HB1' ' A' ' 301' ' ' ALA . 19.5 m -144.38 148.72 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.296 0.57 . . . . 0.0 111.014 175.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.51 ' O ' HG21 ' A' ' 298' ' ' THR . 50.0 m -97.22 146.78 24.77 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 172.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.47 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.1 mp -117.51 136.73 53.03 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.299 -176.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 38.1 m -133.66 129.45 36.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.494 -174.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 82.53 88.85 0.69 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.2 174.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 10.9 m -129.99 122.38 20.3 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 121.016 0.436 . . . . 0.0 110.821 176.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -87.28 56.61 3.14 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.888 2.392 . . . . 0.0 111.987 178.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 8.9 tt -82.74 99.06 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.538 0.685 . . . . 0.0 110.877 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -138.55 77.92 1.65 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.33 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -162.61 -51.74 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.11 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 38.1 p -112.84 39.42 2.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.276 0.56 . . . . 0.0 110.438 175.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 3.9 m -80.47 -68.02 0.72 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.628 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 61.97 95.08 0.05 OUTLIER Pre-proline 0 N--CA 1.474 0.747 0 O-C-N 123.621 0.575 . . . . 0.0 112.123 170.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -73.13 140.39 31.01 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.678 1.585 . . . . 0.0 110.568 175.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -84.61 18.94 2.13 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.947 -176.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 69.08 -67.06 0.23 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.584 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -97.82 -12.89 21.68 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.675 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 46.5 m 70.31 103.61 0.06 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.019 -174.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 3.4 t -88.51 20.35 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.554 0.692 . . . . 0.0 110.573 -174.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 20.0 m 56.22 45.78 22.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.964 178.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -81.27 112.39 18.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.782 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . 0.52 ' O ' HD11 ' A' ' 276' ' ' LEU . 79.2 mm-40 -98.3 154.3 17.91 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.44 ' HB ' ' OE1' ' A' ' 233' ' ' GLN . 0.8 OUTLIER -76.69 170.55 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.867 -179.072 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . 0.594 ' N ' ' HG3' ' A' ' 233' ' ' GLN . 10.8 tp10 -158.67 130.34 6.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.606 0.241 . . . . 0.0 110.7 -173.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -66.22 158.35 29.09 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.295 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 130.07 -1.24 5.8 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.673 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 271' ' ' THR . 10.3 p-10 -89.08 -171.3 3.22 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 122.333 0.253 . . . . 0.0 110.742 176.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -129.04 162.57 27.35 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -171.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 270' ' ' PHE . 98.3 t -128.56 142.62 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.968 -175.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.462 ' HB3' ' HB2' ' A' ' 269' ' ' LYS . 33.7 t -127.63 165.17 20.48 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 170.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.485 HG11 ' H ' ' A' ' 343' ' ' GLY . 39.5 t -120.76 148.72 23.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 122.328 0.251 . . . . 0.0 110.386 -177.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 267' ' ' GLN . 7.5 p -85.01 -31.28 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 121.025 0.44 . . . . 0.0 110.691 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . 0.485 ' H ' HG11 ' A' ' 341' ' ' VAL . . . 78.07 -110.38 3.02 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.996 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 17.4 p -122.4 -95.92 0.47 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.811 0.339 . . . . 0.0 111.063 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.493 -0.765 . . . . 0.0 110.096 179.5 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.648 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 71.58 147.61 0.08 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.633 0.73 . . . . 0.0 111.421 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -69.86 -21.5 63.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.277 -176.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 130.98 -35.87 2.37 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -65.43 115.49 7.71 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.283 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 27.1 m -111.05 141.06 45.04 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.468 HD21 ' CE2' ' A' ' 261' ' ' PHE . 8.6 mt -139.34 172.07 13.35 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.575 -173.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 40.3 m -128.0 152.74 47.56 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 -176.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.447 ' HB ' ' H ' ' A' ' 337' ' ' ASP . 61.3 t -94.08 108.16 20.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -95.49 -32.41 12.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.192 0.52 . . . . 0.0 110.888 -174.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.559 ' OG1' ' HB ' ' A' ' 250' ' ' THR . 61.6 p -129.09 -167.44 1.78 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.604 178.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.545 ' HB3' ' CG2' ' A' ' 333' ' ' VAL . 13.1 mt-30 -112.72 128.51 25.48 Favored Pre-proline 0 C--N 1.32 -0.702 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.61 -171.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.28 107.92 2.27 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.682 2.255 . . . . 0.0 112.739 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 13.5 t -112.54 147.47 36.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.007 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.0 t -110.52 136.97 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -166.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 22.5 m -101.91 116.89 33.68 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 168.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -103.16 131.5 50.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.039 0.447 . . . . 0.0 111.87 -176.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.434 HD21 ' HA ' ' A' ' 239' ' ' ASN . 0.2 OUTLIER -142.1 88.66 2.12 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.508 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -88.79 -41.0 12.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.293 -162.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.3 -23.22 32.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.706 0.765 . . . . 0.0 109.037 175.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -94.69 -12.33 27.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.016 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 6.3 t70 60.73 57.93 2.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.713 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 21.4 m -146.5 115.64 6.99 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.929 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . 0.461 ' HB3' ' HA3' ' A' ' 315' ' ' GLY . 17.9 m-85 -120.29 133.56 55.44 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -143.33 126.72 16.73 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 313' ' ' LEU . 18.7 p90 -130.17 133.33 46.52 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.429 174.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 92.9 m -104.52 142.19 35.06 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.988 -167.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 8.5 p -145.69 133.06 15.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.36 0.6 . . . . 0.0 112.294 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.559 ' HB ' ' OG1' ' A' ' 232' ' ' THR . 52.9 m -97.23 116.81 30.12 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 168.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.44 170.89 7.97 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.486 0.66 . . . . 0.0 109.893 -175.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.54 150.25 35.22 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.486 171.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.41 ' CA ' HD22 ' A' ' 228' ' ' LEU . . . -148.27 -144.12 3.92 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.515 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -106.39 -176.5 3.09 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -175.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.565 HG21 ' H ' ' A' ' 256' ' ' ALA . 1.3 m -68.42 178.99 1.77 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.519 -171.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.565 ' H ' HG21 ' A' ' 255' ' ' THR . . . -61.76 -176.14 0.08 Allowed 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.718 0.807 . . . . 0.0 112.323 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 28.9 t 81.07 6.83 1.28 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.835 0.854 . . . . 0.0 110.894 -178.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 40.1 t -126.03 89.96 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.463 0.649 . . . . 0.0 109.304 172.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 10.8 m -69.37 97.31 0.96 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.376 -178.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 68.21 99.46 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.494 -177.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.468 ' CE2' HD21 ' A' ' 228' ' ' LEU . 11.9 m-85 -43.23 -49.99 6.51 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.742 0.271 . . . . 0.0 111.371 170.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -166.08 166.16 17.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.677 -175.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.425 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 59.0 mtmt -140.79 -165.82 2.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.722 0.296 . . . . 0.0 111.685 -177.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -51.91 118.27 3.31 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.448 0.642 . . . . 0.0 111.877 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 107.02 -10.3 40.24 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.975 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' A' ' 344' ' ' THR . 38.7 m-20 -93.3 136.97 33.06 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -108.31 151.52 25.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.533 0.682 . . . . 0.0 112.313 -172.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 294' ' ' THR . 1.3 m -125.26 163.8 25.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.901 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.13 126.91 29.22 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 169.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -144.71 163.71 33.19 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.909 -0.494 . . . . 0.0 110.906 -174.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.585 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 5.0 t -121.67 101.3 7.51 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.893 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -103.6 143.59 32.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.366 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' THR . . . . . 0.444 HG21 ' HA ' ' A' ' 288' ' ' ALA . 1.8 p -74.76 81.53 2.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.479 0.657 . . . . 0.0 112.405 -176.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.448 ' HH ' HD13 ' A' ' 318' ' ' ILE . 38.5 m-85 -84.93 159.36 20.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.559 170.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.41 ' HB2' ' O ' ' A' ' 274' ' ' TYR . 7.0 m-90 72.39 -51.91 0.7 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.348 0.659 . . . . 0.0 110.887 -174.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 32.6 mt 69.36 -67.51 0.22 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.815 0.846 . . . . 0.0 113.174 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -81.15 -49.3 10.99 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -167.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' A' ' 283' ' ' ALA . 27.0 mp0 -103.09 -80.49 0.52 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.531 0.681 . . . . 0.0 112.223 -173.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -66.88 14.72 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -169.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 1.1 p -73.12 -50.65 21.59 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.607 -0.683 . . . . 0.0 109.92 172.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 285' ' ' TYR . 74.2 mmtt -108.95 -68.43 0.92 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.023 174.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -134.81 -81.47 0.44 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.62 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 278' ' ' GLN . . . -154.12 -54.22 0.1 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.983 0.42 . . . . 0.0 110.527 177.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.21 13.3 25.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.093 0.473 . . . . 0.0 110.539 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . 0.434 ' O ' ' HB2' ' A' ' 281' ' ' LYS . 82.7 m-85 -130.11 106.46 8.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.922 -178.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -94.37 171.62 8.71 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.412 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 156.09 -101.49 0.21 Allowed Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 111.356 -0.697 . . . . 0.0 111.356 177.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . 0.444 ' HA ' HG21 ' A' ' 273' ' ' THR . . . -149.2 140.92 23.55 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.844 0.354 . . . . 0.0 110.14 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 7.1 t -93.21 137.71 23.48 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.919 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.7 -0.15 9.85 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.579 2.186 . . . . 0.0 112.02 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 72.5 mt -72.17 124.67 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.429 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 42.8 m -116.35 143.74 45.16 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.19 145.43 51.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.967 0.413 . . . . 0.0 110.936 -175.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 87.1 m -90.02 131.07 36.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.798 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -129.63 -178.4 4.67 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 89.7 m -141.71 134.15 28.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.392 0.615 . . . . 0.0 112.385 -177.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 94.9 t -86.32 146.01 6.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.719 -178.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 13.6 t -125.57 18.11 8.12 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.572 -175.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.461 ' H ' HG11 ' A' ' 297' ' ' VAL . . . -154.58 -177.86 6.77 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.425 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 2.7 m-20 -69.78 163.0 26.72 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.168 -178.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.505 ' HB2' ' CG1' ' A' ' 311' ' ' VAL . . . -147.28 167.88 23.14 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.973 -178.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.661 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 21.0 m120 -142.59 128.97 20.04 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.469 -174.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.6 OUTLIER -109.48 94.97 5.31 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 163.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -101.62 -176.94 3.28 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.207 -175.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 13.1 t -60.59 -33.03 72.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.792 0.33 . . . . 0.0 111.424 -175.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -82.67 -2.8 90.67 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.696 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 63.5 44.44 96.65 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.203 -178.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -115.02 126.51 54.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 118.0 0.9 . . . . 0.0 111.0 177.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.661 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.2 OUTLIER -134.7 119.65 29.24 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.568 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.843 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.468 ' OG1' HG22 ' A' ' 250' ' ' THR . 53.1 m -113.39 134.98 54.35 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.285 -0.26 . . . . 0.0 110.498 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.505 ' CG1' ' HB2' ' A' ' 301' ' ' ALA . 6.9 m -145.8 164.39 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.361 0.601 . . . . 0.0 110.547 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.444 ' O ' HG21 ' A' ' 298' ' ' THR . 19.7 m -119.99 138.54 53.43 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.421 173.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.505 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 4.1 mp -109.59 169.58 8.61 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.631 -175.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' SER . . . . . 0.594 ' O ' HG13 ' A' ' 316' ' ' VAL . 19.7 m -87.15 64.69 8.51 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -172.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 245' ' ' TYR . . . 29.07 31.71 0.01 OUTLIER Glycine 0 N--CA 1.471 1.002 0 N-CA-C 118.046 1.978 . . . . 0.0 118.046 173.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 314' ' ' SER . 29.2 m -85.09 131.34 48.89 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 119.066 1.433 . . . . 0.0 110.816 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.72 134.15 31.73 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 122.422 2.081 . . . . 0.0 111.455 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.448 HD13 ' HH ' ' A' ' 274' ' ' TYR . 0.2 OUTLIER -123.82 97.11 4.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.314 0.578 . . . . 0.0 110.191 -177.004 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 59.9 29.73 19.29 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.912 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.417 ' C ' ' HG1' ' A' ' 321' ' ' THR . 56.1 m-20 -98.13 38.98 1.26 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.318 -178.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.417 ' HG1' ' C ' ' A' ' 320' ' ' ASP . 65.8 p 52.79 -159.5 0.13 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.985 -177.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 14.2 t -160.46 -175.99 5.33 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.46 ' N ' ' HD3' ' A' ' 324' ' ' PRO . 10.8 m120 57.79 57.95 7.11 Favored Pre-proline 0 C--N 1.318 -0.766 0 O-C-N 123.716 0.635 . . . . 0.0 111.17 -178.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 327' ' ' ASN . 16.5 Cg_exo -68.66 2.65 2.77 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.81 2.34 . . . . 0.0 113.354 -174.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -69.33 -54.98 11.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.996 0.427 . . . . 0.0 109.885 177.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -103.48 -15.67 15.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.036 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . 0.577 ' O ' ' HA ' ' A' ' 324' ' ' PRO . 13.1 t30 -111.73 67.53 0.65 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 14.6 m -84.64 70.3 10.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.65 -174.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 52.4 t -79.62 127.58 39.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.236 0.541 . . . . 0.0 110.904 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 17.1 t -96.4 111.02 23.26 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -68.35 123.54 21.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.413 -172.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -108.05 107.75 18.55 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 171.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.545 ' CG2' ' HB3' ' A' ' 233' ' ' GLN . 0.2 OUTLIER -91.72 170.63 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.227 0.537 . . . . 0.0 112.117 -173.833 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -144.65 147.86 33.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.328 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -98.95 173.18 6.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.767 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 98.99 8.16 54.36 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.818 -0.706 . . . . 0.0 113.05 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.585 ' HB3' ' O ' ' A' ' 271' ' ' THR . 30.6 m-20 -92.81 -172.96 3.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.793 0.33 . . . . 0.0 111.795 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -112.12 142.71 44.24 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.665 -172.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 82.9 t -126.97 149.55 32.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.373 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 50.7 m -147.98 158.86 44.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.921 0.391 . . . . 0.0 110.528 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 48.9 t -102.22 137.04 31.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.797 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.5 -42.26 72.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.078 175.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 149.16 -79.58 0.21 Allowed Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 266' ' ' ASP . 4.1 p -143.48 -87.45 0.13 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.028 0.442 . . . . 0.0 110.281 176.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.367 -0.825 . . . . 0.0 109.819 179.124 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.672 0 N-CA-C 112.175 -0.37 . . . . 0.0 112.175 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -144.53 100.71 3.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.894 0.378 . . . . 0.0 110.798 178.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -76.5 162.59 27.68 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.905 177.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 119.7 -0.36 13.74 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.857 -177.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -74.97 -167.28 19.68 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.241 -179.182 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.9 m -91.01 147.61 22.96 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.159 0.504 . . . . 0.0 111.434 -175.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 4.4 mp -138.34 176.01 9.07 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 168.138 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 33.0 m -135.92 161.79 34.64 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.634 0.254 . . . . 0.0 110.893 -170.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 59.3 t -118.09 126.09 74.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 176.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.405 ' HE2' HG23 ' A' ' 252' ' ' THR . 20.4 ttmm -108.67 -11.34 15.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.131 0.491 . . . . 0.0 111.126 -177.657 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.46 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 57.5 p -124.11 -166.83 1.55 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.476 -179.327 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -102.82 112.49 65.75 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -170.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -65.08 103.53 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.503 1.469 . . . . 0.0 111.154 175.399 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.3 t -103.01 120.22 40.25 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.509 0.671 . . . . 0.0 110.532 -177.057 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.414 ' HA ' ' CB ' ' A' ' 247' ' ' PHE . 21.3 t -77.26 123.17 33.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.848 -175.856 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 29.2 m -96.72 105.15 17.21 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.12 178.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -89.84 116.09 27.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.607 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.474 ' OD1' ' HG3' ' A' ' 242' ' ' LYS . 0.8 OUTLIER -122.71 76.14 1.32 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 176.547 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -84.3 -32.28 24.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.126 -160.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 38.8 t -65.39 -22.17 30.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 122.164 0.983 . . . . 0.0 108.529 173.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.474 ' HG3' ' OD1' ' A' ' 239' ' ' ASN . 43.4 mmtt -101.77 0.47 35.87 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.166 179.196 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 51.4 37.67 19.75 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.056 -178.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.9 m -119.17 127.32 53.2 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.009 178.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -125.17 112.11 16.06 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.079 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . 0.422 ' HB3' ' O ' ' A' ' 313' ' ' LEU . 18.2 mt-30 -130.79 -178.87 4.99 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.685 -175.276 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.416 ' CE2' ' HB2' ' A' ' 313' ' ' LEU . 6.9 p90 -156.76 137.83 13.59 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.476 171.611 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 61.4 m -103.15 134.95 45.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.177 -173.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -147.62 149.36 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.563 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.546 HG22 ' OG1' ' A' ' 310' ' ' THR . 38.3 m -99.09 111.4 23.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 164.721 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.488 ' HB2' HG13 ' A' ' 309' ' ' VAL . 4.6 mp -104.3 168.06 9.35 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -172.751 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.405 HG23 ' HE2' ' A' ' 231' ' ' LYS . 0.7 OUTLIER -120.57 130.24 54.11 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.693 0.282 . . . . 0.0 110.367 177.467 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.466 ' N ' HG11 ' A' ' 309' ' ' VAL . . . -124.08 -143.15 6.15 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.944 -171.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -113.5 -171.33 1.86 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -173.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.446 HG23 ' H ' ' A' ' 256' ' ' ALA . 1.8 m -51.12 167.34 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -173.157 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 257' ' ' SER . . . -69.95 -175.78 0.99 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.177 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 257' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 67.6 m 80.6 9.15 1.21 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.794 176.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 94.4 t -119.52 94.5 3.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 170.585 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 22.6 m -74.6 89.56 2.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.42 -178.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 80.1 102.32 0.28 Allowed Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.623 -175.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.462 ' CE1' ' HB2' ' A' ' 303' ' ' SER . 10.6 m-85 -48.17 -59.11 3.66 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.673 0.749 . . . . 0.0 110.392 173.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 266' ' ' ASP . 89.3 mt -141.7 168.4 19.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.009 -175.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -131.63 -169.27 2.16 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.18 0.3 . . . . 0.0 111.006 -179.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -56.82 114.41 2.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.255 0.55 . . . . 0.0 111.652 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 112.75 -6.07 25.97 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.562 177.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . 0.511 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 64.6 m-20 -96.19 138.14 34.24 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.416 ' HB2' HG11 ' A' ' 342' ' ' VAL . 30.5 mt-30 -108.94 159.76 16.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.636 0.732 . . . . 0.0 111.779 -173.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.06 -175.48 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.827 -179.29 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.472 ' HB3' ' HB2' ' A' ' 340' ' ' SER . 23.9 tptt -120.9 104.56 9.93 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.834 174.419 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -95.29 120.71 35.99 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 120.942 0.401 . . . . 0.0 110.127 -175.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.419 HG21 ' O ' ' A' ' 291' ' ' ILE . 54.8 m -110.6 89.25 2.98 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.767 178.352 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -75.12 142.98 43.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.611 179.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 36.4 p -114.13 121.35 43.52 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.498 -173.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -96.35 113.9 25.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.122 0.487 . . . . 0.0 109.959 173.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.411 ' CZ2' ' HA ' ' A' ' 288' ' ' ALA . 73.0 m95 -149.97 33.52 0.67 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.489 178.113 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 85.3 mt -81.66 179.69 7.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.941 -174.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -68.93 -5.02 18.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.093 0.473 . . . . 0.0 110.882 178.107 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -64.74 -13.96 56.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.883 175.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -57.28 -14.49 4.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.486 173.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 24.1 p -67.4 -33.85 76.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.262 0.553 . . . . 0.0 110.352 174.138 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -91.13 -29.04 17.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.937 177.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -105.48 48.79 0.83 Allowed 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.732 0.777 . . . . 0.0 109.255 178.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -69.19 86.23 0.39 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.526 -176.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 92.3 mt -115.17 32.37 6.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.432 -178.501 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 58.99 31.96 21.84 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.901 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.66 85.93 0.14 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.001 -177.185 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -83.74 -100.08 0.57 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.441 -178.007 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . 0.427 ' C ' ' HD3' ' A' ' 290' ' ' PRO . . . -166.68 179.36 5.45 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.066 0.46 . . . . 0.0 109.931 -179.102 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 6.8 t -131.54 61.29 57.89 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.189 178.45 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . 0.427 ' HD3' ' C ' ' A' ' 288' ' ' ALA . 1.7 Cg_endo -81.6 65.93 8.6 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.295 2.663 . . . . 0.0 112.35 -173.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.419 ' O ' HG21 ' A' ' 271' ' ' THR . 20.5 pt -128.74 154.26 39.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.3 179.002 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 55.7 p -162.09 141.72 9.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.256 178.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -143.45 148.27 35.85 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 66.7 m -74.94 115.99 15.16 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.675 -179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -103.14 -179.95 4.1 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 177.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.596 ' HB ' ' O ' ' A' ' 314' ' ' SER . 90.7 m -139.82 133.8 30.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -175.1 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.486 HG13 HG22 ' A' ' 311' ' ' VAL . 50.7 t -78.64 135.91 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.715 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 5.1 m -108.62 -13.43 14.81 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -173.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -154.38 -178.66 7.29 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.172 -0.33 . . . . 0.0 110.916 -175.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.58 105.58 0.66 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.178 0.513 . . . . 0.0 110.447 178.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -95.41 100.43 12.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.499 -177.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.406 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 65.3 t30 -61.04 149.49 36.74 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -168.569 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.497 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 36.6 t -128.78 95.23 4.04 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 166.374 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -104.9 173.03 6.48 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.89 -179.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 8.5 t -58.25 -32.08 68.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.861 0.362 . . . . 0.0 111.472 -173.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -73.77 3.45 35.25 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.217 -177.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 66.27 41.85 94.46 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.739 178.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -116.84 139.08 51.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.901 0.35 . . . . 0.0 110.694 -178.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.488 HG13 ' HB2' ' A' ' 251' ' ' LEU . 1.8 p -147.7 95.17 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.366 0.603 . . . . 0.0 111.352 179.186 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.546 ' OG1' HG22 ' A' ' 250' ' ' THR . 53.0 m -96.12 130.37 43.18 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 121.597 -0.689 . . . . 0.0 110.896 179.523 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.486 HG22 HG13 ' A' ' 297' ' ' VAL . 14.5 p -165.81 150.24 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.109 0.48 . . . . 0.0 110.424 175.216 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 25.0 m -93.69 145.49 24.52 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.632 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.506 ' HA ' ' O ' ' A' ' 296' ' ' THR . 5.1 mp -110.62 140.95 44.48 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.086 -175.662 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 314' ' ' SER . . . . . 0.596 ' O ' ' HB ' ' A' ' 296' ' ' THR . 39.0 t -119.95 137.93 53.77 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.677 -176.14 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 93.18 85.57 1.58 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.946 175.17 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 6.5 m -127.71 114.88 20.86 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 121.136 0.493 . . . . 0.0 110.688 176.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.72 55.03 5.05 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.797 2.331 . . . . 0.0 112.641 -178.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 26.4 pt -107.39 111.3 35.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.145 0.497 . . . . 0.0 110.292 179.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -120.68 74.14 1.05 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.231 0.539 . . . . 0.0 111.935 -175.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -93.47 -20.64 20.1 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.586 0.708 . . . . 0.0 109.377 170.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 69.4 p 54.85 17.63 1.86 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.89 177.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 3.3 m -139.58 -62.9 0.52 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.435 ' N ' ' HD3' ' A' ' 324' ' ' PRO . 90.5 m-20 53.29 60.71 11.83 Favored Pre-proline 0 N--CA 1.473 0.717 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.953 176.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 328' ' ' SER . 1.5 Cg_endo -79.85 -75.86 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.346 2.031 . . . . 0.0 111.304 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 66.54 -71.52 0.09 Allowed 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.413 0.685 . . . . 0.0 111.576 177.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . 0.462 ' O ' ' HB3' ' A' ' 327' ' ' ASN . 4.0 m-85 -108.28 79.6 1.27 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.168 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . 0.462 ' HB3' ' O ' ' A' ' 326' ' ' TYR . 37.7 t30 86.11 -69.95 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.101 178.042 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 328' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 324' ' ' PRO . 19.1 p -168.94 -77.83 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.949 0.404 . . . . 0.0 111.442 174.282 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 28.6 t -87.3 -23.28 6.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.202 0.525 . . . . 0.0 110.819 -176.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 27.5 t -86.33 46.3 1.33 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.907 -178.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . 0.51 ' HD3' ' H ' ' A' ' 331' ' ' ARG . 0.0 OUTLIER -63.5 137.85 58.29 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.37 178.518 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -135.12 147.85 49.61 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -179.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 35.2 m -116.52 173.43 4.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.877 176.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -127.43 134.83 49.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.92 0.39 . . . . 0.0 110.628 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -66.53 157.16 32.94 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.584 -175.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.38 3.12 5.75 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.401 178.21 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.11 166.85 10.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.222 0.534 . . . . 0.0 111.49 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -116.56 148.05 41.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.993 -179.048 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 70.7 t -130.38 150.59 34.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.809 0.338 . . . . 0.0 111.086 -172.573 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.472 ' HB2' ' HB3' ' A' ' 269' ' ' LYS . 30.0 m -150.05 177.77 9.57 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.318 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.456 HG12 ' H ' ' A' ' 343' ' ' GLY . 39.3 t -113.56 142.58 25.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' A' ' 267' ' ' GLN . 9.9 p -69.46 -24.59 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 121.053 0.454 . . . . 0.0 111.051 -175.095 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . 0.456 ' H ' HG12 ' A' ' 341' ' ' VAL . . . 120.2 76.44 0.47 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.34 174.621 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 15.6 p -88.0 -55.78 3.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.193 0.521 . . . . 0.0 111.356 -178.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.288 178.26 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.761 0 N-CA-C 112.345 -0.302 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -88.75 -8.68 54.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.782 0.291 . . . . 0.0 111.36 -176.017 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -63.5 -17.13 62.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.182 0.515 . . . . 0.0 110.796 178.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 120.32 6.7 9.61 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.653 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -84.16 -143.76 5.95 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.942 179.297 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.1 m -105.94 147.84 28.33 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.975 0.417 . . . . 0.0 111.184 -174.466 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.457 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.9 mp -132.61 -178.66 5.04 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 167.152 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.45 ' HB ' ' OG1' ' A' ' 252' ' ' THR . 23.1 m -127.47 155.82 43.11 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 122.324 -0.235 . . . . 0.0 111.072 -173.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.483 HG21 ' CG2' ' A' ' 339' ' ' VAL . 0.9 OUTLIER -111.22 137.43 43.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.275 177.399 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 59.3 mtmt -109.57 -26.92 9.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.769 174.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.448 ' O ' HG13 ' A' ' 230' ' ' VAL . 58.6 p -137.07 -179.7 5.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.535 ' HB3' ' HB ' ' A' ' 333' ' ' VAL . 17.9 mm-40 -116.57 157.01 46.92 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -166.797 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.464 ' HG3' ' CZ ' ' A' ' 293' ' ' PHE . 73.8 Cg_endo -73.05 104.24 1.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.076 2.517 . . . . 0.0 113.127 178.576 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.449 ' N ' ' HB2' ' A' ' 247' ' ' PHE . 10.1 t -157.11 110.44 2.57 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.659 170.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.766 ' O ' ' HB2' ' A' ' 246' ' ' GLN . 75.7 t -154.74 79.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.34 0.656 . . . . 0.0 109.559 165.814 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 26.0 m 81.44 92.73 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.536 0.684 . . . . 0.0 110.645 174.117 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -106.95 104.96 14.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.341 178.13 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -129.29 126.82 39.87 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -102.61 -43.0 5.74 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.622 -170.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 67.3 t -61.55 -26.9 40.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.39 0.614 . . . . 0.0 109.916 178.085 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -99.05 -4.77 31.66 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.874 -179.425 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 53.3 57.9 5.77 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.059 -177.051 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 23.7 m -138.51 111.14 7.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.458 -177.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -128.57 120.08 26.02 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.321 -177.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . 0.766 ' HB2' ' O ' ' A' ' 236' ' ' VAL . 47.3 mt-30 -128.57 163.36 25.18 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 173.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.529 ' HA ' ' N ' ' A' ' 236' ' ' VAL . 20.9 p90 -168.64 151.43 5.21 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 174.007 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 50.0 m -113.97 138.54 50.21 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 31.6 t -137.91 139.71 42.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.526 -178.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.502 HG22 ' OG1' ' A' ' 310' ' ' THR . 15.8 m -102.09 113.74 27.25 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.565 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.49 ' HB2' HG13 ' A' ' 309' ' ' VAL . 4.9 mp -110.39 170.63 7.96 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.943 0.402 . . . . 0.0 110.027 -171.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.626 HG22 ' O ' ' A' ' 307' ' ' GLY . 0.0 OUTLIER -126.87 120.97 30.5 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.402 176.761 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.441 ' N ' HG11 ' A' ' 309' ' ' VAL . . . -156.78 134.77 4.16 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.81 -0.709 . . . . 0.0 111.404 178.049 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -112.7 93.41 4.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.107 0.48 . . . . 0.0 112.179 -173.293 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 18.3 m -126.16 102.74 7.34 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 169.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -56.0 134.86 52.67 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -175.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 24.5 t 63.31 53.65 2.16 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.901 172.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 84.2 t -132.47 95.97 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.291 0.567 . . . . 0.0 110.377 175.61 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.5 m -75.97 86.31 2.89 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.567 0.698 . . . . 0.0 109.857 177.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 95.62 92.51 1.75 Allowed Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.251 -177.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.554 ' CD1' ' HB2' ' A' ' 303' ' ' SER . 3.6 m-85 -45.34 -58.79 3.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.786 0.803 . . . . 0.0 109.958 169.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.446 ' HB3' ' CB ' ' A' ' 266' ' ' ASP . 75.8 mt -141.53 169.83 16.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.168 -1.378 . . . . 0.0 108.031 -175.63 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 96.0 mttt -137.68 -171.22 2.94 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 121.173 -0.211 . . . . 0.0 110.884 -179.386 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -54.11 113.95 1.43 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.261 0.553 . . . . 0.0 111.413 -179.061 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 113.03 -6.82 25.42 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.77 177.087 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . 0.446 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 22.9 m-20 -90.37 136.03 33.31 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.722 -0.281 . . . . 0.0 110.262 179.049 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -107.15 142.28 37.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.5 0.667 . . . . 0.0 111.981 -174.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.456 HG21 ' HB2' ' A' ' 295' ' ' ALA . 0.7 OUTLIER -126.09 164.04 26.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.569 179.006 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.408 ' HZ3' ' HB3' ' A' ' 340' ' ' SER . 0.0 OUTLIER -135.68 147.99 48.75 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.674 174.221 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -110.95 130.03 55.71 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -174.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 44.0 m -104.25 126.63 51.52 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.453 ' CB ' HG23 ' A' ' 289' ' ' THR . 26.6 p-10 -107.28 147.59 30.04 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.893 0.854 . . . . 0.0 113.184 -163.208 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 20.0 p -100.89 96.03 7.01 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 162.007 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 289' ' ' THR . 26.1 p90 -80.67 127.07 32.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.22 0.533 . . . . 0.0 110.899 -165.553 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.465 ' HB3' ' CB ' ' A' ' 288' ' ' ALA . 62.5 t-105 -166.01 -58.25 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.051 -174.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.463 HD22 ' HB2' ' A' ' 334' ' ' GLU . 17.2 mt 62.0 92.49 0.05 Allowed 'General case' 0 C--O 1.237 0.403 0 O-C-N 123.421 0.451 . . . . 0.0 111.419 -178.562 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . 0.442 ' HA ' ' OG1' ' A' ' 280' ' ' THR . 35.8 mt-30 -70.63 -19.31 62.83 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.818 0.342 . . . . 0.0 110.684 -176.338 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 282' ' ' GLN . 24.4 mt-30 -67.33 -38.49 84.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.238 178.417 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -81.67 -38.09 26.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.001 -178.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.442 ' OG1' ' HA ' ' A' ' 277' ' ' GLN . 8.2 p -78.38 -56.04 4.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.111 -175.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -108.56 -78.79 0.59 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 121.136 -0.226 . . . . 0.0 111.575 -175.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 278' ' ' GLN . 77.0 mm-40 -143.65 -69.55 0.32 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.128 0.49 . . . . 0.0 110.514 -176.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -174.51 -61.0 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.672 -179.04 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 89.4 mt 57.9 33.88 23.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.965 175.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 67.77 -70.21 0.13 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.274 0.629 . . . . 0.0 112.221 176.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.637 ' HA ' ' OE1' ' A' ' 334' ' ' GLU . 9.8 p30 -166.47 171.03 12.27 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -178.327 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 162.43 -25.29 0.22 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 119.746 -1.216 . . . . 0.0 113.562 177.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . 0.465 ' CB ' ' HB3' ' A' ' 275' ' ' TRP . . . -127.96 -141.59 0.26 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.868 0.334 . . . . 0.0 110.789 -177.097 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.601 ' CG2' ' HB3' ' A' ' 337' ' ' ASP . 13.5 m -157.01 151.54 20.46 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 110.484 -0.191 . . . . 0.0 110.484 179.021 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.57 -77.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.468 2.112 . . . . 0.0 113.641 173.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 14.9 tt -139.61 159.3 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -166.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 32.8 p -85.66 135.45 33.77 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 176.206 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . 0.464 ' CZ ' ' HG3' ' A' ' 234' ' ' PRO . 35.9 p90 -161.58 177.2 10.23 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.992 0.425 . . . . 0.0 111.403 -176.652 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 53.8 m -124.06 132.67 53.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.508 -178.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . 0.456 ' HB2' HG21 ' A' ' 268' ' ' VAL . . . -114.97 -179.74 3.71 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.802 0.334 . . . . 0.0 111.249 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 96.1 m -143.67 121.64 12.06 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.569 0.699 . . . . 0.0 111.675 178.358 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.495 HG12 HG21 ' A' ' 311' ' ' VAL . 78.0 t -66.86 138.79 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.544 -178.04 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 312' ' ' THR . 6.0 t -121.4 6.54 10.13 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.108 -175.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -163.18 -167.03 1.37 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -72.46 113.8 9.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.246 0.546 . . . . 0.0 110.047 179.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -91.98 101.28 13.83 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.343 178.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -56.36 134.01 53.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.503 -0.772 . . . . 0.0 112.802 -169.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.554 ' HB2' ' CD1' ' A' ' 261' ' ' PHE . 30.5 t -128.23 111.39 13.36 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 120.913 0.387 . . . . 0.0 110.873 173.583 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.49 157.41 41.23 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 3.9 t -71.07 -10.14 59.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.009 -171.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -69.17 -15.05 69.41 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 173.004 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . 0.626 ' O ' HG22 ' A' ' 252' ' ' THR . . . 90.07 41.03 5.68 Favored Glycine 0 C--O 1.223 -0.558 0 C-N-CA 120.925 -0.655 . . . . 0.0 114.379 174.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -126.22 130.73 51.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.151 0.976 . . . . 0.0 111.427 178.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.49 HG13 ' HB2' ' A' ' 251' ' ' LEU . 0.8 OUTLIER -141.93 112.06 2.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.744 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.525 176.018 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.502 ' OG1' HG22 ' A' ' 250' ' ' THR . 99.0 m -110.15 129.47 55.7 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.491 -0.756 . . . . 0.0 110.618 177.375 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.495 HG21 HG12 ' A' ' 297' ' ' VAL . 2.6 p -151.72 144.38 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 121.141 0.496 . . . . 0.0 111.23 178.252 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.517 ' O ' HG22 ' A' ' 298' ' ' THR . 22.6 m -100.34 145.21 28.43 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.679 175.418 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.477 ' N ' HD21 ' A' ' 313' ' ' LEU . 1.3 mm? -121.44 129.81 53.21 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.484 -172.065 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 16.0 p -144.47 151.14 38.75 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.932 -174.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 74.66 47.33 15.59 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.333 175.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 7.0 m -118.99 111.56 37.07 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 120.976 0.417 . . . . 0.0 111.284 -177.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -71.99 78.91 1.74 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.696 2.264 . . . . 0.0 111.075 174.356 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 6.9 tt -82.46 99.29 5.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.561 0.696 . . . . 0.0 110.758 -177.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -135.77 88.61 2.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.569 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -77.95 -65.3 0.99 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 40.8 p 39.18 39.4 0.41 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 179.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 24.6 m -138.31 -52.01 0.59 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.893 0.378 . . . . 0.0 110.882 179.037 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -71.65 -45.82 12.72 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.68 -19.22 36.76 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.031 1.821 . . . . 0.0 112.217 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 70.07 -60.74 0.48 Allowed 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.902 0.751 . . . . 0.0 111.895 178.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -74.89 -50.31 17.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.708 -177.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 43.0 t30 70.71 81.44 0.16 Allowed 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -178.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 19.1 m -71.77 -15.36 62.17 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.895 -170.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 66.0 t 75.46 143.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.198 177.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 68.7 p 51.4 62.09 2.89 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.587 0.755 . . . . 0.0 111.829 178.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -72.03 144.76 48.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.221 179.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -88.22 149.56 23.78 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 175.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 233' ' ' GLN . 15.4 m -90.09 161.65 2.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.627 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . 0.637 ' OE1' ' HA ' ' A' ' 286' ' ' ASN . 6.1 tp10 -155.92 112.16 3.1 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.483 -174.133 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -74.64 143.71 44.18 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -171.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 131.51 11.55 2.16 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 120.787 -0.72 . . . . 0.0 114.231 175.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.601 ' HB3' ' CG2' ' A' ' 289' ' ' THR . 4.5 p-10 -76.72 174.48 10.4 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 117.498 0.649 . . . . 0.0 112.03 175.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -112.0 132.0 55.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.731 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.483 ' CG2' HG21 ' A' ' 230' ' ' VAL . 54.5 t -102.67 152.91 5.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.668 -169.498 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.408 ' HB3' ' HZ3' ' A' ' 269' ' ' LYS . 23.2 t -157.45 177.16 11.75 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 174.77 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 46.6 t -112.52 138.59 41.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.65 0.262 . . . . 0.0 110.767 -174.04 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 56.5 t -82.91 -36.69 13.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.78 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -57.45 -61.21 7.74 Favored Glycine 0 C--N 1.332 0.349 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.742 -179.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 2.0 p -78.56 -72.14 0.39 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.626 0.213 . . . . 0.0 111.299 179.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.445 -0.788 . . . . 0.0 111.497 179.527 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.847 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 68.11 -73.76 0.08 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.548 0.739 . . . . 0.0 112.198 179.035 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.482 ' C ' ' H ' ' A' ' 226' ' ' GLY . 0.4 OUTLIER -132.43 154.52 49.77 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 122.573 0.349 . . . . 0.0 110.207 -177.924 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 71.45 -20.49 0.77 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.641 174.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 224' ' ' PHE . . . -51.46 137.63 29.83 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.832 -0.223 . . . . 0.0 113.526 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 19.1 m -102.66 142.44 33.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.926 0.393 . . . . 0.0 110.886 -178.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.522 HD21 ' CE1' ' A' ' 261' ' ' PHE . 19.2 mt -144.39 176.61 9.24 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 42.7 m -135.97 160.23 39.26 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 122.27 -0.269 . . . . 0.0 110.485 -174.142 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.628 ' HB ' ' OD2' ' A' ' 337' ' ' ASP . 3.4 t -118.63 152.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 177.581 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.475 ' HE2' ' O ' ' A' ' 251' ' ' LEU . 53.1 pttt -130.38 14.43 5.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.857 0.36 . . . . 0.0 111.132 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.527 ' H ' HG13 ' A' ' 230' ' ' VAL . 24.1 p -151.73 -178.55 6.79 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -175.56 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.533 ' HB3' ' CG2' ' A' ' 333' ' ' VAL . 0.3 OUTLIER -115.79 129.46 25.14 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -174.28 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.49 105.79 1.32 Allowed 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.452 2.101 . . . . 0.0 112.243 -179.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 5.8 t -107.0 129.6 54.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.307 178.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 8.1 t -85.61 123.63 39.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.203 -173.054 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 49.2 m -82.17 96.66 7.89 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.048 173.145 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.75 109.07 13.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.511 -178.548 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.405 ' OD1' ' HG3' ' A' ' 242' ' ' LYS . 0.2 OUTLIER -121.0 81.2 1.74 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.419 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -85.11 -36.86 20.85 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.067 -164.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.03 -23.15 32.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.757 0.789 . . . . 0.0 109.162 174.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.405 ' HG3' ' OD1' ' A' ' 239' ' ' ASN . 13.4 mmmm -103.62 -6.76 21.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.262 -176.212 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 58.32 58.95 3.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.57 -177.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 41.7 m -145.53 128.63 16.61 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.372 176.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -129.14 100.4 5.61 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.199 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -133.97 144.18 48.62 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -120.11 136.59 54.54 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.644 -178.083 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 97.9 m -100.95 141.25 34.1 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -173.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.498 HG13 ' CD1' ' A' ' 251' ' ' LEU . 1.4 p -144.48 146.14 20.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.418 -177.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.412 HG22 ' HE3' ' A' ' 231' ' ' LYS . 4.9 m -107.84 124.95 50.84 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 174.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.547 ' HB2' HG21 ' A' ' 309' ' ' VAL . 3.9 mp -115.21 171.74 7.5 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.668 0.747 . . . . 0.0 110.926 -167.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.11 142.28 50.94 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.218 169.151 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -140.98 -144.54 4.45 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.007 -173.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.515 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -101.91 -173.54 2.37 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -176.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.566 HG21 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -70.83 -177.81 1.7 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.337 -171.635 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.566 ' H ' HG21 ' A' ' 255' ' ' THR . . . -67.32 -175.39 0.47 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.266 -178.599 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 257' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 50.7 m 80.59 6.22 1.53 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.002 0.921 . . . . 0.0 111.244 179.46 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.9 88.79 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.505 0.669 . . . . 0.0 109.411 171.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 62.9 m -89.09 103.68 16.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.953 179.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 83.22 79.44 1.03 Allowed Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.068 -176.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.642 ' CE1' ' HB2' ' A' ' 303' ' ' SER . 6.8 m-85 -45.32 -54.59 6.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.788 0.804 . . . . 0.0 109.932 170.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.5 pp -158.11 173.7 16.33 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.288 -1.323 . . . . 0.0 108.677 -175.021 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.544 ' HE2' ' OD2' ' A' ' 300' ' ' ASP . 94.4 mttt -136.29 -167.54 2.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.702 0.287 . . . . 0.0 111.54 -174.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -55.4 116.57 2.93 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.436 0.636 . . . . 0.0 111.446 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 115.08 -14.96 18.84 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.199 177.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -86.06 141.89 29.12 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.254 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -104.86 150.16 25.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.878 0.847 . . . . 0.0 112.668 -172.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.35 173.71 13.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.668 175.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.437 ' HE2' ' CB ' ' A' ' 340' ' ' SER . 0.0 OUTLIER -134.57 149.88 50.67 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 167.091 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . 0.496 ' O ' ' HA ' ' A' ' 292' ' ' SER . 55.4 m-85 -106.5 130.73 54.23 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.494 -175.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 45.6 m -107.16 88.34 2.71 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 171.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -122.65 144.59 49.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.424 0.631 . . . . 0.0 111.767 -172.3 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 31.5 p -97.91 109.81 22.5 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.665 173.459 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -83.16 113.38 20.6 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.012 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 41.6 t90 -141.42 92.74 2.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.329 0.585 . . . . 0.0 110.522 -172.685 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -115.68 130.06 56.71 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 175.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -57.21 -26.4 60.63 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -167.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -80.04 -44.13 20.66 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.524 0.678 . . . . 0.0 110.413 178.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -76.01 -24.8 55.29 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.583 -174.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 17.0 p -69.8 -15.11 63.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.974 0.416 . . . . 0.0 111.401 179.495 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -76.46 -7.71 55.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.4 178.32 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -82.71 66.29 8.25 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 122.263 1.03 . . . . 0.0 109.073 175.209 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -75.81 66.82 2.14 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.41 -1.723 . . . . 0.0 111.596 -175.544 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 78.2 mt -94.28 4.38 53.96 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.875 178.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 75.06 -42.57 0.49 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.149 179.257 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -84.73 65.01 8.87 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -172.26 36.73 0.15 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.934 -177.26 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -100.8 33.91 2.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.188 0.518 . . . . 0.0 110.657 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.404 ' N ' ' HD3' ' A' ' 290' ' ' PRO . 9.1 t 44.43 61.94 10.57 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 124.75 1.22 . . . . 0.0 113.776 178.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . 0.404 ' HD3' ' N ' ' A' ' 289' ' ' THR . 83.9 Cg_endo -95.99 57.81 0.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.933 2.422 . . . . 0.0 110.951 173.313 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 37.4 pt -113.77 162.71 11.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.245 0.545 . . . . 0.0 112.343 -170.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 292' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 17.8 p -167.35 100.15 0.51 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.28 177.25 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -111.63 147.39 35.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.856 0.36 . . . . 0.0 111.127 -174.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 51.9 m -88.02 127.27 35.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.783 -179.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -120.23 179.13 4.38 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 95.3 m -136.97 130.65 31.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.534 0.683 . . . . 0.0 112.543 -177.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.495 HG11 ' H ' ' A' ' 299' ' ' ALA . 61.1 t -85.1 144.08 10.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.484 -178.359 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 0.6 OUTLIER -119.33 24.74 10.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.821 -174.993 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.495 ' H ' HG11 ' A' ' 297' ' ' VAL . . . -166.83 173.34 9.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.763 0.316 . . . . 0.0 111.668 -177.346 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.544 ' OD2' ' HE2' ' A' ' 263' ' ' LYS . 2.3 m-20 -64.8 116.55 6.42 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.256 176.688 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -93.26 112.75 24.76 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.664 179.023 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.717 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 65.9 t30 -85.55 134.47 34.02 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -171.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.642 ' HB2' ' CE1' ' A' ' 261' ' ' PHE . 7.7 t -113.88 95.72 5.46 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 163.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -98.53 179.25 4.76 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.976 -178.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 20.5 m -57.07 -32.92 66.75 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -173.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -83.39 5.54 76.97 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.468 -176.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 64.49 42.69 97.42 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.864 -178.345 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -120.22 142.91 48.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.367 0.584 . . . . 0.0 111.682 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.717 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.2 OUTLIER -143.89 152.7 15.93 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.616 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.096 176.973 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 95.5 m -149.72 120.04 7.34 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.692 -0.63 . . . . 0.0 110.619 178.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.401 HG21 HD11 ' A' ' 251' ' ' LEU . 35.4 m -145.87 160.88 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.41 0.624 . . . . 0.0 111.23 -177.362 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 23.7 m -114.75 140.93 48.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.582 176.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.52 126.52 54.47 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.367 -171.245 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 7.6 p -96.5 137.43 35.6 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.329 -176.118 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 92.95 153.62 30.41 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -176.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 3.9 m -114.4 86.19 11.88 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-O 121.126 0.488 . . . . 0.0 111.793 -177.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -83.44 47.68 2.43 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.757 2.305 . . . . 0.0 110.598 176.022 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.46 HD12 ' HB ' ' A' ' 322' ' ' THR . 10.3 tt -146.59 127.94 6.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.636 -174.495 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -113.4 -64.52 1.3 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.71 -174.493 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -121.3 -19.45 7.03 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.78 -173.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.9 p -56.85 -27.35 60.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.197 0.522 . . . . 0.0 111.464 -177.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 322' ' ' THR . . . . . 0.46 ' HB ' HD12 ' A' ' 318' ' ' ILE . 2.4 m -153.1 128.68 10.03 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 167.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -156.45 138.62 10.21 Favored Pre-proline 0 C--N 1.307 -1.28 0 CA-C-N 115.428 -0.805 . . . . 0.0 108.849 -178.097 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.07 -15.46 23.22 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.368 1.378 . . . . 0.0 112.702 -177.449 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -82.07 69.56 8.8 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.928 0.87 . . . . 0.0 112.09 -175.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -100.65 -35.69 9.4 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 166.358 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -139.48 -52.71 0.54 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.283 170.195 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 32.9 t -153.98 -67.4 0.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.097 171.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 5.0 t -143.68 40.56 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 3.2 p -67.14 -68.25 0.39 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.519 -1.219 . . . . 0.0 112.689 -172.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . 0.564 ' NE ' ' HA ' ' A' ' 331' ' ' ARG . 3.8 mmp_? -100.5 149.97 23.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.74 0.305 . . . . 0.0 111.392 -175.451 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -127.93 -168.54 1.91 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.813 179.182 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.533 ' CG2' ' HB3' ' A' ' 233' ' ' GLN . 2.6 m -68.78 169.4 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.381 0.61 . . . . 0.0 112.113 -179.304 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -147.22 161.82 40.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.937 -177.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -65.96 173.09 3.18 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.507 0.504 . . . . 0.0 111.358 178.596 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 112.26 13.73 11.64 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -176.086 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.628 ' OD2' ' HB ' ' A' ' 230' ' ' VAL . 0.4 OUTLIER -96.29 146.68 24.51 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.742 0.782 . . . . 0.0 112.617 -173.885 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -144.08 163.56 33.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.779 178.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.468 HG23 HD21 ' A' ' 251' ' ' LEU . 74.7 t -125.24 143.03 40.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.227 0.537 . . . . 0.0 111.285 -169.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.437 ' CB ' ' HE2' ' A' ' 269' ' ' LYS . 20.0 m -147.51 127.21 13.38 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 172.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 19.1 t -76.04 143.12 13.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 120.867 0.365 . . . . 0.0 111.311 -173.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 53.4 t -87.43 -42.91 15.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.471 176.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 157.04 143.56 3.69 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.821 179.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 17.3 p -90.9 -80.87 0.33 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.953 0.406 . . . . 0.0 111.155 -178.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.526 -0.749 . . . . 0.0 110.291 -179.565 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.769 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.02 136.4 39.96 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 176.388 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -94.21 -21.0 19.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.191 0.52 . . . . 0.0 110.87 -177.435 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 106.03 34.82 3.11 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.139 -172.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -62.61 -170.04 1.1 Allowed Glycine 0 CA--C 1.523 0.565 0 CA-C-O 121.533 0.518 . . . . 0.0 114.083 177.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 5.3 m -67.28 145.35 55.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.435 0.636 . . . . 0.0 112.401 -173.077 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 1.3 mt -133.68 179.13 6.42 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.89 177.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.409 ' O ' ' HB3' ' A' ' 251' ' ' LEU . 48.1 m -139.08 158.84 43.46 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 122.303 -0.248 . . . . 0.0 110.498 -175.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 17.6 t -106.08 133.19 51.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 179.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -104.46 -39.05 6.56 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 178.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 63.5 p -118.77 -169.56 1.75 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.785 0.326 . . . . 0.0 110.489 -177.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.433 ' HB3' HG23 ' A' ' 333' ' ' VAL . 91.2 mt-30 -105.27 126.1 31.83 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.507 -169.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.629 ' HB3' ' CD2' ' A' ' 247' ' ' PHE . 23.7 Cg_exo -62.56 104.73 0.38 Allowed 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.687 2.258 . . . . 0.0 111.861 176.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.8 t -142.55 104.87 4.45 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.661 0.743 . . . . 0.0 112.187 -177.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.595 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.16 175.42 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.879 171.931 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.507 ' H ' HG12 ' A' ' 236' ' ' VAL . 55.9 m -34.09 114.27 0.2 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -169.648 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -116.04 88.13 2.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.465 173.178 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -113.73 133.16 55.52 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -179.225 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -104.28 -40.39 6.13 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.621 -172.163 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.73 -29.77 46.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.516 0.674 . . . . 0.0 109.74 176.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.486 ' HA ' ' HE2' ' A' ' 242' ' ' LYS . 11.2 mmpt? -100.45 -3.43 30.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.084 -178.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 53.72 51.57 14.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 113.998 -1.456 . . . . 0.0 111.089 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.2 m -126.28 99.16 5.75 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.095 -175.239 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -116.44 108.42 16.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.071 0.462 . . . . 0.0 110.502 -177.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . 0.468 ' HB2' HG13 ' A' ' 236' ' ' VAL . 95.0 mt-30 -129.5 164.16 24.35 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.057 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.629 ' CD2' ' HB3' ' A' ' 234' ' ' PRO . 31.3 p90 -159.79 135.66 8.59 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.565 -0.454 . . . . 0.0 112.143 176.712 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 51.9 m -98.09 138.92 34.66 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.7 150.83 17.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.765 -179.305 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.584 HG23 ' OG1' ' A' ' 310' ' ' THR . 96.2 m -104.38 117.45 34.21 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 167.488 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.513 ' HB2' HG12 ' A' ' 309' ' ' VAL . 4.0 mp -118.49 169.49 9.73 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.209 -170.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.444 HG21 ' O ' ' A' ' 307' ' ' GLY . 0.0 OUTLIER -110.4 141.72 43.09 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.279 176.114 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.407 ' N ' HG13 ' A' ' 309' ' ' VAL . . . -138.34 -143.92 4.57 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.999 -178.653 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -109.96 -173.61 2.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.814 0.34 . . . . 0.0 111.877 -177.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.552 HG23 ' H ' ' A' ' 256' ' ' ALA . 2.2 m -67.04 173.68 3.55 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.388 -0.823 . . . . 0.0 112.877 -170.125 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.552 ' H ' HG23 ' A' ' 255' ' ' THR . . . -62.94 -175.34 0.09 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.861 0.864 . . . . 0.0 112.663 -178.785 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 257' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 31.3 t 81.53 6.4 1.2 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.95 0.9 . . . . 0.0 111.101 -178.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.499 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 64.4 t -125.32 90.54 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.545 0.688 . . . . 0.0 109.571 171.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 22.2 m -75.81 97.86 4.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.735 178.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 80.52 87.82 0.58 Allowed Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.495 -177.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.461 ' CD2' ' HB2' ' A' ' 303' ' ' SER . 2.6 m-85 -44.6 -61.39 1.57 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.666 0.746 . . . . 0.0 110.143 170.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.45 HD23 ' HB3' ' A' ' 261' ' ' PHE . 2.9 mm? -135.22 166.01 24.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.405 -1.27 . . . . 0.0 108.483 179.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -134.74 -170.98 2.67 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 123.164 0.29 . . . . 0.0 110.822 178.022 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -59.51 117.28 4.7 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.112 0.482 . . . . 0.0 110.57 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 115.26 -14.93 18.36 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.514 177.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -86.9 138.48 31.51 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -100.6 154.2 18.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.072 0.463 . . . . 0.0 110.319 -178.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 294' ' ' THR . 1.3 m -135.17 176.33 8.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.314 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.403 ' HE3' HG22 ' A' ' 342' ' ' VAL . 1.7 mptm? -122.8 139.99 53.41 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 171.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -137.68 136.76 37.72 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.803 174.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.628 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 29.7 m -110.14 88.54 2.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.428 -175.79 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.467 ' HA ' ' CG ' ' A' ' 337' ' ' ASP . 3.2 t-20 -85.24 108.3 17.69 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.205 176.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 273' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 289' ' ' THR . 19.2 p -123.19 80.32 1.76 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.967 0.413 . . . . 0.0 111.473 -176.145 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -143.41 119.73 10.9 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.473 0.654 . . . . 0.0 111.042 177.091 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.415 ' CE2' HG23 ' A' ' 280' ' ' THR . 26.9 t90 -91.18 83.96 5.61 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.759 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 74.8 mt -82.0 172.03 13.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.608 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . 0.499 ' HA ' ' OE1' ' A' ' 277' ' ' GLN . 14.6 mm-40 -64.66 -50.42 67.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -176.179 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 61.2 mm-40 -68.9 -28.39 66.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.72 0.771 . . . . 0.0 109.752 178.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -79.63 0.73 28.94 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.369 -178.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.415 HG23 ' CE2' ' A' ' 275' ' ' TRP . 30.8 p -63.33 -34.81 78.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.04 0.448 . . . . 0.0 111.125 178.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -72.87 -12.4 60.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.034 -178.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.504 HE22 ' NE ' ' A' ' 331' ' ' ARG . 67.6 mt-30 -108.85 3.58 22.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.683 -177.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -63.92 115.02 4.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.282 178.252 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 6.5 mp -73.0 -44.4 61.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.108 -172.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -144.98 123.48 12.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.996 0.427 . . . . 0.0 111.009 -173.18 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 63.6 24.56 14.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.284 171.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 67.01 56.51 12.17 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.718 -178.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . 0.5 ' C ' ' HD3' ' A' ' 290' ' ' PRO . . . -153.31 168.37 26.25 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.657 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 273' ' ' THR . 17.2 m -122.44 66.36 25.48 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.194 -179.259 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . 0.5 ' HD3' ' C ' ' A' ' 288' ' ' ALA . 57.9 Cg_endo -99.49 72.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.312 2.674 . . . . 0.0 112.794 -176.522 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.465 ' H ' HD11 ' A' ' 291' ' ' ILE . 0.2 OUTLIER -126.47 173.25 12.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.01 0.433 . . . . 0.0 111.292 -179.416 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 10.3 p -156.81 133.5 10.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.25 176.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -153.3 168.87 24.58 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.248 0.547 . . . . 0.0 111.737 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 90.0 m -89.35 133.57 34.44 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.814 -172.614 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -119.15 -170.43 1.92 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.963 175.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 16.9 m -139.01 131.82 29.19 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.58 0.705 . . . . 0.0 112.877 -177.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.491 HG12 HG21 ' A' ' 311' ' ' VAL . 55.1 t -82.42 142.09 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 114.207 -1.361 . . . . 0.0 109.488 179.155 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 41.5 p -129.19 18.44 5.98 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -173.576 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -167.59 177.95 5.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.394 0.14 . . . . 0.0 110.67 179.092 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.41 108.66 2.04 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.846 0.716 . . . . 0.0 109.556 178.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -92.67 100.91 13.33 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.275 0.56 . . . . 0.0 110.241 -177.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.438 ' OD1' ' HB3' ' A' ' 304' ' ' ASP . 9.0 t-20 -63.35 135.06 56.76 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -169.204 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.499 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 27.5 t -115.68 96.52 5.65 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 166.38 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . 0.438 ' HB3' ' OD1' ' A' ' 302' ' ' ASN . 0.4 OUTLIER -106.25 174.7 5.77 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.476 -176.864 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 20.3 m -60.67 -32.24 71.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.749 0.309 . . . . 0.0 111.589 -176.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -74.21 1.05 51.2 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.188 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . 0.444 ' O ' HG21 ' A' ' 252' ' ' THR . . . 63.91 40.68 98.56 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.309 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -114.16 127.77 56.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.695 0.284 . . . . 0.0 110.683 -179.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.513 HG12 ' HB2' ' A' ' 251' ' ' LEU . 2.7 p -131.97 101.06 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.392 0.615 . . . . 0.0 111.134 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.584 ' OG1' HG23 ' A' ' 250' ' ' THR . 54.3 m -104.03 126.63 51.3 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 121.95 -0.469 . . . . 0.0 110.864 -179.009 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.491 HG21 HG12 ' A' ' 297' ' ' VAL . 12.7 p -160.43 151.4 5.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.066 0.46 . . . . 0.0 110.237 175.37 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 48.4 m -92.4 148.9 21.75 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.307 178.449 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.493 ' HB2' ' CE2' ' A' ' 247' ' ' PHE . 5.7 mp -117.23 149.3 40.64 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.795 -179.076 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 36.8 m -143.15 119.24 10.73 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.74 -178.461 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 97.03 113.77 3.08 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.553 179.133 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.22 137.69 13.51 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.981 0.42 . . . . 0.0 110.799 177.559 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.45 66.24 8.8 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.827 2.351 . . . . 0.0 113.401 -177.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.44 ' H ' HD12 ' A' ' 318' ' ' ILE . 0.2 OUTLIER -110.97 143.27 21.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 173.624 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -105.99 -47.44 3.85 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.156 0.503 . . . . 0.0 110.45 -178.199 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 38.2 t70 62.21 15.33 7.43 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.038 171.378 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 5.6 p 48.05 96.49 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.756 0.822 . . . . 0.0 111.965 -173.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.02 -7.22 59.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.297 0.57 . . . . 0.0 110.704 -174.468 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.578 ' HB3' ' HD3' ' A' ' 324' ' ' PRO . 44.3 t-20 -71.09 -53.4 8.37 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.114 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' A' ' 323' ' ' ASN . 9.7 Cg_endo -93.95 103.72 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.684 2.256 . . . . 0.0 111.187 177.279 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . 0.421 ' O ' ' HB2' ' A' ' 326' ' ' TYR . 12.9 mm100 -115.75 -64.55 1.3 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.645 -175.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 325' ' ' GLN . 51.2 m-85 73.74 -66.13 0.32 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.282 176.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -128.6 -17.22 4.14 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.57 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 23.9 m 71.42 -61.12 0.5 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.924 0.765 . . . . 0.0 111.247 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 58.9 t 70.44 135.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 121.26 0.552 . . . . 0.0 111.228 179.066 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 9.5 m -59.45 126.92 29.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.517 176.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . 0.504 ' NE ' HE22 ' A' ' 282' ' ' GLN . 0.0 OUTLIER -73.51 116.7 14.4 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.123 -174.658 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -96.83 116.7 29.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.307 0.575 . . . . 0.0 110.795 178.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 233' ' ' GLN . 22.2 m -101.35 171.97 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.847 178.613 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -131.34 153.89 49.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.0 0.429 . . . . 0.0 110.638 -178.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -97.95 165.21 12.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.857 -179.079 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 103.5 12.17 31.46 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.344 175.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.628 ' HB3' ' O ' ' A' ' 271' ' ' THR . 23.8 m-20 -95.19 -178.77 4.57 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.021 0.438 . . . . 0.0 112.126 -178.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -104.73 153.92 20.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.61 -173.444 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.414 HG22 HD21 ' A' ' 251' ' ' LEU . 50.5 t -132.86 150.34 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.791 -176.367 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 31.6 t -144.85 171.34 14.57 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 175.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 32.2 t -118.29 160.28 18.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.403 HG22 ' HE3' ' A' ' 269' ' ' LYS . 94.3 t -67.86 -60.56 2.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 118.212 0.46 . . . . 0.0 110.392 -179.582 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 172.91 -115.78 0.58 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.385 179.209 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 12.9 p -86.46 -57.51 2.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.214 0.53 . . . . 0.0 111.451 -178.529 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.61 -179.316 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.724 0 N-CA-C 112.148 -0.381 . . . . 0.0 112.148 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.21 99.57 0.92 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.191 0.52 . . . . 0.0 111.399 -178.162 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -100.77 -13.46 18.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.061 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 122.44 -47.81 0.99 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -175.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -119.14 113.7 2.6 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 167.097 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 20.3 m -129.74 131.49 46.3 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.738 0.304 . . . . 0.0 110.383 -173.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.473 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 2.2 mp -138.47 -177.3 4.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.122 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 95.3 m -143.74 156.14 44.42 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.997 -176.799 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 66.3 t -108.05 122.77 62.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.197 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -106.05 -6.28 18.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.106 0.479 . . . . 0.0 110.716 -175.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 17.5 p -130.25 -168.32 1.95 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.732 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -113.74 113.65 47.39 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -175.347 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.17 106.98 0.51 Allowed 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.894 2.396 . . . . 0.0 112.494 -179.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.0 t -149.37 118.44 6.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.533 0.682 . . . . 0.0 112.269 179.556 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.588 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -155.9 174.72 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.164 171.569 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.462 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 34.8 m -23.09 100.19 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.609 1.164 . . . . 0.0 113.525 -177.318 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.95 83.42 1.82 Allowed 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.408 174.158 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.41 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 35.7 t-20 -108.79 129.96 55.38 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.016 -178.326 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -102.46 -41.39 6.32 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.68 -170.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.8 -33.77 65.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.43 0.633 . . . . 0.0 109.944 178.1 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.472 ' HA ' ' HE2' ' A' ' 242' ' ' LYS . 10.8 mmpt? -88.77 -11.25 45.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.481 178.835 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 26.5 t70 58.1 69.19 0.75 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.277 -178.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.9 m -146.8 104.84 3.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.159 -177.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -123.33 106.33 10.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.783 -176.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . 0.46 ' HB2' HG11 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -124.03 161.92 24.53 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 171.551 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.588 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 35.2 p90 -149.09 134.82 18.78 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.67 174.818 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 46.5 m -98.8 137.49 37.32 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.41 ' HB ' ' CD1' ' A' ' 251' ' ' LEU . 0.2 OUTLIER -142.29 148.58 20.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.878 -178.946 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.582 HG23 ' OG1' ' A' ' 310' ' ' THR . 41.6 m -99.51 107.84 20.12 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 166.519 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 309' ' ' VAL . 5.2 mp -102.82 167.97 9.53 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -170.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.19 144.13 43.69 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.813 175.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -142.82 -142.48 4.01 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.369 -173.144 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -113.37 -173.66 2.31 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -176.362 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.558 HG22 ' H ' ' A' ' 256' ' ' ALA . 1.8 m -70.9 174.0 6.69 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.185 -171.726 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.558 ' H ' HG22 ' A' ' 255' ' ' THR . . . -62.51 -177.46 0.14 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.495 0.718 . . . . 0.0 112.862 -177.17 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 23.1 t 80.83 10.93 0.95 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.185 0.994 . . . . 0.0 111.155 -176.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 40.4 t -124.33 94.06 2.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 169.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.2 m -67.65 88.89 0.24 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.515 -177.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 69.48 107.42 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.109 -174.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -44.19 -57.35 3.49 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 117.243 0.521 . . . . 0.0 111.091 174.254 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 91.9 mt -147.83 146.81 29.26 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -177.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.511 ' HD2' ' N ' ' A' ' 263' ' ' LYS . 9.5 mptt -112.86 -166.45 1.08 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.033 0.444 . . . . 0.0 111.561 176.53 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -52.79 114.15 1.32 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.66 -175.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 114.2 -16.07 20.26 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.416 171.392 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . 0.417 ' HA ' HG22 ' A' ' 344' ' ' THR . 0.6 OUTLIER -82.54 134.79 35.2 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.83 -177.014 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.19 145.94 24.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.24 -173.592 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.33 165.3 22.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.744 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.513 ' HB3' ' HB2' ' A' ' 340' ' ' SER . 0.8 OUTLIER -97.57 120.3 37.69 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 172.433 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -122.55 120.55 34.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.857 0.361 . . . . 0.0 110.085 -174.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 30.4 m -125.79 113.0 16.69 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.491 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.624 ' O ' ' HA ' ' A' ' 290' ' ' PRO . 19.4 m120 -84.09 153.27 23.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.031 -177.584 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 21.4 p -91.95 162.94 14.19 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.676 175.53 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -84.61 142.71 29.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.217 0.532 . . . . 0.0 111.787 -176.168 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -155.02 -36.98 0.09 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.972 176.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 67.7 mt -72.41 77.0 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.981 176.497 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . 0.517 ' HA ' ' OG1' ' A' ' 280' ' ' THR . 51.9 mt-30 -63.83 -22.43 66.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.006 -173.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -60.24 -38.71 84.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.728 0.775 . . . . 0.0 109.642 176.267 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.499 ' HB3' ' O ' ' A' ' 287' ' ' GLY . 74.1 mm-40 -89.17 -41.38 12.28 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.418 -175.698 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.517 ' OG1' ' HA ' ' A' ' 277' ' ' GLN . 43.6 p -68.21 -25.62 65.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.979 0.418 . . . . 0.0 111.256 -177.373 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -91.07 -58.87 2.32 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.716 176.321 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -97.8 -75.43 0.55 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -173.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 51.17 79.67 0.09 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.276 0.56 . . . . 0.0 111.086 -171.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.8 -26.71 57.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.942 -178.4 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -110.42 -70.06 0.83 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.157 0.503 . . . . 0.0 109.735 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.415 ' OD1' ' HA ' ' A' ' 320' ' ' ASP . 6.3 p30 -169.5 143.16 2.74 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.707 177.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 279' ' ' GLN . . . 168.79 101.82 0.15 Allowed Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.892 -177.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -126.13 114.47 18.42 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.204 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.48 ' HB ' ' HD3' ' A' ' 290' ' ' PRO . 8.1 m -88.12 -52.94 0.38 Allowed Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.615 -178.644 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . 0.624 ' HA ' ' O ' ' A' ' 272' ' ' ASN . 72.6 Cg_endo -76.13 66.83 6.95 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.771 1.648 . . . . 0.0 112.08 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 14.3 pt -99.82 151.22 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.656 -177.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 12.2 p -111.86 90.52 3.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.227 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -118.96 174.99 5.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.046 0.45 . . . . 0.0 110.665 -178.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 67.9 m -109.22 117.91 35.35 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.852 178.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -104.24 -175.85 2.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 -176.148 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 91.4 m -141.63 131.16 23.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.384 0.612 . . . . 0.0 112.282 -176.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.509 HG11 HG23 ' A' ' 311' ' ' VAL . 64.3 t -75.13 136.67 24.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.053 176.372 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 2.4 m -111.45 -9.04 14.24 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.97 -167.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -164.45 -168.9 1.63 Allowed 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.912 -0.492 . . . . 0.0 111.676 -177.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.16 151.71 35.1 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.77 0.795 . . . . 0.0 110.762 179.35 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -148.13 -178.38 6.26 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.315 -1.311 . . . . 0.0 109.433 -178.135 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -136.56 135.83 38.77 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -173.482 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.8 OUTLIER -112.94 95.62 5.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 161.618 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -99.88 175.49 5.76 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.662 -176.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 53.5 m -60.91 -31.39 70.9 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -177.027 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -78.55 -2.43 84.85 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.213 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 69.2 42.06 77.36 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.739 179.006 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -114.67 135.52 54.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.92 0.86 . . . . 0.0 110.856 175.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' ' 251' ' ' LEU . 2.3 p -136.51 105.29 4.41 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.507 -179.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.582 ' OG1' HG23 ' A' ' 250' ' ' THR . 90.7 m -102.82 129.84 49.62 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 121.664 -0.648 . . . . 0.0 111.365 -178.31 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.509 HG23 HG11 ' A' ' 297' ' ' VAL . 14.4 p -165.93 155.41 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.033 0.444 . . . . 0.0 110.237 174.303 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 52.4 m -96.64 149.32 21.93 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.453 -179.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.466 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.4 mp -117.21 136.62 52.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.542 -178.422 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 5.4 m -133.46 132.19 40.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.446 -173.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 94.64 80.21 1.49 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.971 175.276 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 12.4 m -134.95 134.72 22.03 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.763 0.316 . . . . 0.0 110.812 177.244 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -88.41 69.64 2.83 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.0 2.467 . . . . 0.0 113.182 -178.465 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.88 114.1 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 175.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -109.87 18.22 20.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.372 0.606 . . . . 0.0 110.319 -178.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.415 ' HA ' ' OD1' ' A' ' 286' ' ' ASN . 16.1 m-20 -87.85 32.18 0.75 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.043 176.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 12.5 p -80.96 32.54 0.32 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.412 -175.319 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 20.8 m -95.2 -22.13 18.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.176 0.513 . . . . 0.0 110.375 179.22 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.448 ' HB3' ' HD3' ' A' ' 324' ' ' PRO . 8.3 t30 -74.05 -48.27 6.12 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.767 176.897 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 323' ' ' ASN . 2.9 Cg_exo -80.72 14.43 2.04 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.756 2.304 . . . . 0.0 113.088 -177.847 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . 0.496 ' HA ' HE21 ' A' ' 325' ' ' GLN . 0.0 OUTLIER -59.79 -60.63 3.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.174 -178.741 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -88.84 -9.92 49.94 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.7 0.286 . . . . 0.0 111.354 -177.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 324' ' ' PRO . 25.8 t-20 -159.76 105.88 1.62 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.243 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 29.5 p -114.76 -0.64 13.47 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.66 178.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 55.5 t -104.79 -34.17 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.756 0.312 . . . . 0.0 111.713 -175.132 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 6.0 m -86.19 -60.26 2.06 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.121 0.486 . . . . 0.0 110.23 179.287 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -82.99 112.51 19.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.936 -178.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -140.42 -168.69 2.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.225 0.536 . . . . 0.0 110.877 -177.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 25.9 m -66.7 172.85 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.892 174.247 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -132.64 144.7 50.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.5 -179.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -67.16 154.01 42.29 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.591 -178.49 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 117.25 6.1 13.98 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.201 -178.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -69.33 159.99 32.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.836 0.35 . . . . 0.0 111.162 -177.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -105.96 138.51 42.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.769 -176.235 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 77.2 t -128.09 145.1 35.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.137 0.494 . . . . 0.0 111.202 -175.436 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.513 ' HB2' ' HB3' ' A' ' 269' ' ' LYS . 36.5 m -145.02 175.54 10.15 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 172.206 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 98.7 t -116.09 122.3 69.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.917 0.389 . . . . 0.0 111.963 -174.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 60.7 t -84.57 -41.1 15.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.428 173.563 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 96.05 -152.53 20.29 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.11 177.246 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.417 HG22 ' HA ' ' A' ' 266' ' ' ASP . 1.0 OUTLIER -142.61 -60.42 0.44 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.701 0.286 . . . . 0.0 110.299 177.509 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.106 -0.949 . . . . 0.0 111.423 179.037 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.678 0 N-CA-C 112.17 -0.372 . . . . 0.0 112.17 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 26.4 m -152.21 98.93 2.47 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 2.2 mp -116.67 -176.66 3.01 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.615 -172.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 87.6 m -134.01 154.77 50.92 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.418 -176.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 41.1 t -93.87 107.26 19.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -90.49 -31.19 16.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.025 0.44 . . . . 0.0 111.194 -172.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 19.2 p -128.71 -168.45 1.92 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.194 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.61 ' HB3' HG23 ' A' ' 333' ' ' VAL . 64.9 mt-30 -108.08 122.02 41.96 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-O 120.887 0.375 . . . . 0.0 110.617 -171.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.77 106.78 2.32 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 123.014 2.476 . . . . 0.0 113.264 -176.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 236' ' ' VAL . 10.2 t -155.33 127.93 7.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.964 0.411 . . . . 0.0 111.911 176.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.652 HG12 ' HB2' ' A' ' 246' ' ' GLN . 0.9 OUTLIER -155.3 173.96 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.308 172.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 237' ' ' THR . . . . . 0.495 ' H ' HG13 ' A' ' 236' ' ' VAL . 57.1 m -20.38 112.04 0.02 OUTLIER 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.535 1.534 . . . . 0.0 114.207 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -115.61 100.85 8.35 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.087 174.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -135.61 131.52 35.94 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.129 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -98.82 -47.82 5.15 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.168 -170.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.68 -23.8 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.437 0.637 . . . . 0.0 110.078 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -100.61 1.07 40.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.296 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 51.0 50.61 18.78 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.324 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 14.7 m -122.31 101.08 7.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.336 -175.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -128.58 112.55 14.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.941 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' GLN . . . . . 0.652 ' HB2' HG12 ' A' ' 236' ' ' VAL . 50.6 mt-30 -138.75 164.62 29.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 175.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.632 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 36.8 p90 -147.02 134.64 21.01 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.244 171.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 38.6 m -100.34 137.79 38.29 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.68 143.96 22.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.317 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 18.3 m -91.22 113.37 25.61 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 160.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.575 ' HB2' HG13 ' A' ' 309' ' ' VAL . 5.1 mp -101.77 167.29 10.18 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -177.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.57 141.07 48.94 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.236 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -141.62 -143.37 4.23 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 121.227 -0.511 . . . . 0.0 111.937 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -112.15 -174.44 2.46 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -175.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.579 HG22 ' H ' ' A' ' 256' ' ' ALA . 3.0 m -67.86 173.55 4.35 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.417 -172.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.579 ' H ' HG22 ' A' ' 255' ' ' THR . . . -60.48 -176.17 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.818 0.847 . . . . 0.0 112.535 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 15.3 t 81.05 6.3 1.34 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.125 0.97 . . . . 0.0 110.619 -176.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 91.6 t -123.74 90.37 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 170.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.4 m -75.54 93.43 3.01 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.345 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 75.74 97.16 0.14 Allowed Glycine 0 N--CA 1.44 -1.068 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.068 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.658 ' HB3' HD13 ' A' ' 262' ' ' LEU . 28.5 m-85 -46.2 -58.75 3.38 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.652 0.739 . . . . 0.0 109.737 172.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.658 HD13 ' HB3' ' A' ' 261' ' ' PHE . 0.0 OUTLIER -151.88 171.32 17.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.807 177.882 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 37.9 mtmm -136.28 -166.84 1.95 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.696 0.284 . . . . 0.0 111.765 -174.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -53.46 118.87 4.19 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.397 0.618 . . . . 0.0 111.69 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 106.31 -12.15 43.82 Favored Glycine 0 C--N 1.316 -0.557 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.118 176.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' ASP . . . . . 0.453 ' CB ' ' HB2' ' A' ' 262' ' ' LEU . 40.9 m-20 -84.47 133.23 34.48 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -94.36 147.62 23.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.326 0.584 . . . . 0.0 111.149 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.5 OUTLIER -120.48 179.59 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.4 174.774 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.49 ' O ' ' HD3' ' A' ' 269' ' ' LYS . 12.8 tmtt? -134.51 102.55 5.35 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 174.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -112.51 143.77 43.11 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.534 -174.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.611 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 84.8 m -127.78 89.54 2.96 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.649 0.737 . . . . 0.0 110.297 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.446 ' HA ' ' CB ' ' A' ' 337' ' ' ASP . 2.4 t-20 . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.562 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.575 0.226 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -142.71 -135.81 0.1 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.512 -169.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 48.7 m -70.49 130.87 43.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.13 0.491 . . . . 0.0 112.031 -173.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -130.11 -169.49 2.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.029 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 54.5 m -139.85 132.63 29.09 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.497 HG13 HG21 ' A' ' 311' ' ' VAL . 64.4 t -82.16 139.89 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.33 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.38 9.64 13.4 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.493 -169.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -171.82 -172.28 0.99 Allowed 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 120.568 0.223 . . . . 0.0 111.509 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.42 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 4.4 m-20 -61.98 123.42 18.03 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.397 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.554 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -111.81 110.02 20.15 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.528 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.418 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 25.5 t-20 -80.0 132.29 35.98 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -166.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.543 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 12.8 t -106.75 95.97 6.12 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 164.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.63 -178.63 3.78 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.261 -175.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 23.3 t -60.76 -34.8 75.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.971 0.415 . . . . 0.0 111.368 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -81.9 -3.12 90.68 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.687 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 65.0 41.17 97.44 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.704 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.32 125.84 54.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.385 0.612 . . . . 0.0 109.852 175.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.575 HG13 ' HB2' ' A' ' 251' ' ' LEU . 2.0 p -127.07 94.08 2.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.946 -175.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 53.5 m -98.79 127.01 44.58 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.003 -0.435 . . . . 0.0 111.676 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.497 HG21 HG13 ' A' ' 297' ' ' VAL . 11.8 p -161.95 151.02 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 175.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 49.2 m -93.22 146.03 23.99 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.079 0.466 . . . . 0.0 110.339 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.49 ' HB2' ' CE2' ' A' ' 247' ' ' PHE . 5.7 mp -117.46 151.21 37.54 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.62 -175.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 C--N 1.319 -0.752 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.589 173.657 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.61 HG23 ' HB3' ' A' ' 233' ' ' GLN . 9.5 m . . . . . 0 N--CA 1.451 -0.386 0 CA-C-O 120.757 0.313 . . . . 0.0 110.76 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -137.52 148.17 45.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.085 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -97.71 172.75 7.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.049 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 112.73 11.64 14.19 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.444 176.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.611 ' HB3' ' O ' ' A' ' 271' ' ' THR . 4.3 m-20 -104.36 -170.77 1.82 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -176.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -114.32 157.17 23.15 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.155 0.503 . . . . 0.0 111.926 -172.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 39.0 t -134.42 145.8 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.28 -176.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 35.9 t -142.62 176.45 9.03 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 50.9 t -119.04 126.58 75.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.966 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 CA--C 1.535 0.373 0 CA-C-O 121.499 0.666 . . . . 0.0 110.979 176.875 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.604 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 23.6 m -124.32 132.03 53.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.177 0.513 . . . . 0.0 110.18 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.644 HD22 HG11 ' A' ' 309' ' ' VAL . 5.5 mt -131.3 173.36 11.14 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.576 -175.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 31.6 m -141.9 156.08 45.5 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -174.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 54.7 t -117.14 127.96 74.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 122.418 -0.177 . . . . 0.0 110.964 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.475 ' NZ ' HG23 ' A' ' 252' ' ' THR . 31.1 mtmm -112.38 -14.9 13.23 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -177.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 75.2 p -120.44 -174.09 2.72 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.23 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -106.59 106.33 57.39 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -170.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.552 ' C ' ' HB2' ' A' ' 247' ' ' PHE . 55.5 Cg_endo -69.83 103.75 1.22 Allowed 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.567 2.178 . . . . 0.0 113.6 -174.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.531 ' O ' HG23 ' A' ' 236' ' ' VAL . 15.1 t -157.93 129.32 6.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.714 170.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.604 ' N ' ' HA ' ' A' ' 247' ' ' PHE . 2.9 t -155.94 114.49 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 C-N-CA 122.827 0.451 . . . . 0.0 110.69 172.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' A' ' 245' ' ' TYR . 23.7 m 64.57 93.65 0.06 Allowed 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.228 0.537 . . . . 0.0 111.649 176.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -109.55 84.44 1.92 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -132.52 129.06 38.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.218 -175.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.22 -35.01 7.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.78 -173.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 61.5 t -62.81 -29.56 47.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.497 0.665 . . . . 0.0 109.62 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.479 ' HA ' ' HE2' ' A' ' 242' ' ' LYS . 9.8 mmpt? -96.81 -12.46 23.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.881 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 60.7 59.92 2.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.001 -1.454 . . . . 0.0 110.55 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 36.8 m -143.93 106.27 4.4 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.151 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' TYR . . . . . 0.619 ' HA ' ' O ' ' A' ' 237' ' ' THR . 59.0 m-85 -129.07 118.17 22.07 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 236' ' ' VAL . 45.0 mt-30 -130.54 -179.16 5.12 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.604 ' HA ' ' N ' ' A' ' 236' ' ' VAL . 13.0 p90 -160.26 136.8 8.89 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.238 165.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.486 ' OG1' HG21 ' A' ' 236' ' ' VAL . 32.8 m -102.66 138.41 39.6 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.461 ' HB ' ' CD1' ' A' ' 251' ' ' LEU . 0.1 OUTLIER -144.92 151.15 15.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.712 -0.795 . . . . 0.0 112.11 -178.336 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.605 HG23 ' OG1' ' A' ' 310' ' ' THR . 91.7 m -103.14 104.85 15.04 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 168.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.616 ' HB2' HG13 ' A' ' 309' ' ' VAL . 5.1 mp -102.7 167.78 9.68 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -169.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.475 HG23 ' NZ ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -114.68 151.37 33.71 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.91 172.711 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -150.97 -142.67 3.57 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 121.197 -0.525 . . . . 0.0 111.907 -173.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.584 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -107.42 -174.59 2.57 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.561 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -69.48 -177.8 1.26 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.41 -172.043 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.561 ' H ' HG22 ' A' ' 255' ' ' THR . . . -64.39 -175.98 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.825 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 49.8 m 80.24 9.05 1.36 Allowed 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.489 0.716 . . . . 0.0 111.287 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 28.6 t -126.85 90.07 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 171.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.9 m -70.9 93.76 1.01 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.892 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 73.62 98.0 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.217 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.408 ' CE1' HD21 ' A' ' 228' ' ' LEU . 6.3 m-85 -44.99 -58.67 3.02 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.816 0.817 . . . . 0.0 109.824 171.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 266' ' ' ASP . 77.8 mt -140.78 169.15 18.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.31 -1.314 . . . . 0.0 109.051 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -133.25 -167.33 1.91 Allowed 'General case' 0 C--N 1.323 -0.554 0 O-C-N 123.079 0.237 . . . . 0.0 110.502 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -59.93 116.28 4.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.286 0.565 . . . . 0.0 111.171 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 111.7 -14.37 27.09 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.547 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' ASP . . . . . 0.518 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 37.3 m-20 -81.0 128.23 33.46 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.938 0.399 . . . . 0.0 110.292 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -88.97 150.93 22.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.449 0.642 . . . . 0.0 111.759 -173.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.444 HG12 HG22 ' A' ' 341' ' ' VAL . 1.3 m -131.38 171.71 17.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.276 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.505 ' HD2' HG13 ' A' ' 342' ' ' VAL . 0.0 OUTLIER -143.77 129.21 18.99 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.2 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 270' ' ' PHE . . . . . 0.469 ' CB ' HG22 ' A' ' 339' ' ' VAL . 8.6 p90 -130.4 158.51 39.67 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.128 -174.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.687 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 93.2 m -108.7 86.89 2.37 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.163 -173.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 . . . . . 0 C--N 1.326 -0.424 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.975 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -145.29 154.25 42.15 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.07 0.462 . . . . 0.0 110.439 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 86.7 m -89.31 134.75 33.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.87 -172.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' ALA . . . . . 0.414 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -129.03 -174.19 3.19 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 80.0 m -142.48 135.36 28.34 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.554 HG13 HG21 ' A' ' 311' ' ' VAL . 58.2 t -78.31 140.53 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.832 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 4.0 m -116.31 1.57 13.09 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -161.56 176.96 10.48 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.908 -0.495 . . . . 0.0 111.517 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.93 104.96 0.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.23 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -93.22 103.42 15.69 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.797 -174.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -61.0 135.07 57.68 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -171.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.07 97.49 6.25 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 162.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.4 174.11 6.85 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.715 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 42.5 m -57.05 -33.74 67.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -77.74 -3.05 83.1 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.449 -176.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' GLY . . . . . 0.584 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 72.73 41.26 50.68 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.246 -178.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -113.37 146.25 39.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.687 0.743 . . . . 0.0 110.909 174.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.644 HG11 HD22 ' A' ' 228' ' ' LEU . 2.2 p -145.56 102.19 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.414 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.605 ' OG1' HG23 ' A' ' 250' ' ' THR . 91.0 m -102.42 124.17 47.5 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.514 -0.741 . . . . 0.0 111.032 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.554 HG21 HG13 ' A' ' 297' ' ' VAL . 14.8 p -160.15 154.31 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.134 0.493 . . . . 0.0 110.213 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 47.0 m -97.87 152.39 19.24 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.65 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.486 HD13 ' CE1' ' A' ' 247' ' ' PHE . 5.7 mp -119.89 135.19 54.98 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.632 -177.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 27.7 p . . . . . 0 C--N 1.325 -0.492 0 CA-C-O 120.807 0.337 . . . . 0.0 111.598 -175.683 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.427 HG22 ' N ' ' A' ' 334' ' ' GLU . 13.1 p . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' GLU . . . . . 0.427 ' N ' HG22 ' A' ' 333' ' ' VAL . 10.4 tp10 -119.87 147.81 44.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.978 0.418 . . . . 0.0 110.485 -175.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -85.85 173.5 9.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.213 -176.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 112.58 11.5 14.8 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.417 173.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.687 ' HB2' ' O ' ' A' ' 271' ' ' THR . 4.9 p-10 -91.05 179.87 5.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.998 0.428 . . . . 0.0 111.52 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -118.04 137.63 52.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.442 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.469 HG22 ' CB ' ' A' ' 270' ' ' PHE . 55.9 t -116.48 150.78 18.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.458 -172.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 41.9 m -146.73 173.22 12.57 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 172.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.444 HG22 HG12 ' A' ' 268' ' ' VAL . 86.1 t -117.85 132.99 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -171.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.505 HG13 ' HD2' ' A' ' 269' ' ' LYS . 32.6 m . . . . . 0 N--CA 1.465 0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 111.561 174.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 0.143 0 CA-C-O 120.899 0.166 . . . . 0.0 113.167 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 21.2 m -107.53 142.66 37.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.04 0.448 . . . . 0.0 110.72 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.677 HD22 HG11 ' A' ' 309' ' ' VAL . 20.4 mt -143.03 175.93 9.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.269 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.569 ' O ' ' HB3' ' A' ' 251' ' ' LEU . 43.6 m -131.7 152.69 50.7 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.414 0.149 . . . . 0.0 110.615 -176.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.475 HG23 HG23 ' A' ' 339' ' ' VAL . 12.2 t -100.03 127.9 52.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 176.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -110.96 -29.1 8.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.373 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.459 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 72.7 p -119.87 -169.33 1.76 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.688 0.28 . . . . 0.0 110.732 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.64 ' HB3' ' HB ' ' A' ' 333' ' ' VAL . 85.1 mt-30 -112.76 125.68 29.52 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -172.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 233' ' ' GLN . 10.0 Cg_endo -92.71 106.39 0.19 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.337 2.691 . . . . 0.0 115.728 -168.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 236' ' ' VAL . 1.2 m -157.52 133.23 9.22 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 165.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.682 ' N ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -158.24 139.6 4.92 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.807 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 176.392 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 97.7 m 69.12 108.51 0.05 Allowed 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.494 0.718 . . . . 0.0 112.635 170.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -116.31 99.81 7.46 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.437 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.53 88.31 2.79 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -83.63 -44.32 14.69 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.773 -163.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 22.8 t -66.47 -23.18 31.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.629 0.728 . . . . 0.0 109.145 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -99.87 -3.75 31.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.888 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 36.1 t70 57.39 68.85 0.8 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.35 -1.296 . . . . 0.0 111.729 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 24.4 t -152.9 119.76 5.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.513 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -129.6 128.51 42.83 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -121.8 -174.74 2.94 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.682 ' HA ' ' N ' ' A' ' 236' ' ' VAL . 1.8 p90 -156.71 125.74 5.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 174.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 52.9 m -95.41 142.29 27.96 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.485 HG13 HD11 ' A' ' 251' ' ' LEU . 7.3 p -144.07 137.92 24.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 119.786 -0.766 . . . . 0.0 112.391 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.459 ' HB ' ' CG2' ' A' ' 232' ' ' THR . 92.2 m -98.43 113.36 25.32 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 168.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.673 ' HB2' HG13 ' A' ' 309' ' ' VAL . 1.4 mp -107.85 168.68 9.1 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -175.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.76 139.4 41.24 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.187 172.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.464 ' HA2' HD23 ' A' ' 228' ' ' LEU . . . -141.86 -149.41 5.19 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.275 -175.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -96.25 -174.23 3.01 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 256' ' ' ALA . 2.8 m -77.01 175.73 9.31 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.021 -170.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.582 ' H ' HG22 ' A' ' 255' ' ' THR . . . -65.03 -176.39 0.28 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.446 0.698 . . . . 0.0 112.275 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 24.8 t 80.2 6.97 1.62 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.834 0.854 . . . . 0.0 110.517 -176.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 24.0 t -123.37 90.71 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 170.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 5.6 m -73.44 92.45 1.86 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.654 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.622 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 80.77 94.2 0.43 Allowed Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.958 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.487 ' CZ ' HD21 ' A' ' 228' ' ' LEU . 4.1 m-85 -43.5 -55.35 4.28 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 169.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.8 pp -165.51 173.85 10.55 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.568 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 60.3 mttp -143.23 -166.32 2.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.997 0.427 . . . . 0.0 111.836 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -53.54 122.74 10.38 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.162 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 109.92 -16.01 30.89 Favored Glycine 0 C--N 1.313 -0.718 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.7 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -84.35 139.43 32.28 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' GLN . . . . . 0.587 ' HB2' HG11 ' A' ' 342' ' ' VAL . 27.5 mt-30 -107.91 151.92 25.13 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.389 0.614 . . . . 0.0 110.765 -178.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.4 OUTLIER -132.4 176.18 9.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.397 -179.24 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.405 ' HE2' HG23 ' A' ' 342' ' ' VAL . 3.2 mptp? -123.64 143.24 50.37 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 172.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' PHE . . . . . 0.497 ' CE2' ' HB2' ' A' ' 295' ' ' ALA . 17.2 p90 -136.68 142.5 43.16 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 173.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 25.7 p -150.17 109.69 4.01 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.876 -174.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.561 HD22 ' HG3' ' A' ' 334' ' ' GLU . 24.1 p-10 . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 121.555 0.693 . . . . 0.0 111.802 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 120.196 0.046 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -161.71 -144.16 0.09 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 -168.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 56.0 m -74.77 137.04 41.71 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -175.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' ALA . . . . . 0.497 ' HB2' ' CE2' ' A' ' 270' ' ' PHE . . . -124.92 172.4 9.41 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 173.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 87.1 m -134.21 129.54 35.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.473 0.654 . . . . 0.0 112.474 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.596 HG12 ' H ' ' A' ' 299' ' ' ALA . 93.3 t -89.87 140.69 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.047 -177.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 1.9 m -125.06 23.86 7.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.009 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.596 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -156.29 -177.25 6.45 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.421 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 2.6 m-20 -76.83 165.57 24.52 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.775 -174.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.622 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -147.5 155.61 42.05 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.688 -175.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -128.99 133.1 47.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.263 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.529 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.8 OUTLIER -111.51 95.45 5.51 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 164.141 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.15 169.37 8.48 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.554 -0.459 . . . . 0.0 110.444 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 67.0 m -57.95 -30.3 65.87 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -76.85 7.51 34.17 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.622 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 59.89 41.88 97.94 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.219 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -121.78 117.98 27.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.316 0.558 . . . . 0.0 111.242 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.677 HG11 HD22 ' A' ' 228' ' ' LEU . 2.6 p -125.42 125.42 68.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.982 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 86.2 m -120.21 135.67 54.9 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 121.729 -0.607 . . . . 0.0 111.249 -177.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.548 ' CG1' ' HB2' ' A' ' 301' ' ' ALA . 6.6 m -146.76 165.21 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.143 0.497 . . . . 0.0 110.445 175.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 28.3 m -121.95 136.32 54.92 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.691 173.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 4.2 mp -112.8 158.93 19.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.999 -173.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 14.3 m . . . . . 0 C--N 1.322 -0.626 0 CA-C-O 120.863 0.363 . . . . 0.0 111.561 -176.455 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.64 ' HB ' ' HB3' ' A' ' 233' ' ' GLN . 28.8 m . . . . . 0 C--O 1.235 0.311 0 CA-C-O 121.991 0.901 . . . . 0.0 112.962 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' GLU . . . . . 0.561 ' HG3' HD22 ' A' ' 272' ' ' ASN . 1.0 OUTLIER -109.19 145.74 35.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.402 -178.533 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -99.97 156.29 17.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.653 174.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 106.86 8.89 31.32 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.487 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.455 ' HB3' ' CG2' ' A' ' 230' ' ' VAL . 10.6 t70 -66.01 150.45 48.65 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.781 0.324 . . . . 0.0 110.854 178.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -98.52 112.64 24.61 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.475 HG23 HG23 ' A' ' 230' ' ' VAL . 57.4 t -97.09 148.85 5.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.387 0.613 . . . . 0.0 111.654 -170.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 65.5 m -143.67 171.58 13.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.762 173.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 24.1 t -119.25 141.85 37.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.587 HG11 ' HB2' ' A' ' 267' ' ' GLN . 8.4 p . . . . . 0 N--CA 1.464 0.241 0 CA-C-O 121.085 0.469 . . . . 0.0 110.555 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.793 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 20.8 m -152.36 96.22 2.14 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 175.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.461 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 4.0 mp -122.73 -179.25 4.17 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.889 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 48.3 m -134.34 162.72 31.41 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.529 -175.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 94.4 t -108.24 130.88 60.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.497 ' HB2' HG23 ' A' ' 252' ' ' THR . 27.2 tptp -108.53 -15.21 14.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.874 0.369 . . . . 0.0 111.482 -173.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 20.6 p -138.44 -169.54 2.62 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.206 -173.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.458 ' HB3' ' HB ' ' A' ' 333' ' ' VAL . 74.7 mt-30 -105.02 118.24 56.6 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.248 -172.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.78 106.15 1.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.716 2.277 . . . . 0.0 111.997 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 236' ' ' VAL . 10.9 t -154.88 124.06 6.33 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.575 -0.45 . . . . 0.0 112.095 -178.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.73 HG12 ' HB2' ' A' ' 246' ' ' GLN . 1.1 t -154.05 168.89 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.606 171.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' THR . . . . . 0.482 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 74.6 m -14.73 112.96 0.02 OUTLIER 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.725 1.61 . . . . 0.0 114.472 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -106.41 88.57 2.81 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 172.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -125.89 139.32 53.56 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.366 0.603 . . . . 0.0 110.236 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.22 -44.58 4.52 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.558 -173.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 63.1 t -61.04 -36.71 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.263 0.554 . . . . 0.0 110.167 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -88.14 -5.48 58.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.316 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 22.4 t70 50.91 67.45 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.036 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.5 m -144.75 100.89 3.58 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.589 -175.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -121.49 100.89 7.28 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' GLN . . . . . 0.73 ' HB2' HG12 ' A' ' 236' ' ' VAL . 80.0 mt-30 -127.6 178.97 5.76 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.629 -171.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.64 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 2.1 p90 -156.64 125.63 5.97 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 19.5 m -95.4 134.53 38.1 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.461 ' HB ' ' CD1' ' A' ' 251' ' ' LEU . 0.2 OUTLIER -141.95 146.71 22.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.676 -178.677 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.478 HG23 ' OG1' ' A' ' 310' ' ' THR . 95.2 m -96.69 112.79 24.4 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 164.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.599 ' HB2' HG13 ' A' ' 309' ' ' VAL . 5.3 mp -102.46 169.16 8.84 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -176.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.497 HG23 ' HB2' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -127.57 108.69 11.0 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.68 0.276 . . . . 0.0 111.628 -177.466 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.491 ' N ' HG12 ' A' ' 309' ' ' VAL . . . -147.39 135.81 5.8 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 177.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.421 ' HB2' ' HA2' ' A' ' 307' ' ' GLY . . . -108.34 93.98 4.82 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -172.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.483 ' HB ' ' OG ' ' A' ' 303' ' ' SER . 10.1 m -126.29 118.97 26.21 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 170.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -73.04 136.82 45.05 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 70.8 m 59.89 55.58 3.8 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.119 174.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.471 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 94.6 t -131.74 95.37 2.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.25 0.548 . . . . 0.0 109.858 174.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 27.4 m -74.15 97.63 2.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.143 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 71.23 99.7 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.844 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.51 ' CE2' ' HB2' ' A' ' 303' ' ' SER . 11.6 m-85 -48.02 -59.18 3.56 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.324 0.583 . . . . 0.0 110.34 170.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.424 HD11 HG13 ' A' ' 341' ' ' VAL . 61.3 mt -143.57 173.52 11.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.537 -173.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -130.7 -169.86 2.23 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.818 0.342 . . . . 0.0 111.172 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -57.95 114.05 2.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.563 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 111.14 -1.6 28.33 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.846 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' ASP . . . . . 0.409 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 13.0 m-20 -87.59 145.32 26.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.704 0.252 . . . . 0.0 110.556 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -102.23 149.23 24.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.48 0.657 . . . . 0.0 111.124 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.666 HG23 ' HB3' ' A' ' 295' ' ' ALA . 0.1 OUTLIER -132.22 174.33 13.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.542 178.357 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' A' ' 293' ' ' PHE . 5.6 mptp? -110.23 135.83 50.38 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 172.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' PHE . . . . . 0.679 ' O ' ' HA ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -142.65 105.87 4.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.806 0.812 . . . . 0.0 110.566 178.887 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.588 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 31.4 m -81.15 86.06 6.24 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 . . . . . 0 C--N 1.319 -0.744 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.93 -170.068 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 292' ' ' SER . . . . . 0.437 ' HB2' ' H ' ' A' ' 293' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.138 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' PHE . . . . . 0.679 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 2.2 p90 -109.77 88.36 2.73 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -166.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 92.3 m -151.63 112.03 4.15 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 122.061 -0.4 . . . . 0.0 110.975 175.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' ALA . . . . . 0.666 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -131.35 -177.1 4.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.555 0.217 . . . . 0.0 111.197 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 7.5 m -143.39 131.56 21.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.876 0.846 . . . . 0.0 113.061 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.552 HG13 HG21 ' A' ' 311' ' ' VAL . 63.2 t -76.75 141.55 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 113.551 -1.658 . . . . 0.0 111.135 -178.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 15.1 m -110.35 -14.23 14.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -176.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -162.03 -175.63 4.74 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 122.158 -0.339 . . . . 0.0 111.266 -177.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -59.15 113.99 2.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.029 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.45 ' HB2' ' HB ' ' A' ' 311' ' ' VAL . . . -94.87 101.5 13.3 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.476 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 309' ' ' VAL . 5.1 m-20 -58.55 127.3 31.49 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.708 -174.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.51 ' HB2' ' CE2' ' A' ' 261' ' ' PHE . 30.2 t -114.97 113.39 24.06 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 120.73 0.3 . . . . 0.0 111.267 172.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -127.16 152.21 47.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 170.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 10.8 t -74.72 -4.31 36.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.712 -172.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -68.63 -11.46 62.56 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 172.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' GLY . . . . . 0.421 ' HA2' ' HB2' ' A' ' 254' ' ' ALA . . . 92.55 37.12 5.93 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.067 -0.567 . . . . 0.0 113.384 176.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -125.81 141.9 51.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 117.225 0.513 . . . . 0.0 111.407 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 302' ' ' ASN . 1.6 p -152.24 100.37 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.16 174.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.478 ' OG1' HG23 ' A' ' 250' ' ' THR . 63.8 m -93.15 129.83 39.02 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.521 -0.737 . . . . 0.0 110.824 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.552 HG21 HG13 ' A' ' 297' ' ' VAL . 2.1 p -157.61 141.92 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 54.7 m -94.48 147.67 23.02 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.047 0.451 . . . . 0.0 110.122 175.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.441 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.0 mp -131.54 170.82 14.19 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.717 -174.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 246' ' ' GLN . 29.8 p . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.066 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.493 HG12 ' H ' ' A' ' 334' ' ' GLU . 2.9 t . . . . . 0 CA--C 1.529 0.165 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' GLU . . . . . 0.493 ' H ' HG12 ' A' ' 333' ' ' VAL . 33.7 tt0 -115.11 134.83 54.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.683 0.277 . . . . 0.0 111.118 -174.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -97.85 173.06 7.27 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.674 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 117.73 1.97 17.14 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.432 -0.89 . . . . 0.0 113.879 170.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 271' ' ' THR . 10.7 p-10 -79.47 173.01 13.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.079 0.439 . . . . 0.0 111.484 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -110.84 148.7 31.85 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.255 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.562 HG21 HD23 ' A' ' 251' ' ' LEU . 73.9 t -127.28 150.74 33.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.841 0.353 . . . . 0.0 111.82 -169.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.539 ' HB3' ' HB2' ' A' ' 269' ' ' LYS . 31.0 t -151.74 178.03 9.79 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 175.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.424 HG13 HD11 ' A' ' 262' ' ' LEU . 58.9 t -119.19 144.03 28.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 122.338 -0.226 . . . . 0.0 110.971 -176.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 50.7 t . . . . . 0 CA--C 1.523 -0.073 0 CA-C-O 121.061 0.457 . . . . 0.0 110.037 174.355 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.109 0 N-CA-C 112.618 -0.193 . . . . 0.0 112.618 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 23.7 m -136.34 136.56 39.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.978 0.418 . . . . 0.0 110.705 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.511 ' HB2' ' CG1' ' A' ' 339' ' ' VAL . 1.2 mp -139.51 175.75 9.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.752 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 24.7 m -130.63 160.24 34.81 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.521 HG23 HG23 ' A' ' 339' ' ' VAL . 73.8 t -118.42 147.01 22.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 122.304 -0.248 . . . . 0.0 110.692 174.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -117.6 -19.02 9.56 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 39.6 p -124.7 -167.61 1.69 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.47 ' HB3' HG23 ' A' ' 333' ' ' VAL . 83.2 mt-30 -112.7 131.01 22.9 Favored Pre-proline 0 C--N 1.316 -0.881 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -173.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.412 ' HA ' HG22 ' A' ' 249' ' ' VAL . 35.2 Cg_endo -66.95 104.04 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.06 1.84 . . . . 0.0 111.545 177.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 5.0 t -154.91 116.86 4.16 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.416 0.627 . . . . 0.0 111.778 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.71 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.5 174.42 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 168.404 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 237' ' ' THR . . . . . 0.505 ' H ' HG13 ' A' ' 236' ' ' VAL . 66.9 m -37.62 110.03 0.11 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -174.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -112.18 83.96 1.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.042 170.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -110.96 132.86 53.85 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.39 -39.91 5.75 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.733 -170.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.45 -27.21 42.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.471 0.653 . . . . 0.0 109.938 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -96.33 -13.93 22.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.837 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 60.45 68.46 0.76 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.471 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 41.7 m -149.08 100.86 3.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.36 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -116.84 109.74 17.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.551 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' GLN . . . . . 0.452 ' HB2' HG12 ' A' ' 236' ' ' VAL . 0.5 OUTLIER -131.41 161.44 32.44 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 172.445 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.71 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 0.7 OUTLIER -160.12 133.67 7.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.471 0.176 . . . . 0.0 111.109 179.056 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 48.2 m -108.47 143.1 37.89 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 122.35 -0.218 . . . . 0.0 110.506 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.517 HG23 ' CD2' ' A' ' 313' ' ' LEU . 0.4 OUTLIER -146.09 148.36 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.923 178.612 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.593 HG23 ' OG1' ' A' ' 310' ' ' THR . 28.2 m -97.68 114.47 26.44 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 169.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 309' ' ' VAL . 4.9 mp -109.81 164.79 12.24 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 -175.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.83 140.42 52.95 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -135.22 -143.32 4.73 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.388 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.512 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -108.75 -176.5 3.06 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.981 0.419 . . . . 0.0 112.102 -177.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.597 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.6 OUTLIER -68.94 -179.54 1.51 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.146 -171.517 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.597 ' H ' HG22 ' A' ' 255' ' ' THR . . . -60.49 -177.39 0.07 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.233 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 46.9 m 79.48 6.19 2.01 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.734 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 10.9 t -124.29 89.51 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.799 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 171.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 11.6 m -73.22 98.38 2.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.831 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 61.84 98.82 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.842 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -43.1 -56.36 3.41 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.827 0.346 . . . . 0.0 111.139 173.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.54 167.08 23.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.928 -177.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.432 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 48.6 mtmt -137.25 -166.34 1.91 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -176.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -46.68 116.09 1.23 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.983 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 117.5 -10.53 14.45 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.092 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -101.96 138.6 38.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.951 0.405 . . . . 0.0 110.829 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' GLN . . . . . 0.401 ' HB2' HG11 ' A' ' 342' ' ' VAL . 2.9 mp0 -107.24 153.43 22.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.32 0.581 . . . . 0.0 110.191 -176.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.624 HG23 ' HB3' ' A' ' 295' ' ' ALA . 1.7 m -133.97 168.2 24.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 176.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.32 135.27 32.03 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.067 170.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' PHE . . . . . 0.608 ' HB3' ' HA ' ' A' ' 339' ' ' VAL . 35.1 p90 -147.64 167.39 24.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.83 -0.168 . . . . 0.0 111.21 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 1.8 t -158.24 119.06 3.4 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.379 0.609 . . . . 0.0 112.19 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.561 ' HB2' ' CA ' ' A' ' 337' ' ' ASP . 51.0 t30 . . . . . 0 C--N 1.324 -0.509 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 160.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 30.4 p . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -127.11 137.19 52.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.099 0.476 . . . . 0.0 110.101 175.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 85.7 m -82.45 136.32 34.95 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.886 -174.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' ALA . . . . . 0.624 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -114.85 177.04 4.79 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.877 176.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 7.2 m -141.02 114.14 8.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.457 0.646 . . . . 0.0 111.398 177.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 67.3 t -75.51 131.77 34.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.013 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 8.4 p -123.31 24.35 8.76 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.101 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -152.4 164.39 37.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.027 0.442 . . . . 0.0 111.983 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.432 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 2.3 m-20 -60.41 112.47 1.97 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.974 176.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -92.66 175.54 6.78 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.032 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.588 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 3.3 t-20 -149.46 122.34 8.74 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -168.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.4 94.87 5.32 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 163.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -96.23 -178.53 4.35 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.005 -174.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 25.5 m -58.66 -33.06 69.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.871 0.367 . . . . 0.0 111.647 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -82.03 -5.8 89.41 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.146 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 67.47 42.46 89.04 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.114 -176.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -116.62 132.27 56.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.78 0.79 . . . . 0.0 111.343 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.588 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.5 OUTLIER -135.06 102.58 3.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.945 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.593 ' OG1' HG23 ' A' ' 250' ' ' THR . 95.3 m -107.66 113.89 27.49 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.774 -0.579 . . . . 0.0 110.533 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 27.5 m -143.06 157.6 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-O 121.545 0.688 . . . . 0.0 110.698 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 26.3 m -109.02 148.24 31.08 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.224 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.573 HD22 ' N ' ' A' ' 313' ' ' LEU . 0.8 OUTLIER -112.23 135.01 53.43 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.237 -176.145 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 41.5 m . . . . . 0 C--N 1.316 -0.875 0 C-N-CA 119.738 -0.785 . . . . 0.0 112.621 -171.794 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 233' ' ' GLN . 16.6 m . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.761 0.315 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -115.41 152.14 33.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.566 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -90.61 126.04 35.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.24 -175.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 336' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 230' ' ' VAL . . . 129.38 13.13 2.39 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.083 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.561 ' CA ' ' HB2' ' A' ' 272' ' ' ASN . 3.0 m-20 -49.03 134.65 16.97 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.92 105.67 3.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.302 168.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.608 ' HA ' ' HB3' ' A' ' 270' ' ' PHE . 75.7 t -95.04 139.16 19.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.399 0.619 . . . . 0.0 111.888 -173.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 41.2 m -147.82 157.28 43.46 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.059 172.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 20.8 t -87.76 151.24 3.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.401 HG11 ' HB2' ' A' ' 267' ' ' GLN . 8.9 p . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.566 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.514 0 N-CA-C 112.719 -0.153 . . . . 0.0 112.719 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 8.3 m -79.15 140.03 37.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.811 0.338 . . . . 0.0 110.493 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.518 HD23 ' HA3' ' A' ' 253' ' ' GLY . 1.8 mp -132.7 177.41 7.64 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 252' ' ' THR . 82.0 m -128.75 159.95 34.06 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.636 0.255 . . . . 0.0 110.853 -174.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 41.8 t -110.05 138.39 38.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 43.3 tttm -111.34 -34.62 6.08 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.388 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 76.3 p -119.91 -169.46 1.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.523 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.532 ' HB3' HG13 ' A' ' 333' ' ' VAL . 87.4 mt-30 -112.37 120.8 40.62 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 120.512 0.196 . . . . 0.0 111.235 -167.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.661 ' HB3' ' CD1' ' A' ' 247' ' ' PHE . 88.9 Cg_exo -51.1 102.68 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.172 2.581 . . . . 0.0 113.313 175.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 236' ' ' VAL . 8.7 t -158.38 113.98 2.67 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 174.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.565 HG12 ' HB2' ' A' ' 246' ' ' GLN . 7.9 t -154.01 125.05 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 120.915 0.388 . . . . 0.0 110.889 169.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 26.5 m 48.15 89.53 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 123.82 0.848 . . . . 0.0 111.906 177.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -99.05 89.09 4.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.332 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -111.07 114.91 28.54 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 175.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -94.78 -50.39 5.17 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -168.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 49.0 t -65.45 -23.27 32.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.306 0.574 . . . . 0.0 110.129 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -96.02 -8.43 33.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.231 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 14.9 t70 55.41 69.61 0.72 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.955 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 17.8 m -145.2 105.11 4.02 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.819 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -129.84 122.43 28.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.847 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' GLN . . . . . 0.565 ' HB2' HG12 ' A' ' 236' ' ' VAL . 0.3 OUTLIER -120.73 -176.9 3.34 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 172.908 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.661 ' CD1' ' HB3' ' A' ' 234' ' ' PRO . 1.2 p90 -166.41 126.81 1.66 Allowed 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 119.969 -0.692 . . . . 0.0 112.793 174.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 37.2 m -99.75 131.25 45.85 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.403 HG22 ' HA ' ' A' ' 234' ' ' PRO . 19.4 t -138.67 141.9 35.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 119.609 -0.836 . . . . 0.0 112.111 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.441 HG23 ' OG1' ' A' ' 310' ' ' THR . 98.3 m -94.08 115.83 28.19 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.556 ' HB2' HG13 ' A' ' 309' ' ' VAL . 5.2 mp -104.18 166.27 10.51 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -177.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' A' ' 229' ' ' THR . 0.7 OUTLIER -134.88 99.81 4.41 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.802 0.334 . . . . 0.0 111.34 -176.203 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.518 ' HA3' HD23 ' A' ' 228' ' ' LEU . . . -137.59 140.26 11.14 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.304 -0.719 . . . . 0.0 111.304 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -110.93 92.75 4.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.092 0.472 . . . . 0.0 112.081 -172.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 38.7 m -125.82 106.77 9.92 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.273 171.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' A' ' 305' ' ' SER . . . -63.16 141.47 58.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -175.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 6.0 t 61.72 53.32 3.24 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.92 171.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 49.0 t -137.45 103.84 2.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.164 0.507 . . . . 0.0 110.009 174.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 36.2 m -79.11 87.75 4.86 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.401 0.619 . . . . 0.0 110.299 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 94.4 92.98 1.64 Allowed Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.384 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.743 ' CE1' ' HB3' ' A' ' 303' ' ' SER . 3.0 m-85 -45.2 -59.26 2.73 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.324 0.583 . . . . 0.0 111.557 172.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.76 HD11 ' HB2' ' A' ' 266' ' ' ASP . 2.8 tm? -166.8 140.51 3.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.679 -166.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -125.94 -171.2 2.33 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -51.89 131.49 31.06 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.084 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 122.32 -32.23 4.59 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.513 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' ASP . . . . . 0.76 ' HB2' HD11 ' A' ' 262' ' ' LEU . 9.5 m-20 -108.07 154.49 21.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.005 0.431 . . . . 0.0 110.449 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' GLN . . . . . 0.534 ' HB2' HG11 ' A' ' 342' ' ' VAL . 44.4 mt-30 -115.04 161.97 17.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.43 0.633 . . . . 0.0 111.44 -173.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.61 HG23 ' HB3' ' A' ' 295' ' ' ALA . 0.4 OUTLIER -126.18 -175.46 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.205 178.297 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.454 ' HD2' ' C ' ' A' ' 269' ' ' LYS . 2.5 tmmm? -148.54 134.71 19.31 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -146.66 148.1 31.7 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 118.779 -1.169 . . . . 0.0 112.258 176.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 81.0 p -95.83 111.44 23.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.569 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.479 ' HA ' ' OD1' ' A' ' 337' ' ' ASP . 25.7 p-10 . . . . . 0 C--N 1.323 -0.58 0 CA-C-O 121.027 0.442 . . . . 0.0 110.877 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 32.2 m . . . . . 0 N--CA 1.448 -0.574 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -161.05 162.29 31.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.472 0.653 . . . . 0.0 111.443 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 268' ' ' VAL . 98.1 m -88.86 127.15 35.62 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.607 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 295' ' ' ALA . . . . . 0.61 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -108.47 175.91 5.3 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 45.0 m -135.32 123.35 22.77 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.816 HG13 HG21 ' A' ' 311' ' ' VAL . 91.0 t -77.72 124.97 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.872 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 312' ' ' THR . 15.0 t -132.77 17.95 4.24 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.303 -170.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -152.78 -173.32 4.53 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.146 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -70.94 139.68 50.73 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.186 0.517 . . . . 0.0 109.717 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.575 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -136.17 167.6 20.96 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.742 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -140.25 157.6 45.32 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.091 -177.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.743 ' HB3' ' CE1' ' A' ' 261' ' ' PHE . 0.0 OUTLIER -139.18 96.01 3.04 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.422 174.546 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 304' ' ' ASP . . . . . 0.421 ' OD2' ' HB2' ' A' ' 308' ' ' ASP . 2.0 p-10 -108.7 153.65 23.14 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 171.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' SER . . . . . 0.522 ' HB3' ' HB2' ' A' ' 256' ' ' ALA . 0.1 OUTLIER -68.65 -7.61 34.79 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -171.476 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -75.31 -4.68 74.67 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 175.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 86.46 42.85 6.38 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.933 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.421 ' HB2' ' OD2' ' A' ' 304' ' ' ASP . 3.9 m-20 -125.21 137.05 54.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.69 0.745 . . . . 0.0 112.119 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 251' ' ' LEU . 1.2 p -154.97 106.33 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.175 174.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.441 ' OG1' HG23 ' A' ' 250' ' ' THR . 54.5 m -106.44 130.28 54.27 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 121.16 -0.962 . . . . 0.0 111.431 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.816 HG21 HG13 ' A' ' 297' ' ' VAL . 7.1 p -159.55 147.43 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.131 0.491 . . . . 0.0 110.549 174.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 52.8 m -86.31 150.1 24.58 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.06 174.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.529 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.2 mp -126.05 164.83 19.99 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.284 -177.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.754 179.57 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.532 HG13 ' HB3' ' A' ' 233' ' ' GLN . 6.8 p . . . . . 0 CA--C 1.533 0.299 0 CA-C-O 120.569 0.224 . . . . 0.0 110.718 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -118.59 144.41 46.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.685 -174.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -100.58 151.98 20.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.401 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 112.45 12.08 14.0 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.391 173.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.479 ' OD1' ' HA ' ' A' ' 272' ' ' ASN . 10.8 m-20 -71.73 168.92 16.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.056 0.455 . . . . 0.0 111.463 -177.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -98.97 122.36 42.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.535 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.482 HG21 HD23 ' A' ' 251' ' ' LEU . 49.6 t -100.79 145.36 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.248 0.547 . . . . 0.0 111.773 -172.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 53.7 m -151.22 179.07 8.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.186 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 29.6 t -111.96 143.69 21.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.534 HG11 ' HB2' ' A' ' 267' ' ' GLN . 9.7 p . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 120.976 0.417 . . . . 0.0 110.88 -175.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 112.857 -0.097 . . . . 0.0 112.857 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 87.2 m -129.38 131.28 46.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 2.4 mp -136.87 -178.36 5.16 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 60.9 m -128.4 153.78 46.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.765 0.317 . . . . 0.0 111.532 -171.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.465 ' CG2' HG23 ' A' ' 339' ' ' VAL . 22.0 t -110.53 133.0 57.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.487 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -125.22 12.09 8.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.824 0.345 . . . . 0.0 111.591 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.4 p -144.61 -172.0 3.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.596 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.716 ' OE1' ' HB2' ' A' ' 335' ' ' ALA . 1.3 mm100 -114.03 134.39 22.17 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -174.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.476 ' HB3' ' CG ' ' A' ' 247' ' ' PHE . 28.4 Cg_exo -61.95 104.97 0.35 Allowed 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.224 1.95 . . . . 0.0 111.454 173.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.422 ' O ' HG23 ' A' ' 236' ' ' VAL . 5.8 t -156.02 103.86 2.24 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.675 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.75 173.41 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.139 0.575 . . . . 0.0 110.561 170.559 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 237' ' ' THR . . . . . 0.548 ' H ' HG13 ' A' ' 236' ' ' VAL . 45.5 m -23.13 115.76 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.467 1.507 . . . . 0.0 114.521 -174.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -111.91 83.58 1.81 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.759 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.482 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 4.5 t30 -103.34 99.65 9.5 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -175.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -86.5 -47.94 8.83 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -163.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 37.7 t -65.88 -23.26 31.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.7 0.762 . . . . 0.0 109.313 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.482 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 28.0 mmmt -93.75 -7.47 43.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.16 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 54.83 58.98 4.35 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.424 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 19.8 m -136.83 102.86 5.01 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.62 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -120.73 116.62 25.62 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' GLN . . . . . 0.479 ' HB2' HG12 ' A' ' 236' ' ' VAL . 86.7 mt-30 -133.61 158.74 42.43 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 177.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.675 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 3.6 p90 -140.83 138.66 34.17 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.101 172.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 54.3 m -97.25 135.89 38.54 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 42.3 t -142.43 141.61 27.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.715 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.481 HG23 ' OG1' ' A' ' 310' ' ' THR . 90.8 m -88.08 113.83 24.1 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 168.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 309' ' ' VAL . 4.9 mp -104.34 163.95 12.07 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -176.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.9 140.87 52.53 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -139.3 -143.07 4.35 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.289 -175.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -106.02 -174.51 2.55 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -174.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.587 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.6 OUTLIER -71.51 -178.54 2.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.733 -172.088 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.587 ' H ' HG22 ' A' ' 255' ' ' THR . . . -62.41 -176.9 0.12 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.123 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 15.6 t 80.77 7.5 1.32 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.991 0.917 . . . . 0.0 110.559 -175.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 21.2 t -126.25 89.52 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-O 121.562 0.696 . . . . 0.0 109.216 170.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 31.2 m -74.37 99.66 3.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.426 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 67.16 94.48 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.455 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -43.42 -59.32 2.18 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 111.427 174.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 266' ' ' ASP . 95.9 mt -148.49 162.68 39.13 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 9.6 mtpm? -137.22 -167.26 2.07 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.625 0.231 . . . . 0.0 111.625 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -53.33 113.32 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.273 0.558 . . . . 0.0 111.86 -175.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 109.93 -17.74 29.57 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.553 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 30.2 m-20 -77.52 144.81 37.38 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' GLN . . . . . 0.63 ' HB2' HG11 ' A' ' 342' ' ' VAL . 35.4 mt-30 -111.98 154.57 25.1 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.619 0.723 . . . . 0.0 111.192 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 295' ' ' ALA . 0.0 OUTLIER -121.98 -176.65 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.623 178.829 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 340' ' ' SER . 16.8 tppt? -125.29 89.02 2.98 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.719 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' PHE . . . . . 0.457 ' HB3' ' CE1' ' A' ' 293' ' ' PHE . 6.8 t80 -81.73 128.33 33.87 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -171.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.456 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 85.7 m -119.25 87.4 2.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.046 0.45 . . . . 0.0 109.855 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.478 ' HA ' ' HB2' ' A' ' 337' ' ' ASP . 22.6 t-20 . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.222 -175.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 120.922 0.391 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 293' ' ' PHE . . . . . 0.457 ' CE1' ' HB3' ' A' ' 270' ' ' PHE . 13.0 p90 -140.69 161.0 38.81 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 46.4 m -88.48 111.41 21.79 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.831 0.348 . . . . 0.0 110.551 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' ALA . . . . . 0.458 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -97.6 -178.16 4.04 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.583 ' O ' ' HA ' ' A' ' 313' ' ' LEU . 93.2 m -136.96 131.85 33.56 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -174.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.53 HG13 HG21 ' A' ' 311' ' ' VAL . 67.3 t -78.5 131.49 34.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.703 174.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 312' ' ' THR . 6.9 t -111.41 2.35 17.5 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.757 -0.777 . . . . 0.0 112.723 -167.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -170.55 -166.49 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.776 -178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.92 144.54 27.89 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.508 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -137.59 173.58 11.51 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.854 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.676 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 26.2 t-20 -146.34 128.7 15.86 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -169.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.453 ' HB2' ' HB ' ' A' ' 258' ' ' VAL . 0.3 OUTLIER -117.87 95.12 4.78 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 165.7 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -104.04 -177.21 3.3 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.925 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 39.1 m -60.88 -30.98 70.48 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.708 0.289 . . . . 0.0 111.425 -177.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -77.61 0.94 68.54 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.207 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 56.32 41.58 87.52 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.408 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -116.38 127.89 55.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.696 0.748 . . . . 0.0 111.005 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.676 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.4 OUTLIER -135.34 104.45 4.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.344 -179.398 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.481 ' OG1' HG23 ' A' ' 250' ' ' THR . 94.6 m -105.35 121.09 43.16 Favored 'General case' 0 C--N 1.316 -0.858 0 O-C-N 121.865 -0.522 . . . . 0.0 110.776 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.53 HG21 HG13 ' A' ' 297' ' ' VAL . 7.7 p -157.65 150.26 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 121.089 0.471 . . . . 0.0 110.006 176.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 58.1 m -85.54 151.95 23.54 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.265 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' A' ' 296' ' ' THR . 5.9 mp -114.53 135.47 54.09 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.747 -177.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 314' ' ' SER . . . . . 0.433 ' HA ' ' HG2' ' A' ' 246' ' ' GLN . 14.1 p . . . . . 0 C--N 1.324 -0.505 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -174.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 13.2 t . . . . . 0 CA--C 1.537 0.471 0 CA-C-O 121.012 0.434 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -97.25 144.54 26.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.493 -165.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.716 ' HB2' ' OE1' ' A' ' 233' ' ' GLN . . . -98.84 172.24 7.56 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.878 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 96.71 9.92 55.9 Favored Glycine 0 CA--C 1.511 -0.205 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.086 171.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.478 ' HB2' ' HA ' ' A' ' 272' ' ' ASN . 12.5 p-10 -88.43 -176.11 5.21 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.831 0.348 . . . . 0.0 110.854 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -120.16 145.76 46.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.438 0.637 . . . . 0.0 111.803 -171.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 79.4 t -108.63 150.23 11.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.973 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.516 ' HB2' ' HB3' ' A' ' 269' ' ' LYS . 69.3 m -144.89 176.7 9.27 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 174.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.413 HG13 HD11 ' A' ' 262' ' ' LEU . 44.6 t -117.94 140.39 41.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.63 HG11 ' HB2' ' A' ' 267' ' ' GLN . 5.3 p . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.83 0.348 . . . . 0.0 110.692 -175.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.412 0 N-CA-C 112.341 -0.304 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 19.3 m -75.04 143.86 43.29 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.958 0.408 . . . . 0.0 111.031 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.448 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.1 mp -135.21 -178.74 5.24 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 70.8 m -130.24 150.43 51.49 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.885 0.374 . . . . 0.0 111.894 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.81 106.68 19.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -93.09 -16.92 24.42 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.972 0.415 . . . . 0.0 111.207 -173.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 32.1 p -130.84 -169.15 2.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.757 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.517 ' HB3' HG23 ' A' ' 333' ' ' VAL . 70.6 mt-30 -105.61 120.49 49.15 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.048 -170.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.527 ' HA ' HG22 ' A' ' 249' ' ' VAL . 15.0 Cg_exo -66.5 105.61 0.93 Allowed 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.378 2.052 . . . . 0.0 111.618 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 8.0 t -154.67 121.84 5.61 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.66 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -155.14 174.02 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 166.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 237' ' ' THR . . . . . 0.532 ' H ' HG13 ' A' ' 236' ' ' VAL . 62.9 m -23.78 110.07 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.88 1.272 . . . . 0.0 114.226 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -103.69 108.87 20.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.487 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.424 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 5.3 t30 -122.79 94.82 4.4 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -83.45 -50.12 8.62 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.08 -162.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 40.3 t -62.49 -23.1 31.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.662 0.744 . . . . 0.0 109.688 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.424 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 13.9 mmmm -96.18 -7.44 35.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.033 -178.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 60.28 57.5 2.89 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.684 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 11.7 t -139.95 112.9 8.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.907 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -129.52 110.12 11.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.591 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' GLN . . . . . 0.657 ' HB2' HG12 ' A' ' 236' ' ' VAL . 0.7 OUTLIER -114.65 165.93 12.26 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 173.618 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.66 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 1.7 p90 -157.65 125.98 5.53 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 51.9 m -94.17 133.07 38.07 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.527 HG22 ' HA ' ' A' ' 234' ' ' PRO . 0.8 OUTLIER -141.12 142.92 28.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 119.182 -1.007 . . . . 0.0 112.231 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.518 HG23 ' OG1' ' A' ' 310' ' ' THR . 21.9 m -93.79 111.97 23.75 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 165.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.57 ' HB2' HG13 ' A' ' 309' ' ' VAL . 5.2 mp -102.92 167.81 9.61 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -176.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.24 140.51 51.07 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -141.64 -143.1 4.19 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.329 -174.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -109.42 -173.93 2.38 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -174.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 256' ' ' ALA . 3.3 m -66.58 174.76 2.64 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.369 -172.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 255' ' ' THR . . . -59.52 -175.38 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.047 0.939 . . . . 0.0 113.012 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 69.8 m 81.18 10.88 0.87 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.992 0.917 . . . . 0.0 111.556 -177.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 22.3 t -128.73 89.79 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 167.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 7.2 m -71.72 97.17 1.71 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.384 -177.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 69.01 98.89 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.021 -172.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -44.34 -60.25 2.02 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 117.108 0.454 . . . . 0.0 110.933 172.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.514 ' HB3' ' CB ' ' A' ' 266' ' ' ASP . 94.4 mt -148.21 166.08 29.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.545 -174.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 97.6 mttt -141.36 -166.68 2.24 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -52.04 113.6 1.06 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.362 0.601 . . . . 0.0 112.058 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 110.92 -17.31 27.44 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.054 177.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' ASP . . . . . 0.514 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 18.0 m-20 -82.58 146.15 29.33 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.42 145.55 45.13 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.607 0.718 . . . . 0.0 111.641 -174.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.609 HG23 ' HB3' ' A' ' 295' ' ' ALA . 0.2 OUTLIER -121.75 -178.97 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.038 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.502 ' HD3' ' C ' ' A' ' 269' ' ' LYS . 1.0 OUTLIER -126.77 139.36 53.18 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.849 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 270' ' ' PHE . . . . . 0.544 ' CE1' ' HB2' ' A' ' 295' ' ' ALA . 8.1 p90 -146.48 157.46 43.75 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.644 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.541 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 5.6 t -137.38 95.89 3.16 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.955 176.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.42 ' HA ' ' CG ' ' A' ' 337' ' ' ASP . 4.0 m120 . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.551 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 25.9 p . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -165.34 -171.05 2.04 Favored 'General case' 0 C--O 1.23 0.079 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.912 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 91.3 m -88.76 134.65 33.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.914 -173.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' ALA . . . . . 0.609 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -117.5 176.0 5.37 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 54.5 m -130.82 125.44 33.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.597 0.713 . . . . 0.0 112.877 -176.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.649 HG13 HG21 ' A' ' 311' ' ' VAL . 60.7 t -75.33 130.5 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.714 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 3.5 m -115.78 -1.59 12.6 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.276 -169.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -160.13 -166.33 1.67 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.085 -0.384 . . . . 0.0 111.138 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.43 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 3.3 m-20 -66.32 157.62 31.25 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.468 0.651 . . . . 0.0 110.229 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.458 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -149.23 177.44 9.64 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.595 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -144.62 137.09 26.45 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.211 -0.196 . . . . 0.0 111.297 -171.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.8 OUTLIER -118.99 95.08 4.67 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 163.644 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.95 177.46 4.85 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.946 -174.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 11.6 t -59.58 -32.41 70.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.898 0.38 . . . . 0.0 111.004 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -78.9 4.23 62.16 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.252 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 59.94 42.33 98.22 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.631 176.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -114.55 131.1 56.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.454 0.627 . . . . 0.0 110.528 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 251' ' ' LEU . 2.1 p -132.45 95.01 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.501 0.667 . . . . 0.0 111.062 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.518 ' OG1' HG23 ' A' ' 250' ' ' THR . 76.7 m -101.42 128.41 47.63 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 122.011 -0.431 . . . . 0.0 111.827 -176.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.649 HG21 HG13 ' A' ' 297' ' ' VAL . 7.3 p -162.21 150.72 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.981 174.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 52.0 m -86.87 146.41 26.21 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.989 0.423 . . . . 0.0 110.584 177.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.485 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.4 mp -120.99 159.04 26.44 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.58 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 17.5 m . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.179 -178.507 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.517 HG23 ' HB3' ' A' ' 233' ' ' GLN . 6.1 m . . . . . 0 N--CA 1.456 -0.168 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.16 162.65 14.07 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.412 0.625 . . . . 0.0 111.627 -176.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -99.04 170.0 9.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.977 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 110.64 10.75 20.89 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.473 172.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.541 ' HB3' ' O ' ' A' ' 271' ' ' THR . 13.6 m-20 -96.27 -177.26 3.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.846 0.323 . . . . 0.0 111.778 -176.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -109.08 153.3 23.87 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -169.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.502 HG21 HD23 ' A' ' 251' ' ' LEU . 76.1 t -135.98 157.31 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.676 -175.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 5.6 t -156.97 179.73 9.02 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 172.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.498 HG13 HD11 ' A' ' 262' ' ' LEU . 69.2 t -115.88 133.08 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.126 0.489 . . . . 0.0 111.946 -175.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 71.8 t . . . . . 0 CA--C 1.529 0.171 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.887 176.114 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.547 0 N-CA-C 111.859 -0.497 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 10.3 m -135.38 136.01 41.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.782 0.325 . . . . 0.0 110.378 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.486 HD21 ' CE1' ' A' ' 261' ' ' PHE . 8.2 mt -147.88 174.68 11.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.267 -177.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 57.2 m -134.59 161.98 33.57 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 12.2 t -116.11 139.61 41.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.426 ' HD2' ' CG2' ' A' ' 252' ' ' THR . 38.0 tttt -120.17 -1.58 10.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.044 0.45 . . . . 0.0 111.117 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.462 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 19.8 p -139.33 -168.23 2.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.932 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -113.67 102.52 54.89 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -174.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 248' ' ' THR . 35.9 Cg_endo -66.99 105.72 1.02 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.216 1.944 . . . . 0.0 112.176 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 247' ' ' PHE . 12.0 t -113.03 144.51 42.48 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.319 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.492 ' HA ' ' HB3' ' A' ' 247' ' ' PHE . 28.9 t -80.81 122.99 36.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.03 -171.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 94.0 m -97.95 124.59 42.47 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.104 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -93.77 124.1 37.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.188 0.518 . . . . 0.0 110.987 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.47 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 20.5 t30 -127.04 70.85 1.3 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -86.06 -28.38 24.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.757 -161.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.46 -22.97 30.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 172.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.47 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 19.6 mmtp -101.05 -0.72 35.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.135 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 23.1 t70 50.82 52.66 14.49 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 113.999 -1.455 . . . . 0.0 111.3 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 24.2 m -140.25 128.96 23.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.423 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -109.47 110.84 22.07 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -118.37 176.65 5.14 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.111 -174.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.492 ' HB3' ' HA ' ' A' ' 236' ' ' VAL . 15.7 p90 -160.58 148.87 16.41 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.366 171.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 55.4 m -112.11 145.07 40.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.786 -168.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 9.9 p -154.08 142.8 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.462 ' HB ' ' CG2' ' A' ' 232' ' ' THR . 19.2 m -103.93 109.93 21.87 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 166.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.69 171.33 7.42 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.287 0.565 . . . . 0.0 109.695 -175.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.426 ' CG2' ' HD2' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -125.77 139.14 53.76 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.066 175.01 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -136.08 -143.72 4.73 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.025 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.532 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -101.75 -174.58 2.62 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.702 HG22 ' H ' ' A' ' 256' ' ' ALA . 2.1 m -73.69 -178.2 3.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.426 -173.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.702 ' H ' HG22 ' A' ' 255' ' ' THR . . . -59.19 -177.19 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.697 0.799 . . . . 0.0 112.868 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 33.8 t 80.89 7.63 1.26 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.077 0.951 . . . . 0.0 111.109 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 59.1 t -128.01 89.7 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 121.538 0.685 . . . . 0.0 109.512 171.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 87.0 m -76.94 98.75 5.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.48 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 68.23 89.64 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.493 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.671 ' HB3' HD22 ' A' ' 262' ' ' LEU . 8.2 m-85 -46.12 -59.58 2.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.538 0.685 . . . . 0.0 109.897 170.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.671 HD22 ' HB3' ' A' ' 261' ' ' PHE . 1.4 mm? -123.31 156.21 35.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.286 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 55.1 mtmt -132.81 -167.6 1.93 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 171.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -54.41 114.23 1.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.212 0.53 . . . . 0.0 111.386 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 106.57 -12.86 42.93 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.527 175.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' ASP . . . . . 0.477 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 8.7 m-20 -78.32 136.67 37.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.827 0.346 . . . . 0.0 110.32 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -110.95 141.69 44.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.715 0.769 . . . . 0.0 112.133 -171.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 294' ' ' THR . 2.4 m -118.58 169.94 8.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.43 176.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.32 135.11 19.96 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' PHE . . . . . 0.463 ' CB ' ' HA ' ' A' ' 339' ' ' VAL . 31.0 p90 -147.03 159.96 42.95 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.06 -1.056 . . . . 0.0 112.664 -173.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 82.7 p -99.69 96.06 7.36 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.943 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 . . . . . 0 C--N 1.323 -0.545 0 CA-C-O 121.372 0.606 . . . . 0.0 110.877 -176.289 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 C--O 1.234 0.251 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -134.56 145.3 48.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.032 0.444 . . . . 0.0 110.328 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 268' ' ' VAL . 91.2 m -90.32 131.17 36.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.157 -176.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -123.19 173.95 7.57 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.403 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 90.2 m -134.4 128.23 33.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.277 0.56 . . . . 0.0 112.456 -175.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 299' ' ' ALA . 40.2 t -86.42 139.6 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.812 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 312' ' ' THR . 15.0 t -111.5 11.44 21.35 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -176.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.616 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -153.23 177.56 10.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.847 0.356 . . . . 0.0 111.504 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.414 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 2.8 m-20 -67.95 114.55 6.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.3 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.531 ' HB3' ' H ' ' A' ' 262' ' ' LEU . . . -93.33 100.1 12.5 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.893 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.743 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 13.6 m120 -68.15 126.85 30.83 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -171.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.536 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 18.8 t -104.75 94.82 5.49 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 161.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.1 178.31 5.58 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.718 -175.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 6.3 t -61.18 -33.63 73.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.815 0.341 . . . . 0.0 111.198 -176.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -82.44 7.19 65.48 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.08 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 61.38 42.35 99.75 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.099 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -117.79 134.54 54.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 117.232 0.516 . . . . 0.0 111.082 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.743 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.1 OUTLIER -141.13 106.03 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.957 -178.003 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.451 ' OG1' HG23 ' A' ' 250' ' ' THR . 47.0 m -112.7 122.8 48.73 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.695 -0.628 . . . . 0.0 110.837 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 17.6 m -147.73 161.55 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-O 121.227 0.537 . . . . 0.0 110.895 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 298' ' ' THR . 15.5 m -113.73 138.24 50.51 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.478 172.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.415 HD13 ' CZ ' ' A' ' 247' ' ' PHE . 4.8 mp -103.26 149.28 24.86 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.609 -175.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--N 1.319 -0.726 0 CA-C-O 121.05 0.452 . . . . 0.0 111.845 -173.561 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 18.7 m . . . . . 0 C--O 1.234 0.254 0 CA-C-O 121.171 0.51 . . . . 0.0 111.902 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -123.87 147.04 47.98 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.798 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -69.14 139.31 54.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.841 -0.163 . . . . 0.0 111.111 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.63 -2.1 6.48 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.932 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 271' ' ' THR . 7.3 p-10 -75.66 168.66 19.6 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.256 0.55 . . . . 0.0 111.292 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -104.36 131.11 52.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.516 -171.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 270' ' ' PHE . 73.8 t -108.44 146.9 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.131 -176.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -143.98 165.09 28.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.277 173.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 48.3 t -109.41 142.4 22.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.235 -176.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 53.2 t . . . . . 0 C--N 1.331 -0.221 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 175.334 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 112.208 -0.357 . . . . 0.0 112.208 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 41.5 m -136.75 101.5 4.62 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.974 0.416 . . . . 0.0 109.948 -177.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.456 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.4 mp -119.4 176.2 5.46 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 63.9 m -138.55 158.34 44.45 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 -174.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.4 HG13 HG11 ' A' ' 249' ' ' VAL . 89.6 t -110.11 106.66 21.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 250' ' ' THR . 17.1 ptmt -93.27 -12.65 29.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.968 0.414 . . . . 0.0 111.02 -174.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.454 HG23 ' HG3' ' A' ' 231' ' ' LYS . 31.8 p -123.79 -166.95 1.55 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.32 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -112.6 121.06 39.71 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.145 -172.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -70.76 113.35 3.51 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.976 2.451 . . . . 0.0 111.849 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 10.1 t -147.23 109.06 4.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.782 0.801 . . . . 0.0 112.784 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.7 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.48 174.39 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 164.745 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 237' ' ' THR . . . . . 0.545 ' H ' HG13 ' A' ' 236' ' ' VAL . 54.3 m -40.94 119.03 1.07 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -173.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -112.71 82.64 1.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 171.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -115.24 136.75 52.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -174.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.68 -45.12 4.29 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.566 -171.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.89 -27.94 43.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.31 0.576 . . . . 0.0 110.035 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -94.55 -7.37 41.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.832 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 56.53 61.48 2.66 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.309 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.8 t -144.43 95.62 2.74 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.575 0.702 . . . . 0.0 110.073 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -108.71 101.53 10.65 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.908 175.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' GLN . . . . . 0.621 ' HB2' HG12 ' A' ' 236' ' ' VAL . 71.6 mt-30 -130.04 156.36 44.62 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.7 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 15.6 p90 -157.47 136.88 11.99 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.588 0.232 . . . . 0.0 111.615 177.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.421 HG23 ' OG1' ' A' ' 312' ' ' THR . 32.8 m -101.02 133.5 45.42 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.494 ' HB ' HD11 ' A' ' 251' ' ' LEU . 0.3 OUTLIER -142.18 148.05 20.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.906 -176.803 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.548 HG23 ' OG1' ' A' ' 310' ' ' THR . 41.3 m -99.07 111.92 24.19 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.516 HD13 HG22 ' A' ' 311' ' ' VAL . 5.4 mp -106.15 167.83 9.54 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -172.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.402 HG23 ' HD2' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -114.41 148.63 37.42 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.839 174.431 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -144.94 -142.35 3.84 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -175.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.53 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -110.2 -174.19 2.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -68.59 -178.34 1.13 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.676 -170.436 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.547 ' H ' HG22 ' A' ' 255' ' ' THR . . . -67.5 -176.3 0.59 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.849 -177.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 22.7 t 81.03 7.99 1.17 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.491 0.716 . . . . 0.0 111.033 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 39.1 t -124.16 90.81 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 173.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 18.4 m -69.62 98.22 1.14 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.691 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 66.98 95.67 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.717 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -41.91 -56.43 2.75 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 172.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.3 pp -165.08 161.58 19.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.979 -0.1 . . . . 0.0 110.905 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.434 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 92.6 mttt -141.29 -165.91 2.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.722 0.296 . . . . 0.0 111.764 -175.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -49.46 117.95 2.48 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.769 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 113.84 -20.07 17.82 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.689 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -89.15 142.28 27.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.888 0.375 . . . . 0.0 110.191 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -112.02 153.25 27.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.343 0.592 . . . . 0.0 110.881 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -131.43 165.93 30.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.401 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.483 ' HD2' HG22 ' A' ' 342' ' ' VAL . 0.0 OUTLIER -119.3 150.37 40.24 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 169.537 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -149.06 143.27 25.95 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.25 168.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.41 ' HB ' ' OG ' ' A' ' 292' ' ' SER . 3.7 t -93.69 105.02 17.09 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.143 176.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.612 ' HA ' ' OD2' ' A' ' 337' ' ' ASP . 2.8 t-20 . . . . . 0 C--N 1.32 -0.683 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.321 -174.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' SER . . . . . 0.41 ' OG ' ' HB ' ' A' ' 271' ' ' THR . 51.5 m . . . . . 0 C--O 1.233 0.236 0 CA-C-O 120.591 0.234 . . . . 0.0 110.415 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -150.04 166.74 28.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.869 0.366 . . . . 0.0 110.719 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 99.7 m -100.19 135.79 41.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.488 -173.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -126.77 177.61 6.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.185 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 87.4 m -134.26 134.69 42.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.29 0.567 . . . . 0.0 112.203 -176.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 84.4 t -93.84 144.54 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.282 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 4.2 m -131.4 25.32 4.82 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.985 0.422 . . . . 0.0 111.803 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.44 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -147.46 171.06 16.11 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.838 -0.539 . . . . 0.0 112.157 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.434 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 28.7 m-20 -63.62 157.18 24.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.721 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.412 ' HB2' ' CG1' ' A' ' 311' ' ' VAL . . . -141.77 168.82 18.84 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.953 -175.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.498 ' OD1' ' HB3' ' A' ' 304' ' ' ASP . 28.1 t-20 -143.85 131.98 21.8 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.869 -174.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.416 ' HB2' ' HB ' ' A' ' 258' ' ' VAL . 0.5 OUTLIER -115.58 94.53 4.74 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 163.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 304' ' ' ASP . . . . . 0.498 ' HB3' ' OD1' ' A' ' 302' ' ' ASN . 0.8 OUTLIER -94.92 176.31 6.3 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.763 -177.117 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 15.5 m -58.22 -32.87 68.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.027 0.441 . . . . 0.0 111.533 -177.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -77.42 -7.59 87.03 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.085 -178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 73.19 43.29 39.88 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.498 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -115.83 138.07 51.5 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 117.963 0.881 . . . . 0.0 111.488 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.9 OUTLIER -141.34 111.01 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.805 179.455 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.548 ' OG1' HG23 ' A' ' 250' ' ' THR . 88.9 m -100.49 122.54 43.38 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.602 -0.686 . . . . 0.0 111.01 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.516 HG22 HD13 ' A' ' 251' ' ' LEU . 9.6 m -145.0 155.72 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.545 0.688 . . . . 0.0 111.409 177.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.421 ' OG1' HG23 ' A' ' 248' ' ' THR . 20.7 m -112.3 140.19 47.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.547 177.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.519 HD13 ' CE2' ' A' ' 247' ' ' PHE . 5.1 mp -113.86 138.1 50.75 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.853 -174.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 C--N 1.32 -0.698 0 CA-C-O 120.786 0.327 . . . . 0.0 110.466 -179.764 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 18.7 m . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 121.799 0.809 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -164.44 132.25 3.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.81 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -99.41 158.05 16.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.69 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.36 -22.1 5.35 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.878 175.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.612 ' OD2' ' HA ' ' A' ' 272' ' ' ASN . 65.3 m-20 -56.34 141.14 42.88 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 117.226 0.513 . . . . 0.0 111.479 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -99.41 139.76 34.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.571 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 53.7 t -117.37 148.01 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -169.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 36.3 t -142.36 175.59 9.66 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 173.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.465 ' O ' ' HE2' ' A' ' 269' ' ' LYS . 40.0 t -118.66 146.07 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 O-C-N 122.265 -0.272 . . . . 0.0 110.602 -174.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.483 HG22 ' HD2' ' A' ' 269' ' ' LYS . 42.0 t . . . . . 0 N--CA 1.463 0.201 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.709 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 112.078 -0.409 . . . . 0.0 112.078 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.8 m -94.71 134.9 36.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.916 0.388 . . . . 0.0 109.978 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.474 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 1.1 mp -134.02 176.04 8.94 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.438 ' HB ' ' OG1' ' A' ' 252' ' ' THR . 35.4 m -122.33 154.79 37.16 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.667 0.27 . . . . 0.0 110.728 -175.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.506 HG21 ' OD2' ' A' ' 337' ' ' ASP . 99.2 t -97.91 133.15 41.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.172 -177.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.557 ' HD3' HG22 ' A' ' 250' ' ' THR . 33.2 mtpt -109.37 -38.19 5.55 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 171.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.712 ' O ' HG13 ' A' ' 249' ' ' VAL . 70.9 p -141.0 160.87 39.15 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 172.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.551 ' CD ' ' HD2' ' A' ' 234' ' ' PRO . 6.0 mm100 -116.12 163.74 20.42 Favored Pre-proline 0 C--N 1.318 -0.772 0 C-N-CA 123.369 0.667 . . . . 0.0 110.075 -176.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.594 ' HB3' ' CD2' ' A' ' 247' ' ' PHE . 5.6 Cg_exo -38.47 109.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 124.824 3.683 . . . . 0.0 115.126 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.441 ' O ' HG23 ' A' ' 236' ' ' VAL . 9.0 t -155.25 92.42 1.42 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.368 0.604 . . . . 0.0 111.596 173.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.75 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -157.75 175.17 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.983 171.947 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 237' ' ' THR . . . . . 0.593 ' H ' HG13 ' A' ' 236' ' ' VAL . 60.7 m -37.28 119.14 0.67 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.811 1.244 . . . . 0.0 114.093 -171.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -108.11 83.91 1.86 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 174.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.454 HD22 ' HA ' ' A' ' 239' ' ' ASN . 0.2 OUTLIER -96.56 115.82 28.07 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -175.513 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -101.18 -42.76 6.23 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -166.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.11 -24.19 33.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.624 0.726 . . . . 0.0 109.405 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -98.32 -8.89 26.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.014 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 16.1 t70 53.1 57.23 6.51 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.442 -175.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.7 m -129.47 96.94 4.41 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.1 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -115.91 109.25 17.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.659 -173.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -126.92 153.47 45.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.75 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 35.2 p90 -148.33 140.73 24.3 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.541 -0.463 . . . . 0.0 111.187 174.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 85.2 m -97.85 143.82 28.06 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 122.19 -0.319 . . . . 0.0 110.287 -178.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.712 HG13 ' O ' ' A' ' 232' ' ' THR . 41.6 t -140.64 125.14 18.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.862 177.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.563 HG23 ' OG1' ' A' ' 310' ' ' THR . 41.5 m -90.85 129.62 36.89 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 173.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.535 HD23 HG11 ' A' ' 339' ' ' VAL . 4.4 mp -120.3 165.39 14.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.585 0.707 . . . . 0.0 110.438 -176.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.463 HG23 ' HD2' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -120.75 136.98 54.73 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.375 -0.83 . . . . 0.0 108.973 169.57 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -127.58 -143.53 5.75 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.011 -176.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -112.99 -173.23 2.21 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 256' ' ' ALA . 1.4 m -56.5 168.82 0.51 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.581 -171.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.478 ' H ' HG22 ' A' ' 255' ' ' THR . . . -66.48 -176.77 0.49 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.294 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 10.9 t 79.6 16.76 0.83 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.009 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 45.1 t -128.96 90.45 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.784 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 172.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 23.2 m -73.68 95.82 2.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.147 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 75.43 93.8 0.16 Allowed Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.358 -0.837 . . . . 0.0 113.067 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -42.63 -56.14 3.25 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 171.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -161.79 164.82 28.64 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -140.02 -166.96 2.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -50.48 123.38 8.61 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.752 0.787 . . . . 0.0 111.903 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 109.39 -21.97 25.43 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.737 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -87.52 139.54 30.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.879 0.371 . . . . 0.0 110.16 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -111.74 143.45 42.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.159 0.504 . . . . 0.0 111.197 -175.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.2 OUTLIER -116.26 179.62 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.277 174.917 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.556 ' HD2' ' C ' ' A' ' 269' ' ' LYS . 3.0 tmmm? -138.35 128.57 25.84 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -116.4 157.66 24.74 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.783 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.503 ' HA ' ' OG ' ' A' ' 292' ' ' SER . 41.4 p -136.92 98.23 3.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.507 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.451 ' HA ' ' CG ' ' A' ' 337' ' ' ASP . 25.5 p-10 . . . . . 0 C--N 1.321 -0.649 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.81 -173.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' SER . . . . . 0.503 ' OG ' ' HA ' ' A' ' 271' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -142.81 -150.47 0.31 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -172.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 35.1 m -74.93 144.97 43.0 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -168.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 295' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -126.86 159.28 34.39 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 165.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 93.1 m -122.77 119.43 30.61 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.801 -0.759 . . . . 0.0 112.381 -175.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 64.9 t -78.81 133.99 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.614 -177.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 3.4 m -129.38 24.65 5.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.307 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.411 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -151.07 166.85 29.5 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.208 0.527 . . . . 0.0 112.134 -175.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -65.86 115.82 6.37 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.244 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.523 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -93.29 170.25 9.76 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.629 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.643 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 19.7 t-20 -149.02 131.75 15.97 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.59 -171.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -113.85 95.52 5.36 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 169.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.35 178.52 5.34 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.007 -176.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 23.2 t -59.9 -34.38 73.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.938 0.399 . . . . 0.0 111.207 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -83.88 4.01 83.9 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.857 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 64.35 43.17 97.23 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.797 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -113.18 133.9 54.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 118.116 0.958 . . . . 0.0 111.634 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.643 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.1 OUTLIER -137.84 119.55 18.08 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.974 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.009 178.603 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.563 ' OG1' HG23 ' A' ' 250' ' ' THR . 76.6 m -120.51 126.11 49.55 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.379 -0.826 . . . . 0.0 110.979 -178.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 30.7 m -138.2 163.47 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.638 0.732 . . . . 0.0 111.485 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 31.4 m -123.25 138.58 54.6 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.1 173.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 313' ' ' LEU . 1.3 mm? -106.68 124.46 49.64 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.014 -169.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 C--N 1.325 -0.494 0 CA-C-O 121.147 0.499 . . . . 0.0 111.813 -171.689 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.518 ' HB ' ' CB ' ' A' ' 233' ' ' GLN . 14.7 m . . . . . 0 C--O 1.238 0.474 0 CA-C-O 120.67 0.271 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 334' ' ' GLU . . . . . 0.404 ' CD ' HD22 ' A' ' 272' ' ' ASN . 0.9 OUTLIER -108.93 129.8 55.43 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -163.02 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -100.26 115.82 30.81 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.003 -0.436 . . . . 0.0 111.975 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 129.05 12.06 2.7 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 119.554 -1.308 . . . . 0.0 114.82 170.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.506 ' OD2' HG21 ' A' ' 230' ' ' VAL . 3.9 p-10 -92.82 -148.74 0.25 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 117.548 0.674 . . . . 0.0 111.322 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -121.54 147.28 46.01 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -168.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.535 HG11 HD23 ' A' ' 251' ' ' LEU . 68.0 t -121.85 149.4 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.145 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.416 ' HB2' ' HE2' ' A' ' 269' ' ' LYS . 25.4 m -147.42 178.62 8.28 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 175.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 46.6 t -112.27 153.34 13.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 74.1 t . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 118.012 0.369 . . . . 0.0 110.52 -179.973 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.544 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 11.3 m -143.33 139.3 30.02 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.8 HD22 HG11 ' A' ' 309' ' ' VAL . 18.4 mt -142.0 176.26 9.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 251' ' ' LEU . 8.3 t -140.5 166.39 24.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.738 0.304 . . . . 0.0 110.335 -178.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 15.1 t -117.88 134.26 62.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.4 -168.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -128.6 11.87 6.3 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.86 0.362 . . . . 0.0 111.528 176.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.448 HG21 ' HB ' ' A' ' 250' ' ' THR . 17.4 p -141.06 -174.46 4.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.221 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -114.24 116.23 44.52 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -176.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.547 ' HB2' ' CD1' ' A' ' 247' ' ' PHE . 73.4 Cg_endo -78.28 106.7 2.18 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.455 2.103 . . . . 0.0 113.361 -176.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.44 ' O ' HG23 ' A' ' 236' ' ' VAL . 9.1 t -155.98 127.1 7.03 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.179 174.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.742 ' O ' ' HB2' ' A' ' 246' ' ' GLN . 47.7 t -154.35 81.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.384 0.674 . . . . 0.0 109.623 170.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 236' ' ' VAL . 33.1 m 83.14 94.89 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.939 175.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -111.67 90.22 3.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.925 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -122.91 135.86 54.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -103.64 -49.79 3.59 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.876 -170.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 75.9 t -60.36 -31.39 48.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.504 0.668 . . . . 0.0 110.071 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -91.05 -6.51 53.74 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.575 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 36.0 t70 54.55 63.98 1.97 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.435 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.7 m -143.27 99.82 3.51 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.622 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -120.78 112.92 19.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.033 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' GLN . . . . . 0.742 ' HB2' ' O ' ' A' ' 236' ' ' VAL . 69.7 mt-30 -135.48 170.33 16.12 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.672 ' HA ' ' N ' ' A' ' 236' ' ' VAL . 26.5 p90 -166.8 142.17 4.3 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 176.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.476 ' H ' HG23 ' A' ' 236' ' ' VAL . 34.0 m -104.5 142.9 33.8 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.96 139.67 27.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.769 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.516 HG23 ' OG1' ' A' ' 310' ' ' THR . 53.0 m -103.61 105.45 15.69 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 170.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.841 ' HB2' HG13 ' A' ' 309' ' ' VAL . 0.4 OUTLIER -106.4 171.36 7.4 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.553 0.692 . . . . 0.0 109.651 -174.809 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 307' ' ' GLY . 0.0 OUTLIER -121.81 144.37 48.86 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.703 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -144.73 -142.6 3.89 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.362 -172.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.535 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -95.58 -176.8 3.86 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -172.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.539 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -81.66 -177.16 6.42 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.867 -171.342 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.539 ' H ' HG22 ' A' ' 255' ' ' THR . . . -61.7 -177.61 0.11 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.668 -177.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 95.6 p 66.9 17.89 10.57 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.086 1.354 . . . . 0.0 110.895 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.444 HG11 ' CE2' ' A' ' 261' ' ' PHE . 12.9 t -129.06 88.83 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 31.6 m -87.79 92.56 9.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.347 -177.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 86.76 86.46 1.08 Allowed Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.533 178.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.444 ' CE2' HG11 ' A' ' 258' ' ' VAL . 0.8 OUTLIER -48.63 -45.06 37.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.093 0.473 . . . . 0.0 110.04 170.405 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.487 ' HB2' ' CB ' ' A' ' 266' ' ' ASP . 2.1 pt? -162.42 168.55 21.88 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.055 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.453 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 97.2 mttt -137.78 -167.53 2.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.634 0.254 . . . . 0.0 111.584 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -56.64 118.97 5.38 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.363 0.602 . . . . 0.0 110.969 178.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 110.73 -16.49 28.5 Favored Glycine 0 C--N 1.313 -0.742 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.541 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' ASP . . . . . 0.487 ' CB ' ' HB2' ' A' ' 262' ' ' LEU . 37.0 m-20 -91.68 140.5 29.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.038 0.447 . . . . 0.0 110.09 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 267' ' ' GLN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 296' ' ' THR . 3.0 mp0 -95.55 168.7 10.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.552 -178.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.1 OUTLIER -126.54 171.83 14.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.514 173.079 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.51 ' HB3' ' HB2' ' A' ' 340' ' ' SER . 16.6 tptm -134.47 89.11 2.51 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.379 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -114.2 159.81 19.7 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 119.189 -1.005 . . . . 0.0 111.098 -172.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.424 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 10.1 t -132.57 99.89 4.79 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.853 0.835 . . . . 0.0 110.246 -177.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.642 178.647 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 43.8 p . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -134.65 171.8 13.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.535 0.683 . . . . 0.0 112.368 -175.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 87.7 m -102.53 127.89 49.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.623 -1.172 . . . . 0.0 111.5 -172.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -127.37 -172.46 2.67 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 267' ' ' GLN . 73.7 m -134.35 135.84 42.99 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -175.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.605 HG12 ' H ' ' A' ' 299' ' ' ALA . 87.0 t -95.9 142.72 13.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.98 176.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 8.9 t -114.84 24.1 12.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.857 0.36 . . . . 0.0 111.742 -174.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.605 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -160.42 170.15 21.58 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.125 0.488 . . . . 0.0 112.029 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.453 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 5.2 m-20 -62.85 111.98 2.36 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.042 177.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.477 ' HB2' HG11 ' A' ' 311' ' ' VAL . . . -92.42 114.25 26.75 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.206 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.662 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 27.3 m-80 -88.46 138.02 31.81 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -170.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 57.7 m -124.24 99.97 6.47 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.827 157.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -98.99 -175.06 2.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.447 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 49.3 m -57.21 -32.46 66.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.705 0.288 . . . . 0.0 111.758 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -79.57 2.56 72.17 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.741 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 307' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 58.17 42.25 95.18 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.284 -177.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -114.75 142.06 47.02 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 117.727 0.764 . . . . 0.0 111.259 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.841 HG13 ' HB2' ' A' ' 251' ' ' LEU . 1.6 p -149.3 104.13 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.74 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.516 ' OG1' HG23 ' A' ' 250' ' ' THR . 55.4 m -113.28 124.78 53.3 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 121.576 -0.703 . . . . 0.0 110.916 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.477 HG11 ' HB2' ' A' ' 301' ' ' ALA . 22.0 m -147.48 164.27 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.1 0.476 . . . . 0.0 110.568 -178.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 31.4 m -116.47 145.54 43.22 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.055 0.455 . . . . 0.0 110.196 176.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.466 HD13 ' CE1' ' A' ' 247' ' ' PHE . 5.2 mp -120.99 152.18 38.87 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.093 -174.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 25.6 m . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.438 179.776 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 120.742 0.306 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -137.96 163.56 31.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.921 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -86.29 159.73 19.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.855 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 110.01 8.35 25.88 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.655 -0.783 . . . . 0.0 114.09 173.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 271' ' ' THR . 14.9 m-20 -93.77 -172.85 2.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.437 0.618 . . . . 0.0 111.713 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -115.56 149.22 38.55 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.816 -172.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.546 HG21 HD22 ' A' ' 251' ' ' LEU . 55.6 t -128.9 147.29 33.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.866 -177.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.51 ' HB2' ' HB3' ' A' ' 269' ' ' LYS . 37.3 m -137.96 178.27 7.25 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 21.1 t -118.0 147.79 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 120.942 0.401 . . . . 0.0 111.751 -171.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 342' ' ' VAL . 47.0 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 122.359 1.076 . . . . 0.0 108.353 173.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.658 0 CA-C-O 121.061 0.256 . . . . 0.0 113.169 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 6.1 m -82.16 144.97 30.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.915 0.388 . . . . 0.0 111.08 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.438 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.0 mp -136.14 -177.25 4.62 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 172.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 41.4 m -131.72 153.79 49.69 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.885 0.374 . . . . 0.0 110.961 -173.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 14.3 t -101.09 130.71 50.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -111.99 -28.13 8.14 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.16 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 32.8 p -123.82 -167.82 1.69 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.991 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 45.6 mt-30 -109.59 121.63 41.72 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -175.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.61 ' O ' HG11 ' A' ' 333' ' ' VAL . 14.6 Cg_exo -68.1 105.39 1.18 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.556 2.17 . . . . 0.0 111.633 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 236' ' ' VAL . 9.8 t -154.26 123.47 6.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.727 0.775 . . . . 0.0 112.868 -177.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.663 HG12 ' HB2' ' A' ' 246' ' ' GLN . 2.1 t -154.18 175.23 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 170.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' THR . . . . . 0.515 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 87.4 m -39.93 116.12 0.61 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -108.36 83.5 1.79 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 172.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -110.29 138.54 46.54 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.96 -41.5 5.17 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.588 -172.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 44.4 t -61.71 -31.62 51.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.435 0.636 . . . . 0.0 109.732 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -95.14 -5.77 43.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.667 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 30.6 t70 53.01 51.11 16.47 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.367 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 22.5 m -127.9 97.56 4.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.474 -173.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -113.69 105.36 13.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.95 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' GLN . . . . . 0.663 ' HB2' HG12 ' A' ' 236' ' ' VAL . 86.8 mt-30 -129.71 152.99 48.61 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.882 -178.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.643 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 2.8 p90 -154.8 129.8 9.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.776 0.322 . . . . 0.0 111.842 176.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 37.0 m -103.26 141.83 35.23 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.618 ' HB ' HD11 ' A' ' 251' ' ' LEU . 0.2 OUTLIER -142.84 146.45 21.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 119.911 -0.716 . . . . 0.0 112.129 179.809 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.559 HG23 ' OG1' ' A' ' 310' ' ' THR . 57.8 m -101.22 111.43 23.64 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 163.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.618 HD11 ' HB ' ' A' ' 249' ' ' VAL . 3.3 mp -114.04 168.57 9.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -172.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.7 138.56 46.93 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.74 0.305 . . . . 0.0 110.517 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -133.05 -142.74 4.88 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -175.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.481 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -106.34 -177.73 3.45 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.332 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.581 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.3 OUTLIER -70.82 -177.32 1.56 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.39 -175.635 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.581 ' H ' HG22 ' A' ' 255' ' ' THR . . . -63.34 -176.65 0.16 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 122.999 0.52 . . . . 0.0 111.672 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 11.7 t 79.63 12.81 1.12 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.073 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 90.9 t -133.02 89.56 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-O 121.621 0.724 . . . . 0.0 109.565 171.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 12.4 m -79.45 97.46 6.4 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.624 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 79.78 93.45 0.37 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.744 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.664 ' CE1' ' HB2' ' A' ' 303' ' ' SER . 7.0 m-85 -53.37 -43.07 67.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.217 0.532 . . . . 0.0 110.469 169.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.486 ' HB2' ' CB ' ' A' ' 266' ' ' ASP . 4.1 pp -161.34 172.96 15.66 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.97 -176.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -129.84 -166.92 1.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.989 0.423 . . . . 0.0 111.48 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -60.93 118.19 6.4 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.193 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 109.83 -15.86 31.2 Favored Glycine 0 C--N 1.316 -0.543 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.444 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' ASP . . . . . 0.486 ' CB ' ' HB2' ' A' ' 262' ' ' LEU . 14.3 m-20 -75.29 134.88 40.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -97.96 151.78 19.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.74 0.781 . . . . 0.0 111.668 -176.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.506 HG23 ' HB3' ' A' ' 295' ' ' ALA . 1.7 m -125.38 172.31 13.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.795 177.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.16 133.17 21.36 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 169.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 270' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 338' ' ' ALA . 47.2 p90 -143.81 167.87 21.28 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.456 -174.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.608 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 13.9 t -133.67 123.92 25.83 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.329 0.585 . . . . 0.0 111.561 -175.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.249 173.525 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 292' ' ' SER . . . . . 0.442 ' HB3' ' HB ' ' A' ' 271' ' ' THR . 16.0 p . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -152.26 159.7 43.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.936 0.398 . . . . 0.0 111.085 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 96.4 m -90.88 129.36 36.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.054 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' ALA . . . . . 0.506 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -119.97 -178.66 3.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.164 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 96.9 m -142.63 128.41 19.35 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.476 0.655 . . . . 0.0 112.503 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 299' ' ' ALA . 39.2 t -94.41 147.54 5.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.019 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 15.1 t -110.15 17.27 21.15 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -173.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.521 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -165.95 176.95 7.41 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 4.5 m-20 -60.91 120.76 10.81 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.58 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.441 ' HA ' ' CG1' ' A' ' 311' ' ' VAL . . . -93.38 115.02 27.58 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.263 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -79.72 130.17 35.11 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -169.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.664 ' HB2' ' CE1' ' A' ' 261' ' ' PHE . 32.7 t -114.06 94.91 5.03 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 162.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -109.66 177.6 4.68 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.152 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 17.2 t -54.78 -33.17 61.08 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -77.05 6.11 44.54 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.625 -176.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 56.24 40.49 84.55 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.927 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -120.17 124.29 45.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.861 0.363 . . . . 0.0 110.544 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.611 HG13 ' HB2' ' A' ' 251' ' ' LEU . 2.6 p -125.05 94.48 2.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.643 0.735 . . . . 0.0 110.359 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.559 ' OG1' HG23 ' A' ' 250' ' ' THR . 56.7 m -102.44 117.26 34.34 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.064 -176.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.441 ' CG1' ' HA ' ' A' ' 301' ' ' ALA . 5.4 m -148.55 160.09 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.306 0.574 . . . . 0.0 110.717 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 26.5 m -110.36 141.62 43.15 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.389 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.481 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.0 mp -109.59 122.39 47.33 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.551 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 23.6 p . . . . . 0 C--N 1.316 -0.871 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.945 -170.951 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.61 HG11 ' O ' ' A' ' 234' ' ' PRO . 21.8 m . . . . . 0 N--CA 1.449 -0.504 0 CA-C-O 121.595 0.712 . . . . 0.0 112.871 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -140.12 153.89 46.83 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.649 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -91.87 141.67 28.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.653 -0.248 . . . . 0.0 111.065 -175.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 115.87 9.3 12.48 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.672 175.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.608 ' HB3' ' O ' ' A' ' 271' ' ' THR . 49.6 m-20 -87.45 -169.14 2.48 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.349 0.574 . . . . 0.0 112.215 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 338' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 270' ' ' PHE . . . -110.94 148.06 33.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.605 -174.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 54.3 t -124.12 151.74 29.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.816 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 24.0 m -150.36 163.25 38.82 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 48.8 t -117.34 138.41 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.611 0.243 . . . . 0.0 110.694 -176.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 71.3 t . . . . . 0 C--N 1.332 -0.181 0 CA-C-O 121.117 0.484 . . . . 0.0 109.953 177.39 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.638 ' O ' ' HA ' ' A' ' 340' ' ' SER . . . . . . . . 0 C--O 1.227 -0.325 0 N-CA-C 112.343 -0.303 . . . . 0.0 112.343 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 17.8 m -92.87 132.11 37.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.907 0.384 . . . . 0.0 111.536 -175.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.445 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.3 mp -138.46 -177.21 4.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 96.8 m -138.45 156.02 47.93 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.321 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.516 HG23 HG23 ' A' ' 339' ' ' VAL . 69.9 t -103.1 126.38 57.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -109.7 -11.69 14.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.048 0.452 . . . . 0.0 110.951 -173.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.509 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 36.5 p -131.22 -167.04 1.79 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.375 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.513 ' HG2' ' HB ' ' A' ' 333' ' ' VAL . 0.9 OUTLIER -111.85 115.27 51.12 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -173.777 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 248' ' ' THR . 65.0 Cg_endo -78.54 105.01 1.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.216 1.944 . . . . 0.0 111.975 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 15.3 t -107.42 136.13 47.73 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.34 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.507 ' HA ' ' HB3' ' A' ' 247' ' ' PHE . 39.2 t -82.58 121.74 36.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.391 0.615 . . . . 0.0 111.788 -175.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 52.7 m -87.38 105.24 17.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.558 175.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -86.46 125.65 33.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.055 0.455 . . . . 0.0 110.801 -178.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.419 HD22 ' HA ' ' A' ' 239' ' ' ASN . 0.2 OUTLIER -138.75 77.68 1.64 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.476 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -83.04 -36.18 25.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.03 -163.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 39.5 t -68.15 -23.4 28.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.407 ' HG3' ' OD1' ' A' ' 239' ' ' ASN . 11.3 mmpt? -97.56 -2.8 40.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.432 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 56.18 46.14 21.97 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.119 -1.401 . . . . 0.0 112.143 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 35.3 t -132.55 125.45 30.56 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.416 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -128.88 102.17 6.41 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' GLN . . . . . 0.405 ' HG2' ' HA ' ' A' ' 314' ' ' SER . 77.5 mt-30 -130.8 159.1 38.31 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -178.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.507 ' HB3' ' HA ' ' A' ' 236' ' ' VAL . 8.1 p90 -137.58 137.54 38.64 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.873 178.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 85.2 m -105.18 143.55 33.19 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 -171.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.526 HG13 ' CD1' ' A' ' 251' ' ' LEU . 4.2 p -148.5 142.79 18.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.581 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.509 ' HB ' ' CG2' ' A' ' 232' ' ' THR . 57.4 m -99.11 126.88 44.96 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 167.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.526 ' CD1' HG13 ' A' ' 249' ' ' VAL . 4.8 mp -111.59 172.56 6.82 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.968 -173.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.52 145.74 47.65 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 169.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -145.39 -142.83 3.87 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.862 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.545 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -113.47 -174.41 2.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.853 0.358 . . . . 0.0 111.725 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.609 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.7 OUTLIER -70.43 -179.82 2.21 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.561 -170.603 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.609 ' H ' HG22 ' A' ' 255' ' ' THR . . . -63.93 -174.93 0.12 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.678 0.791 . . . . 0.0 112.256 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' SER . . . . . 0.476 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 34.5 t 81.94 7.4 1.01 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.819 0.847 . . . . 0.0 111.172 -177.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.578 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 42.4 t -128.45 89.04 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.619 0 CA-C-O 121.615 0.721 . . . . 0.0 109.377 170.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 26.4 m -81.86 88.42 6.34 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.105 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 96.31 81.69 1.59 Allowed Glycine 0 N--CA 1.439 -1.115 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.347 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -47.05 -59.7 2.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.382 0.61 . . . . 0.0 110.194 168.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 300' ' ' ASP . 88.1 mt -137.65 169.63 17.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.907 -174.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -135.78 -167.64 2.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.641 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.61 114.29 3.86 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.792 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 116.06 -5.64 19.96 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.989 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -87.06 127.47 35.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.951 0.405 . . . . 0.0 110.696 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 296' ' ' THR . 2.9 mp0 -86.84 149.36 24.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.103 0.478 . . . . 0.0 110.748 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 294' ' ' THR . 1.1 m -120.9 172.54 7.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.261 174.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.569 ' HD3' ' C ' ' A' ' 269' ' ' LYS . 0.7 OUTLIER -131.62 124.84 30.77 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.307 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -146.78 160.41 42.29 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.052 176.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 292' ' ' SER . 14.9 t -122.4 134.01 54.62 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.708 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.728 ' HA ' ' OD1' ' A' ' 337' ' ' ASP . 54.5 t30 . . . . . 0 C--N 1.32 -0.711 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.805 -174.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 271' ' ' THR . 4.4 m . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -151.97 167.09 29.5 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.23 0.538 . . . . 0.0 111.697 -177.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 94.6 m -97.93 129.75 44.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.992 -176.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -121.95 -171.68 2.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.298 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 267' ' ' GLN . 23.4 m -141.17 129.11 21.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.555 HG12 ' H ' ' A' ' 299' ' ' ALA . 50.4 t -86.47 138.59 18.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.678 176.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 312' ' ' THR . 6.0 t -112.59 14.91 20.2 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.895 0.379 . . . . 0.0 111.988 -174.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.555 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -165.95 -178.56 4.77 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.849 0.357 . . . . 0.0 111.743 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 4.3 m-20 -68.13 145.87 53.97 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.514 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.439 ' HB2' HG11 ' A' ' 311' ' ' VAL . . . -121.44 127.62 51.31 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.818 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.607 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 2.6 t-20 -90.06 123.17 33.7 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -171.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.578 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 8.9 t -100.73 95.09 6.42 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 163.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.64 175.03 6.53 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.888 -174.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 8.3 t -59.84 -33.34 71.64 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.698 0.285 . . . . 0.0 111.57 -176.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -80.68 -3.94 90.26 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.15 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 307' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 71.54 41.56 57.4 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.238 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -121.99 133.63 54.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.365 0.582 . . . . 0.0 111.247 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.2 OUTLIER -128.24 155.5 39.92 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.046 179.039 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.449 ' OG1' HG23 ' A' ' 250' ' ' THR . 55.1 m -147.98 125.74 11.89 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.584 -0.698 . . . . 0.0 110.932 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.439 HG11 ' HB2' ' A' ' 301' ' ' ALA . 18.7 m -148.1 159.31 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.592 0.711 . . . . 0.0 111.25 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.486 ' O ' HG22 ' A' ' 298' ' ' THR . 16.4 m -108.94 140.21 42.74 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.488 174.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 5.3 mp -105.27 122.45 45.97 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.719 -174.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' SER . . . . . 0.405 ' HA ' ' HG2' ' A' ' 246' ' ' GLN . 16.6 p . . . . . 0 C--N 1.319 -0.753 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.94 -176.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.513 ' HB ' ' HG2' ' A' ' 233' ' ' GLN . 15.5 m . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 120.805 0.336 . . . . 0.0 111.362 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 334' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 334' ' ' GLU . 0.5 OUTLIER -140.8 112.88 7.79 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.178 0.513 . . . . 0.0 111.257 179.748 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -100.66 138.85 37.16 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.93 -0.481 . . . . 0.0 112.029 178.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.42 -10.25 6.49 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.667 171.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.728 ' OD1' ' HA ' ' A' ' 272' ' ' ASN . 2.9 m-20 -54.33 150.75 8.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.388 0.613 . . . . 0.0 112.642 -178.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -102.41 134.93 44.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.012 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.516 HG23 HG23 ' A' ' 230' ' ' VAL . 57.8 t -114.82 147.23 18.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.32 0.581 . . . . 0.0 112.248 -169.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 226' ' ' GLY . 9.0 t -144.44 172.36 13.06 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.882 172.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.41 HG11 HD21 ' A' ' 262' ' ' LEU . 95.3 t -119.76 127.13 75.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.644 0.259 . . . . 0.0 111.655 -173.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 85.6 t . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 120.99 0.424 . . . . 0.0 110.367 175.764 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 N-CA-C 112.054 -0.418 . . . . 0.0 112.054 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 26.4 m -119.38 134.24 55.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.014 0.435 . . . . 0.0 109.964 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.504 HD23 ' CA ' ' A' ' 253' ' ' GLY . 9.7 mt -140.32 171.66 13.83 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.292 -174.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 62.6 m -136.68 165.94 24.73 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.583 HG21 ' HB2' ' A' ' 337' ' ' ASP . 70.9 t -117.22 132.24 67.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 O-C-N 122.078 -0.389 . . . . 0.0 110.287 176.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.41 ' HE3' HG21 ' A' ' 252' ' ' THR . 34.8 ttmt -120.62 11.88 11.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.51 0.671 . . . . 0.0 110.32 -177.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.442 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 7.5 p -139.33 -170.49 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.323 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.442 ' HG2' ' HA ' ' A' ' 334' ' ' GLU . 36.0 mt-30 -114.79 111.22 45.86 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -177.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.94 105.71 1.87 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.382 2.055 . . . . 0.0 113.048 -176.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 4.6 t -155.81 130.82 9.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.122 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.644 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -154.71 171.84 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 171.783 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 237' ' ' THR . . . . . 0.469 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 38.5 m -12.36 113.37 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.75 1.62 . . . . 0.0 114.798 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.47 ' HD1' ' CD2' ' A' ' 245' ' ' TYR . 95.7 m-85 -115.45 84.04 2.03 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.332 173.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -122.97 133.21 54.38 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.15 -33.47 7.84 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -170.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.94 -28.82 45.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.581 0.705 . . . . 0.0 109.512 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.478 ' HA ' ' HE2' ' A' ' 242' ' ' LYS . 8.2 mmpt? -98.44 -9.14 25.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.06 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 61.48 40.51 13.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.234 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.9 m -113.03 95.73 5.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.026 -175.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' TYR . . . . . 0.47 ' CD2' ' HD1' ' A' ' 238' ' ' TYR . 4.8 m-85 -126.93 109.66 12.18 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 176.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' GLN . . . . . 0.553 ' HB2' HG12 ' A' ' 236' ' ' VAL . 70.6 mt-30 -136.94 173.16 12.0 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.644 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 4.7 p90 -154.14 134.8 13.59 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.369 -0.533 . . . . 0.0 112.374 176.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 59.3 m -99.34 139.17 35.38 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.512 HG13 ' HG ' ' A' ' 251' ' ' LEU . 5.5 p -142.75 142.3 26.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.501 -176.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.442 ' HB ' ' CG2' ' A' ' 232' ' ' THR . 38.9 m -99.36 103.97 15.82 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 166.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.613 HD11 HG22 ' A' ' 311' ' ' VAL . 0.4 OUTLIER -87.18 171.01 10.99 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.96 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.41 HG21 ' HE3' ' A' ' 231' ' ' LYS . 0.2 OUTLIER -128.53 141.46 51.37 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.025 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.504 ' CA ' HD23 ' A' ' 228' ' ' LEU . . . -146.76 -142.45 3.72 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.433 -174.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -106.28 -173.64 2.34 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.565 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -67.37 -179.31 1.0 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.408 -168.48 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.565 ' H ' HG22 ' A' ' 255' ' ' THR . . . -65.99 -175.33 0.3 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.352 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 49.2 m 80.2 17.31 0.68 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.908 0.883 . . . . 0.0 111.362 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 49.5 t -133.43 90.9 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 170.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 31.2 m -68.1 100.72 1.04 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.493 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 70.73 92.32 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.934 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -41.96 -59.69 1.64 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 169.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.472 ' H ' ' HB3' ' A' ' 301' ' ' ALA . 91.7 mt -146.68 163.21 36.64 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.673 0.273 . . . . 0.0 111.106 -174.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 49.4 mtmt -134.89 -167.88 2.07 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.632 177.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -63.58 120.78 12.4 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.353 0.597 . . . . 0.0 111.234 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 106.62 -3.95 36.82 Favored Glycine 0 C--N 1.316 -0.553 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.162 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' ASP . . . . . 0.422 ' HB3' HD22 ' A' ' 262' ' ' LEU . 66.3 m-20 -92.59 134.94 34.51 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -103.12 152.31 21.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.566 0.698 . . . . 0.0 111.869 -174.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.77 153.67 39.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.745 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 340' ' ' SER . 0.8 OUTLIER -86.2 94.9 9.42 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 166.576 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 270' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 293' ' ' PHE . 76.7 t80 -115.15 106.94 14.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.582 -165.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 292' ' ' SER . 89.4 m -88.29 94.96 10.0 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.922 -178.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.705 ' HA ' ' OD1' ' A' ' 337' ' ' ASP . 3.0 t-20 . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 121.448 0.642 . . . . 0.0 109.521 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 271' ' ' THR . 15.0 m . . . . . 0 C--O 1.226 -0.138 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' PHE . . . . . 0.558 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 0.8 OUTLIER -162.54 86.03 0.57 Allowed 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 21.3 m -160.79 124.28 3.4 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.027 -0.42 . . . . 0.0 111.003 175.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -152.85 179.88 8.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.323 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 90.8 m -140.31 132.39 27.92 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.595 0.712 . . . . 0.0 112.304 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 299' ' ' ALA . 59.2 t -79.54 136.52 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 114.35 -1.296 . . . . 0.0 110.339 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 4.4 m -124.86 25.01 7.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.13 0.49 . . . . 0.0 111.086 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -166.62 178.26 6.11 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.401 ' O ' HG12 ' A' ' 311' ' ' VAL . 40.8 m-20 -66.96 165.88 14.69 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.563 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.521 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -144.87 171.27 14.67 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.82 -177.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.689 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 16.6 m120 -142.29 126.27 17.26 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 119.687 -0.197 . . . . 0.0 110.964 -173.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.7 OUTLIER -107.88 96.88 6.69 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 168.253 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.16 178.71 4.53 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.023 -176.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 10.8 t -61.76 -33.17 73.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.991 0.424 . . . . 0.0 111.044 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -81.7 1.76 85.09 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.897 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 61.51 42.01 99.68 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 121.016 -0.612 . . . . 0.0 113.704 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.83 132.67 55.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 118.06 0.93 . . . . 0.0 110.454 175.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.689 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.1 OUTLIER -138.23 109.44 5.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.807 -177.308 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 250' ' ' THR . 54.0 m -101.5 135.22 43.38 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.962 -0.461 . . . . 0.0 111.712 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.613 HG22 HD11 ' A' ' 251' ' ' LEU . 26.8 m -145.71 165.36 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 173.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 46.4 m -117.02 138.9 51.27 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 171.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 4.9 mp -112.25 141.59 45.77 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.736 -173.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.321 -0.65 0 CA-C-O 121.327 0.584 . . . . 0.0 109.851 178.385 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 C--O 1.235 0.307 0 CA-C-O 121.341 0.591 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 334' ' ' GLU . . . . . 0.442 ' HA ' ' HG2' ' A' ' 233' ' ' GLN . 0.8 OUTLIER -112.66 -166.82 1.11 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.477 176.363 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -81.56 155.11 25.88 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.041 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 129.59 -8.35 6.18 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.054 -1.07 . . . . 0.0 113.444 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.705 ' OD1' ' HA ' ' A' ' 272' ' ' ASN . 4.1 m-20 -52.12 140.62 20.41 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.978 0.389 . . . . 0.0 110.784 174.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -100.56 132.65 45.84 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.503 ' CG1' ' HB2' ' A' ' 228' ' ' LEU . 93.2 t -120.69 140.18 45.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.479 0.657 . . . . 0.0 112.029 -171.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 269' ' ' LYS . 22.7 m -141.09 167.6 21.79 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 47.8 t -116.24 140.62 37.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.693 0.282 . . . . 0.0 111.122 -175.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 76.8 t . . . . . 0 C--O 1.23 0.072 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.265 175.791 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.407 0 CA-C-O 121.023 0.235 . . . . 0.0 113.438 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 6.8 m -65.48 132.31 48.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.763 0.316 . . . . 0.0 111.246 -177.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.489 HD22 ' HA2' ' A' ' 253' ' ' GLY . 29.2 mt -137.16 -175.95 4.22 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -177.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 84.9 m -104.26 148.87 25.85 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -171.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 60.3 t -99.41 133.23 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.482 175.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.611 ' HE3' HG21 ' A' ' 252' ' ' THR . 22.9 mmtp -102.92 -41.29 6.19 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 121.138 -0.225 . . . . 0.0 110.906 175.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.454 ' O ' HG13 ' A' ' 249' ' ' VAL . 40.2 p -136.55 175.76 9.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.925 0.393 . . . . 0.0 110.781 177.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.534 ' H ' ' HB ' ' A' ' 333' ' ' VAL . 0.4 OUTLIER -115.68 156.19 46.55 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.986 -170.72 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.499 ' HD2' ' HG3' ' A' ' 233' ' ' GLN . 3.9 Cg_endo -45.48 107.43 0.11 Allowed 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 124.127 3.218 . . . . 0.0 113.473 175.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 65.2 m -152.77 94.77 1.92 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.069 0.461 . . . . 0.0 111.34 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.749 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -157.85 173.97 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 123.874 0.87 . . . . 0.0 109.1 168.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 237' ' ' THR . . . . . 0.534 ' H ' HG13 ' A' ' 236' ' ' VAL . 27.2 m -29.8 109.16 0.05 OUTLIER 'General case' 0 C--O 1.236 0.373 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -172.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -112.95 87.74 2.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.945 171.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -128.43 133.8 48.63 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -177.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -105.22 -42.85 5.16 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -169.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.93 -27.51 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.318 0.58 . . . . 0.0 109.963 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' A' ' 242' ' ' LYS . 27.9 mmmt -90.72 -12.63 36.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.805 178.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 60.84 66.67 0.89 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.131 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 55.6 m -150.76 99.03 2.68 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.571 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -120.13 102.21 8.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.949 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -135.42 160.25 39.03 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.749 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 27.2 p90 -148.17 139.84 23.76 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.07 174.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 53.5 m -99.81 136.7 39.33 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 232' ' ' THR . 99.2 t -137.92 141.39 38.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.841 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.544 HG23 ' OG1' ' A' ' 310' ' ' THR . 84.8 m -95.87 119.26 34.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 170.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.515 ' HB2' HG13 ' A' ' 309' ' ' VAL . 3.6 mp -115.33 163.02 16.3 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -176.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.611 HG21 ' HE3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -126.77 111.12 13.85 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 121.014 -0.275 . . . . 0.0 110.566 175.662 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.489 ' HA2' HD22 ' A' ' 228' ' ' LEU . . . -95.17 -147.27 22.36 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.034 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -109.46 -173.72 2.33 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 256' ' ' ALA . 3.1 m -58.84 167.31 1.61 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.801 -1.091 . . . . 0.0 113.476 -169.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.489 ' H ' HG22 ' A' ' 255' ' ' THR . . . -62.43 -176.56 0.11 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.819 -176.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 42.6 m 79.47 12.2 1.23 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.68 -176.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 23.8 t -125.44 94.78 2.87 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.2 m -77.3 94.2 4.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.099 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 74.02 93.15 0.13 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.491 178.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.66 ' CE1' ' HB3' ' A' ' 303' ' ' SER . 4.1 m-85 -44.4 -42.11 6.69 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 169.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 266' ' ' ASP . 1.0 OUTLIER -166.51 173.63 9.65 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.287 -173.005 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 63.8 mttm -142.65 -165.91 2.15 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.04 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -57.84 114.41 2.3 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.54 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 114.5 -16.21 19.49 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.932 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 262' ' ' LEU . 14.3 m-20 -78.83 126.42 30.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -93.29 150.01 20.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.711 0.767 . . . . 0.0 111.954 -176.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 341' ' ' VAL . 2.9 m -127.02 170.6 16.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.453 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.04 144.62 43.3 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 167.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 270' ' ' PHE . . . . . 0.651 ' O ' ' HA ' ' A' ' 292' ' ' SER . 56.8 m-85 -110.99 129.34 55.92 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.332 -175.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 338' ' ' ALA . 81.3 p -95.16 88.16 5.1 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 166.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.53 ' HA ' ' CG ' ' A' ' 337' ' ' ASP . 3.2 p-10 . . . . . 0 C--N 1.319 -0.757 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.355 -170.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 292' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 71.2 m . . . . . 0 CA--C 1.53 0.19 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -155.15 145.67 22.14 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 173.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 99.0 m -91.63 123.26 34.9 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.237 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -120.61 -176.18 3.18 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 121.173 -0.211 . . . . 0.0 110.625 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 94.1 m -141.32 130.06 22.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.327 0.584 . . . . 0.0 112.287 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.499 HG12 ' H ' ' A' ' 299' ' ' ALA . 59.6 t -83.63 145.79 7.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.752 177.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 2.3 m -123.46 24.02 8.76 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -173.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -167.71 -176.94 3.29 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 178.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.57 159.0 25.61 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.38 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.523 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -139.92 166.25 25.14 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.45 -177.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.541 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 18.2 m120 -136.51 122.22 19.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -174.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.66 ' HB3' ' CE1' ' A' ' 261' ' ' PHE . 0.0 OUTLIER -108.6 94.76 5.23 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 165.013 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.96 -170.56 1.86 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.022 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 10.1 t -60.03 -33.85 72.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.359 . . . . 0.0 111.418 -175.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -98.36 0.52 58.48 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 59.99 43.17 98.42 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 114.963 0.745 . . . . 0.0 114.963 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -88.34 110.19 20.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 119.557 1.679 . . . . 0.0 109.964 176.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.541 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 1.3 p -124.11 94.71 2.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.473 0.654 . . . . 0.0 111.394 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.544 ' OG1' HG23 ' A' ' 250' ' ' THR . 92.9 m -100.65 118.38 36.67 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.109 -0.369 . . . . 0.0 110.332 177.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.402 ' HB ' HG13 ' A' ' 297' ' ' VAL . 9.6 m -138.6 156.47 29.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.31 0.576 . . . . 0.0 110.795 178.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 44.9 m -108.32 133.69 52.18 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.137 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.428 ' HB2' ' CE2' ' A' ' 247' ' ' PHE . 5.2 mp -102.24 124.69 48.28 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.432 -174.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--N 1.322 -0.628 0 CA-C-O 120.803 0.335 . . . . 0.0 111.415 -173.945 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.534 ' HB ' ' H ' ' A' ' 233' ' ' GLN . 26.9 m . . . . . 0 CA--C 1.534 0.362 0 CA-C-O 120.822 0.344 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -115.56 111.72 21.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.547 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -79.71 164.0 24.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.799 0.333 . . . . 0.0 110.963 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.87 -16.09 5.86 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.89 176.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.53 ' CG ' ' HA ' ' A' ' 272' ' ' ASN . 70.6 m-20 -81.53 -177.7 6.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.837 0.351 . . . . 0.0 111.089 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 338' ' ' ALA . . . . . 0.475 ' HB3' ' OG1' ' A' ' 271' ' ' THR . . . -122.77 150.02 43.34 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.316 0.579 . . . . 0.0 111.736 -176.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 53.0 t -103.04 147.53 9.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.386 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 11.6 p -156.85 151.95 26.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.018 0.437 . . . . 0.0 111.21 173.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 268' ' ' VAL . 41.0 t -108.37 147.03 13.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.238 -176.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 54.5 t . . . . . 0 C--O 1.232 0.152 0 CA-C-O 121.216 0.532 . . . . 0.0 110.044 177.432 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.614 ' C ' ' HB3' ' A' ' 340' ' ' SER . . . . . . . . 0 N--CA 1.442 -0.963 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.743 HG23 ' HB ' ' A' ' 339' ' ' VAL . 52.4 m -153.29 135.49 14.88 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.664 -0.315 . . . . 0.0 111.311 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.662 ' H ' ' HA ' ' A' ' 339' ' ' VAL . 3.2 mt -128.36 87.63 2.62 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.951 ' HA ' ' O ' ' A' ' 338' ' ' ALA . 1.2 m -83.64 133.85 34.81 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.345 -174.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.678 ' O ' ' HA2' ' A' ' 336' ' ' GLY . 39.3 t -82.68 158.52 3.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.916 -160.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.435 ' HG3' HG23 ' A' ' 232' ' ' THR . 16.8 ptmt -131.75 -12.26 3.38 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.161 175.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 335' ' ' ALA . 40.6 p -129.32 -166.97 1.72 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.475 0.31 . . . . 0.0 110.829 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 34.1 mt-30 -112.91 118.24 44.94 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -173.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.548 ' HA ' ' O ' ' A' ' 248' ' ' THR . 1.1 Cg_endo -75.44 107.58 2.51 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.88 2.387 . . . . 0.0 113.007 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 236' ' ' VAL . 19.4 m -155.39 131.07 9.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.408 177.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.653 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -154.93 175.91 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.245 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 237' ' ' THR . . . . . 0.575 ' H ' HG13 ' A' ' 236' ' ' VAL . 98.1 m -32.84 124.74 0.35 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.18 1.392 . . . . 0.0 114.578 -173.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -104.13 108.42 19.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.631 172.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.437 HD22 ' HA ' ' A' ' 239' ' ' ASN . 0.4 OUTLIER -114.01 91.45 3.64 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.215 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -88.16 -37.74 15.91 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.773 -161.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 40.0 t -64.69 -22.88 32.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -103.7 -0.67 29.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.14 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 24.6 t70 53.7 48.82 20.65 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.051 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 14.9 m -127.2 113.14 15.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.524 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -128.44 105.97 8.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -174.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' GLN . . . . . 0.535 ' HB2' HG12 ' A' ' 236' ' ' VAL . 2.0 mp0 -108.28 154.11 22.26 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.653 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 4.6 p90 -149.81 124.72 9.92 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.679 177.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 78.3 m -91.7 140.6 29.56 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.515 HG13 HD11 ' A' ' 251' ' ' LEU . 8.2 p -139.97 136.03 38.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 C-N-CA 119.848 -0.741 . . . . 0.0 112.354 -177.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.58 HG23 ' OG1' ' A' ' 310' ' ' THR . 94.0 m -96.99 115.85 28.16 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 168.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.515 HD11 HG13 ' A' ' 249' ' ' VAL . 1.0 OUTLIER -113.8 171.55 7.52 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.968 0.889 . . . . 0.0 110.463 -173.108 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.495 HG22 ' O ' ' A' ' 307' ' ' GLY . 0.0 OUTLIER -121.21 94.13 4.24 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.094 169.854 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.543 ' H ' HG12 ' A' ' 309' ' ' VAL . . . -120.52 135.12 10.7 Favored Glycine 0 CA--C 1.505 -0.58 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.705 -176.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -115.6 93.42 4.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -165.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.471 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 93.5 m -128.23 103.91 7.45 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.119 165.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.547 ' HA ' ' CB ' ' A' ' 305' ' ' SER . . . -50.57 130.69 24.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 35.9 m 57.76 58.56 3.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.64 -1.164 . . . . 0.0 113.108 168.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.43 ' HB ' ' OG ' ' A' ' 303' ' ' SER . 60.2 t -140.2 101.29 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-O 121.022 0.439 . . . . 0.0 110.249 174.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 33.6 m -71.44 86.99 0.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.407 0.623 . . . . 0.0 109.855 177.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 78.81 111.44 0.21 Allowed Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.569 -174.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.705 ' CE2' ' HB3' ' A' ' 303' ' ' SER . 57.3 m-85 -49.91 -61.27 2.23 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 121.85 0.833 . . . . 0.0 109.168 173.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 261' ' ' PHE . 73.6 mt -167.38 -179.93 4.7 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.336 -1.756 . . . . 0.0 106.603 -175.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -108.92 -169.8 1.55 Allowed 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -35.37 114.97 0.27 Allowed 'General case' 0 N--CA 1.464 0.238 0 O-C-N 124.181 0.925 . . . . 0.0 112.516 -177.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 131.92 -14.0 5.23 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.123 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' ASP . . . . . 0.501 ' OD1' ' HB2' ' A' ' 262' ' ' LEU . 80.8 m-20 -64.05 146.69 53.72 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 120.758 0.314 . . . . 0.0 110.207 175.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.14 174.49 6.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.447 -174.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.93 ' HA ' ' N ' ' A' ' 341' ' ' VAL . 34.8 m -151.89 142.63 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.805 -175.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.729 ' N ' HG23 ' A' ' 341' ' ' VAL . 0.0 OUTLIER -77.6 97.76 5.19 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 157.139 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 270' ' ' PHE . . . . . 0.495 ' HA ' ' HB1' ' A' ' 338' ' ' ALA . 14.2 t80 -78.75 86.58 4.69 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.662 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 53.7 m -78.9 107.68 11.81 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 33.5 t30 . . . . . 0 C--N 1.319 -0.726 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.237 -178.908 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -141.67 144.0 33.89 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 88.6 m -85.21 125.94 33.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.71 0.291 . . . . 0.0 111.503 -172.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -119.38 -179.5 3.88 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 84.9 m -136.14 138.15 41.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.428 0.632 . . . . 0.0 112.531 -174.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.598 HG12 ' H ' ' A' ' 299' ' ' ALA . 48.9 t -93.66 139.3 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.228 179.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 8.4 t -109.93 24.1 13.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.044 0.449 . . . . 0.0 111.5 -175.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.598 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -156.69 174.99 14.65 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.177 0.513 . . . . 0.0 112.087 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.97 113.13 2.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.709 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.46 ' HA ' ' CG1' ' A' ' 311' ' ' VAL . . . -93.18 106.86 18.77 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.059 -176.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.522 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 65.4 t30 -69.63 147.08 51.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.818 0.342 . . . . 0.0 111.532 -177.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.705 ' HB3' ' CE2' ' A' ' 261' ' ' PHE . 2.5 p -142.01 95.98 2.89 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.151 0.501 . . . . 0.0 110.517 171.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.58 151.87 21.83 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 172.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 305' ' ' SER . . . . . 0.547 ' CB ' ' HA ' ' A' ' 256' ' ' ALA . 0.3 OUTLIER -70.77 -12.31 61.47 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -171.639 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -71.16 -11.62 70.99 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 169.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 307' ' ' GLY . . . . . 0.495 ' O ' HG22 ' A' ' 252' ' ' THR . . . 75.77 41.36 28.86 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.784 -0.708 . . . . 0.0 113.869 174.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -125.55 111.18 14.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.034 0.917 . . . . 0.0 111.602 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.543 HG12 ' H ' ' A' ' 253' ' ' GLY . 0.6 OUTLIER -132.59 138.79 51.32 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.103 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.58 ' OG1' HG23 ' A' ' 250' ' ' THR . 94.7 m -123.17 126.34 46.82 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.129 -0.357 . . . . 0.0 110.305 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 301' ' ' ALA . 15.4 m -146.47 164.89 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.944 0.402 . . . . 0.0 110.156 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 56.8 m -114.3 139.43 49.44 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.128 0.489 . . . . 0.0 110.573 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.404 HD13 ' CE2' ' A' ' 247' ' ' PHE . 4.8 mp -105.28 150.34 25.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.853 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 34.1 t . . . . . 0 C--N 1.323 -0.548 0 CA-C-O 121.16 0.505 . . . . 0.0 112.047 -174.65 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.471 HG12 ' HD2' ' A' ' 234' ' ' PRO . 23.5 t . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.785 0.326 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.66 129.25 34.31 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -168.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 232' ' ' THR . . . -99.59 114.26 27.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.901 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 336' ' ' GLY . . . . . 0.678 ' HA2' ' O ' ' A' ' 230' ' ' VAL . . . 128.8 13.34 2.5 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 119.179 -1.486 . . . . 0.0 115.82 163.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.662 ' HB3' ' O ' ' A' ' 271' ' ' THR . 3.6 t0 -108.83 -67.34 0.98 Allowed 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -171.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 338' ' ' ALA . . . . . 0.951 ' O ' ' HA ' ' A' ' 229' ' ' THR . . . -51.11 178.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 116.917 2.191 . . . . 0.0 116.917 -156.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.743 ' HB ' HG23 ' A' ' 227' ' ' THR . 3.1 m -149.42 -164.77 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 CA-C-O 117.855 -1.069 . . . . 0.0 108.833 -168.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.614 ' HB3' ' C ' ' A' ' 226' ' ' GLY . 29.1 t -119.63 152.35 37.21 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 121.247 1.839 . . . . 0.0 114.404 -168.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.93 ' N ' ' HA ' ' A' ' 268' ' ' VAL . 53.3 t -124.83 58.03 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.827 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 164.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.445 HG23 ' OG ' ' A' ' 340' ' ' SER . 3.5 t . . . . . 0 C--N 1.318 -0.793 0 CA-C-O 122.446 1.117 . . . . 0.0 108.094 175.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 112.208 -0.357 . . . . 0.0 112.208 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 27.5 m -141.43 135.12 30.01 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 8.9 mt -139.31 178.11 7.43 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.705 -176.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.8 m -124.27 154.91 39.53 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.826 0.346 . . . . 0.0 110.735 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 67.2 t -99.63 128.78 51.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.974 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 51.2 tttt -112.47 -28.09 8.0 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.929 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 27.1 p -139.38 -169.97 2.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.696 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 61.2 mt-30 -112.64 116.81 47.67 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -174.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.719 ' HA ' ' O ' ' A' ' 248' ' ' THR . 7.4 Cg_exo -72.58 104.81 1.78 Allowed 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.361 2.041 . . . . 0.0 112.722 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.9 t -154.26 131.92 11.44 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.028 0.442 . . . . 0.0 111.782 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.684 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.87 176.47 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 168.908 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 237' ' ' THR . . . . . 0.534 ' H ' HG13 ' A' ' 236' ' ' VAL . 91.6 m -37.17 111.0 0.14 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -176.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -97.45 84.04 3.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.221 173.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.508 ' OD1' ' HB2' ' A' ' 242' ' ' LYS . 0.8 OUTLIER -87.09 121.25 29.29 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -176.091 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -105.99 -56.92 2.11 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -164.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 32.8 t -64.66 -29.7 48.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.388 0.613 . . . . 0.0 109.57 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.508 ' HB2' ' OD1' ' A' ' 239' ' ' ASN . 27.6 mtpt -89.56 -16.92 29.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.754 178.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 68.54 70.67 0.3 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 114.495 -1.229 . . . . 0.0 112.617 174.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.4 t -154.03 96.5 1.97 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.384 0.612 . . . . 0.0 110.298 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 17.1 m-30 -103.85 108.22 19.44 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.32 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -112.84 149.34 33.23 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 173.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.684 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 1.3 p90 -160.17 139.82 11.17 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 121.339 -0.144 . . . . 0.0 110.819 177.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.719 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 52.4 m -109.22 142.53 39.91 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.218 -0.193 . . . . 0.0 111.167 -174.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.97 131.35 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 121.466 0.651 . . . . 0.0 112.727 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 21.3 m -96.94 120.69 37.74 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 165.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.456 ' HB2' HG13 ' A' ' 309' ' ' VAL . 0.4 OUTLIER -116.47 171.54 7.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.242 0.544 . . . . 0.0 109.831 -175.725 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.01 147.68 46.39 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.364 172.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -148.45 -143.75 3.85 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.62 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.478 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -104.76 -174.47 2.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -176.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.617 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.5 OUTLIER -72.31 -177.91 2.32 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.49 -169.628 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.617 ' H ' HG22 ' A' ' 255' ' ' THR . . . -62.83 -176.89 0.13 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.451 0.701 . . . . 0.0 112.506 -178.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 68.3 m 80.32 16.31 0.71 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.838 0.855 . . . . 0.0 111.613 -177.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 61.8 t -135.34 94.76 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 171.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 4.3 m -72.05 92.27 1.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.622 -177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 76.72 92.86 0.22 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.925 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' A' ' 303' ' ' SER . 3.2 m-85 -42.92 -53.5 4.67 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.775 0.321 . . . . 0.0 111.66 168.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 18.3 mt -141.29 147.01 37.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.308 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 57.8 mtmt -139.38 -169.39 2.66 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 123.249 0.343 . . . . 0.0 110.886 175.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -53.66 119.39 4.85 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.278 0.561 . . . . 0.0 111.411 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 107.25 -7.87 37.75 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.45 176.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -90.45 130.97 36.45 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -109.23 140.7 42.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.877 0.37 . . . . 0.0 110.686 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 295' ' ' ALA . 1.0 OUTLIER -122.24 171.41 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 121.305 0.574 . . . . 0.0 111.834 -178.399 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.401 ' C ' ' HD2' ' A' ' 269' ' ' LYS . 0.2 OUTLIER -131.42 129.64 41.51 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.887 179.18 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 270' ' ' PHE . . . . . 0.439 ' O ' ' HA ' ' A' ' 292' ' ' SER . 47.5 m-85 -100.04 127.57 46.24 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.129 -0.357 . . . . 0.0 110.261 177.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.51 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 51.7 m -102.73 88.15 3.14 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 173.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.656 ' HA ' ' CB ' ' A' ' 337' ' ' ASP . 4.3 p-10 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.071 -167.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 52.0 m . . . . . 0 C--O 1.233 0.233 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -135.77 150.59 49.54 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 121.018 0.437 . . . . 0.0 111.472 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 98.4 m -95.65 136.51 35.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.755 -173.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 295' ' ' ALA . . . . . 0.536 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -121.25 171.07 8.99 Favored 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 122.447 -0.158 . . . . 0.0 110.705 176.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 96.6 m -135.2 121.59 20.43 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.282 0.563 . . . . 0.0 112.168 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 59.5 t -79.36 139.96 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.333 -178.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 0.9 OUTLIER -130.62 24.24 5.07 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.017 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.552 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -162.14 179.83 7.64 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.436 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 5.6 m-20 -69.17 163.48 24.79 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.81 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.442 ' HB2' ' CG1' ' A' ' 311' ' ' VAL . . . -149.48 172.86 14.29 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.668 -174.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.662 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 16.8 m120 -138.28 122.71 18.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -175.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.483 ' HB3' ' CE1' ' A' ' 261' ' ' PHE . 0.6 OUTLIER -105.87 93.37 4.6 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 162.622 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.33 178.91 4.46 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.436 -0.505 . . . . 0.0 110.92 -173.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 17.7 m -57.65 -33.1 67.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.851 0.358 . . . . 0.0 111.649 -177.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -82.05 0.89 88.11 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.321 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 307' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 62.01 43.11 99.61 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.438 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -121.04 126.65 50.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.717 0.758 . . . . 0.0 110.855 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.662 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.3 OUTLIER -136.67 126.2 38.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.846 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -177.901 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 34.1 m -123.65 132.58 53.89 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.939 -0.475 . . . . 0.0 111.117 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.442 ' CG1' ' HB2' ' A' ' 301' ' ' ALA . 9.2 m -144.71 162.19 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.213 0.53 . . . . 0.0 110.418 176.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 21.0 m -117.01 142.21 47.26 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.48 0.657 . . . . 0.0 109.891 174.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 313' ' ' LEU . 0.5 OUTLIER -107.83 133.27 52.44 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.874 -173.591 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 C--N 1.32 -0.704 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.532 -171.418 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.47 HG11 ' O ' ' A' ' 234' ' ' PRO . 34.3 m . . . . . 0 N--CA 1.45 -0.438 0 CA-C-O 121.606 0.717 . . . . 0.0 111.867 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -146.88 145.72 29.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.967 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -99.29 142.97 30.08 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.676 -174.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 129.09 11.43 2.83 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.569 171.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.656 ' CB ' ' HA ' ' A' ' 272' ' ' ASN . 10.9 p-10 -104.4 -153.32 0.48 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.926 0.363 . . . . 0.0 111.093 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -126.23 139.24 53.49 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 121.207 0.527 . . . . 0.0 111.774 -173.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.434 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 75.1 t -103.08 145.44 12.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.657 -177.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 10.5 m -142.97 178.92 7.35 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 268' ' ' VAL . 60.5 t -117.58 141.54 35.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.673 0.273 . . . . 0.0 110.563 -175.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 72.1 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.87 177.034 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.644 0 N-CA-C 111.771 -0.531 . . . . 0.0 111.771 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.9 m -127.9 141.34 51.58 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.821 0.343 . . . . 0.0 110.421 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.456 HD21 ' CE2' ' A' ' 261' ' ' PHE . 12.7 mt -143.08 175.19 10.05 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.985 -177.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 63.3 m -128.65 157.46 41.26 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.219 -176.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.501 HG21 ' OD2' ' A' ' 337' ' ' ASP . 92.6 t -99.13 138.67 22.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 120.622 0.249 . . . . 0.0 110.648 -177.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.415 ' HB3' HG22 ' A' ' 250' ' ' THR . 35.6 tptt -117.53 -34.7 4.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.547 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 53.9 p -137.04 -173.67 3.52 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.599 ' HG3' ' N ' ' A' ' 334' ' ' GLU . 24.3 mm-40 -115.57 155.96 46.69 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -168.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.481 ' HB3' ' CD1' ' A' ' 247' ' ' PHE . 28.3 Cg_endo -63.47 105.95 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.176 2.584 . . . . 0.0 111.985 174.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 236' ' ' VAL . 5.1 t -148.27 96.98 2.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.574 0.702 . . . . 0.0 111.741 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.736 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.73 174.01 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 168.217 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 237' ' ' THR . . . . . 0.497 ' H ' HG13 ' A' ' 236' ' ' VAL . 44.2 m -29.06 109.54 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -175.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -108.72 87.63 2.54 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 168.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.51 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 4.9 t30 -113.88 102.47 10.24 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.642 -174.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -84.51 -52.14 6.37 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -164.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 26.1 t -67.28 -23.59 30.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.411 0.624 . . . . 0.0 109.578 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.51 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 43.2 mmtt -89.88 -12.77 38.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.566 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 30.0 t70 63.37 69.65 0.56 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.183 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.2 m -149.5 106.86 3.61 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.879 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -125.29 102.76 7.59 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' GLN . . . . . 0.454 ' HB2' HG12 ' A' ' 236' ' ' VAL . 38.8 mt-30 -129.76 160.01 34.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.736 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 7.4 p90 -154.92 132.91 11.58 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.629 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 53.0 m -97.94 131.89 44.0 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 25.3 t -136.86 140.32 43.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.867 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.415 HG22 ' HB3' ' A' ' 231' ' ' LYS . 24.2 m -96.9 121.49 38.83 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 167.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.542 HD23 HG21 ' A' ' 339' ' ' VAL . 4.8 mp -110.24 167.37 10.24 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -123.54 140.63 52.81 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.415 ' HA2' HD23 ' A' ' 228' ' ' LEU . . . -142.11 -143.56 4.22 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.709 -174.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -102.63 -174.32 2.53 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.629 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.9 OUTLIER -72.18 -179.43 2.84 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.446 -169.907 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.629 ' H ' HG22 ' A' ' 255' ' ' THR . . . -61.22 -176.44 0.07 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.93 0.892 . . . . 0.0 112.898 -177.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 257' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 27.7 t 80.52 6.73 1.51 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.82 0.848 . . . . 0.0 110.922 -178.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 17.3 t -122.07 90.21 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 17.0 m -74.8 88.02 2.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.595 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 83.44 91.48 0.69 Allowed Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.383 -178.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.456 ' CE2' HD21 ' A' ' 228' ' ' LEU . 4.1 m-85 -43.01 -60.09 1.76 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 170.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 63.9 mt -149.02 161.76 41.29 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.12 -172.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 85.6 mttt -142.92 -167.19 2.47 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.119 0.262 . . . . 0.0 111.138 175.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -49.63 116.68 1.87 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.276 0.56 . . . . 0.0 111.686 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 108.36 -5.14 33.39 Favored Glycine 0 C--N 1.316 -0.53 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.299 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -94.96 143.27 26.61 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' GLN . . . . . 0.402 ' O ' HG12 ' A' ' 342' ' ' VAL . 23.0 mt-30 -114.06 152.7 30.63 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.551 0.691 . . . . 0.0 111.455 -176.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.3 OUTLIER -130.09 165.97 28.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.865 177.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 340' ' ' SER . 0.8 OUTLIER -122.64 87.45 2.75 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.1 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 270' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 339' ' ' VAL . 5.3 p90 -92.16 132.38 36.67 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.807 -175.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.606 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 77.2 m -98.24 87.14 3.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.36 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 . . . . . 0 C--N 1.32 -0.69 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.006 -177.525 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.45 -0.454 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.96 144.57 50.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.19 0.519 . . . . 0.0 111.014 -176.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 60.3 m -81.53 122.89 28.13 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.275 -176.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 295' ' ' ALA . . . . . 0.429 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -114.48 175.45 5.48 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 63.8 m -135.19 130.58 35.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.573 0.701 . . . . 0.0 112.808 -176.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 62.8 t -80.57 139.39 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.811 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 312' ' ' THR . 13.8 t -121.71 1.8 10.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.782 0.325 . . . . 0.0 111.399 -176.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -142.46 -177.12 5.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -173.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.422 ' O ' HG12 ' A' ' 311' ' ' VAL . 10.9 m-20 -71.51 164.65 25.43 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.121 -178.071 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.56 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -149.58 156.08 41.36 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.316 -173.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.546 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 3.9 m-20 -129.17 126.88 40.2 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.624 -175.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.496 ' HB2' ' HB ' ' A' ' 258' ' ' VAL . 0.4 OUTLIER -111.24 95.5 5.56 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 163.966 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -102.16 178.2 4.67 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.646 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 50.4 m -60.21 -32.28 70.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.729 0.299 . . . . 0.0 111.697 -177.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -73.64 -8.83 77.62 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.175 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 70.61 42.39 63.11 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.511 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -118.43 136.01 54.02 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.734 0.767 . . . . 0.0 111.474 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.546 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.7 OUTLIER -142.92 110.31 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.804 -178.478 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 25.5 m -105.16 127.4 52.89 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.609 -0.682 . . . . 0.0 111.537 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.522 HG22 HD13 ' A' ' 251' ' ' LEU . 19.5 m -144.38 148.72 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.296 0.57 . . . . 0.0 111.014 175.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.517 ' O ' HG22 ' A' ' 298' ' ' THR . 50.0 m -97.22 146.78 24.77 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 172.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.483 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.1 mp -117.51 136.73 53.03 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.299 -176.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 38.1 m . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.494 -174.217 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.447 ' HB ' ' OE1' ' A' ' 233' ' ' GLN . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.25 0 CA-C-O 120.24 0.066 . . . . 0.0 110.867 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 334' ' ' GLU . . . . . 0.599 ' N ' ' HG3' ' A' ' 233' ' ' GLN . 10.8 tp10 -158.67 130.34 6.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.606 0.241 . . . . 0.0 110.7 -173.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -66.22 158.35 29.09 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.295 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 130.07 -1.24 5.8 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.673 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.606 ' HB2' ' O ' ' A' ' 271' ' ' THR . 10.3 p-10 -89.08 -171.3 3.22 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 122.333 0.253 . . . . 0.0 110.742 176.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -129.04 162.57 27.35 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -171.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.542 HG21 HD23 ' A' ' 251' ' ' LEU . 98.3 t -128.56 142.62 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.968 -175.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.486 ' HB3' ' HB2' ' A' ' 269' ' ' LYS . 33.7 t -127.63 165.17 20.48 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 170.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 39.5 t -120.76 148.72 23.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 122.328 0.251 . . . . 0.0 110.386 -177.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.433 ' HB ' ' HE3' ' A' ' 269' ' ' LYS . 7.5 p . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 121.025 0.44 . . . . 0.0 110.691 177.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.719 0 N-CA-C 112.283 -0.327 . . . . 0.0 112.283 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 27.1 m -111.05 141.06 45.04 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.456 HD21 ' CE2' ' A' ' 261' ' ' PHE . 8.6 mt -139.34 172.07 13.35 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.575 -173.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 40.3 m -128.0 152.74 47.56 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 -176.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.506 ' HB ' ' H ' ' A' ' 337' ' ' ASP . 61.3 t -94.08 108.16 20.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -95.49 -32.41 12.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.192 0.52 . . . . 0.0 110.888 -174.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.564 ' OG1' ' HB ' ' A' ' 250' ' ' THR . 61.6 p -129.09 -167.44 1.78 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.604 178.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.57 ' HB3' ' CG2' ' A' ' 333' ' ' VAL . 63.7 mt-30 -112.72 128.51 25.48 Favored Pre-proline 0 C--N 1.32 -0.702 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.61 -171.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.28 107.92 2.27 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.682 2.255 . . . . 0.0 112.739 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 13.5 t -112.54 147.47 36.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.007 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.408 HG11 ' CZ ' ' A' ' 238' ' ' TYR . 16.0 t -110.52 136.97 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -166.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 22.5 m -101.91 116.89 33.68 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 168.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.408 ' CZ ' HG11 ' A' ' 236' ' ' VAL . 43.1 m-85 -103.16 131.5 50.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.039 0.447 . . . . 0.0 111.87 -176.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.47 HD22 ' HA ' ' A' ' 239' ' ' ASN . 0.2 OUTLIER -142.1 88.66 2.12 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.508 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -88.79 -41.0 12.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.293 -162.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.3 -23.22 32.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.706 0.765 . . . . 0.0 109.037 175.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -94.69 -12.33 27.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.016 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 6.3 t70 60.73 57.93 2.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.713 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 21.4 m -146.5 115.64 6.99 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.929 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -120.29 133.56 55.44 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -143.33 126.72 16.73 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.522 ' CE1' ' HB2' ' A' ' 313' ' ' LEU . 18.7 p90 -130.17 133.33 46.52 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.429 174.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 92.9 m -104.52 142.19 35.06 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.988 -167.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 8.5 p -145.69 133.06 15.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.36 0.6 . . . . 0.0 112.294 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.564 ' HB ' ' OG1' ' A' ' 232' ' ' THR . 52.9 m -97.23 116.81 30.12 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 168.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.44 170.89 7.97 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.486 0.66 . . . . 0.0 109.893 -175.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.54 150.25 35.22 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.486 171.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.417 ' CA ' HD23 ' A' ' 228' ' ' LEU . . . -148.27 -144.12 3.92 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.53 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -106.39 -176.5 3.09 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -175.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.615 HG22 ' H ' ' A' ' 256' ' ' ALA . 1.3 m -68.42 178.99 1.77 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.519 -171.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.615 ' H ' HG22 ' A' ' 255' ' ' THR . . . -61.76 -176.14 0.08 Allowed 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.718 0.807 . . . . 0.0 112.323 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 28.9 t 81.07 6.83 1.28 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.835 0.854 . . . . 0.0 110.894 -178.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 40.1 t -126.03 89.96 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.463 0.649 . . . . 0.0 109.304 172.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 10.8 m -69.37 97.31 0.96 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.376 -178.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 68.21 99.46 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.494 -177.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.456 ' CE2' HD21 ' A' ' 228' ' ' LEU . 11.9 m-85 -43.23 -49.99 6.51 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.742 0.271 . . . . 0.0 111.371 170.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 266' ' ' ASP . 0.7 OUTLIER -166.08 166.16 17.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.677 -175.794 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.448 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 59.0 mtmt -140.79 -165.82 2.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.722 0.296 . . . . 0.0 111.685 -177.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -51.91 118.27 3.31 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.448 0.642 . . . . 0.0 111.877 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 107.02 -10.3 40.24 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.975 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' ASP . . . . . 0.411 ' HB2' ' HB2' ' A' ' 262' ' ' LEU . 38.7 m-20 -93.3 136.97 33.06 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -108.31 151.52 25.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.533 0.682 . . . . 0.0 112.313 -172.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 294' ' ' THR . 1.3 m -125.26 163.8 25.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.901 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.547 ' HE2' HG22 ' A' ' 342' ' ' VAL . 0.0 OUTLIER -135.13 126.91 29.22 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 169.223 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -144.71 163.71 33.19 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.909 -0.494 . . . . 0.0 110.906 -174.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.589 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 5.0 t -121.67 101.3 7.51 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.893 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.366 -179.201 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 42.8 m . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.19 145.43 51.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.967 0.413 . . . . 0.0 110.936 -175.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 87.1 m -90.02 131.07 36.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.798 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -129.63 -178.4 4.67 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 89.7 m -141.71 134.15 28.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.392 0.615 . . . . 0.0 112.385 -177.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.559 HG12 ' H ' ' A' ' 299' ' ' ALA . 94.9 t -86.32 146.01 6.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.719 -178.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 13.6 t -125.57 18.11 8.12 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.572 -175.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.559 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -154.58 -177.86 6.77 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.448 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 2.7 m-20 -69.78 163.0 26.72 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.168 -178.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.46 ' HB2' ' CG1' ' A' ' 311' ' ' VAL . . . -147.28 167.88 23.14 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.973 -178.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.692 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 21.0 m120 -142.59 128.97 20.04 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.469 -174.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.6 OUTLIER -109.48 94.97 5.31 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 163.934 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -101.62 -176.94 3.28 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.207 -175.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 13.1 t -60.59 -33.03 72.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.792 0.33 . . . . 0.0 111.424 -175.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -82.67 -2.8 90.67 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.696 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 307' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 63.5 44.44 96.65 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.203 -178.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -115.02 126.51 54.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 118.0 0.9 . . . . 0.0 111.0 177.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.692 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.2 OUTLIER -134.7 119.65 29.24 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.568 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.843 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.475 ' OG1' HG23 ' A' ' 250' ' ' THR . 53.1 m -113.39 134.98 54.35 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.285 -0.26 . . . . 0.0 110.498 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.46 ' CG1' ' HB2' ' A' ' 301' ' ' ALA . 6.9 m -145.8 164.39 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.361 0.601 . . . . 0.0 110.547 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.445 ' O ' HG22 ' A' ' 298' ' ' THR . 19.7 m -119.99 138.54 53.43 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.421 173.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.522 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 4.1 mp -109.59 169.58 8.61 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.631 -175.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 C--N 1.326 -0.449 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -172.91 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.57 ' CG2' ' HB3' ' A' ' 233' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 121.227 0.537 . . . . 0.0 112.117 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -144.65 147.86 33.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.328 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -98.95 173.18 6.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.767 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 98.99 8.16 54.36 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.818 -0.706 . . . . 0.0 113.05 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.589 ' HB3' ' O ' ' A' ' 271' ' ' THR . 30.6 m-20 -92.81 -172.96 3.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.793 0.33 . . . . 0.0 111.795 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -112.12 142.71 44.24 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.665 -172.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 82.9 t -126.97 149.55 32.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.373 -178.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 50.7 m -147.98 158.86 44.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.921 0.391 . . . . 0.0 110.528 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 48.9 t -102.22 137.04 31.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.797 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.547 HG22 ' HE2' ' A' ' 269' ' ' LYS . 53.1 t . . . . . 0 C--N 1.332 -0.181 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.078 175.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.61 0 CA-C-O 121.201 0.334 . . . . 0.0 113.241 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.9 m -91.01 147.61 22.96 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.159 0.504 . . . . 0.0 111.434 -175.701 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 4.4 mp -138.34 176.01 9.07 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 168.138 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 33.0 m -135.92 161.79 34.64 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.634 0.254 . . . . 0.0 110.893 -170.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 59.3 t -118.09 126.09 74.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 176.515 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.456 ' HE2' HG21 ' A' ' 252' ' ' THR . 20.4 ttmm -108.67 -11.34 15.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.131 0.491 . . . . 0.0 111.126 -177.657 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.475 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 57.5 p -124.11 -166.83 1.55 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.476 -179.327 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -102.82 112.49 65.75 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -170.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -65.08 103.53 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.503 1.469 . . . . 0.0 111.154 175.399 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.3 t -103.01 120.22 40.25 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.509 0.671 . . . . 0.0 110.532 -177.057 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.428 ' HA ' ' CB ' ' A' ' 247' ' ' PHE . 21.3 t -77.26 123.17 33.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.848 -175.856 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 29.2 m -96.72 105.15 17.21 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.12 178.826 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -89.84 116.09 27.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.607 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.484 ' OD1' ' HG3' ' A' ' 242' ' ' LYS . 0.8 OUTLIER -122.71 76.14 1.32 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 176.547 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -84.3 -32.28 24.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.126 -160.688 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 38.8 t -65.39 -22.17 30.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 122.164 0.983 . . . . 0.0 108.529 173.54 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.484 ' HG3' ' OD1' ' A' ' 239' ' ' ASN . 43.4 mmtt -101.77 0.47 35.87 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.166 179.196 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 51.4 37.67 19.75 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.056 -178.788 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.9 m -119.17 127.32 53.2 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.009 178.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -125.17 112.11 16.06 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.079 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 246' ' ' GLN . . . . . 0.42 ' HB3' ' O ' ' A' ' 313' ' ' LEU . 66.2 mt-30 -130.79 -178.87 4.99 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.685 -175.276 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 313' ' ' LEU . 6.9 p90 -156.76 137.83 13.59 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.476 171.611 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 61.4 m -103.15 134.95 45.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.177 -173.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.409 ' HB ' HD11 ' A' ' 251' ' ' LEU . 0.5 OUTLIER -147.62 149.36 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.563 -179.839 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.551 HG23 ' OG1' ' A' ' 310' ' ' THR . 38.3 m -99.09 111.4 23.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 164.721 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.576 HD23 HG21 ' A' ' 339' ' ' VAL . 4.6 mp -104.3 168.06 9.35 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -172.751 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.456 HG21 ' HE2' ' A' ' 231' ' ' LYS . 0.7 OUTLIER -120.57 130.24 54.11 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.693 0.282 . . . . 0.0 110.367 177.467 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.422 ' N ' HG12 ' A' ' 309' ' ' VAL . . . -124.08 -143.15 6.15 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.944 -171.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -113.5 -171.33 1.86 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -173.312 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 256' ' ' ALA . 1.8 m -51.12 167.34 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -173.157 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 257' ' ' SER . . . -69.95 -175.78 0.99 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.177 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 257' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 67.6 m 80.6 9.15 1.21 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.794 176.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 94.4 t -119.52 94.5 3.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 170.585 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 22.6 m -74.6 89.56 2.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.42 -178.459 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 80.1 102.32 0.28 Allowed Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.623 -175.726 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.456 ' CE1' ' HB2' ' A' ' 303' ' ' SER . 10.6 m-85 -48.17 -59.11 3.66 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.673 0.749 . . . . 0.0 110.392 173.719 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 266' ' ' ASP . 89.3 mt -141.7 168.4 19.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.009 -175.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -131.63 -169.27 2.16 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.18 0.3 . . . . 0.0 111.006 -179.535 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -56.82 114.41 2.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.255 0.55 . . . . 0.0 111.652 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 112.75 -6.07 25.97 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.562 177.313 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 266' ' ' ASP . . . . . 0.547 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 64.6 m-20 -96.19 138.14 34.24 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 267' ' ' GLN . . . . . 0.554 ' HB2' HG11 ' A' ' 342' ' ' VAL . 30.5 mt-30 -108.94 159.76 16.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.636 0.732 . . . . 0.0 111.779 -173.617 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.06 -175.48 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.827 -179.29 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 340' ' ' SER . 23.9 tptt -120.9 104.56 9.93 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.834 174.419 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -95.29 120.71 35.99 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 120.942 0.401 . . . . 0.0 110.127 -175.108 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 54.8 m -110.6 89.25 2.98 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.767 178.352 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 . . . . . 0 C--N 1.323 -0.571 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.611 179.115 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 55.7 p . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -143.45 148.27 35.85 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.0 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 66.7 m -74.94 115.99 15.16 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.675 -179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -103.14 -179.95 4.1 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 177.288 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.593 ' HB ' ' O ' ' A' ' 314' ' ' SER . 90.7 m -139.82 133.8 30.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -175.1 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.57 HG13 HG21 ' A' ' 311' ' ' VAL . 50.7 t -78.64 135.91 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.715 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 5.1 m -108.62 -13.43 14.81 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -173.178 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -154.38 -178.66 7.29 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.172 -0.33 . . . . 0.0 110.916 -175.499 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.58 105.58 0.66 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.178 0.513 . . . . 0.0 110.447 178.055 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -95.41 100.43 12.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.499 -177.382 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.434 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 65.3 t30 -61.04 149.49 36.74 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -168.569 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.519 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 36.6 t -128.78 95.23 4.04 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 166.374 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -104.9 173.03 6.48 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.89 -179.321 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 8.5 t -58.25 -32.08 68.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.861 0.362 . . . . 0.0 111.472 -173.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -73.77 3.45 35.25 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.217 -177.797 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 66.27 41.85 94.46 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.739 178.125 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -116.84 139.08 51.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.901 0.35 . . . . 0.0 110.694 -178.756 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 251' ' ' LEU . 1.8 p -147.7 95.17 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.366 0.603 . . . . 0.0 111.352 179.186 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.551 ' OG1' HG23 ' A' ' 250' ' ' THR . 53.0 m -96.12 130.37 43.18 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 121.597 -0.689 . . . . 0.0 110.896 179.523 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.57 HG21 HG13 ' A' ' 297' ' ' VAL . 14.5 p -165.81 150.24 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.109 0.48 . . . . 0.0 110.424 175.216 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 25.0 m -93.69 145.49 24.52 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.632 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.526 ' HA ' ' O ' ' A' ' 296' ' ' THR . 5.1 mp -110.62 140.95 44.48 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.086 -175.662 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 314' ' ' SER . . . . . 0.593 ' O ' ' HB ' ' A' ' 296' ' ' THR . 39.0 t . . . . . 0 C--N 1.32 -0.709 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.677 -176.14 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.232 0.156 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -127.43 134.83 49.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.92 0.39 . . . . 0.0 110.628 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -66.53 157.16 32.94 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.584 -175.845 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.38 3.12 5.75 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.401 178.21 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.11 166.85 10.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.222 0.534 . . . . 0.0 111.49 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -116.56 148.05 41.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.993 -179.048 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.576 HG21 HD23 ' A' ' 251' ' ' LEU . 70.7 t -130.38 150.59 34.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.809 0.338 . . . . 0.0 111.086 -172.573 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.503 ' HB2' ' HB3' ' A' ' 269' ' ' LYS . 30.0 m -150.05 177.77 9.57 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.318 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 39.3 t -113.56 142.58 25.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.695 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.554 HG11 ' HB2' ' A' ' 267' ' ' GLN . 9.9 p . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 121.053 0.454 . . . . 0.0 111.051 -175.095 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.7 0 CA-C-O 121.047 0.248 . . . . 0.0 112.942 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.1 m -105.94 147.84 28.33 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.975 0.417 . . . . 0.0 111.184 -174.466 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.9 mp -132.61 -178.66 5.04 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 167.152 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.48 ' HB ' ' OG1' ' A' ' 252' ' ' THR . 23.1 m -127.47 155.82 43.11 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 122.324 -0.235 . . . . 0.0 111.072 -173.815 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.497 HG23 ' CG2' ' A' ' 339' ' ' VAL . 0.9 OUTLIER -111.22 137.43 43.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.275 177.399 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.415 ' HE3' HG22 ' A' ' 250' ' ' THR . 59.3 mtmt -109.57 -26.92 9.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.769 174.981 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.451 ' O ' HG13 ' A' ' 230' ' ' VAL . 58.6 p -137.07 -179.7 5.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.903 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.546 ' HB3' ' HB ' ' A' ' 333' ' ' VAL . 17.9 mm-40 -116.57 157.01 46.92 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -166.797 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.466 ' HG3' ' CZ ' ' A' ' 293' ' ' PHE . 73.8 Cg_endo -73.05 104.24 1.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.076 2.517 . . . . 0.0 113.127 178.576 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.475 ' N ' ' HB2' ' A' ' 247' ' ' PHE . 10.1 t -157.11 110.44 2.57 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.659 170.744 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.768 ' O ' ' HB2' ' A' ' 246' ' ' GLN . 75.7 t -154.74 79.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.34 0.656 . . . . 0.0 109.559 165.814 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 26.0 m 81.44 92.73 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.536 0.684 . . . . 0.0 110.645 174.117 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -106.95 104.96 14.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.341 178.13 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -129.29 126.82 39.87 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -102.61 -43.0 5.74 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.622 -170.282 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 67.3 t -61.55 -26.9 40.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.39 0.614 . . . . 0.0 109.916 178.085 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -99.05 -4.77 31.66 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.874 -179.425 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 53.3 57.9 5.77 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.059 -177.051 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 23.7 m -138.51 111.14 7.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.458 -177.073 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -128.57 120.08 26.02 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.321 -177.654 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 246' ' ' GLN . . . . . 0.768 ' HB2' ' O ' ' A' ' 236' ' ' VAL . 47.3 mt-30 -128.57 163.36 25.18 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 173.759 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.526 ' HA ' ' N ' ' A' ' 236' ' ' VAL . 20.9 p90 -168.64 151.43 5.21 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 174.007 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.411 ' H ' HG23 ' A' ' 236' ' ' VAL . 50.0 m -113.97 138.54 50.21 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 31.6 t -137.91 139.71 42.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.526 -178.796 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.542 HG23 ' OG1' ' A' ' 310' ' ' THR . 15.8 m -102.09 113.74 27.25 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.565 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.617 ' HB2' HG13 ' A' ' 309' ' ' VAL . 4.9 mp -110.39 170.63 7.96 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.943 0.402 . . . . 0.0 110.027 -171.768 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.636 HG22 ' O ' ' A' ' 307' ' ' GLY . 0.0 OUTLIER -126.87 120.97 30.5 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.402 176.761 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.442 ' HA3' HD23 ' A' ' 228' ' ' LEU . . . -156.78 134.77 4.16 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.81 -0.709 . . . . 0.0 111.404 178.049 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -112.7 93.41 4.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.107 0.48 . . . . 0.0 112.179 -173.293 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 18.3 m -126.16 102.74 7.34 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 169.894 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -56.0 134.86 52.67 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -175.741 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 24.5 t 63.31 53.65 2.16 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.901 172.577 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.446 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 84.2 t -132.47 95.97 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.291 0.567 . . . . 0.0 110.377 175.61 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.5 m -75.97 86.31 2.89 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.567 0.698 . . . . 0.0 109.857 177.995 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 95.62 92.51 1.75 Allowed Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.251 -177.235 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.552 ' CD1' ' HB2' ' A' ' 303' ' ' SER . 3.6 m-85 -45.34 -58.79 3.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.786 0.803 . . . . 0.0 109.958 169.622 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 266' ' ' ASP . 75.8 mt -141.53 169.83 16.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.168 -1.378 . . . . 0.0 108.031 -175.63 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 96.0 mttt -137.68 -171.22 2.94 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 121.173 -0.211 . . . . 0.0 110.884 -179.386 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -54.11 113.95 1.43 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.261 0.553 . . . . 0.0 111.413 -179.061 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 113.03 -6.82 25.42 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.77 177.087 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 266' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 22.9 m-20 -90.37 136.03 33.31 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.722 -0.281 . . . . 0.0 110.262 179.049 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -107.15 142.28 37.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.5 0.667 . . . . 0.0 111.981 -174.859 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 295' ' ' ALA . 0.7 OUTLIER -126.09 164.04 26.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.569 179.006 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 294' ' ' THR . 0.0 OUTLIER -135.68 147.99 48.75 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.674 174.221 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -110.95 130.03 55.71 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -174.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 44.0 m -104.25 126.63 51.52 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.763 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 . . . . . 0 C--N 1.316 -0.885 0 CA-C-O 121.893 0.854 . . . . 0.0 113.184 -163.208 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 32.8 p . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 293' ' ' PHE . . . . . 0.466 ' CZ ' ' HG3' ' A' ' 234' ' ' PRO . 35.9 p90 -161.58 177.2 10.23 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.992 0.425 . . . . 0.0 111.403 -176.652 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 269' ' ' LYS . 53.8 m -124.06 132.67 53.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.508 -178.787 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 295' ' ' ALA . . . . . 0.485 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -114.97 -179.74 3.71 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.802 0.334 . . . . 0.0 111.249 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 96.1 m -143.67 121.64 12.06 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.569 0.699 . . . . 0.0 111.675 178.358 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.703 HG13 HG21 ' A' ' 311' ' ' VAL . 78.0 t -66.86 138.79 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.544 -178.04 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 312' ' ' THR . 6.0 t -121.4 6.54 10.13 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.108 -175.655 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -163.18 -167.03 1.37 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -72.46 113.8 9.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.246 0.546 . . . . 0.0 110.047 179.179 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -91.98 101.28 13.83 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.343 178.212 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -56.36 134.01 53.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.503 -0.772 . . . . 0.0 112.802 -169.839 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.552 ' HB2' ' CD1' ' A' ' 261' ' ' PHE . 30.5 t -128.23 111.39 13.36 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 120.913 0.387 . . . . 0.0 110.873 173.583 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.49 157.41 41.23 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 3.9 t -71.07 -10.14 59.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.009 -171.235 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -69.17 -15.05 69.41 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 173.004 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 307' ' ' GLY . . . . . 0.636 ' O ' HG22 ' A' ' 252' ' ' THR . . . 90.07 41.03 5.68 Favored Glycine 0 C--O 1.223 -0.558 0 C-N-CA 120.925 -0.655 . . . . 0.0 114.379 174.845 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -126.22 130.73 51.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.151 0.976 . . . . 0.0 111.427 178.786 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.617 HG13 ' HB2' ' A' ' 251' ' ' LEU . 0.8 OUTLIER -141.93 112.06 2.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.744 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.525 176.018 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.542 ' OG1' HG23 ' A' ' 250' ' ' THR . 99.0 m -110.15 129.47 55.7 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.491 -0.756 . . . . 0.0 110.618 177.375 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.703 HG21 HG13 ' A' ' 297' ' ' VAL . 2.6 p -151.72 144.38 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 121.141 0.496 . . . . 0.0 111.23 178.252 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.525 ' O ' HG22 ' A' ' 298' ' ' THR . 22.6 m -100.34 145.21 28.43 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.679 175.418 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 313' ' ' LEU . 1.3 mm? -121.44 129.81 53.21 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.484 -172.065 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 16.0 p . . . . . 0 C--N 1.316 -0.861 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.932 -174.762 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 233' ' ' GLN . 15.4 m . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -155.92 112.16 3.1 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.483 -174.133 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -74.64 143.71 44.18 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -171.55 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 131.51 11.55 2.16 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 120.787 -0.72 . . . . 0.0 114.231 175.778 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -76.72 174.48 10.4 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 117.498 0.649 . . . . 0.0 112.03 175.589 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -112.0 132.0 55.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.731 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.497 ' CG2' HG23 ' A' ' 230' ' ' VAL . 54.5 t -102.67 152.91 5.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.668 -169.498 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 23.2 t -157.45 177.16 11.75 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 174.77 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 46.6 t -112.52 138.59 41.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.65 0.262 . . . . 0.0 110.767 -174.04 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 269' ' ' LYS . 56.5 t . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.78 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.233 0 N-CA-C 113.526 0.17 . . . . 0.0 113.526 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 19.1 m -102.66 142.44 33.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.926 0.393 . . . . 0.0 110.886 -178.683 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.558 HD21 ' CE1' ' A' ' 261' ' ' PHE . 19.2 mt -144.39 176.61 9.24 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.85 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 42.7 m -135.97 160.23 39.26 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 122.27 -0.269 . . . . 0.0 110.485 -174.142 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.628 ' HB ' ' OD2' ' A' ' 337' ' ' ASP . 3.4 t -118.63 152.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 177.581 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.578 ' HE3' HG22 ' A' ' 250' ' ' THR . 53.1 pttt -130.38 14.43 5.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.857 0.36 . . . . 0.0 111.132 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.617 ' H ' HG12 ' A' ' 230' ' ' VAL . 24.1 p -151.73 -178.55 6.79 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -175.56 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.553 ' HB3' ' CG2' ' A' ' 333' ' ' VAL . 0.3 OUTLIER -115.79 129.46 25.14 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -174.28 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.49 105.79 1.32 Allowed 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.452 2.101 . . . . 0.0 112.243 -179.598 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 5.8 t -107.0 129.6 54.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.307 178.624 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.439 HG22 ' HB3' ' A' ' 247' ' ' PHE . 8.1 t -85.61 123.63 39.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.203 -173.054 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 49.2 m -82.17 96.66 7.89 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.048 173.145 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.75 109.07 13.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.511 -178.548 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.5 HD22 ' HA ' ' A' ' 239' ' ' ASN . 0.2 OUTLIER -121.0 81.2 1.74 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.419 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -85.11 -36.86 20.85 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.067 -164.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.03 -23.15 32.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.757 0.789 . . . . 0.0 109.162 174.782 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.409 ' HG3' ' OD1' ' A' ' 239' ' ' ASN . 13.4 mmmm -103.62 -6.76 21.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.262 -176.212 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 58.32 58.95 3.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.57 -177.831 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 41.7 m -145.53 128.63 16.61 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.372 176.693 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -129.14 100.4 5.61 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.199 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -133.97 144.18 48.62 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.498 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.439 ' HB3' HG22 ' A' ' 236' ' ' VAL . 41.7 p90 -120.11 136.59 54.54 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.644 -178.083 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 97.9 m -100.95 141.25 34.1 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -173.794 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.519 HG13 ' CD1' ' A' ' 251' ' ' LEU . 1.4 p -144.48 146.14 20.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.418 -177.811 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.578 HG22 ' HE3' ' A' ' 231' ' ' LYS . 4.9 m -107.84 124.95 50.84 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 174.957 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.56 HD23 HG21 ' A' ' 339' ' ' VAL . 3.9 mp -115.21 171.74 7.5 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.668 0.747 . . . . 0.0 110.926 -167.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.406 HG23 ' HD3' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -129.11 142.28 50.94 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.218 169.151 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -140.98 -144.54 4.45 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.007 -173.783 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.524 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -101.91 -173.54 2.37 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -176.863 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.581 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -70.83 -177.81 1.7 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.337 -171.635 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.581 ' H ' HG22 ' A' ' 255' ' ' THR . . . -67.32 -175.39 0.47 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.266 -178.599 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 257' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 50.7 m 80.59 6.22 1.53 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.002 0.921 . . . . 0.0 111.244 179.46 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.9 88.79 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.505 0.669 . . . . 0.0 109.411 171.377 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 62.9 m -89.09 103.68 16.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.953 179.824 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 83.22 79.44 1.03 Allowed Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.068 -176.706 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.638 ' CE1' ' HB2' ' A' ' 303' ' ' SER . 6.8 m-85 -45.32 -54.59 6.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.788 0.804 . . . . 0.0 109.932 170.701 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.5 pp -158.11 173.7 16.33 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.288 -1.323 . . . . 0.0 108.677 -175.021 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.543 ' HE2' ' OD2' ' A' ' 300' ' ' ASP . 94.4 mttt -136.29 -167.54 2.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.702 0.287 . . . . 0.0 111.54 -174.782 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -55.4 116.57 2.93 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.436 0.636 . . . . 0.0 111.446 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 115.08 -14.96 18.84 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.199 177.624 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -86.06 141.89 29.12 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.254 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -104.86 150.16 25.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.878 0.847 . . . . 0.0 112.668 -172.376 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.35 173.71 13.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.668 175.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.454 ' HE2' ' CB ' ' A' ' 340' ' ' SER . 0.0 OUTLIER -134.57 149.88 50.67 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 167.091 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 270' ' ' PHE . . . . . 0.512 ' O ' ' HA ' ' A' ' 292' ' ' SER . 55.4 m-85 -106.5 130.73 54.23 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.494 -175.798 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 45.6 m -107.16 88.34 2.71 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 171.387 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 121.424 0.631 . . . . 0.0 111.767 -172.3 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 292' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 17.8 p . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -111.63 147.39 35.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.856 0.36 . . . . 0.0 111.127 -174.212 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 269' ' ' LYS . 51.9 m -88.02 127.27 35.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.783 -179.21 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -120.23 179.13 4.38 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 95.3 m -136.97 130.65 31.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.534 0.683 . . . . 0.0 112.543 -177.773 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 299' ' ' ALA . 61.1 t -85.1 144.08 10.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.484 -178.359 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 0.6 OUTLIER -119.33 24.74 10.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.821 -174.993 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.557 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -166.83 173.34 9.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.763 0.316 . . . . 0.0 111.668 -177.346 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.543 ' OD2' ' HE2' ' A' ' 263' ' ' LYS . 2.3 m-20 -64.8 116.55 6.42 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.256 176.688 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -93.26 112.75 24.76 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.664 179.023 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.74 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 65.9 t30 -85.55 134.47 34.02 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -171.528 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.638 ' HB2' ' CE1' ' A' ' 261' ' ' PHE . 7.7 t -113.88 95.72 5.46 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 163.925 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -98.53 179.25 4.76 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.976 -178.55 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 20.5 m -57.07 -32.92 66.75 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -173.552 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -83.39 5.54 76.97 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.468 -176.047 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 307' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 64.49 42.69 97.42 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.864 -178.345 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -120.22 142.91 48.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.367 0.584 . . . . 0.0 111.682 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.74 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.2 OUTLIER -143.89 152.7 15.93 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.616 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.096 176.973 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.448 ' OG1' HG23 ' A' ' 250' ' ' THR . 95.5 m -149.72 120.04 7.34 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.692 -0.63 . . . . 0.0 110.619 178.946 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 35.4 m -145.87 160.88 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.41 0.624 . . . . 0.0 111.23 -177.362 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 23.7 m -114.75 140.93 48.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.582 176.785 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.52 126.52 54.47 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.367 -171.245 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 7.6 p . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.329 -176.118 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.553 ' CG2' ' HB3' ' A' ' 233' ' ' GLN . 2.6 m . . . . . 0 C--O 1.236 0.393 0 CA-C-O 121.381 0.61 . . . . 0.0 112.113 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -147.22 161.82 40.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.937 -177.423 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -65.96 173.09 3.18 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.507 0.504 . . . . 0.0 111.358 178.596 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 112.26 13.73 11.64 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -176.086 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.628 ' OD2' ' HB ' ' A' ' 230' ' ' VAL . 0.4 OUTLIER -96.29 146.68 24.51 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.742 0.782 . . . . 0.0 112.617 -173.885 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -144.08 163.56 33.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.779 178.849 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.56 HG21 HD23 ' A' ' 251' ' ' LEU . 74.7 t -125.24 143.03 40.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.227 0.537 . . . . 0.0 111.285 -169.897 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.454 ' CB ' ' HE2' ' A' ' 269' ' ' LYS . 20.0 m -147.51 127.21 13.38 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 172.828 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 19.1 t -76.04 143.12 13.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 120.867 0.365 . . . . 0.0 111.311 -173.349 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 53.4 t . . . . . 0 C--N 1.333 -0.15 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.471 176.969 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.565 0 CA-C-O 121.533 0.518 . . . . 0.0 114.083 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 5.3 m -67.28 145.35 55.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.435 0.636 . . . . 0.0 112.401 -173.077 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.431 HD22 HG11 ' A' ' 309' ' ' VAL . 1.3 mt -133.68 179.13 6.42 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.89 177.991 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 251' ' ' LEU . 48.1 m -139.08 158.84 43.46 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 122.303 -0.248 . . . . 0.0 110.498 -175.761 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 17.6 t -106.08 133.19 51.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 179.496 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -104.46 -39.05 6.56 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 178.67 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 63.5 p -118.77 -169.56 1.75 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.785 0.326 . . . . 0.0 110.489 -177.021 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.45 ' HB3' HG23 ' A' ' 333' ' ' VAL . 91.2 mt-30 -105.27 126.1 31.83 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.507 -169.767 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.646 ' HB3' ' CD2' ' A' ' 247' ' ' PHE . 23.7 Cg_exo -62.56 104.73 0.38 Allowed 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.687 2.258 . . . . 0.0 111.861 176.739 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.8 t -142.55 104.87 4.45 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.661 0.743 . . . . 0.0 112.187 -177.85 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.706 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.16 175.42 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.879 171.931 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 237' ' ' THR . . . . . 0.602 ' H ' HG13 ' A' ' 236' ' ' VAL . 55.9 m -34.09 114.27 0.2 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -169.648 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -116.04 88.13 2.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.465 173.178 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -113.73 133.16 55.52 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -179.225 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -104.28 -40.39 6.13 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.621 -172.163 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.73 -29.77 46.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.516 0.674 . . . . 0.0 109.74 176.757 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.49 ' HA ' ' HE2' ' A' ' 242' ' ' LYS . 11.2 mmpt? -100.45 -3.43 30.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.084 -178.946 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 53.72 51.57 14.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 113.998 -1.456 . . . . 0.0 111.089 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.2 m -126.28 99.16 5.75 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.095 -175.239 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -116.44 108.42 16.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.071 0.462 . . . . 0.0 110.502 -177.912 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 246' ' ' GLN . . . . . 0.505 ' HB2' HG12 ' A' ' 236' ' ' VAL . 95.0 mt-30 -129.5 164.16 24.35 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.057 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.706 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 31.3 p90 -159.79 135.66 8.59 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.565 -0.454 . . . . 0.0 112.143 176.712 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 51.9 m -98.09 138.92 34.66 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.487 ' HB ' HD11 ' A' ' 251' ' ' LEU . 0.2 OUTLIER -142.7 150.83 17.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.765 -179.305 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.595 HG23 ' OG1' ' A' ' 310' ' ' THR . 96.2 m -104.38 117.45 34.21 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 167.488 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.582 ' HB2' HG13 ' A' ' 309' ' ' VAL . 4.0 mp -118.49 169.49 9.73 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.209 -170.973 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 307' ' ' GLY . 0.0 OUTLIER -110.4 141.72 43.09 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.279 176.114 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.417 ' HA2' HD23 ' A' ' 228' ' ' LEU . . . -138.34 -143.92 4.57 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.999 -178.653 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -109.96 -173.61 2.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.814 0.34 . . . . 0.0 111.877 -177.099 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.577 HG22 ' H ' ' A' ' 256' ' ' ALA . 2.2 m -67.04 173.68 3.55 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.388 -0.823 . . . . 0.0 112.877 -170.125 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.577 ' H ' HG22 ' A' ' 255' ' ' THR . . . -62.94 -175.34 0.09 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.861 0.864 . . . . 0.0 112.663 -178.785 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 257' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 31.3 t 81.53 6.4 1.2 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.95 0.9 . . . . 0.0 111.101 -178.792 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 64.4 t -125.32 90.54 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.545 0.688 . . . . 0.0 109.571 171.565 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 22.2 m -75.81 97.86 4.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.735 178.408 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 80.52 87.82 0.58 Allowed Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.495 -177.547 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.565 ' HB3' HD22 ' A' ' 262' ' ' LEU . 2.6 m-85 -44.6 -61.39 1.57 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.666 0.746 . . . . 0.0 110.143 170.824 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.565 HD22 ' HB3' ' A' ' 261' ' ' PHE . 2.9 mm? -135.22 166.01 24.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.405 -1.27 . . . . 0.0 108.483 179.64 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 98.2 mttt -134.74 -170.98 2.67 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 123.164 0.29 . . . . 0.0 110.822 178.022 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -59.51 117.28 4.7 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.112 0.482 . . . . 0.0 110.57 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 115.26 -14.93 18.36 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.514 177.831 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 266' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 28.5 m-20 -86.9 138.48 31.51 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.807 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -100.6 154.2 18.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.072 0.463 . . . . 0.0 110.319 -178.747 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 294' ' ' THR . 1.3 m -135.17 176.33 8.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.314 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.425 ' HE3' HG22 ' A' ' 342' ' ' VAL . 1.7 mptm? -122.8 139.99 53.41 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 171.831 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -137.68 136.76 37.72 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.803 174.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.631 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 29.7 m -110.14 88.54 2.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.428 -175.79 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.462 ' HA ' ' CG ' ' A' ' 337' ' ' ASP . 3.2 t-20 . . . . . 0 N--CA 1.467 0.384 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.205 176.86 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 10.3 p . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -153.3 168.87 24.58 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.248 0.547 . . . . 0.0 111.737 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 90.0 m -89.35 133.57 34.44 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.814 -172.614 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 295' ' ' ALA . . . . . 0.406 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -119.15 -170.43 1.92 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.963 175.871 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 16.9 m -139.01 131.82 29.19 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.58 0.705 . . . . 0.0 112.877 -177.732 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.639 HG13 HG21 ' A' ' 311' ' ' VAL . 55.1 t -82.42 142.09 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 114.207 -1.361 . . . . 0.0 109.488 179.155 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 41.5 p -129.19 18.44 5.98 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -173.576 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.409 ' HB3' HG23 ' A' ' 311' ' ' VAL . . . -167.59 177.95 5.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.394 0.14 . . . . 0.0 110.67 179.092 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.41 108.66 2.04 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.846 0.716 . . . . 0.0 109.556 178.043 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -92.67 100.91 13.33 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.275 0.56 . . . . 0.0 110.241 -177.439 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.449 ' OD1' ' HB3' ' A' ' 304' ' ' ASP . 9.0 t-20 -63.35 135.06 56.76 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -169.204 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.526 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 27.5 t -115.68 96.52 5.65 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 166.38 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 304' ' ' ASP . . . . . 0.449 ' HB3' ' OD1' ' A' ' 302' ' ' ASN . 0.4 OUTLIER -106.25 174.7 5.77 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.476 -176.864 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 20.3 m -60.67 -32.24 71.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.749 0.309 . . . . 0.0 111.589 -176.792 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -74.21 1.05 51.2 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.188 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 307' ' ' GLY . . . . . 0.465 ' O ' HG22 ' A' ' 252' ' ' THR . . . 63.91 40.68 98.56 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.309 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -114.16 127.77 56.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.695 0.284 . . . . 0.0 110.683 -179.6 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.582 HG13 ' HB2' ' A' ' 251' ' ' LEU . 2.7 p -131.97 101.06 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.392 0.615 . . . . 0.0 111.134 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.595 ' OG1' HG23 ' A' ' 250' ' ' THR . 54.3 m -104.03 126.63 51.3 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 121.95 -0.469 . . . . 0.0 110.864 -179.009 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.639 HG21 HG13 ' A' ' 297' ' ' VAL . 12.7 p -160.43 151.4 5.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.066 0.46 . . . . 0.0 110.237 175.37 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 48.4 m -92.4 148.9 21.75 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.307 178.449 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.502 ' HB2' ' CE2' ' A' ' 247' ' ' PHE . 5.7 mp -117.23 149.3 40.64 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.795 -179.076 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 36.8 m . . . . . 0 C--N 1.32 -0.713 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.74 -178.461 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.45 HG23 ' HB3' ' A' ' 233' ' ' GLN . 22.2 m . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -131.34 153.89 49.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.0 0.429 . . . . 0.0 110.638 -178.513 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -97.95 165.21 12.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.857 -179.079 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 103.5 12.17 31.46 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.344 175.909 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.631 ' HB3' ' O ' ' A' ' 271' ' ' THR . 23.8 m-20 -95.19 -178.77 4.57 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.021 0.438 . . . . 0.0 112.126 -178.641 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -104.73 153.92 20.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.61 -173.444 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.453 HG21 HD23 ' A' ' 251' ' ' LEU . 50.5 t -132.86 150.34 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.791 -176.367 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 31.6 t -144.85 171.34 14.57 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 175.318 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 32.2 t -118.29 160.28 18.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.669 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.425 HG22 ' HE3' ' A' ' 269' ' ' LYS . 94.3 t . . . . . 0 C--O 1.235 0.293 0 CA-C-N 118.212 0.46 . . . . 0.0 110.392 -179.582 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.964 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 20.3 m -129.74 131.49 46.3 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.738 0.304 . . . . 0.0 110.383 -173.795 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 2.2 mp -138.47 -177.3 4.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.122 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 95.3 m -143.74 156.14 44.42 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.997 -176.799 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.438 HG23 HG23 ' A' ' 339' ' ' VAL . 66.3 t -108.05 122.77 62.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.197 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -106.05 -6.28 18.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.106 0.479 . . . . 0.0 110.716 -175.555 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 17.5 p -130.25 -168.32 1.95 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.732 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.418 ' HA ' ' HD2' ' A' ' 234' ' ' PRO . 6.8 mt-30 -113.74 113.65 47.39 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -175.347 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 233' ' ' GLN . 18.3 Cg_endo -62.17 106.98 0.51 Allowed 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.894 2.396 . . . . 0.0 112.494 -179.65 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.0 t -149.37 118.44 6.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.533 0.682 . . . . 0.0 112.269 179.556 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.666 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -155.9 174.72 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.164 171.569 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 237' ' ' THR . . . . . 0.497 ' H ' HG13 ' A' ' 236' ' ' VAL . 34.8 m -23.09 100.19 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.609 1.164 . . . . 0.0 113.525 -177.318 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.95 83.42 1.82 Allowed 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.408 174.158 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.423 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 35.7 t-20 -108.79 129.96 55.38 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.016 -178.326 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -102.46 -41.39 6.32 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.68 -170.519 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.8 -33.77 65.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.43 0.633 . . . . 0.0 109.944 178.1 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.492 ' HA ' ' HE2' ' A' ' 242' ' ' LYS . 10.8 mmpt? -88.77 -11.25 45.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.481 178.835 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 26.5 t70 58.1 69.19 0.75 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.277 -178.796 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.9 m -146.8 104.84 3.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.159 -177.216 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -123.33 106.33 10.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.783 -176.846 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 246' ' ' GLN . . . . . 0.564 ' HB2' HG12 ' A' ' 236' ' ' VAL . 0.1 OUTLIER -124.03 161.92 24.53 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 171.551 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.666 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 35.2 p90 -149.09 134.82 18.78 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.67 174.818 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 46.5 m -98.8 137.49 37.32 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.957 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.428 ' HB ' ' CD1' ' A' ' 251' ' ' LEU . 0.2 OUTLIER -142.29 148.58 20.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.878 -178.946 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.6 HG23 ' OG1' ' A' ' 310' ' ' THR . 41.6 m -99.51 107.84 20.12 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 166.519 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.561 ' HB2' HG13 ' A' ' 309' ' ' VAL . 5.2 mp -102.82 167.97 9.53 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -170.685 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.19 144.13 43.69 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.813 175.95 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -142.82 -142.48 4.01 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.369 -173.144 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.414 ' H ' ' HZ ' ' A' ' 261' ' ' PHE . . . -113.37 -173.66 2.31 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -176.362 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.577 HG22 ' H ' ' A' ' 256' ' ' ALA . 1.8 m -70.9 174.0 6.69 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.185 -171.726 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.577 ' H ' HG22 ' A' ' 255' ' ' THR . . . -62.51 -177.46 0.14 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.495 0.718 . . . . 0.0 112.862 -177.17 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 23.1 t 80.83 10.93 0.95 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.185 0.994 . . . . 0.0 111.155 -176.764 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 40.4 t -124.33 94.06 2.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 169.705 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.2 m -67.65 88.89 0.24 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.515 -177.865 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 69.48 107.42 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.109 -174.555 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.414 ' HZ ' ' H ' ' A' ' 254' ' ' ALA . 15.1 m-85 -44.19 -57.35 3.49 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 117.243 0.521 . . . . 0.0 111.091 174.254 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.524 HD11 HG13 ' A' ' 341' ' ' VAL . 91.9 mt -147.83 146.81 29.26 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -177.838 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.514 ' HD2' ' N ' ' A' ' 263' ' ' LYS . 9.5 mptt -112.86 -166.45 1.08 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.033 0.444 . . . . 0.0 111.561 176.53 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -52.79 114.15 1.32 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.66 -175.505 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 114.2 -16.07 20.26 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.416 171.392 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.54 134.79 35.2 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.83 -177.014 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.19 145.94 24.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.24 -173.592 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.408 HG23 ' HB3' ' A' ' 295' ' ' ALA . 0.2 OUTLIER -125.33 165.3 22.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.744 179.97 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 340' ' ' SER . 0.8 OUTLIER -97.57 120.3 37.69 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 172.433 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -122.55 120.55 34.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.857 0.361 . . . . 0.0 110.085 -174.648 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 30.4 m -125.79 113.0 16.69 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.491 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 19.4 m120 . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.031 -177.584 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.449 -0.488 0 CA-C-O 120.739 0.304 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -118.96 174.99 5.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.046 0.45 . . . . 0.0 110.665 -178.588 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 67.9 m -109.22 117.91 35.35 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.852 178.955 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 295' ' ' ALA . . . . . 0.408 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -104.24 -175.85 2.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 -176.148 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 91.4 m -141.63 131.16 23.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.384 0.612 . . . . 0.0 112.282 -176.869 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.589 HG13 HG21 ' A' ' 311' ' ' VAL . 64.3 t -75.13 136.67 24.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.053 176.372 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 2.4 m -111.45 -9.04 14.24 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.97 -167.698 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -164.45 -168.9 1.63 Allowed 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.912 -0.492 . . . . 0.0 111.676 -177.872 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.16 151.71 35.1 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.77 0.795 . . . . 0.0 110.762 179.35 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -148.13 -178.38 6.26 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.315 -1.311 . . . . 0.0 109.433 -178.135 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -136.56 135.83 38.77 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -173.482 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.8 OUTLIER -112.94 95.62 5.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 161.618 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -99.88 175.49 5.76 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.662 -176.735 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 53.5 m -60.91 -31.39 70.9 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -177.027 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -78.55 -2.43 84.85 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.213 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 69.2 42.06 77.36 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.739 179.006 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -114.67 135.52 54.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.92 0.86 . . . . 0.0 110.856 175.279 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.561 HG13 ' HB2' ' A' ' 251' ' ' LEU . 2.3 p -136.51 105.29 4.41 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.507 -179.588 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.6 ' OG1' HG23 ' A' ' 250' ' ' THR . 90.7 m -102.82 129.84 49.62 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 121.664 -0.648 . . . . 0.0 111.365 -178.31 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.589 HG21 HG13 ' A' ' 297' ' ' VAL . 14.4 p -165.93 155.41 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.033 0.444 . . . . 0.0 110.237 174.303 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 52.4 m -96.64 149.32 21.93 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.453 -179.539 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.474 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.4 mp -117.21 136.62 52.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.542 -178.422 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.446 -173.915 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 25.9 m . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.873 0.368 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -132.64 144.7 50.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.5 -179.422 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -67.16 154.01 42.29 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.591 -178.49 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 117.25 6.1 13.98 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.201 -178.709 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -69.33 159.99 32.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.836 0.35 . . . . 0.0 111.162 -177.558 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -105.96 138.51 42.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.769 -176.235 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.48 HG21 HD23 ' A' ' 251' ' ' LEU . 77.2 t -128.09 145.1 35.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.137 0.494 . . . . 0.0 111.202 -175.436 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.536 ' HB2' ' HB3' ' A' ' 269' ' ' LYS . 36.5 m -145.02 175.54 10.15 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 172.206 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.524 HG13 HD11 ' A' ' 262' ' ' LEU . 98.7 t -116.09 122.3 69.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.917 0.389 . . . . 0.0 111.963 -174.667 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.428 173.563 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.701 0 N-CA-C 111.871 -0.492 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -115.72 140.11 49.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.178 0.513 . . . . 0.0 111.033 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -79.73 -22.23 43.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.26 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 100.76 12.65 36.89 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.4 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -111.74 115.7 3.94 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.17 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 26.4 m -152.21 98.93 2.47 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 2.2 mp -116.67 -176.66 3.01 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.615 -172.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 87.6 m -134.01 154.77 50.92 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.418 -176.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 41.1 t -93.87 107.26 19.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -90.49 -31.19 16.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.025 0.44 . . . . 0.0 111.194 -172.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 19.2 p -128.71 -168.45 1.92 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.194 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.61 ' HB3' HG23 ' A' ' 333' ' ' VAL . 64.9 mt-30 -108.08 122.02 41.96 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-O 120.887 0.375 . . . . 0.0 110.617 -171.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.77 106.78 2.32 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 123.014 2.476 . . . . 0.0 113.264 -176.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 236' ' ' VAL . 10.2 t -155.33 127.93 7.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.964 0.411 . . . . 0.0 111.911 176.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.652 HG12 ' HB2' ' A' ' 246' ' ' GLN . 0.9 OUTLIER -155.3 173.96 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.308 172.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.495 ' H ' HG13 ' A' ' 236' ' ' VAL . 57.1 m -20.38 112.04 0.02 OUTLIER 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.535 1.534 . . . . 0.0 114.207 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -115.61 100.85 8.35 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.087 174.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -135.61 131.52 35.94 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.129 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -98.82 -47.82 5.15 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.168 -170.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.68 -23.8 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.437 0.637 . . . . 0.0 110.078 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -100.61 1.07 40.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.296 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 51.0 50.61 18.78 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.324 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 14.7 m -122.31 101.08 7.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.336 -175.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -128.58 112.55 14.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.941 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' GLN . . . . . 0.652 ' HB2' HG12 ' A' ' 236' ' ' VAL . 50.6 mt-30 -138.75 164.62 29.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 175.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.632 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 36.8 p90 -147.02 134.64 21.01 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.244 171.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 38.6 m -100.34 137.79 38.29 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.68 143.96 22.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.317 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 18.3 m -91.22 113.37 25.61 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 160.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.575 ' HB2' HG13 ' A' ' 309' ' ' VAL . 5.1 mp -101.77 167.29 10.18 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -177.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.57 141.07 48.94 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.236 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -141.62 -143.37 4.23 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 121.227 -0.511 . . . . 0.0 111.937 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -112.15 -174.44 2.46 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -175.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.579 HG22 ' H ' ' A' ' 256' ' ' ALA . 3.0 m -67.86 173.55 4.35 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.417 -172.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.579 ' H ' HG22 ' A' ' 255' ' ' THR . . . -60.48 -176.17 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.818 0.847 . . . . 0.0 112.535 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 15.3 t 81.05 6.3 1.34 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.125 0.97 . . . . 0.0 110.619 -176.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 91.6 t -123.74 90.37 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 170.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.4 m -75.54 93.43 3.01 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.345 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 75.74 97.16 0.14 Allowed Glycine 0 N--CA 1.44 -1.068 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.068 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.658 ' HB3' HD13 ' A' ' 262' ' ' LEU . 28.5 m-85 -46.2 -58.75 3.38 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.652 0.739 . . . . 0.0 109.737 172.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.658 HD13 ' HB3' ' A' ' 261' ' ' PHE . 0.0 OUTLIER -151.88 171.32 17.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.807 177.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 37.9 mtmm -136.28 -166.84 1.95 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.696 0.284 . . . . 0.0 111.765 -174.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -53.46 118.87 4.19 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.397 0.618 . . . . 0.0 111.69 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 106.31 -12.15 43.82 Favored Glycine 0 C--N 1.316 -0.557 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.118 176.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ASP . . . . . 0.453 ' CB ' ' HB2' ' A' ' 262' ' ' LEU . 40.9 m-20 -84.47 133.23 34.48 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -94.36 147.62 23.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.326 0.584 . . . . 0.0 111.149 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.5 OUTLIER -120.48 179.59 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.4 174.774 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.49 ' O ' ' HD3' ' A' ' 269' ' ' LYS . 12.8 tmtt? -134.51 102.55 5.35 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 174.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -112.51 143.77 43.11 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.534 -174.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.611 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 84.8 m -127.78 89.54 2.96 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.649 0.737 . . . . 0.0 110.297 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.446 ' HA ' ' CB ' ' A' ' 337' ' ' ASP . 2.4 t-20 -102.39 95.13 6.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.562 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' THR . . . . . 0.566 ' HB ' ' OG1' ' A' ' 289' ' ' THR . 68.2 p -88.89 111.7 22.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.772 -171.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -85.21 115.94 23.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.815 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 41.1 t-105 -101.69 14.06 33.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.885 0.85 . . . . 0.0 109.503 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.0 47.08 0.96 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.932 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -101.96 -46.81 4.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.724 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -59.2 -47.65 84.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.247 -173.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -73.54 -33.44 64.71 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.386 -176.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 33.4 p -78.72 -34.0 46.26 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.908 0.385 . . . . 0.0 111.097 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -85.84 -10.08 55.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.497 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 62.43 11.46 4.64 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.822 0.849 . . . . 0.0 111.197 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -177.82 -171.6 0.31 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.57 -1.196 . . . . 0.0 107.953 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 8.6 mp 61.59 71.95 0.53 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -52.54 -36.74 56.24 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.186 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 14.1 m120 65.89 167.16 0.2 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.876 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -143.17 15.5 2.33 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.488 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -136.23 119.39 16.6 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.133 0.492 . . . . 0.0 110.438 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.566 ' OG1' ' HB ' ' A' ' 273' ' ' THR . 10.0 t -90.47 149.0 40.13 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.278 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' PRO . . . . . 0.452 ' HD2' ' OG1' ' A' ' 289' ' ' THR . 35.0 Cg_exo -35.28 -58.34 0.42 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.332 3.354 . . . . 0.0 114.516 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 289' ' ' THR . 68.9 mt 64.13 95.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.401 0.62 . . . . 0.0 110.737 -176.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.23 177.26 7.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.088 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -142.71 -135.81 0.1 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.512 -169.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 48.7 m -70.49 130.87 43.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.13 0.491 . . . . 0.0 112.031 -173.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -130.11 -169.49 2.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.029 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 54.5 m -139.85 132.63 29.09 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.497 HG13 HG21 ' A' ' 311' ' ' VAL . 64.4 t -82.16 139.89 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.33 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.38 9.64 13.4 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.493 -169.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -171.82 -172.28 0.99 Allowed 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 120.568 0.223 . . . . 0.0 111.509 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.42 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 4.4 m-20 -61.98 123.42 18.03 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.397 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.554 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -111.81 110.02 20.15 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.528 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.418 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 25.5 t-20 -80.0 132.29 35.98 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -166.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.543 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 12.8 t -106.75 95.97 6.12 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 164.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.63 -178.63 3.78 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.261 -175.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 23.3 t -60.76 -34.8 75.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.971 0.415 . . . . 0.0 111.368 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -81.9 -3.12 90.68 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.687 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 65.0 41.17 97.44 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.704 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.32 125.84 54.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.385 0.612 . . . . 0.0 109.852 175.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.575 HG13 ' HB2' ' A' ' 251' ' ' LEU . 2.0 p -127.07 94.08 2.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.946 -175.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 53.5 m -98.79 127.01 44.58 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.003 -0.435 . . . . 0.0 111.676 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.497 HG21 HG13 ' A' ' 297' ' ' VAL . 11.8 p -161.95 151.02 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 175.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 49.2 m -93.22 146.03 23.99 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.079 0.466 . . . . 0.0 110.339 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.49 ' HB2' ' CE2' ' A' ' 247' ' ' PHE . 5.7 mp -117.46 151.21 37.54 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.62 -175.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 2.8 p -100.32 135.6 41.5 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.589 173.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 116.89 -171.58 13.86 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -175.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 318' ' ' ILE . 1.5 m -157.71 170.09 9.52 Favored Pre-proline 0 N--CA 1.466 0.358 0 C-N-CA 122.985 0.514 . . . . 0.0 109.844 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.31 92.09 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.458 2.105 . . . . 0.0 110.693 169.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 316' ' ' VAL . 96.3 mt -80.95 146.69 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.528 -171.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 79.7 -13.55 0.94 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.179 0.991 . . . . 0.0 111.103 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -113.21 -62.06 1.65 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.263 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 32.1 p -88.07 52.56 2.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.449 0.642 . . . . 0.0 110.494 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 2.1 m -102.61 5.7 39.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.033 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -113.75 88.75 14.46 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.096 -174.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.42 -44.66 21.64 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 121.577 1.518 . . . . 0.0 111.165 173.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' GLN . . . . . 0.43 ' HB3' ' HB3' ' A' ' 328' ' ' SER . 13.7 mt-30 72.93 -41.37 0.5 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.753 171.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 75.73 -32.14 0.21 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.642 0.777 . . . . 0.0 112.509 172.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -111.04 -48.87 3.07 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' A' ' 325' ' ' GLN . 23.1 t -74.57 102.92 4.69 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.532 173.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 34.5 t -49.63 122.58 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.078 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 19.3 m -61.06 150.61 33.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.515 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.28 142.08 57.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.917 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -88.49 149.53 23.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.095 0.474 . . . . 0.0 110.444 -174.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.61 HG23 ' HB3' ' A' ' 233' ' ' GLN . 9.5 m -77.64 150.27 5.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.76 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -137.52 148.17 45.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.085 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -97.71 172.75 7.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.049 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 112.73 11.64 14.19 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.444 176.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.611 ' HB3' ' O ' ' A' ' 271' ' ' THR . 4.3 m-20 -104.36 -170.77 1.82 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -176.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -114.32 157.17 23.15 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.155 0.503 . . . . 0.0 111.926 -172.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 39.0 t -134.42 145.8 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.28 -176.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 35.9 t -142.62 176.45 9.03 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 50.9 t -119.04 126.58 75.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.966 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 9.7 p -112.06 4.75 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 121.499 0.666 . . . . 0.0 110.979 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -81.33 169.05 50.94 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.117 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 18.9 p -120.29 -82.05 0.64 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.07 0.462 . . . . 0.0 111.272 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.898 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.14 -179.793 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.816 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -59.69 121.58 11.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.17 0.509 . . . . 0.0 111.327 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.514 ' HB3' ' HB ' ' A' ' 341' ' ' VAL . 85.0 t80 -82.71 -28.2 30.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.785 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 96.55 -1.96 62.33 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.621 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -89.77 145.14 18.13 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.073 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 23.6 m -124.32 132.03 53.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.177 0.513 . . . . 0.0 110.18 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.644 HD22 HG11 ' A' ' 309' ' ' VAL . 5.5 mt -131.3 173.36 11.14 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.576 -175.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 31.6 m -141.9 156.08 45.5 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -174.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 54.7 t -117.14 127.96 74.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 122.418 -0.177 . . . . 0.0 110.964 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.475 ' NZ ' HG23 ' A' ' 252' ' ' THR . 31.1 mtmm -112.38 -14.9 13.23 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -177.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 75.2 p -120.44 -174.09 2.72 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.23 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -106.59 106.33 57.39 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -170.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.552 ' C ' ' HB2' ' A' ' 247' ' ' PHE . 55.5 Cg_endo -69.83 103.75 1.22 Allowed 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.567 2.178 . . . . 0.0 113.6 -174.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.531 ' O ' HG23 ' A' ' 236' ' ' VAL . 15.1 t -157.93 129.32 6.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.714 170.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.604 ' N ' ' HA ' ' A' ' 247' ' ' PHE . 2.9 t -155.94 114.49 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 C-N-CA 122.827 0.451 . . . . 0.0 110.69 172.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' A' ' 245' ' ' TYR . 23.7 m 64.57 93.65 0.06 Allowed 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.228 0.537 . . . . 0.0 111.649 176.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -109.55 84.44 1.92 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -132.52 129.06 38.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.218 -175.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.22 -35.01 7.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.78 -173.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 61.5 t -62.81 -29.56 47.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.497 0.665 . . . . 0.0 109.62 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.479 ' HA ' ' HE2' ' A' ' 242' ' ' LYS . 9.8 mmpt? -96.81 -12.46 23.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.881 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 60.7 59.92 2.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.001 -1.454 . . . . 0.0 110.55 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 36.8 m -143.93 106.27 4.4 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.151 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' TYR . . . . . 0.619 ' HA ' ' O ' ' A' ' 237' ' ' THR . 59.0 m-85 -129.07 118.17 22.07 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 236' ' ' VAL . 45.0 mt-30 -130.54 -179.16 5.12 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.604 ' HA ' ' N ' ' A' ' 236' ' ' VAL . 13.0 p90 -160.26 136.8 8.89 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.238 165.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.486 ' OG1' HG21 ' A' ' 236' ' ' VAL . 32.8 m -102.66 138.41 39.6 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.461 ' HB ' ' CD1' ' A' ' 251' ' ' LEU . 0.1 OUTLIER -144.92 151.15 15.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.712 -0.795 . . . . 0.0 112.11 -178.336 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.605 HG23 ' OG1' ' A' ' 310' ' ' THR . 91.7 m -103.14 104.85 15.04 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 168.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.616 ' HB2' HG13 ' A' ' 309' ' ' VAL . 5.1 mp -102.7 167.78 9.68 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -169.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.475 HG23 ' NZ ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -114.68 151.37 33.71 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.91 172.711 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -150.97 -142.67 3.57 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 121.197 -0.525 . . . . 0.0 111.907 -173.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.584 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -107.42 -174.59 2.57 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.561 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -69.48 -177.8 1.26 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.41 -172.043 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.561 ' H ' HG22 ' A' ' 255' ' ' THR . . . -64.39 -175.98 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.825 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 49.8 m 80.24 9.05 1.36 Allowed 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.489 0.716 . . . . 0.0 111.287 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 28.6 t -126.85 90.07 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 171.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.9 m -70.9 93.76 1.01 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.892 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 73.62 98.0 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.217 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.408 ' CE1' HD21 ' A' ' 228' ' ' LEU . 6.3 m-85 -44.99 -58.67 3.02 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.816 0.817 . . . . 0.0 109.824 171.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 266' ' ' ASP . 77.8 mt -140.78 169.15 18.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.31 -1.314 . . . . 0.0 109.051 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -133.25 -167.33 1.91 Allowed 'General case' 0 C--N 1.323 -0.554 0 O-C-N 123.079 0.237 . . . . 0.0 110.502 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -59.93 116.28 4.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.286 0.565 . . . . 0.0 111.171 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 111.7 -14.37 27.09 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.547 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ASP . . . . . 0.518 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 37.3 m-20 -81.0 128.23 33.46 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.938 0.399 . . . . 0.0 110.292 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -88.97 150.93 22.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.449 0.642 . . . . 0.0 111.759 -173.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.444 HG12 HG22 ' A' ' 341' ' ' VAL . 1.3 m -131.38 171.71 17.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.276 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.505 ' HD2' HG13 ' A' ' 342' ' ' VAL . 0.0 OUTLIER -143.77 129.21 18.99 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.2 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.469 ' CB ' HG22 ' A' ' 339' ' ' VAL . 8.6 p90 -130.4 158.51 39.67 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.128 -174.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.687 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 93.2 m -108.7 86.89 2.37 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.163 -173.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -116.1 89.96 3.23 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 19.6 p -76.62 85.9 3.29 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.531 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -86.64 157.57 19.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.273 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.505 ' HA ' ' HB2' ' A' ' 279' ' ' GLN . 9.3 p-90 -158.23 81.16 0.84 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.047 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.609 ' HB2' ' OD1' ' A' ' 320' ' ' ASP . 2.9 mm? -107.38 -74.93 0.64 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.39 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' GLN . . . . . 0.532 ' OE1' ' HA ' ' A' ' 321' ' ' THR . 69.4 mt-30 -106.39 -56.1 2.24 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -174.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.586 ' HG3' ' O ' ' A' ' 320' ' ' ASP . 75.8 mt-30 -74.6 -59.85 2.55 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.546 0.689 . . . . 0.0 110.16 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.505 ' HB2' ' HA ' ' A' ' 275' ' ' TRP . 32.6 mm-40 -70.76 9.3 0.69 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.46 -1.246 . . . . 0.0 113.38 -170.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.64 -45.21 8.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.81 0.338 . . . . 0.0 110.445 171.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -92.02 -37.25 12.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.056 0.455 . . . . 0.0 110.489 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 61.72 19.7 10.74 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.445 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.462 ' HB3' HD22 ' A' ' 284' ' ' LEU . . . 67.16 -57.02 0.43 Allowed 'General case' 0 CA--C 1.532 0.253 0 O-C-N 124.589 1.181 . . . . 0.0 112.163 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.462 HD22 ' HB3' ' A' ' 283' ' ' ALA . 1.1 mm? -106.11 -4.7 20.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.726 0.298 . . . . 0.0 110.596 -177.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 60.51 92.31 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.407 -172.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -96.71 -41.28 8.57 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.51 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 102.66 24.16 8.37 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.313 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -149.65 -171.39 3.88 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 120.945 0.402 . . . . 0.0 110.24 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.593 ' OG1' ' HD2' ' A' ' 290' ' ' PRO . 9.3 t -172.11 158.35 4.2 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' PRO . . . . . 0.593 ' HD2' ' OG1' ' A' ' 289' ' ' THR . 6.6 Cg_endo -49.45 118.34 3.6 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.835 2.357 . . . . 0.0 112.109 177.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 50.0 mm -75.59 -60.6 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.462 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 36.9 m -132.04 143.31 49.96 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.4 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -145.29 154.25 42.15 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.07 0.462 . . . . 0.0 110.439 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 86.7 m -89.31 134.75 33.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.87 -172.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ALA . . . . . 0.414 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -129.03 -174.19 3.19 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 80.0 m -142.48 135.36 28.34 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.554 HG13 HG21 ' A' ' 311' ' ' VAL . 58.2 t -78.31 140.53 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.832 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 4.0 m -116.31 1.57 13.09 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -161.56 176.96 10.48 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.908 -0.495 . . . . 0.0 111.517 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.93 104.96 0.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.23 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -93.22 103.42 15.69 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.797 -174.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -61.0 135.07 57.68 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -171.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.07 97.49 6.25 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 162.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.4 174.11 6.85 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.715 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 42.5 m -57.05 -33.74 67.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -77.74 -3.05 83.1 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.449 -176.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' GLY . . . . . 0.584 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 72.73 41.26 50.68 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.246 -178.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -113.37 146.25 39.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.687 0.743 . . . . 0.0 110.909 174.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.644 HG11 HD22 ' A' ' 228' ' ' LEU . 2.2 p -145.56 102.19 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.414 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.605 ' OG1' HG23 ' A' ' 250' ' ' THR . 91.0 m -102.42 124.17 47.5 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.514 -0.741 . . . . 0.0 111.032 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.554 HG21 HG13 ' A' ' 297' ' ' VAL . 14.8 p -160.15 154.31 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.134 0.493 . . . . 0.0 110.213 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 47.0 m -97.87 152.39 19.24 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.65 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.486 HD13 ' CE1' ' A' ' 247' ' ' PHE . 5.7 mp -119.89 135.19 54.98 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.632 -177.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 27.7 p -122.51 151.43 41.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.807 0.337 . . . . 0.0 111.598 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 78.67 50.06 6.24 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.959 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -138.37 85.62 17.87 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 121.079 0.466 . . . . 0.0 111.425 -174.758 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -76.5 78.54 3.27 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.943 2.428 . . . . 0.0 112.444 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 11.0 mm -83.57 128.36 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.382 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -115.69 134.88 54.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.125 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.609 ' OD1' ' HB2' ' A' ' 276' ' ' LEU . 24.3 t70 -172.98 -38.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.358 174.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.532 ' HA ' ' OE1' ' A' ' 277' ' ' GLN . 0.0 OUTLIER -82.75 73.95 9.74 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.449 176.862 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 4.9 m -80.78 -23.04 39.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.555 0.693 . . . . 0.0 110.087 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -66.4 136.83 95.17 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.37 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.41 20.23 0.43 Allowed 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.81 1.674 . . . . 0.0 113.943 -174.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' GLN . . . . . 0.484 ' NE2' ' HA ' ' A' ' 329' ' ' VAL . 97.5 mt-30 74.44 -50.81 0.68 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.648 0.779 . . . . 0.0 112.912 173.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 65.07 22.72 12.38 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.478 0.656 . . . . 0.0 109.6 -174.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -176.87 159.77 1.78 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -173.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 20.4 m -75.85 90.44 2.93 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.398 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' VAL . . . . . 0.484 ' HA ' ' NE2' ' A' ' 325' ' ' GLN . 23.7 t 64.85 103.48 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.984 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 19.3 p -98.42 -69.41 0.76 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.182 -176.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -102.29 153.57 19.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.747 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -133.55 -177.33 4.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.321 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.427 HG22 ' N ' ' A' ' 334' ' ' GLU . 13.1 p -88.98 166.03 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' GLU . . . . . 0.427 ' N ' HG22 ' A' ' 333' ' ' VAL . 10.4 tp10 -119.87 147.81 44.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.978 0.418 . . . . 0.0 110.485 -175.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -85.85 173.5 9.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.213 -176.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 112.58 11.5 14.8 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.417 173.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.687 ' HB2' ' O ' ' A' ' 271' ' ' THR . 4.9 p-10 -91.05 179.87 5.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.998 0.428 . . . . 0.0 111.52 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -118.04 137.63 52.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.442 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.469 HG22 ' CB ' ' A' ' 270' ' ' PHE . 55.9 t -116.48 150.78 18.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.458 -172.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 41.9 m -146.73 173.22 12.57 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 172.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 224' ' ' PHE . 86.1 t -117.85 132.99 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -171.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.505 HG13 ' HD2' ' A' ' 269' ' ' LYS . 32.6 m -117.14 10.4 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 111.561 174.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 343' ' ' GLY . . . . . 0.406 ' H ' HG12 ' A' ' 341' ' ' VAL . . . -97.49 96.41 1.82 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.603 -177.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 8.5 p -127.07 -67.15 0.86 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.287 0.565 . . . . 0.0 109.742 175.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.947 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.955 177.503 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.56 0 N-CA-C 112.184 -0.366 . . . . 0.0 112.184 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -87.21 52.2 2.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.331 0.586 . . . . 0.0 110.631 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -82.46 46.51 1.06 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.779 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 67.12 36.68 90.74 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.054 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -41.23 115.51 0.75 Allowed Glycine 0 C--N 1.338 0.653 0 O-C-N 124.18 0.576 . . . . 0.0 113.167 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 21.2 m -107.53 142.66 37.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.04 0.448 . . . . 0.0 110.72 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.677 HD22 HG11 ' A' ' 309' ' ' VAL . 20.4 mt -143.03 175.93 9.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.269 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.569 ' O ' ' HB3' ' A' ' 251' ' ' LEU . 43.6 m -131.7 152.69 50.7 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.414 0.149 . . . . 0.0 110.615 -176.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.475 HG23 HG23 ' A' ' 339' ' ' VAL . 12.2 t -100.03 127.9 52.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 176.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -110.96 -29.1 8.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.373 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.459 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 72.7 p -119.87 -169.33 1.76 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.688 0.28 . . . . 0.0 110.732 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.64 ' HB3' ' HB ' ' A' ' 333' ' ' VAL . 85.1 mt-30 -112.76 125.68 29.52 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -172.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 233' ' ' GLN . 10.0 Cg_endo -92.71 106.39 0.19 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.337 2.691 . . . . 0.0 115.728 -168.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 236' ' ' VAL . 1.2 m -157.52 133.23 9.22 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 165.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.682 ' N ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -158.24 139.6 4.92 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.807 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 176.392 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 97.7 m 69.12 108.51 0.05 Allowed 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.494 0.718 . . . . 0.0 112.635 170.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.411 ' OH ' ' HD2' ' A' ' 319' ' ' TYR . 4.4 m-85 -116.31 99.81 7.46 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.437 175.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.53 88.31 2.79 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -83.63 -44.32 14.69 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.773 -163.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 22.8 t -66.47 -23.18 31.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.629 0.728 . . . . 0.0 109.145 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -99.87 -3.75 31.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.888 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 36.1 t70 57.39 68.85 0.8 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.35 -1.296 . . . . 0.0 111.729 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 24.4 t -152.9 119.76 5.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.513 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -129.6 128.51 42.83 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -121.8 -174.74 2.94 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.682 ' HA ' ' N ' ' A' ' 236' ' ' VAL . 1.8 p90 -156.71 125.74 5.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 174.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 52.9 m -95.41 142.29 27.96 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.485 HG13 HD11 ' A' ' 251' ' ' LEU . 7.3 p -144.07 137.92 24.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 119.786 -0.766 . . . . 0.0 112.391 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.459 ' HB ' ' CG2' ' A' ' 232' ' ' THR . 92.2 m -98.43 113.36 25.32 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 168.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.673 ' HB2' HG13 ' A' ' 309' ' ' VAL . 1.4 mp -107.85 168.68 9.1 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -175.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.76 139.4 41.24 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.187 172.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.464 ' HA2' HD23 ' A' ' 228' ' ' LEU . . . -141.86 -149.41 5.19 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.275 -175.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -96.25 -174.23 3.01 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 256' ' ' ALA . 2.8 m -77.01 175.73 9.31 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.021 -170.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.582 ' H ' HG22 ' A' ' 255' ' ' THR . . . -65.03 -176.39 0.28 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.446 0.698 . . . . 0.0 112.275 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 24.8 t 80.2 6.97 1.62 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.834 0.854 . . . . 0.0 110.517 -176.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 24.0 t -123.37 90.71 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 170.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 5.6 m -73.44 92.45 1.86 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.654 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.622 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 80.77 94.2 0.43 Allowed Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.958 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.487 ' CZ ' HD21 ' A' ' 228' ' ' LEU . 4.1 m-85 -43.5 -55.35 4.28 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 169.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.8 pp -165.51 173.85 10.55 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.568 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 60.3 mttp -143.23 -166.32 2.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.997 0.427 . . . . 0.0 111.836 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -53.54 122.74 10.38 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.162 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 109.92 -16.01 30.89 Favored Glycine 0 C--N 1.313 -0.718 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.7 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -84.35 139.43 32.28 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.587 ' HB2' HG11 ' A' ' 342' ' ' VAL . 27.5 mt-30 -107.91 151.92 25.13 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.389 0.614 . . . . 0.0 110.765 -178.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.4 OUTLIER -132.4 176.18 9.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.397 -179.24 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.405 ' HE2' HG23 ' A' ' 342' ' ' VAL . 3.2 mptp? -123.64 143.24 50.37 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 172.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.497 ' CE2' ' HB2' ' A' ' 295' ' ' ALA . 17.2 p90 -136.68 142.5 43.16 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 173.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 25.7 p -150.17 109.69 4.01 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.876 -174.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.561 HD22 ' HG3' ' A' ' 334' ' ' GLU . 24.1 p-10 -109.19 147.38 32.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.555 0.693 . . . . 0.0 111.802 -176.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 20.3 p -121.79 81.44 1.81 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.495 168.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -146.96 140.33 25.52 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.15 -172.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -86.43 121.73 29.39 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.327 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -78.93 102.46 8.28 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' GLN . . . . . 0.58 ' O ' ' HG2' ' A' ' 281' ' ' LYS . 96.7 mt-30 -56.49 -29.58 61.94 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -172.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -71.03 -45.15 64.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.125 0.488 . . . . 0.0 110.437 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.42 ' HG2' ' NE2' ' A' ' 332' ' ' GLN . 11.4 mm-40 -72.05 -36.81 69.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.986 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 34.4 p -69.01 -12.15 61.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.674 0.273 . . . . 0.0 111.562 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 277' ' ' GLN . 47.1 mmtm -63.45 -43.91 95.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.369 0.604 . . . . 0.0 109.378 171.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -84.51 -58.81 2.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.907 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 49.46 65.07 1.5 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.187 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 284' ' ' LEU . 3.1 mm? -107.81 -40.97 5.12 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.148 176.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -136.39 23.61 3.2 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.904 -175.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -93.57 -54.72 3.54 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.042 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 86.09 -64.55 4.03 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.241 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -162.42 -151.31 0.2 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 6.9 t -77.22 125.55 86.38 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-O 120.959 0.409 . . . . 0.0 110.294 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.69 141.64 24.93 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.521 2.147 . . . . 0.0 111.738 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 41.4 pt -89.08 132.16 34.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.047 0.451 . . . . 0.0 110.582 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.33 -165.85 1.34 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.004 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -161.71 -144.16 0.09 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 -168.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 56.0 m -74.77 137.04 41.71 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -175.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ALA . . . . . 0.497 ' HB2' ' CE2' ' A' ' 270' ' ' PHE . . . -124.92 172.4 9.41 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 173.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 87.1 m -134.21 129.54 35.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.473 0.654 . . . . 0.0 112.474 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.596 HG12 ' H ' ' A' ' 299' ' ' ALA . 93.3 t -89.87 140.69 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.047 -177.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 1.9 m -125.06 23.86 7.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.009 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.596 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -156.29 -177.25 6.45 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.421 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 2.6 m-20 -76.83 165.57 24.52 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.775 -174.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.622 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -147.5 155.61 42.05 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.688 -175.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -128.99 133.1 47.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.263 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.529 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.8 OUTLIER -111.51 95.45 5.51 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 164.141 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.15 169.37 8.48 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.554 -0.459 . . . . 0.0 110.444 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 67.0 m -57.95 -30.3 65.87 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -76.85 7.51 34.17 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.622 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 59.89 41.88 97.94 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.219 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -121.78 117.98 27.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.316 0.558 . . . . 0.0 111.242 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.677 HG11 HD22 ' A' ' 228' ' ' LEU . 2.6 p -125.42 125.42 68.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.982 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 86.2 m -120.21 135.67 54.9 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 121.729 -0.607 . . . . 0.0 111.249 -177.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.548 ' CG1' ' HB2' ' A' ' 301' ' ' ALA . 6.6 m -146.76 165.21 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.143 0.497 . . . . 0.0 110.445 175.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 28.3 m -121.95 136.32 54.92 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.691 173.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 4.2 mp -112.8 158.93 19.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.999 -173.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 14.3 m -133.15 140.07 47.41 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.863 0.363 . . . . 0.0 111.561 -176.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 101.06 78.77 1.37 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.65 170.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 1.9 m -146.13 129.18 8.15 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 120.618 0.247 . . . . 0.0 110.695 173.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -81.67 48.43 2.85 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.65 2.233 . . . . 0.0 111.376 175.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.516 HG12 ' CD2' ' A' ' 319' ' ' TYR . 20.7 tt -83.97 133.46 29.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.952 -175.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.516 ' CD2' HG12 ' A' ' 318' ' ' ILE . 49.0 m-85 73.02 36.05 0.9 Allowed 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.028 176.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -76.05 -58.91 3.0 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.463 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 2.6 p -149.68 -155.22 0.61 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 23.9 m -99.58 -39.28 8.38 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.422 0.63 . . . . 0.0 109.761 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -137.65 68.24 51.96 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.511 -169.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -59.96 -67.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.171 1.914 . . . . 0.0 111.932 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' GLN . . . . . 0.42 ' O ' ' HB2' ' A' ' 326' ' ' TYR . 26.4 mm-40 -107.38 67.0 0.68 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 325' ' ' GLN . 69.8 m-85 73.25 -39.92 0.46 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.305 -176.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -172.28 114.81 0.32 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 170.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 9.3 m -144.15 111.11 5.75 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.769 -0.582 . . . . 0.0 111.277 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 5.5 t 58.76 42.22 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-O 121.907 0.86 . . . . 0.0 111.186 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 9.6 t -80.14 57.63 2.76 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 173.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -92.32 144.2 25.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.623 -173.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' GLN . . . . . 0.42 ' NE2' ' HG2' ' A' ' 279' ' ' GLN . 25.9 mp0 -121.85 123.0 40.73 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 168.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.64 ' HB ' ' HB3' ' A' ' 233' ' ' GLN . 28.8 m -44.8 107.34 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.991 0.901 . . . . 0.0 112.962 -168.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' GLU . . . . . 0.561 ' HG3' HD22 ' A' ' 272' ' ' ASN . 1.0 OUTLIER -109.19 145.74 35.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.402 -178.533 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -99.97 156.29 17.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.653 174.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 106.86 8.89 31.32 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.487 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.455 ' HB3' ' CG2' ' A' ' 230' ' ' VAL . 10.6 t70 -66.01 150.45 48.65 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.781 0.324 . . . . 0.0 110.854 178.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -98.52 112.64 24.61 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.475 HG23 HG23 ' A' ' 230' ' ' VAL . 57.4 t -97.09 148.85 5.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.387 0.613 . . . . 0.0 111.654 -170.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 65.5 m -143.67 171.58 13.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.762 173.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 343' ' ' GLY . 24.1 t -119.25 141.85 37.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.587 HG11 ' HB2' ' A' ' 267' ' ' GLN . 8.4 p -73.91 -28.41 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.085 0.469 . . . . 0.0 110.555 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' GLY . . . . . 0.582 ' H ' HG12 ' A' ' 341' ' ' VAL . . . 158.88 -174.87 35.92 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 17.6 p -102.17 -75.8 0.59 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.103 0.478 . . . . 0.0 110.55 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.033 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.725 178.051 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.817 0 N-CA-C 112.267 -0.333 . . . . 0.0 112.267 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -117.69 -78.32 0.58 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.505 0.193 . . . . 0.0 110.629 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -99.79 178.0 4.96 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 111.24 3.06 27.85 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.735 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -80.26 122.26 5.69 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.088 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 20.8 m -152.36 96.22 2.14 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 175.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.461 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 4.0 mp -122.73 -179.25 4.17 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.889 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 48.3 m -134.34 162.72 31.41 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.529 -175.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 94.4 t -108.24 130.88 60.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.497 ' HB2' HG23 ' A' ' 252' ' ' THR . 27.2 tptp -108.53 -15.21 14.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.874 0.369 . . . . 0.0 111.482 -173.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 20.6 p -138.44 -169.54 2.62 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.206 -173.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.458 ' HB3' ' HB ' ' A' ' 333' ' ' VAL . 74.7 mt-30 -105.02 118.24 56.6 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.248 -172.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.78 106.15 1.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.716 2.277 . . . . 0.0 111.997 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.438 ' OG1' ' HA ' ' A' ' 320' ' ' ASP . 10.9 t -154.88 124.06 6.33 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.575 -0.45 . . . . 0.0 112.095 -178.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.73 HG12 ' HB2' ' A' ' 246' ' ' GLN . 1.1 t -154.05 168.89 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.606 171.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.482 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 74.6 m -14.73 112.96 0.02 OUTLIER 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.725 1.61 . . . . 0.0 114.472 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -106.41 88.57 2.81 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 172.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -125.89 139.32 53.56 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.366 0.603 . . . . 0.0 110.236 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.22 -44.58 4.52 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.558 -173.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 63.1 t -61.04 -36.71 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.263 0.554 . . . . 0.0 110.167 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -88.14 -5.48 58.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.316 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 22.4 t70 50.91 67.45 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.036 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.5 m -144.75 100.89 3.58 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.589 -175.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -121.49 100.89 7.28 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' GLN . . . . . 0.73 ' HB2' HG12 ' A' ' 236' ' ' VAL . 80.0 mt-30 -127.6 178.97 5.76 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.629 -171.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.64 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 2.1 p90 -156.64 125.63 5.97 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 19.5 m -95.4 134.53 38.1 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.461 ' HB ' ' CD1' ' A' ' 251' ' ' LEU . 0.2 OUTLIER -141.95 146.71 22.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.676 -178.677 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.478 HG23 ' OG1' ' A' ' 310' ' ' THR . 95.2 m -96.69 112.79 24.4 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 164.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.599 ' HB2' HG13 ' A' ' 309' ' ' VAL . 5.3 mp -102.46 169.16 8.84 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -176.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.497 HG23 ' HB2' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -127.57 108.69 11.0 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.68 0.276 . . . . 0.0 111.628 -177.466 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.491 ' N ' HG12 ' A' ' 309' ' ' VAL . . . -147.39 135.81 5.8 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 177.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.421 ' HB2' ' HA2' ' A' ' 307' ' ' GLY . . . -108.34 93.98 4.82 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -172.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.483 ' HB ' ' OG ' ' A' ' 303' ' ' SER . 10.1 m -126.29 118.97 26.21 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 170.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -73.04 136.82 45.05 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 70.8 m 59.89 55.58 3.8 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.119 174.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.471 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 94.6 t -131.74 95.37 2.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.25 0.548 . . . . 0.0 109.858 174.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 27.4 m -74.15 97.63 2.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.143 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 71.23 99.7 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.844 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.51 ' CE2' ' HB2' ' A' ' 303' ' ' SER . 11.6 m-85 -48.02 -59.18 3.56 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.324 0.583 . . . . 0.0 110.34 170.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.424 HD11 HG13 ' A' ' 341' ' ' VAL . 61.3 mt -143.57 173.52 11.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.537 -173.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -130.7 -169.86 2.23 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.818 0.342 . . . . 0.0 111.172 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -57.95 114.05 2.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.563 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 111.14 -1.6 28.33 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.846 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ASP . . . . . 0.409 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 13.0 m-20 -87.59 145.32 26.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.704 0.252 . . . . 0.0 110.556 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -102.23 149.23 24.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.48 0.657 . . . . 0.0 111.124 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.666 HG23 ' HB3' ' A' ' 295' ' ' ALA . 0.1 OUTLIER -132.22 174.33 13.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.542 178.357 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' A' ' 293' ' ' PHE . 5.6 mptp? -110.23 135.83 50.38 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 172.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.679 ' O ' ' HA ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -142.65 105.87 4.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.806 0.812 . . . . 0.0 110.566 178.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.588 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 31.4 m -81.15 86.06 6.24 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -108.97 86.5 2.29 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.93 -170.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 22.8 p -114.27 98.42 6.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.198 0.523 . . . . 0.0 112.26 -173.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -165.41 174.33 10.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.6 174.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 35.0 p-90 -144.14 151.91 40.2 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 177.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 82.5 mt -108.66 140.27 42.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.132 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -72.46 -10.4 59.74 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.127 0.489 . . . . 0.0 110.619 -178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -86.8 -51.97 5.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.298 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -66.84 -26.7 67.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.712 -174.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 17.7 p -59.96 -34.05 72.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.032 0.444 . . . . 0.0 111.179 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -82.15 -33.3 29.65 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.024 0.44 . . . . 0.0 110.008 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -66.64 -36.39 82.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.022 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 286' ' ' ASN . . . -99.33 28.42 4.55 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.359 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 8.3 mp 64.72 63.85 0.7 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.349 171.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 69.75 25.37 5.12 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.289 1.042 . . . . 0.0 110.319 173.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.648 ' O ' ' HB3' ' A' ' 283' ' ' ALA . 2.3 t30 -144.85 138.11 26.79 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.5 -1.682 . . . . 0.0 108.318 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -104.3 -128.54 6.3 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.463 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -167.34 124.9 1.23 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 93.9 m -147.73 116.35 4.2 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.774 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.51 127.54 18.55 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.432 2.088 . . . . 0.0 111.188 174.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 18.5 tt -63.08 -35.98 73.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.378 -172.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' SER . . . . . 0.437 ' HB2' ' H ' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -162.95 -147.76 0.12 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 175.371 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 293' ' ' PHE . . . . . 0.679 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 2.2 p90 -109.77 88.36 2.73 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -166.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 92.3 m -151.63 112.03 4.15 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 122.061 -0.4 . . . . 0.0 110.975 175.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ALA . . . . . 0.666 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -131.35 -177.1 4.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.555 0.217 . . . . 0.0 111.197 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 7.5 m -143.39 131.56 21.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.876 0.846 . . . . 0.0 113.061 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.552 HG13 HG21 ' A' ' 311' ' ' VAL . 63.2 t -76.75 141.55 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 113.551 -1.658 . . . . 0.0 111.135 -178.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 15.1 m -110.35 -14.23 14.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -176.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -162.03 -175.63 4.74 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 122.158 -0.339 . . . . 0.0 111.266 -177.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -59.15 113.99 2.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.029 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.45 ' HB2' ' HB ' ' A' ' 311' ' ' VAL . . . -94.87 101.5 13.3 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.476 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 309' ' ' VAL . 5.1 m-20 -58.55 127.3 31.49 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.708 -174.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.51 ' HB2' ' CE2' ' A' ' 261' ' ' PHE . 30.2 t -114.97 113.39 24.06 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 120.73 0.3 . . . . 0.0 111.267 172.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -127.16 152.21 47.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 170.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 10.8 t -74.72 -4.31 36.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.712 -172.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -68.63 -11.46 62.56 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 172.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' GLY . . . . . 0.421 ' HA2' ' HB2' ' A' ' 254' ' ' ALA . . . 92.55 37.12 5.93 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.067 -0.567 . . . . 0.0 113.384 176.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -125.81 141.9 51.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 117.225 0.513 . . . . 0.0 111.407 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 302' ' ' ASN . 1.6 p -152.24 100.37 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.16 174.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.478 ' OG1' HG23 ' A' ' 250' ' ' THR . 63.8 m -93.15 129.83 39.02 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.521 -0.737 . . . . 0.0 110.824 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.552 HG21 HG13 ' A' ' 297' ' ' VAL . 2.1 p -157.61 141.92 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 54.7 m -94.48 147.67 23.02 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.047 0.451 . . . . 0.0 110.122 175.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.441 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.0 mp -131.54 170.82 14.19 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.717 -174.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 246' ' ' GLN . 29.8 p -132.91 157.17 45.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.066 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 94.18 72.85 1.19 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.151 -0.547 . . . . 0.0 113.809 171.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.498 HG13 ' CE2' ' A' ' 247' ' ' PHE . 2.6 m -148.44 158.61 40.44 Favored Pre-proline 0 N--CA 1.466 0.342 0 CA-C-N 116.929 0.364 . . . . 0.0 111.462 177.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -96.8 47.01 0.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.086 2.524 . . . . 0.0 110.838 167.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 82.7 mt -118.45 122.38 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.193 -176.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -66.4 153.89 41.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.254 0.55 . . . . 0.0 111.857 -176.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.438 ' HA ' ' OG1' ' A' ' 235' ' ' THR . 13.0 p-10 -86.45 29.71 0.75 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.961 -173.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 20.6 p 45.78 42.05 8.3 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 173.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 7.3 p -118.1 100.41 7.52 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 175.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -150.11 159.36 35.49 Favored Pre-proline 0 C--N 1.312 -1.038 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.146 -169.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.532 ' HB2' ' CE1' ' A' ' 326' ' ' TYR . 84.6 Cg_endo -79.99 103.65 1.58 Allowed 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.297 1.998 . . . . 0.0 111.518 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -58.59 -67.46 0.36 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.791 -1.549 . . . . 0.0 111.271 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' TYR . . . . . 0.532 ' CE1' ' HB2' ' A' ' 324' ' ' PRO . 17.6 m-85 69.2 -45.96 0.56 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.677 0.791 . . . . 0.0 112.824 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -99.81 -76.87 0.54 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.671 0.272 . . . . 0.0 110.378 -174.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 10.2 p -163.05 -70.16 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.487 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 23.0 t -69.17 126.91 30.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.087 0.47 . . . . 0.0 110.587 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 12.1 m -87.0 160.61 18.58 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.61 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -73.05 111.57 8.29 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 174.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -123.03 153.18 40.18 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.995 0.426 . . . . 0.0 111.132 -169.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.493 HG12 ' H ' ' A' ' 334' ' ' GLU . 2.9 t -88.31 168.99 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.006 177.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' GLU . . . . . 0.493 ' H ' HG12 ' A' ' 333' ' ' VAL . 33.7 tt0 -115.11 134.83 54.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.683 0.277 . . . . 0.0 111.118 -174.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -97.85 173.06 7.27 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.674 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 117.73 1.97 17.14 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.432 -0.89 . . . . 0.0 113.879 170.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 271' ' ' THR . 10.7 p-10 -79.47 173.01 13.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.079 0.439 . . . . 0.0 111.484 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -110.84 148.7 31.85 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.255 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.562 HG21 HD23 ' A' ' 251' ' ' LEU . 73.9 t -127.28 150.74 33.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.841 0.353 . . . . 0.0 111.82 -169.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.539 ' HB3' ' HB2' ' A' ' 269' ' ' LYS . 31.0 t -151.74 178.03 9.79 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 175.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.424 HG13 HD11 ' A' ' 262' ' ' LEU . 58.9 t -119.19 144.03 28.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 122.338 -0.226 . . . . 0.0 110.971 -176.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 50.7 t -71.21 -47.01 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.073 0 CA-C-O 121.061 0.457 . . . . 0.0 110.037 174.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' GLY . . . . . 0.409 ' N ' HG12 ' A' ' 341' ' ' VAL . . . 126.38 174.73 13.92 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.008 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 13.2 p -132.85 -74.64 0.5 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.235 0.541 . . . . 0.0 110.288 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.809 177.932 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 63.26 18.98 11.4 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 122.97 0.508 . . . . 0.0 111.931 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.535 ' HD1' ' N ' ' A' ' 225' ' ' GLY . 0.5 OUTLIER -94.58 122.12 36.84 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -178.666 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.535 ' N ' ' HD1' ' A' ' 224' ' ' PHE . . . 85.59 28.96 28.19 Favored Glycine 0 CA--C 1.501 -0.84 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 176.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -49.9 114.49 2.44 Favored Glycine 0 N--CA 1.454 -0.109 0 CA-C-N 114.52 -0.84 . . . . 0.0 112.618 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 23.7 m -136.34 136.56 39.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.978 0.418 . . . . 0.0 110.705 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.511 ' HB2' ' CG1' ' A' ' 339' ' ' VAL . 1.2 mp -139.51 175.75 9.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.752 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 24.7 m -130.63 160.24 34.81 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.521 HG23 HG23 ' A' ' 339' ' ' VAL . 73.8 t -118.42 147.01 22.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 122.304 -0.248 . . . . 0.0 110.692 174.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -117.6 -19.02 9.56 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 39.6 p -124.7 -167.61 1.69 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.47 ' HB3' HG23 ' A' ' 333' ' ' VAL . 83.2 mt-30 -112.7 131.01 22.9 Favored Pre-proline 0 C--N 1.316 -0.881 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -173.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.412 ' HA ' HG22 ' A' ' 249' ' ' VAL . 35.2 Cg_endo -66.95 104.04 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.06 1.84 . . . . 0.0 111.545 177.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 5.0 t -154.91 116.86 4.16 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.416 0.627 . . . . 0.0 111.778 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.71 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.5 174.42 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 168.404 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.505 ' H ' HG13 ' A' ' 236' ' ' VAL . 66.9 m -37.62 110.03 0.11 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -174.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -112.18 83.96 1.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.042 170.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -110.96 132.86 53.85 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.39 -39.91 5.75 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.733 -170.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.45 -27.21 42.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.471 0.653 . . . . 0.0 109.938 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -96.33 -13.93 22.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.837 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 60.45 68.46 0.76 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.471 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 41.7 m -149.08 100.86 3.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.36 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -116.84 109.74 17.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.551 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' GLN . . . . . 0.452 ' HB2' HG12 ' A' ' 236' ' ' VAL . 0.5 OUTLIER -131.41 161.44 32.44 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 172.445 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.71 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 0.7 OUTLIER -160.12 133.67 7.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.471 0.176 . . . . 0.0 111.109 179.056 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 48.2 m -108.47 143.1 37.89 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 122.35 -0.218 . . . . 0.0 110.506 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.517 HG23 ' CD2' ' A' ' 313' ' ' LEU . 0.4 OUTLIER -146.09 148.36 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.923 178.612 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.593 HG23 ' OG1' ' A' ' 310' ' ' THR . 28.2 m -97.68 114.47 26.44 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 169.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 309' ' ' VAL . 4.9 mp -109.81 164.79 12.24 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 -175.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.83 140.42 52.95 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -135.22 -143.32 4.73 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.388 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.512 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -108.75 -176.5 3.06 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.981 0.419 . . . . 0.0 112.102 -177.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.597 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.6 OUTLIER -68.94 -179.54 1.51 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.146 -171.517 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.597 ' H ' HG22 ' A' ' 255' ' ' THR . . . -60.49 -177.39 0.07 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.233 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 46.9 m 79.48 6.19 2.01 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.734 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 10.9 t -124.29 89.51 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.799 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 171.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 11.6 m -73.22 98.38 2.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.831 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 61.84 98.82 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.842 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -43.1 -56.36 3.41 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.827 0.346 . . . . 0.0 111.139 173.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.54 167.08 23.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.928 -177.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.432 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 48.6 mtmt -137.25 -166.34 1.91 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -176.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -46.68 116.09 1.23 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.983 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.542 ' HA2' ' OH ' ' A' ' 319' ' ' TYR . . . 117.5 -10.53 14.45 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.092 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -101.96 138.6 38.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.951 0.405 . . . . 0.0 110.829 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.401 ' HB2' HG11 ' A' ' 342' ' ' VAL . 2.9 mp0 -107.24 153.43 22.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.32 0.581 . . . . 0.0 110.191 -176.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.624 HG23 ' HB3' ' A' ' 295' ' ' ALA . 1.7 m -133.97 168.2 24.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 176.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.32 135.27 32.03 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.067 170.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.608 ' HB3' ' HA ' ' A' ' 339' ' ' VAL . 35.1 p90 -147.64 167.39 24.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.83 -0.168 . . . . 0.0 111.21 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 1.8 t -158.24 119.06 3.4 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.379 0.609 . . . . 0.0 112.19 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.561 ' HB2' ' CA ' ' A' ' 337' ' ' ASP . 1.3 t-20 -123.47 79.39 1.68 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 160.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 2.0 p -107.48 87.23 2.45 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.394 -173.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -85.79 114.55 22.83 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 175.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 6.1 p90 37.2 53.5 1.24 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 124.273 0.983 . . . . 0.0 112.98 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.37 153.46 29.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.616 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -74.42 -10.19 59.33 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-O 121.124 0.488 . . . . 0.0 110.858 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -88.34 -2.22 58.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.878 -172.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.431 ' OE1' ' HB ' ' A' ' 289' ' ' THR . 46.0 mt-30 -47.92 -67.91 0.23 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.588 176.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 16.6 p -118.85 -82.12 0.64 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.949 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -113.12 -70.97 0.78 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.984 0.421 . . . . 0.0 110.499 174.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -117.49 -24.43 7.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.021 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' A' ' 279' ' ' GLN . . . 53.96 82.21 0.09 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.47 -0.787 . . . . 0.0 112.344 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 6.7 mp -84.55 -39.56 18.64 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.608 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -110.36 101.27 10.01 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.766 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -83.16 147.75 27.87 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.292 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -153.95 -46.13 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -136.63 116.88 13.52 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 173.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.431 ' HB ' ' OE1' ' A' ' 279' ' ' GLN . 1.9 t -122.33 88.51 48.89 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 121.495 0.664 . . . . 0.0 111.267 -173.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' PRO . . . . . 0.402 ' O ' ' HB ' ' A' ' 291' ' ' ILE . 96.0 Cg_endo -95.89 -157.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.479 2.786 . . . . 0.0 112.499 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.402 ' HB ' ' O ' ' A' ' 290' ' ' PRO . 47.5 mm 75.86 120.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.576 0.703 . . . . 0.0 111.634 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 30.4 p -105.59 171.66 7.21 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.304 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -127.11 137.19 52.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.099 0.476 . . . . 0.0 110.101 175.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 85.7 m -82.45 136.32 34.95 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.886 -174.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ALA . . . . . 0.624 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -114.85 177.04 4.79 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.877 176.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 7.2 m -141.02 114.14 8.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.457 0.646 . . . . 0.0 111.398 177.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 67.3 t -75.51 131.77 34.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.013 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 8.4 p -123.31 24.35 8.76 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.101 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -152.4 164.39 37.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.027 0.442 . . . . 0.0 111.983 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.432 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 2.3 m-20 -60.41 112.47 1.97 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.974 176.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -92.66 175.54 6.78 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.032 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.588 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 3.3 t-20 -149.46 122.34 8.74 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -168.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.4 94.87 5.32 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 163.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -96.23 -178.53 4.35 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.005 -174.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 25.5 m -58.66 -33.06 69.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.871 0.367 . . . . 0.0 111.647 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -82.03 -5.8 89.41 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.146 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 67.47 42.46 89.04 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.114 -176.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -116.62 132.27 56.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.78 0.79 . . . . 0.0 111.343 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.588 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.5 OUTLIER -135.06 102.58 3.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.945 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.593 ' OG1' HG23 ' A' ' 250' ' ' THR . 95.3 m -107.66 113.89 27.49 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.774 -0.579 . . . . 0.0 110.533 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 27.5 m -143.06 157.6 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-O 121.545 0.688 . . . . 0.0 110.698 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 26.3 m -109.02 148.24 31.08 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.224 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.573 HD22 ' N ' ' A' ' 313' ' ' LEU . 0.8 OUTLIER -112.23 135.01 53.43 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.237 -176.145 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 41.5 m -147.02 145.63 29.78 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 119.738 -0.785 . . . . 0.0 112.621 -171.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 132.02 152.28 7.07 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.74 169.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.651 ' HB ' ' HD2' ' A' ' 317' ' ' PRO . 18.0 m -68.36 -179.8 0.55 Allowed Pre-proline 0 CA--C 1.54 0.594 0 CA-C-O 117.406 -1.283 . . . . 0.0 108.648 172.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.651 ' HD2' ' HB ' ' A' ' 316' ' ' VAL . 4.3 Cg_exo -30.71 106.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 123.056 2.504 . . . . 0.0 113.632 -169.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 11.7 pt -82.88 102.89 9.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.739 -164.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.542 ' OH ' ' HA2' ' A' ' 265' ' ' GLY . 44.3 m-85 57.39 24.99 10.76 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.535 173.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 52.6 32.31 11.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.563 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 41.1 p -83.98 -3.73 58.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.693 0.758 . . . . 0.0 109.48 174.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 1.2 t -137.37 128.03 26.96 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.883 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.544 ' HB3' ' HD3' ' A' ' 324' ' ' PRO . 66.3 t30 -167.71 -46.98 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.004 -178.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 323' ' ' ASN . 4.8 Cg_exo -84.32 3.8 7.32 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.329 2.019 . . . . 0.0 110.857 173.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -64.9 -55.19 20.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.186 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 54.34 53.49 10.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.859 0.838 . . . . 0.0 108.841 -174.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -119.31 26.34 9.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.854 -172.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 5.8 m -84.12 53.1 2.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.636 0.731 . . . . 0.0 109.671 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 27.9 t -119.84 154.24 22.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.528 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 9.7 t -70.43 77.11 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.572 0.701 . . . . 0.0 109.263 175.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -80.0 144.84 32.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.504 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -89.23 107.64 19.17 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 233' ' ' GLN . 16.6 m -84.37 137.37 20.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.964 -175.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -115.41 152.14 33.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.566 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -90.61 126.04 35.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.24 -175.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 230' ' ' VAL . . . 129.38 13.13 2.39 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.083 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.561 ' CA ' ' HB2' ' A' ' 272' ' ' ASN . 3.0 m-20 -49.03 134.65 16.97 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.92 105.67 3.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.302 168.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.608 ' HA ' ' HB3' ' A' ' 270' ' ' PHE . 75.7 t -95.04 139.16 19.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.399 0.619 . . . . 0.0 111.888 -173.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 41.2 m -147.82 157.28 43.46 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.059 172.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.462 HG12 ' H ' ' A' ' 343' ' ' GLY . 20.8 t -87.76 151.24 3.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.401 HG11 ' HB2' ' A' ' 267' ' ' GLN . 8.9 p -69.14 -24.45 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.566 -176.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' GLY . . . . . 0.462 ' H ' HG12 ' A' ' 341' ' ' VAL . . . -141.04 -144.43 4.43 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.082 -0.58 . . . . 0.0 111.684 174.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 7.6 p -111.72 -53.27 2.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.423 0.63 . . . . 0.0 110.539 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.569 176.348 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.738 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -129.16 16.81 6.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.829 0.347 . . . . 0.0 111.498 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -81.42 -30.39 33.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.108 0.48 . . . . 0.0 110.627 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 80.78 26.83 52.75 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.073 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -73.52 159.3 53.09 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.719 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 8.3 m -79.15 140.03 37.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.811 0.338 . . . . 0.0 110.493 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.518 HD23 ' HA3' ' A' ' 253' ' ' GLY . 1.8 mp -132.7 177.41 7.64 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 252' ' ' THR . 82.0 m -128.75 159.95 34.06 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.636 0.255 . . . . 0.0 110.853 -174.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 41.8 t -110.05 138.39 38.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 43.3 tttm -111.34 -34.62 6.08 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.388 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 76.3 p -119.91 -169.46 1.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.523 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.532 ' HB3' HG13 ' A' ' 333' ' ' VAL . 87.4 mt-30 -112.37 120.8 40.62 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 120.512 0.196 . . . . 0.0 111.235 -167.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.661 ' HB3' ' CD1' ' A' ' 247' ' ' PHE . 88.9 Cg_exo -51.1 102.68 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.172 2.581 . . . . 0.0 113.313 175.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 236' ' ' VAL . 8.7 t -158.38 113.98 2.67 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 174.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.565 HG12 ' HB2' ' A' ' 246' ' ' GLN . 7.9 t -154.01 125.05 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 120.915 0.388 . . . . 0.0 110.889 169.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 26.5 m 48.15 89.53 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 123.82 0.848 . . . . 0.0 111.906 177.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -99.05 89.09 4.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.332 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -111.07 114.91 28.54 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 175.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -94.78 -50.39 5.17 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -168.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 49.0 t -65.45 -23.27 32.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.306 0.574 . . . . 0.0 110.129 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -96.02 -8.43 33.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.231 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 14.9 t70 55.41 69.61 0.72 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.955 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 17.8 m -145.2 105.11 4.02 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.819 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -129.84 122.43 28.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.847 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' GLN . . . . . 0.565 ' HB2' HG12 ' A' ' 236' ' ' VAL . 0.3 OUTLIER -120.73 -176.9 3.34 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 172.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.661 ' CD1' ' HB3' ' A' ' 234' ' ' PRO . 1.2 p90 -166.41 126.81 1.66 Allowed 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 119.969 -0.692 . . . . 0.0 112.793 174.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 37.2 m -99.75 131.25 45.85 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.403 HG22 ' HA ' ' A' ' 234' ' ' PRO . 19.4 t -138.67 141.9 35.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 119.609 -0.836 . . . . 0.0 112.111 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.441 HG23 ' OG1' ' A' ' 310' ' ' THR . 98.3 m -94.08 115.83 28.19 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.556 ' HB2' HG13 ' A' ' 309' ' ' VAL . 5.2 mp -104.18 166.27 10.51 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -177.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' A' ' 229' ' ' THR . 0.7 OUTLIER -134.88 99.81 4.41 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.802 0.334 . . . . 0.0 111.34 -176.203 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.518 ' HA3' HD23 ' A' ' 228' ' ' LEU . . . -137.59 140.26 11.14 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.304 -0.719 . . . . 0.0 111.304 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -110.93 92.75 4.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.092 0.472 . . . . 0.0 112.081 -172.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 38.7 m -125.82 106.77 9.92 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.273 171.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' A' ' 305' ' ' SER . . . -63.16 141.47 58.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -175.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 6.0 t 61.72 53.32 3.24 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.92 171.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 49.0 t -137.45 103.84 2.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.164 0.507 . . . . 0.0 110.009 174.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 36.2 m -79.11 87.75 4.86 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.401 0.619 . . . . 0.0 110.299 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 94.4 92.98 1.64 Allowed Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.384 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.743 ' CE1' ' HB3' ' A' ' 303' ' ' SER . 3.0 m-85 -45.2 -59.26 2.73 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.324 0.583 . . . . 0.0 111.557 172.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.76 HD11 ' HB2' ' A' ' 266' ' ' ASP . 2.8 tm? -166.8 140.51 3.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.679 -166.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -125.94 -171.2 2.33 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -51.89 131.49 31.06 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.084 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 122.32 -32.23 4.59 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.513 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ASP . . . . . 0.76 ' HB2' HD11 ' A' ' 262' ' ' LEU . 9.5 m-20 -108.07 154.49 21.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.005 0.431 . . . . 0.0 110.449 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.534 ' HB2' HG11 ' A' ' 342' ' ' VAL . 44.4 mt-30 -115.04 161.97 17.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.43 0.633 . . . . 0.0 111.44 -173.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.61 HG23 ' HB3' ' A' ' 295' ' ' ALA . 0.4 OUTLIER -126.18 -175.46 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.205 178.297 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.454 ' HD2' ' C ' ' A' ' 269' ' ' LYS . 2.5 tmmm? -148.54 134.71 19.31 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -146.66 148.1 31.7 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 118.779 -1.169 . . . . 0.0 112.258 176.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 81.0 p -95.83 111.44 23.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.569 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.479 ' HA ' ' OD1' ' A' ' 337' ' ' ASP . 25.7 p-10 -104.22 153.73 20.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.027 0.442 . . . . 0.0 110.877 -176.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 32.9 p -122.99 159.95 27.29 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.718 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -126.44 113.24 16.58 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 173.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 31.6 p-90 -159.71 36.05 0.19 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.387 0.613 . . . . 0.0 110.404 174.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 92.1 mt -66.92 173.97 3.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.804 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' GLN . . . . . 0.464 ' O ' ' HG3' ' A' ' 281' ' ' LYS . 18.4 mp0 -55.93 -50.41 70.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.716 0.293 . . . . 0.0 111.186 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -68.25 -46.0 71.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.472 0.653 . . . . 0.0 110.283 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -57.84 -40.32 79.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.242 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 4.1 p -67.48 -26.51 66.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.808 0.337 . . . . 0.0 111.577 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 277' ' ' GLN . 28.2 mtpp -83.07 -31.13 27.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.932 0.396 . . . . 0.0 110.748 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -86.84 -13.84 43.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.573 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.89 148.05 26.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.981 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 284' ' ' LEU . 6.8 mp -100.49 0.15 39.03 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.605 176.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 66.88 104.46 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.928 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -93.75 -26.93 16.77 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.339 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 132.01 -41.57 1.49 Allowed Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.23 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.511 ' O ' ' HD3' ' A' ' 290' ' ' PRO . . . -158.71 154.09 25.78 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 99.0 m -111.52 85.55 5.98 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.917 175.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 288' ' ' ALA . 12.3 Cg_endo -92.24 60.05 0.77 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.351 2.701 . . . . 0.0 112.402 -177.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 49.0 mm -92.6 134.96 28.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.978 0.418 . . . . 0.0 109.949 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 32.2 m -140.05 142.74 36.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.115 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -161.05 162.29 31.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.472 0.653 . . . . 0.0 111.443 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 268' ' ' VAL . 98.1 m -88.86 127.15 35.62 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.607 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ALA . . . . . 0.61 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -108.47 175.91 5.3 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 45.0 m -135.32 123.35 22.77 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.816 HG13 HG21 ' A' ' 311' ' ' VAL . 91.0 t -77.72 124.97 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.872 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 312' ' ' THR . 15.0 t -132.77 17.95 4.24 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.303 -170.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -152.78 -173.32 4.53 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.146 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -70.94 139.68 50.73 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.186 0.517 . . . . 0.0 109.717 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.575 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -136.17 167.6 20.96 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.742 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -140.25 157.6 45.32 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.091 -177.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.743 ' HB3' ' CE1' ' A' ' 261' ' ' PHE . 0.0 OUTLIER -139.18 96.01 3.04 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.422 174.546 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 304' ' ' ASP . . . . . 0.421 ' OD2' ' HB2' ' A' ' 308' ' ' ASP . 2.0 p-10 -108.7 153.65 23.14 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 171.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.522 ' HB3' ' HB2' ' A' ' 256' ' ' ALA . 0.1 OUTLIER -68.65 -7.61 34.79 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -171.476 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -75.31 -4.68 74.67 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 175.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 86.46 42.85 6.38 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.933 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.421 ' HB2' ' OD2' ' A' ' 304' ' ' ASP . 3.9 m-20 -125.21 137.05 54.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.69 0.745 . . . . 0.0 112.119 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 251' ' ' LEU . 1.2 p -154.97 106.33 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.175 174.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.441 ' OG1' HG23 ' A' ' 250' ' ' THR . 54.5 m -106.44 130.28 54.27 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 121.16 -0.962 . . . . 0.0 111.431 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.816 HG21 HG13 ' A' ' 297' ' ' VAL . 7.1 p -159.55 147.43 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.131 0.491 . . . . 0.0 110.549 174.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 52.8 m -86.31 150.1 24.58 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.06 174.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.529 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.2 mp -126.05 164.83 19.99 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.284 -177.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 15.9 m -131.03 134.26 46.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.754 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 89.67 104.15 1.12 Allowed Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.978 173.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.629 HG13 ' CE2' ' A' ' 247' ' ' PHE . 0.0 OUTLIER -127.09 143.59 47.52 Favored Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 122.208 0.203 . . . . 0.0 110.851 177.738 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.92 104.58 1.53 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.048 2.498 . . . . 0.0 111.673 174.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.667 HG22 ' H ' ' A' ' 319' ' ' TYR . 24.1 mm -97.11 178.51 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.845 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.667 ' H ' HG22 ' A' ' 318' ' ' ILE . 96.8 m-85 77.38 -46.2 0.47 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.976 0.91 . . . . 0.0 110.786 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 56.08 66.05 1.29 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.612 0.72 . . . . 0.0 110.329 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 23.6 p -99.69 11.18 39.88 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.279 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 23.3 m -101.09 -48.62 4.36 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.678 -175.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.575 ' HB3' ' HD3' ' A' ' 324' ' ' PRO . 31.7 t-20 -74.19 -55.94 2.78 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.749 -176.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 323' ' ' ASN . 3.3 Cg_exo -83.52 -6.87 10.81 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.292 1.994 . . . . 0.0 112.511 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 58.45 -77.63 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.781 0.832 . . . . 0.0 112.581 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -105.86 -17.33 14.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.154 -172.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -110.65 52.69 0.72 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.117 0.484 . . . . 0.0 110.239 -173.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 61.0 m -80.52 66.65 6.11 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.289 -177.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 38.5 t -64.35 138.17 23.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 174.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 16.0 m -56.97 106.16 0.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.175 0.512 . . . . 0.0 110.992 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' ARG . . . . . 0.538 ' HD2' ' O ' ' A' ' 331' ' ' ARG . 3.8 ppt_? -85.35 154.89 21.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.987 -177.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 332' ' ' GLN . . . . . 0.426 ' HA ' ' OE1' ' A' ' 332' ' ' GLN . 11.6 mm-40 -94.67 154.38 17.35 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 173.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.532 HG13 ' HB3' ' A' ' 233' ' ' GLN . 6.8 p -77.76 143.73 12.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.718 -177.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -118.59 144.41 46.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.685 -174.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -100.58 151.98 20.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.401 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 112.45 12.08 14.0 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.391 173.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.479 ' OD1' ' HA ' ' A' ' 272' ' ' ASN . 10.8 m-20 -71.73 168.92 16.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.056 0.455 . . . . 0.0 111.463 -177.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -98.97 122.36 42.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.535 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.482 HG21 HD23 ' A' ' 251' ' ' LEU . 49.6 t -100.79 145.36 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.248 0.547 . . . . 0.0 111.773 -172.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 53.7 m -151.22 179.07 8.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.186 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 343' ' ' GLY . 29.6 t -111.96 143.69 21.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -175.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.534 HG11 ' HB2' ' A' ' 267' ' ' GLN . 9.7 p -69.57 -24.33 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.976 0.417 . . . . 0.0 110.88 -175.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 343' ' ' GLY . . . . . 0.545 ' H ' HG12 ' A' ' 341' ' ' VAL . . . -87.46 87.01 1.53 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.768 178.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 70.4 p 61.42 117.33 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.788 1.235 . . . . 0.0 112.803 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -1.009 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.733 179.479 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.563 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -153.52 -81.68 0.09 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.629 0.215 . . . . 0.0 110.656 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.426 ' CG ' ' N ' ' A' ' 225' ' ' GLY . 24.3 t80 54.18 -157.51 0.19 Allowed 'General case' 0 CA--C 1.542 0.642 0 O-C-N 123.266 0.354 . . . . 0.0 110.068 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.426 ' N ' ' CG ' ' A' ' 224' ' ' PHE . . . 121.88 -31.24 5.03 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.239 177.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -118.11 137.24 12.91 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.857 -177.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 87.2 m -129.38 131.28 46.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 2.4 mp -136.87 -178.36 5.16 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 60.9 m -128.4 153.78 46.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.765 0.317 . . . . 0.0 111.532 -171.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.465 ' CG2' HG23 ' A' ' 339' ' ' VAL . 22.0 t -110.53 133.0 57.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.487 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -125.22 12.09 8.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.824 0.345 . . . . 0.0 111.591 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.4 p -144.61 -172.0 3.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.596 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.716 ' OE1' ' HB2' ' A' ' 335' ' ' ALA . 1.3 mm100 -114.03 134.39 22.17 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -174.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.476 ' HB3' ' CG ' ' A' ' 247' ' ' PHE . 28.4 Cg_exo -61.95 104.97 0.35 Allowed 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.224 1.95 . . . . 0.0 111.454 173.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.422 ' O ' HG23 ' A' ' 236' ' ' VAL . 5.8 t -156.02 103.86 2.24 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.675 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.75 173.41 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.139 0.575 . . . . 0.0 110.561 170.559 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.548 ' H ' HG13 ' A' ' 236' ' ' VAL . 45.5 m -23.13 115.76 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.467 1.507 . . . . 0.0 114.521 -174.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -111.91 83.58 1.81 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.759 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.482 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 4.5 t30 -103.34 99.65 9.5 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -175.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -86.5 -47.94 8.83 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -163.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 37.7 t -65.88 -23.26 31.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.7 0.762 . . . . 0.0 109.313 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.482 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 28.0 mmmt -93.75 -7.47 43.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.16 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 54.83 58.98 4.35 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.424 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 19.8 m -136.83 102.86 5.01 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.62 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -120.73 116.62 25.62 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' GLN . . . . . 0.479 ' HB2' HG12 ' A' ' 236' ' ' VAL . 86.7 mt-30 -133.61 158.74 42.43 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 177.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.675 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 3.6 p90 -140.83 138.66 34.17 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.101 172.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 54.3 m -97.25 135.89 38.54 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 42.3 t -142.43 141.61 27.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.715 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.481 HG23 ' OG1' ' A' ' 310' ' ' THR . 90.8 m -88.08 113.83 24.1 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 168.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 309' ' ' VAL . 4.9 mp -104.34 163.95 12.07 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -176.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.9 140.87 52.53 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -139.3 -143.07 4.35 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.289 -175.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -106.02 -174.51 2.55 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -174.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.587 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.6 OUTLIER -71.51 -178.54 2.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.733 -172.088 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.587 ' H ' HG22 ' A' ' 255' ' ' THR . . . -62.41 -176.9 0.12 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.123 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 15.6 t 80.77 7.5 1.32 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.991 0.917 . . . . 0.0 110.559 -175.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 21.2 t -126.25 89.52 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-O 121.562 0.696 . . . . 0.0 109.216 170.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 31.2 m -74.37 99.66 3.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.426 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 67.16 94.48 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.455 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -43.42 -59.32 2.18 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 111.427 174.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 266' ' ' ASP . 95.9 mt -148.49 162.68 39.13 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 9.6 mtpm? -137.22 -167.26 2.07 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.625 0.231 . . . . 0.0 111.625 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -53.33 113.32 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.273 0.558 . . . . 0.0 111.86 -175.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 109.93 -17.74 29.57 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.553 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 30.2 m-20 -77.52 144.81 37.38 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.63 ' HB2' HG11 ' A' ' 342' ' ' VAL . 35.4 mt-30 -111.98 154.57 25.1 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.619 0.723 . . . . 0.0 111.192 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 295' ' ' ALA . 0.0 OUTLIER -121.98 -176.65 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.623 178.829 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 340' ' ' SER . 16.8 tppt? -125.29 89.02 2.98 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.719 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.457 ' HB3' ' CE1' ' A' ' 293' ' ' PHE . 6.8 t80 -81.73 128.33 33.87 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -171.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 291' ' ' ILE . 85.7 m -119.25 87.4 2.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.046 0.45 . . . . 0.0 109.855 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' A' ' 291' ' ' ILE . 22.6 t-20 -93.66 152.51 18.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.222 -175.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 12.4 p -84.83 134.23 34.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.022 0.439 . . . . 0.0 110.711 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.418 ' HA ' ' HB ' ' A' ' 289' ' ' THR . 21.0 p90 -83.27 116.05 22.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.714 0.768 . . . . 0.0 110.839 -174.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 36.0 t90 -147.35 -22.23 0.39 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.367 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.11 23.68 3.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.781 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' GLN . . . . . 0.497 ' O ' ' HB2' ' A' ' 283' ' ' ALA . 90.2 mt-30 -83.88 -70.77 0.54 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.073 0.463 . . . . 0.0 110.433 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -95.39 -26.8 15.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.339 -174.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 -85.91 13.06 8.0 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.226 -173.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.75 -80.44 0.44 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.87 0.367 . . . . 0.0 111.793 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -111.43 -80.02 0.58 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.015 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -162.94 86.83 0.56 Allowed 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 277' ' ' GLN . . . -65.85 -77.29 0.07 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.925 -174.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 53.19 37.48 25.17 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -170.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 63.27 93.42 0.06 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.792 -177.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -146.4 -36.32 0.26 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.746 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -138.15 -130.16 2.77 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . 177.04 -174.9 0.12 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.367 0.604 . . . . 0.0 110.184 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.418 ' HB ' ' HA ' ' A' ' 274' ' ' TYR . 86.3 m -137.98 102.93 8.28 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 173.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' PRO . . . . . 0.438 ' O ' ' HB3' ' A' ' 272' ' ' ASN . 69.5 Cg_exo -40.72 104.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 124.163 3.242 . . . . 0.0 114.091 -171.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 271' ' ' THR . 13.4 tt -88.95 -26.81 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.138 -176.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 43.3 t -156.99 95.14 1.48 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.922 0.391 . . . . 0.0 110.001 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' PHE . . . . . 0.457 ' CE1' ' HB3' ' A' ' 270' ' ' PHE . 13.0 p90 -140.69 161.0 38.81 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 46.4 m -88.48 111.41 21.79 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.831 0.348 . . . . 0.0 110.551 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ALA . . . . . 0.458 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -97.6 -178.16 4.04 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.583 ' O ' ' HA ' ' A' ' 313' ' ' LEU . 93.2 m -136.96 131.85 33.56 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -174.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.53 HG13 HG21 ' A' ' 311' ' ' VAL . 67.3 t -78.5 131.49 34.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.703 174.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 312' ' ' THR . 6.9 t -111.41 2.35 17.5 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.757 -0.777 . . . . 0.0 112.723 -167.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -170.55 -166.49 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.776 -178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.92 144.54 27.89 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.508 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -137.59 173.58 11.51 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.854 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.676 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 26.2 t-20 -146.34 128.7 15.86 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -169.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.453 ' HB2' ' HB ' ' A' ' 258' ' ' VAL . 0.3 OUTLIER -117.87 95.12 4.78 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 165.7 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -104.04 -177.21 3.3 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.925 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 39.1 m -60.88 -30.98 70.48 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.708 0.289 . . . . 0.0 111.425 -177.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -77.61 0.94 68.54 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.207 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 56.32 41.58 87.52 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.408 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -116.38 127.89 55.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.696 0.748 . . . . 0.0 111.005 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.676 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.4 OUTLIER -135.34 104.45 4.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.344 -179.398 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.481 ' OG1' HG23 ' A' ' 250' ' ' THR . 94.6 m -105.35 121.09 43.16 Favored 'General case' 0 C--N 1.316 -0.858 0 O-C-N 121.865 -0.522 . . . . 0.0 110.776 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.53 HG21 HG13 ' A' ' 297' ' ' VAL . 7.7 p -157.65 150.26 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 121.089 0.471 . . . . 0.0 110.006 176.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 58.1 m -85.54 151.95 23.54 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.265 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' A' ' 296' ' ' THR . 5.9 mp -114.53 135.47 54.09 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.747 -177.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' SER . . . . . 0.433 ' HA ' ' HG2' ' A' ' 246' ' ' GLN . 14.1 p -113.53 154.51 26.98 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -174.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 72.12 40.35 56.51 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.071 176.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 2.6 m -142.89 112.74 5.79 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-O 121.006 0.431 . . . . 0.0 111.637 -170.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -90.31 87.28 0.35 Allowed 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.048 2.499 . . . . 0.0 113.535 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 49.4 mt -128.16 101.6 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 120.791 0.329 . . . . 0.0 111.016 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.499 ' HE1' ' O ' ' A' ' 236' ' ' VAL . 1.1 m-85 -150.6 136.91 18.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.317 174.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -109.76 -48.17 3.25 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.711 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 69.4 p 47.74 56.82 6.64 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.159 0.584 . . . . 0.0 111.074 -174.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 10.4 m -89.63 -68.44 0.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.998 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.426 ' HA ' ' HB2' ' A' ' 331' ' ' ARG . 65.5 t30 29.24 78.61 0.27 Allowed Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -178.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.438 ' HB2' ' CD1' ' A' ' 326' ' ' TYR . 7.5 Cg_exo -74.12 -179.01 4.28 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.022 1.814 . . . . 0.0 111.06 175.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -102.04 26.45 7.59 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.86 -168.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' TYR . . . . . 0.438 ' CD1' ' HB2' ' A' ' 324' ' ' PRO . 81.9 m-85 -63.29 -55.97 20.33 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.249 178.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -139.97 -4.11 1.38 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.274 0.559 . . . . 0.0 110.357 176.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 9.5 t 60.65 52.47 4.46 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.984 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 2.5 t -92.34 17.51 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.615 0.721 . . . . 0.0 110.312 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 8.2 t 58.07 57.54 4.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.338 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' ARG . . . . . 0.426 ' HB2' ' HA ' ' A' ' 323' ' ' ASN . 30.8 mmt180 -67.77 115.2 7.05 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.296 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -131.51 -165.05 1.52 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -177.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.419 ' H ' HG23 ' A' ' 333' ' ' VAL . 13.2 t -44.44 154.07 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 O-C-N 123.759 0.662 . . . . 0.0 110.893 175.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -97.25 144.54 26.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.493 -165.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.716 ' HB2' ' OE1' ' A' ' 233' ' ' GLN . . . -98.84 172.24 7.56 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.878 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 96.71 9.92 55.9 Favored Glycine 0 CA--C 1.511 -0.205 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.086 171.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.478 ' HB2' ' HA ' ' A' ' 272' ' ' ASN . 12.5 p-10 -88.43 -176.11 5.21 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.831 0.348 . . . . 0.0 110.854 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -120.16 145.76 46.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.438 0.637 . . . . 0.0 111.803 -171.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 79.4 t -108.63 150.23 11.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.973 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.516 ' HB2' ' HB3' ' A' ' 269' ' ' LYS . 69.3 m -144.89 176.7 9.27 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 174.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 343' ' ' GLY . 44.6 t -117.94 140.39 41.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.63 HG11 ' HB2' ' A' ' 267' ' ' GLN . 5.3 p -69.75 -27.42 33.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 CA-C-O 120.83 0.348 . . . . 0.0 110.692 -175.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' GLY . . . . . 0.531 ' H ' HG12 ' A' ' 341' ' ' VAL . . . 172.67 -122.15 0.91 Allowed Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 3.5 p -142.24 -54.61 0.43 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.036 0.446 . . . . 0.0 110.563 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.931 -179.164 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 N-CA-C 112.035 -0.426 . . . . 0.0 112.035 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -148.42 117.18 6.67 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -89.64 20.87 3.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.757 -174.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 92.07 32.51 8.35 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.422 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -75.86 -141.96 1.06 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.369 -0.443 . . . . 0.0 112.341 177.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 19.3 m -75.04 143.86 43.29 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.958 0.408 . . . . 0.0 111.031 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.448 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.1 mp -135.21 -178.74 5.24 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 70.8 m -130.24 150.43 51.49 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.885 0.374 . . . . 0.0 111.894 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.81 106.68 19.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -93.09 -16.92 24.42 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.972 0.415 . . . . 0.0 111.207 -173.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 32.1 p -130.84 -169.15 2.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.757 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.517 ' HB3' HG23 ' A' ' 333' ' ' VAL . 70.6 mt-30 -105.61 120.49 49.15 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.048 -170.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.527 ' HA ' HG22 ' A' ' 249' ' ' VAL . 15.0 Cg_exo -66.5 105.61 0.93 Allowed 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.378 2.052 . . . . 0.0 111.618 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 8.0 t -154.67 121.84 5.61 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.66 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -155.14 174.02 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 166.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.532 ' H ' HG13 ' A' ' 236' ' ' VAL . 62.9 m -23.78 110.07 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.88 1.272 . . . . 0.0 114.226 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -103.69 108.87 20.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.487 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.424 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 5.3 t30 -122.79 94.82 4.4 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -83.45 -50.12 8.62 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.08 -162.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 40.3 t -62.49 -23.1 31.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.662 0.744 . . . . 0.0 109.688 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.424 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 13.9 mmmm -96.18 -7.44 35.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.033 -178.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 60.28 57.5 2.89 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.684 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 11.7 t -139.95 112.9 8.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.907 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -129.52 110.12 11.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.591 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' GLN . . . . . 0.657 ' HB2' HG12 ' A' ' 236' ' ' VAL . 0.7 OUTLIER -114.65 165.93 12.26 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 173.618 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.66 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 1.7 p90 -157.65 125.98 5.53 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 51.9 m -94.17 133.07 38.07 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.527 HG22 ' HA ' ' A' ' 234' ' ' PRO . 0.8 OUTLIER -141.12 142.92 28.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 119.182 -1.007 . . . . 0.0 112.231 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.518 HG23 ' OG1' ' A' ' 310' ' ' THR . 21.9 m -93.79 111.97 23.75 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 165.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.57 ' HB2' HG13 ' A' ' 309' ' ' VAL . 5.2 mp -102.92 167.81 9.61 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -176.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.24 140.51 51.07 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -141.64 -143.1 4.19 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.329 -174.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -109.42 -173.93 2.38 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -174.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 256' ' ' ALA . 3.3 m -66.58 174.76 2.64 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.369 -172.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 255' ' ' THR . . . -59.52 -175.38 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.047 0.939 . . . . 0.0 113.012 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 69.8 m 81.18 10.88 0.87 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.992 0.917 . . . . 0.0 111.556 -177.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 22.3 t -128.73 89.79 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 167.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 7.2 m -71.72 97.17 1.71 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.384 -177.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 69.01 98.89 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.021 -172.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -44.34 -60.25 2.02 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 117.108 0.454 . . . . 0.0 110.933 172.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.514 ' HB3' ' CB ' ' A' ' 266' ' ' ASP . 94.4 mt -148.21 166.08 29.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.545 -174.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 97.6 mttt -141.36 -166.68 2.24 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -52.04 113.6 1.06 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.362 0.601 . . . . 0.0 112.058 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 110.92 -17.31 27.44 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.054 177.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ASP . . . . . 0.514 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 18.0 m-20 -82.58 146.15 29.33 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.42 145.55 45.13 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.607 0.718 . . . . 0.0 111.641 -174.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.609 HG23 ' HB3' ' A' ' 295' ' ' ALA . 0.2 OUTLIER -121.75 -178.97 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.038 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.502 ' HD3' ' C ' ' A' ' 269' ' ' LYS . 1.0 OUTLIER -126.77 139.36 53.18 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.544 ' CE1' ' HB2' ' A' ' 295' ' ' ALA . 8.1 p90 -146.48 157.46 43.75 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.644 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.541 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 5.6 t -137.38 95.89 3.16 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.955 176.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.42 ' HA ' ' CG ' ' A' ' 337' ' ' ASP . 4.0 m120 -95.34 113.73 25.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.551 177.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 19.1 p -91.74 79.88 5.34 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.398 0.618 . . . . 0.0 110.55 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -94.99 123.87 38.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.191 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -82.72 17.9 1.71 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.473 0.654 . . . . 0.0 110.511 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.47 12.39 2.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.701 -178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -107.85 -8.72 15.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.051 172.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -69.08 -81.38 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.039 0.447 . . . . 0.0 112.037 -171.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -79.52 -21.47 45.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.09 -173.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 39.4 p -67.54 -44.65 77.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.177 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -95.16 -74.09 0.56 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.0 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -138.73 -102.12 0.17 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -175.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -170.18 116.62 0.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 8.1 mp -101.74 -33.15 9.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.672 0.272 . . . . 0.0 110.584 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 68.53 -58.73 0.47 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.001 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -107.17 122.88 47.4 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.98 0.419 . . . . 0.0 110.068 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 93.24 123.07 3.42 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.04 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.61 ' O ' ' HB ' ' A' ' 289' ' ' THR . . . -67.1 -41.7 85.84 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.711 0.767 . . . . 0.0 109.484 177.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.61 ' HB ' ' O ' ' A' ' 288' ' ' ALA . 5.6 t 169.8 128.81 0.05 OUTLIER Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 113.487 -1.688 . . . . 0.0 109.99 173.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.96 46.25 2.11 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.763 2.308 . . . . 0.0 112.551 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.406 HG12 ' OG1' ' A' ' 289' ' ' THR . 36.3 mm -86.11 116.29 28.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.156 0.503 . . . . 0.0 111.208 -177.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 25.9 p -152.74 122.17 6.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.492 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -165.34 -171.05 2.04 Favored 'General case' 0 C--O 1.23 0.079 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.912 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 91.3 m -88.76 134.65 33.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.914 -173.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ALA . . . . . 0.609 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -117.5 176.0 5.37 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 54.5 m -130.82 125.44 33.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.597 0.713 . . . . 0.0 112.877 -176.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.649 HG13 HG21 ' A' ' 311' ' ' VAL . 60.7 t -75.33 130.5 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.714 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 3.5 m -115.78 -1.59 12.6 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.276 -169.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -160.13 -166.33 1.67 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.085 -0.384 . . . . 0.0 111.138 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.43 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 3.3 m-20 -66.32 157.62 31.25 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.468 0.651 . . . . 0.0 110.229 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.458 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -149.23 177.44 9.64 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.595 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -144.62 137.09 26.45 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.211 -0.196 . . . . 0.0 111.297 -171.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.8 OUTLIER -118.99 95.08 4.67 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 163.644 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.95 177.46 4.85 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.946 -174.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 11.6 t -59.58 -32.41 70.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.898 0.38 . . . . 0.0 111.004 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -78.9 4.23 62.16 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.252 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 59.94 42.33 98.22 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.631 176.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -114.55 131.1 56.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.454 0.627 . . . . 0.0 110.528 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 251' ' ' LEU . 2.1 p -132.45 95.01 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.501 0.667 . . . . 0.0 111.062 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.518 ' OG1' HG23 ' A' ' 250' ' ' THR . 76.7 m -101.42 128.41 47.63 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 122.011 -0.431 . . . . 0.0 111.827 -176.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.649 HG21 HG13 ' A' ' 297' ' ' VAL . 7.3 p -162.21 150.72 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.981 174.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 52.0 m -86.87 146.41 26.21 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.989 0.423 . . . . 0.0 110.584 177.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.485 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.4 mp -120.99 159.04 26.44 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.58 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 17.5 m -138.48 127.75 24.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.179 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 100.7 94.18 2.16 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.607 -0.806 . . . . 0.0 114.007 172.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.414 HG13 ' CE2' ' A' ' 247' ' ' PHE . 0.5 OUTLIER -138.64 110.28 8.06 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 172.843 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.26 62.49 3.44 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.89 2.393 . . . . 0.0 112.377 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 41.0 pt -122.04 147.49 26.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.924 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -116.99 119.43 35.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.974 0.416 . . . . 0.0 111.211 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -93.51 20.87 6.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.744 176.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 20.3 p 50.57 -107.14 0.27 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.402 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 38.1 m -159.62 -63.95 0.07 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.418 ' CB ' ' HB2' ' A' ' 330' ' ' SER . 43.1 m-80 55.4 64.65 5.36 Favored Pre-proline 0 N--CA 1.469 0.477 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.637 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.563 ' HA ' ' O ' ' A' ' 328' ' ' SER . 71.5 Cg_endo -90.9 -165.8 0.18 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.482 2.122 . . . . 0.0 111.565 -177.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 66.53 -69.91 0.11 Allowed 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.94 0.775 . . . . 0.0 111.707 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -57.57 -47.93 80.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.422 -174.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -136.26 21.54 3.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.799 0.333 . . . . 0.0 110.415 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' SER . . . . . 0.563 ' O ' ' HA ' ' A' ' 324' ' ' PRO . 41.1 m 67.8 -65.99 0.23 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.124 -176.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 10.6 t -136.91 104.65 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 172.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' SER . . . . . 0.418 ' HB2' ' CB ' ' A' ' 323' ' ' ASN . 9.1 m -90.18 58.23 4.02 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.351 0.596 . . . . 0.0 110.947 -173.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -96.37 112.85 24.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.726 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -123.25 109.55 14.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.819 0.342 . . . . 0.0 110.526 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.517 HG23 ' HB3' ' A' ' 233' ' ' GLN . 6.1 m -103.04 132.44 49.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.16 162.65 14.07 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.412 0.625 . . . . 0.0 111.627 -176.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -99.04 170.0 9.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.977 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 110.64 10.75 20.89 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.473 172.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.541 ' HB3' ' O ' ' A' ' 271' ' ' THR . 13.6 m-20 -96.27 -177.26 3.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.846 0.323 . . . . 0.0 111.778 -176.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -109.08 153.3 23.87 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -169.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.502 HG21 HD23 ' A' ' 251' ' ' LEU . 76.1 t -135.98 157.31 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.676 -175.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 5.6 t -156.97 179.73 9.02 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 172.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.498 HG13 HD11 ' A' ' 262' ' ' LEU . 69.2 t -115.88 133.08 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.126 0.489 . . . . 0.0 111.946 -175.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 71.8 t -96.39 -44.76 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.887 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 113.06 -126.67 7.57 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 111.396 -0.681 . . . . 0.0 111.396 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 4.6 p -134.5 -71.57 0.49 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.313 0.578 . . . . 0.0 110.068 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.881 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.578 176.916 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.69 ' N ' ' HG1' ' A' ' 227' ' ' THR . . . . . . . . 0 N--CA 1.481 1.655 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 63.23 -81.16 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.352 0.661 . . . . 0.0 112.06 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -88.11 -23.25 23.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.87 0.367 . . . . 0.0 110.66 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 129.78 -38.78 1.93 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.127 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -118.35 121.75 5.15 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.859 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.69 ' HG1' ' N ' ' A' ' 222' ' ' GLY . 10.3 m -135.38 136.01 41.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.782 0.325 . . . . 0.0 110.378 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.486 HD21 ' CE1' ' A' ' 261' ' ' PHE . 8.2 mt -147.88 174.68 11.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.267 -177.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 57.2 m -134.59 161.98 33.57 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 12.2 t -116.11 139.61 41.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.426 ' HD2' ' CG2' ' A' ' 252' ' ' THR . 38.0 tttt -120.17 -1.58 10.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.044 0.45 . . . . 0.0 111.117 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.462 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 19.8 p -139.33 -168.23 2.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.932 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -113.67 102.52 54.89 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -174.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 248' ' ' THR . 35.9 Cg_endo -66.99 105.72 1.02 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.216 1.944 . . . . 0.0 112.176 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 247' ' ' PHE . 12.0 t -113.03 144.51 42.48 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.319 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.492 ' HA ' ' HB3' ' A' ' 247' ' ' PHE . 28.9 t -80.81 122.99 36.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.03 -171.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 94.0 m -97.95 124.59 42.47 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.104 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -93.77 124.1 37.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.188 0.518 . . . . 0.0 110.987 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.47 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 20.5 t30 -127.04 70.85 1.3 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -86.06 -28.38 24.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.757 -161.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.46 -22.97 30.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 172.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.47 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 19.6 mmtp -101.05 -0.72 35.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.135 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 23.1 t70 50.82 52.66 14.49 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 113.999 -1.455 . . . . 0.0 111.3 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 24.2 m -140.25 128.96 23.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.423 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -109.47 110.84 22.07 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -118.37 176.65 5.14 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.111 -174.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.492 ' HB3' ' HA ' ' A' ' 236' ' ' VAL . 15.7 p90 -160.58 148.87 16.41 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.366 171.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 55.4 m -112.11 145.07 40.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.786 -168.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 9.9 p -154.08 142.8 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.462 ' HB ' ' CG2' ' A' ' 232' ' ' THR . 19.2 m -103.93 109.93 21.87 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 166.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.69 171.33 7.42 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.287 0.565 . . . . 0.0 109.695 -175.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.426 ' CG2' ' HD2' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -125.77 139.14 53.76 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.066 175.01 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -136.08 -143.72 4.73 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.025 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.532 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -101.75 -174.58 2.62 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.702 HG22 ' H ' ' A' ' 256' ' ' ALA . 2.1 m -73.69 -178.2 3.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.426 -173.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.702 ' H ' HG22 ' A' ' 255' ' ' THR . . . -59.19 -177.19 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.697 0.799 . . . . 0.0 112.868 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 33.8 t 80.89 7.63 1.26 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.077 0.951 . . . . 0.0 111.109 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 59.1 t -128.01 89.7 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 121.538 0.685 . . . . 0.0 109.512 171.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 87.0 m -76.94 98.75 5.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.48 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 68.23 89.64 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.493 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.671 ' HB3' HD22 ' A' ' 262' ' ' LEU . 8.2 m-85 -46.12 -59.58 2.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.538 0.685 . . . . 0.0 109.897 170.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.671 HD22 ' HB3' ' A' ' 261' ' ' PHE . 1.4 mm? -123.31 156.21 35.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.286 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 55.1 mtmt -132.81 -167.6 1.93 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 171.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -54.41 114.23 1.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.212 0.53 . . . . 0.0 111.386 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 106.57 -12.86 42.93 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.527 175.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ASP . . . . . 0.477 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 8.7 m-20 -78.32 136.67 37.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.827 0.346 . . . . 0.0 110.32 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -110.95 141.69 44.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.715 0.769 . . . . 0.0 112.133 -171.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 294' ' ' THR . 2.4 m -118.58 169.94 8.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.43 176.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.32 135.11 19.96 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.463 ' CB ' ' HA ' ' A' ' 339' ' ' VAL . 31.0 p90 -147.03 159.96 42.95 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.06 -1.056 . . . . 0.0 112.664 -173.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 82.7 p -99.69 96.06 7.36 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.943 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -77.38 160.52 28.71 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.372 0.606 . . . . 0.0 110.877 -176.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' THR . . . . . 0.485 HG23 ' HB3' ' A' ' 337' ' ' ASP . 1.0 OUTLIER -70.26 123.4 21.59 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.912 -173.505 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -134.58 162.44 32.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.995 170.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.631 ' O ' ' HG3' ' A' ' 278' ' ' GLN . 32.1 t-105 57.84 72.65 0.51 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.717 0.635 . . . . 0.0 109.296 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.02 14.9 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.227 -175.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' GLN . . . . . 0.428 ' H ' ' C ' ' A' ' 275' ' ' TRP . 41.7 mt-30 -93.02 -14.07 27.86 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 176.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 275' ' ' TRP . 63.5 mt-30 -63.49 -51.27 66.27 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.422 0.629 . . . . 0.0 110.208 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -67.12 -27.0 66.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.454 -175.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 1.8 p -91.57 -47.84 7.18 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -176.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -77.94 -32.12 51.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.932 0.396 . . . . 0.0 110.987 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 57.85 18.93 5.29 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.8 0.84 . . . . 0.0 112.072 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -145.88 -164.99 2.08 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.315 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 90.4 mt 67.49 27.79 7.83 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 123.611 0.569 . . . . 0.0 111.199 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 63.84 102.24 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.648 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -158.67 158.15 33.2 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.592 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 156.59 -32.98 0.58 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.63 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -137.64 103.96 5.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.706 0.289 . . . . 0.0 110.929 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.405 HG23 ' HB ' ' A' ' 271' ' ' THR . 11.7 t -65.38 134.0 95.55 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' PRO . . . . . 0.61 ' O ' HG12 ' A' ' 291' ' ' ILE . 49.7 Cg_endo -69.77 158.02 58.36 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.56 2.173 . . . . 0.0 112.824 -177.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 290' ' ' PRO . 7.9 pt 59.37 170.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.085 1.354 . . . . 0.0 113.186 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 20.1 m -154.2 164.63 38.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.888 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -134.56 145.3 48.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.032 0.444 . . . . 0.0 110.328 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 268' ' ' VAL . 91.2 m -90.32 131.17 36.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.157 -176.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -123.19 173.95 7.57 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.403 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 90.2 m -134.4 128.23 33.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.277 0.56 . . . . 0.0 112.456 -175.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 299' ' ' ALA . 40.2 t -86.42 139.6 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.812 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 312' ' ' THR . 15.0 t -111.5 11.44 21.35 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -176.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.616 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -153.23 177.56 10.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.847 0.356 . . . . 0.0 111.504 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.414 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 2.8 m-20 -67.95 114.55 6.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.3 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.531 ' HB3' ' H ' ' A' ' 262' ' ' LEU . . . -93.33 100.1 12.5 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.893 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.743 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 13.6 m120 -68.15 126.85 30.83 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -171.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.536 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 18.8 t -104.75 94.82 5.49 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 161.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.1 178.31 5.58 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.718 -175.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 6.3 t -61.18 -33.63 73.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.815 0.341 . . . . 0.0 111.198 -176.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -82.44 7.19 65.48 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.08 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 61.38 42.35 99.75 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.099 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -117.79 134.54 54.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 117.232 0.516 . . . . 0.0 111.082 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.743 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.1 OUTLIER -141.13 106.03 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.957 -178.003 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.451 ' OG1' HG23 ' A' ' 250' ' ' THR . 47.0 m -112.7 122.8 48.73 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.695 -0.628 . . . . 0.0 110.837 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 17.6 m -147.73 161.55 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-O 121.227 0.537 . . . . 0.0 110.895 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 298' ' ' THR . 15.5 m -113.73 138.24 50.51 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.478 172.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.415 HD13 ' CZ ' ' A' ' 247' ' ' PHE . 4.8 mp -103.26 149.28 24.86 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.609 -175.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 20.3 m -138.48 139.0 38.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.05 0.452 . . . . 0.0 111.845 -173.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 92.92 41.66 4.59 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.509 -0.768 . . . . 0.0 112.43 174.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 4.7 m -127.42 98.96 28.08 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.203 0.525 . . . . 0.0 111.042 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.06 48.83 2.37 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 123.003 2.469 . . . . 0.0 111.817 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.51 122.96 38.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.425 0.631 . . . . 0.0 109.62 -176.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.496 ' HB3' ' HB ' ' A' ' 322' ' ' THR . 29.1 m-85 -102.88 73.6 1.27 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.138 0.494 . . . . 0.0 110.533 -175.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.61 -50.04 75.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.628 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 14.5 p -101.79 -7.3 22.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.954 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' A' ' 319' ' ' TYR . 0.6 OUTLIER -101.02 -1.38 34.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.065 0.46 . . . . 0.0 110.889 -174.163 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.491 ' ND2' ' HB2' ' A' ' 319' ' ' TYR . 39.8 m-20 -124.43 74.36 61.22 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.567 176.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.459 ' HB3' ' HA ' ' A' ' 328' ' ' SER . 38.5 Cg_exo -58.64 -58.03 0.84 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.836 1.691 . . . . 0.0 111.707 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 63.67 -79.81 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.934 175.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -79.19 -36.95 39.42 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.469 -176.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -165.7 147.88 7.41 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -174.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' SER . . . . . 0.459 ' HA ' ' HB3' ' A' ' 324' ' ' PRO . 50.6 m -77.9 76.88 4.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.372 0.606 . . . . 0.0 109.982 176.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 38.8 t -71.59 -49.38 46.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.331 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 11.5 p 44.07 55.78 5.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.518 0.675 . . . . 0.0 111.34 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -102.82 154.03 19.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.898 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -107.99 142.07 38.68 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 171.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 18.7 m -58.52 154.98 2.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.902 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -123.87 147.04 47.98 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.798 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -69.14 139.31 54.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.841 -0.163 . . . . 0.0 111.111 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.63 -2.1 6.48 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.932 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 271' ' ' THR . 7.3 p-10 -75.66 168.66 19.6 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.256 0.55 . . . . 0.0 111.292 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -104.36 131.11 52.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.516 -171.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 270' ' ' PHE . 73.8 t -108.44 146.9 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.131 -176.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -143.98 165.09 28.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.277 173.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 48.3 t -109.41 142.4 22.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.235 -176.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 53.2 t -73.16 -46.46 50.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 48.81 -123.77 11.2 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.972 176.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.419 ' HG1' ' H ' ' A' ' 345' ' ' ALA . 25.5 p 58.38 -66.33 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.26 1.424 . . . . 0.0 112.92 -178.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' ALA . . . . . 0.419 ' H ' ' HG1' ' A' ' 344' ' ' THR . . . . . . . . 0 C--O 1.25 1.1 0 C-N-CA 123.52 0.728 . . . . 0.0 111.288 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.83 134.47 34.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.537 0.169 . . . . 0.0 110.681 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 39.8 t80 68.85 -43.88 0.52 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.901 0.88 . . . . 0.0 112.584 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 100.65 6.11 53.08 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -56.3 126.36 40.58 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.128 -0.536 . . . . 0.0 112.208 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 41.5 m -136.75 101.5 4.62 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.974 0.416 . . . . 0.0 109.948 -177.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.456 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.4 mp -119.4 176.2 5.46 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 63.9 m -138.55 158.34 44.45 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 -174.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.4 HG13 HG11 ' A' ' 249' ' ' VAL . 89.6 t -110.11 106.66 21.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 250' ' ' THR . 17.1 ptmt -93.27 -12.65 29.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.968 0.414 . . . . 0.0 111.02 -174.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.454 HG23 ' HG3' ' A' ' 231' ' ' LYS . 31.8 p -123.79 -166.95 1.55 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.32 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -112.6 121.06 39.71 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.145 -172.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -70.76 113.35 3.51 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.976 2.451 . . . . 0.0 111.849 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 10.1 t -147.23 109.06 4.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.782 0.801 . . . . 0.0 112.784 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.7 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.48 174.39 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 164.745 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.545 ' H ' HG13 ' A' ' 236' ' ' VAL . 54.3 m -40.94 119.03 1.07 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -173.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -112.71 82.64 1.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 171.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -115.24 136.75 52.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -174.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.68 -45.12 4.29 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.566 -171.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.89 -27.94 43.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.31 0.576 . . . . 0.0 110.035 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -94.55 -7.37 41.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.832 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 56.53 61.48 2.66 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.309 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.8 t -144.43 95.62 2.74 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.575 0.702 . . . . 0.0 110.073 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -108.71 101.53 10.65 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.908 175.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' GLN . . . . . 0.621 ' HB2' HG12 ' A' ' 236' ' ' VAL . 71.6 mt-30 -130.04 156.36 44.62 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.7 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 15.6 p90 -157.47 136.88 11.99 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.588 0.232 . . . . 0.0 111.615 177.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.421 HG23 ' OG1' ' A' ' 312' ' ' THR . 32.8 m -101.02 133.5 45.42 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.494 ' HB ' HD11 ' A' ' 251' ' ' LEU . 0.3 OUTLIER -142.18 148.05 20.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.906 -176.803 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.548 HG23 ' OG1' ' A' ' 310' ' ' THR . 41.3 m -99.07 111.92 24.19 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.516 HD13 HG22 ' A' ' 311' ' ' VAL . 5.4 mp -106.15 167.83 9.54 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -172.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.402 HG23 ' HD2' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -114.41 148.63 37.42 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.839 174.431 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -144.94 -142.35 3.84 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -175.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.53 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -110.2 -174.19 2.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -68.59 -178.34 1.13 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.676 -170.436 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.547 ' H ' HG22 ' A' ' 255' ' ' THR . . . -67.5 -176.3 0.59 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.849 -177.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 22.7 t 81.03 7.99 1.17 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.491 0.716 . . . . 0.0 111.033 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 39.1 t -124.16 90.81 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 173.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 18.4 m -69.62 98.22 1.14 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.691 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 66.98 95.67 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.717 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -41.91 -56.43 2.75 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 172.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.3 pp -165.08 161.58 19.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.979 -0.1 . . . . 0.0 110.905 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.434 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 92.6 mttt -141.29 -165.91 2.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.722 0.296 . . . . 0.0 111.764 -175.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -49.46 117.95 2.48 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.769 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 113.84 -20.07 17.82 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.689 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -89.15 142.28 27.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.888 0.375 . . . . 0.0 110.191 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -112.02 153.25 27.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.343 0.592 . . . . 0.0 110.881 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -131.43 165.93 30.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.401 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.483 ' HD2' HG22 ' A' ' 342' ' ' VAL . 0.0 OUTLIER -119.3 150.37 40.24 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 169.537 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -149.06 143.27 25.95 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.25 168.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.41 ' HB ' ' OG ' ' A' ' 292' ' ' SER . 3.7 t -93.69 105.02 17.09 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.143 176.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.612 ' HA ' ' OD2' ' A' ' 337' ' ' ASP . 30.4 t30 -91.26 130.02 37.18 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.321 -174.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 16.0 p -112.16 111.33 22.15 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.713 174.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -87.88 113.0 23.12 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.641 ' O ' ' HB2' ' A' ' 279' ' ' GLN . 18.2 p-90 -157.43 -45.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.558 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 7.3 mp 59.6 174.73 0.08 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.485 0.659 . . . . 0.0 111.298 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -87.08 -10.39 53.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.022 0.439 . . . . 0.0 110.699 -177.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -93.46 -47.43 6.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.136 -175.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.641 ' HB2' ' O ' ' A' ' 275' ' ' TRP . 15.7 mm100 -67.08 -29.45 69.23 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.239 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.708 ' HA ' ' O ' ' A' ' 283' ' ' ALA . 1.2 p -72.71 0.23 11.32 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -176.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -75.22 -36.69 61.34 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -98.07 -44.07 6.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.561 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.708 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -103.42 107.68 18.61 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.953 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 72.0 mt -88.36 9.18 24.25 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -169.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -137.26 -70.14 0.45 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.748 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 62.38 67.46 0.72 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.734 0.646 . . . . 0.0 110.788 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -101.59 9.76 57.33 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.381 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -91.93 9.43 33.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.247 0.546 . . . . 0.0 110.417 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 15.2 t -67.61 145.2 98.13 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.791 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.95 111.63 0.96 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.861 2.374 . . . . 0.0 112.048 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.616 HG23 ' H ' ' A' ' 292' ' ' SER . 3.6 tp -45.2 -68.55 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -170.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' SER . . . . . 0.616 ' H ' HG23 ' A' ' 291' ' ' ILE . 51.5 m -155.71 145.04 20.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 118.198 0.454 . . . . 0.0 110.415 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -150.04 166.74 28.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.869 0.366 . . . . 0.0 110.719 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 99.7 m -100.19 135.79 41.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.488 -173.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ALA . . . . . 0.498 ' HA ' ' HD2' ' A' ' 317' ' ' PRO . . . -126.77 177.61 6.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.185 176.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 87.4 m -134.26 134.69 42.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.29 0.567 . . . . 0.0 112.203 -176.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 84.4 t -93.84 144.54 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.282 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 4.2 m -131.4 25.32 4.82 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.985 0.422 . . . . 0.0 111.803 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.44 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -147.46 171.06 16.11 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.838 -0.539 . . . . 0.0 112.157 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.434 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 28.7 m-20 -63.62 157.18 24.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.721 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.412 ' HB2' ' CG1' ' A' ' 311' ' ' VAL . . . -141.77 168.82 18.84 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.953 -175.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.498 ' OD1' ' HB3' ' A' ' 304' ' ' ASP . 28.1 t-20 -143.85 131.98 21.8 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.869 -174.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.416 ' HB2' ' HB ' ' A' ' 258' ' ' VAL . 0.5 OUTLIER -115.58 94.53 4.74 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 163.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 304' ' ' ASP . . . . . 0.498 ' HB3' ' OD1' ' A' ' 302' ' ' ASN . 0.8 OUTLIER -94.92 176.31 6.3 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.763 -177.117 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 15.5 m -58.22 -32.87 68.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.027 0.441 . . . . 0.0 111.533 -177.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -77.42 -7.59 87.03 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.085 -178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 73.19 43.29 39.88 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.498 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -115.83 138.07 51.5 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 117.963 0.881 . . . . 0.0 111.488 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.9 OUTLIER -141.34 111.01 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.805 179.455 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.548 ' OG1' HG23 ' A' ' 250' ' ' THR . 88.9 m -100.49 122.54 43.38 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.602 -0.686 . . . . 0.0 111.01 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.516 HG22 HD13 ' A' ' 251' ' ' LEU . 9.6 m -145.0 155.72 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.545 0.688 . . . . 0.0 111.409 177.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.421 ' OG1' HG23 ' A' ' 248' ' ' THR . 20.7 m -112.3 140.19 47.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.547 177.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.519 HD13 ' CE2' ' A' ' 247' ' ' PHE . 5.1 mp -113.86 138.1 50.75 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.853 -174.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 78.6 p -139.4 116.85 11.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.786 0.327 . . . . 0.0 110.466 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 101.9 136.15 9.12 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.442 ' HB ' HG23 ' A' ' 318' ' ' ILE . 3.9 m -119.3 89.61 40.36 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 121.303 0.573 . . . . 0.0 111.993 -176.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.498 ' HD2' ' HA ' ' A' ' 295' ' ' ALA . 5.4 Cg_exo -76.57 54.52 4.42 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.529 2.82 . . . . 0.0 111.122 173.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.442 HG23 ' HB ' ' A' ' 316' ' ' VAL . 17.2 pt -94.02 155.91 3.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.069 -173.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -103.48 51.9 0.78 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.448 0.642 . . . . 0.0 109.82 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -127.92 60.9 1.44 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.785 -176.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 55.9 p 63.51 110.93 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.683 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 18.8 m -84.05 -27.01 28.61 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.401 ' CG ' ' HD2' ' A' ' 324' ' ' PRO . 27.1 t-20 -89.56 147.95 39.08 Favored Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.149 173.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.401 ' HD2' ' CG ' ' A' ' 323' ' ' ASN . 73.2 Cg_endo -72.1 61.85 3.26 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.89 1.726 . . . . 0.0 112.61 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -90.51 32.03 0.99 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.937 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 66.47 97.31 0.05 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.869 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -154.99 -63.64 0.12 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.066 175.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 20.2 m 54.16 86.5 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.469 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 48.5 t -80.53 130.82 35.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 41.8 m -142.31 102.68 4.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.071 0.462 . . . . 0.0 111.518 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' ARG . . . . . 0.48 ' HA ' ' HE ' ' A' ' 331' ' ' ARG . 3.9 tpm_? -87.11 112.78 22.25 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -91.71 -177.6 4.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 174.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 18.7 m -67.77 106.44 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.799 0.809 . . . . 0.0 111.138 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -164.44 132.25 3.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.81 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -99.41 158.05 16.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.69 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.36 -22.1 5.35 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.878 175.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.612 ' OD2' ' HA ' ' A' ' 272' ' ' ASN . 65.3 m-20 -56.34 141.14 42.88 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 117.226 0.513 . . . . 0.0 111.479 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -99.41 139.76 34.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.571 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 53.7 t -117.37 148.01 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -169.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 36.3 t -142.36 175.59 9.66 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 173.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.465 ' O ' ' HE2' ' A' ' 269' ' ' LYS . 40.0 t -118.66 146.07 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 O-C-N 122.265 -0.272 . . . . 0.0 110.602 -174.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.483 HG22 ' HD2' ' A' ' 269' ' ' LYS . 42.0 t -75.4 -40.79 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.709 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -128.5 -168.16 12.36 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.995 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -73.6 -44.84 56.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.884 0.373 . . . . 0.0 111.522 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.844 179.742 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.554 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -106.73 131.95 53.27 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -62.84 156.38 24.25 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.008 0.432 . . . . 0.0 111.364 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 106.48 17.49 12.27 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -172.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -59.42 121.51 26.98 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.078 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.8 m -94.71 134.9 36.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.916 0.388 . . . . 0.0 109.978 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.474 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 1.1 mp -134.02 176.04 8.94 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.438 ' HB ' ' OG1' ' A' ' 252' ' ' THR . 35.4 m -122.33 154.79 37.16 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.667 0.27 . . . . 0.0 110.728 -175.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.506 HG21 ' OD2' ' A' ' 337' ' ' ASP . 99.2 t -97.91 133.15 41.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.172 -177.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.557 ' HD3' HG22 ' A' ' 250' ' ' THR . 33.2 mtpt -109.37 -38.19 5.55 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 171.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.712 ' O ' HG13 ' A' ' 249' ' ' VAL . 70.9 p -141.0 160.87 39.15 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 172.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.551 ' CD ' ' HD2' ' A' ' 234' ' ' PRO . 6.0 mm100 -116.12 163.74 20.42 Favored Pre-proline 0 C--N 1.318 -0.772 0 C-N-CA 123.369 0.667 . . . . 0.0 110.075 -176.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.594 ' HB3' ' CD2' ' A' ' 247' ' ' PHE . 5.6 Cg_exo -38.47 109.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 124.824 3.683 . . . . 0.0 115.126 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.441 ' O ' HG23 ' A' ' 236' ' ' VAL . 9.0 t -155.25 92.42 1.42 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.368 0.604 . . . . 0.0 111.596 173.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.75 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -157.75 175.17 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.983 171.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.593 ' H ' HG13 ' A' ' 236' ' ' VAL . 60.7 m -37.28 119.14 0.67 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.811 1.244 . . . . 0.0 114.093 -171.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -108.11 83.91 1.86 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 174.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.454 HD22 ' HA ' ' A' ' 239' ' ' ASN . 0.2 OUTLIER -96.56 115.82 28.07 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -175.513 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -101.18 -42.76 6.23 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -166.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.11 -24.19 33.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.624 0.726 . . . . 0.0 109.405 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -98.32 -8.89 26.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.014 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 16.1 t70 53.1 57.23 6.51 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.442 -175.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.7 m -129.47 96.94 4.41 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.1 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -115.91 109.25 17.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.659 -173.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -126.92 153.47 45.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.75 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 35.2 p90 -148.33 140.73 24.3 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.541 -0.463 . . . . 0.0 111.187 174.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 85.2 m -97.85 143.82 28.06 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 122.19 -0.319 . . . . 0.0 110.287 -178.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.712 HG13 ' O ' ' A' ' 232' ' ' THR . 41.6 t -140.64 125.14 18.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.862 177.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.563 HG23 ' OG1' ' A' ' 310' ' ' THR . 41.5 m -90.85 129.62 36.89 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 173.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.535 HD23 HG11 ' A' ' 339' ' ' VAL . 4.4 mp -120.3 165.39 14.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.585 0.707 . . . . 0.0 110.438 -176.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.463 HG23 ' HD2' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -120.75 136.98 54.73 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.375 -0.83 . . . . 0.0 108.973 169.57 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -127.58 -143.53 5.75 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.011 -176.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -112.99 -173.23 2.21 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 256' ' ' ALA . 1.4 m -56.5 168.82 0.51 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.581 -171.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.478 ' H ' HG22 ' A' ' 255' ' ' THR . . . -66.48 -176.77 0.49 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.294 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 10.9 t 79.6 16.76 0.83 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.009 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 45.1 t -128.96 90.45 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.784 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 172.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 23.2 m -73.68 95.82 2.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.147 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 75.43 93.8 0.16 Allowed Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.358 -0.837 . . . . 0.0 113.067 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -42.63 -56.14 3.25 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 171.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -161.79 164.82 28.64 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -140.02 -166.96 2.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -50.48 123.38 8.61 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.752 0.787 . . . . 0.0 111.903 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 109.39 -21.97 25.43 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.737 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -87.52 139.54 30.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.879 0.371 . . . . 0.0 110.16 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -111.74 143.45 42.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.159 0.504 . . . . 0.0 111.197 -175.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.2 OUTLIER -116.26 179.62 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.277 174.917 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.556 ' HD2' ' C ' ' A' ' 269' ' ' LYS . 3.0 tmmm? -138.35 128.57 25.84 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -116.4 157.66 24.74 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.783 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.503 ' HA ' ' OG ' ' A' ' 292' ' ' SER . 41.4 p -136.92 98.23 3.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.507 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.451 ' HA ' ' CG ' ' A' ' 337' ' ' ASP . 25.5 p-10 -91.25 162.29 14.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.81 -173.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 9.7 p -83.78 171.34 13.24 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.464 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.575 ' HB2' ' H ' ' A' ' 289' ' ' THR . 45.5 t80 -79.94 113.73 18.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.417 0.627 . . . . 0.0 109.901 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.96 0.94 0.65 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.258 -177.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.453 ' HA ' ' HB2' ' A' ' 331' ' ' ARG . 3.9 mp -103.9 -163.01 0.94 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.401 -176.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -66.38 -72.13 0.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.956 0.408 . . . . 0.0 110.954 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -115.08 -80.96 0.6 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.0 0.429 . . . . 0.0 109.965 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.402 ' OE1' ' HB3' ' A' ' 284' ' ' LEU . 32.1 mt-30 -117.23 -63.08 1.49 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.91 175.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 18.9 p -110.91 -77.68 0.59 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.534 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -92.71 -78.28 0.42 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.076 -0.249 . . . . 0.0 111.364 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -138.39 -9.71 1.46 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 284' ' ' LEU . . . -132.02 -146.97 0.3 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -170.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.507 ' HB2' ' O ' ' A' ' 283' ' ' ALA . 52.7 mt 84.59 8.71 0.46 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.621 1.169 . . . . 0.0 111.963 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 71.24 -67.01 0.27 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 169.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -43.93 -47.91 8.49 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.458 0.911 . . . . 0.0 113.458 -167.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 79.86 30.96 41.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.227 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.668 ' O ' ' HD3' ' A' ' 290' ' ' PRO . . . -148.57 137.57 21.65 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.575 ' H ' ' HB2' ' A' ' 274' ' ' TYR . 17.3 m -107.85 86.43 3.03 Favored Pre-proline 0 C--N 1.317 -0.826 0 O-C-N 123.109 0.255 . . . . 0.0 110.624 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' PRO . . . . . 0.668 ' HD3' ' O ' ' A' ' 288' ' ' ALA . 76.9 Cg_endo -102.62 12.25 0.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.309 2.673 . . . . 0.0 112.913 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 10.4 tp -165.37 145.87 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.047 0.451 . . . . 0.0 111.157 -175.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' SER . . . . . 0.503 ' OG ' ' HA ' ' A' ' 271' ' ' THR . 0.0 OUTLIER -142.73 -162.38 1.42 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.315 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -142.81 -150.47 0.31 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -172.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 35.1 m -74.93 144.97 43.0 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -168.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 295' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -126.86 159.28 34.39 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 165.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 93.1 m -122.77 119.43 30.61 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.801 -0.759 . . . . 0.0 112.381 -175.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 64.9 t -78.81 133.99 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.614 -177.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 3.4 m -129.38 24.65 5.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.307 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.411 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -151.07 166.85 29.5 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.208 0.527 . . . . 0.0 112.134 -175.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -65.86 115.82 6.37 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.244 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.523 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -93.29 170.25 9.76 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.629 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.643 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 19.7 t-20 -149.02 131.75 15.97 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.59 -171.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -113.85 95.52 5.36 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 169.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.35 178.52 5.34 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.007 -176.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 23.2 t -59.9 -34.38 73.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.938 0.399 . . . . 0.0 111.207 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -83.88 4.01 83.9 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.857 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 64.35 43.17 97.23 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.797 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -113.18 133.9 54.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 118.116 0.958 . . . . 0.0 111.634 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.643 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.1 OUTLIER -137.84 119.55 18.08 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.974 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.009 178.603 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.563 ' OG1' HG23 ' A' ' 250' ' ' THR . 76.6 m -120.51 126.11 49.55 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.379 -0.826 . . . . 0.0 110.979 -178.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 30.7 m -138.2 163.47 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.638 0.732 . . . . 0.0 111.485 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 31.4 m -123.25 138.58 54.6 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.1 173.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 313' ' ' LEU . 1.3 mm? -106.68 124.46 49.64 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.014 -169.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 47.6 t -120.53 144.22 48.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.147 0.499 . . . . 0.0 111.813 -171.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 78.37 38.03 26.3 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.936 176.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.62 112.79 5.46 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-O 120.868 0.366 . . . . 0.0 110.842 -174.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.23 72.35 5.95 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.876 2.384 . . . . 0.0 113.598 -175.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.573 ' HB ' ' CE1' ' A' ' 247' ' ' PHE . 8.3 mm -103.5 128.53 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -71.95 113.03 8.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.846 -173.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -63.46 -62.71 1.5 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.842 174.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 38.6 p 45.36 27.26 0.35 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 27.3 m -119.6 -34.63 3.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.05 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.416 ' HB3' ' HD3' ' A' ' 324' ' ' PRO . 27.6 t-20 -61.77 -48.15 90.2 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' A' ' 323' ' ' ASN . 20.0 Cg_exo -69.58 2.09 3.74 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.661 2.241 . . . . 0.0 113.104 -176.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -84.04 78.16 9.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.601 0.715 . . . . 0.0 109.427 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -101.75 -8.7 21.48 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.661 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -164.16 -49.84 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.9 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 13.2 m -85.54 68.52 10.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.847 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 15.2 t -79.62 113.46 19.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.57 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' SER . . . . . 0.433 ' H ' ' HG ' ' A' ' 330' ' ' SER . 4.0 p -117.24 -71.06 0.76 Allowed 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.815 -178.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 331' ' ' ARG . . . . . 0.603 ' HD3' ' H ' ' A' ' 331' ' ' ARG . 0.0 OUTLIER -103.37 145.74 29.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.64 0.257 . . . . 0.0 110.392 178.714 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -142.34 133.14 25.58 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.518 ' HB ' ' CB ' ' A' ' 233' ' ' GLN . 14.7 m -57.82 145.87 8.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 O-C-N 123.334 0.396 . . . . 0.0 110.383 175.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 334' ' ' GLU . . . . . 0.404 ' CD ' HD22 ' A' ' 272' ' ' ASN . 0.9 OUTLIER -108.93 129.8 55.43 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -163.02 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -100.26 115.82 30.81 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.003 -0.436 . . . . 0.0 111.975 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 129.05 12.06 2.7 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 119.554 -1.308 . . . . 0.0 114.82 170.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.506 ' OD2' HG21 ' A' ' 230' ' ' VAL . 3.9 p-10 -92.82 -148.74 0.25 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 117.548 0.674 . . . . 0.0 111.322 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -121.54 147.28 46.01 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -168.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.535 HG11 HD23 ' A' ' 251' ' ' LEU . 68.0 t -121.85 149.4 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.145 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.416 ' HB2' ' HE2' ' A' ' 269' ' ' LYS . 25.4 m -147.42 178.62 8.28 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 175.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 46.6 t -112.27 153.34 13.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 74.1 t -68.71 -63.38 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 118.012 0.369 . . . . 0.0 110.52 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 69.5 67.03 2.05 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.939 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.38 -45.27 18.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.565 0.698 . . . . 0.0 110.557 176.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.532 179.168 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.815 0 N-CA-C 111.721 -0.552 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 53.76 69.16 0.74 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.168 0.509 . . . . 0.0 110.362 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.43 ' CG ' ' N ' ' A' ' 225' ' ' GLY . 12.6 t80 61.42 -161.25 0.29 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.391 -173.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.43 ' N ' ' CG ' ' A' ' 224' ' ' PHE . . . 131.07 -8.56 5.71 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.674 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -65.3 113.29 5.7 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.23 -0.986 . . . . 0.0 111.454 176.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 11.3 m -143.33 139.3 30.02 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.8 HD22 HG11 ' A' ' 309' ' ' VAL . 18.4 mt -142.0 176.26 9.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 251' ' ' LEU . 8.3 t -140.5 166.39 24.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.738 0.304 . . . . 0.0 110.335 -178.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 15.1 t -117.88 134.26 62.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.4 -168.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -128.6 11.87 6.3 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.86 0.362 . . . . 0.0 111.528 176.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.448 HG21 ' HB ' ' A' ' 250' ' ' THR . 17.4 p -141.06 -174.46 4.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.221 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -114.24 116.23 44.52 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -176.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.547 ' HB2' ' CD1' ' A' ' 247' ' ' PHE . 73.4 Cg_endo -78.28 106.7 2.18 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.455 2.103 . . . . 0.0 113.361 -176.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.44 ' O ' HG23 ' A' ' 236' ' ' VAL . 9.1 t -155.98 127.1 7.03 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.179 174.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.742 ' O ' ' HB2' ' A' ' 246' ' ' GLN . 47.7 t -154.35 81.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.384 0.674 . . . . 0.0 109.623 170.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 236' ' ' VAL . 33.1 m 83.14 94.89 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.939 175.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -111.67 90.22 3.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.925 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -122.91 135.86 54.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.447 ' HB1' ' OD2' ' A' ' 320' ' ' ASP . . . -103.64 -49.79 3.59 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.876 -170.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 75.9 t -60.36 -31.39 48.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.504 0.668 . . . . 0.0 110.071 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -91.05 -6.51 53.74 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.575 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 36.0 t70 54.55 63.98 1.97 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.435 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.7 m -143.27 99.82 3.51 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.622 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -120.78 112.92 19.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.033 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' GLN . . . . . 0.742 ' HB2' ' O ' ' A' ' 236' ' ' VAL . 69.7 mt-30 -135.48 170.33 16.12 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.672 ' HA ' ' N ' ' A' ' 236' ' ' VAL . 26.5 p90 -166.8 142.17 4.3 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 176.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.476 ' H ' HG23 ' A' ' 236' ' ' VAL . 34.0 m -104.5 142.9 33.8 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.96 139.67 27.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.769 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.516 HG23 ' OG1' ' A' ' 310' ' ' THR . 53.0 m -103.61 105.45 15.69 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 170.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.841 ' HB2' HG13 ' A' ' 309' ' ' VAL . 0.4 OUTLIER -106.4 171.36 7.4 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.553 0.692 . . . . 0.0 109.651 -174.809 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 307' ' ' GLY . 0.0 OUTLIER -121.81 144.37 48.86 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.703 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -144.73 -142.6 3.89 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.362 -172.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.535 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -95.58 -176.8 3.86 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -172.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.539 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -81.66 -177.16 6.42 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.867 -171.342 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.539 ' H ' HG22 ' A' ' 255' ' ' THR . . . -61.7 -177.61 0.11 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.668 -177.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 95.6 p 66.9 17.89 10.57 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.086 1.354 . . . . 0.0 110.895 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.444 HG11 ' CE2' ' A' ' 261' ' ' PHE . 12.9 t -129.06 88.83 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 31.6 m -87.79 92.56 9.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.347 -177.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 86.76 86.46 1.08 Allowed Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.533 178.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.444 ' CE2' HG11 ' A' ' 258' ' ' VAL . 0.8 OUTLIER -48.63 -45.06 37.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.093 0.473 . . . . 0.0 110.04 170.405 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.487 ' HB2' ' CB ' ' A' ' 266' ' ' ASP . 2.1 pt? -162.42 168.55 21.88 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.055 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.453 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 97.2 mttt -137.78 -167.53 2.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.634 0.254 . . . . 0.0 111.584 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -56.64 118.97 5.38 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.363 0.602 . . . . 0.0 110.969 178.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 110.73 -16.49 28.5 Favored Glycine 0 C--N 1.313 -0.742 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.541 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' ASP . . . . . 0.487 ' CB ' ' HB2' ' A' ' 262' ' ' LEU . 37.0 m-20 -91.68 140.5 29.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.038 0.447 . . . . 0.0 110.09 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 296' ' ' THR . 3.0 mp0 -95.55 168.7 10.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.552 -178.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.1 OUTLIER -126.54 171.83 14.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.514 173.079 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.51 ' HB3' ' HB2' ' A' ' 340' ' ' SER . 16.6 tptm -134.47 89.11 2.51 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.379 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -114.2 159.81 19.7 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 119.189 -1.005 . . . . 0.0 111.098 -172.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.424 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 10.1 t -132.57 99.89 4.79 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.853 0.835 . . . . 0.0 110.246 -177.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -94.88 81.29 3.75 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.642 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' THR . . . . . 0.442 ' HB ' ' CB ' ' A' ' 288' ' ' ALA . 48.9 p -67.87 105.91 2.12 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.557 -178.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -82.5 112.97 19.9 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.565 ' O ' ' HG3' ' A' ' 278' ' ' GLN . 15.6 t-105 174.44 71.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -176.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -83.23 25.86 0.68 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -169.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.68 -5.35 58.82 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 172.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.565 ' HG3' ' O ' ' A' ' 275' ' ' TRP . 39.0 mt-30 -58.14 -41.24 83.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.517 174.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -63.88 -31.39 72.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.482 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 11.9 p -93.52 -22.31 18.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.642 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -89.56 -42.22 11.55 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.262 -0.175 . . . . 0.0 111.147 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 68.19 -37.72 0.35 Allowed 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.597 1.159 . . . . 0.0 113.857 175.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -71.47 -18.67 62.29 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.201 0.524 . . . . 0.0 110.87 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 87.5 mt 61.5 28.18 17.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.798 171.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -76.86 -14.92 59.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.127 0.489 . . . . 0.0 109.807 174.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -83.14 153.54 24.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.505 175.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -103.49 -128.27 6.29 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.416 177.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.442 ' CB ' ' HB ' ' A' ' 273' ' ' THR . . . 176.36 -172.72 0.09 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -175.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.432 ' O ' HG22 ' A' ' 273' ' ' THR . 8.4 t -85.13 117.01 67.89 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.68 175.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.61 53.53 4.77 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.866 2.377 . . . . 0.0 113.238 -174.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 21.1 pt -85.94 114.89 26.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.228 0.537 . . . . 0.0 111.092 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 43.8 p -127.11 116.08 20.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.596 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -134.65 171.8 13.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.535 0.683 . . . . 0.0 112.368 -175.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 87.7 m -102.53 127.89 49.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.623 -1.172 . . . . 0.0 111.5 -172.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -127.37 -172.46 2.67 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 267' ' ' GLN . 73.7 m -134.35 135.84 42.99 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -175.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.605 HG12 ' H ' ' A' ' 299' ' ' ALA . 87.0 t -95.9 142.72 13.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.98 176.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 8.9 t -114.84 24.1 12.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.857 0.36 . . . . 0.0 111.742 -174.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.605 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -160.42 170.15 21.58 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.125 0.488 . . . . 0.0 112.029 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.453 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 5.2 m-20 -62.85 111.98 2.36 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.042 177.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.477 ' HB2' HG11 ' A' ' 311' ' ' VAL . . . -92.42 114.25 26.75 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.206 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.662 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 27.3 m-80 -88.46 138.02 31.81 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -170.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 57.7 m -124.24 99.97 6.47 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.827 157.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -98.99 -175.06 2.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.447 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 49.3 m -57.21 -32.46 66.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.705 0.288 . . . . 0.0 111.758 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -79.57 2.56 72.17 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.741 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 58.17 42.25 95.18 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.284 -177.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -114.75 142.06 47.02 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 117.727 0.764 . . . . 0.0 111.259 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.841 HG13 ' HB2' ' A' ' 251' ' ' LEU . 1.6 p -149.3 104.13 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.74 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.516 ' OG1' HG23 ' A' ' 250' ' ' THR . 55.4 m -113.28 124.78 53.3 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 121.576 -0.703 . . . . 0.0 110.916 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.477 HG11 ' HB2' ' A' ' 301' ' ' ALA . 22.0 m -147.48 164.27 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.1 0.476 . . . . 0.0 110.568 -178.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 31.4 m -116.47 145.54 43.22 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.055 0.455 . . . . 0.0 110.196 176.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.466 HD13 ' CE1' ' A' ' 247' ' ' PHE . 5.2 mp -120.99 152.18 38.87 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.093 -174.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 25.6 m -139.98 119.19 12.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.438 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 98.46 133.11 7.87 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.967 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 30.5 m -136.6 155.35 76.87 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.51 47.55 2.32 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.609 2.206 . . . . 0.0 112.339 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.518 HG21 HH12 ' A' ' 331' ' ' ARG . 80.9 mt -118.01 122.47 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -101.35 140.16 36.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.054 0.454 . . . . 0.0 110.727 -174.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.447 ' OD2' ' HB1' ' A' ' 240' ' ' ALA . 37.1 t70 -87.42 3.27 47.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.601 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 3.6 p -54.71 -60.74 2.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.074 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 8.7 m -102.34 -43.93 5.54 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.591 175.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.455 ' N ' ' HD3' ' A' ' 324' ' ' PRO . 7.5 t-20 44.97 56.06 14.4 Favored Pre-proline 0 N--CA 1.472 0.663 0 O-C-N 123.807 0.692 . . . . 0.0 111.649 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.455 ' HD3' ' N ' ' A' ' 323' ' ' ASN . 25.5 Cg_endo -98.39 26.36 0.19 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.311 2.674 . . . . 0.0 112.59 -175.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -77.2 77.67 3.74 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.868 -172.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 65.82 -61.54 0.26 Allowed 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.32 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -152.72 -27.18 0.16 Allowed 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.424 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 10.1 t 77.05 -51.71 0.56 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.143 175.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 26.2 t -75.72 -18.45 15.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.401 0.619 . . . . 0.0 110.623 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 15.5 m -110.67 35.54 3.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.175 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 331' ' ' ARG . . . . . 0.518 HH12 HG21 ' A' ' 318' ' ' ILE . 86.7 mtm180 -92.32 113.75 26.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.573 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -111.72 151.52 28.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.842 0.353 . . . . 0.0 110.285 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 25.6 m -116.51 163.01 14.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.302 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -137.96 163.56 31.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.921 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -86.29 159.73 19.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.855 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 110.01 8.35 25.88 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.655 -0.783 . . . . 0.0 114.09 173.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 271' ' ' THR . 14.9 m-20 -93.77 -172.85 2.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.437 0.618 . . . . 0.0 111.713 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -115.56 149.22 38.55 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.816 -172.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.546 HG21 HD22 ' A' ' 251' ' ' LEU . 55.6 t -128.9 147.29 33.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.866 -177.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.51 ' HB2' ' HB3' ' A' ' 269' ' ' LYS . 37.3 m -137.96 178.27 7.25 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.489 HG12 ' H ' ' A' ' 343' ' ' GLY . 21.1 t -118.0 147.79 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 120.942 0.401 . . . . 0.0 111.751 -171.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 342' ' ' VAL . 47.0 t -128.76 50.62 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 122.359 1.076 . . . . 0.0 108.353 173.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 343' ' ' GLY . . . . . 0.489 ' H ' HG12 ' A' ' 341' ' ' VAL . . . -53.87 148.27 18.31 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 114.203 -1.362 . . . . 0.0 113.036 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 21.2 p -105.35 -61.05 1.53 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.04 0.447 . . . . 0.0 111.067 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.505 -179.539 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.79 0 N-CA-C 112.218 -0.353 . . . . 0.0 112.218 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.7 91.0 5.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.829 0.347 . . . . 0.0 111.099 -177.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -64.2 -41.83 96.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.214 0.531 . . . . 0.0 110.628 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 77.27 29.55 56.12 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.001 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -90.98 -143.43 11.26 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.169 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 6.1 m -82.16 144.97 30.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.915 0.388 . . . . 0.0 111.08 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.438 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.0 mp -136.14 -177.25 4.62 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 172.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 41.4 m -131.72 153.79 49.69 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.885 0.374 . . . . 0.0 110.961 -173.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 14.3 t -101.09 130.71 50.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -111.99 -28.13 8.14 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.16 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 32.8 p -123.82 -167.82 1.69 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.991 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 45.6 mt-30 -109.59 121.63 41.72 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -175.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.61 ' O ' HG11 ' A' ' 333' ' ' VAL . 14.6 Cg_exo -68.1 105.39 1.18 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.556 2.17 . . . . 0.0 111.633 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 236' ' ' VAL . 9.8 t -154.26 123.47 6.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.727 0.775 . . . . 0.0 112.868 -177.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.663 HG12 ' HB2' ' A' ' 246' ' ' GLN . 2.1 t -154.18 175.23 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 170.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.515 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 87.4 m -39.93 116.12 0.61 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -108.36 83.5 1.79 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 172.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -110.29 138.54 46.54 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.96 -41.5 5.17 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.588 -172.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 44.4 t -61.71 -31.62 51.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.435 0.636 . . . . 0.0 109.732 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -95.14 -5.77 43.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.667 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 30.6 t70 53.01 51.11 16.47 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.367 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 22.5 m -127.9 97.56 4.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.474 -173.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -113.69 105.36 13.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.95 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' GLN . . . . . 0.663 ' HB2' HG12 ' A' ' 236' ' ' VAL . 86.8 mt-30 -129.71 152.99 48.61 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.882 -178.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.643 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 2.8 p90 -154.8 129.8 9.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.776 0.322 . . . . 0.0 111.842 176.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 37.0 m -103.26 141.83 35.23 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.618 ' HB ' HD11 ' A' ' 251' ' ' LEU . 0.2 OUTLIER -142.84 146.45 21.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 119.911 -0.716 . . . . 0.0 112.129 179.809 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.559 HG23 ' OG1' ' A' ' 310' ' ' THR . 57.8 m -101.22 111.43 23.64 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 163.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.618 HD11 ' HB ' ' A' ' 249' ' ' VAL . 3.3 mp -114.04 168.57 9.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -172.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.7 138.56 46.93 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.74 0.305 . . . . 0.0 110.517 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -133.05 -142.74 4.88 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -175.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.481 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -106.34 -177.73 3.45 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.332 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.581 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.3 OUTLIER -70.82 -177.32 1.56 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.39 -175.635 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.581 ' H ' HG22 ' A' ' 255' ' ' THR . . . -63.34 -176.65 0.16 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 122.999 0.52 . . . . 0.0 111.672 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 11.7 t 79.63 12.81 1.12 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.073 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 90.9 t -133.02 89.56 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-O 121.621 0.724 . . . . 0.0 109.565 171.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 12.4 m -79.45 97.46 6.4 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.624 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 79.78 93.45 0.37 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.744 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.664 ' CE1' ' HB2' ' A' ' 303' ' ' SER . 7.0 m-85 -53.37 -43.07 67.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.217 0.532 . . . . 0.0 110.469 169.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.486 ' HB2' ' CB ' ' A' ' 266' ' ' ASP . 4.1 pp -161.34 172.96 15.66 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.97 -176.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -129.84 -166.92 1.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.989 0.423 . . . . 0.0 111.48 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -60.93 118.19 6.4 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.193 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 109.83 -15.86 31.2 Favored Glycine 0 C--N 1.316 -0.543 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.444 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' ASP . . . . . 0.486 ' CB ' ' HB2' ' A' ' 262' ' ' LEU . 14.3 m-20 -75.29 134.88 40.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -97.96 151.78 19.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.74 0.781 . . . . 0.0 111.668 -176.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.506 HG23 ' HB3' ' A' ' 295' ' ' ALA . 1.7 m -125.38 172.31 13.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.795 177.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.16 133.17 21.36 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 169.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 338' ' ' ALA . 47.2 p90 -143.81 167.87 21.28 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.456 -174.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.608 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 13.9 t -133.67 123.92 25.83 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.329 0.585 . . . . 0.0 111.561 -175.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.572 ' O ' ' HA ' ' A' ' 290' ' ' PRO . 3.2 t-20 -88.45 109.23 19.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.249 173.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' THR . . . . . 0.404 ' H ' ' CG ' ' A' ' 337' ' ' ASP . 11.5 p -118.26 81.07 1.62 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.434 0.635 . . . . 0.0 111.327 -173.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -142.57 -171.85 3.5 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.738 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 46.8 t-105 -131.56 77.77 1.79 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.129 0.49 . . . . 0.0 109.777 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -89.27 22.75 2.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.667 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' GLN . . . . . 0.565 ' HA ' HG23 ' A' ' 280' ' ' THR . 12.7 mp0 -60.91 -23.71 65.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.753 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -64.84 -29.37 70.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.368 0.604 . . . . 0.0 109.729 175.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -107.8 13.34 26.49 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.118 -176.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.565 HG23 ' HA ' ' A' ' 277' ' ' GLN . 35.3 p -80.45 12.85 2.75 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.683 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -76.58 -29.09 56.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.236 0.541 . . . . 0.0 109.555 176.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -79.48 -26.55 41.63 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.394 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -85.82 -173.9 4.85 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.75 172.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.402 ' N ' HD22 ' A' ' 284' ' ' LEU . 2.9 mm? -98.13 34.79 1.87 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.131 0.491 . . . . 0.0 110.112 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 57.26 96.65 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.236 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -128.88 159.09 36.9 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.897 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -123.11 -3.21 8.97 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.338 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -102.57 56.64 0.78 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.931 0.396 . . . . 0.0 110.878 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.475 ' HB ' ' HD3' ' A' ' 290' ' ' PRO . 70.0 m -68.73 -46.4 33.79 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.073 178.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 272' ' ' ASN . 23.4 Cg_exo -66.12 79.46 0.3 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 122.171 1.914 . . . . 0.0 112.437 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 9.7 tp -124.17 149.99 28.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.157 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' SER . . . . . 0.442 ' HB3' ' HB ' ' A' ' 271' ' ' THR . 16.0 p -113.38 138.83 49.5 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 176.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -152.26 159.7 43.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.936 0.398 . . . . 0.0 111.085 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 96.4 m -90.88 129.36 36.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.054 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' ALA . . . . . 0.506 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -119.97 -178.66 3.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.164 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 96.9 m -142.63 128.41 19.35 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.476 0.655 . . . . 0.0 112.503 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 299' ' ' ALA . 39.2 t -94.41 147.54 5.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.019 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 15.1 t -110.15 17.27 21.15 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -173.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.521 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -165.95 176.95 7.41 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 4.5 m-20 -60.91 120.76 10.81 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.58 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.441 ' HA ' ' CG1' ' A' ' 311' ' ' VAL . . . -93.38 115.02 27.58 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.263 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -79.72 130.17 35.11 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -169.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.664 ' HB2' ' CE1' ' A' ' 261' ' ' PHE . 32.7 t -114.06 94.91 5.03 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 162.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -109.66 177.6 4.68 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.152 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 17.2 t -54.78 -33.17 61.08 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -77.05 6.11 44.54 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.625 -176.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 56.24 40.49 84.55 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.927 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -120.17 124.29 45.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.861 0.363 . . . . 0.0 110.544 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.611 HG13 ' HB2' ' A' ' 251' ' ' LEU . 2.6 p -125.05 94.48 2.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.643 0.735 . . . . 0.0 110.359 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.559 ' OG1' HG23 ' A' ' 250' ' ' THR . 56.7 m -102.44 117.26 34.34 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.064 -176.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.441 ' CG1' ' HA ' ' A' ' 301' ' ' ALA . 5.4 m -148.55 160.09 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.306 0.574 . . . . 0.0 110.717 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 26.5 m -110.36 141.62 43.15 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.389 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.481 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.0 mp -109.59 122.39 47.33 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.551 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 23.6 p -144.13 152.46 40.96 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.945 -170.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 82.25 32.52 28.37 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.792 174.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 2.9 m -127.17 84.06 64.42 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 121.189 0.518 . . . . 0.0 111.635 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.73 78.12 3.82 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.217 2.611 . . . . 0.0 110.506 174.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 6.4 tt -82.09 99.15 4.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.28 -172.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -123.14 70.43 1.03 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.026 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.449 ' OD1' ' HB2' ' A' ' 326' ' ' TYR . 14.0 t70 -65.61 -62.01 1.76 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.593 -177.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 1.1 p -139.03 138.91 37.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.1 0.476 . . . . 0.0 110.596 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.2 -18.44 42.64 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.733 0.778 . . . . 0.0 109.57 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -80.45 159.42 69.78 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.711 172.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.44 34.62 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.351 2.034 . . . . 0.0 113.793 -174.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -81.12 -63.42 1.41 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 174.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 326' ' ' TYR . . . . . 0.449 ' HB2' ' OD1' ' A' ' 320' ' ' ASP . 86.8 m-85 -137.75 72.98 1.42 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.534 0.683 . . . . 0.0 109.436 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -106.62 71.23 0.85 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.244 -175.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 16.0 m -73.18 6.43 2.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.174 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 59.4 t -75.66 -37.9 37.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.745 175.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 51.3 m -79.39 52.19 1.33 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.702 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -97.38 142.39 29.29 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.638 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -125.48 108.42 11.61 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.61 HG11 ' O ' ' A' ' 234' ' ' PRO . 21.8 m -73.33 137.52 23.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.871 -167.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -140.12 153.89 46.83 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.649 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -91.87 141.67 28.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.653 -0.248 . . . . 0.0 111.065 -175.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 115.87 9.3 12.48 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.672 175.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.608 ' HB3' ' O ' ' A' ' 271' ' ' THR . 49.6 m-20 -87.45 -169.14 2.48 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.349 0.574 . . . . 0.0 112.215 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 338' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 270' ' ' PHE . . . -110.94 148.06 33.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.605 -174.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 54.3 t -124.12 151.74 29.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.816 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 24.0 m -150.36 163.25 38.82 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 343' ' ' GLY . 48.8 t -117.34 138.41 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.611 0.243 . . . . 0.0 110.694 -176.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 71.3 t -69.82 -35.96 67.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.117 0.484 . . . . 0.0 109.953 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 343' ' ' GLY . . . . . 0.51 ' H ' HG12 ' A' ' 341' ' ' VAL . . . 90.15 -60.64 3.38 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.407 174.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 4.8 p -155.71 123.57 5.69 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.518 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.364 179.869 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.59 0 N-CA-C 111.974 -0.45 . . . . 0.0 111.974 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 68.13 97.71 0.06 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.381 0.61 . . . . 0.0 111.033 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -65.93 -47.93 73.08 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.948 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 85.76 -2.77 87.77 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.996 -176.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.638 ' O ' ' HA ' ' A' ' 340' ' ' SER . . . -55.74 125.65 37.49 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.343 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 17.8 m -92.87 132.11 37.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.907 0.384 . . . . 0.0 111.536 -175.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.445 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.3 mp -138.46 -177.21 4.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 96.8 m -138.45 156.02 47.93 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.321 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.516 HG23 HG23 ' A' ' 339' ' ' VAL . 69.9 t -103.1 126.38 57.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -109.7 -11.69 14.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.048 0.452 . . . . 0.0 110.951 -173.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.509 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 36.5 p -131.22 -167.04 1.79 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.375 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.513 ' HG2' ' HB ' ' A' ' 333' ' ' VAL . 0.9 OUTLIER -111.85 115.27 51.12 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -173.777 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 248' ' ' THR . 65.0 Cg_endo -78.54 105.01 1.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.216 1.944 . . . . 0.0 111.975 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.448 ' OG1' ' HB2' ' A' ' 331' ' ' ARG . 15.3 t -107.42 136.13 47.73 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.34 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.507 ' HA ' ' HB3' ' A' ' 247' ' ' PHE . 39.2 t -82.58 121.74 36.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.391 0.615 . . . . 0.0 111.788 -175.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 52.7 m -87.38 105.24 17.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.558 175.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -86.46 125.65 33.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.055 0.455 . . . . 0.0 110.801 -178.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.419 HD22 ' HA ' ' A' ' 239' ' ' ASN . 0.2 OUTLIER -138.75 77.68 1.64 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.476 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -83.04 -36.18 25.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.03 -163.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 39.5 t -68.15 -23.4 28.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.407 ' HG3' ' OD1' ' A' ' 239' ' ' ASN . 11.3 mmpt? -97.56 -2.8 40.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.432 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 56.18 46.14 21.97 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.119 -1.401 . . . . 0.0 112.143 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 35.3 t -132.55 125.45 30.56 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.416 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -128.88 102.17 6.41 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' GLN . . . . . 0.405 ' HG2' ' HA ' ' A' ' 314' ' ' SER . 77.5 mt-30 -130.8 159.1 38.31 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -178.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.507 ' HB3' ' HA ' ' A' ' 236' ' ' VAL . 8.1 p90 -137.58 137.54 38.64 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.873 178.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 85.2 m -105.18 143.55 33.19 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 -171.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.526 HG13 ' CD1' ' A' ' 251' ' ' LEU . 4.2 p -148.5 142.79 18.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.581 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.509 ' HB ' ' CG2' ' A' ' 232' ' ' THR . 57.4 m -99.11 126.88 44.96 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 167.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.526 ' CD1' HG13 ' A' ' 249' ' ' VAL . 4.8 mp -111.59 172.56 6.82 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.968 -173.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.52 145.74 47.65 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 169.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -145.39 -142.83 3.87 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.862 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.545 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -113.47 -174.41 2.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.853 0.358 . . . . 0.0 111.725 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.609 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.7 OUTLIER -70.43 -179.82 2.21 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.561 -170.603 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.609 ' H ' HG22 ' A' ' 255' ' ' THR . . . -63.93 -174.93 0.12 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.678 0.791 . . . . 0.0 112.256 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' SER . . . . . 0.476 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 34.5 t 81.94 7.4 1.01 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.819 0.847 . . . . 0.0 111.172 -177.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.578 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 42.4 t -128.45 89.04 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.619 0 CA-C-O 121.615 0.721 . . . . 0.0 109.377 170.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 26.4 m -81.86 88.42 6.34 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.105 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 96.31 81.69 1.59 Allowed Glycine 0 N--CA 1.439 -1.115 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.347 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -47.05 -59.7 2.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.382 0.61 . . . . 0.0 110.194 168.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 300' ' ' ASP . 88.1 mt -137.65 169.63 17.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.907 -174.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -135.78 -167.64 2.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.641 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.61 114.29 3.86 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.792 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 116.06 -5.64 19.96 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.989 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -87.06 127.47 35.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.951 0.405 . . . . 0.0 110.696 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 296' ' ' THR . 2.9 mp0 -86.84 149.36 24.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.103 0.478 . . . . 0.0 110.748 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 294' ' ' THR . 1.1 m -120.9 172.54 7.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.261 174.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.569 ' HD3' ' C ' ' A' ' 269' ' ' LYS . 0.7 OUTLIER -131.62 124.84 30.77 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.307 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -146.78 160.41 42.29 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.052 176.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 292' ' ' SER . 14.9 t -122.4 134.01 54.62 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.708 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.728 ' HA ' ' OD1' ' A' ' 337' ' ' ASP . 4.5 t-20 -76.67 83.33 3.31 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.805 -174.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 273' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 337' ' ' ASP . 12.9 p -86.91 77.95 9.13 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.569 0.7 . . . . 0.0 110.042 175.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -166.03 133.26 2.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.301 177.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 23.6 m-90 -91.9 89.9 7.22 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 6.4 mp -68.28 167.98 13.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.405 0.621 . . . . 0.0 111.29 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -73.33 -4.13 31.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.608 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -64.15 -46.84 82.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.003 177.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -66.39 -26.33 67.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.633 -177.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 17.1 p -100.37 -56.85 2.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -173.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -86.27 -31.58 21.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.743 -172.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -101.62 -9.03 21.3 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.909 -0.317 . . . . 0.0 111.472 -173.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -153.06 172.69 16.48 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.974 0.416 . . . . 0.0 111.208 -177.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 93.1 mt -116.21 32.09 6.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.34 175.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -121.93 98.4 5.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.928 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -132.63 172.39 12.59 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.31 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 144.21 -79.34 0.25 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -128.44 -168.89 1.98 Allowed 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.9 t -159.28 77.66 2.99 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-O 121.941 0.877 . . . . 0.0 110.841 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -93.44 38.68 0.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.45 2.766 . . . . 0.0 112.326 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 24.1 mt -77.29 92.65 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.19 -178.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 271' ' ' THR . 4.4 m -107.84 127.55 53.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.165 -177.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -151.97 167.09 29.5 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.23 0.538 . . . . 0.0 111.697 -177.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 94.6 m -97.93 129.75 44.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.992 -176.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -121.95 -171.68 2.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.298 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 267' ' ' GLN . 23.4 m -141.17 129.11 21.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.555 HG12 ' H ' ' A' ' 299' ' ' ALA . 50.4 t -86.47 138.59 18.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.678 176.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 312' ' ' THR . 6.0 t -112.59 14.91 20.2 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.895 0.379 . . . . 0.0 111.988 -174.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.555 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -165.95 -178.56 4.77 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.849 0.357 . . . . 0.0 111.743 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 4.3 m-20 -68.13 145.87 53.97 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.514 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.439 ' HB2' HG11 ' A' ' 311' ' ' VAL . . . -121.44 127.62 51.31 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.818 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.607 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 2.6 t-20 -90.06 123.17 33.7 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -171.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.578 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 8.9 t -100.73 95.09 6.42 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 163.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.64 175.03 6.53 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.888 -174.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 8.3 t -59.84 -33.34 71.64 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.698 0.285 . . . . 0.0 111.57 -176.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -80.68 -3.94 90.26 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.15 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 71.54 41.56 57.4 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.238 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -121.99 133.63 54.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.365 0.582 . . . . 0.0 111.247 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.2 OUTLIER -128.24 155.5 39.92 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.046 179.039 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.449 ' OG1' HG23 ' A' ' 250' ' ' THR . 55.1 m -147.98 125.74 11.89 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.584 -0.698 . . . . 0.0 110.932 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.439 HG11 ' HB2' ' A' ' 301' ' ' ALA . 18.7 m -148.1 159.31 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.592 0.711 . . . . 0.0 111.25 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.486 ' O ' HG22 ' A' ' 298' ' ' THR . 16.4 m -108.94 140.21 42.74 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.488 174.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 5.3 mp -105.27 122.45 45.97 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.719 -174.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' SER . . . . . 0.405 ' HA ' ' HG2' ' A' ' 246' ' ' GLN . 16.6 p -96.79 125.77 41.47 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.94 -176.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 95.67 115.4 2.97 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.648 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 15.6 m -73.39 120.7 82.45 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-O 121.013 0.435 . . . . 0.0 110.541 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.8 47.66 2.39 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.977 2.451 . . . . 0.0 112.509 -177.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 7.5 pt -136.56 131.15 47.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.12 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.408 ' O ' ' HB3' ' A' ' 323' ' ' ASN . 97.1 m-85 -119.23 112.58 19.66 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.862 0.363 . . . . 0.0 111.022 -174.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.58 -10.34 17.92 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.171 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 9.3 p -66.49 -60.92 2.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.583 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 22.3 m -94.91 -25.02 16.73 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.313 0.578 . . . . 0.0 110.727 -177.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.408 ' HB3' ' O ' ' A' ' 319' ' ' TYR . 26.8 t30 -99.77 117.79 62.97 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.814 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.5 -13.3 22.66 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 121.134 1.223 . . . . 0.0 111.772 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 69.16 -60.36 0.46 Allowed 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.841 0.856 . . . . 0.0 112.072 176.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 57.04 34.58 25.15 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.747 0.784 . . . . 0.0 109.644 -173.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -171.41 120.03 0.48 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.886 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 35.1 m -66.87 116.26 7.54 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 20.9 t -48.64 116.47 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.134 -177.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 34.0 m -128.78 157.37 41.64 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.4 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 331' ' ' ARG . . . . . 0.448 ' HB2' ' OG1' ' A' ' 235' ' ' THR . 10.1 ptp180 -69.22 111.83 5.41 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.826 0.346 . . . . 0.0 110.687 -178.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -112.51 153.55 27.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.736 0.303 . . . . 0.0 110.362 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.513 ' HB ' ' HG2' ' A' ' 233' ' ' GLN . 15.5 m -118.63 118.54 58.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.362 176.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 334' ' ' GLU . . . . . 0.512 ' HG3' HD21 ' A' ' 272' ' ' ASN . 0.5 OUTLIER -140.8 112.88 7.79 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.178 0.513 . . . . 0.0 111.257 179.748 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -100.66 138.85 37.16 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.93 -0.481 . . . . 0.0 112.029 178.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.42 -10.25 6.49 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.667 171.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.728 ' OD1' ' HA ' ' A' ' 272' ' ' ASN . 2.9 m-20 -54.33 150.75 8.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.388 0.613 . . . . 0.0 112.642 -178.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -102.41 134.93 44.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.012 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.516 HG23 HG23 ' A' ' 230' ' ' VAL . 57.8 t -114.82 147.23 18.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.32 0.581 . . . . 0.0 112.248 -169.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 226' ' ' GLY . 9.0 t -144.44 172.36 13.06 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.882 172.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.41 HG11 HD21 ' A' ' 262' ' ' LEU . 95.3 t -119.76 127.13 75.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.644 0.259 . . . . 0.0 111.655 -173.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 85.6 t -91.24 -45.02 14.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.99 0.424 . . . . 0.0 110.367 175.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 93.6 -135.97 12.85 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.771 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 3.7 p -125.68 -69.72 0.77 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.654 0.264 . . . . 0.0 110.82 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.903 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.832 -179.228 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.602 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -109.59 24.74 12.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.999 0.428 . . . . 0.0 111.236 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -73.49 155.28 39.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.593 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 117.96 20.92 4.34 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.612 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -61.67 115.43 7.92 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.054 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 26.4 m -119.38 134.24 55.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.014 0.435 . . . . 0.0 109.964 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.504 HD23 ' CA ' ' A' ' 253' ' ' GLY . 9.7 mt -140.32 171.66 13.83 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.292 -174.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 62.6 m -136.68 165.94 24.73 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.583 HG21 ' HB2' ' A' ' 337' ' ' ASP . 70.9 t -117.22 132.24 67.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 O-C-N 122.078 -0.389 . . . . 0.0 110.287 176.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.41 ' HE3' HG21 ' A' ' 252' ' ' THR . 34.8 ttmt -120.62 11.88 11.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.51 0.671 . . . . 0.0 110.32 -177.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.442 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 7.5 p -139.33 -170.49 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.323 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.442 ' HG2' ' HA ' ' A' ' 334' ' ' GLU . 36.0 mt-30 -114.79 111.22 45.86 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -177.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.94 105.71 1.87 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.382 2.055 . . . . 0.0 113.048 -176.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 4.6 t -155.81 130.82 9.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.122 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.644 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -154.71 171.84 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 171.783 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.469 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 38.5 m -12.36 113.37 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.75 1.62 . . . . 0.0 114.798 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.526 ' CE1' ' HG2' ' A' ' 317' ' ' PRO . 95.7 m-85 -115.45 84.04 2.03 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.332 173.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -122.97 133.21 54.38 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.15 -33.47 7.84 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -170.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.94 -28.82 45.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.581 0.705 . . . . 0.0 109.512 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.478 ' HA ' ' HE2' ' A' ' 242' ' ' LYS . 8.2 mmpt? -98.44 -9.14 25.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.06 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 61.48 40.51 13.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.234 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.9 m -113.03 95.73 5.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.026 -175.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' TYR . . . . . 0.47 ' CD2' ' HD1' ' A' ' 238' ' ' TYR . 4.8 m-85 -126.93 109.66 12.18 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 176.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' GLN . . . . . 0.553 ' HB2' HG12 ' A' ' 236' ' ' VAL . 70.6 mt-30 -136.94 173.16 12.0 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.644 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 4.7 p90 -154.14 134.8 13.59 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.369 -0.533 . . . . 0.0 112.374 176.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 59.3 m -99.34 139.17 35.38 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.512 HG13 ' HG ' ' A' ' 251' ' ' LEU . 5.5 p -142.75 142.3 26.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.501 -176.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.442 ' HB ' ' CG2' ' A' ' 232' ' ' THR . 38.9 m -99.36 103.97 15.82 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 166.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.613 HD11 HG22 ' A' ' 311' ' ' VAL . 0.4 OUTLIER -87.18 171.01 10.99 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.96 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.41 HG21 ' HE3' ' A' ' 231' ' ' LYS . 0.2 OUTLIER -128.53 141.46 51.37 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.025 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.504 ' CA ' HD23 ' A' ' 228' ' ' LEU . . . -146.76 -142.45 3.72 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.433 -174.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -106.28 -173.64 2.34 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.565 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -67.37 -179.31 1.0 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.408 -168.48 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.565 ' H ' HG22 ' A' ' 255' ' ' THR . . . -65.99 -175.33 0.3 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.352 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 49.2 m 80.2 17.31 0.68 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.908 0.883 . . . . 0.0 111.362 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 49.5 t -133.43 90.9 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 170.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 31.2 m -68.1 100.72 1.04 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.493 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 70.73 92.32 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.934 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -41.96 -59.69 1.64 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 169.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.472 ' H ' ' HB3' ' A' ' 301' ' ' ALA . 91.7 mt -146.68 163.21 36.64 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.673 0.273 . . . . 0.0 111.106 -174.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 49.4 mtmt -134.89 -167.88 2.07 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.632 177.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -63.58 120.78 12.4 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.353 0.597 . . . . 0.0 111.234 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 106.62 -3.95 36.82 Favored Glycine 0 C--N 1.316 -0.553 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.162 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' ASP . . . . . 0.422 ' HB3' HD22 ' A' ' 262' ' ' LEU . 66.3 m-20 -92.59 134.94 34.51 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -103.12 152.31 21.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.566 0.698 . . . . 0.0 111.869 -174.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.77 153.67 39.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.745 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 340' ' ' SER . 0.8 OUTLIER -86.2 94.9 9.42 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 166.576 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 293' ' ' PHE . 76.7 t80 -115.15 106.94 14.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.582 -165.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 292' ' ' SER . 89.4 m -88.29 94.96 10.0 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.922 -178.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.705 ' HA ' ' OD1' ' A' ' 337' ' ' ASP . 3.0 t-20 -90.22 84.95 6.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.448 0.642 . . . . 0.0 109.521 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 18.7 p -123.85 157.63 33.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.143 -178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.527 ' CE2' HG23 ' A' ' 321' ' ' THR . 53.0 m-85 -82.98 113.84 20.84 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -126.64 57.34 1.44 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.572 0.701 . . . . 0.0 111.075 -170.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.454 ' HB2' HG23 ' A' ' 280' ' ' THR . 97.7 mt -59.98 125.65 24.5 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 166.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -61.42 -24.61 66.64 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -161.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -115.11 -62.7 1.56 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.928 -174.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -62.13 -17.52 58.09 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -167.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.454 HG23 ' HB2' ' A' ' 276' ' ' LEU . 29.3 p -83.04 -78.1 0.22 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 118.484 0.584 . . . . 0.0 111.965 -176.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -79.19 -32.31 44.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.539 0.685 . . . . 0.0 110.764 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 67.77 16.49 9.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.241 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -127.86 107.46 9.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.767 176.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 68.3 mt -81.24 21.79 0.72 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.264 -174.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -110.8 -7.92 14.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.008 -177.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -132.48 78.67 1.81 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.816 0.341 . . . . 0.0 111.126 -175.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -81.7 54.57 4.82 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.301 178.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -146.49 128.63 15.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.78 0.324 . . . . 0.0 110.298 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.462 ' O ' HG21 ' A' ' 271' ' ' THR . 16.8 p -112.18 92.49 18.82 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.6 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -90.06 107.04 0.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.661 2.241 . . . . 0.0 112.953 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.481 HG23 ' H ' ' A' ' 292' ' ' SER . 4.7 tp -167.13 -58.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.194 176.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 292' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 271' ' ' THR . 15.0 m -127.91 138.57 52.7 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 293' ' ' PHE . . . . . 0.558 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 0.8 OUTLIER -162.54 86.03 0.57 Allowed 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 21.3 m -160.79 124.28 3.4 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.027 -0.42 . . . . 0.0 111.003 175.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -152.85 179.88 8.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.323 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 90.8 m -140.31 132.39 27.92 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.595 0.712 . . . . 0.0 112.304 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 299' ' ' ALA . 59.2 t -79.54 136.52 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 114.35 -1.296 . . . . 0.0 110.339 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 4.4 m -124.86 25.01 7.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.13 0.49 . . . . 0.0 111.086 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -166.62 178.26 6.11 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.401 ' O ' HG12 ' A' ' 311' ' ' VAL . 40.8 m-20 -66.96 165.88 14.69 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.563 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.521 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -144.87 171.27 14.67 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.82 -177.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.689 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 16.6 m120 -142.29 126.27 17.26 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 119.687 -0.197 . . . . 0.0 110.964 -173.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.7 OUTLIER -107.88 96.88 6.69 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 168.253 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.16 178.71 4.53 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.023 -176.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 10.8 t -61.76 -33.17 73.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.991 0.424 . . . . 0.0 111.044 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -81.7 1.76 85.09 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.897 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 61.51 42.01 99.68 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 121.016 -0.612 . . . . 0.0 113.704 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.83 132.67 55.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 118.06 0.93 . . . . 0.0 110.454 175.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.689 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.1 OUTLIER -138.23 109.44 5.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.807 -177.308 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 250' ' ' THR . 54.0 m -101.5 135.22 43.38 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.962 -0.461 . . . . 0.0 111.712 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.613 HG22 HD11 ' A' ' 251' ' ' LEU . 26.8 m -145.71 165.36 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 173.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 46.4 m -117.02 138.9 51.27 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 171.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 4.9 mp -112.25 141.59 45.77 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.736 -173.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 22.9 t -111.01 131.01 55.41 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.327 0.584 . . . . 0.0 109.851 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 132.93 155.97 7.99 Favored Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -174.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.409 ' HA ' ' HB3' ' A' ' 245' ' ' TYR . 16.1 m -66.98 116.97 41.16 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 120.932 0.396 . . . . 0.0 111.909 -173.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.595 ' HG3' ' CD2' ' A' ' 247' ' ' PHE . 62.2 Cg_exo -57.13 138.91 88.39 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.524 2.149 . . . . 0.0 110.663 171.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.674 ' H ' HD13 ' A' ' 318' ' ' ILE . 0.1 OUTLIER -102.01 111.24 31.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-O 121.374 0.607 . . . . 0.0 110.714 -168.513 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -77.62 115.01 17.03 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.83 -175.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.03 -13.58 62.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.088 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.527 HG23 ' CE2' ' A' ' 274' ' ' TYR . 1.2 p -75.72 52.58 0.68 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.938 176.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 322' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 323' ' ' ASN . 0.6 OUTLIER -112.2 87.88 2.68 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.629 0.728 . . . . 0.0 110.378 178.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.607 ' HB3' ' HD3' ' A' ' 324' ' ' PRO . 13.5 t-20 165.88 -53.72 0.0 OUTLIER Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 113.646 -1.616 . . . . 0.0 109.206 -175.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.607 ' HD3' ' HB3' ' A' ' 323' ' ' ASN . 23.5 Cg_endo -101.48 112.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 123.463 2.776 . . . . 0.0 111.356 176.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -71.96 -32.13 66.99 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.831 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 70.8 -65.19 0.35 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 124.201 0.938 . . . . 0.0 109.938 -177.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 177.58 -61.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 32.1 t -145.13 -129.67 0.08 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.39 -1.277 . . . . 0.0 107.963 175.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 24.2 t -83.88 119.66 33.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 31.5 m -123.79 -68.32 0.88 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.829 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -91.38 137.54 32.28 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 120.699 0.285 . . . . 0.0 110.748 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -118.24 169.91 9.32 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 26.7 m -76.14 131.86 34.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.341 0.591 . . . . 0.0 111.665 -176.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 334' ' ' GLU . . . . . 0.482 ' OE2' ' HA ' ' A' ' 274' ' ' TYR . 0.8 OUTLIER -112.66 -166.82 1.11 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.477 176.363 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -81.56 155.11 25.88 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.041 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 129.59 -8.35 6.18 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.054 -1.07 . . . . 0.0 113.444 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.705 ' OD1' ' HA ' ' A' ' 272' ' ' ASN . 4.1 m-20 -52.12 140.62 20.41 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.978 0.389 . . . . 0.0 110.784 174.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -100.56 132.65 45.84 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.503 ' CG1' ' HB2' ' A' ' 228' ' ' LEU . 93.2 t -120.69 140.18 45.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.479 0.657 . . . . 0.0 112.029 -171.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 269' ' ' LYS . 22.7 m -141.09 167.6 21.79 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 343' ' ' GLY . 47.8 t -116.24 140.62 37.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.693 0.282 . . . . 0.0 111.122 -175.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 76.8 t -81.24 -37.43 15.72 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.265 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 343' ' ' GLY . . . . . 0.429 ' N ' HG12 ' A' ' 341' ' ' VAL . . . -61.17 129.77 46.33 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.781 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 7.3 p -79.1 -61.15 2.1 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.4 0.619 . . . . 0.0 110.997 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.941 177.639 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 N-CA-C 112.176 -0.369 . . . . 0.0 112.176 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 68.8 -74.7 0.07 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.535 0.734 . . . . 0.0 111.982 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -80.17 132.45 35.9 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.729 0.299 . . . . 0.0 110.361 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.42 ' HA3' ' HB ' ' A' ' 341' ' ' VAL . . . 99.53 35.71 4.57 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -174.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -67.46 -176.7 9.36 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.258 -0.471 . . . . 0.0 113.438 -177.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 6.8 m -65.48 132.31 48.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.763 0.316 . . . . 0.0 111.246 -177.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.489 HD22 ' HA2' ' A' ' 253' ' ' GLY . 29.2 mt -137.16 -175.95 4.22 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -177.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 84.9 m -104.26 148.87 25.85 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -171.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 60.3 t -99.41 133.23 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.482 175.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.611 ' HE3' HG21 ' A' ' 252' ' ' THR . 22.9 mmtp -102.92 -41.29 6.19 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 121.138 -0.225 . . . . 0.0 110.906 175.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.454 ' O ' HG13 ' A' ' 249' ' ' VAL . 40.2 p -136.55 175.76 9.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.925 0.393 . . . . 0.0 110.781 177.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.534 ' H ' ' HB ' ' A' ' 333' ' ' VAL . 0.4 OUTLIER -115.68 156.19 46.55 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.986 -170.72 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.499 ' HD2' ' HG3' ' A' ' 233' ' ' GLN . 3.9 Cg_endo -45.48 107.43 0.11 Allowed 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 124.127 3.218 . . . . 0.0 113.473 175.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 65.2 m -152.77 94.77 1.92 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.069 0.461 . . . . 0.0 111.34 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.749 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -157.85 173.97 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 123.874 0.87 . . . . 0.0 109.1 168.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.534 ' H ' HG13 ' A' ' 236' ' ' VAL . 27.2 m -29.8 109.16 0.05 OUTLIER 'General case' 0 C--O 1.236 0.373 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -172.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -112.95 87.74 2.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.945 171.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -128.43 133.8 48.63 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -177.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -105.22 -42.85 5.16 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -169.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.93 -27.51 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.318 0.58 . . . . 0.0 109.963 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' A' ' 242' ' ' LYS . 27.9 mmmt -90.72 -12.63 36.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.805 178.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 60.84 66.67 0.89 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.131 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 55.6 m -150.76 99.03 2.68 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.571 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -120.13 102.21 8.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.949 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -135.42 160.25 39.03 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.749 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 27.2 p90 -148.17 139.84 23.76 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.07 174.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 53.5 m -99.81 136.7 39.33 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 232' ' ' THR . 99.2 t -137.92 141.39 38.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.841 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.544 HG23 ' OG1' ' A' ' 310' ' ' THR . 84.8 m -95.87 119.26 34.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 170.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.515 ' HB2' HG13 ' A' ' 309' ' ' VAL . 3.6 mp -115.33 163.02 16.3 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -176.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.611 HG21 ' HE3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -126.77 111.12 13.85 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 121.014 -0.275 . . . . 0.0 110.566 175.662 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.489 ' HA2' HD22 ' A' ' 228' ' ' LEU . . . -95.17 -147.27 22.36 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.034 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -109.46 -173.72 2.33 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 256' ' ' ALA . 3.1 m -58.84 167.31 1.61 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.801 -1.091 . . . . 0.0 113.476 -169.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.489 ' H ' HG22 ' A' ' 255' ' ' THR . . . -62.43 -176.56 0.11 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.819 -176.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 42.6 m 79.47 12.2 1.23 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.68 -176.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 23.8 t -125.44 94.78 2.87 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.2 m -77.3 94.2 4.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.099 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 74.02 93.15 0.13 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.491 178.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.66 ' CE1' ' HB3' ' A' ' 303' ' ' SER . 4.1 m-85 -44.4 -42.11 6.69 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 169.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 266' ' ' ASP . 1.0 OUTLIER -166.51 173.63 9.65 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.287 -173.005 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 63.8 mttm -142.65 -165.91 2.15 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.04 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -57.84 114.41 2.3 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.54 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 114.5 -16.21 19.49 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.932 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 262' ' ' LEU . 14.3 m-20 -78.83 126.42 30.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -93.29 150.01 20.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.711 0.767 . . . . 0.0 111.954 -176.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 341' ' ' VAL . 2.9 m -127.02 170.6 16.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.453 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.04 144.62 43.3 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 167.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.651 ' O ' ' HA ' ' A' ' 292' ' ' SER . 56.8 m-85 -110.99 129.34 55.92 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.332 -175.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 338' ' ' ALA . 81.3 p -95.16 88.16 5.1 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 166.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.696 ' O ' ' HA ' ' A' ' 291' ' ' ILE . 3.2 p-10 -122.96 164.22 18.92 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.355 -170.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 1.9 p -117.91 99.21 6.77 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.046 173.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.591 ' O ' HG23 ' A' ' 289' ' ' THR . 26.3 t80 -82.91 114.25 21.07 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -148.84 68.14 1.06 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.878 0.846 . . . . 0.0 109.394 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.403 ' HA ' ' HG2' ' A' ' 331' ' ' ARG . 8.6 mp -98.85 166.07 11.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.209 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 277' ' ' GLN . . . . . 0.58 ' O ' ' HG3' ' A' ' 281' ' ' LYS . 73.9 mt-30 -63.96 -16.61 61.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.604 -173.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -55.46 -39.79 70.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.442 0.639 . . . . 0.0 109.896 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -72.47 -48.46 40.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.068 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 29.5 p -71.45 -24.42 62.01 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -171.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.58 ' HG3' ' O ' ' A' ' 277' ' ' GLN . 96.9 mttt -60.98 -54.97 38.43 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.913 0.387 . . . . 0.0 110.798 177.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -84.04 -26.17 29.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.903 -177.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 62.15 22.28 13.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.094 175.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 80.2 mt -88.59 -34.25 17.39 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.977 0.418 . . . . 0.0 110.924 -177.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -124.91 90.28 3.22 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.321 0.581 . . . . 0.0 111.038 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -129.45 -3.72 4.85 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.691 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -85.65 -22.18 51.18 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.592 -176.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -128.2 120.71 27.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.977 0.418 . . . . 0.0 110.357 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.591 HG23 ' O ' ' A' ' 274' ' ' TYR . 17.5 m -99.83 117.72 63.03 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.068 178.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -52.43 115.79 2.43 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.824 2.349 . . . . 0.0 111.647 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.696 ' HA ' ' O ' ' A' ' 272' ' ' ASN . 33.9 pt -110.11 -17.27 8.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -172.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 71.2 m -153.5 139.17 17.88 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.886 -0.726 . . . . 0.0 112.774 -176.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -155.15 145.67 22.14 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 173.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 99.0 m -91.63 123.26 34.9 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.237 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -120.61 -176.18 3.18 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 121.173 -0.211 . . . . 0.0 110.625 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 94.1 m -141.32 130.06 22.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.327 0.584 . . . . 0.0 112.287 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.499 HG12 ' H ' ' A' ' 299' ' ' ALA . 59.6 t -83.63 145.79 7.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.752 177.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 2.3 m -123.46 24.02 8.76 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -173.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -167.71 -176.94 3.29 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 178.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.57 159.0 25.61 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.38 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.523 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -139.92 166.25 25.14 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.45 -177.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.541 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 18.2 m120 -136.51 122.22 19.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -174.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.66 ' HB3' ' CE1' ' A' ' 261' ' ' PHE . 0.0 OUTLIER -108.6 94.76 5.23 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 165.013 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.96 -170.56 1.86 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.022 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 10.1 t -60.03 -33.85 72.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.359 . . . . 0.0 111.418 -175.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -98.36 0.52 58.48 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 59.99 43.17 98.42 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 114.963 0.745 . . . . 0.0 114.963 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -88.34 110.19 20.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 119.557 1.679 . . . . 0.0 109.964 176.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.541 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 1.3 p -124.11 94.71 2.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.473 0.654 . . . . 0.0 111.394 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.544 ' OG1' HG23 ' A' ' 250' ' ' THR . 92.9 m -100.65 118.38 36.67 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.109 -0.369 . . . . 0.0 110.332 177.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.402 ' HB ' HG13 ' A' ' 297' ' ' VAL . 9.6 m -138.6 156.47 29.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.31 0.576 . . . . 0.0 110.795 178.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 44.9 m -108.32 133.69 52.18 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.137 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.428 ' HB2' ' CE2' ' A' ' 247' ' ' PHE . 5.2 mp -102.24 124.69 48.28 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.432 -174.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 14.6 m -125.72 144.92 50.41 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.803 0.335 . . . . 0.0 111.415 -173.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 77.24 60.65 2.81 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.365 176.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 18.6 m -113.34 136.41 21.87 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.625 0.25 . . . . 0.0 110.942 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -83.32 46.87 2.21 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.749 2.3 . . . . 0.0 112.083 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 83.3 mt -117.24 99.42 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.558 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -107.83 61.16 0.61 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.768 0.794 . . . . 0.0 110.02 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -91.7 -51.02 5.44 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.129 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 3.1 p -83.51 49.1 1.52 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.331 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' THR . . . . . 0.597 ' O ' ' HD3' ' A' ' 324' ' ' PRO . 7.3 m -81.26 1.33 32.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.754 0.788 . . . . 0.0 110.003 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -101.51 94.03 3.86 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.419 178.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.597 ' HD3' ' O ' ' A' ' 322' ' ' THR . 5.8 Cg_exo -80.94 -168.49 0.64 Allowed 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.756 1.638 . . . . 0.0 111.541 173.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 69.02 -49.12 0.59 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.792 0.837 . . . . 0.0 112.028 -178.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -84.81 15.57 3.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.144 0.497 . . . . 0.0 111.051 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -109.09 23.7 14.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.05 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 7.1 t -78.59 56.52 1.83 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.152 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 41.0 t 65.81 119.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.613 0.72 . . . . 0.0 111.981 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 12.3 t -173.19 -72.37 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.075 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 331' ' ' ARG . . . . . 0.403 ' HG2' ' HA ' ' A' ' 276' ' ' LEU . 7.4 tpm_? -102.78 111.11 23.27 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 171.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -99.5 -168.89 1.67 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.534 ' HB ' ' H ' ' A' ' 233' ' ' GLN . 26.9 m -55.31 135.55 18.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.822 0.344 . . . . 0.0 111.059 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -115.56 111.72 21.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.547 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -79.71 164.0 24.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.799 0.333 . . . . 0.0 110.963 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.87 -16.09 5.86 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.89 176.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.53 ' CG ' ' HA ' ' A' ' 272' ' ' ASN . 70.6 m-20 -81.53 -177.7 6.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.837 0.351 . . . . 0.0 111.089 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 338' ' ' ALA . . . . . 0.475 ' HB3' ' OG1' ' A' ' 271' ' ' THR . . . -122.77 150.02 43.34 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.316 0.579 . . . . 0.0 111.736 -176.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 53.0 t -103.04 147.53 9.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.386 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 11.6 p -156.85 151.95 26.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.018 0.437 . . . . 0.0 111.21 173.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.559 HG12 ' H ' ' A' ' 343' ' ' GLY . 41.0 t -108.37 147.03 13.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.238 -176.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 54.5 t -77.95 -34.06 19.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-O 121.216 0.532 . . . . 0.0 110.044 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 343' ' ' GLY . . . . . 0.559 ' H ' HG12 ' A' ' 341' ' ' VAL . . . 114.1 -165.32 12.04 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.172 175.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.6 p -88.15 -51.66 5.66 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.337 0.589 . . . . 0.0 110.873 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.353 178.639 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.713 0 N-CA-C 111.819 -0.512 . . . . 0.0 111.819 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -130.38 137.42 49.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.84 0.352 . . . . 0.0 111.027 -176.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.27 -30.56 71.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.179 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 130.24 -45.79 1.12 Allowed Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -174.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.614 ' C ' ' HB3' ' A' ' 340' ' ' SER . . . -104.52 114.59 4.74 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 173.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.743 HG23 ' HB ' ' A' ' 339' ' ' VAL . 52.4 m -153.29 135.49 14.88 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.664 -0.315 . . . . 0.0 111.311 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.662 ' H ' ' HA ' ' A' ' 339' ' ' VAL . 3.2 mt -128.36 87.63 2.62 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.951 ' HA ' ' O ' ' A' ' 338' ' ' ALA . 1.2 m -83.64 133.85 34.81 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.345 -174.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.678 ' O ' ' HA2' ' A' ' 336' ' ' GLY . 39.3 t -82.68 158.52 3.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.916 -160.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.435 ' HG3' HG23 ' A' ' 232' ' ' THR . 16.8 ptmt -131.75 -12.26 3.38 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.161 175.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 335' ' ' ALA . 40.6 p -129.32 -166.97 1.72 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.475 0.31 . . . . 0.0 110.829 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 34.1 mt-30 -112.91 118.24 44.94 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -173.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.548 ' HA ' ' O ' ' A' ' 248' ' ' THR . 1.1 Cg_endo -75.44 107.58 2.51 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.88 2.387 . . . . 0.0 113.007 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 236' ' ' VAL . 19.4 m -155.39 131.07 9.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.408 177.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.653 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -154.93 175.91 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.245 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.575 ' H ' HG13 ' A' ' 236' ' ' VAL . 98.1 m -32.84 124.74 0.35 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.18 1.392 . . . . 0.0 114.578 -173.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -104.13 108.42 19.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.631 172.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.437 HD22 ' HA ' ' A' ' 239' ' ' ASN . 0.4 OUTLIER -114.01 91.45 3.64 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.215 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -88.16 -37.74 15.91 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.773 -161.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 40.0 t -64.69 -22.88 32.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -103.7 -0.67 29.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.14 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 24.6 t70 53.7 48.82 20.65 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.051 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 14.9 m -127.2 113.14 15.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.524 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -128.44 105.97 8.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -174.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' GLN . . . . . 0.535 ' HB2' HG12 ' A' ' 236' ' ' VAL . 2.0 mp0 -108.28 154.11 22.26 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.653 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 4.6 p90 -149.81 124.72 9.92 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.679 177.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 78.3 m -91.7 140.6 29.56 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.515 HG13 HD11 ' A' ' 251' ' ' LEU . 8.2 p -139.97 136.03 38.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 C-N-CA 119.848 -0.741 . . . . 0.0 112.354 -177.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.58 HG23 ' OG1' ' A' ' 310' ' ' THR . 94.0 m -96.99 115.85 28.16 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 168.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.515 HD11 HG13 ' A' ' 249' ' ' VAL . 1.0 OUTLIER -113.8 171.55 7.52 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.968 0.889 . . . . 0.0 110.463 -173.108 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.495 HG22 ' O ' ' A' ' 307' ' ' GLY . 0.0 OUTLIER -121.21 94.13 4.24 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.094 169.854 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.543 ' H ' HG12 ' A' ' 309' ' ' VAL . . . -120.52 135.12 10.7 Favored Glycine 0 CA--C 1.505 -0.58 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.705 -176.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -115.6 93.42 4.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -165.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.471 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 93.5 m -128.23 103.91 7.45 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.119 165.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.547 ' HA ' ' CB ' ' A' ' 305' ' ' SER . . . -50.57 130.69 24.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 35.9 m 57.76 58.56 3.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.64 -1.164 . . . . 0.0 113.108 168.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.43 ' HB ' ' OG ' ' A' ' 303' ' ' SER . 60.2 t -140.2 101.29 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-O 121.022 0.439 . . . . 0.0 110.249 174.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 33.6 m -71.44 86.99 0.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.407 0.623 . . . . 0.0 109.855 177.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 78.81 111.44 0.21 Allowed Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.569 -174.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.705 ' CE2' ' HB3' ' A' ' 303' ' ' SER . 57.3 m-85 -49.91 -61.27 2.23 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 121.85 0.833 . . . . 0.0 109.168 173.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 261' ' ' PHE . 73.6 mt -167.38 -179.93 4.7 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.336 -1.756 . . . . 0.0 106.603 -175.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -108.92 -169.8 1.55 Allowed 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -35.37 114.97 0.27 Allowed 'General case' 0 N--CA 1.464 0.238 0 O-C-N 124.181 0.925 . . . . 0.0 112.516 -177.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 131.92 -14.0 5.23 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.123 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' ASP . . . . . 0.501 ' OD1' ' HB2' ' A' ' 262' ' ' LEU . 80.8 m-20 -64.05 146.69 53.72 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 120.758 0.314 . . . . 0.0 110.207 175.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.14 174.49 6.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.447 -174.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.93 ' HA ' ' N ' ' A' ' 341' ' ' VAL . 34.8 m -151.89 142.63 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.805 -175.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.729 ' N ' HG23 ' A' ' 341' ' ' VAL . 0.0 OUTLIER -77.6 97.76 5.19 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 157.139 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.495 ' HA ' ' HB1' ' A' ' 338' ' ' ALA . 14.2 t80 -78.75 86.58 4.69 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.662 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 53.7 m -78.9 107.68 11.81 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -124.31 95.38 4.52 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.237 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' THR . . . . . 0.455 HG22 HG21 ' A' ' 289' ' ' THR . 1.3 p -70.67 93.26 0.92 Allowed 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 166.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.578 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 84.9 t80 -84.03 156.22 22.35 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.578 ' HB2' ' O ' ' A' ' 274' ' ' TYR . 85.2 m95 82.47 39.0 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 O-C-N 124.039 0.837 . . . . 0.0 111.051 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.617 ' HG ' ' CG ' ' A' ' 334' ' ' GLU . 12.2 mt -76.38 155.08 34.37 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.348 177.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -65.71 -77.99 0.06 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.817 0.341 . . . . 0.0 110.664 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -118.62 -82.65 0.64 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.935 0.398 . . . . 0.0 110.747 174.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -119.08 -73.12 0.66 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -176.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 3.2 p -105.1 -19.25 13.88 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -168.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -62.95 -31.5 72.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.783 0.325 . . . . 0.0 111.014 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.508 ' O ' ' HA ' ' A' ' 276' ' ' LEU . 78.7 mt-30 64.25 -68.49 0.1 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.523 1.129 . . . . 0.0 112.043 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -177.86 122.81 0.11 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.31 -173.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 89.1 mt -104.94 -30.41 9.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.04 0.448 . . . . 0.0 110.809 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -123.86 7.13 8.7 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.397 -178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -129.37 168.69 15.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.699 -177.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 160.31 102.88 0.18 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.006 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -154.99 83.58 1.08 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.922 0.392 . . . . 0.0 110.802 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.455 HG21 HG22 ' A' ' 273' ' ' THR . 8.9 t -135.26 142.21 40.76 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.16 45.1 0.91 Allowed 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.132 2.554 . . . . 0.0 113.496 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 62.8 mt 66.62 -77.08 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.55 0.74 . . . . 0.0 111.997 177.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 8.5 t -163.85 158.93 20.54 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -141.67 144.0 33.89 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 88.6 m -85.21 125.94 33.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.71 0.291 . . . . 0.0 111.503 -172.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -119.38 -179.5 3.88 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 84.9 m -136.14 138.15 41.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.428 0.632 . . . . 0.0 112.531 -174.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.598 HG12 ' H ' ' A' ' 299' ' ' ALA . 48.9 t -93.66 139.3 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.228 179.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 8.4 t -109.93 24.1 13.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.044 0.449 . . . . 0.0 111.5 -175.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.598 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -156.69 174.99 14.65 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.177 0.513 . . . . 0.0 112.087 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.97 113.13 2.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.709 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.46 ' HA ' ' CG1' ' A' ' 311' ' ' VAL . . . -93.18 106.86 18.77 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.059 -176.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.522 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 65.4 t30 -69.63 147.08 51.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.818 0.342 . . . . 0.0 111.532 -177.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.705 ' HB3' ' CE2' ' A' ' 261' ' ' PHE . 2.5 p -142.01 95.98 2.89 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.151 0.501 . . . . 0.0 110.517 171.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.58 151.87 21.83 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 172.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.547 ' CB ' ' HA ' ' A' ' 256' ' ' ALA . 0.3 OUTLIER -70.77 -12.31 61.47 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -171.639 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -71.16 -11.62 70.99 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 169.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' GLY . . . . . 0.495 ' O ' HG22 ' A' ' 252' ' ' THR . . . 75.77 41.36 28.86 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.784 -0.708 . . . . 0.0 113.869 174.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -125.55 111.18 14.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.034 0.917 . . . . 0.0 111.602 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.543 HG12 ' H ' ' A' ' 253' ' ' GLY . 0.6 OUTLIER -132.59 138.79 51.32 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.103 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.58 ' OG1' HG23 ' A' ' 250' ' ' THR . 94.7 m -123.17 126.34 46.82 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.129 -0.357 . . . . 0.0 110.305 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 301' ' ' ALA . 15.4 m -146.47 164.89 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.944 0.402 . . . . 0.0 110.156 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 56.8 m -114.3 139.43 49.44 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.128 0.489 . . . . 0.0 110.573 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.404 HD13 ' CE2' ' A' ' 247' ' ' PHE . 4.8 mp -105.28 150.34 25.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.853 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 34.1 t -135.87 129.4 32.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.16 0.505 . . . . 0.0 112.047 -174.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 125.04 -43.55 1.37 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.891 167.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 34.0 m -108.11 146.24 33.11 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-O 120.928 0.394 . . . . 0.0 111.963 -172.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -92.47 139.8 1.96 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.119 2.546 . . . . 0.0 113.363 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.635 ' H ' HD13 ' A' ' 318' ' ' ILE . 0.1 OUTLIER -94.22 125.21 46.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 172.212 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -82.81 72.93 9.88 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -167.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -81.28 -8.45 59.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.746 0.784 . . . . 0.0 109.028 170.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 2.4 p -87.93 24.61 1.74 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.375 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 15.1 m -84.89 -15.16 45.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.887 0.851 . . . . 0.0 108.885 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -81.22 147.12 59.91 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.418 174.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.429 ' O ' ' HB2' ' A' ' 325' ' ' GLN . 60.3 Cg_endo -70.63 -19.0 32.53 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.115 1.876 . . . . 0.0 113.242 -174.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 325' ' ' GLN . . . . . 0.52 ' O ' ' HB ' ' A' ' 329' ' ' VAL . 78.5 mt-30 73.5 -58.75 0.58 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.447 0.699 . . . . 0.0 111.864 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 326' ' ' TYR . . . . . 0.401 ' HB2' ' O ' ' A' ' 325' ' ' GLN . 47.2 m-85 72.29 -63.64 0.42 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.448 0.699 . . . . 0.0 110.135 -178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -175.94 -60.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.634 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 19.7 m -99.9 -15.93 18.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.849 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 329' ' ' VAL . . . . . 0.52 ' HB ' ' O ' ' A' ' 325' ' ' GLN . 49.1 t -81.19 134.29 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 62.0 m -148.82 144.89 27.26 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.728 0.299 . . . . 0.0 110.278 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 331' ' ' ARG . . . . . 0.477 ' HG2' ' OH ' ' A' ' 274' ' ' TYR . 17.9 tpt180 -102.39 149.85 23.94 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.072 178.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -111.49 152.12 27.82 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 173.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.471 HG12 ' HD2' ' A' ' 234' ' ' PRO . 23.5 t -68.07 150.44 10.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.203 -178.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 334' ' ' GLU . . . . . 0.617 ' CG ' ' HG ' ' A' ' 276' ' ' LEU . 0.7 OUTLIER -79.66 129.25 34.31 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -168.166 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 232' ' ' THR . . . -99.59 114.26 27.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.901 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 336' ' ' GLY . . . . . 0.678 ' HA2' ' O ' ' A' ' 230' ' ' VAL . . . 128.8 13.34 2.5 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 119.179 -1.486 . . . . 0.0 115.82 163.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.662 ' HB3' ' O ' ' A' ' 271' ' ' THR . 3.6 t0 -108.83 -67.34 0.98 Allowed 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -171.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 338' ' ' ALA . . . . . 0.951 ' O ' ' HA ' ' A' ' 229' ' ' THR . . . -51.11 178.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 116.917 2.191 . . . . 0.0 116.917 -156.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.743 ' HB ' HG23 ' A' ' 227' ' ' THR . 3.1 m -149.42 -164.77 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 CA-C-O 117.855 -1.069 . . . . 0.0 108.833 -168.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.614 ' HB3' ' C ' ' A' ' 226' ' ' GLY . 29.1 t -119.63 152.35 37.21 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 121.247 1.839 . . . . 0.0 114.404 -168.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.93 ' N ' ' HA ' ' A' ' 268' ' ' VAL . 53.3 t -124.83 58.03 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.827 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 164.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.445 HG23 ' OG ' ' A' ' 340' ' ' SER . 3.5 t -119.81 47.37 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 122.446 1.117 . . . . 0.0 108.094 175.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 113.96 129.89 4.97 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 113.758 -1.564 . . . . 0.0 110.417 -170.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 80.6 p 62.05 118.1 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.523 1.129 . . . . 0.0 112.151 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.128 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.642 -176.302 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.793 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.15 -31.71 58.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.58 0.229 . . . . 0.0 110.813 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -60.9 136.15 58.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.145 178.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 93.35 10.19 59.65 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -173.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -89.92 168.76 34.49 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.208 -178.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 27.5 m -141.43 135.12 30.01 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 8.9 mt -139.31 178.11 7.43 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.705 -176.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.8 m -124.27 154.91 39.53 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.826 0.346 . . . . 0.0 110.735 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 67.2 t -99.63 128.78 51.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.974 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 51.2 tttt -112.47 -28.09 8.0 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.929 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 27.1 p -139.38 -169.97 2.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.696 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 61.2 mt-30 -112.64 116.81 47.67 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -174.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.719 ' HA ' ' O ' ' A' ' 248' ' ' THR . 7.4 Cg_exo -72.58 104.81 1.78 Allowed 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.361 2.041 . . . . 0.0 112.722 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.9 t -154.26 131.92 11.44 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.028 0.442 . . . . 0.0 111.782 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.684 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.87 176.47 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 168.908 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.534 ' H ' HG13 ' A' ' 236' ' ' VAL . 91.6 m -37.17 111.0 0.14 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -176.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -97.45 84.04 3.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.221 173.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.508 ' OD1' ' HB2' ' A' ' 242' ' ' LYS . 0.8 OUTLIER -87.09 121.25 29.29 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -176.091 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -105.99 -56.92 2.11 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -164.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 32.8 t -64.66 -29.7 48.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.388 0.613 . . . . 0.0 109.57 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.508 ' HB2' ' OD1' ' A' ' 239' ' ' ASN . 27.6 mtpt -89.56 -16.92 29.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.754 178.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 68.54 70.67 0.3 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 114.495 -1.229 . . . . 0.0 112.617 174.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.4 t -154.03 96.5 1.97 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.384 0.612 . . . . 0.0 110.298 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 17.1 m-30 -103.85 108.22 19.44 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.32 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -112.84 149.34 33.23 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 173.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.684 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 1.3 p90 -160.17 139.82 11.17 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 121.339 -0.144 . . . . 0.0 110.819 177.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.719 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 52.4 m -109.22 142.53 39.91 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.218 -0.193 . . . . 0.0 111.167 -174.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.97 131.35 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 121.466 0.651 . . . . 0.0 112.727 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 21.3 m -96.94 120.69 37.74 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 165.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.456 ' HB2' HG13 ' A' ' 309' ' ' VAL . 0.4 OUTLIER -116.47 171.54 7.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.242 0.544 . . . . 0.0 109.831 -175.725 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.01 147.68 46.39 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.364 172.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -148.45 -143.75 3.85 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.62 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.478 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -104.76 -174.47 2.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -176.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.617 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.5 OUTLIER -72.31 -177.91 2.32 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.49 -169.628 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.617 ' H ' HG22 ' A' ' 255' ' ' THR . . . -62.83 -176.89 0.13 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.451 0.701 . . . . 0.0 112.506 -178.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 68.3 m 80.32 16.31 0.71 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.838 0.855 . . . . 0.0 111.613 -177.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 61.8 t -135.34 94.76 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 171.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 4.3 m -72.05 92.27 1.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.622 -177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 76.72 92.86 0.22 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.925 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' A' ' 303' ' ' SER . 3.2 m-85 -42.92 -53.5 4.67 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.775 0.321 . . . . 0.0 111.66 168.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 18.3 mt -141.29 147.01 37.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.308 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 57.8 mtmt -139.38 -169.39 2.66 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 123.249 0.343 . . . . 0.0 110.886 175.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -53.66 119.39 4.85 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.278 0.561 . . . . 0.0 111.411 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 107.25 -7.87 37.75 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.45 176.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -90.45 130.97 36.45 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -109.23 140.7 42.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.877 0.37 . . . . 0.0 110.686 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 295' ' ' ALA . 1.0 OUTLIER -122.24 171.41 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 121.305 0.574 . . . . 0.0 111.834 -178.399 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.401 ' C ' ' HD2' ' A' ' 269' ' ' LYS . 0.2 OUTLIER -131.42 129.64 41.51 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.887 179.18 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.439 ' O ' ' HA ' ' A' ' 292' ' ' SER . 47.5 m-85 -100.04 127.57 46.24 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.129 -0.357 . . . . 0.0 110.261 177.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.51 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 51.7 m -102.73 88.15 3.14 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 173.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.656 ' HA ' ' CB ' ' A' ' 337' ' ' ASP . 4.3 p-10 -91.08 155.58 18.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.071 -167.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 11.7 p -123.03 169.47 11.15 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.678 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -80.79 115.17 20.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.781 0.801 . . . . 0.0 110.985 -176.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 54.5 m95 -134.51 -22.39 1.71 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.22 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.516 ' HG ' ' OE1' ' A' ' 334' ' ' GLU . 97.0 mt -43.3 99.27 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 O-C-N 123.92 0.763 . . . . 0.0 112.753 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -78.26 -11.54 59.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.243 0.544 . . . . 0.0 109.675 175.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.416 ' H ' ' HG3' ' A' ' 278' ' ' GLN . 32.0 mt-30 -63.98 -28.59 69.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.052 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.451 ' OE1' ' HB2' ' A' ' 286' ' ' ASN . 15.6 mm100 -67.32 -6.77 20.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.532 -175.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 35.8 p -72.76 -37.53 67.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.097 0.475 . . . . 0.0 110.407 177.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -110.02 -62.45 1.51 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.021 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.4 ' HB3' ' CD2' ' A' ' 285' ' ' TYR . 21.7 mt-30 -95.38 63.89 2.59 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 122.072 0.939 . . . . 0.0 111.039 -172.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -86.21 5.52 33.8 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.088 -1.415 . . . . 0.0 110.524 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 42.0 mt -85.28 -24.82 27.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.166 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' TYR . . . . . 0.4 ' CD2' ' HB3' ' A' ' 282' ' ' GLN . 39.2 m-85 -80.7 -57.15 3.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.352 -178.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.451 ' HB2' ' OE1' ' A' ' 279' ' ' GLN . 81.1 m-20 -101.08 134.28 44.33 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.942 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -75.94 -45.36 16.59 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.492 175.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -176.1 159.68 2.14 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.0 t -54.89 142.58 54.85 Favored Pre-proline 0 C--N 1.32 -0.716 0 O-C-N 123.491 0.495 . . . . 0.0 109.731 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.16 -170.0 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.529 2.153 . . . . 0.0 112.833 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 40.6 mm -103.32 -65.4 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.475 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 52.0 m -159.72 129.94 5.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.139 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -135.77 150.59 49.54 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 121.018 0.437 . . . . 0.0 111.472 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 98.4 m -95.65 136.51 35.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.755 -173.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 295' ' ' ALA . . . . . 0.536 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -121.25 171.07 8.99 Favored 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 122.447 -0.158 . . . . 0.0 110.705 176.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 96.6 m -135.2 121.59 20.43 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.282 0.563 . . . . 0.0 112.168 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 59.5 t -79.36 139.96 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.333 -178.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 0.9 OUTLIER -130.62 24.24 5.07 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.017 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.552 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -162.14 179.83 7.64 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.436 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 5.6 m-20 -69.17 163.48 24.79 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.81 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.442 ' HB2' ' CG1' ' A' ' 311' ' ' VAL . . . -149.48 172.86 14.29 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.668 -174.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.662 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 16.8 m120 -138.28 122.71 18.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -175.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.483 ' HB3' ' CE1' ' A' ' 261' ' ' PHE . 0.6 OUTLIER -105.87 93.37 4.6 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 162.622 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.33 178.91 4.46 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.436 -0.505 . . . . 0.0 110.92 -173.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 17.7 m -57.65 -33.1 67.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.851 0.358 . . . . 0.0 111.649 -177.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -82.05 0.89 88.11 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.321 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 307' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 62.01 43.11 99.61 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.438 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -121.04 126.65 50.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.717 0.758 . . . . 0.0 110.855 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.662 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.3 OUTLIER -136.67 126.2 38.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.846 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -177.901 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 34.1 m -123.65 132.58 53.89 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.939 -0.475 . . . . 0.0 111.117 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.442 ' CG1' ' HB2' ' A' ' 301' ' ' ALA . 9.2 m -144.71 162.19 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.213 0.53 . . . . 0.0 110.418 176.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 21.0 m -117.01 142.21 47.26 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.48 0.657 . . . . 0.0 109.891 174.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 313' ' ' LEU . 0.5 OUTLIER -107.83 133.27 52.44 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.874 -173.591 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 46.7 t -137.93 138.37 38.92 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.532 -171.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.45 49.25 71.41 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 114.774 -1.103 . . . . 0.0 113.666 170.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 20.3 m -82.94 123.8 77.41 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 121.077 0.465 . . . . 0.0 110.644 177.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -82.46 64.33 8.2 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.919 2.413 . . . . 0.0 112.006 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 321' ' ' THR . 22.9 mm -94.31 99.89 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-O 121.352 0.596 . . . . 0.0 111.296 -176.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -114.53 -63.7 1.42 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.122 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -139.42 33.74 2.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -177.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.413 HG21 HD13 ' A' ' 318' ' ' ILE . 3.5 p -52.99 117.3 2.88 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.984 -175.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 2.8 m -95.26 -5.71 43.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.679 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.534 ' HB3' ' HD3' ' A' ' 324' ' ' PRO . 19.2 t-20 -56.81 -47.32 99.24 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.453 173.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' A' ' 323' ' ' ASN . 1.4 Cg_endo -86.94 -166.41 0.3 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.537 2.158 . . . . 0.0 111.096 173.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -87.98 58.74 4.97 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.542 0.687 . . . . 0.0 110.627 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 59.07 96.84 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 113.705 -1.589 . . . . 0.0 111.026 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 327' ' ' ASN . . . . . 0.535 HD21 ' HG2' ' A' ' 331' ' ' ARG . 25.7 t-20 -129.37 108.05 9.99 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 22.8 t -113.52 68.61 0.69 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 120.771 0.319 . . . . 0.0 110.596 -174.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 53.6 t 75.07 -42.21 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.634 175.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 16.5 m -66.86 82.02 0.11 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.318 0.58 . . . . 0.0 111.46 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 331' ' ' ARG . . . . . 0.535 ' HG2' HD21 ' A' ' 327' ' ' ASN . 81.4 mtt180 -103.75 113.02 26.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.277 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -89.19 122.17 32.21 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.47 HG11 ' O ' ' A' ' 234' ' ' PRO . 34.3 m -99.16 123.24 51.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.606 0.717 . . . . 0.0 111.867 -175.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 334' ' ' GLU . . . . . 0.516 ' OE1' ' HG ' ' A' ' 276' ' ' LEU . 2.6 pt-20 -146.88 145.72 29.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.967 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -99.29 142.97 30.08 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.676 -174.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 129.09 11.43 2.83 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.569 171.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.656 ' CB ' ' HA ' ' A' ' 272' ' ' ASN . 10.9 p-10 -104.4 -153.32 0.48 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.926 0.363 . . . . 0.0 111.093 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -126.23 139.24 53.49 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 121.207 0.527 . . . . 0.0 111.774 -173.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.434 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 75.1 t -103.08 145.44 12.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.657 -177.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 10.5 m -142.97 178.92 7.35 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 268' ' ' VAL . 60.5 t -117.58 141.54 35.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.673 0.273 . . . . 0.0 110.563 -175.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 72.1 t -97.02 -44.93 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.87 177.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -179.47 168.41 38.95 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.967 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 19.0 p -124.91 -68.81 0.83 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.396 0.617 . . . . 0.0 110.333 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.189 -0.91 . . . . 0.0 109.365 175.034 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 112.249 -0.34 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.435 ' O ' ' HA3' ' A' ' 343' ' ' GLY . . . -78.04 71.16 4.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.292 0.568 . . . . 0.0 111.183 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -99.08 161.66 13.5 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.567 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 105.11 6.27 39.7 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -176.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -76.49 117.52 5.0 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.771 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.9 m -127.9 141.34 51.58 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.821 0.343 . . . . 0.0 110.421 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.456 HD21 ' CE2' ' A' ' 261' ' ' PHE . 12.7 mt -143.08 175.19 10.05 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.985 -177.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 63.3 m -128.65 157.46 41.26 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.219 -176.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.501 HG21 ' OD2' ' A' ' 337' ' ' ASP . 92.6 t -99.13 138.67 22.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 120.622 0.249 . . . . 0.0 110.648 -177.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.415 ' HB3' HG22 ' A' ' 250' ' ' THR . 35.6 tptt -117.53 -34.7 4.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.547 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 53.9 p -137.04 -173.67 3.52 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.599 ' HG3' ' N ' ' A' ' 334' ' ' GLU . 24.3 mm-40 -115.57 155.96 46.69 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -168.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.481 ' HB3' ' CD1' ' A' ' 247' ' ' PHE . 28.3 Cg_endo -63.47 105.95 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.176 2.584 . . . . 0.0 111.985 174.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 236' ' ' VAL . 5.1 t -148.27 96.98 2.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.574 0.702 . . . . 0.0 111.741 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.736 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.73 174.01 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 168.217 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.497 ' H ' HG13 ' A' ' 236' ' ' VAL . 44.2 m -29.06 109.54 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -175.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -108.72 87.63 2.54 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 168.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.51 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 4.9 t30 -113.88 102.47 10.24 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.642 -174.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -84.51 -52.14 6.37 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -164.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 26.1 t -67.28 -23.59 30.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.411 0.624 . . . . 0.0 109.578 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.51 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 43.2 mmtt -89.88 -12.77 38.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.566 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 30.0 t70 63.37 69.65 0.56 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.183 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.2 m -149.5 106.86 3.61 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.879 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -125.29 102.76 7.59 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' GLN . . . . . 0.454 ' HB2' HG12 ' A' ' 236' ' ' VAL . 38.8 mt-30 -129.76 160.01 34.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.736 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 7.4 p90 -154.92 132.91 11.58 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.629 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 53.0 m -97.94 131.89 44.0 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 25.3 t -136.86 140.32 43.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.867 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.415 HG22 ' HB3' ' A' ' 231' ' ' LYS . 24.2 m -96.9 121.49 38.83 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 167.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.542 HD23 HG21 ' A' ' 339' ' ' VAL . 4.8 mp -110.24 167.37 10.24 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -123.54 140.63 52.81 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.415 ' HA2' HD23 ' A' ' 228' ' ' LEU . . . -142.11 -143.56 4.22 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.709 -174.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -102.63 -174.32 2.53 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.629 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.9 OUTLIER -72.18 -179.43 2.84 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.446 -169.907 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.629 ' H ' HG22 ' A' ' 255' ' ' THR . . . -61.22 -176.44 0.07 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.93 0.892 . . . . 0.0 112.898 -177.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 27.7 t 80.52 6.73 1.51 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.82 0.848 . . . . 0.0 110.922 -178.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 17.3 t -122.07 90.21 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 17.0 m -74.8 88.02 2.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.595 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 83.44 91.48 0.69 Allowed Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.383 -178.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.456 ' CE2' HD21 ' A' ' 228' ' ' LEU . 4.1 m-85 -43.01 -60.09 1.76 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 170.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 63.9 mt -149.02 161.76 41.29 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.12 -172.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 85.6 mttt -142.92 -167.19 2.47 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.119 0.262 . . . . 0.0 111.138 175.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -49.63 116.68 1.87 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.276 0.56 . . . . 0.0 111.686 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 108.36 -5.14 33.39 Favored Glycine 0 C--N 1.316 -0.53 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.299 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -94.96 143.27 26.61 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.402 ' O ' HG12 ' A' ' 342' ' ' VAL . 23.0 mt-30 -114.06 152.7 30.63 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.551 0.691 . . . . 0.0 111.455 -176.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.3 OUTLIER -130.09 165.97 28.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.865 177.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 340' ' ' SER . 0.8 OUTLIER -122.64 87.45 2.75 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.1 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 339' ' ' VAL . 5.3 p90 -92.16 132.38 36.67 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.807 -175.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.606 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 77.2 m -98.24 87.14 3.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.36 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -99.21 101.97 13.47 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.006 -177.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 3.0 p -77.01 80.91 3.54 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.616 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -91.22 113.0 25.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.434 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -174.07 53.62 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.525 HD12 ' O ' ' A' ' 332' ' ' GLN . 25.4 mt -91.11 91.14 8.13 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.587 -170.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -99.62 -71.99 0.68 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.155 -176.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -115.24 -81.34 0.61 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.04 0.448 . . . . 0.0 110.858 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -86.58 -22.95 25.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.308 -176.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 28.1 p -64.35 -17.51 63.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.871 0.367 . . . . 0.0 111.228 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.476 ' HG2' ' HB3' ' A' ' 276' ' ' LEU . 7.3 mtpm? -63.58 -28.34 69.87 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.076 0.465 . . . . 0.0 110.325 176.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -104.5 -9.44 18.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.599 -178.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -130.88 88.94 2.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.906 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.9 -3.2 27.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.253 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -77.87 -18.05 56.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.065 0.46 . . . . 0.0 109.876 177.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -116.95 132.39 56.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.247 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -160.95 -122.63 0.64 Allowed Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.658 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -174.0 39.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.083 0.468 . . . . 0.0 110.07 -177.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.2 t -165.82 88.84 0.91 Allowed Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.682 0.753 . . . . 0.0 110.916 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -89.78 45.82 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.011 2.474 . . . . 0.0 112.65 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 271' ' ' THR . 50.2 pt -119.82 171.59 7.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.227 -176.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 8.0 t -135.22 142.04 45.92 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.96 144.57 50.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.19 0.519 . . . . 0.0 111.014 -176.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 60.3 m -81.53 122.89 28.13 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.275 -176.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' ALA . . . . . 0.429 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -114.48 175.45 5.48 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 63.8 m -135.19 130.58 35.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.573 0.701 . . . . 0.0 112.808 -176.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 62.8 t -80.57 139.39 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.811 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 312' ' ' THR . 13.8 t -121.71 1.8 10.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.782 0.325 . . . . 0.0 111.399 -176.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -142.46 -177.12 5.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -173.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.422 ' O ' HG12 ' A' ' 311' ' ' VAL . 10.9 m-20 -71.51 164.65 25.43 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.121 -178.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.56 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -149.58 156.08 41.36 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.316 -173.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.546 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 3.9 m-20 -129.17 126.88 40.2 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.624 -175.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.496 ' HB2' ' HB ' ' A' ' 258' ' ' VAL . 0.4 OUTLIER -111.24 95.5 5.56 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 163.966 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -102.16 178.2 4.67 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.646 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 50.4 m -60.21 -32.28 70.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.729 0.299 . . . . 0.0 111.697 -177.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -73.64 -8.83 77.62 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.175 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 70.61 42.39 63.11 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.511 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -118.43 136.01 54.02 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.734 0.767 . . . . 0.0 111.474 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.546 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.7 OUTLIER -142.92 110.31 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.804 -178.478 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 25.5 m -105.16 127.4 52.89 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.609 -0.682 . . . . 0.0 111.537 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.522 HG22 HD13 ' A' ' 251' ' ' LEU . 19.5 m -144.38 148.72 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.296 0.57 . . . . 0.0 111.014 175.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.517 ' O ' HG22 ' A' ' 298' ' ' THR . 50.0 m -97.22 146.78 24.77 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 172.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.483 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.1 mp -117.51 136.73 53.03 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.299 -176.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 38.1 m -133.66 129.45 36.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.494 -174.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 82.53 88.85 0.69 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.2 174.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 10.9 m -129.99 122.38 20.3 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 121.016 0.436 . . . . 0.0 110.821 176.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -87.28 56.61 3.14 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.888 2.392 . . . . 0.0 111.987 178.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 8.9 tt -82.74 99.06 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.538 0.685 . . . . 0.0 110.877 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -138.55 77.92 1.65 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.33 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -162.61 -51.74 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.11 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 38.1 p -112.84 39.42 2.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.276 0.56 . . . . 0.0 110.438 175.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 3.9 m -80.47 -68.02 0.72 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.628 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 6.2 t30 61.97 95.08 0.05 OUTLIER Pre-proline 0 N--CA 1.474 0.747 0 O-C-N 123.621 0.575 . . . . 0.0 112.123 170.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -73.13 140.39 31.01 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.678 1.585 . . . . 0.0 110.568 175.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -84.61 18.94 2.13 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.947 -176.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 69.08 -67.06 0.23 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.584 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -97.82 -12.89 21.68 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.675 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 46.5 m 70.31 103.61 0.06 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.019 -174.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 3.4 t -88.51 20.35 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.554 0.692 . . . . 0.0 110.573 -174.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 20.0 m 56.22 45.78 22.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.964 178.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -81.27 112.39 18.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.782 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 332' ' ' GLN . . . . . 0.525 ' O ' HD12 ' A' ' 276' ' ' LEU . 79.2 mm-40 -98.3 154.3 17.91 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.447 ' HB ' ' OE1' ' A' ' 233' ' ' GLN . 0.8 OUTLIER -76.69 170.55 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.867 -179.072 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 334' ' ' GLU . . . . . 0.599 ' N ' ' HG3' ' A' ' 233' ' ' GLN . 10.8 tp10 -158.67 130.34 6.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.606 0.241 . . . . 0.0 110.7 -173.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -66.22 158.35 29.09 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.295 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 130.07 -1.24 5.8 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.673 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.606 ' HB2' ' O ' ' A' ' 271' ' ' THR . 10.3 p-10 -89.08 -171.3 3.22 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 122.333 0.253 . . . . 0.0 110.742 176.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -129.04 162.57 27.35 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -171.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.542 HG21 HD23 ' A' ' 251' ' ' LEU . 98.3 t -128.56 142.62 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.968 -175.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.486 ' HB3' ' HB2' ' A' ' 269' ' ' LYS . 33.7 t -127.63 165.17 20.48 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 170.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.59 HG12 ' H ' ' A' ' 343' ' ' GLY . 39.5 t -120.76 148.72 23.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 122.328 0.251 . . . . 0.0 110.386 -177.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.433 ' HB ' ' HE3' ' A' ' 269' ' ' LYS . 7.5 p -85.01 -31.28 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 121.025 0.44 . . . . 0.0 110.691 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 343' ' ' GLY . . . . . 0.59 ' H ' HG12 ' A' ' 341' ' ' VAL . . . 78.07 -110.38 3.02 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.996 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 17.4 p -122.4 -95.92 0.47 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.811 0.339 . . . . 0.0 111.063 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.493 -0.765 . . . . 0.0 110.096 179.5 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.648 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 71.58 147.61 0.08 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.633 0.73 . . . . 0.0 111.421 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.407 ' CG ' ' HA2' ' A' ' 343' ' ' GLY . 59.8 t80 -69.86 -21.5 63.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.277 -176.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 130.98 -35.87 2.37 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -65.43 115.49 7.71 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.283 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 27.1 m -111.05 141.06 45.04 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.456 HD21 ' CE2' ' A' ' 261' ' ' PHE . 8.6 mt -139.34 172.07 13.35 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.575 -173.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 40.3 m -128.0 152.74 47.56 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 -176.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.506 ' HB ' ' H ' ' A' ' 337' ' ' ASP . 61.3 t -94.08 108.16 20.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -95.49 -32.41 12.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.192 0.52 . . . . 0.0 110.888 -174.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.564 ' OG1' ' HB ' ' A' ' 250' ' ' THR . 61.6 p -129.09 -167.44 1.78 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.604 178.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.57 ' HB3' ' CG2' ' A' ' 333' ' ' VAL . 63.7 mt-30 -112.72 128.51 25.48 Favored Pre-proline 0 C--N 1.32 -0.702 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.61 -171.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.28 107.92 2.27 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.682 2.255 . . . . 0.0 112.739 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 13.5 t -112.54 147.47 36.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.007 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.408 HG11 ' CZ ' ' A' ' 238' ' ' TYR . 16.0 t -110.52 136.97 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -166.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 22.5 m -101.91 116.89 33.68 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 168.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.408 ' CZ ' HG11 ' A' ' 236' ' ' VAL . 43.1 m-85 -103.16 131.5 50.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.039 0.447 . . . . 0.0 111.87 -176.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.47 HD22 ' HA ' ' A' ' 239' ' ' ASN . 0.2 OUTLIER -142.1 88.66 2.12 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.508 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -88.79 -41.0 12.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.293 -162.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.3 -23.22 32.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.706 0.765 . . . . 0.0 109.037 175.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -94.69 -12.33 27.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.016 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 6.3 t70 60.73 57.93 2.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.713 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 21.4 m -146.5 115.64 6.99 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.929 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' TYR . . . . . 0.493 ' HB3' ' HA3' ' A' ' 315' ' ' GLY . 17.9 m-85 -120.29 133.56 55.44 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -143.33 126.72 16.73 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.522 ' CE1' ' HB2' ' A' ' 313' ' ' LEU . 18.7 p90 -130.17 133.33 46.52 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.429 174.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 92.9 m -104.52 142.19 35.06 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.988 -167.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 8.5 p -145.69 133.06 15.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.36 0.6 . . . . 0.0 112.294 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.564 ' HB ' ' OG1' ' A' ' 232' ' ' THR . 52.9 m -97.23 116.81 30.12 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 168.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.44 170.89 7.97 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.486 0.66 . . . . 0.0 109.893 -175.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.54 150.25 35.22 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.486 171.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.417 ' CA ' HD23 ' A' ' 228' ' ' LEU . . . -148.27 -144.12 3.92 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.53 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -106.39 -176.5 3.09 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -175.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.615 HG22 ' H ' ' A' ' 256' ' ' ALA . 1.3 m -68.42 178.99 1.77 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.519 -171.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.615 ' H ' HG22 ' A' ' 255' ' ' THR . . . -61.76 -176.14 0.08 Allowed 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.718 0.807 . . . . 0.0 112.323 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 28.9 t 81.07 6.83 1.28 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.835 0.854 . . . . 0.0 110.894 -178.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 40.1 t -126.03 89.96 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.463 0.649 . . . . 0.0 109.304 172.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 10.8 m -69.37 97.31 0.96 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.376 -178.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 68.21 99.46 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.494 -177.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.456 ' CE2' HD21 ' A' ' 228' ' ' LEU . 11.9 m-85 -43.23 -49.99 6.51 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.742 0.271 . . . . 0.0 111.371 170.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 266' ' ' ASP . 0.7 OUTLIER -166.08 166.16 17.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.677 -175.794 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.448 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 59.0 mtmt -140.79 -165.82 2.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.722 0.296 . . . . 0.0 111.685 -177.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -51.91 118.27 3.31 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.448 0.642 . . . . 0.0 111.877 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 107.02 -10.3 40.24 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.975 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 344' ' ' THR . 38.7 m-20 -93.3 136.97 33.06 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -108.31 151.52 25.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.533 0.682 . . . . 0.0 112.313 -172.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 294' ' ' THR . 1.3 m -125.26 163.8 25.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.901 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.547 ' HE2' HG22 ' A' ' 342' ' ' VAL . 0.0 OUTLIER -135.13 126.91 29.22 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 169.223 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -144.71 163.71 33.19 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.909 -0.494 . . . . 0.0 110.906 -174.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.589 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 5.0 t -121.67 101.3 7.51 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.893 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -103.6 143.59 32.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.366 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' THR . . . . . 0.473 HG22 ' HA ' ' A' ' 288' ' ' ALA . 1.8 p -74.76 81.53 2.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.479 0.657 . . . . 0.0 112.405 -176.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.403 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 38.5 m-85 -84.93 159.36 20.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.559 170.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.403 ' HB2' ' O ' ' A' ' 274' ' ' TYR . 7.0 m-90 72.39 -51.91 0.7 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.348 0.659 . . . . 0.0 110.887 -174.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 32.6 mt 69.36 -67.51 0.22 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.815 0.846 . . . . 0.0 113.174 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -81.15 -49.3 10.99 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -167.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 283' ' ' ALA . 27.0 mp0 -103.09 -80.49 0.52 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.531 0.681 . . . . 0.0 112.223 -173.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -66.88 14.72 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -169.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 1.1 p -73.12 -50.65 21.59 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.607 -0.683 . . . . 0.0 109.92 172.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 285' ' ' TYR . 74.2 mmtt -108.95 -68.43 0.92 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.023 174.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -134.81 -81.47 0.44 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.62 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 278' ' ' GLN . . . -154.12 -54.22 0.1 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.983 0.42 . . . . 0.0 110.527 177.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.21 13.3 25.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.093 0.473 . . . . 0.0 110.539 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' TYR . . . . . 0.436 ' O ' ' HB2' ' A' ' 281' ' ' LYS . 82.7 m-85 -130.11 106.46 8.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.922 -178.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -94.37 171.62 8.71 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.412 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 156.09 -101.49 0.21 Allowed Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 111.356 -0.697 . . . . 0.0 111.356 177.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.473 ' HA ' HG22 ' A' ' 273' ' ' THR . . . -149.2 140.92 23.55 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.844 0.354 . . . . 0.0 110.14 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 7.1 t -93.21 137.71 23.48 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.919 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.7 -0.15 9.85 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.579 2.186 . . . . 0.0 112.02 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 72.5 mt -72.17 124.67 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.429 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 42.8 m -116.35 143.74 45.16 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.19 145.43 51.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.967 0.413 . . . . 0.0 110.936 -175.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 87.1 m -90.02 131.07 36.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.798 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -129.63 -178.4 4.67 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 89.7 m -141.71 134.15 28.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.392 0.615 . . . . 0.0 112.385 -177.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.559 HG12 ' H ' ' A' ' 299' ' ' ALA . 94.9 t -86.32 146.01 6.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.719 -178.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 13.6 t -125.57 18.11 8.12 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.572 -175.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.559 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -154.58 -177.86 6.77 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.448 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 2.7 m-20 -69.78 163.0 26.72 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.168 -178.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.46 ' HB2' ' CG1' ' A' ' 311' ' ' VAL . . . -147.28 167.88 23.14 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.973 -178.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.692 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 21.0 m120 -142.59 128.97 20.04 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.469 -174.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.6 OUTLIER -109.48 94.97 5.31 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 163.934 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -101.62 -176.94 3.28 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.207 -175.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 13.1 t -60.59 -33.03 72.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.792 0.33 . . . . 0.0 111.424 -175.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -82.67 -2.8 90.67 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.696 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 307' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 63.5 44.44 96.65 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.203 -178.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -115.02 126.51 54.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 118.0 0.9 . . . . 0.0 111.0 177.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.692 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.2 OUTLIER -134.7 119.65 29.24 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.568 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.843 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.475 ' OG1' HG23 ' A' ' 250' ' ' THR . 53.1 m -113.39 134.98 54.35 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.285 -0.26 . . . . 0.0 110.498 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.46 ' CG1' ' HB2' ' A' ' 301' ' ' ALA . 6.9 m -145.8 164.39 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.361 0.601 . . . . 0.0 110.547 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.445 ' O ' HG22 ' A' ' 298' ' ' THR . 19.7 m -119.99 138.54 53.43 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.421 173.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.522 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 4.1 mp -109.59 169.58 8.61 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.631 -175.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 314' ' ' SER . . . . . 0.604 ' O ' HG13 ' A' ' 316' ' ' VAL . 19.7 m -87.15 64.69 8.51 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -172.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.493 ' HA3' ' HB3' ' A' ' 245' ' ' TYR . . . 29.07 31.71 0.01 OUTLIER Glycine 0 N--CA 1.471 1.002 0 N-CA-C 118.046 1.978 . . . . 0.0 118.046 173.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 314' ' ' SER . 29.2 m -85.09 131.34 48.89 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 119.066 1.433 . . . . 0.0 110.816 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.72 134.15 31.73 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 122.422 2.081 . . . . 0.0 111.455 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.454 ' O ' HG12 ' A' ' 318' ' ' ILE . 0.2 OUTLIER -123.82 97.11 4.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.314 0.578 . . . . 0.0 110.191 -177.004 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 59.9 29.73 19.29 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.912 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -98.13 38.98 1.26 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.318 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 65.8 p 52.79 -159.5 0.13 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.985 -177.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 14.2 t -160.46 -175.99 5.33 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.46 ' N ' ' HD3' ' A' ' 324' ' ' PRO . 10.8 m120 57.79 57.95 7.11 Favored Pre-proline 0 C--N 1.318 -0.766 0 O-C-N 123.716 0.635 . . . . 0.0 111.17 -178.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.588 ' HA ' ' O ' ' A' ' 327' ' ' ASN . 16.5 Cg_exo -68.66 2.65 2.77 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.81 2.34 . . . . 0.0 113.354 -174.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -69.33 -54.98 11.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.996 0.427 . . . . 0.0 109.885 177.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -103.48 -15.67 15.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.036 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 327' ' ' ASN . . . . . 0.588 ' O ' ' HA ' ' A' ' 324' ' ' PRO . 28.6 t-20 -111.73 67.53 0.65 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 14.6 m -84.64 70.3 10.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.65 -174.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 52.4 t -79.62 127.58 39.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.236 0.541 . . . . 0.0 110.904 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 17.1 t -96.4 111.02 23.26 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -68.35 123.54 21.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.413 -172.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -108.05 107.75 18.55 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 171.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.57 ' CG2' ' HB3' ' A' ' 233' ' ' GLN . 0.2 OUTLIER -91.72 170.63 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.227 0.537 . . . . 0.0 112.117 -173.833 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -144.65 147.86 33.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.328 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -98.95 173.18 6.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.767 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 98.99 8.16 54.36 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.818 -0.706 . . . . 0.0 113.05 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.589 ' HB3' ' O ' ' A' ' 271' ' ' THR . 30.6 m-20 -92.81 -172.96 3.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.793 0.33 . . . . 0.0 111.795 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -112.12 142.71 44.24 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.665 -172.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 82.9 t -126.97 149.55 32.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.373 -178.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 50.7 m -147.98 158.86 44.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.921 0.391 . . . . 0.0 110.528 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 48.9 t -102.22 137.04 31.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.797 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.547 HG22 ' HE2' ' A' ' 269' ' ' LYS . 53.1 t -71.5 -42.26 72.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.078 175.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 343' ' ' GLY . . . . . 0.407 ' HA2' ' CG ' ' A' ' 224' ' ' PHE . . . 149.16 -79.58 0.21 Allowed Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 266' ' ' ASP . 4.1 p -143.48 -87.45 0.13 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.028 0.442 . . . . 0.0 110.281 176.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.367 -0.825 . . . . 0.0 109.819 179.124 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.672 0 N-CA-C 112.175 -0.37 . . . . 0.0 112.175 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -144.53 100.71 3.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.894 0.378 . . . . 0.0 110.798 178.353 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -76.5 162.59 27.68 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.905 177.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 119.7 -0.36 13.74 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.857 -177.249 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -74.97 -167.28 19.68 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.241 -179.182 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.9 m -91.01 147.61 22.96 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.159 0.504 . . . . 0.0 111.434 -175.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 4.4 mp -138.34 176.01 9.07 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 168.138 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 33.0 m -135.92 161.79 34.64 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.634 0.254 . . . . 0.0 110.893 -170.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 59.3 t -118.09 126.09 74.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 176.515 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.456 ' HE2' HG21 ' A' ' 252' ' ' THR . 20.4 ttmm -108.67 -11.34 15.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.131 0.491 . . . . 0.0 111.126 -177.657 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.475 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 57.5 p -124.11 -166.83 1.55 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.476 -179.327 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -102.82 112.49 65.75 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -170.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -65.08 103.53 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.503 1.469 . . . . 0.0 111.154 175.399 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.3 t -103.01 120.22 40.25 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.509 0.671 . . . . 0.0 110.532 -177.057 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.428 ' HA ' ' CB ' ' A' ' 247' ' ' PHE . 21.3 t -77.26 123.17 33.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.848 -175.856 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 29.2 m -96.72 105.15 17.21 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.12 178.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -89.84 116.09 27.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.607 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.484 ' OD1' ' HG3' ' A' ' 242' ' ' LYS . 0.8 OUTLIER -122.71 76.14 1.32 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 176.547 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -84.3 -32.28 24.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.126 -160.688 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 38.8 t -65.39 -22.17 30.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 122.164 0.983 . . . . 0.0 108.529 173.54 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.484 ' HG3' ' OD1' ' A' ' 239' ' ' ASN . 43.4 mmtt -101.77 0.47 35.87 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.166 179.196 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 51.4 37.67 19.75 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.056 -178.788 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.9 m -119.17 127.32 53.2 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.009 178.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -125.17 112.11 16.06 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.079 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 246' ' ' GLN . . . . . 0.42 ' HB3' ' O ' ' A' ' 313' ' ' LEU . 66.2 mt-30 -130.79 -178.87 4.99 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.685 -175.276 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 313' ' ' LEU . 6.9 p90 -156.76 137.83 13.59 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.476 171.611 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 61.4 m -103.15 134.95 45.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.177 -173.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.409 ' HB ' HD11 ' A' ' 251' ' ' LEU . 0.5 OUTLIER -147.62 149.36 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.563 -179.839 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.551 HG23 ' OG1' ' A' ' 310' ' ' THR . 38.3 m -99.09 111.4 23.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 164.721 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.576 HD23 HG21 ' A' ' 339' ' ' VAL . 4.6 mp -104.3 168.06 9.35 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -172.751 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.456 HG21 ' HE2' ' A' ' 231' ' ' LYS . 0.7 OUTLIER -120.57 130.24 54.11 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.693 0.282 . . . . 0.0 110.367 177.467 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.422 ' N ' HG12 ' A' ' 309' ' ' VAL . . . -124.08 -143.15 6.15 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.944 -171.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -113.5 -171.33 1.86 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -173.312 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 256' ' ' ALA . 1.8 m -51.12 167.34 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -173.157 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 257' ' ' SER . . . -69.95 -175.78 0.99 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.177 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 257' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 67.6 m 80.6 9.15 1.21 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.794 176.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 94.4 t -119.52 94.5 3.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 170.585 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 22.6 m -74.6 89.56 2.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.42 -178.459 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 80.1 102.32 0.28 Allowed Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.623 -175.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.456 ' CE1' ' HB2' ' A' ' 303' ' ' SER . 10.6 m-85 -48.17 -59.11 3.66 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.673 0.749 . . . . 0.0 110.392 173.719 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 266' ' ' ASP . 89.3 mt -141.7 168.4 19.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.009 -175.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -131.63 -169.27 2.16 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.18 0.3 . . . . 0.0 111.006 -179.535 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -56.82 114.41 2.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.255 0.55 . . . . 0.0 111.652 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 112.75 -6.07 25.97 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.562 177.313 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 266' ' ' ASP . . . . . 0.547 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 64.6 m-20 -96.19 138.14 34.24 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.554 ' HB2' HG11 ' A' ' 342' ' ' VAL . 30.5 mt-30 -108.94 159.76 16.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.636 0.732 . . . . 0.0 111.779 -173.617 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.06 -175.48 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.827 -179.29 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 340' ' ' SER . 23.9 tptt -120.9 104.56 9.93 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.834 174.419 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -95.29 120.71 35.99 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 120.942 0.401 . . . . 0.0 110.127 -175.108 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 291' ' ' ILE . 54.8 m -110.6 89.25 2.98 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.767 178.352 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -75.12 142.98 43.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.611 179.115 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 36.4 p -114.13 121.35 43.52 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.498 -173.008 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -96.35 113.9 25.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.122 0.487 . . . . 0.0 109.959 173.537 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.419 ' CZ2' ' HA ' ' A' ' 288' ' ' ALA . 73.0 m95 -149.97 33.52 0.67 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.489 178.113 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 85.3 mt -81.66 179.69 7.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.941 -174.328 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -68.93 -5.02 18.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.093 0.473 . . . . 0.0 110.882 178.107 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -64.74 -13.96 56.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.883 175.741 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -57.28 -14.49 4.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.486 173.071 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 24.1 p -67.4 -33.85 76.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.262 0.553 . . . . 0.0 110.352 174.138 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -91.13 -29.04 17.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.937 177.835 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -105.48 48.79 0.83 Allowed 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.732 0.777 . . . . 0.0 109.255 178.11 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -69.19 86.23 0.39 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.526 -176.386 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 92.3 mt -115.17 32.37 6.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.432 -178.501 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 58.99 31.96 21.84 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.901 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 66.66 85.93 0.14 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.001 -177.185 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -83.74 -100.08 0.57 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.441 -178.007 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.43 ' C ' ' HD3' ' A' ' 290' ' ' PRO . . . -166.68 179.36 5.45 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.066 0.46 . . . . 0.0 109.931 -179.102 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 6.8 t -131.54 61.29 57.89 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.189 178.45 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 290' ' ' PRO . . . . . 0.43 ' HD3' ' C ' ' A' ' 288' ' ' ALA . 1.7 Cg_endo -81.6 65.93 8.6 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.295 2.663 . . . . 0.0 112.35 -173.394 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 271' ' ' THR . 20.5 pt -128.74 154.26 39.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.3 179.002 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 55.7 p -162.09 141.72 9.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.256 178.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -143.45 148.27 35.85 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 66.7 m -74.94 115.99 15.16 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.675 -179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -103.14 -179.95 4.1 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 177.288 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.593 ' HB ' ' O ' ' A' ' 314' ' ' SER . 90.7 m -139.82 133.8 30.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -175.1 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.57 HG13 HG21 ' A' ' 311' ' ' VAL . 50.7 t -78.64 135.91 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.715 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 5.1 m -108.62 -13.43 14.81 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -173.178 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -154.38 -178.66 7.29 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.172 -0.33 . . . . 0.0 110.916 -175.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.58 105.58 0.66 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.178 0.513 . . . . 0.0 110.447 178.055 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -95.41 100.43 12.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.499 -177.382 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.434 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 65.3 t30 -61.04 149.49 36.74 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -168.569 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.519 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 36.6 t -128.78 95.23 4.04 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 166.374 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -104.9 173.03 6.48 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.89 -179.321 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 8.5 t -58.25 -32.08 68.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.861 0.362 . . . . 0.0 111.472 -173.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -73.77 3.45 35.25 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.217 -177.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 66.27 41.85 94.46 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.739 178.125 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -116.84 139.08 51.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.901 0.35 . . . . 0.0 110.694 -178.756 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 251' ' ' LEU . 1.8 p -147.7 95.17 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.366 0.603 . . . . 0.0 111.352 179.186 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.551 ' OG1' HG23 ' A' ' 250' ' ' THR . 53.0 m -96.12 130.37 43.18 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 121.597 -0.689 . . . . 0.0 110.896 179.523 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.57 HG21 HG13 ' A' ' 297' ' ' VAL . 14.5 p -165.81 150.24 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.109 0.48 . . . . 0.0 110.424 175.216 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 25.0 m -93.69 145.49 24.52 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.632 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.526 ' HA ' ' O ' ' A' ' 296' ' ' THR . 5.1 mp -110.62 140.95 44.48 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.086 -175.662 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 314' ' ' SER . . . . . 0.593 ' O ' ' HB ' ' A' ' 296' ' ' THR . 39.0 t -119.95 137.93 53.77 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.677 -176.14 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 93.18 85.57 1.58 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.946 175.17 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 6.5 m -127.71 114.88 20.86 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 121.136 0.493 . . . . 0.0 110.688 176.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.72 55.03 5.05 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.797 2.331 . . . . 0.0 112.641 -178.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 26.4 pt -107.39 111.3 35.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.145 0.497 . . . . 0.0 110.292 179.627 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -120.68 74.14 1.05 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.231 0.539 . . . . 0.0 111.935 -175.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -93.47 -20.64 20.1 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.586 0.708 . . . . 0.0 109.377 170.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 69.4 p 54.85 17.63 1.86 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.89 177.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 3.3 m -139.58 -62.9 0.52 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.615 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.438 ' N ' ' HD3' ' A' ' 324' ' ' PRO . 90.5 m-20 53.29 60.71 11.83 Favored Pre-proline 0 N--CA 1.473 0.717 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.953 176.691 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 328' ' ' SER . 1.5 Cg_endo -79.85 -75.86 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.346 2.031 . . . . 0.0 111.304 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 66.54 -71.52 0.09 Allowed 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.413 0.685 . . . . 0.0 111.576 177.073 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 326' ' ' TYR . . . . . 0.475 ' O ' ' HB3' ' A' ' 327' ' ' ASN . 4.0 m-85 -108.28 79.6 1.27 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.168 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 327' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 326' ' ' TYR . 37.7 t30 86.11 -69.95 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.101 178.042 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 328' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' A' ' 324' ' ' PRO . 19.1 p -168.94 -77.83 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.949 0.404 . . . . 0.0 111.442 174.282 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 329' ' ' VAL . . . . . 0.417 ' O ' ' HD3' ' A' ' 331' ' ' ARG . 28.6 t -87.3 -23.28 6.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.202 0.525 . . . . 0.0 110.819 -176.173 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 27.5 t -86.33 46.3 1.33 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.907 -178.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 331' ' ' ARG . . . . . 0.593 ' HD3' ' H ' ' A' ' 331' ' ' ARG . 0.0 OUTLIER -63.5 137.85 58.29 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.37 178.518 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -135.12 147.85 49.61 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -179.25 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 35.2 m -116.52 173.43 4.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.877 176.83 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -127.43 134.83 49.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.92 0.39 . . . . 0.0 110.628 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -66.53 157.16 32.94 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.584 -175.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.38 3.12 5.75 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.401 178.21 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.11 166.85 10.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.222 0.534 . . . . 0.0 111.49 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -116.56 148.05 41.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.993 -179.048 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.576 HG21 HD23 ' A' ' 251' ' ' LEU . 70.7 t -130.38 150.59 34.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.809 0.338 . . . . 0.0 111.086 -172.573 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.503 ' HB2' ' HB3' ' A' ' 269' ' ' LYS . 30.0 m -150.05 177.77 9.57 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.318 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 343' ' ' GLY . 39.3 t -113.56 142.58 25.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.695 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.554 HG11 ' HB2' ' A' ' 267' ' ' GLN . 9.9 p -69.46 -24.59 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 121.053 0.454 . . . . 0.0 111.051 -175.095 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 343' ' ' GLY . . . . . 0.521 ' H ' HG12 ' A' ' 341' ' ' VAL . . . 120.2 76.44 0.47 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.34 174.621 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 15.6 p -88.0 -55.78 3.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.193 0.521 . . . . 0.0 111.356 -178.77 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.288 178.26 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.761 0 N-CA-C 112.345 -0.302 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -88.75 -8.68 54.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.782 0.291 . . . . 0.0 111.36 -176.017 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -63.5 -17.13 62.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.182 0.515 . . . . 0.0 110.796 178.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 120.32 6.7 9.61 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.653 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -84.16 -143.76 5.95 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.942 179.297 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.1 m -105.94 147.84 28.33 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.975 0.417 . . . . 0.0 111.184 -174.466 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.9 mp -132.61 -178.66 5.04 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 167.152 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.48 ' HB ' ' OG1' ' A' ' 252' ' ' THR . 23.1 m -127.47 155.82 43.11 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 122.324 -0.235 . . . . 0.0 111.072 -173.815 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.497 HG23 ' CG2' ' A' ' 339' ' ' VAL . 0.9 OUTLIER -111.22 137.43 43.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.275 177.399 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.415 ' HE3' HG22 ' A' ' 250' ' ' THR . 59.3 mtmt -109.57 -26.92 9.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.769 174.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.451 ' O ' HG13 ' A' ' 230' ' ' VAL . 58.6 p -137.07 -179.7 5.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.546 ' HB3' ' HB ' ' A' ' 333' ' ' VAL . 17.9 mm-40 -116.57 157.01 46.92 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -166.797 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.466 ' HG3' ' CZ ' ' A' ' 293' ' ' PHE . 73.8 Cg_endo -73.05 104.24 1.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.076 2.517 . . . . 0.0 113.127 178.576 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.475 ' N ' ' HB2' ' A' ' 247' ' ' PHE . 10.1 t -157.11 110.44 2.57 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.659 170.744 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.768 ' O ' ' HB2' ' A' ' 246' ' ' GLN . 75.7 t -154.74 79.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.34 0.656 . . . . 0.0 109.559 165.814 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 26.0 m 81.44 92.73 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.536 0.684 . . . . 0.0 110.645 174.117 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -106.95 104.96 14.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.341 178.13 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -129.29 126.82 39.87 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -102.61 -43.0 5.74 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.622 -170.282 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 67.3 t -61.55 -26.9 40.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.39 0.614 . . . . 0.0 109.916 178.085 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -99.05 -4.77 31.66 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.874 -179.425 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 53.3 57.9 5.77 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.059 -177.051 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 23.7 m -138.51 111.14 7.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.458 -177.073 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -128.57 120.08 26.02 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.321 -177.654 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 246' ' ' GLN . . . . . 0.768 ' HB2' ' O ' ' A' ' 236' ' ' VAL . 47.3 mt-30 -128.57 163.36 25.18 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 173.759 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.526 ' HA ' ' N ' ' A' ' 236' ' ' VAL . 20.9 p90 -168.64 151.43 5.21 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 174.007 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.411 ' H ' HG23 ' A' ' 236' ' ' VAL . 50.0 m -113.97 138.54 50.21 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 31.6 t -137.91 139.71 42.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.526 -178.796 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.542 HG23 ' OG1' ' A' ' 310' ' ' THR . 15.8 m -102.09 113.74 27.25 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.565 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.617 ' HB2' HG13 ' A' ' 309' ' ' VAL . 4.9 mp -110.39 170.63 7.96 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.943 0.402 . . . . 0.0 110.027 -171.768 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.636 HG22 ' O ' ' A' ' 307' ' ' GLY . 0.0 OUTLIER -126.87 120.97 30.5 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.402 176.761 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.442 ' HA3' HD23 ' A' ' 228' ' ' LEU . . . -156.78 134.77 4.16 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.81 -0.709 . . . . 0.0 111.404 178.049 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -112.7 93.41 4.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.107 0.48 . . . . 0.0 112.179 -173.293 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 18.3 m -126.16 102.74 7.34 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 169.894 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -56.0 134.86 52.67 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -175.741 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 24.5 t 63.31 53.65 2.16 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.901 172.577 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.446 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 84.2 t -132.47 95.97 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.291 0.567 . . . . 0.0 110.377 175.61 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.5 m -75.97 86.31 2.89 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.567 0.698 . . . . 0.0 109.857 177.995 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 95.62 92.51 1.75 Allowed Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.251 -177.235 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.552 ' CD1' ' HB2' ' A' ' 303' ' ' SER . 3.6 m-85 -45.34 -58.79 3.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.786 0.803 . . . . 0.0 109.958 169.622 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 266' ' ' ASP . 75.8 mt -141.53 169.83 16.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.168 -1.378 . . . . 0.0 108.031 -175.63 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 96.0 mttt -137.68 -171.22 2.94 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 121.173 -0.211 . . . . 0.0 110.884 -179.386 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -54.11 113.95 1.43 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.261 0.553 . . . . 0.0 111.413 -179.061 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 113.03 -6.82 25.42 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.77 177.087 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 266' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 22.9 m-20 -90.37 136.03 33.31 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.722 -0.281 . . . . 0.0 110.262 179.049 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -107.15 142.28 37.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.5 0.667 . . . . 0.0 111.981 -174.859 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 295' ' ' ALA . 0.7 OUTLIER -126.09 164.04 26.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.569 179.006 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 294' ' ' THR . 0.0 OUTLIER -135.68 147.99 48.75 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.674 174.221 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -110.95 130.03 55.71 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -174.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 44.0 m -104.25 126.63 51.52 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.763 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.426 ' ND2' ' HB3' ' A' ' 274' ' ' TYR . 26.6 p-10 -107.28 147.59 30.04 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.893 0.854 . . . . 0.0 113.184 -163.208 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 20.0 p -100.89 96.03 7.01 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 162.007 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' A' ' 289' ' ' THR . 26.1 p90 -80.67 127.07 32.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.22 0.533 . . . . 0.0 110.899 -165.553 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.483 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 62.5 t-105 -166.01 -58.25 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.051 -174.86 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.573 HD23 ' HB2' ' A' ' 334' ' ' GLU . 17.2 mt 62.0 92.49 0.05 Allowed 'General case' 0 C--O 1.237 0.403 0 O-C-N 123.421 0.451 . . . . 0.0 111.419 -178.562 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 277' ' ' GLN . . . . . 0.445 ' HA ' ' OG1' ' A' ' 280' ' ' THR . 35.8 mt-30 -70.63 -19.31 62.83 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.818 0.342 . . . . 0.0 110.684 -176.338 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 282' ' ' GLN . 24.4 mt-30 -67.33 -38.49 84.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.238 178.417 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -81.67 -38.09 26.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.001 -178.275 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.445 ' OG1' ' HA ' ' A' ' 277' ' ' GLN . 8.2 p -78.38 -56.04 4.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.111 -175.882 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -108.56 -78.79 0.59 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 121.136 -0.226 . . . . 0.0 111.575 -175.65 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 278' ' ' GLN . 77.0 mm-40 -143.65 -69.55 0.32 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.128 0.49 . . . . 0.0 110.514 -176.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -174.51 -61.0 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.672 -179.04 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 89.4 mt 57.9 33.88 23.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.965 175.524 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 67.77 -70.21 0.13 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.274 0.629 . . . . 0.0 112.221 176.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.639 ' HA ' ' OE1' ' A' ' 334' ' ' GLU . 9.8 p30 -166.47 171.03 12.27 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -178.327 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 162.43 -25.29 0.22 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 119.746 -1.216 . . . . 0.0 113.562 177.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.483 ' HB1' ' HB3' ' A' ' 275' ' ' TRP . . . -127.96 -141.59 0.26 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.868 0.334 . . . . 0.0 110.789 -177.097 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.619 ' CG2' ' HB3' ' A' ' 337' ' ' ASP . 13.5 m -157.01 151.54 20.46 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 110.484 -0.191 . . . . 0.0 110.484 179.021 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 290' ' ' PRO . . . . . 0.404 ' HG3' ' HA ' ' A' ' 333' ' ' VAL . 2.7 Cg_exo -78.57 -77.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.468 2.112 . . . . 0.0 113.641 173.37 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 14.9 tt -139.61 159.3 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -166.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 32.8 p -85.66 135.45 33.77 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 176.206 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 293' ' ' PHE . . . . . 0.466 ' CZ ' ' HG3' ' A' ' 234' ' ' PRO . 35.9 p90 -161.58 177.2 10.23 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.992 0.425 . . . . 0.0 111.403 -176.652 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 269' ' ' LYS . 53.8 m -124.06 132.67 53.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.508 -178.787 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 295' ' ' ALA . . . . . 0.485 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -114.97 -179.74 3.71 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.802 0.334 . . . . 0.0 111.249 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 96.1 m -143.67 121.64 12.06 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.569 0.699 . . . . 0.0 111.675 178.358 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.703 HG13 HG21 ' A' ' 311' ' ' VAL . 78.0 t -66.86 138.79 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.544 -178.04 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 312' ' ' THR . 6.0 t -121.4 6.54 10.13 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.108 -175.655 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -163.18 -167.03 1.37 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -72.46 113.8 9.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.246 0.546 . . . . 0.0 110.047 179.179 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -91.98 101.28 13.83 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.343 178.212 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -56.36 134.01 53.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.503 -0.772 . . . . 0.0 112.802 -169.839 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.552 ' HB2' ' CD1' ' A' ' 261' ' ' PHE . 30.5 t -128.23 111.39 13.36 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 120.913 0.387 . . . . 0.0 110.873 173.583 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.49 157.41 41.23 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 3.9 t -71.07 -10.14 59.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.009 -171.235 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -69.17 -15.05 69.41 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 173.004 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 307' ' ' GLY . . . . . 0.636 ' O ' HG22 ' A' ' 252' ' ' THR . . . 90.07 41.03 5.68 Favored Glycine 0 C--O 1.223 -0.558 0 C-N-CA 120.925 -0.655 . . . . 0.0 114.379 174.845 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -126.22 130.73 51.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.151 0.976 . . . . 0.0 111.427 178.786 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.617 HG13 ' HB2' ' A' ' 251' ' ' LEU . 0.8 OUTLIER -141.93 112.06 2.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.744 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.525 176.018 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.542 ' OG1' HG23 ' A' ' 250' ' ' THR . 99.0 m -110.15 129.47 55.7 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.491 -0.756 . . . . 0.0 110.618 177.375 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.703 HG21 HG13 ' A' ' 297' ' ' VAL . 2.6 p -151.72 144.38 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 121.141 0.496 . . . . 0.0 111.23 178.252 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.525 ' O ' HG22 ' A' ' 298' ' ' THR . 22.6 m -100.34 145.21 28.43 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.679 175.418 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 313' ' ' LEU . 1.3 mm? -121.44 129.81 53.21 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.484 -172.065 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 16.0 p -144.47 151.14 38.75 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.932 -174.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 74.66 47.33 15.59 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.333 175.867 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 7.0 m -118.99 111.56 37.07 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 120.976 0.417 . . . . 0.0 111.284 -177.776 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -71.99 78.91 1.74 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.696 2.264 . . . . 0.0 111.075 174.356 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 6.9 tt -82.46 99.29 5.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.561 0.696 . . . . 0.0 110.758 -177.473 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -135.77 88.61 2.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.569 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -77.95 -65.3 0.99 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.623 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 40.8 p 39.18 39.4 0.41 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 179.244 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 24.6 m -138.31 -52.01 0.59 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.893 0.378 . . . . 0.0 110.882 179.037 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -71.65 -45.82 12.72 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.548 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.68 -19.22 36.76 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.031 1.821 . . . . 0.0 112.217 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 70.07 -60.74 0.48 Allowed 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.902 0.751 . . . . 0.0 111.895 178.578 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -74.89 -50.31 17.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.708 -177.462 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 43.0 t30 70.71 81.44 0.16 Allowed 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -178.118 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 328' ' ' SER . . . . . 0.402 ' O ' ' HB ' ' A' ' 329' ' ' VAL . 19.1 m -71.77 -15.36 62.17 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.895 -170.572 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 329' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 328' ' ' SER . 66.0 t 75.46 143.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.198 177.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 68.7 p 51.4 62.09 2.89 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.587 0.755 . . . . 0.0 111.829 178.328 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -72.03 144.76 48.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.221 179.46 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 332' ' ' GLN . . . . . 0.405 ' O ' HD21 ' A' ' 276' ' ' LEU . 26.3 mp0 -88.22 149.56 23.78 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 175.545 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 233' ' ' GLN . 15.4 m -90.09 161.65 2.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.627 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 334' ' ' GLU . . . . . 0.639 ' OE1' ' HA ' ' A' ' 286' ' ' ASN . 6.1 tp10 -155.92 112.16 3.1 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.483 -174.133 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -74.64 143.71 44.18 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -171.55 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 131.51 11.55 2.16 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 120.787 -0.72 . . . . 0.0 114.231 175.778 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.619 ' HB3' ' CG2' ' A' ' 289' ' ' THR . 4.5 p-10 -76.72 174.48 10.4 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 117.498 0.649 . . . . 0.0 112.03 175.589 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -112.0 132.0 55.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.731 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.497 ' CG2' HG23 ' A' ' 230' ' ' VAL . 54.5 t -102.67 152.91 5.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.668 -169.498 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 23.2 t -157.45 177.16 11.75 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 174.77 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 46.6 t -112.52 138.59 41.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.65 0.262 . . . . 0.0 110.767 -174.04 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 269' ' ' LYS . 56.5 t -82.91 -36.69 13.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.78 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -57.45 -61.21 7.74 Favored Glycine 0 C--N 1.332 0.349 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.742 -179.748 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 2.0 p -78.56 -72.14 0.39 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.626 0.213 . . . . 0.0 111.299 179.643 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.445 -0.788 . . . . 0.0 111.497 179.527 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.847 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 68.11 -73.76 0.08 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.548 0.739 . . . . 0.0 112.198 179.035 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.434 ' C ' ' H ' ' A' ' 226' ' ' GLY . 0.4 OUTLIER -132.43 154.52 49.77 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 122.573 0.349 . . . . 0.0 110.207 -177.924 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 71.45 -20.49 0.77 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.641 174.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 224' ' ' PHE . . . -51.46 137.63 29.83 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.832 -0.223 . . . . 0.0 113.526 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 19.1 m -102.66 142.44 33.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.926 0.393 . . . . 0.0 110.886 -178.683 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.558 HD21 ' CE1' ' A' ' 261' ' ' PHE . 19.2 mt -144.39 176.61 9.24 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.85 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 42.7 m -135.97 160.23 39.26 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 122.27 -0.269 . . . . 0.0 110.485 -174.142 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.628 ' HB ' ' OD2' ' A' ' 337' ' ' ASP . 3.4 t -118.63 152.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 177.581 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.578 ' HE3' HG22 ' A' ' 250' ' ' THR . 53.1 pttt -130.38 14.43 5.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.857 0.36 . . . . 0.0 111.132 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.617 ' H ' HG12 ' A' ' 230' ' ' VAL . 24.1 p -151.73 -178.55 6.79 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -175.56 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.553 ' HB3' ' CG2' ' A' ' 333' ' ' VAL . 0.3 OUTLIER -115.79 129.46 25.14 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -174.28 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.49 105.79 1.32 Allowed 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.452 2.101 . . . . 0.0 112.243 -179.598 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 5.8 t -107.0 129.6 54.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.307 178.624 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.439 HG22 ' HB3' ' A' ' 247' ' ' PHE . 8.1 t -85.61 123.63 39.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.203 -173.054 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 49.2 m -82.17 96.66 7.89 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.048 173.145 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.75 109.07 13.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.511 -178.548 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.5 HD22 ' HA ' ' A' ' 239' ' ' ASN . 0.2 OUTLIER -121.0 81.2 1.74 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.419 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -85.11 -36.86 20.85 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.067 -164.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.03 -23.15 32.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.757 0.789 . . . . 0.0 109.162 174.782 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.409 ' HG3' ' OD1' ' A' ' 239' ' ' ASN . 13.4 mmmm -103.62 -6.76 21.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.262 -176.212 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 58.32 58.95 3.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.57 -177.831 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 41.7 m -145.53 128.63 16.61 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.372 176.693 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -129.14 100.4 5.61 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.199 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -133.97 144.18 48.62 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.498 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.439 ' HB3' HG22 ' A' ' 236' ' ' VAL . 41.7 p90 -120.11 136.59 54.54 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.644 -178.083 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 97.9 m -100.95 141.25 34.1 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -173.794 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.519 HG13 ' CD1' ' A' ' 251' ' ' LEU . 1.4 p -144.48 146.14 20.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.418 -177.811 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.578 HG22 ' HE3' ' A' ' 231' ' ' LYS . 4.9 m -107.84 124.95 50.84 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 174.957 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.56 HD23 HG21 ' A' ' 339' ' ' VAL . 3.9 mp -115.21 171.74 7.5 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.668 0.747 . . . . 0.0 110.926 -167.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.406 HG23 ' HD3' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -129.11 142.28 50.94 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.218 169.151 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -140.98 -144.54 4.45 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.007 -173.783 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.524 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -101.91 -173.54 2.37 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -176.863 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.581 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -70.83 -177.81 1.7 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.337 -171.635 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.581 ' H ' HG22 ' A' ' 255' ' ' THR . . . -67.32 -175.39 0.47 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.266 -178.599 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 257' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 50.7 m 80.59 6.22 1.53 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.002 0.921 . . . . 0.0 111.244 179.46 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.9 88.79 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.505 0.669 . . . . 0.0 109.411 171.377 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 62.9 m -89.09 103.68 16.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.953 179.824 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 83.22 79.44 1.03 Allowed Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.068 -176.706 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.638 ' CE1' ' HB2' ' A' ' 303' ' ' SER . 6.8 m-85 -45.32 -54.59 6.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.788 0.804 . . . . 0.0 109.932 170.701 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.5 pp -158.11 173.7 16.33 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.288 -1.323 . . . . 0.0 108.677 -175.021 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.543 ' HE2' ' OD2' ' A' ' 300' ' ' ASP . 94.4 mttt -136.29 -167.54 2.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.702 0.287 . . . . 0.0 111.54 -174.782 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -55.4 116.57 2.93 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.436 0.636 . . . . 0.0 111.446 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 115.08 -14.96 18.84 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.199 177.624 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -86.06 141.89 29.12 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.254 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -104.86 150.16 25.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.878 0.847 . . . . 0.0 112.668 -172.376 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.35 173.71 13.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.668 175.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.454 ' HE2' ' CB ' ' A' ' 340' ' ' SER . 0.0 OUTLIER -134.57 149.88 50.67 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 167.091 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.512 ' O ' ' HA ' ' A' ' 292' ' ' SER . 55.4 m-85 -106.5 130.73 54.23 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.494 -175.798 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 45.6 m -107.16 88.34 2.71 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 171.387 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -122.65 144.59 49.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.424 0.631 . . . . 0.0 111.767 -172.3 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 31.5 p -97.91 109.81 22.5 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.665 173.459 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -83.16 113.38 20.6 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.012 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 41.6 t90 -141.42 92.74 2.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.329 0.585 . . . . 0.0 110.522 -172.685 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -115.68 130.06 56.71 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 175.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -57.21 -26.4 60.63 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -167.67 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -80.04 -44.13 20.66 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.524 0.678 . . . . 0.0 110.413 178.255 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -76.01 -24.8 55.29 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.583 -174.553 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 17.0 p -69.8 -15.11 63.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.974 0.416 . . . . 0.0 111.401 179.495 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -76.46 -7.71 55.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.4 178.32 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -82.71 66.29 8.25 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 122.263 1.03 . . . . 0.0 109.073 175.209 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -75.81 66.82 2.14 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.41 -1.723 . . . . 0.0 111.596 -175.544 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 78.2 mt -94.28 4.38 53.96 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.875 178.285 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 75.06 -42.57 0.49 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.149 179.257 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -84.73 65.01 8.87 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -172.26 36.73 0.15 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.934 -177.26 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -100.8 33.91 2.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.188 0.518 . . . . 0.0 110.657 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.417 ' N ' ' HD3' ' A' ' 290' ' ' PRO . 9.1 t 44.43 61.94 10.57 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 124.75 1.22 . . . . 0.0 113.776 178.917 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 290' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 289' ' ' THR . 83.9 Cg_endo -95.99 57.81 0.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.933 2.422 . . . . 0.0 110.951 173.313 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 37.4 pt -113.77 162.71 11.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.245 0.545 . . . . 0.0 112.343 -170.655 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 292' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 17.8 p -167.35 100.15 0.51 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.28 177.25 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -111.63 147.39 35.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.856 0.36 . . . . 0.0 111.127 -174.212 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 269' ' ' LYS . 51.9 m -88.02 127.27 35.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.783 -179.21 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -120.23 179.13 4.38 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 95.3 m -136.97 130.65 31.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.534 0.683 . . . . 0.0 112.543 -177.773 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 299' ' ' ALA . 61.1 t -85.1 144.08 10.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.484 -178.359 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 0.6 OUTLIER -119.33 24.74 10.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.821 -174.993 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.557 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -166.83 173.34 9.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.763 0.316 . . . . 0.0 111.668 -177.346 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.543 ' OD2' ' HE2' ' A' ' 263' ' ' LYS . 2.3 m-20 -64.8 116.55 6.42 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.256 176.688 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -93.26 112.75 24.76 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.664 179.023 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.74 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 65.9 t30 -85.55 134.47 34.02 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -171.528 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.638 ' HB2' ' CE1' ' A' ' 261' ' ' PHE . 7.7 t -113.88 95.72 5.46 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 163.925 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -98.53 179.25 4.76 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.976 -178.55 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 20.5 m -57.07 -32.92 66.75 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -173.552 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -83.39 5.54 76.97 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.468 -176.047 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 307' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 64.49 42.69 97.42 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.864 -178.345 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -120.22 142.91 48.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.367 0.584 . . . . 0.0 111.682 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.74 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.2 OUTLIER -143.89 152.7 15.93 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.616 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.096 176.973 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.448 ' OG1' HG23 ' A' ' 250' ' ' THR . 95.5 m -149.72 120.04 7.34 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.692 -0.63 . . . . 0.0 110.619 178.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 35.4 m -145.87 160.88 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.41 0.624 . . . . 0.0 111.23 -177.362 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 23.7 m -114.75 140.93 48.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.582 176.785 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.52 126.52 54.47 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.367 -171.245 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 7.6 p -96.5 137.43 35.6 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.329 -176.118 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 92.95 153.62 30.41 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -176.811 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 3.9 m -114.4 86.19 11.88 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-O 121.126 0.488 . . . . 0.0 111.793 -177.879 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -83.44 47.68 2.43 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.757 2.305 . . . . 0.0 110.598 176.022 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.537 HD11 ' HB ' ' A' ' 322' ' ' THR . 10.3 tt -146.59 127.94 6.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.636 -174.495 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -113.4 -64.52 1.3 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.71 -174.493 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -121.3 -19.45 7.03 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.78 -173.75 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.9 p -56.85 -27.35 60.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.197 0.522 . . . . 0.0 111.464 -177.868 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 322' ' ' THR . . . . . 0.537 ' HB ' HD11 ' A' ' 318' ' ' ILE . 2.4 m -153.1 128.68 10.03 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 167.939 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -156.45 138.62 10.21 Favored Pre-proline 0 C--N 1.307 -1.28 0 CA-C-N 115.428 -0.805 . . . . 0.0 108.849 -178.097 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.07 -15.46 23.22 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.368 1.378 . . . . 0.0 112.702 -177.449 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -82.07 69.56 8.8 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.928 0.87 . . . . 0.0 112.09 -175.533 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -100.65 -35.69 9.4 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 166.358 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -139.48 -52.71 0.54 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.283 170.195 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 32.9 t -153.98 -67.4 0.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.097 171.499 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 5.0 t -143.68 40.56 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 3.2 p -67.14 -68.25 0.39 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.519 -1.219 . . . . 0.0 112.689 -172.189 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 331' ' ' ARG . . . . . 0.561 ' NE ' ' HA ' ' A' ' 331' ' ' ARG . 3.8 mmp_? -100.5 149.97 23.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.74 0.305 . . . . 0.0 111.392 -175.451 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -127.93 -168.54 1.91 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.813 179.182 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.553 ' CG2' ' HB3' ' A' ' 233' ' ' GLN . 2.6 m -68.78 169.4 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.381 0.61 . . . . 0.0 112.113 -179.304 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -147.22 161.82 40.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.937 -177.423 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -65.96 173.09 3.18 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.507 0.504 . . . . 0.0 111.358 178.596 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 112.26 13.73 11.64 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -176.086 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.628 ' OD2' ' HB ' ' A' ' 230' ' ' VAL . 0.4 OUTLIER -96.29 146.68 24.51 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.742 0.782 . . . . 0.0 112.617 -173.885 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -144.08 163.56 33.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.779 178.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.56 HG21 HD23 ' A' ' 251' ' ' LEU . 74.7 t -125.24 143.03 40.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.227 0.537 . . . . 0.0 111.285 -169.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.454 ' CB ' ' HE2' ' A' ' 269' ' ' LYS . 20.0 m -147.51 127.21 13.38 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 172.828 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 19.1 t -76.04 143.12 13.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 120.867 0.365 . . . . 0.0 111.311 -173.349 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 53.4 t -87.43 -42.91 15.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.471 176.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 157.04 143.56 3.69 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.821 179.479 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 17.3 p -90.9 -80.87 0.33 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.953 0.406 . . . . 0.0 111.155 -178.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.526 -0.749 . . . . 0.0 110.291 -179.565 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.769 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.02 136.4 39.96 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 176.388 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -94.21 -21.0 19.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.191 0.52 . . . . 0.0 110.87 -177.435 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 106.03 34.82 3.11 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.139 -172.689 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -62.61 -170.04 1.1 Allowed Glycine 0 CA--C 1.523 0.565 0 CA-C-O 121.533 0.518 . . . . 0.0 114.083 177.843 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 5.3 m -67.28 145.35 55.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.435 0.636 . . . . 0.0 112.401 -173.077 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.431 HD22 HG11 ' A' ' 309' ' ' VAL . 1.3 mt -133.68 179.13 6.42 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.89 177.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 251' ' ' LEU . 48.1 m -139.08 158.84 43.46 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 122.303 -0.248 . . . . 0.0 110.498 -175.761 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 17.6 t -106.08 133.19 51.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 179.496 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -104.46 -39.05 6.56 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 178.67 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 63.5 p -118.77 -169.56 1.75 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.785 0.326 . . . . 0.0 110.489 -177.021 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.45 ' HB3' HG23 ' A' ' 333' ' ' VAL . 91.2 mt-30 -105.27 126.1 31.83 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.507 -169.767 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.646 ' HB3' ' CD2' ' A' ' 247' ' ' PHE . 23.7 Cg_exo -62.56 104.73 0.38 Allowed 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.687 2.258 . . . . 0.0 111.861 176.739 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.8 t -142.55 104.87 4.45 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.661 0.743 . . . . 0.0 112.187 -177.85 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.706 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.16 175.42 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.879 171.931 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.602 ' H ' HG13 ' A' ' 236' ' ' VAL . 55.9 m -34.09 114.27 0.2 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -169.648 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -116.04 88.13 2.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.465 173.178 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -113.73 133.16 55.52 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -179.225 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -104.28 -40.39 6.13 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.621 -172.163 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.73 -29.77 46.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.516 0.674 . . . . 0.0 109.74 176.757 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.49 ' HA ' ' HE2' ' A' ' 242' ' ' LYS . 11.2 mmpt? -100.45 -3.43 30.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.084 -178.946 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 53.72 51.57 14.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 113.998 -1.456 . . . . 0.0 111.089 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.2 m -126.28 99.16 5.75 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.095 -175.239 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -116.44 108.42 16.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.071 0.462 . . . . 0.0 110.502 -177.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 246' ' ' GLN . . . . . 0.505 ' HB2' HG12 ' A' ' 236' ' ' VAL . 95.0 mt-30 -129.5 164.16 24.35 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.057 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.706 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 31.3 p90 -159.79 135.66 8.59 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.565 -0.454 . . . . 0.0 112.143 176.712 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 51.9 m -98.09 138.92 34.66 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.487 ' HB ' HD11 ' A' ' 251' ' ' LEU . 0.2 OUTLIER -142.7 150.83 17.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.765 -179.305 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.595 HG23 ' OG1' ' A' ' 310' ' ' THR . 96.2 m -104.38 117.45 34.21 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 167.488 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.582 ' HB2' HG13 ' A' ' 309' ' ' VAL . 4.0 mp -118.49 169.49 9.73 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.209 -170.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 307' ' ' GLY . 0.0 OUTLIER -110.4 141.72 43.09 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.279 176.114 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.417 ' HA2' HD23 ' A' ' 228' ' ' LEU . . . -138.34 -143.92 4.57 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.999 -178.653 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -109.96 -173.61 2.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.814 0.34 . . . . 0.0 111.877 -177.099 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.577 HG22 ' H ' ' A' ' 256' ' ' ALA . 2.2 m -67.04 173.68 3.55 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.388 -0.823 . . . . 0.0 112.877 -170.125 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.577 ' H ' HG22 ' A' ' 255' ' ' THR . . . -62.94 -175.34 0.09 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.861 0.864 . . . . 0.0 112.663 -178.785 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 257' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 31.3 t 81.53 6.4 1.2 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.95 0.9 . . . . 0.0 111.101 -178.792 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 64.4 t -125.32 90.54 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.545 0.688 . . . . 0.0 109.571 171.565 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 22.2 m -75.81 97.86 4.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.735 178.408 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 80.52 87.82 0.58 Allowed Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.495 -177.547 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.565 ' HB3' HD22 ' A' ' 262' ' ' LEU . 2.6 m-85 -44.6 -61.39 1.57 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.666 0.746 . . . . 0.0 110.143 170.824 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.565 HD22 ' HB3' ' A' ' 261' ' ' PHE . 2.9 mm? -135.22 166.01 24.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.405 -1.27 . . . . 0.0 108.483 179.64 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 98.2 mttt -134.74 -170.98 2.67 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 123.164 0.29 . . . . 0.0 110.822 178.022 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -59.51 117.28 4.7 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.112 0.482 . . . . 0.0 110.57 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 115.26 -14.93 18.36 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.514 177.831 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 266' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 28.5 m-20 -86.9 138.48 31.51 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.807 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -100.6 154.2 18.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.072 0.463 . . . . 0.0 110.319 -178.747 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 294' ' ' THR . 1.3 m -135.17 176.33 8.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.314 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.425 ' HE3' HG22 ' A' ' 342' ' ' VAL . 1.7 mptm? -122.8 139.99 53.41 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 171.831 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -137.68 136.76 37.72 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.803 174.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.631 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 29.7 m -110.14 88.54 2.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.428 -175.79 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.462 ' HA ' ' CG ' ' A' ' 337' ' ' ASP . 3.2 t-20 -85.24 108.3 17.69 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.205 176.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 273' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 289' ' ' THR . 19.2 p -123.19 80.32 1.76 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.967 0.413 . . . . 0.0 111.473 -176.145 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -143.41 119.73 10.9 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.473 0.654 . . . . 0.0 111.042 177.091 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.421 ' CE2' HG22 ' A' ' 280' ' ' THR . 26.9 t90 -91.18 83.96 5.61 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.759 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 74.8 mt -82.0 172.03 13.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.608 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 277' ' ' GLN . . . . . 0.497 ' HA ' ' OE1' ' A' ' 277' ' ' GLN . 14.6 mm-40 -64.66 -50.42 67.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -176.179 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 61.2 mm-40 -68.9 -28.39 66.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.72 0.771 . . . . 0.0 109.752 178.829 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -79.63 0.73 28.94 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.369 -178.373 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.421 HG22 ' CE2' ' A' ' 275' ' ' TRP . 30.8 p -63.33 -34.81 78.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.04 0.448 . . . . 0.0 111.125 178.717 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -72.87 -12.4 60.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.034 -178.356 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.547 HE22 ' NE ' ' A' ' 331' ' ' ARG . 67.6 mt-30 -108.85 3.58 22.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.683 -177.811 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -63.92 115.02 4.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.282 178.252 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 6.5 mp -73.0 -44.4 61.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.108 -172.693 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -144.98 123.48 12.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.996 0.427 . . . . 0.0 111.009 -173.18 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 63.6 24.56 14.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.284 171.843 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 67.01 56.51 12.17 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.718 -178.232 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.508 ' C ' ' HD3' ' A' ' 290' ' ' PRO . . . -153.31 168.37 26.25 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.657 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 273' ' ' THR . 17.2 m -122.44 66.36 25.48 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.194 -179.259 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 290' ' ' PRO . . . . . 0.508 ' HD3' ' C ' ' A' ' 288' ' ' ALA . 57.9 Cg_endo -99.49 72.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.312 2.674 . . . . 0.0 112.794 -176.522 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.577 ' H ' HD13 ' A' ' 291' ' ' ILE . 0.2 OUTLIER -126.47 173.25 12.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.01 0.433 . . . . 0.0 111.292 -179.416 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 10.3 p -156.81 133.5 10.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.25 176.737 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -153.3 168.87 24.58 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.248 0.547 . . . . 0.0 111.737 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 90.0 m -89.35 133.57 34.44 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.814 -172.614 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 295' ' ' ALA . . . . . 0.406 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -119.15 -170.43 1.92 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.963 175.871 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 16.9 m -139.01 131.82 29.19 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.58 0.705 . . . . 0.0 112.877 -177.732 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.639 HG13 HG21 ' A' ' 311' ' ' VAL . 55.1 t -82.42 142.09 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 114.207 -1.361 . . . . 0.0 109.488 179.155 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 41.5 p -129.19 18.44 5.98 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -173.576 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.409 ' HB3' HG23 ' A' ' 311' ' ' VAL . . . -167.59 177.95 5.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.394 0.14 . . . . 0.0 110.67 179.092 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.41 108.66 2.04 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.846 0.716 . . . . 0.0 109.556 178.043 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -92.67 100.91 13.33 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.275 0.56 . . . . 0.0 110.241 -177.439 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.449 ' OD1' ' HB3' ' A' ' 304' ' ' ASP . 9.0 t-20 -63.35 135.06 56.76 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -169.204 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.526 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 27.5 t -115.68 96.52 5.65 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 166.38 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 304' ' ' ASP . . . . . 0.449 ' HB3' ' OD1' ' A' ' 302' ' ' ASN . 0.4 OUTLIER -106.25 174.7 5.77 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.476 -176.864 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 20.3 m -60.67 -32.24 71.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.749 0.309 . . . . 0.0 111.589 -176.792 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -74.21 1.05 51.2 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.188 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 307' ' ' GLY . . . . . 0.465 ' O ' HG22 ' A' ' 252' ' ' THR . . . 63.91 40.68 98.56 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.309 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -114.16 127.77 56.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.695 0.284 . . . . 0.0 110.683 -179.6 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.582 HG13 ' HB2' ' A' ' 251' ' ' LEU . 2.7 p -131.97 101.06 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.392 0.615 . . . . 0.0 111.134 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.595 ' OG1' HG23 ' A' ' 250' ' ' THR . 54.3 m -104.03 126.63 51.3 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 121.95 -0.469 . . . . 0.0 110.864 -179.009 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.639 HG21 HG13 ' A' ' 297' ' ' VAL . 12.7 p -160.43 151.4 5.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.066 0.46 . . . . 0.0 110.237 175.37 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 48.4 m -92.4 148.9 21.75 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.307 178.449 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.502 ' HB2' ' CE2' ' A' ' 247' ' ' PHE . 5.7 mp -117.23 149.3 40.64 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.795 -179.076 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 36.8 m -143.15 119.24 10.73 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.74 -178.461 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 97.03 113.77 3.08 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.553 179.133 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.436 HG23 HD12 ' A' ' 318' ' ' ILE . 0.2 OUTLIER -145.22 137.69 13.51 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.981 0.42 . . . . 0.0 110.799 177.559 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.45 66.24 8.8 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.827 2.351 . . . . 0.0 113.401 -177.628 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.576 ' H ' HD13 ' A' ' 318' ' ' ILE . 0.2 OUTLIER -110.97 143.27 21.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 173.624 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -105.99 -47.44 3.85 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.156 0.503 . . . . 0.0 110.45 -178.199 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 38.2 t70 62.21 15.33 7.43 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.038 171.378 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.41 ' O ' ' HD2' ' A' ' 324' ' ' PRO . 5.6 p 48.05 96.49 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.756 0.822 . . . . 0.0 111.965 -173.857 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.02 -7.22 59.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.297 0.57 . . . . 0.0 110.704 -174.468 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.586 ' HB3' ' HD3' ' A' ' 324' ' ' PRO . 44.3 t-20 -71.09 -53.4 8.37 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.114 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' A' ' 323' ' ' ASN . 9.7 Cg_endo -93.95 103.72 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.684 2.256 . . . . 0.0 111.187 177.279 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 325' ' ' GLN . . . . . 0.422 ' O ' ' HB2' ' A' ' 326' ' ' TYR . 12.9 mm100 -115.75 -64.55 1.3 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.645 -175.836 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 326' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 325' ' ' GLN . 51.2 m-85 73.74 -66.13 0.32 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.282 176.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -128.6 -17.22 4.14 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.57 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 23.9 m 71.42 -61.12 0.5 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.924 0.765 . . . . 0.0 111.247 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 58.9 t 70.44 135.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 121.26 0.552 . . . . 0.0 111.228 179.066 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 9.5 m -59.45 126.92 29.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.517 176.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 331' ' ' ARG . . . . . 0.547 ' NE ' HE22 ' A' ' 282' ' ' GLN . 0.0 OUTLIER -73.51 116.7 14.4 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.123 -174.658 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -96.83 116.7 29.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.307 0.575 . . . . 0.0 110.795 178.43 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.45 HG23 ' HB3' ' A' ' 233' ' ' GLN . 22.2 m -101.35 171.97 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.847 178.613 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -131.34 153.89 49.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.0 0.429 . . . . 0.0 110.638 -178.513 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -97.95 165.21 12.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.857 -179.079 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 103.5 12.17 31.46 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.344 175.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.631 ' HB3' ' O ' ' A' ' 271' ' ' THR . 23.8 m-20 -95.19 -178.77 4.57 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.021 0.438 . . . . 0.0 112.126 -178.641 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -104.73 153.92 20.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.61 -173.444 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.453 HG21 HD23 ' A' ' 251' ' ' LEU . 50.5 t -132.86 150.34 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.791 -176.367 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 31.6 t -144.85 171.34 14.57 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 175.318 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 32.2 t -118.29 160.28 18.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.669 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.425 HG22 ' HE3' ' A' ' 269' ' ' LYS . 94.3 t -67.86 -60.56 2.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 118.212 0.46 . . . . 0.0 110.392 -179.582 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 172.91 -115.78 0.58 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.385 179.209 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 12.9 p -86.46 -57.51 2.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.214 0.53 . . . . 0.0 111.451 -178.529 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.61 -179.316 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.724 0 N-CA-C 112.148 -0.381 . . . . 0.0 112.148 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.21 99.57 0.92 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.191 0.52 . . . . 0.0 111.399 -178.162 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -100.77 -13.46 18.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.061 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 122.44 -47.81 0.99 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -175.62 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -119.14 113.7 2.6 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 167.097 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 20.3 m -129.74 131.49 46.3 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.738 0.304 . . . . 0.0 110.383 -173.795 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 2.2 mp -138.47 -177.3 4.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.122 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 95.3 m -143.74 156.14 44.42 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.997 -176.799 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.438 HG23 HG23 ' A' ' 339' ' ' VAL . 66.3 t -108.05 122.77 62.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.197 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -106.05 -6.28 18.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.106 0.479 . . . . 0.0 110.716 -175.555 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 17.5 p -130.25 -168.32 1.95 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.732 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.418 ' HA ' ' HD2' ' A' ' 234' ' ' PRO . 6.8 mt-30 -113.74 113.65 47.39 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -175.347 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 233' ' ' GLN . 18.3 Cg_endo -62.17 106.98 0.51 Allowed 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.894 2.396 . . . . 0.0 112.494 -179.65 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.0 t -149.37 118.44 6.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.533 0.682 . . . . 0.0 112.269 179.556 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.666 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -155.9 174.72 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.164 171.569 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.497 ' H ' HG13 ' A' ' 236' ' ' VAL . 34.8 m -23.09 100.19 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.609 1.164 . . . . 0.0 113.525 -177.318 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.95 83.42 1.82 Allowed 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.408 174.158 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.423 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 35.7 t-20 -108.79 129.96 55.38 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.016 -178.326 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -102.46 -41.39 6.32 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.68 -170.519 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.8 -33.77 65.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.43 0.633 . . . . 0.0 109.944 178.1 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.492 ' HA ' ' HE2' ' A' ' 242' ' ' LYS . 10.8 mmpt? -88.77 -11.25 45.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.481 178.835 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 26.5 t70 58.1 69.19 0.75 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.277 -178.796 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.9 m -146.8 104.84 3.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.159 -177.216 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -123.33 106.33 10.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.783 -176.846 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 246' ' ' GLN . . . . . 0.564 ' HB2' HG12 ' A' ' 236' ' ' VAL . 0.1 OUTLIER -124.03 161.92 24.53 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 171.551 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.666 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 35.2 p90 -149.09 134.82 18.78 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.67 174.818 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 46.5 m -98.8 137.49 37.32 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.428 ' HB ' ' CD1' ' A' ' 251' ' ' LEU . 0.2 OUTLIER -142.29 148.58 20.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.878 -178.946 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.6 HG23 ' OG1' ' A' ' 310' ' ' THR . 41.6 m -99.51 107.84 20.12 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 166.519 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.561 ' HB2' HG13 ' A' ' 309' ' ' VAL . 5.2 mp -102.82 167.97 9.53 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -170.685 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.19 144.13 43.69 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.813 175.95 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -142.82 -142.48 4.01 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.369 -173.144 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.414 ' H ' ' HZ ' ' A' ' 261' ' ' PHE . . . -113.37 -173.66 2.31 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -176.362 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.577 HG22 ' H ' ' A' ' 256' ' ' ALA . 1.8 m -70.9 174.0 6.69 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.185 -171.726 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.577 ' H ' HG22 ' A' ' 255' ' ' THR . . . -62.51 -177.46 0.14 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.495 0.718 . . . . 0.0 112.862 -177.17 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 23.1 t 80.83 10.93 0.95 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.185 0.994 . . . . 0.0 111.155 -176.764 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 40.4 t -124.33 94.06 2.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 169.705 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.2 m -67.65 88.89 0.24 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.515 -177.865 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 69.48 107.42 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.109 -174.555 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.414 ' HZ ' ' H ' ' A' ' 254' ' ' ALA . 15.1 m-85 -44.19 -57.35 3.49 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 117.243 0.521 . . . . 0.0 111.091 174.254 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.524 HD11 HG13 ' A' ' 341' ' ' VAL . 91.9 mt -147.83 146.81 29.26 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -177.838 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.514 ' HD2' ' N ' ' A' ' 263' ' ' LYS . 9.5 mptt -112.86 -166.45 1.08 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.033 0.444 . . . . 0.0 111.561 176.53 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -52.79 114.15 1.32 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.66 -175.505 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 114.2 -16.07 20.26 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.416 171.392 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 266' ' ' ASP . . . . . 0.537 ' HA ' HG23 ' A' ' 344' ' ' THR . 0.6 OUTLIER -82.54 134.79 35.2 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.83 -177.014 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.19 145.94 24.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.24 -173.592 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.408 HG23 ' HB3' ' A' ' 295' ' ' ALA . 0.2 OUTLIER -125.33 165.3 22.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.744 179.97 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 340' ' ' SER . 0.8 OUTLIER -97.57 120.3 37.69 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 172.433 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -122.55 120.55 34.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.857 0.361 . . . . 0.0 110.085 -174.648 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 30.4 m -125.79 113.0 16.69 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.491 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.634 ' O ' ' HA ' ' A' ' 290' ' ' PRO . 19.4 m120 -84.09 153.27 23.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.031 -177.584 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 21.4 p -91.95 162.94 14.19 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.676 175.53 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -84.61 142.71 29.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.217 0.532 . . . . 0.0 111.787 -176.168 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -155.02 -36.98 0.09 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.972 176.953 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 67.7 mt -72.41 77.0 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.981 176.497 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 277' ' ' GLN . . . . . 0.533 ' HA ' ' OG1' ' A' ' 280' ' ' THR . 51.9 mt-30 -63.83 -22.43 66.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.006 -173.813 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -60.24 -38.71 84.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.728 0.775 . . . . 0.0 109.642 176.267 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.515 ' HB3' ' O ' ' A' ' 287' ' ' GLY . 74.1 mm-40 -89.17 -41.38 12.28 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.418 -175.698 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.533 ' OG1' ' HA ' ' A' ' 277' ' ' GLN . 43.6 p -68.21 -25.62 65.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.979 0.418 . . . . 0.0 111.256 -177.373 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -91.07 -58.87 2.32 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.716 176.321 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -97.8 -75.43 0.55 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -173.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 51.17 79.67 0.09 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.276 0.56 . . . . 0.0 111.086 -171.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.8 -26.71 57.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.942 -178.4 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -110.42 -70.06 0.83 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.157 0.503 . . . . 0.0 109.735 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.424 ' OD1' ' HA ' ' A' ' 320' ' ' ASP . 6.3 p30 -169.5 143.16 2.74 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.707 177.91 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 279' ' ' GLN . . . 168.79 101.82 0.15 Allowed Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.892 -177.947 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -126.13 114.47 18.42 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.204 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.516 ' HB ' ' HD3' ' A' ' 290' ' ' PRO . 8.1 m -88.12 -52.94 0.38 Allowed Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.615 -178.644 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 290' ' ' PRO . . . . . 0.634 ' HA ' ' O ' ' A' ' 272' ' ' ASN . 72.6 Cg_endo -76.13 66.83 6.95 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.771 1.648 . . . . 0.0 112.08 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 14.3 pt -99.82 151.22 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.656 -177.877 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 12.2 p -111.86 90.52 3.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.227 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -118.96 174.99 5.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.046 0.45 . . . . 0.0 110.665 -178.588 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 67.9 m -109.22 117.91 35.35 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.852 178.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 295' ' ' ALA . . . . . 0.408 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -104.24 -175.85 2.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 -176.148 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 91.4 m -141.63 131.16 23.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.384 0.612 . . . . 0.0 112.282 -176.869 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.589 HG13 HG21 ' A' ' 311' ' ' VAL . 64.3 t -75.13 136.67 24.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.053 176.372 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 2.4 m -111.45 -9.04 14.24 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.97 -167.698 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -164.45 -168.9 1.63 Allowed 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.912 -0.492 . . . . 0.0 111.676 -177.872 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.16 151.71 35.1 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.77 0.795 . . . . 0.0 110.762 179.35 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -148.13 -178.38 6.26 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.315 -1.311 . . . . 0.0 109.433 -178.135 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -136.56 135.83 38.77 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -173.482 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.8 OUTLIER -112.94 95.62 5.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 161.618 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -99.88 175.49 5.76 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.662 -176.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 53.5 m -60.91 -31.39 70.9 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -177.027 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -78.55 -2.43 84.85 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.213 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 69.2 42.06 77.36 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.739 179.006 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -114.67 135.52 54.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.92 0.86 . . . . 0.0 110.856 175.279 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.561 HG13 ' HB2' ' A' ' 251' ' ' LEU . 2.3 p -136.51 105.29 4.41 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.507 -179.588 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.6 ' OG1' HG23 ' A' ' 250' ' ' THR . 90.7 m -102.82 129.84 49.62 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 121.664 -0.648 . . . . 0.0 111.365 -178.31 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.589 HG21 HG13 ' A' ' 297' ' ' VAL . 14.4 p -165.93 155.41 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.033 0.444 . . . . 0.0 110.237 174.303 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 52.4 m -96.64 149.32 21.93 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.453 -179.539 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.474 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.4 mp -117.21 136.62 52.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.542 -178.422 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 5.4 m -133.46 132.19 40.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.446 -173.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 94.64 80.21 1.49 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.971 175.276 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 12.4 m -134.95 134.72 22.03 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.763 0.316 . . . . 0.0 110.812 177.244 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -88.41 69.64 2.83 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.0 2.467 . . . . 0.0 113.182 -178.465 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.88 114.1 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 175.74 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -109.87 18.22 20.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.372 0.606 . . . . 0.0 110.319 -178.55 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.424 ' HA ' ' OD1' ' A' ' 286' ' ' ASN . 16.1 m-20 -87.85 32.18 0.75 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.043 176.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 12.5 p -80.96 32.54 0.32 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.412 -175.319 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 20.8 m -95.2 -22.13 18.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.176 0.513 . . . . 0.0 110.375 179.22 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.446 ' HB3' ' HD3' ' A' ' 324' ' ' PRO . 8.3 t30 -74.05 -48.27 6.12 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.767 176.897 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 327' ' ' ASN . 2.9 Cg_exo -80.72 14.43 2.04 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.756 2.304 . . . . 0.0 113.088 -177.847 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -59.79 -60.63 3.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.174 -178.741 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -88.84 -9.92 49.94 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.7 0.286 . . . . 0.0 111.354 -177.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 327' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 324' ' ' PRO . 25.8 t-20 -159.76 105.88 1.62 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.243 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 29.5 p -114.76 -0.64 13.47 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.66 178.531 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 55.5 t -104.79 -34.17 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.756 0.312 . . . . 0.0 111.713 -175.132 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 6.0 m -86.19 -60.26 2.06 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.121 0.486 . . . . 0.0 110.23 179.287 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -82.99 112.51 19.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.936 -178.73 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -140.42 -168.69 2.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.225 0.536 . . . . 0.0 110.877 -177.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 25.9 m -66.7 172.85 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.892 174.247 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -132.64 144.7 50.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.5 -179.422 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -67.16 154.01 42.29 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.591 -178.49 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 117.25 6.1 13.98 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.201 -178.709 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -69.33 159.99 32.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.836 0.35 . . . . 0.0 111.162 -177.558 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -105.96 138.51 42.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.769 -176.235 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.48 HG21 HD23 ' A' ' 251' ' ' LEU . 77.2 t -128.09 145.1 35.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.137 0.494 . . . . 0.0 111.202 -175.436 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.536 ' HB2' ' HB3' ' A' ' 269' ' ' LYS . 36.5 m -145.02 175.54 10.15 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 172.206 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.524 HG13 HD11 ' A' ' 262' ' ' LEU . 98.7 t -116.09 122.3 69.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.917 0.389 . . . . 0.0 111.963 -174.667 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 60.7 t -84.57 -41.1 15.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.428 173.563 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 96.05 -152.53 20.29 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.11 177.246 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.537 HG23 ' HA ' ' A' ' 266' ' ' ASP . 1.0 OUTLIER -142.61 -60.42 0.44 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.701 0.286 . . . . 0.0 110.299 177.509 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.106 -0.949 . . . . 0.0 111.423 179.037 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.678 0 N-CA-C 112.17 -0.372 . . . . 0.0 112.17 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 26.4 m -152.21 98.93 2.47 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 2.2 mp -116.67 -176.66 3.01 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.615 -172.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 87.6 m -134.01 154.77 50.92 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.418 -176.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 41.1 t -93.87 107.26 19.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -90.49 -31.19 16.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.025 0.44 . . . . 0.0 111.194 -172.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 19.2 p -128.71 -168.45 1.92 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.194 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.61 ' HB3' HG23 ' A' ' 333' ' ' VAL . 64.9 mt-30 -108.08 122.02 41.96 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-O 120.887 0.375 . . . . 0.0 110.617 -171.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.77 106.78 2.32 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 123.014 2.476 . . . . 0.0 113.264 -176.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 236' ' ' VAL . 10.2 t -155.33 127.93 7.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.964 0.411 . . . . 0.0 111.911 176.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.652 HG12 ' HB2' ' A' ' 246' ' ' GLN . 0.9 OUTLIER -155.3 173.96 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.308 172.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . 0.495 ' H ' HG13 ' A' ' 236' ' ' VAL . 57.1 m -20.38 112.04 0.02 OUTLIER 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.535 1.534 . . . . 0.0 114.207 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -115.61 100.85 8.35 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.087 174.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -135.61 131.52 35.94 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.129 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -98.82 -47.82 5.15 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.168 -170.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.68 -23.8 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.437 0.637 . . . . 0.0 110.078 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -100.61 1.07 40.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.296 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 51.0 50.61 18.78 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.324 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 14.7 m -122.31 101.08 7.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.336 -175.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -128.58 112.55 14.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.941 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . 0.652 ' HB2' HG12 ' A' ' 236' ' ' VAL . 50.6 mt-30 -138.75 164.62 29.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 175.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.632 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 36.8 p90 -147.02 134.64 21.01 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.244 171.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 38.6 m -100.34 137.79 38.29 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.68 143.96 22.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.317 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 18.3 m -91.22 113.37 25.61 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 160.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.575 ' HB2' HG13 ' A' ' 309' ' ' VAL . 5.1 mp -101.77 167.29 10.18 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -177.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.57 141.07 48.94 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.236 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -141.62 -143.37 4.23 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 121.227 -0.511 . . . . 0.0 111.937 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -112.15 -174.44 2.46 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -175.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.579 HG22 ' H ' ' A' ' 256' ' ' ALA . 3.0 m -67.86 173.55 4.35 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.417 -172.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.579 ' H ' HG22 ' A' ' 255' ' ' THR . . . -60.48 -176.17 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.818 0.847 . . . . 0.0 112.535 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 15.3 t 81.05 6.3 1.34 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.125 0.97 . . . . 0.0 110.619 -176.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 91.6 t -123.74 90.37 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 170.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.4 m -75.54 93.43 3.01 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.345 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 75.74 97.16 0.14 Allowed Glycine 0 N--CA 1.44 -1.068 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.068 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.658 ' HB3' HD13 ' A' ' 262' ' ' LEU . 28.5 m-85 -46.2 -58.75 3.38 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.652 0.739 . . . . 0.0 109.737 172.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.658 HD13 ' HB3' ' A' ' 261' ' ' PHE . 0.0 OUTLIER -151.88 171.32 17.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.807 177.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 37.9 mtmm -136.28 -166.84 1.95 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.696 0.284 . . . . 0.0 111.765 -174.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -53.46 118.87 4.19 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.397 0.618 . . . . 0.0 111.69 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 106.31 -12.15 43.82 Favored Glycine 0 C--N 1.316 -0.557 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.118 176.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . 0.453 ' CB ' ' HB2' ' A' ' 262' ' ' LEU . 40.9 m-20 -84.47 133.23 34.48 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -94.36 147.62 23.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.326 0.584 . . . . 0.0 111.149 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.5 OUTLIER -120.48 179.59 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.4 174.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.49 ' O ' ' HD3' ' A' ' 269' ' ' LYS . 12.8 tmtt? -134.51 102.55 5.35 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 174.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -112.51 143.77 43.11 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.534 -174.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.611 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 84.8 m -127.78 89.54 2.96 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.649 0.737 . . . . 0.0 110.297 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.446 ' HA ' ' CB ' ' A' ' 337' ' ' ASP . 2.4 t-20 . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.562 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.575 0.226 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -142.71 -135.81 0.1 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.512 -169.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 48.7 m -70.49 130.87 43.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.13 0.491 . . . . 0.0 112.031 -173.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -130.11 -169.49 2.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.029 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 54.5 m -139.85 132.63 29.09 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.497 HG13 HG21 ' A' ' 311' ' ' VAL . 64.4 t -82.16 139.89 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.33 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.38 9.64 13.4 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.493 -169.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -171.82 -172.28 0.99 Allowed 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 120.568 0.223 . . . . 0.0 111.509 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.42 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 4.4 m-20 -61.98 123.42 18.03 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.397 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.554 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -111.81 110.02 20.15 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.528 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.418 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 25.5 t-20 -80.0 132.29 35.98 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -166.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.543 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 12.8 t -106.75 95.97 6.12 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 164.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.63 -178.63 3.78 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.261 -175.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 23.3 t -60.76 -34.8 75.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.971 0.415 . . . . 0.0 111.368 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -81.9 -3.12 90.68 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.687 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 65.0 41.17 97.44 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.704 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.32 125.84 54.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.385 0.612 . . . . 0.0 109.852 175.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.575 HG13 ' HB2' ' A' ' 251' ' ' LEU . 2.0 p -127.07 94.08 2.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.946 -175.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 53.5 m -98.79 127.01 44.58 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.003 -0.435 . . . . 0.0 111.676 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.497 HG21 HG13 ' A' ' 297' ' ' VAL . 11.8 p -161.95 151.02 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 175.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 49.2 m -93.22 146.03 23.99 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.079 0.466 . . . . 0.0 110.339 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.49 ' HB2' ' CE2' ' A' ' 247' ' ' PHE . 5.7 mp -117.46 151.21 37.54 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.62 -175.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 C--N 1.319 -0.752 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.589 173.657 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.61 HG23 ' HB3' ' A' ' 233' ' ' GLN . 9.5 m . . . . . 0 N--CA 1.451 -0.386 0 CA-C-O 120.757 0.313 . . . . 0.0 110.76 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -137.52 148.17 45.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.085 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -97.71 172.75 7.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.049 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 112.73 11.64 14.19 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.444 176.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.611 ' HB3' ' O ' ' A' ' 271' ' ' THR . 4.3 m-20 -104.36 -170.77 1.82 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -176.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -114.32 157.17 23.15 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.155 0.503 . . . . 0.0 111.926 -172.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 39.0 t -134.42 145.8 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.28 -176.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 35.9 t -142.62 176.45 9.03 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 50.9 t -119.04 126.58 75.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.966 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 CA--C 1.535 0.373 0 CA-C-O 121.499 0.666 . . . . 0.0 110.979 176.875 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.604 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 23.6 m -124.32 132.03 53.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.177 0.513 . . . . 0.0 110.18 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.644 HD22 HG11 ' A' ' 309' ' ' VAL . 5.5 mt -131.3 173.36 11.14 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.576 -175.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 31.6 m -141.9 156.08 45.5 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -174.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 54.7 t -117.14 127.96 74.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 122.418 -0.177 . . . . 0.0 110.964 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.475 ' NZ ' HG23 ' A' ' 252' ' ' THR . 31.1 mtmm -112.38 -14.9 13.23 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -177.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 75.2 p -120.44 -174.09 2.72 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.23 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -106.59 106.33 57.39 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -170.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.552 ' C ' ' HB2' ' A' ' 247' ' ' PHE . 55.5 Cg_endo -69.83 103.75 1.22 Allowed 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.567 2.178 . . . . 0.0 113.6 -174.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.531 ' O ' HG23 ' A' ' 236' ' ' VAL . 15.1 t -157.93 129.32 6.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.714 170.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.604 ' N ' ' HA ' ' A' ' 247' ' ' PHE . 2.9 t -155.94 114.49 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 C-N-CA 122.827 0.451 . . . . 0.0 110.69 172.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' A' ' 245' ' ' TYR . 23.7 m 64.57 93.65 0.06 Allowed 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.228 0.537 . . . . 0.0 111.649 176.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -109.55 84.44 1.92 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -132.52 129.06 38.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.218 -175.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.22 -35.01 7.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.78 -173.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 61.5 t -62.81 -29.56 47.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.497 0.665 . . . . 0.0 109.62 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.479 ' HA ' ' HE2' ' A' ' 242' ' ' LYS . 9.8 mmpt? -96.81 -12.46 23.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.881 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 60.7 59.92 2.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.001 -1.454 . . . . 0.0 110.55 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 36.8 m -143.93 106.27 4.4 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.151 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . 0.619 ' HA ' ' O ' ' A' ' 237' ' ' THR . 59.0 m-85 -129.07 118.17 22.07 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 236' ' ' VAL . 45.0 mt-30 -130.54 -179.16 5.12 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.604 ' HA ' ' N ' ' A' ' 236' ' ' VAL . 13.0 p90 -160.26 136.8 8.89 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.238 165.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.486 ' OG1' HG21 ' A' ' 236' ' ' VAL . 32.8 m -102.66 138.41 39.6 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.461 ' HB ' ' CD1' ' A' ' 251' ' ' LEU . 0.1 OUTLIER -144.92 151.15 15.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.712 -0.795 . . . . 0.0 112.11 -178.336 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.605 HG23 ' OG1' ' A' ' 310' ' ' THR . 91.7 m -103.14 104.85 15.04 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 168.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.616 ' HB2' HG13 ' A' ' 309' ' ' VAL . 5.1 mp -102.7 167.78 9.68 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -169.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.475 HG23 ' NZ ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -114.68 151.37 33.71 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.91 172.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -150.97 -142.67 3.57 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 121.197 -0.525 . . . . 0.0 111.907 -173.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.584 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -107.42 -174.59 2.57 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.561 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -69.48 -177.8 1.26 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.41 -172.043 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.561 ' H ' HG22 ' A' ' 255' ' ' THR . . . -64.39 -175.98 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.825 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 49.8 m 80.24 9.05 1.36 Allowed 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.489 0.716 . . . . 0.0 111.287 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 28.6 t -126.85 90.07 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 171.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.9 m -70.9 93.76 1.01 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.892 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 73.62 98.0 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.217 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.408 ' CE1' HD21 ' A' ' 228' ' ' LEU . 6.3 m-85 -44.99 -58.67 3.02 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.816 0.817 . . . . 0.0 109.824 171.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 266' ' ' ASP . 77.8 mt -140.78 169.15 18.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.31 -1.314 . . . . 0.0 109.051 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -133.25 -167.33 1.91 Allowed 'General case' 0 C--N 1.323 -0.554 0 O-C-N 123.079 0.237 . . . . 0.0 110.502 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -59.93 116.28 4.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.286 0.565 . . . . 0.0 111.171 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 111.7 -14.37 27.09 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.547 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . 0.518 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 37.3 m-20 -81.0 128.23 33.46 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.938 0.399 . . . . 0.0 110.292 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.97 150.93 22.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.449 0.642 . . . . 0.0 111.759 -173.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.444 HG12 HG22 ' A' ' 341' ' ' VAL . 1.3 m -131.38 171.71 17.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.276 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.505 ' HD2' HG13 ' A' ' 342' ' ' VAL . 0.0 OUTLIER -143.77 129.21 18.99 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.2 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . 0.469 ' CB ' HG22 ' A' ' 339' ' ' VAL . 8.6 p90 -130.4 158.51 39.67 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.128 -174.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.687 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 93.2 m -108.7 86.89 2.37 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.163 -173.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 . . . . . 0 C--N 1.326 -0.424 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.975 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -145.29 154.25 42.15 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.07 0.462 . . . . 0.0 110.439 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 86.7 m -89.31 134.75 33.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.87 -172.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . 0.414 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -129.03 -174.19 3.19 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 80.0 m -142.48 135.36 28.34 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.554 HG13 HG21 ' A' ' 311' ' ' VAL . 58.2 t -78.31 140.53 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.832 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 4.0 m -116.31 1.57 13.09 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -161.56 176.96 10.48 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.908 -0.495 . . . . 0.0 111.517 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.93 104.96 0.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.23 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -93.22 103.42 15.69 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.797 -174.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -61.0 135.07 57.68 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -171.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.07 97.49 6.25 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 162.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.4 174.11 6.85 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.715 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 42.5 m -57.05 -33.74 67.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -77.74 -3.05 83.1 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.449 -176.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . 0.584 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 72.73 41.26 50.68 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.246 -178.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -113.37 146.25 39.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.687 0.743 . . . . 0.0 110.909 174.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.644 HG11 HD22 ' A' ' 228' ' ' LEU . 2.2 p -145.56 102.19 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.414 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.605 ' OG1' HG23 ' A' ' 250' ' ' THR . 91.0 m -102.42 124.17 47.5 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.514 -0.741 . . . . 0.0 111.032 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.554 HG21 HG13 ' A' ' 297' ' ' VAL . 14.8 p -160.15 154.31 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.134 0.493 . . . . 0.0 110.213 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 47.0 m -97.87 152.39 19.24 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.65 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.486 HD13 ' CE1' ' A' ' 247' ' ' PHE . 5.7 mp -119.89 135.19 54.98 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.632 -177.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 27.7 p . . . . . 0 C--N 1.325 -0.492 0 CA-C-O 120.807 0.337 . . . . 0.0 111.598 -175.683 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.427 HG22 ' N ' ' A' ' 334' ' ' GLU . 13.1 p . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . 0.427 ' N ' HG22 ' A' ' 333' ' ' VAL . 10.4 tp10 -119.87 147.81 44.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.978 0.418 . . . . 0.0 110.485 -175.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -85.85 173.5 9.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.213 -176.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 112.58 11.5 14.8 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.417 173.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.687 ' HB2' ' O ' ' A' ' 271' ' ' THR . 4.9 p-10 -91.05 179.87 5.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.998 0.428 . . . . 0.0 111.52 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -118.04 137.63 52.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.442 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.469 HG22 ' CB ' ' A' ' 270' ' ' PHE . 55.9 t -116.48 150.78 18.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.458 -172.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 41.9 m -146.73 173.22 12.57 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 172.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.444 HG22 HG12 ' A' ' 268' ' ' VAL . 86.1 t -117.85 132.99 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -171.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.505 HG13 ' HD2' ' A' ' 269' ' ' LYS . 32.6 m . . . . . 0 N--CA 1.465 0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 111.561 174.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 0.143 0 CA-C-O 120.899 0.166 . . . . 0.0 113.167 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 21.2 m -107.53 142.66 37.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.04 0.448 . . . . 0.0 110.72 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.677 HD22 HG11 ' A' ' 309' ' ' VAL . 20.4 mt -143.03 175.93 9.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.269 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.569 ' O ' ' HB3' ' A' ' 251' ' ' LEU . 43.6 m -131.7 152.69 50.7 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.414 0.149 . . . . 0.0 110.615 -176.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.475 HG23 HG23 ' A' ' 339' ' ' VAL . 12.2 t -100.03 127.9 52.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 176.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -110.96 -29.1 8.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.373 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.459 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 72.7 p -119.87 -169.33 1.76 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.688 0.28 . . . . 0.0 110.732 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.64 ' HB3' ' HB ' ' A' ' 333' ' ' VAL . 85.1 mt-30 -112.76 125.68 29.52 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -172.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 233' ' ' GLN . 10.0 Cg_endo -92.71 106.39 0.19 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.337 2.691 . . . . 0.0 115.728 -168.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 236' ' ' VAL . 1.2 m -157.52 133.23 9.22 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 165.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.682 ' N ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -158.24 139.6 4.92 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.807 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 176.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 97.7 m 69.12 108.51 0.05 Allowed 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.494 0.718 . . . . 0.0 112.635 170.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -116.31 99.81 7.46 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.437 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.53 88.31 2.79 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -83.63 -44.32 14.69 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.773 -163.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 22.8 t -66.47 -23.18 31.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.629 0.728 . . . . 0.0 109.145 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -99.87 -3.75 31.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.888 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 36.1 t70 57.39 68.85 0.8 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.35 -1.296 . . . . 0.0 111.729 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 24.4 t -152.9 119.76 5.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.513 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -129.6 128.51 42.83 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -121.8 -174.74 2.94 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.682 ' HA ' ' N ' ' A' ' 236' ' ' VAL . 1.8 p90 -156.71 125.74 5.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 174.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 52.9 m -95.41 142.29 27.96 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.485 HG13 HD11 ' A' ' 251' ' ' LEU . 7.3 p -144.07 137.92 24.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 119.786 -0.766 . . . . 0.0 112.391 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.459 ' HB ' ' CG2' ' A' ' 232' ' ' THR . 92.2 m -98.43 113.36 25.32 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 168.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.673 ' HB2' HG13 ' A' ' 309' ' ' VAL . 1.4 mp -107.85 168.68 9.1 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -175.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.76 139.4 41.24 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.187 172.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.464 ' HA2' HD23 ' A' ' 228' ' ' LEU . . . -141.86 -149.41 5.19 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.275 -175.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -96.25 -174.23 3.01 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 256' ' ' ALA . 2.8 m -77.01 175.73 9.31 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.021 -170.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.582 ' H ' HG22 ' A' ' 255' ' ' THR . . . -65.03 -176.39 0.28 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.446 0.698 . . . . 0.0 112.275 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 24.8 t 80.2 6.97 1.62 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.834 0.854 . . . . 0.0 110.517 -176.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 24.0 t -123.37 90.71 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 170.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 5.6 m -73.44 92.45 1.86 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.654 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.622 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 80.77 94.2 0.43 Allowed Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.958 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.487 ' CZ ' HD21 ' A' ' 228' ' ' LEU . 4.1 m-85 -43.5 -55.35 4.28 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 169.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.8 pp -165.51 173.85 10.55 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.568 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 60.3 mttp -143.23 -166.32 2.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.997 0.427 . . . . 0.0 111.836 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -53.54 122.74 10.38 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.162 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 109.92 -16.01 30.89 Favored Glycine 0 C--N 1.313 -0.718 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.7 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -84.35 139.43 32.28 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' GLN . . . . . 0.587 ' HB2' HG11 ' A' ' 342' ' ' VAL . 27.5 mt-30 -107.91 151.92 25.13 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.389 0.614 . . . . 0.0 110.765 -178.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.4 OUTLIER -132.4 176.18 9.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.397 -179.24 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.405 ' HE2' HG23 ' A' ' 342' ' ' VAL . 3.2 mptp? -123.64 143.24 50.37 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 172.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . 0.497 ' CE2' ' HB2' ' A' ' 295' ' ' ALA . 17.2 p90 -136.68 142.5 43.16 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 173.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 25.7 p -150.17 109.69 4.01 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.876 -174.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.561 HD22 ' HG3' ' A' ' 334' ' ' GLU . 24.1 p-10 . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 121.555 0.693 . . . . 0.0 111.802 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 120.196 0.046 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -161.71 -144.16 0.09 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 -168.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 56.0 m -74.77 137.04 41.71 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -175.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . 0.497 ' HB2' ' CE2' ' A' ' 270' ' ' PHE . . . -124.92 172.4 9.41 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 173.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 87.1 m -134.21 129.54 35.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.473 0.654 . . . . 0.0 112.474 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.596 HG12 ' H ' ' A' ' 299' ' ' ALA . 93.3 t -89.87 140.69 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.047 -177.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 1.9 m -125.06 23.86 7.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.009 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.596 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -156.29 -177.25 6.45 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.421 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 2.6 m-20 -76.83 165.57 24.52 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.775 -174.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.622 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -147.5 155.61 42.05 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.688 -175.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -128.99 133.1 47.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.263 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.529 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.8 OUTLIER -111.51 95.45 5.51 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 164.141 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.15 169.37 8.48 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.554 -0.459 . . . . 0.0 110.444 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 67.0 m -57.95 -30.3 65.87 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -76.85 7.51 34.17 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.622 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 59.89 41.88 97.94 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.219 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -121.78 117.98 27.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.316 0.558 . . . . 0.0 111.242 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.677 HG11 HD22 ' A' ' 228' ' ' LEU . 2.6 p -125.42 125.42 68.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.982 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 86.2 m -120.21 135.67 54.9 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 121.729 -0.607 . . . . 0.0 111.249 -177.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.548 ' CG1' ' HB2' ' A' ' 301' ' ' ALA . 6.6 m -146.76 165.21 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.143 0.497 . . . . 0.0 110.445 175.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 28.3 m -121.95 136.32 54.92 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.691 173.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 4.2 mp -112.8 158.93 19.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.999 -173.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 14.3 m . . . . . 0 C--N 1.322 -0.626 0 CA-C-O 120.863 0.363 . . . . 0.0 111.561 -176.455 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.64 ' HB ' ' HB3' ' A' ' 233' ' ' GLN . 28.8 m . . . . . 0 C--O 1.235 0.311 0 CA-C-O 121.991 0.901 . . . . 0.0 112.962 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . 0.561 ' HG3' HD22 ' A' ' 272' ' ' ASN . 1.0 OUTLIER -109.19 145.74 35.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.402 -178.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -99.97 156.29 17.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.653 174.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 106.86 8.89 31.32 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.487 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.455 ' HB3' ' CG2' ' A' ' 230' ' ' VAL . 10.6 t70 -66.01 150.45 48.65 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.781 0.324 . . . . 0.0 110.854 178.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -98.52 112.64 24.61 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.475 HG23 HG23 ' A' ' 230' ' ' VAL . 57.4 t -97.09 148.85 5.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.387 0.613 . . . . 0.0 111.654 -170.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 65.5 m -143.67 171.58 13.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.762 173.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 24.1 t -119.25 141.85 37.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.587 HG11 ' HB2' ' A' ' 267' ' ' GLN . 8.4 p . . . . . 0 N--CA 1.464 0.241 0 CA-C-O 121.085 0.469 . . . . 0.0 110.555 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.793 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 20.8 m -152.36 96.22 2.14 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 175.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.461 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 4.0 mp -122.73 -179.25 4.17 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.889 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 48.3 m -134.34 162.72 31.41 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.529 -175.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 94.4 t -108.24 130.88 60.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.497 ' HB2' HG23 ' A' ' 252' ' ' THR . 27.2 tptp -108.53 -15.21 14.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.874 0.369 . . . . 0.0 111.482 -173.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 20.6 p -138.44 -169.54 2.62 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.206 -173.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.458 ' HB3' ' HB ' ' A' ' 333' ' ' VAL . 74.7 mt-30 -105.02 118.24 56.6 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.248 -172.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.78 106.15 1.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.716 2.277 . . . . 0.0 111.997 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 236' ' ' VAL . 10.9 t -154.88 124.06 6.33 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.575 -0.45 . . . . 0.0 112.095 -178.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.73 HG12 ' HB2' ' A' ' 246' ' ' GLN . 1.1 t -154.05 168.89 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.606 171.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . 0.482 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 74.6 m -14.73 112.96 0.02 OUTLIER 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.725 1.61 . . . . 0.0 114.472 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -106.41 88.57 2.81 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 172.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -125.89 139.32 53.56 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.366 0.603 . . . . 0.0 110.236 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.22 -44.58 4.52 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.558 -173.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 63.1 t -61.04 -36.71 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.263 0.554 . . . . 0.0 110.167 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -88.14 -5.48 58.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.316 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 22.4 t70 50.91 67.45 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.036 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.5 m -144.75 100.89 3.58 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.589 -175.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -121.49 100.89 7.28 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . 0.73 ' HB2' HG12 ' A' ' 236' ' ' VAL . 80.0 mt-30 -127.6 178.97 5.76 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.629 -171.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.64 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 2.1 p90 -156.64 125.63 5.97 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 19.5 m -95.4 134.53 38.1 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.461 ' HB ' ' CD1' ' A' ' 251' ' ' LEU . 0.2 OUTLIER -141.95 146.71 22.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.676 -178.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.478 HG23 ' OG1' ' A' ' 310' ' ' THR . 95.2 m -96.69 112.79 24.4 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 164.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.599 ' HB2' HG13 ' A' ' 309' ' ' VAL . 5.3 mp -102.46 169.16 8.84 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -176.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.497 HG23 ' HB2' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -127.57 108.69 11.0 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.68 0.276 . . . . 0.0 111.628 -177.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.491 ' N ' HG12 ' A' ' 309' ' ' VAL . . . -147.39 135.81 5.8 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 177.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.421 ' HB2' ' HA2' ' A' ' 307' ' ' GLY . . . -108.34 93.98 4.82 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -172.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.483 ' HB ' ' OG ' ' A' ' 303' ' ' SER . 10.1 m -126.29 118.97 26.21 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 170.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -73.04 136.82 45.05 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 70.8 m 59.89 55.58 3.8 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.119 174.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.471 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 94.6 t -131.74 95.37 2.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.25 0.548 . . . . 0.0 109.858 174.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 27.4 m -74.15 97.63 2.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.143 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 71.23 99.7 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.844 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.51 ' CE2' ' HB2' ' A' ' 303' ' ' SER . 11.6 m-85 -48.02 -59.18 3.56 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.324 0.583 . . . . 0.0 110.34 170.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.424 HD11 HG13 ' A' ' 341' ' ' VAL . 61.3 mt -143.57 173.52 11.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.537 -173.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -130.7 -169.86 2.23 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.818 0.342 . . . . 0.0 111.172 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -57.95 114.05 2.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.563 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 111.14 -1.6 28.33 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.846 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . 0.409 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 13.0 m-20 -87.59 145.32 26.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.704 0.252 . . . . 0.0 110.556 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -102.23 149.23 24.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.48 0.657 . . . . 0.0 111.124 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.666 HG23 ' HB3' ' A' ' 295' ' ' ALA . 0.1 OUTLIER -132.22 174.33 13.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.542 178.357 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' A' ' 293' ' ' PHE . 5.6 mptp? -110.23 135.83 50.38 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 172.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . 0.679 ' O ' ' HA ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -142.65 105.87 4.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.806 0.812 . . . . 0.0 110.566 178.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.588 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 31.4 m -81.15 86.06 6.24 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 . . . . . 0 C--N 1.319 -0.744 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.93 -170.068 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . 0.437 ' HB2' ' H ' ' A' ' 293' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.138 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . 0.679 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 2.2 p90 -109.77 88.36 2.73 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -166.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 92.3 m -151.63 112.03 4.15 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 122.061 -0.4 . . . . 0.0 110.975 175.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . 0.666 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -131.35 -177.1 4.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.555 0.217 . . . . 0.0 111.197 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 7.5 m -143.39 131.56 21.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.876 0.846 . . . . 0.0 113.061 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.552 HG13 HG21 ' A' ' 311' ' ' VAL . 63.2 t -76.75 141.55 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 113.551 -1.658 . . . . 0.0 111.135 -178.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 15.1 m -110.35 -14.23 14.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -176.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -162.03 -175.63 4.74 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 122.158 -0.339 . . . . 0.0 111.266 -177.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -59.15 113.99 2.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.029 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.45 ' HB2' ' HB ' ' A' ' 311' ' ' VAL . . . -94.87 101.5 13.3 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.476 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 309' ' ' VAL . 5.1 m-20 -58.55 127.3 31.49 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.708 -174.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.51 ' HB2' ' CE2' ' A' ' 261' ' ' PHE . 30.2 t -114.97 113.39 24.06 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 120.73 0.3 . . . . 0.0 111.267 172.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -127.16 152.21 47.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 170.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 10.8 t -74.72 -4.31 36.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.712 -172.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -68.63 -11.46 62.56 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 172.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . 0.421 ' HA2' ' HB2' ' A' ' 254' ' ' ALA . . . 92.55 37.12 5.93 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.067 -0.567 . . . . 0.0 113.384 176.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -125.81 141.9 51.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 117.225 0.513 . . . . 0.0 111.407 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 302' ' ' ASN . 1.6 p -152.24 100.37 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.16 174.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.478 ' OG1' HG23 ' A' ' 250' ' ' THR . 63.8 m -93.15 129.83 39.02 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.521 -0.737 . . . . 0.0 110.824 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.552 HG21 HG13 ' A' ' 297' ' ' VAL . 2.1 p -157.61 141.92 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 54.7 m -94.48 147.67 23.02 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.047 0.451 . . . . 0.0 110.122 175.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.441 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.0 mp -131.54 170.82 14.19 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.717 -174.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 246' ' ' GLN . 29.8 p . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.066 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.493 HG12 ' H ' ' A' ' 334' ' ' GLU . 2.9 t . . . . . 0 CA--C 1.529 0.165 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . 0.493 ' H ' HG12 ' A' ' 333' ' ' VAL . 33.7 tt0 -115.11 134.83 54.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.683 0.277 . . . . 0.0 111.118 -174.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -97.85 173.06 7.27 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.674 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 117.73 1.97 17.14 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.432 -0.89 . . . . 0.0 113.879 170.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 271' ' ' THR . 10.7 p-10 -79.47 173.01 13.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.079 0.439 . . . . 0.0 111.484 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -110.84 148.7 31.85 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.255 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.562 HG21 HD23 ' A' ' 251' ' ' LEU . 73.9 t -127.28 150.74 33.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.841 0.353 . . . . 0.0 111.82 -169.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.539 ' HB3' ' HB2' ' A' ' 269' ' ' LYS . 31.0 t -151.74 178.03 9.79 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 175.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.424 HG13 HD11 ' A' ' 262' ' ' LEU . 58.9 t -119.19 144.03 28.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 122.338 -0.226 . . . . 0.0 110.971 -176.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 50.7 t . . . . . 0 CA--C 1.523 -0.073 0 CA-C-O 121.061 0.457 . . . . 0.0 110.037 174.355 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.109 0 N-CA-C 112.618 -0.193 . . . . 0.0 112.618 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 23.7 m -136.34 136.56 39.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.978 0.418 . . . . 0.0 110.705 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.511 ' HB2' ' CG1' ' A' ' 339' ' ' VAL . 1.2 mp -139.51 175.75 9.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.752 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 24.7 m -130.63 160.24 34.81 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.521 HG23 HG23 ' A' ' 339' ' ' VAL . 73.8 t -118.42 147.01 22.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 122.304 -0.248 . . . . 0.0 110.692 174.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -117.6 -19.02 9.56 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 39.6 p -124.7 -167.61 1.69 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.47 ' HB3' HG23 ' A' ' 333' ' ' VAL . 83.2 mt-30 -112.7 131.01 22.9 Favored Pre-proline 0 C--N 1.316 -0.881 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -173.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.412 ' HA ' HG22 ' A' ' 249' ' ' VAL . 35.2 Cg_endo -66.95 104.04 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.06 1.84 . . . . 0.0 111.545 177.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 5.0 t -154.91 116.86 4.16 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.416 0.627 . . . . 0.0 111.778 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.71 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.5 174.42 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 168.404 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . 0.505 ' H ' HG13 ' A' ' 236' ' ' VAL . 66.9 m -37.62 110.03 0.11 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -174.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -112.18 83.96 1.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.042 170.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -110.96 132.86 53.85 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.39 -39.91 5.75 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.733 -170.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.45 -27.21 42.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.471 0.653 . . . . 0.0 109.938 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -96.33 -13.93 22.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.837 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 60.45 68.46 0.76 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.471 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 41.7 m -149.08 100.86 3.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.36 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -116.84 109.74 17.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.551 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . 0.452 ' HB2' HG12 ' A' ' 236' ' ' VAL . 0.5 OUTLIER -131.41 161.44 32.44 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 172.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.71 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 0.7 OUTLIER -160.12 133.67 7.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.471 0.176 . . . . 0.0 111.109 179.056 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 48.2 m -108.47 143.1 37.89 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 122.35 -0.218 . . . . 0.0 110.506 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.517 HG23 ' CD2' ' A' ' 313' ' ' LEU . 0.4 OUTLIER -146.09 148.36 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.923 178.612 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.593 HG23 ' OG1' ' A' ' 310' ' ' THR . 28.2 m -97.68 114.47 26.44 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 169.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 309' ' ' VAL . 4.9 mp -109.81 164.79 12.24 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 -175.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.83 140.42 52.95 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -135.22 -143.32 4.73 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.388 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.512 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -108.75 -176.5 3.06 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.981 0.419 . . . . 0.0 112.102 -177.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.597 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.6 OUTLIER -68.94 -179.54 1.51 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.146 -171.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.597 ' H ' HG22 ' A' ' 255' ' ' THR . . . -60.49 -177.39 0.07 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.233 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 46.9 m 79.48 6.19 2.01 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.734 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 10.9 t -124.29 89.51 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.799 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 171.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 11.6 m -73.22 98.38 2.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.831 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 61.84 98.82 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.842 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -43.1 -56.36 3.41 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.827 0.346 . . . . 0.0 111.139 173.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.54 167.08 23.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.928 -177.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.432 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 48.6 mtmt -137.25 -166.34 1.91 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -176.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -46.68 116.09 1.23 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.983 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 117.5 -10.53 14.45 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.092 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -101.96 138.6 38.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.951 0.405 . . . . 0.0 110.829 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' GLN . . . . . 0.401 ' HB2' HG11 ' A' ' 342' ' ' VAL . 1.9 mp0 -107.24 153.43 22.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.32 0.581 . . . . 0.0 110.191 -176.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.624 HG23 ' HB3' ' A' ' 295' ' ' ALA . 1.7 m -133.97 168.2 24.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 176.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.32 135.27 32.03 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.067 170.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . 0.608 ' HB3' ' HA ' ' A' ' 339' ' ' VAL . 35.1 p90 -147.64 167.39 24.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.83 -0.168 . . . . 0.0 111.21 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 1.8 t -158.24 119.06 3.4 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.379 0.609 . . . . 0.0 112.19 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.561 ' HB2' ' CA ' ' A' ' 337' ' ' ASP . 51.0 t30 . . . . . 0 C--N 1.324 -0.509 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 160.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 30.4 p . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -127.11 137.19 52.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.099 0.476 . . . . 0.0 110.101 175.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 85.7 m -82.45 136.32 34.95 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.886 -174.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . 0.624 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -114.85 177.04 4.79 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.877 176.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 7.2 m -141.02 114.14 8.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.457 0.646 . . . . 0.0 111.398 177.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 67.3 t -75.51 131.77 34.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.013 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 8.4 p -123.31 24.35 8.76 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.101 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -152.4 164.39 37.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.027 0.442 . . . . 0.0 111.983 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.432 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 2.3 m-20 -60.41 112.47 1.97 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.974 176.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -92.66 175.54 6.78 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.032 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.588 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 64.2 t30 -149.46 122.34 8.74 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -168.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.4 94.87 5.32 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 163.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . 0.429 ' HB3' HD21 ' A' ' 302' ' ' ASN . 2.2 p-10 -96.23 -178.53 4.35 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.005 -174.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 25.5 m -58.66 -33.06 69.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.871 0.367 . . . . 0.0 111.647 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -82.03 -5.8 89.41 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.146 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 67.47 42.46 89.04 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.114 -176.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -116.62 132.27 56.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.78 0.79 . . . . 0.0 111.343 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.588 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.5 OUTLIER -135.06 102.58 3.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.945 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.593 ' OG1' HG23 ' A' ' 250' ' ' THR . 95.3 m -107.66 113.89 27.49 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.774 -0.579 . . . . 0.0 110.533 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 27.5 m -143.06 157.6 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-O 121.545 0.688 . . . . 0.0 110.698 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 26.3 m -109.02 148.24 31.08 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.224 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.573 HD22 ' N ' ' A' ' 313' ' ' LEU . 0.8 OUTLIER -112.23 135.01 53.43 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.237 -176.145 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 41.5 m . . . . . 0 C--N 1.316 -0.875 0 C-N-CA 119.738 -0.785 . . . . 0.0 112.621 -171.794 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 233' ' ' GLN . 16.6 m . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.761 0.315 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -115.41 152.14 33.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.566 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -90.61 126.04 35.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.24 -175.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 230' ' ' VAL . . . 129.38 13.13 2.39 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.083 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.561 ' CA ' ' HB2' ' A' ' 272' ' ' ASN . 3.0 m-20 -49.03 134.65 16.97 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.92 105.67 3.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.302 168.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.608 ' HA ' ' HB3' ' A' ' 270' ' ' PHE . 75.7 t -95.04 139.16 19.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.399 0.619 . . . . 0.0 111.888 -173.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 41.2 m -147.82 157.28 43.46 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.059 172.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 20.8 t -87.76 151.24 3.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.401 HG11 ' HB2' ' A' ' 267' ' ' GLN . 8.9 p . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.566 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.514 0 N-CA-C 112.719 -0.153 . . . . 0.0 112.719 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 8.3 m -79.15 140.03 37.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.811 0.338 . . . . 0.0 110.493 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.518 HD23 ' HA3' ' A' ' 253' ' ' GLY . 1.8 mp -132.7 177.41 7.64 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 252' ' ' THR . 82.0 m -128.75 159.95 34.06 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.636 0.255 . . . . 0.0 110.853 -174.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 41.8 t -110.05 138.39 38.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 43.3 tttm -111.34 -34.62 6.08 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.388 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 76.3 p -119.91 -169.46 1.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.523 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.532 ' HB3' HG13 ' A' ' 333' ' ' VAL . 87.4 mt-30 -112.37 120.8 40.62 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 120.512 0.196 . . . . 0.0 111.235 -167.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.661 ' HB3' ' CD1' ' A' ' 247' ' ' PHE . 88.9 Cg_exo -51.1 102.68 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.172 2.581 . . . . 0.0 113.313 175.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 236' ' ' VAL . 8.7 t -158.38 113.98 2.67 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 174.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.565 HG12 ' HB2' ' A' ' 246' ' ' GLN . 7.9 t -154.01 125.05 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 120.915 0.388 . . . . 0.0 110.889 169.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 26.5 m 48.15 89.53 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 123.82 0.848 . . . . 0.0 111.906 177.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -99.05 89.09 4.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.332 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -111.07 114.91 28.54 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 175.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -94.78 -50.39 5.17 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -168.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 49.0 t -65.45 -23.27 32.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.306 0.574 . . . . 0.0 110.129 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -96.02 -8.43 33.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.231 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 14.9 t70 55.41 69.61 0.72 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.955 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 17.8 m -145.2 105.11 4.02 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.819 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -129.84 122.43 28.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.847 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . 0.565 ' HB2' HG12 ' A' ' 236' ' ' VAL . 0.3 OUTLIER -120.73 -176.9 3.34 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 172.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.661 ' CD1' ' HB3' ' A' ' 234' ' ' PRO . 1.2 p90 -166.41 126.81 1.66 Allowed 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 119.969 -0.692 . . . . 0.0 112.793 174.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 37.2 m -99.75 131.25 45.85 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.403 HG22 ' HA ' ' A' ' 234' ' ' PRO . 19.4 t -138.67 141.9 35.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 119.609 -0.836 . . . . 0.0 112.111 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.441 HG23 ' OG1' ' A' ' 310' ' ' THR . 98.3 m -94.08 115.83 28.19 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.556 ' HB2' HG13 ' A' ' 309' ' ' VAL . 5.2 mp -104.18 166.27 10.51 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -177.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' A' ' 229' ' ' THR . 0.7 OUTLIER -134.88 99.81 4.41 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.802 0.334 . . . . 0.0 111.34 -176.203 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.518 ' HA3' HD23 ' A' ' 228' ' ' LEU . . . -137.59 140.26 11.14 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.304 -0.719 . . . . 0.0 111.304 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -110.93 92.75 4.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.092 0.472 . . . . 0.0 112.081 -172.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 38.7 m -125.82 106.77 9.92 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.273 171.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' A' ' 305' ' ' SER . . . -63.16 141.47 58.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -175.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 6.0 t 61.72 53.32 3.24 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.92 171.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 49.0 t -137.45 103.84 2.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.164 0.507 . . . . 0.0 110.009 174.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 36.2 m -79.11 87.75 4.86 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.401 0.619 . . . . 0.0 110.299 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 94.4 92.98 1.64 Allowed Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.384 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.743 ' CE1' ' HB3' ' A' ' 303' ' ' SER . 3.0 m-85 -45.2 -59.26 2.73 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.324 0.583 . . . . 0.0 111.557 172.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.76 HD11 ' HB2' ' A' ' 266' ' ' ASP . 2.8 tm? -166.8 140.51 3.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.679 -166.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -125.94 -171.2 2.33 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -51.89 131.49 31.06 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.084 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 122.32 -32.23 4.59 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.513 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . 0.76 ' HB2' HD11 ' A' ' 262' ' ' LEU . 9.5 m-20 -108.07 154.49 21.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.005 0.431 . . . . 0.0 110.449 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' GLN . . . . . 0.534 ' HB2' HG11 ' A' ' 342' ' ' VAL . 10.7 mt-30 -115.04 161.97 17.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.43 0.633 . . . . 0.0 111.44 -173.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.61 HG23 ' HB3' ' A' ' 295' ' ' ALA . 0.4 OUTLIER -126.18 -175.46 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.205 178.297 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.454 ' HD2' ' C ' ' A' ' 269' ' ' LYS . 2.5 tmmm? -148.54 134.71 19.31 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -146.66 148.1 31.7 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 118.779 -1.169 . . . . 0.0 112.258 176.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 81.0 p -95.83 111.44 23.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.569 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.479 ' HA ' ' OD1' ' A' ' 337' ' ' ASP . 25.7 p-10 . . . . . 0 C--N 1.323 -0.58 0 CA-C-O 121.027 0.442 . . . . 0.0 110.877 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 32.2 m . . . . . 0 N--CA 1.448 -0.574 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -161.05 162.29 31.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.472 0.653 . . . . 0.0 111.443 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 268' ' ' VAL . 98.1 m -88.86 127.15 35.62 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.607 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . 0.61 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -108.47 175.91 5.3 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 45.0 m -135.32 123.35 22.77 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.816 HG13 HG21 ' A' ' 311' ' ' VAL . 91.0 t -77.72 124.97 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.872 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 312' ' ' THR . 15.0 t -132.77 17.95 4.24 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.303 -170.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -152.78 -173.32 4.53 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.146 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -70.94 139.68 50.73 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.186 0.517 . . . . 0.0 109.717 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.575 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -136.17 167.6 20.96 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.742 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -140.25 157.6 45.32 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.091 -177.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.743 ' HB3' ' CE1' ' A' ' 261' ' ' PHE . 0.0 OUTLIER -139.18 96.01 3.04 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.422 174.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . 0.421 ' OD2' ' HB2' ' A' ' 308' ' ' ASP . 2.0 p-10 -108.7 153.65 23.14 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 171.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . 0.522 ' HB3' ' HB2' ' A' ' 256' ' ' ALA . 0.1 OUTLIER -68.65 -7.61 34.79 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -171.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -75.31 -4.68 74.67 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 175.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 86.46 42.85 6.38 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.933 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.421 ' HB2' ' OD2' ' A' ' 304' ' ' ASP . 3.9 m-20 -125.21 137.05 54.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.69 0.745 . . . . 0.0 112.119 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 251' ' ' LEU . 1.2 p -154.97 106.33 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.175 174.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.441 ' OG1' HG23 ' A' ' 250' ' ' THR . 54.5 m -106.44 130.28 54.27 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 121.16 -0.962 . . . . 0.0 111.431 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.816 HG21 HG13 ' A' ' 297' ' ' VAL . 7.1 p -159.55 147.43 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.131 0.491 . . . . 0.0 110.549 174.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 52.8 m -86.31 150.1 24.58 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.06 174.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.529 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.2 mp -126.05 164.83 19.99 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.284 -177.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.754 179.57 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.532 HG13 ' HB3' ' A' ' 233' ' ' GLN . 6.8 p . . . . . 0 CA--C 1.533 0.299 0 CA-C-O 120.569 0.224 . . . . 0.0 110.718 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -118.59 144.41 46.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.685 -174.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -100.58 151.98 20.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.401 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 112.45 12.08 14.0 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.391 173.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.479 ' OD1' ' HA ' ' A' ' 272' ' ' ASN . 10.8 m-20 -71.73 168.92 16.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.056 0.455 . . . . 0.0 111.463 -177.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -98.97 122.36 42.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.535 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.482 HG21 HD23 ' A' ' 251' ' ' LEU . 49.6 t -100.79 145.36 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.248 0.547 . . . . 0.0 111.773 -172.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 53.7 m -151.22 179.07 8.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.186 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 29.6 t -111.96 143.69 21.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.534 HG11 ' HB2' ' A' ' 267' ' ' GLN . 9.7 p . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 120.976 0.417 . . . . 0.0 110.88 -175.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 112.857 -0.097 . . . . 0.0 112.857 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 87.2 m -129.38 131.28 46.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 2.4 mp -136.87 -178.36 5.16 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 60.9 m -128.4 153.78 46.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.765 0.317 . . . . 0.0 111.532 -171.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.465 ' CG2' HG23 ' A' ' 339' ' ' VAL . 22.0 t -110.53 133.0 57.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.487 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -125.22 12.09 8.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.824 0.345 . . . . 0.0 111.591 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.4 p -144.61 -172.0 3.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.596 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.716 ' OE1' ' HB2' ' A' ' 335' ' ' ALA . 1.3 mm100 -114.03 134.39 22.17 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -174.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.476 ' HB3' ' CG ' ' A' ' 247' ' ' PHE . 28.4 Cg_exo -61.95 104.97 0.35 Allowed 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.224 1.95 . . . . 0.0 111.454 173.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.422 ' O ' HG23 ' A' ' 236' ' ' VAL . 5.8 t -156.02 103.86 2.24 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.675 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.75 173.41 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.139 0.575 . . . . 0.0 110.561 170.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . 0.548 ' H ' HG13 ' A' ' 236' ' ' VAL . 45.5 m -23.13 115.76 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.467 1.507 . . . . 0.0 114.521 -174.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -111.91 83.58 1.81 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.759 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.482 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 4.5 t30 -103.34 99.65 9.5 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -175.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -86.5 -47.94 8.83 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -163.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 37.7 t -65.88 -23.26 31.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.7 0.762 . . . . 0.0 109.313 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.482 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 28.0 mmmt -93.75 -7.47 43.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.16 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 54.83 58.98 4.35 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.424 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 19.8 m -136.83 102.86 5.01 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.62 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -120.73 116.62 25.62 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . 0.479 ' HB2' HG12 ' A' ' 236' ' ' VAL . 22.5 mt-30 -133.61 158.74 42.43 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 177.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.675 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 3.6 p90 -140.83 138.66 34.17 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.101 172.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 54.3 m -97.25 135.89 38.54 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 42.3 t -142.43 141.61 27.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.715 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.481 HG23 ' OG1' ' A' ' 310' ' ' THR . 90.8 m -88.08 113.83 24.1 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 168.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 309' ' ' VAL . 4.9 mp -104.34 163.95 12.07 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -176.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.9 140.87 52.53 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -139.3 -143.07 4.35 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.289 -175.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -106.02 -174.51 2.55 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -174.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.587 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.6 OUTLIER -71.51 -178.54 2.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.733 -172.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.587 ' H ' HG22 ' A' ' 255' ' ' THR . . . -62.41 -176.9 0.12 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.123 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 15.6 t 80.77 7.5 1.32 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.991 0.917 . . . . 0.0 110.559 -175.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 21.2 t -126.25 89.52 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-O 121.562 0.696 . . . . 0.0 109.216 170.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 31.2 m -74.37 99.66 3.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.426 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 67.16 94.48 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.455 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -43.42 -59.32 2.18 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 111.427 174.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 266' ' ' ASP . 95.9 mt -148.49 162.68 39.13 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 9.6 mtpm? -137.22 -167.26 2.07 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.625 0.231 . . . . 0.0 111.625 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -53.33 113.32 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.273 0.558 . . . . 0.0 111.86 -175.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 109.93 -17.74 29.57 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.553 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 30.2 m-20 -77.52 144.81 37.38 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' GLN . . . . . 0.63 ' HB2' HG11 ' A' ' 342' ' ' VAL . 35.4 mt-30 -111.98 154.57 25.1 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.619 0.723 . . . . 0.0 111.192 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 295' ' ' ALA . 0.0 OUTLIER -121.98 -176.65 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.623 178.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 340' ' ' SER . 16.8 tppt? -125.29 89.02 2.98 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.719 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . 0.457 ' HB3' ' CE1' ' A' ' 293' ' ' PHE . 6.8 t80 -81.73 128.33 33.87 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -171.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.456 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 85.7 m -119.25 87.4 2.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.046 0.45 . . . . 0.0 109.855 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.478 ' HA ' ' HB2' ' A' ' 337' ' ' ASP . 22.6 t-20 . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.222 -175.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 120.922 0.391 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . 0.457 ' CE1' ' HB3' ' A' ' 270' ' ' PHE . 13.0 p90 -140.69 161.0 38.81 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 46.4 m -88.48 111.41 21.79 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.831 0.348 . . . . 0.0 110.551 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . 0.458 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -97.6 -178.16 4.04 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.583 ' O ' ' HA ' ' A' ' 313' ' ' LEU . 93.2 m -136.96 131.85 33.56 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -174.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.53 HG13 HG21 ' A' ' 311' ' ' VAL . 67.3 t -78.5 131.49 34.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.703 174.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 312' ' ' THR . 6.9 t -111.41 2.35 17.5 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.757 -0.777 . . . . 0.0 112.723 -167.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -170.55 -166.49 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.776 -178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.92 144.54 27.89 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.508 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -137.59 173.58 11.51 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.854 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.676 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 6.9 t30 -146.34 128.7 15.86 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -169.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.453 ' HB2' ' HB ' ' A' ' 258' ' ' VAL . 0.3 OUTLIER -117.87 95.12 4.78 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 165.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . 0.51 ' HB3' HD21 ' A' ' 302' ' ' ASN . 4.6 p-10 -104.04 -177.21 3.3 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.925 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 39.1 m -60.88 -30.98 70.48 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.708 0.289 . . . . 0.0 111.425 -177.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -77.61 0.94 68.54 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.207 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 56.32 41.58 87.52 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.408 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -116.38 127.89 55.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.696 0.748 . . . . 0.0 111.005 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.676 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.4 OUTLIER -135.34 104.45 4.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.344 -179.398 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.481 ' OG1' HG23 ' A' ' 250' ' ' THR . 94.6 m -105.35 121.09 43.16 Favored 'General case' 0 C--N 1.316 -0.858 0 O-C-N 121.865 -0.522 . . . . 0.0 110.776 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.53 HG21 HG13 ' A' ' 297' ' ' VAL . 7.7 p -157.65 150.26 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 121.089 0.471 . . . . 0.0 110.006 176.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 58.1 m -85.54 151.95 23.54 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.265 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' A' ' 296' ' ' THR . 5.9 mp -114.53 135.47 54.09 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.747 -177.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . 0.433 ' HA ' ' HG2' ' A' ' 246' ' ' GLN . 14.1 p . . . . . 0 C--N 1.324 -0.505 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -174.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 13.2 t . . . . . 0 CA--C 1.537 0.471 0 CA-C-O 121.012 0.434 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -97.25 144.54 26.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.493 -165.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.716 ' HB2' ' OE1' ' A' ' 233' ' ' GLN . . . -98.84 172.24 7.56 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.878 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 96.71 9.92 55.9 Favored Glycine 0 CA--C 1.511 -0.205 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.086 171.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.478 ' HB2' ' HA ' ' A' ' 272' ' ' ASN . 12.5 p-10 -88.43 -176.11 5.21 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.831 0.348 . . . . 0.0 110.854 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -120.16 145.76 46.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.438 0.637 . . . . 0.0 111.803 -171.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 79.4 t -108.63 150.23 11.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.973 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.516 ' HB2' ' HB3' ' A' ' 269' ' ' LYS . 69.3 m -144.89 176.7 9.27 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 174.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.413 HG13 HD11 ' A' ' 262' ' ' LEU . 44.6 t -117.94 140.39 41.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.63 HG11 ' HB2' ' A' ' 267' ' ' GLN . 5.3 p . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.83 0.348 . . . . 0.0 110.692 -175.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.412 0 N-CA-C 112.341 -0.304 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 19.3 m -75.04 143.86 43.29 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.958 0.408 . . . . 0.0 111.031 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.448 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.1 mp -135.21 -178.74 5.24 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 70.8 m -130.24 150.43 51.49 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.885 0.374 . . . . 0.0 111.894 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.81 106.68 19.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -93.09 -16.92 24.42 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.972 0.415 . . . . 0.0 111.207 -173.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 32.1 p -130.84 -169.15 2.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.757 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.517 ' HB3' HG23 ' A' ' 333' ' ' VAL . 70.6 mt-30 -105.61 120.49 49.15 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.048 -170.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.527 ' HA ' HG22 ' A' ' 249' ' ' VAL . 15.0 Cg_exo -66.5 105.61 0.93 Allowed 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.378 2.052 . . . . 0.0 111.618 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 8.0 t -154.67 121.84 5.61 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.66 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -155.14 174.02 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 166.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . 0.532 ' H ' HG13 ' A' ' 236' ' ' VAL . 62.9 m -23.78 110.07 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.88 1.272 . . . . 0.0 114.226 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -103.69 108.87 20.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.487 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.424 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 5.3 t30 -122.79 94.82 4.4 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -83.45 -50.12 8.62 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.08 -162.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 40.3 t -62.49 -23.1 31.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.662 0.744 . . . . 0.0 109.688 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.424 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 13.9 mmmm -96.18 -7.44 35.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.033 -178.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 60.28 57.5 2.89 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.684 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 11.7 t -139.95 112.9 8.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.907 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -129.52 110.12 11.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.591 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . 0.657 ' HB2' HG12 ' A' ' 236' ' ' VAL . 0.7 OUTLIER -114.65 165.93 12.26 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 173.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.66 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 1.7 p90 -157.65 125.98 5.53 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 51.9 m -94.17 133.07 38.07 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.527 HG22 ' HA ' ' A' ' 234' ' ' PRO . 0.8 OUTLIER -141.12 142.92 28.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 119.182 -1.007 . . . . 0.0 112.231 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.518 HG23 ' OG1' ' A' ' 310' ' ' THR . 21.9 m -93.79 111.97 23.75 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 165.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.57 ' HB2' HG13 ' A' ' 309' ' ' VAL . 5.2 mp -102.92 167.81 9.61 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -176.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.24 140.51 51.07 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -141.64 -143.1 4.19 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.329 -174.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -109.42 -173.93 2.38 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -174.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 256' ' ' ALA . 3.3 m -66.58 174.76 2.64 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.369 -172.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 255' ' ' THR . . . -59.52 -175.38 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.047 0.939 . . . . 0.0 113.012 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 69.8 m 81.18 10.88 0.87 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.992 0.917 . . . . 0.0 111.556 -177.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 22.3 t -128.73 89.79 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 167.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 7.2 m -71.72 97.17 1.71 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.384 -177.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 69.01 98.89 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.021 -172.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -44.34 -60.25 2.02 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 117.108 0.454 . . . . 0.0 110.933 172.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.514 ' HB3' ' CB ' ' A' ' 266' ' ' ASP . 94.4 mt -148.21 166.08 29.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.545 -174.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 97.6 mttt -141.36 -166.68 2.24 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -52.04 113.6 1.06 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.362 0.601 . . . . 0.0 112.058 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 110.92 -17.31 27.44 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.054 177.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . 0.514 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 18.0 m-20 -82.58 146.15 29.33 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.42 145.55 45.13 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.607 0.718 . . . . 0.0 111.641 -174.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.609 HG23 ' HB3' ' A' ' 295' ' ' ALA . 0.2 OUTLIER -121.75 -178.97 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.038 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.502 ' HD3' ' C ' ' A' ' 269' ' ' LYS . 1.0 OUTLIER -126.77 139.36 53.18 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . 0.544 ' CE1' ' HB2' ' A' ' 295' ' ' ALA . 8.1 p90 -146.48 157.46 43.75 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.644 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.541 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 5.6 t -137.38 95.89 3.16 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.955 176.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.42 ' HA ' ' CG ' ' A' ' 337' ' ' ASP . 4.0 m120 . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.551 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 25.9 p . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -165.34 -171.05 2.04 Favored 'General case' 0 C--O 1.23 0.079 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.912 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 91.3 m -88.76 134.65 33.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.914 -173.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . 0.609 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -117.5 176.0 5.37 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 54.5 m -130.82 125.44 33.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.597 0.713 . . . . 0.0 112.877 -176.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.649 HG13 HG21 ' A' ' 311' ' ' VAL . 60.7 t -75.33 130.5 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.714 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 3.5 m -115.78 -1.59 12.6 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.276 -169.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -160.13 -166.33 1.67 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.085 -0.384 . . . . 0.0 111.138 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.43 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 3.3 m-20 -66.32 157.62 31.25 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.468 0.651 . . . . 0.0 110.229 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.458 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -149.23 177.44 9.64 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.595 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -144.62 137.09 26.45 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.211 -0.196 . . . . 0.0 111.297 -171.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.8 OUTLIER -118.99 95.08 4.67 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 163.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.95 177.46 4.85 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.946 -174.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 11.6 t -59.58 -32.41 70.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.898 0.38 . . . . 0.0 111.004 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -78.9 4.23 62.16 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.252 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 59.94 42.33 98.22 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.631 176.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -114.55 131.1 56.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.454 0.627 . . . . 0.0 110.528 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 251' ' ' LEU . 2.1 p -132.45 95.01 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.501 0.667 . . . . 0.0 111.062 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.518 ' OG1' HG23 ' A' ' 250' ' ' THR . 76.7 m -101.42 128.41 47.63 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 122.011 -0.431 . . . . 0.0 111.827 -176.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.649 HG21 HG13 ' A' ' 297' ' ' VAL . 7.3 p -162.21 150.72 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.981 174.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 52.0 m -86.87 146.41 26.21 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.989 0.423 . . . . 0.0 110.584 177.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.485 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.4 mp -120.99 159.04 26.44 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.58 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 17.5 m . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.179 -178.507 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.517 HG23 ' HB3' ' A' ' 233' ' ' GLN . 6.1 m . . . . . 0 N--CA 1.456 -0.168 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.16 162.65 14.07 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.412 0.625 . . . . 0.0 111.627 -176.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -99.04 170.0 9.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.977 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 110.64 10.75 20.89 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.473 172.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.541 ' HB3' ' O ' ' A' ' 271' ' ' THR . 13.6 m-20 -96.27 -177.26 3.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.846 0.323 . . . . 0.0 111.778 -176.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -109.08 153.3 23.87 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -169.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.502 HG21 HD23 ' A' ' 251' ' ' LEU . 76.1 t -135.98 157.31 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.676 -175.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 5.6 t -156.97 179.73 9.02 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 172.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.498 HG13 HD11 ' A' ' 262' ' ' LEU . 69.2 t -115.88 133.08 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.126 0.489 . . . . 0.0 111.946 -175.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 71.8 t . . . . . 0 CA--C 1.529 0.171 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.887 176.114 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.547 0 N-CA-C 111.859 -0.497 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 10.3 m -135.38 136.01 41.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.782 0.325 . . . . 0.0 110.378 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.486 HD21 ' CE1' ' A' ' 261' ' ' PHE . 8.2 mt -147.88 174.68 11.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.267 -177.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 57.2 m -134.59 161.98 33.57 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 12.2 t -116.11 139.61 41.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.426 ' HD2' ' CG2' ' A' ' 252' ' ' THR . 38.0 tttt -120.17 -1.58 10.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.044 0.45 . . . . 0.0 111.117 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.462 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 19.8 p -139.33 -168.23 2.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.932 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -113.67 102.52 54.89 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -174.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 248' ' ' THR . 35.9 Cg_endo -66.99 105.72 1.02 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.216 1.944 . . . . 0.0 112.176 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 247' ' ' PHE . 12.0 t -113.03 144.51 42.48 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.319 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.492 ' HA ' ' HB3' ' A' ' 247' ' ' PHE . 28.9 t -80.81 122.99 36.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.03 -171.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 94.0 m -97.95 124.59 42.47 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.104 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -93.77 124.1 37.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.188 0.518 . . . . 0.0 110.987 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.47 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 20.5 t30 -127.04 70.85 1.3 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -86.06 -28.38 24.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.757 -161.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.46 -22.97 30.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 172.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.47 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 19.6 mmtp -101.05 -0.72 35.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.135 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 23.1 t70 50.82 52.66 14.49 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 113.999 -1.455 . . . . 0.0 111.3 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 24.2 m -140.25 128.96 23.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.423 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -109.47 110.84 22.07 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -118.37 176.65 5.14 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.111 -174.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.492 ' HB3' ' HA ' ' A' ' 236' ' ' VAL . 15.7 p90 -160.58 148.87 16.41 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.366 171.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 55.4 m -112.11 145.07 40.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.786 -168.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 9.9 p -154.08 142.8 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.462 ' HB ' ' CG2' ' A' ' 232' ' ' THR . 19.2 m -103.93 109.93 21.87 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 166.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.69 171.33 7.42 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.287 0.565 . . . . 0.0 109.695 -175.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.426 ' CG2' ' HD2' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -125.77 139.14 53.76 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.066 175.01 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -136.08 -143.72 4.73 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.025 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.532 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -101.75 -174.58 2.62 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.702 HG22 ' H ' ' A' ' 256' ' ' ALA . 2.1 m -73.69 -178.2 3.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.426 -173.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.702 ' H ' HG22 ' A' ' 255' ' ' THR . . . -59.19 -177.19 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.697 0.799 . . . . 0.0 112.868 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 33.8 t 80.89 7.63 1.26 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.077 0.951 . . . . 0.0 111.109 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 59.1 t -128.01 89.7 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 121.538 0.685 . . . . 0.0 109.512 171.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 87.0 m -76.94 98.75 5.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.48 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 68.23 89.64 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.493 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.671 ' HB3' HD22 ' A' ' 262' ' ' LEU . 8.2 m-85 -46.12 -59.58 2.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.538 0.685 . . . . 0.0 109.897 170.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.671 HD22 ' HB3' ' A' ' 261' ' ' PHE . 1.4 mm? -123.31 156.21 35.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.286 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 55.1 mtmt -132.81 -167.6 1.93 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 171.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -54.41 114.23 1.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.212 0.53 . . . . 0.0 111.386 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 106.57 -12.86 42.93 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.527 175.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . 0.477 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 8.7 m-20 -78.32 136.67 37.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.827 0.346 . . . . 0.0 110.32 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -110.95 141.69 44.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.715 0.769 . . . . 0.0 112.133 -171.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 294' ' ' THR . 2.4 m -118.58 169.94 8.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.43 176.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.32 135.11 19.96 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . 0.463 ' CB ' ' HA ' ' A' ' 339' ' ' VAL . 31.0 p90 -147.03 159.96 42.95 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.06 -1.056 . . . . 0.0 112.664 -173.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 82.7 p -99.69 96.06 7.36 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.943 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 . . . . . 0 C--N 1.323 -0.545 0 CA-C-O 121.372 0.606 . . . . 0.0 110.877 -176.289 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 C--O 1.234 0.251 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -134.56 145.3 48.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.032 0.444 . . . . 0.0 110.328 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 268' ' ' VAL . 91.2 m -90.32 131.17 36.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.157 -176.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -123.19 173.95 7.57 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.403 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 90.2 m -134.4 128.23 33.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.277 0.56 . . . . 0.0 112.456 -175.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 299' ' ' ALA . 40.2 t -86.42 139.6 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.812 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 312' ' ' THR . 15.0 t -111.5 11.44 21.35 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -176.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.616 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -153.23 177.56 10.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.847 0.356 . . . . 0.0 111.504 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.414 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 2.8 m-20 -67.95 114.55 6.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.3 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.531 ' HB3' ' H ' ' A' ' 262' ' ' LEU . . . -93.33 100.1 12.5 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.893 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.743 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 13.6 m120 -68.15 126.85 30.83 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -171.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.536 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 18.8 t -104.75 94.82 5.49 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 161.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.1 178.31 5.58 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.718 -175.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 6.3 t -61.18 -33.63 73.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.815 0.341 . . . . 0.0 111.198 -176.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -82.44 7.19 65.48 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.08 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 61.38 42.35 99.75 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.099 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -117.79 134.54 54.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 117.232 0.516 . . . . 0.0 111.082 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.743 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.1 OUTLIER -141.13 106.03 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.957 -178.003 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.451 ' OG1' HG23 ' A' ' 250' ' ' THR . 47.0 m -112.7 122.8 48.73 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.695 -0.628 . . . . 0.0 110.837 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 17.6 m -147.73 161.55 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-O 121.227 0.537 . . . . 0.0 110.895 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 298' ' ' THR . 15.5 m -113.73 138.24 50.51 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.478 172.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.415 HD13 ' CZ ' ' A' ' 247' ' ' PHE . 4.8 mp -103.26 149.28 24.86 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.609 -175.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--N 1.319 -0.726 0 CA-C-O 121.05 0.452 . . . . 0.0 111.845 -173.561 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 18.7 m . . . . . 0 C--O 1.234 0.254 0 CA-C-O 121.171 0.51 . . . . 0.0 111.902 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -123.87 147.04 47.98 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.798 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -69.14 139.31 54.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.841 -0.163 . . . . 0.0 111.111 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.63 -2.1 6.48 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.932 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 271' ' ' THR . 7.3 p-10 -75.66 168.66 19.6 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.256 0.55 . . . . 0.0 111.292 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -104.36 131.11 52.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.516 -171.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 270' ' ' PHE . 73.8 t -108.44 146.9 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.131 -176.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -143.98 165.09 28.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.277 173.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 48.3 t -109.41 142.4 22.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.235 -176.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 53.2 t . . . . . 0 C--N 1.331 -0.221 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 175.334 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 112.208 -0.357 . . . . 0.0 112.208 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 41.5 m -136.75 101.5 4.62 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.974 0.416 . . . . 0.0 109.948 -177.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.456 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.4 mp -119.4 176.2 5.46 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 63.9 m -138.55 158.34 44.45 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 -174.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.4 HG13 HG11 ' A' ' 249' ' ' VAL . 89.6 t -110.11 106.66 21.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 250' ' ' THR . 17.1 ptmt -93.27 -12.65 29.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.968 0.414 . . . . 0.0 111.02 -174.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.454 HG23 ' HG3' ' A' ' 231' ' ' LYS . 31.8 p -123.79 -166.95 1.55 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.32 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -112.6 121.06 39.71 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.145 -172.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -70.76 113.35 3.51 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.976 2.451 . . . . 0.0 111.849 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 10.1 t -147.23 109.06 4.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.782 0.801 . . . . 0.0 112.784 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.7 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.48 174.39 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 164.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . 0.545 ' H ' HG13 ' A' ' 236' ' ' VAL . 54.3 m -40.94 119.03 1.07 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -173.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -112.71 82.64 1.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 171.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -115.24 136.75 52.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -174.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.68 -45.12 4.29 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.566 -171.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.89 -27.94 43.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.31 0.576 . . . . 0.0 110.035 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -94.55 -7.37 41.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.832 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 56.53 61.48 2.66 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.309 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.8 t -144.43 95.62 2.74 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.575 0.702 . . . . 0.0 110.073 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -108.71 101.53 10.65 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.908 175.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . 0.621 ' HB2' HG12 ' A' ' 236' ' ' VAL . 71.6 mt-30 -130.04 156.36 44.62 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.7 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 15.6 p90 -157.47 136.88 11.99 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.588 0.232 . . . . 0.0 111.615 177.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.421 HG23 ' OG1' ' A' ' 312' ' ' THR . 32.8 m -101.02 133.5 45.42 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.494 ' HB ' HD11 ' A' ' 251' ' ' LEU . 0.3 OUTLIER -142.18 148.05 20.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.906 -176.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.548 HG23 ' OG1' ' A' ' 310' ' ' THR . 41.3 m -99.07 111.92 24.19 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.516 HD13 HG22 ' A' ' 311' ' ' VAL . 5.4 mp -106.15 167.83 9.54 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -172.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.402 HG23 ' HD2' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -114.41 148.63 37.42 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.839 174.431 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -144.94 -142.35 3.84 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -175.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.53 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -110.2 -174.19 2.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -68.59 -178.34 1.13 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.676 -170.436 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.547 ' H ' HG22 ' A' ' 255' ' ' THR . . . -67.5 -176.3 0.59 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.849 -177.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 22.7 t 81.03 7.99 1.17 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.491 0.716 . . . . 0.0 111.033 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 39.1 t -124.16 90.81 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 173.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 18.4 m -69.62 98.22 1.14 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.691 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 66.98 95.67 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.717 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -41.91 -56.43 2.75 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 172.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.3 pp -165.08 161.58 19.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.979 -0.1 . . . . 0.0 110.905 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.434 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 92.6 mttt -141.29 -165.91 2.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.722 0.296 . . . . 0.0 111.764 -175.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -49.46 117.95 2.48 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.769 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 113.84 -20.07 17.82 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.689 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -89.15 142.28 27.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.888 0.375 . . . . 0.0 110.191 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -112.02 153.25 27.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.343 0.592 . . . . 0.0 110.881 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -131.43 165.93 30.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.401 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.483 ' HD2' HG22 ' A' ' 342' ' ' VAL . 0.0 OUTLIER -119.3 150.37 40.24 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 169.537 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -149.06 143.27 25.95 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.25 168.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.41 ' HB ' ' OG ' ' A' ' 292' ' ' SER . 3.7 t -93.69 105.02 17.09 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.143 176.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.612 ' HA ' ' OD2' ' A' ' 337' ' ' ASP . 2.8 t-20 . . . . . 0 C--N 1.32 -0.683 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.321 -174.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . 0.41 ' OG ' ' HB ' ' A' ' 271' ' ' THR . 51.5 m . . . . . 0 C--O 1.233 0.236 0 CA-C-O 120.591 0.234 . . . . 0.0 110.415 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -150.04 166.74 28.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.869 0.366 . . . . 0.0 110.719 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 99.7 m -100.19 135.79 41.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.488 -173.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -126.77 177.61 6.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.185 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 87.4 m -134.26 134.69 42.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.29 0.567 . . . . 0.0 112.203 -176.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 84.4 t -93.84 144.54 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.282 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 4.2 m -131.4 25.32 4.82 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.985 0.422 . . . . 0.0 111.803 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.44 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -147.46 171.06 16.11 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.838 -0.539 . . . . 0.0 112.157 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.434 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 28.7 m-20 -63.62 157.18 24.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.721 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.412 ' HB2' ' CG1' ' A' ' 311' ' ' VAL . . . -141.77 168.82 18.84 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.953 -175.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.498 ' OD1' ' HB3' ' A' ' 304' ' ' ASP . 28.1 t-20 -143.85 131.98 21.8 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.869 -174.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.416 ' HB2' ' HB ' ' A' ' 258' ' ' VAL . 0.5 OUTLIER -115.58 94.53 4.74 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 163.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . 0.498 ' HB3' ' OD1' ' A' ' 302' ' ' ASN . 0.8 OUTLIER -94.92 176.31 6.3 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.763 -177.117 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 15.5 m -58.22 -32.87 68.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.027 0.441 . . . . 0.0 111.533 -177.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -77.42 -7.59 87.03 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.085 -178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 73.19 43.29 39.88 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.498 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -115.83 138.07 51.5 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 117.963 0.881 . . . . 0.0 111.488 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.9 OUTLIER -141.34 111.01 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.805 179.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.548 ' OG1' HG23 ' A' ' 250' ' ' THR . 88.9 m -100.49 122.54 43.38 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.602 -0.686 . . . . 0.0 111.01 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.516 HG22 HD13 ' A' ' 251' ' ' LEU . 9.6 m -145.0 155.72 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.545 0.688 . . . . 0.0 111.409 177.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.421 ' OG1' HG23 ' A' ' 248' ' ' THR . 20.7 m -112.3 140.19 47.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.547 177.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.519 HD13 ' CE2' ' A' ' 247' ' ' PHE . 5.1 mp -113.86 138.1 50.75 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.853 -174.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 C--N 1.32 -0.698 0 CA-C-O 120.786 0.327 . . . . 0.0 110.466 -179.764 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 18.7 m . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 121.799 0.809 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -164.44 132.25 3.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.81 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -99.41 158.05 16.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.69 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.36 -22.1 5.35 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.878 175.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.612 ' OD2' ' HA ' ' A' ' 272' ' ' ASN . 65.3 m-20 -56.34 141.14 42.88 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 117.226 0.513 . . . . 0.0 111.479 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -99.41 139.76 34.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.571 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 53.7 t -117.37 148.01 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -169.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 36.3 t -142.36 175.59 9.66 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 173.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.465 ' O ' ' HE2' ' A' ' 269' ' ' LYS . 40.0 t -118.66 146.07 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 O-C-N 122.265 -0.272 . . . . 0.0 110.602 -174.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.483 HG22 ' HD2' ' A' ' 269' ' ' LYS . 42.0 t . . . . . 0 N--CA 1.463 0.201 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.709 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 112.078 -0.409 . . . . 0.0 112.078 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.8 m -94.71 134.9 36.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.916 0.388 . . . . 0.0 109.978 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.474 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 1.1 mp -134.02 176.04 8.94 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.438 ' HB ' ' OG1' ' A' ' 252' ' ' THR . 35.4 m -122.33 154.79 37.16 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.667 0.27 . . . . 0.0 110.728 -175.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.506 HG21 ' OD2' ' A' ' 337' ' ' ASP . 99.2 t -97.91 133.15 41.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.172 -177.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.557 ' HD3' HG22 ' A' ' 250' ' ' THR . 33.2 mtpt -109.37 -38.19 5.55 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 171.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.712 ' O ' HG13 ' A' ' 249' ' ' VAL . 70.9 p -141.0 160.87 39.15 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 172.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.551 ' CD ' ' HD2' ' A' ' 234' ' ' PRO . 6.0 mm100 -116.12 163.74 20.42 Favored Pre-proline 0 C--N 1.318 -0.772 0 C-N-CA 123.369 0.667 . . . . 0.0 110.075 -176.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.594 ' HB3' ' CD2' ' A' ' 247' ' ' PHE . 5.6 Cg_exo -38.47 109.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 124.824 3.683 . . . . 0.0 115.126 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.441 ' O ' HG23 ' A' ' 236' ' ' VAL . 9.0 t -155.25 92.42 1.42 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.368 0.604 . . . . 0.0 111.596 173.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.75 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -157.75 175.17 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.983 171.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . 0.593 ' H ' HG13 ' A' ' 236' ' ' VAL . 60.7 m -37.28 119.14 0.67 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.811 1.244 . . . . 0.0 114.093 -171.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -108.11 83.91 1.86 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 174.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.454 HD22 ' HA ' ' A' ' 239' ' ' ASN . 0.2 OUTLIER -96.56 115.82 28.07 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -175.513 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -101.18 -42.76 6.23 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -166.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.11 -24.19 33.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.624 0.726 . . . . 0.0 109.405 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -98.32 -8.89 26.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.014 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 16.1 t70 53.1 57.23 6.51 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.442 -175.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.7 m -129.47 96.94 4.41 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.1 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -115.91 109.25 17.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.659 -173.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -126.92 153.47 45.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.75 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 35.2 p90 -148.33 140.73 24.3 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.541 -0.463 . . . . 0.0 111.187 174.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 85.2 m -97.85 143.82 28.06 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 122.19 -0.319 . . . . 0.0 110.287 -178.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.712 HG13 ' O ' ' A' ' 232' ' ' THR . 41.6 t -140.64 125.14 18.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.862 177.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.563 HG23 ' OG1' ' A' ' 310' ' ' THR . 41.5 m -90.85 129.62 36.89 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 173.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.535 HD23 HG11 ' A' ' 339' ' ' VAL . 4.4 mp -120.3 165.39 14.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.585 0.707 . . . . 0.0 110.438 -176.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.463 HG23 ' HD2' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -120.75 136.98 54.73 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.375 -0.83 . . . . 0.0 108.973 169.57 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -127.58 -143.53 5.75 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.011 -176.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -112.99 -173.23 2.21 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 256' ' ' ALA . 1.4 m -56.5 168.82 0.51 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.581 -171.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.478 ' H ' HG22 ' A' ' 255' ' ' THR . . . -66.48 -176.77 0.49 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.294 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 10.9 t 79.6 16.76 0.83 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.009 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 45.1 t -128.96 90.45 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.784 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 172.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 23.2 m -73.68 95.82 2.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.147 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 75.43 93.8 0.16 Allowed Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.358 -0.837 . . . . 0.0 113.067 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -42.63 -56.14 3.25 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 171.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -161.79 164.82 28.64 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -140.02 -166.96 2.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -50.48 123.38 8.61 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.752 0.787 . . . . 0.0 111.903 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 109.39 -21.97 25.43 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.737 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -87.52 139.54 30.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.879 0.371 . . . . 0.0 110.16 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -111.74 143.45 42.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.159 0.504 . . . . 0.0 111.197 -175.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.2 OUTLIER -116.26 179.62 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.277 174.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.556 ' HD2' ' C ' ' A' ' 269' ' ' LYS . 3.0 tmmm? -138.35 128.57 25.84 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -116.4 157.66 24.74 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.783 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.503 ' HA ' ' OG ' ' A' ' 292' ' ' SER . 41.4 p -136.92 98.23 3.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.507 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.451 ' HA ' ' CG ' ' A' ' 337' ' ' ASP . 25.5 p-10 . . . . . 0 C--N 1.321 -0.649 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.81 -173.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . 0.503 ' OG ' ' HA ' ' A' ' 271' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -142.81 -150.47 0.31 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -172.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 35.1 m -74.93 144.97 43.0 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -168.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -126.86 159.28 34.39 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 165.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 93.1 m -122.77 119.43 30.61 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.801 -0.759 . . . . 0.0 112.381 -175.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 64.9 t -78.81 133.99 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.614 -177.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 3.4 m -129.38 24.65 5.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.307 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.411 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -151.07 166.85 29.5 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.208 0.527 . . . . 0.0 112.134 -175.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -65.86 115.82 6.37 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.244 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.523 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -93.29 170.25 9.76 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.629 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.643 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 9.5 t30 -149.02 131.75 15.97 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.59 -171.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -113.85 95.52 5.36 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 169.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . 0.596 ' HB3' HD21 ' A' ' 302' ' ' ASN . 0.8 OUTLIER -96.35 178.52 5.34 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.007 -176.652 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 23.2 t -59.9 -34.38 73.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.938 0.399 . . . . 0.0 111.207 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -83.88 4.01 83.9 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.857 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 64.35 43.17 97.23 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.797 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -113.18 133.9 54.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 118.116 0.958 . . . . 0.0 111.634 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.643 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.1 OUTLIER -137.84 119.55 18.08 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.974 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.009 178.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.563 ' OG1' HG23 ' A' ' 250' ' ' THR . 76.6 m -120.51 126.11 49.55 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.379 -0.826 . . . . 0.0 110.979 -178.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 30.7 m -138.2 163.47 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.638 0.732 . . . . 0.0 111.485 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 31.4 m -123.25 138.58 54.6 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.1 173.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 313' ' ' LEU . 1.3 mm? -106.68 124.46 49.64 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.014 -169.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 C--N 1.325 -0.494 0 CA-C-O 121.147 0.499 . . . . 0.0 111.813 -171.689 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.518 ' HB ' ' CB ' ' A' ' 233' ' ' GLN . 14.7 m . . . . . 0 C--O 1.238 0.474 0 CA-C-O 120.67 0.271 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . 0.404 ' CD ' HD22 ' A' ' 272' ' ' ASN . 0.9 OUTLIER -108.93 129.8 55.43 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -163.02 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -100.26 115.82 30.81 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.003 -0.436 . . . . 0.0 111.975 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 129.05 12.06 2.7 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 119.554 -1.308 . . . . 0.0 114.82 170.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.506 ' OD2' HG21 ' A' ' 230' ' ' VAL . 3.9 p-10 -92.82 -148.74 0.25 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 117.548 0.674 . . . . 0.0 111.322 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -121.54 147.28 46.01 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -168.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.535 HG11 HD23 ' A' ' 251' ' ' LEU . 68.0 t -121.85 149.4 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.145 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.416 ' HB2' ' HE2' ' A' ' 269' ' ' LYS . 25.4 m -147.42 178.62 8.28 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 175.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 46.6 t -112.27 153.34 13.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 74.1 t . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 118.012 0.369 . . . . 0.0 110.52 -179.973 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.544 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 11.3 m -143.33 139.3 30.02 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.8 HD22 HG11 ' A' ' 309' ' ' VAL . 18.4 mt -142.0 176.26 9.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 251' ' ' LEU . 8.3 t -140.5 166.39 24.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.738 0.304 . . . . 0.0 110.335 -178.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 15.1 t -117.88 134.26 62.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.4 -168.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -128.6 11.87 6.3 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.86 0.362 . . . . 0.0 111.528 176.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.448 HG21 ' HB ' ' A' ' 250' ' ' THR . 17.4 p -141.06 -174.46 4.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.221 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -114.24 116.23 44.52 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -176.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.547 ' HB2' ' CD1' ' A' ' 247' ' ' PHE . 73.4 Cg_endo -78.28 106.7 2.18 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.455 2.103 . . . . 0.0 113.361 -176.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.44 ' O ' HG23 ' A' ' 236' ' ' VAL . 9.1 t -155.98 127.1 7.03 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.179 174.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.742 ' O ' ' HB2' ' A' ' 246' ' ' GLN . 47.7 t -154.35 81.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.384 0.674 . . . . 0.0 109.623 170.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 236' ' ' VAL . 33.1 m 83.14 94.89 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.939 175.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -111.67 90.22 3.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.925 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -122.91 135.86 54.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -103.64 -49.79 3.59 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.876 -170.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 75.9 t -60.36 -31.39 48.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.504 0.668 . . . . 0.0 110.071 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -91.05 -6.51 53.74 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.575 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 36.0 t70 54.55 63.98 1.97 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.435 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.7 m -143.27 99.82 3.51 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.622 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -120.78 112.92 19.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.033 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . 0.742 ' HB2' ' O ' ' A' ' 236' ' ' VAL . 69.7 mt-30 -135.48 170.33 16.12 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.672 ' HA ' ' N ' ' A' ' 236' ' ' VAL . 26.5 p90 -166.8 142.17 4.3 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 176.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.476 ' H ' HG23 ' A' ' 236' ' ' VAL . 34.0 m -104.5 142.9 33.8 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.96 139.67 27.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.769 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.516 HG23 ' OG1' ' A' ' 310' ' ' THR . 53.0 m -103.61 105.45 15.69 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 170.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.841 ' HB2' HG13 ' A' ' 309' ' ' VAL . 0.4 OUTLIER -106.4 171.36 7.4 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.553 0.692 . . . . 0.0 109.651 -174.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 307' ' ' GLY . 0.0 OUTLIER -121.81 144.37 48.86 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.703 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -144.73 -142.6 3.89 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.362 -172.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.535 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -95.58 -176.8 3.86 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -172.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.539 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -81.66 -177.16 6.42 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.867 -171.342 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.539 ' H ' HG22 ' A' ' 255' ' ' THR . . . -61.7 -177.61 0.11 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.668 -177.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 95.6 p 66.9 17.89 10.57 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.086 1.354 . . . . 0.0 110.895 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.444 HG11 ' CE2' ' A' ' 261' ' ' PHE . 12.9 t -129.06 88.83 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 31.6 m -87.79 92.56 9.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.347 -177.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 86.76 86.46 1.08 Allowed Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.533 178.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.444 ' CE2' HG11 ' A' ' 258' ' ' VAL . 0.8 OUTLIER -48.63 -45.06 37.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.093 0.473 . . . . 0.0 110.04 170.405 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.487 ' HB2' ' CB ' ' A' ' 266' ' ' ASP . 2.1 pt? -162.42 168.55 21.88 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.055 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.453 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 97.2 mttt -137.78 -167.53 2.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.634 0.254 . . . . 0.0 111.584 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -56.64 118.97 5.38 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.363 0.602 . . . . 0.0 110.969 178.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 110.73 -16.49 28.5 Favored Glycine 0 C--N 1.313 -0.742 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.541 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . 0.487 ' CB ' ' HB2' ' A' ' 262' ' ' LEU . 37.0 m-20 -91.68 140.5 29.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.038 0.447 . . . . 0.0 110.09 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' GLN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 296' ' ' THR . 2.2 mp0 -95.55 168.7 10.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.552 -178.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.1 OUTLIER -126.54 171.83 14.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.514 173.079 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.51 ' HB3' ' HB2' ' A' ' 340' ' ' SER . 16.6 tptm -134.47 89.11 2.51 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.379 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -114.2 159.81 19.7 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 119.189 -1.005 . . . . 0.0 111.098 -172.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.424 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 10.1 t -132.57 99.89 4.79 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.853 0.835 . . . . 0.0 110.246 -177.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.642 178.647 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 43.8 p . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -134.65 171.8 13.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.535 0.683 . . . . 0.0 112.368 -175.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 87.7 m -102.53 127.89 49.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.623 -1.172 . . . . 0.0 111.5 -172.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -127.37 -172.46 2.67 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 267' ' ' GLN . 73.7 m -134.35 135.84 42.99 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -175.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.605 HG12 ' H ' ' A' ' 299' ' ' ALA . 87.0 t -95.9 142.72 13.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.98 176.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 8.9 t -114.84 24.1 12.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.857 0.36 . . . . 0.0 111.742 -174.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.605 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -160.42 170.15 21.58 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.125 0.488 . . . . 0.0 112.029 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.453 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 5.2 m-20 -62.85 111.98 2.36 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.042 177.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.477 ' HB2' HG11 ' A' ' 311' ' ' VAL . . . -92.42 114.25 26.75 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.206 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.662 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 27.3 m-80 -88.46 138.02 31.81 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -170.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 57.7 m -124.24 99.97 6.47 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.827 157.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -98.99 -175.06 2.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.447 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 49.3 m -57.21 -32.46 66.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.705 0.288 . . . . 0.0 111.758 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -79.57 2.56 72.17 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.741 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 58.17 42.25 95.18 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.284 -177.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -114.75 142.06 47.02 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 117.727 0.764 . . . . 0.0 111.259 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.841 HG13 ' HB2' ' A' ' 251' ' ' LEU . 1.6 p -149.3 104.13 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.74 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.516 ' OG1' HG23 ' A' ' 250' ' ' THR . 55.4 m -113.28 124.78 53.3 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 121.576 -0.703 . . . . 0.0 110.916 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.477 HG11 ' HB2' ' A' ' 301' ' ' ALA . 22.0 m -147.48 164.27 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.1 0.476 . . . . 0.0 110.568 -178.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 31.4 m -116.47 145.54 43.22 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.055 0.455 . . . . 0.0 110.196 176.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.466 HD13 ' CE1' ' A' ' 247' ' ' PHE . 5.2 mp -120.99 152.18 38.87 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.093 -174.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 25.6 m . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.438 179.776 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 120.742 0.306 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -137.96 163.56 31.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.921 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -86.29 159.73 19.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.855 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 110.01 8.35 25.88 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.655 -0.783 . . . . 0.0 114.09 173.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 271' ' ' THR . 14.9 m-20 -93.77 -172.85 2.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.437 0.618 . . . . 0.0 111.713 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -115.56 149.22 38.55 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.816 -172.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.546 HG21 HD22 ' A' ' 251' ' ' LEU . 55.6 t -128.9 147.29 33.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.866 -177.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.51 ' HB2' ' HB3' ' A' ' 269' ' ' LYS . 37.3 m -137.96 178.27 7.25 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 21.1 t -118.0 147.79 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 120.942 0.401 . . . . 0.0 111.751 -171.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 342' ' ' VAL . 47.0 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 122.359 1.076 . . . . 0.0 108.353 173.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.658 0 CA-C-O 121.061 0.256 . . . . 0.0 113.169 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 6.1 m -82.16 144.97 30.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.915 0.388 . . . . 0.0 111.08 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.438 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.0 mp -136.14 -177.25 4.62 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 172.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 41.4 m -131.72 153.79 49.69 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.885 0.374 . . . . 0.0 110.961 -173.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 14.3 t -101.09 130.71 50.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -111.99 -28.13 8.14 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.16 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 32.8 p -123.82 -167.82 1.69 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.991 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 45.6 mt-30 -109.59 121.63 41.72 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -175.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.61 ' O ' HG11 ' A' ' 333' ' ' VAL . 14.6 Cg_exo -68.1 105.39 1.18 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.556 2.17 . . . . 0.0 111.633 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 236' ' ' VAL . 9.8 t -154.26 123.47 6.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.727 0.775 . . . . 0.0 112.868 -177.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.663 HG12 ' HB2' ' A' ' 246' ' ' GLN . 2.1 t -154.18 175.23 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 170.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . 0.515 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 87.4 m -39.93 116.12 0.61 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -108.36 83.5 1.79 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 172.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -110.29 138.54 46.54 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.96 -41.5 5.17 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.588 -172.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 44.4 t -61.71 -31.62 51.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.435 0.636 . . . . 0.0 109.732 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -95.14 -5.77 43.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.667 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 30.6 t70 53.01 51.11 16.47 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.367 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 22.5 m -127.9 97.56 4.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.474 -173.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -113.69 105.36 13.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.95 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . 0.663 ' HB2' HG12 ' A' ' 236' ' ' VAL . 86.8 mt-30 -129.71 152.99 48.61 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.882 -178.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.643 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 2.8 p90 -154.8 129.8 9.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.776 0.322 . . . . 0.0 111.842 176.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 37.0 m -103.26 141.83 35.23 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.618 ' HB ' HD11 ' A' ' 251' ' ' LEU . 0.2 OUTLIER -142.84 146.45 21.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 119.911 -0.716 . . . . 0.0 112.129 179.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.559 HG23 ' OG1' ' A' ' 310' ' ' THR . 57.8 m -101.22 111.43 23.64 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 163.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.618 HD11 ' HB ' ' A' ' 249' ' ' VAL . 3.3 mp -114.04 168.57 9.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -172.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.7 138.56 46.93 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.74 0.305 . . . . 0.0 110.517 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -133.05 -142.74 4.88 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -175.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.481 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -106.34 -177.73 3.45 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.332 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.581 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.3 OUTLIER -70.82 -177.32 1.56 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.39 -175.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.581 ' H ' HG22 ' A' ' 255' ' ' THR . . . -63.34 -176.65 0.16 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 122.999 0.52 . . . . 0.0 111.672 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 11.7 t 79.63 12.81 1.12 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.073 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 90.9 t -133.02 89.56 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-O 121.621 0.724 . . . . 0.0 109.565 171.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 12.4 m -79.45 97.46 6.4 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.624 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 79.78 93.45 0.37 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.744 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.664 ' CE1' ' HB2' ' A' ' 303' ' ' SER . 7.0 m-85 -53.37 -43.07 67.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.217 0.532 . . . . 0.0 110.469 169.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.486 ' HB2' ' CB ' ' A' ' 266' ' ' ASP . 4.1 pp -161.34 172.96 15.66 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.97 -176.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -129.84 -166.92 1.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.989 0.423 . . . . 0.0 111.48 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -60.93 118.19 6.4 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.193 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 109.83 -15.86 31.2 Favored Glycine 0 C--N 1.316 -0.543 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.444 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . 0.486 ' CB ' ' HB2' ' A' ' 262' ' ' LEU . 14.3 m-20 -75.29 134.88 40.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -97.96 151.78 19.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.74 0.781 . . . . 0.0 111.668 -176.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.506 HG23 ' HB3' ' A' ' 295' ' ' ALA . 1.7 m -125.38 172.31 13.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.795 177.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.16 133.17 21.36 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 169.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 338' ' ' ALA . 47.2 p90 -143.81 167.87 21.28 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.456 -174.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.608 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 13.9 t -133.67 123.92 25.83 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.329 0.585 . . . . 0.0 111.561 -175.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.249 173.525 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . 0.442 ' HB3' ' HB ' ' A' ' 271' ' ' THR . 16.0 p . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -152.26 159.7 43.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.936 0.398 . . . . 0.0 111.085 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 96.4 m -90.88 129.36 36.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.054 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . 0.506 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -119.97 -178.66 3.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.164 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 96.9 m -142.63 128.41 19.35 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.476 0.655 . . . . 0.0 112.503 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 299' ' ' ALA . 39.2 t -94.41 147.54 5.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.019 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 15.1 t -110.15 17.27 21.15 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -173.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.521 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -165.95 176.95 7.41 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 4.5 m-20 -60.91 120.76 10.81 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.58 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.441 ' HA ' ' CG1' ' A' ' 311' ' ' VAL . . . -93.38 115.02 27.58 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.263 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -79.72 130.17 35.11 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -169.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.664 ' HB2' ' CE1' ' A' ' 261' ' ' PHE . 32.7 t -114.06 94.91 5.03 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 162.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -109.66 177.6 4.68 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.152 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 17.2 t -54.78 -33.17 61.08 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -77.05 6.11 44.54 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.625 -176.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 56.24 40.49 84.55 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.927 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -120.17 124.29 45.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.861 0.363 . . . . 0.0 110.544 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.611 HG13 ' HB2' ' A' ' 251' ' ' LEU . 2.6 p -125.05 94.48 2.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.643 0.735 . . . . 0.0 110.359 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.559 ' OG1' HG23 ' A' ' 250' ' ' THR . 56.7 m -102.44 117.26 34.34 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.064 -176.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.441 ' CG1' ' HA ' ' A' ' 301' ' ' ALA . 5.4 m -148.55 160.09 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.306 0.574 . . . . 0.0 110.717 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 26.5 m -110.36 141.62 43.15 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.389 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.481 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.0 mp -109.59 122.39 47.33 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.551 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 23.6 p . . . . . 0 C--N 1.316 -0.871 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.945 -170.951 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.61 HG11 ' O ' ' A' ' 234' ' ' PRO . 21.8 m . . . . . 0 N--CA 1.449 -0.504 0 CA-C-O 121.595 0.712 . . . . 0.0 112.871 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -140.12 153.89 46.83 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.649 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -91.87 141.67 28.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.653 -0.248 . . . . 0.0 111.065 -175.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 115.87 9.3 12.48 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.672 175.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.608 ' HB3' ' O ' ' A' ' 271' ' ' THR . 49.6 m-20 -87.45 -169.14 2.48 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.349 0.574 . . . . 0.0 112.215 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 270' ' ' PHE . . . -110.94 148.06 33.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.605 -174.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 54.3 t -124.12 151.74 29.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.816 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 24.0 m -150.36 163.25 38.82 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 48.8 t -117.34 138.41 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.611 0.243 . . . . 0.0 110.694 -176.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 71.3 t . . . . . 0 C--N 1.332 -0.181 0 CA-C-O 121.117 0.484 . . . . 0.0 109.953 177.39 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.638 ' O ' ' HA ' ' A' ' 340' ' ' SER . . . . . . . . 0 C--O 1.227 -0.325 0 N-CA-C 112.343 -0.303 . . . . 0.0 112.343 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 17.8 m -92.87 132.11 37.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.907 0.384 . . . . 0.0 111.536 -175.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.445 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.3 mp -138.46 -177.21 4.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 96.8 m -138.45 156.02 47.93 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.321 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.516 HG23 HG23 ' A' ' 339' ' ' VAL . 69.9 t -103.1 126.38 57.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -109.7 -11.69 14.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.048 0.452 . . . . 0.0 110.951 -173.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.509 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 36.5 p -131.22 -167.04 1.79 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.375 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.583 HE21 ' HB2' ' A' ' 335' ' ' ALA . 1.3 mp0 -111.85 115.27 51.12 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -173.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 248' ' ' THR . 65.0 Cg_endo -78.54 105.01 1.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.216 1.944 . . . . 0.0 111.975 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 15.3 t -107.42 136.13 47.73 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.34 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.507 ' HA ' ' HB3' ' A' ' 247' ' ' PHE . 39.2 t -82.58 121.74 36.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.391 0.615 . . . . 0.0 111.788 -175.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 52.7 m -87.38 105.24 17.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.558 175.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -86.46 125.65 33.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.055 0.455 . . . . 0.0 110.801 -178.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.419 HD22 ' HA ' ' A' ' 239' ' ' ASN . 0.2 OUTLIER -138.75 77.68 1.64 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.476 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -83.04 -36.18 25.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.03 -163.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 39.5 t -68.15 -23.4 28.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.407 ' HG3' ' OD1' ' A' ' 239' ' ' ASN . 11.3 mmpt? -97.56 -2.8 40.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.432 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 56.18 46.14 21.97 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.119 -1.401 . . . . 0.0 112.143 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 35.3 t -132.55 125.45 30.56 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.416 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -128.88 102.17 6.41 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . 0.405 ' HG2' ' HA ' ' A' ' 314' ' ' SER . 77.5 mt-30 -130.8 159.1 38.31 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -178.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.507 ' HB3' ' HA ' ' A' ' 236' ' ' VAL . 8.1 p90 -137.58 137.54 38.64 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.873 178.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 85.2 m -105.18 143.55 33.19 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 -171.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.526 HG13 ' CD1' ' A' ' 251' ' ' LEU . 4.2 p -148.5 142.79 18.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.581 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.509 ' HB ' ' CG2' ' A' ' 232' ' ' THR . 57.4 m -99.11 126.88 44.96 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 167.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.526 ' CD1' HG13 ' A' ' 249' ' ' VAL . 4.8 mp -111.59 172.56 6.82 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.968 -173.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.52 145.74 47.65 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 169.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -145.39 -142.83 3.87 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.862 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.545 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -113.47 -174.41 2.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.853 0.358 . . . . 0.0 111.725 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.609 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.7 OUTLIER -70.43 -179.82 2.21 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.561 -170.603 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.609 ' H ' HG22 ' A' ' 255' ' ' THR . . . -63.93 -174.93 0.12 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.678 0.791 . . . . 0.0 112.256 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . 0.476 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 34.5 t 81.94 7.4 1.01 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.819 0.847 . . . . 0.0 111.172 -177.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.578 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 42.4 t -128.45 89.04 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.619 0 CA-C-O 121.615 0.721 . . . . 0.0 109.377 170.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 26.4 m -81.86 88.42 6.34 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.105 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 96.31 81.69 1.59 Allowed Glycine 0 N--CA 1.439 -1.115 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.347 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -47.05 -59.7 2.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.382 0.61 . . . . 0.0 110.194 168.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 300' ' ' ASP . 88.1 mt -137.65 169.63 17.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.907 -174.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -135.78 -167.64 2.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.641 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.61 114.29 3.86 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.792 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 116.06 -5.64 19.96 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.989 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -87.06 127.47 35.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.951 0.405 . . . . 0.0 110.696 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 296' ' ' THR . 2.0 mp0 -86.84 149.36 24.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.103 0.478 . . . . 0.0 110.748 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 294' ' ' THR . 1.1 m -120.9 172.54 7.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.261 174.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.569 ' HD3' ' C ' ' A' ' 269' ' ' LYS . 0.7 OUTLIER -131.62 124.84 30.77 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.307 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -146.78 160.41 42.29 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.052 176.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 292' ' ' SER . 14.9 t -122.4 134.01 54.62 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.708 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.728 ' HA ' ' OD1' ' A' ' 337' ' ' ASP . 4.5 t-20 . . . . . 0 C--N 1.32 -0.711 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.805 -174.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 271' ' ' THR . 4.4 m . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -151.97 167.09 29.5 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.23 0.538 . . . . 0.0 111.697 -177.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 94.6 m -97.93 129.75 44.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.992 -176.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -121.95 -171.68 2.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.298 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 267' ' ' GLN . 23.4 m -141.17 129.11 21.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.555 HG12 ' H ' ' A' ' 299' ' ' ALA . 50.4 t -86.47 138.59 18.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.678 176.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 312' ' ' THR . 6.0 t -112.59 14.91 20.2 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.895 0.379 . . . . 0.0 111.988 -174.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.555 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -165.95 -178.56 4.77 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.849 0.357 . . . . 0.0 111.743 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 4.3 m-20 -68.13 145.87 53.97 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.514 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.439 ' HB2' HG11 ' A' ' 311' ' ' VAL . . . -121.44 127.62 51.31 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.818 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.607 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 63.7 t30 -90.06 123.17 33.7 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -171.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.578 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 8.9 t -100.73 95.09 6.42 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 163.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . 0.487 ' HB3' ' ND2' ' A' ' 302' ' ' ASN . 0.3 OUTLIER -96.64 175.03 6.53 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.888 -174.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 8.3 t -59.84 -33.34 71.64 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.698 0.285 . . . . 0.0 111.57 -176.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -80.68 -3.94 90.26 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.15 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 71.54 41.56 57.4 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.238 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -121.99 133.63 54.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.365 0.582 . . . . 0.0 111.247 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.2 OUTLIER -128.24 155.5 39.92 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.046 179.039 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.449 ' OG1' HG23 ' A' ' 250' ' ' THR . 55.1 m -147.98 125.74 11.89 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.584 -0.698 . . . . 0.0 110.932 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.439 HG11 ' HB2' ' A' ' 301' ' ' ALA . 18.7 m -148.1 159.31 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.592 0.711 . . . . 0.0 111.25 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.486 ' O ' HG22 ' A' ' 298' ' ' THR . 16.4 m -108.94 140.21 42.74 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.488 174.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 5.3 mp -105.27 122.45 45.97 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.719 -174.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . 0.405 ' HA ' ' HG2' ' A' ' 246' ' ' GLN . 16.6 p . . . . . 0 C--N 1.319 -0.753 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.94 -176.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.513 ' HB ' ' HG2' ' A' ' 233' ' ' GLN . 15.5 m . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 120.805 0.336 . . . . 0.0 111.362 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . 0.512 ' HG3' HD21 ' A' ' 272' ' ' ASN . 0.5 OUTLIER -140.8 112.88 7.79 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.178 0.513 . . . . 0.0 111.257 179.748 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.583 ' HB2' HE21 ' A' ' 233' ' ' GLN . . . -100.66 138.85 37.16 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.93 -0.481 . . . . 0.0 112.029 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.42 -10.25 6.49 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.667 171.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.728 ' OD1' ' HA ' ' A' ' 272' ' ' ASN . 2.9 m-20 -54.33 150.75 8.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.388 0.613 . . . . 0.0 112.642 -178.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -102.41 134.93 44.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.012 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.516 HG23 HG23 ' A' ' 230' ' ' VAL . 57.8 t -114.82 147.23 18.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.32 0.581 . . . . 0.0 112.248 -169.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 226' ' ' GLY . 9.0 t -144.44 172.36 13.06 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.882 172.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.41 HG11 HD21 ' A' ' 262' ' ' LEU . 95.3 t -119.76 127.13 75.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.644 0.259 . . . . 0.0 111.655 -173.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 85.6 t . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 120.99 0.424 . . . . 0.0 110.367 175.764 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 N-CA-C 112.054 -0.418 . . . . 0.0 112.054 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 26.4 m -119.38 134.24 55.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.014 0.435 . . . . 0.0 109.964 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.504 HD23 ' CA ' ' A' ' 253' ' ' GLY . 9.7 mt -140.32 171.66 13.83 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.292 -174.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 62.6 m -136.68 165.94 24.73 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.583 HG21 ' HB2' ' A' ' 337' ' ' ASP . 70.9 t -117.22 132.24 67.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 O-C-N 122.078 -0.389 . . . . 0.0 110.287 176.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.41 ' HE3' HG21 ' A' ' 252' ' ' THR . 34.8 ttmt -120.62 11.88 11.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.51 0.671 . . . . 0.0 110.32 -177.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.442 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 7.5 p -139.33 -170.49 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.323 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.547 HE21 ' HA ' ' A' ' 334' ' ' GLU . 34.7 mt-30 -114.79 111.22 45.86 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -177.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.94 105.71 1.87 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.382 2.055 . . . . 0.0 113.048 -176.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 4.6 t -155.81 130.82 9.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.122 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.644 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -154.71 171.84 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 171.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . 0.469 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 38.5 m -12.36 113.37 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.75 1.62 . . . . 0.0 114.798 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.47 ' HD1' ' CD2' ' A' ' 245' ' ' TYR . 95.7 m-85 -115.45 84.04 2.03 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.332 173.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -122.97 133.21 54.38 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.15 -33.47 7.84 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -170.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.94 -28.82 45.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.581 0.705 . . . . 0.0 109.512 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.478 ' HA ' ' HE2' ' A' ' 242' ' ' LYS . 8.2 mmpt? -98.44 -9.14 25.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.06 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 61.48 40.51 13.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.234 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.9 m -113.03 95.73 5.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.026 -175.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . 0.47 ' CD2' ' HD1' ' A' ' 238' ' ' TYR . 4.8 m-85 -126.93 109.66 12.18 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 176.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . 0.553 ' HB2' HG12 ' A' ' 236' ' ' VAL . 70.6 mt-30 -136.94 173.16 12.0 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.644 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 4.7 p90 -154.14 134.8 13.59 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.369 -0.533 . . . . 0.0 112.374 176.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 59.3 m -99.34 139.17 35.38 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.512 HG13 ' HG ' ' A' ' 251' ' ' LEU . 5.5 p -142.75 142.3 26.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.501 -176.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.442 ' HB ' ' CG2' ' A' ' 232' ' ' THR . 38.9 m -99.36 103.97 15.82 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 166.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.613 HD11 HG22 ' A' ' 311' ' ' VAL . 0.4 OUTLIER -87.18 171.01 10.99 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.41 HG21 ' HE3' ' A' ' 231' ' ' LYS . 0.2 OUTLIER -128.53 141.46 51.37 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.025 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.504 ' CA ' HD23 ' A' ' 228' ' ' LEU . . . -146.76 -142.45 3.72 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.433 -174.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -106.28 -173.64 2.34 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.565 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -67.37 -179.31 1.0 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.408 -168.48 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.565 ' H ' HG22 ' A' ' 255' ' ' THR . . . -65.99 -175.33 0.3 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.352 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 49.2 m 80.2 17.31 0.68 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.908 0.883 . . . . 0.0 111.362 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 49.5 t -133.43 90.9 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 170.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 31.2 m -68.1 100.72 1.04 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.493 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 70.73 92.32 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.934 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -41.96 -59.69 1.64 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 169.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.472 ' H ' ' HB3' ' A' ' 301' ' ' ALA . 91.7 mt -146.68 163.21 36.64 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.673 0.273 . . . . 0.0 111.106 -174.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 49.4 mtmt -134.89 -167.88 2.07 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.632 177.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -63.58 120.78 12.4 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.353 0.597 . . . . 0.0 111.234 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 106.62 -3.95 36.82 Favored Glycine 0 C--N 1.316 -0.553 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.162 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . 0.422 ' HB3' HD22 ' A' ' 262' ' ' LEU . 66.3 m-20 -92.59 134.94 34.51 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -103.12 152.31 21.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.566 0.698 . . . . 0.0 111.869 -174.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.77 153.67 39.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.745 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 340' ' ' SER . 0.8 OUTLIER -86.2 94.9 9.42 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 166.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 293' ' ' PHE . 76.7 t80 -115.15 106.94 14.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.582 -165.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 292' ' ' SER . 89.4 m -88.29 94.96 10.0 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.922 -178.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.705 ' HA ' ' OD1' ' A' ' 337' ' ' ASP . 3.0 t-20 . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 121.448 0.642 . . . . 0.0 109.521 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 271' ' ' THR . 15.0 m . . . . . 0 C--O 1.226 -0.138 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . 0.558 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 0.8 OUTLIER -162.54 86.03 0.57 Allowed 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 21.3 m -160.79 124.28 3.4 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.027 -0.42 . . . . 0.0 111.003 175.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -152.85 179.88 8.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.323 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 90.8 m -140.31 132.39 27.92 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.595 0.712 . . . . 0.0 112.304 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 299' ' ' ALA . 59.2 t -79.54 136.52 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 114.35 -1.296 . . . . 0.0 110.339 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 4.4 m -124.86 25.01 7.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.13 0.49 . . . . 0.0 111.086 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -166.62 178.26 6.11 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.401 ' O ' HG12 ' A' ' 311' ' ' VAL . 40.8 m-20 -66.96 165.88 14.69 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.563 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.521 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -144.87 171.27 14.67 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.82 -177.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.689 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 16.6 m120 -142.29 126.27 17.26 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 119.687 -0.197 . . . . 0.0 110.964 -173.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.7 OUTLIER -107.88 96.88 6.69 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 168.253 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.16 178.71 4.53 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.023 -176.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 10.8 t -61.76 -33.17 73.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.991 0.424 . . . . 0.0 111.044 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -81.7 1.76 85.09 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.897 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 61.51 42.01 99.68 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 121.016 -0.612 . . . . 0.0 113.704 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.83 132.67 55.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 118.06 0.93 . . . . 0.0 110.454 175.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.689 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.1 OUTLIER -138.23 109.44 5.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.807 -177.308 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 250' ' ' THR . 54.0 m -101.5 135.22 43.38 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.962 -0.461 . . . . 0.0 111.712 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.613 HG22 HD11 ' A' ' 251' ' ' LEU . 26.8 m -145.71 165.36 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 173.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 46.4 m -117.02 138.9 51.27 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 171.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 4.9 mp -112.25 141.59 45.77 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.736 -173.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.321 -0.65 0 CA-C-O 121.327 0.584 . . . . 0.0 109.851 178.385 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 C--O 1.235 0.307 0 CA-C-O 121.341 0.591 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . 0.547 ' HA ' HE21 ' A' ' 233' ' ' GLN . 0.8 OUTLIER -112.66 -166.82 1.11 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.477 176.363 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -81.56 155.11 25.88 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.041 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 129.59 -8.35 6.18 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.054 -1.07 . . . . 0.0 113.444 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.705 ' OD1' ' HA ' ' A' ' 272' ' ' ASN . 4.1 m-20 -52.12 140.62 20.41 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.978 0.389 . . . . 0.0 110.784 174.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -100.56 132.65 45.84 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.503 ' CG1' ' HB2' ' A' ' 228' ' ' LEU . 93.2 t -120.69 140.18 45.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.479 0.657 . . . . 0.0 112.029 -171.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 269' ' ' LYS . 22.7 m -141.09 167.6 21.79 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 47.8 t -116.24 140.62 37.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.693 0.282 . . . . 0.0 111.122 -175.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 76.8 t . . . . . 0 C--O 1.23 0.072 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.265 175.791 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.407 0 CA-C-O 121.023 0.235 . . . . 0.0 113.438 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 6.8 m -65.48 132.31 48.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.763 0.316 . . . . 0.0 111.246 -177.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.489 HD22 ' HA2' ' A' ' 253' ' ' GLY . 29.2 mt -137.16 -175.95 4.22 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -177.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 84.9 m -104.26 148.87 25.85 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -171.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 60.3 t -99.41 133.23 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.482 175.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.611 ' HE3' HG21 ' A' ' 252' ' ' THR . 22.9 mmtp -102.92 -41.29 6.19 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 121.138 -0.225 . . . . 0.0 110.906 175.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.454 ' O ' HG13 ' A' ' 249' ' ' VAL . 40.2 p -136.55 175.76 9.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.925 0.393 . . . . 0.0 110.781 177.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.534 ' H ' ' HB ' ' A' ' 333' ' ' VAL . 0.4 OUTLIER -115.68 156.19 46.55 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.986 -170.72 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.499 ' HD2' ' HG3' ' A' ' 233' ' ' GLN . 3.9 Cg_endo -45.48 107.43 0.11 Allowed 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 124.127 3.218 . . . . 0.0 113.473 175.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 65.2 m -152.77 94.77 1.92 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.069 0.461 . . . . 0.0 111.34 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.749 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -157.85 173.97 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 123.874 0.87 . . . . 0.0 109.1 168.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . 0.534 ' H ' HG13 ' A' ' 236' ' ' VAL . 27.2 m -29.8 109.16 0.05 OUTLIER 'General case' 0 C--O 1.236 0.373 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -172.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -112.95 87.74 2.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.945 171.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -128.43 133.8 48.63 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -177.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -105.22 -42.85 5.16 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -169.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.93 -27.51 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.318 0.58 . . . . 0.0 109.963 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' A' ' 242' ' ' LYS . 27.9 mmmt -90.72 -12.63 36.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.805 178.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 60.84 66.67 0.89 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.131 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 55.6 m -150.76 99.03 2.68 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.571 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -120.13 102.21 8.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.949 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -135.42 160.25 39.03 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.749 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 27.2 p90 -148.17 139.84 23.76 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.07 174.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 53.5 m -99.81 136.7 39.33 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 232' ' ' THR . 99.2 t -137.92 141.39 38.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.841 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.544 HG23 ' OG1' ' A' ' 310' ' ' THR . 84.8 m -95.87 119.26 34.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 170.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.515 ' HB2' HG13 ' A' ' 309' ' ' VAL . 3.6 mp -115.33 163.02 16.3 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -176.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.611 HG21 ' HE3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -126.77 111.12 13.85 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 121.014 -0.275 . . . . 0.0 110.566 175.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.489 ' HA2' HD22 ' A' ' 228' ' ' LEU . . . -95.17 -147.27 22.36 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.034 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -109.46 -173.72 2.33 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 256' ' ' ALA . 3.1 m -58.84 167.31 1.61 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.801 -1.091 . . . . 0.0 113.476 -169.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.489 ' H ' HG22 ' A' ' 255' ' ' THR . . . -62.43 -176.56 0.11 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.819 -176.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 42.6 m 79.47 12.2 1.23 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.68 -176.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 23.8 t -125.44 94.78 2.87 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.2 m -77.3 94.2 4.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.099 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 74.02 93.15 0.13 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.491 178.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.66 ' CE1' ' HB3' ' A' ' 303' ' ' SER . 4.1 m-85 -44.4 -42.11 6.69 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 169.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 266' ' ' ASP . 1.0 OUTLIER -166.51 173.63 9.65 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.287 -173.005 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 63.8 mttm -142.65 -165.91 2.15 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.04 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -57.84 114.41 2.3 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.54 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 114.5 -16.21 19.49 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.932 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 262' ' ' LEU . 14.3 m-20 -78.83 126.42 30.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -93.29 150.01 20.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.711 0.767 . . . . 0.0 111.954 -176.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 341' ' ' VAL . 2.9 m -127.02 170.6 16.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.453 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.04 144.62 43.3 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 167.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . 0.651 ' O ' ' HA ' ' A' ' 292' ' ' SER . 56.8 m-85 -110.99 129.34 55.92 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.332 -175.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 338' ' ' ALA . 81.3 p -95.16 88.16 5.1 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 166.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.53 ' HA ' ' CG ' ' A' ' 337' ' ' ASP . 3.2 p-10 . . . . . 0 C--N 1.319 -0.757 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.355 -170.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 71.2 m . . . . . 0 CA--C 1.53 0.19 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -155.15 145.67 22.14 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 173.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 99.0 m -91.63 123.26 34.9 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.237 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -120.61 -176.18 3.18 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 121.173 -0.211 . . . . 0.0 110.625 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 94.1 m -141.32 130.06 22.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.327 0.584 . . . . 0.0 112.287 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.499 HG12 ' H ' ' A' ' 299' ' ' ALA . 59.6 t -83.63 145.79 7.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.752 177.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 2.3 m -123.46 24.02 8.76 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -173.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -167.71 -176.94 3.29 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 178.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.57 159.0 25.61 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.38 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.523 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -139.92 166.25 25.14 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.45 -177.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.541 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 18.2 m120 -136.51 122.22 19.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -174.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.66 ' HB3' ' CE1' ' A' ' 261' ' ' PHE . 0.0 OUTLIER -108.6 94.76 5.23 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 165.013 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.96 -170.56 1.86 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.022 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 10.1 t -60.03 -33.85 72.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.359 . . . . 0.0 111.418 -175.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -98.36 0.52 58.48 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 59.99 43.17 98.42 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 114.963 0.745 . . . . 0.0 114.963 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -88.34 110.19 20.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 119.557 1.679 . . . . 0.0 109.964 176.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.541 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 1.3 p -124.11 94.71 2.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.473 0.654 . . . . 0.0 111.394 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.544 ' OG1' HG23 ' A' ' 250' ' ' THR . 92.9 m -100.65 118.38 36.67 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.109 -0.369 . . . . 0.0 110.332 177.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.402 ' HB ' HG13 ' A' ' 297' ' ' VAL . 9.6 m -138.6 156.47 29.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.31 0.576 . . . . 0.0 110.795 178.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 44.9 m -108.32 133.69 52.18 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.137 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.428 ' HB2' ' CE2' ' A' ' 247' ' ' PHE . 5.2 mp -102.24 124.69 48.28 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.432 -174.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--N 1.322 -0.628 0 CA-C-O 120.803 0.335 . . . . 0.0 111.415 -173.945 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.534 ' HB ' ' H ' ' A' ' 233' ' ' GLN . 26.9 m . . . . . 0 CA--C 1.534 0.362 0 CA-C-O 120.822 0.344 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -115.56 111.72 21.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.547 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -79.71 164.0 24.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.799 0.333 . . . . 0.0 110.963 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.87 -16.09 5.86 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.89 176.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.53 ' CG ' ' HA ' ' A' ' 272' ' ' ASN . 70.6 m-20 -81.53 -177.7 6.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.837 0.351 . . . . 0.0 111.089 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . 0.475 ' HB3' ' OG1' ' A' ' 271' ' ' THR . . . -122.77 150.02 43.34 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.316 0.579 . . . . 0.0 111.736 -176.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 53.0 t -103.04 147.53 9.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.386 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 11.6 p -156.85 151.95 26.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.018 0.437 . . . . 0.0 111.21 173.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 268' ' ' VAL . 41.0 t -108.37 147.03 13.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.238 -176.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 54.5 t . . . . . 0 C--O 1.232 0.152 0 CA-C-O 121.216 0.532 . . . . 0.0 110.044 177.432 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.614 ' C ' ' HB3' ' A' ' 340' ' ' SER . . . . . . . . 0 N--CA 1.442 -0.963 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.743 HG23 ' HB ' ' A' ' 339' ' ' VAL . 52.4 m -153.29 135.49 14.88 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.664 -0.315 . . . . 0.0 111.311 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.662 ' H ' ' HA ' ' A' ' 339' ' ' VAL . 3.2 mt -128.36 87.63 2.62 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.951 ' HA ' ' O ' ' A' ' 338' ' ' ALA . 1.2 m -83.64 133.85 34.81 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.345 -174.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.678 ' O ' ' HA2' ' A' ' 336' ' ' GLY . 39.3 t -82.68 158.52 3.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.916 -160.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.435 ' HG3' HG23 ' A' ' 232' ' ' THR . 16.8 ptmt -131.75 -12.26 3.38 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.161 175.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 335' ' ' ALA . 40.6 p -129.32 -166.97 1.72 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.475 0.31 . . . . 0.0 110.829 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 34.1 mt-30 -112.91 118.24 44.94 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -173.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.548 ' HA ' ' O ' ' A' ' 248' ' ' THR . 1.1 Cg_endo -75.44 107.58 2.51 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.88 2.387 . . . . 0.0 113.007 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 236' ' ' VAL . 19.4 m -155.39 131.07 9.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.408 177.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.653 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -154.93 175.91 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.245 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . 0.575 ' H ' HG13 ' A' ' 236' ' ' VAL . 98.1 m -32.84 124.74 0.35 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.18 1.392 . . . . 0.0 114.578 -173.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -104.13 108.42 19.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.631 172.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.437 HD22 ' HA ' ' A' ' 239' ' ' ASN . 0.4 OUTLIER -114.01 91.45 3.64 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.215 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -88.16 -37.74 15.91 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.773 -161.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 40.0 t -64.69 -22.88 32.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -103.7 -0.67 29.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.14 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 24.6 t70 53.7 48.82 20.65 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.051 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 14.9 m -127.2 113.14 15.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.524 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -128.44 105.97 8.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -174.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . 0.535 ' HB2' HG12 ' A' ' 236' ' ' VAL . 2.0 mp0 -108.28 154.11 22.26 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.653 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 4.6 p90 -149.81 124.72 9.92 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.679 177.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 78.3 m -91.7 140.6 29.56 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.515 HG13 HD11 ' A' ' 251' ' ' LEU . 8.2 p -139.97 136.03 38.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 C-N-CA 119.848 -0.741 . . . . 0.0 112.354 -177.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.58 HG23 ' OG1' ' A' ' 310' ' ' THR . 94.0 m -96.99 115.85 28.16 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 168.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.515 HD11 HG13 ' A' ' 249' ' ' VAL . 1.0 OUTLIER -113.8 171.55 7.52 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.968 0.889 . . . . 0.0 110.463 -173.108 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.495 HG22 ' O ' ' A' ' 307' ' ' GLY . 0.0 OUTLIER -121.21 94.13 4.24 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.094 169.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.543 ' H ' HG12 ' A' ' 309' ' ' VAL . . . -120.52 135.12 10.7 Favored Glycine 0 CA--C 1.505 -0.58 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.705 -176.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -115.6 93.42 4.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -165.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.471 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 93.5 m -128.23 103.91 7.45 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.119 165.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.547 ' HA ' ' CB ' ' A' ' 305' ' ' SER . . . -50.57 130.69 24.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 35.9 m 57.76 58.56 3.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.64 -1.164 . . . . 0.0 113.108 168.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.43 ' HB ' ' OG ' ' A' ' 303' ' ' SER . 60.2 t -140.2 101.29 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-O 121.022 0.439 . . . . 0.0 110.249 174.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 33.6 m -71.44 86.99 0.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.407 0.623 . . . . 0.0 109.855 177.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 78.81 111.44 0.21 Allowed Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.569 -174.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.705 ' CE2' ' HB3' ' A' ' 303' ' ' SER . 57.3 m-85 -49.91 -61.27 2.23 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 121.85 0.833 . . . . 0.0 109.168 173.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 261' ' ' PHE . 73.6 mt -167.38 -179.93 4.7 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.336 -1.756 . . . . 0.0 106.603 -175.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -108.92 -169.8 1.55 Allowed 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -35.37 114.97 0.27 Allowed 'General case' 0 N--CA 1.464 0.238 0 O-C-N 124.181 0.925 . . . . 0.0 112.516 -177.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 131.92 -14.0 5.23 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.123 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . 0.501 ' OD1' ' HB2' ' A' ' 262' ' ' LEU . 80.8 m-20 -64.05 146.69 53.72 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 120.758 0.314 . . . . 0.0 110.207 175.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.14 174.49 6.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.447 -174.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.93 ' HA ' ' N ' ' A' ' 341' ' ' VAL . 34.8 m -151.89 142.63 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.805 -175.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.729 ' N ' HG23 ' A' ' 341' ' ' VAL . 0.0 OUTLIER -77.6 97.76 5.19 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 157.139 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . 0.495 ' HA ' ' HB1' ' A' ' 338' ' ' ALA . 14.2 t80 -78.75 86.58 4.69 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.662 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 53.7 m -78.9 107.68 11.81 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.464 HD21 ' HB2' ' A' ' 334' ' ' GLU . 2.6 t-20 . . . . . 0 C--N 1.319 -0.726 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.237 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -141.67 144.0 33.89 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 88.6 m -85.21 125.94 33.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.71 0.291 . . . . 0.0 111.503 -172.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -119.38 -179.5 3.88 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 84.9 m -136.14 138.15 41.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.428 0.632 . . . . 0.0 112.531 -174.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.598 HG12 ' H ' ' A' ' 299' ' ' ALA . 48.9 t -93.66 139.3 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.228 179.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 8.4 t -109.93 24.1 13.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.044 0.449 . . . . 0.0 111.5 -175.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.598 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -156.69 174.99 14.65 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.177 0.513 . . . . 0.0 112.087 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.97 113.13 2.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.709 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.46 ' HA ' ' CG1' ' A' ' 311' ' ' VAL . . . -93.18 106.86 18.77 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.059 -176.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.522 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 65.4 t30 -69.63 147.08 51.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.818 0.342 . . . . 0.0 111.532 -177.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.705 ' HB3' ' CE2' ' A' ' 261' ' ' PHE . 2.5 p -142.01 95.98 2.89 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.151 0.501 . . . . 0.0 110.517 171.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.58 151.87 21.83 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 172.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . 0.547 ' CB ' ' HA ' ' A' ' 256' ' ' ALA . 0.3 OUTLIER -70.77 -12.31 61.47 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -171.639 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -71.16 -11.62 70.99 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 169.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . 0.495 ' O ' HG22 ' A' ' 252' ' ' THR . . . 75.77 41.36 28.86 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.784 -0.708 . . . . 0.0 113.869 174.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -125.55 111.18 14.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.034 0.917 . . . . 0.0 111.602 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.543 HG12 ' H ' ' A' ' 253' ' ' GLY . 0.6 OUTLIER -132.59 138.79 51.32 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.103 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.58 ' OG1' HG23 ' A' ' 250' ' ' THR . 94.7 m -123.17 126.34 46.82 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.129 -0.357 . . . . 0.0 110.305 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 301' ' ' ALA . 15.4 m -146.47 164.89 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.944 0.402 . . . . 0.0 110.156 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 56.8 m -114.3 139.43 49.44 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.128 0.489 . . . . 0.0 110.573 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.404 HD13 ' CE2' ' A' ' 247' ' ' PHE . 4.8 mp -105.28 150.34 25.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.853 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 34.1 t . . . . . 0 C--N 1.323 -0.548 0 CA-C-O 121.16 0.505 . . . . 0.0 112.047 -174.65 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.471 HG12 ' HD2' ' A' ' 234' ' ' PRO . 23.5 t . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.785 0.326 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . 0.464 ' HB2' HD21 ' A' ' 272' ' ' ASN . 0.7 OUTLIER -79.66 129.25 34.31 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -168.166 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 232' ' ' THR . . . -99.59 114.26 27.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.901 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . 0.678 ' HA2' ' O ' ' A' ' 230' ' ' VAL . . . 128.8 13.34 2.5 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 119.179 -1.486 . . . . 0.0 115.82 163.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.662 ' HB3' ' O ' ' A' ' 271' ' ' THR . 3.6 t0 -108.83 -67.34 0.98 Allowed 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -171.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . 0.951 ' O ' ' HA ' ' A' ' 229' ' ' THR . . . -51.11 178.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 116.917 2.191 . . . . 0.0 116.917 -156.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.743 ' HB ' HG23 ' A' ' 227' ' ' THR . 3.1 m -149.42 -164.77 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 CA-C-O 117.855 -1.069 . . . . 0.0 108.833 -168.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.614 ' HB3' ' C ' ' A' ' 226' ' ' GLY . 29.1 t -119.63 152.35 37.21 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 121.247 1.839 . . . . 0.0 114.404 -168.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.93 ' N ' ' HA ' ' A' ' 268' ' ' VAL . 53.3 t -124.83 58.03 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.827 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 164.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.445 HG23 ' OG ' ' A' ' 340' ' ' SER . 3.5 t . . . . . 0 C--N 1.318 -0.793 0 CA-C-O 122.446 1.117 . . . . 0.0 108.094 175.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 112.208 -0.357 . . . . 0.0 112.208 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 27.5 m -141.43 135.12 30.01 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 8.9 mt -139.31 178.11 7.43 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.705 -176.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.8 m -124.27 154.91 39.53 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.826 0.346 . . . . 0.0 110.735 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 67.2 t -99.63 128.78 51.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.974 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 51.2 tttt -112.47 -28.09 8.0 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.929 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 27.1 p -139.38 -169.97 2.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.696 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 61.2 mt-30 -112.64 116.81 47.67 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -174.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.719 ' HA ' ' O ' ' A' ' 248' ' ' THR . 7.4 Cg_exo -72.58 104.81 1.78 Allowed 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.361 2.041 . . . . 0.0 112.722 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.9 t -154.26 131.92 11.44 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.028 0.442 . . . . 0.0 111.782 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.684 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.87 176.47 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 168.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . 0.534 ' H ' HG13 ' A' ' 236' ' ' VAL . 91.6 m -37.17 111.0 0.14 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -176.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -97.45 84.04 3.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.221 173.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.508 ' OD1' ' HB2' ' A' ' 242' ' ' LYS . 0.8 OUTLIER -87.09 121.25 29.29 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -176.091 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -105.99 -56.92 2.11 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -164.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 32.8 t -64.66 -29.7 48.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.388 0.613 . . . . 0.0 109.57 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.508 ' HB2' ' OD1' ' A' ' 239' ' ' ASN . 27.6 mtpt -89.56 -16.92 29.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.754 178.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 68.54 70.67 0.3 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 114.495 -1.229 . . . . 0.0 112.617 174.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.4 t -154.03 96.5 1.97 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.384 0.612 . . . . 0.0 110.298 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 17.1 m-30 -103.85 108.22 19.44 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.32 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -112.84 149.34 33.23 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 173.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.684 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 1.3 p90 -160.17 139.82 11.17 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 121.339 -0.144 . . . . 0.0 110.819 177.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.719 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 52.4 m -109.22 142.53 39.91 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.218 -0.193 . . . . 0.0 111.167 -174.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.97 131.35 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 121.466 0.651 . . . . 0.0 112.727 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 21.3 m -96.94 120.69 37.74 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 165.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.456 ' HB2' HG13 ' A' ' 309' ' ' VAL . 0.4 OUTLIER -116.47 171.54 7.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.242 0.544 . . . . 0.0 109.831 -175.725 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.01 147.68 46.39 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.364 172.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -148.45 -143.75 3.85 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.62 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.478 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -104.76 -174.47 2.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -176.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.617 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.5 OUTLIER -72.31 -177.91 2.32 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.49 -169.628 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.617 ' H ' HG22 ' A' ' 255' ' ' THR . . . -62.83 -176.89 0.13 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.451 0.701 . . . . 0.0 112.506 -178.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 68.3 m 80.32 16.31 0.71 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.838 0.855 . . . . 0.0 111.613 -177.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 61.8 t -135.34 94.76 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 171.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 4.3 m -72.05 92.27 1.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.622 -177.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 76.72 92.86 0.22 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.925 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' A' ' 303' ' ' SER . 3.2 m-85 -42.92 -53.5 4.67 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.775 0.321 . . . . 0.0 111.66 168.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 18.3 mt -141.29 147.01 37.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.308 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 57.8 mtmt -139.38 -169.39 2.66 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 123.249 0.343 . . . . 0.0 110.886 175.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -53.66 119.39 4.85 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.278 0.561 . . . . 0.0 111.411 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 107.25 -7.87 37.75 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.45 176.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -90.45 130.97 36.45 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -109.23 140.7 42.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.877 0.37 . . . . 0.0 110.686 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 295' ' ' ALA . 1.0 OUTLIER -122.24 171.41 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 121.305 0.574 . . . . 0.0 111.834 -178.399 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.401 ' C ' ' HD2' ' A' ' 269' ' ' LYS . 0.2 OUTLIER -131.42 129.64 41.51 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.887 179.18 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . 0.439 ' O ' ' HA ' ' A' ' 292' ' ' SER . 47.5 m-85 -100.04 127.57 46.24 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.129 -0.357 . . . . 0.0 110.261 177.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.51 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 51.7 m -102.73 88.15 3.14 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 173.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.656 ' HA ' ' CB ' ' A' ' 337' ' ' ASP . 4.3 p-10 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.071 -167.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 52.0 m . . . . . 0 C--O 1.233 0.233 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -135.77 150.59 49.54 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 121.018 0.437 . . . . 0.0 111.472 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 98.4 m -95.65 136.51 35.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.755 -173.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . 0.536 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -121.25 171.07 8.99 Favored 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 122.447 -0.158 . . . . 0.0 110.705 176.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 96.6 m -135.2 121.59 20.43 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.282 0.563 . . . . 0.0 112.168 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 59.5 t -79.36 139.96 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.333 -178.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 0.9 OUTLIER -130.62 24.24 5.07 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.017 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.552 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -162.14 179.83 7.64 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.436 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 5.6 m-20 -69.17 163.48 24.79 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.81 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.442 ' HB2' ' CG1' ' A' ' 311' ' ' VAL . . . -149.48 172.86 14.29 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.668 -174.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.662 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 16.8 m120 -138.28 122.71 18.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -175.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.483 ' HB3' ' CE1' ' A' ' 261' ' ' PHE . 0.6 OUTLIER -105.87 93.37 4.6 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 162.622 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.33 178.91 4.46 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.436 -0.505 . . . . 0.0 110.92 -173.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 17.7 m -57.65 -33.1 67.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.851 0.358 . . . . 0.0 111.649 -177.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -82.05 0.89 88.11 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.321 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 62.01 43.11 99.61 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.438 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -121.04 126.65 50.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.717 0.758 . . . . 0.0 110.855 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.662 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.3 OUTLIER -136.67 126.2 38.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.846 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -177.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 34.1 m -123.65 132.58 53.89 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.939 -0.475 . . . . 0.0 111.117 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.442 ' CG1' ' HB2' ' A' ' 301' ' ' ALA . 9.2 m -144.71 162.19 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.213 0.53 . . . . 0.0 110.418 176.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 21.0 m -117.01 142.21 47.26 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.48 0.657 . . . . 0.0 109.891 174.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 313' ' ' LEU . 0.5 OUTLIER -107.83 133.27 52.44 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.874 -173.591 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 C--N 1.32 -0.704 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.532 -171.418 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.47 HG11 ' O ' ' A' ' 234' ' ' PRO . 34.3 m . . . . . 0 N--CA 1.45 -0.438 0 CA-C-O 121.606 0.717 . . . . 0.0 111.867 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -146.88 145.72 29.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.967 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -99.29 142.97 30.08 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.676 -174.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 129.09 11.43 2.83 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.569 171.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.656 ' CB ' ' HA ' ' A' ' 272' ' ' ASN . 10.9 p-10 -104.4 -153.32 0.48 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.926 0.363 . . . . 0.0 111.093 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -126.23 139.24 53.49 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 121.207 0.527 . . . . 0.0 111.774 -173.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.434 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 75.1 t -103.08 145.44 12.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.657 -177.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 10.5 m -142.97 178.92 7.35 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 268' ' ' VAL . 60.5 t -117.58 141.54 35.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.673 0.273 . . . . 0.0 110.563 -175.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 72.1 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.87 177.034 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.644 0 N-CA-C 111.771 -0.531 . . . . 0.0 111.771 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.9 m -127.9 141.34 51.58 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.821 0.343 . . . . 0.0 110.421 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.456 HD21 ' CE2' ' A' ' 261' ' ' PHE . 12.7 mt -143.08 175.19 10.05 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.985 -177.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 63.3 m -128.65 157.46 41.26 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.219 -176.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.501 HG21 ' OD2' ' A' ' 337' ' ' ASP . 92.6 t -99.13 138.67 22.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 120.622 0.249 . . . . 0.0 110.648 -177.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.415 ' HB3' HG22 ' A' ' 250' ' ' THR . 35.6 tptt -117.53 -34.7 4.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.547 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 53.9 p -137.04 -173.67 3.52 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.599 ' HG3' ' N ' ' A' ' 334' ' ' GLU . 24.3 mm-40 -115.57 155.96 46.69 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -168.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.481 ' HB3' ' CD1' ' A' ' 247' ' ' PHE . 28.3 Cg_endo -63.47 105.95 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.176 2.584 . . . . 0.0 111.985 174.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 236' ' ' VAL . 5.1 t -148.27 96.98 2.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.574 0.702 . . . . 0.0 111.741 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.736 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.73 174.01 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 168.217 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . 0.497 ' H ' HG13 ' A' ' 236' ' ' VAL . 44.2 m -29.06 109.54 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -175.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -108.72 87.63 2.54 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 168.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.51 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 4.9 t30 -113.88 102.47 10.24 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.642 -174.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -84.51 -52.14 6.37 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -164.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 26.1 t -67.28 -23.59 30.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.411 0.624 . . . . 0.0 109.578 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.51 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 43.2 mmtt -89.88 -12.77 38.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.566 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 30.0 t70 63.37 69.65 0.56 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.183 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.2 m -149.5 106.86 3.61 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.879 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -125.29 102.76 7.59 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . 0.454 ' HB2' HG12 ' A' ' 236' ' ' VAL . 38.8 mt-30 -129.76 160.01 34.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.736 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 7.4 p90 -154.92 132.91 11.58 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.629 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 53.0 m -97.94 131.89 44.0 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 25.3 t -136.86 140.32 43.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.867 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.415 HG22 ' HB3' ' A' ' 231' ' ' LYS . 24.2 m -96.9 121.49 38.83 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 167.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.542 HD23 HG21 ' A' ' 339' ' ' VAL . 4.8 mp -110.24 167.37 10.24 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -123.54 140.63 52.81 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.415 ' HA2' HD23 ' A' ' 228' ' ' LEU . . . -142.11 -143.56 4.22 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.709 -174.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -102.63 -174.32 2.53 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.629 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.9 OUTLIER -72.18 -179.43 2.84 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.446 -169.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.629 ' H ' HG22 ' A' ' 255' ' ' THR . . . -61.22 -176.44 0.07 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.93 0.892 . . . . 0.0 112.898 -177.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 27.7 t 80.52 6.73 1.51 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.82 0.848 . . . . 0.0 110.922 -178.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 17.3 t -122.07 90.21 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 17.0 m -74.8 88.02 2.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.595 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 83.44 91.48 0.69 Allowed Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.383 -178.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.456 ' CE2' HD21 ' A' ' 228' ' ' LEU . 4.1 m-85 -43.01 -60.09 1.76 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 170.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 63.9 mt -149.02 161.76 41.29 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.12 -172.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 85.6 mttt -142.92 -167.19 2.47 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.119 0.262 . . . . 0.0 111.138 175.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -49.63 116.68 1.87 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.276 0.56 . . . . 0.0 111.686 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 108.36 -5.14 33.39 Favored Glycine 0 C--N 1.316 -0.53 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.299 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -94.96 143.27 26.61 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' GLN . . . . . 0.402 ' O ' HG12 ' A' ' 342' ' ' VAL . 23.0 mt-30 -114.06 152.7 30.63 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.551 0.691 . . . . 0.0 111.455 -176.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.3 OUTLIER -130.09 165.97 28.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.865 177.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 340' ' ' SER . 0.8 OUTLIER -122.64 87.45 2.75 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.1 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 339' ' ' VAL . 5.3 p90 -92.16 132.38 36.67 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.807 -175.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.606 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 77.2 m -98.24 87.14 3.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.36 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 . . . . . 0 C--N 1.32 -0.69 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.006 -177.525 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.45 -0.454 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.96 144.57 50.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.19 0.519 . . . . 0.0 111.014 -176.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 60.3 m -81.53 122.89 28.13 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.275 -176.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . 0.429 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -114.48 175.45 5.48 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 63.8 m -135.19 130.58 35.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.573 0.701 . . . . 0.0 112.808 -176.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 62.8 t -80.57 139.39 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.811 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 312' ' ' THR . 13.8 t -121.71 1.8 10.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.782 0.325 . . . . 0.0 111.399 -176.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -142.46 -177.12 5.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -173.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.422 ' O ' HG12 ' A' ' 311' ' ' VAL . 10.9 m-20 -71.51 164.65 25.43 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.121 -178.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.56 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -149.58 156.08 41.36 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.316 -173.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.546 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 3.9 m-20 -129.17 126.88 40.2 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.624 -175.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.496 ' HB2' ' HB ' ' A' ' 258' ' ' VAL . 0.4 OUTLIER -111.24 95.5 5.56 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 163.966 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -102.16 178.2 4.67 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.646 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 50.4 m -60.21 -32.28 70.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.729 0.299 . . . . 0.0 111.697 -177.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -73.64 -8.83 77.62 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.175 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 70.61 42.39 63.11 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.511 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -118.43 136.01 54.02 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.734 0.767 . . . . 0.0 111.474 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.546 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.7 OUTLIER -142.92 110.31 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.804 -178.478 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 25.5 m -105.16 127.4 52.89 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.609 -0.682 . . . . 0.0 111.537 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.522 HG22 HD13 ' A' ' 251' ' ' LEU . 19.5 m -144.38 148.72 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.296 0.57 . . . . 0.0 111.014 175.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.517 ' O ' HG22 ' A' ' 298' ' ' THR . 50.0 m -97.22 146.78 24.77 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 172.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.483 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.1 mp -117.51 136.73 53.03 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.299 -176.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 38.1 m . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.494 -174.217 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.447 ' HB ' ' OE1' ' A' ' 233' ' ' GLN . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.25 0 CA-C-O 120.24 0.066 . . . . 0.0 110.867 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . 0.599 ' N ' ' HG3' ' A' ' 233' ' ' GLN . 10.8 tp10 -158.67 130.34 6.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.606 0.241 . . . . 0.0 110.7 -173.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -66.22 158.35 29.09 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.295 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 130.07 -1.24 5.8 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.673 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.606 ' HB2' ' O ' ' A' ' 271' ' ' THR . 10.3 p-10 -89.08 -171.3 3.22 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 122.333 0.253 . . . . 0.0 110.742 176.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -129.04 162.57 27.35 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -171.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.542 HG21 HD23 ' A' ' 251' ' ' LEU . 98.3 t -128.56 142.62 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.968 -175.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.486 ' HB3' ' HB2' ' A' ' 269' ' ' LYS . 33.7 t -127.63 165.17 20.48 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 170.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 39.5 t -120.76 148.72 23.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 122.328 0.251 . . . . 0.0 110.386 -177.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.433 ' HB ' ' HE3' ' A' ' 269' ' ' LYS . 7.5 p . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 121.025 0.44 . . . . 0.0 110.691 177.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.719 0 N-CA-C 112.283 -0.327 . . . . 0.0 112.283 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 27.1 m -111.05 141.06 45.04 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.456 HD21 ' CE2' ' A' ' 261' ' ' PHE . 8.6 mt -139.34 172.07 13.35 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.575 -173.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 40.3 m -128.0 152.74 47.56 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 -176.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.506 ' HB ' ' H ' ' A' ' 337' ' ' ASP . 61.3 t -94.08 108.16 20.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -95.49 -32.41 12.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.192 0.52 . . . . 0.0 110.888 -174.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.564 ' OG1' ' HB ' ' A' ' 250' ' ' THR . 61.6 p -129.09 -167.44 1.78 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.604 178.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.57 ' HB3' ' CG2' ' A' ' 333' ' ' VAL . 13.1 mt-30 -112.72 128.51 25.48 Favored Pre-proline 0 C--N 1.32 -0.702 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.61 -171.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.28 107.92 2.27 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.682 2.255 . . . . 0.0 112.739 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 13.5 t -112.54 147.47 36.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.007 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.408 HG11 ' CZ ' ' A' ' 238' ' ' TYR . 16.0 t -110.52 136.97 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -166.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 22.5 m -101.91 116.89 33.68 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 168.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.408 ' CZ ' HG11 ' A' ' 236' ' ' VAL . 43.1 m-85 -103.16 131.5 50.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.039 0.447 . . . . 0.0 111.87 -176.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.47 HD22 ' HA ' ' A' ' 239' ' ' ASN . 0.2 OUTLIER -142.1 88.66 2.12 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.508 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -88.79 -41.0 12.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.293 -162.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.3 -23.22 32.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.706 0.765 . . . . 0.0 109.037 175.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -94.69 -12.33 27.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.016 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 6.3 t70 60.73 57.93 2.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.713 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 21.4 m -146.5 115.64 6.99 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.929 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -120.29 133.56 55.44 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -143.33 126.72 16.73 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.522 ' CE1' ' HB2' ' A' ' 313' ' ' LEU . 18.7 p90 -130.17 133.33 46.52 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.429 174.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 92.9 m -104.52 142.19 35.06 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.988 -167.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 8.5 p -145.69 133.06 15.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.36 0.6 . . . . 0.0 112.294 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.564 ' HB ' ' OG1' ' A' ' 232' ' ' THR . 52.9 m -97.23 116.81 30.12 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 168.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.44 170.89 7.97 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.486 0.66 . . . . 0.0 109.893 -175.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.54 150.25 35.22 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.486 171.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.417 ' CA ' HD23 ' A' ' 228' ' ' LEU . . . -148.27 -144.12 3.92 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.53 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -106.39 -176.5 3.09 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -175.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.615 HG22 ' H ' ' A' ' 256' ' ' ALA . 1.3 m -68.42 178.99 1.77 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.519 -171.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.615 ' H ' HG22 ' A' ' 255' ' ' THR . . . -61.76 -176.14 0.08 Allowed 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.718 0.807 . . . . 0.0 112.323 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 28.9 t 81.07 6.83 1.28 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.835 0.854 . . . . 0.0 110.894 -178.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 40.1 t -126.03 89.96 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.463 0.649 . . . . 0.0 109.304 172.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 10.8 m -69.37 97.31 0.96 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.376 -178.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 68.21 99.46 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.494 -177.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.456 ' CE2' HD21 ' A' ' 228' ' ' LEU . 11.9 m-85 -43.23 -49.99 6.51 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.742 0.271 . . . . 0.0 111.371 170.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 266' ' ' ASP . 0.7 OUTLIER -166.08 166.16 17.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.677 -175.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.448 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 59.0 mtmt -140.79 -165.82 2.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.722 0.296 . . . . 0.0 111.685 -177.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -51.91 118.27 3.31 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.448 0.642 . . . . 0.0 111.877 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 107.02 -10.3 40.24 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.975 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . 0.411 ' HB2' ' HB2' ' A' ' 262' ' ' LEU . 38.7 m-20 -93.3 136.97 33.06 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -108.31 151.52 25.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.533 0.682 . . . . 0.0 112.313 -172.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 294' ' ' THR . 1.3 m -125.26 163.8 25.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.901 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.547 ' HE2' HG22 ' A' ' 342' ' ' VAL . 0.0 OUTLIER -135.13 126.91 29.22 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 169.223 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -144.71 163.71 33.19 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.909 -0.494 . . . . 0.0 110.906 -174.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.589 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 5.0 t -121.67 101.3 7.51 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.893 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.366 -179.201 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 42.8 m . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.19 145.43 51.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.967 0.413 . . . . 0.0 110.936 -175.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 87.1 m -90.02 131.07 36.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.798 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -129.63 -178.4 4.67 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 89.7 m -141.71 134.15 28.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.392 0.615 . . . . 0.0 112.385 -177.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.559 HG12 ' H ' ' A' ' 299' ' ' ALA . 94.9 t -86.32 146.01 6.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.719 -178.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 13.6 t -125.57 18.11 8.12 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.572 -175.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.559 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -154.58 -177.86 6.77 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.448 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 2.7 m-20 -69.78 163.0 26.72 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.168 -178.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.46 ' HB2' ' CG1' ' A' ' 311' ' ' VAL . . . -147.28 167.88 23.14 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.973 -178.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.692 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 21.0 m120 -142.59 128.97 20.04 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.469 -174.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.6 OUTLIER -109.48 94.97 5.31 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 163.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -101.62 -176.94 3.28 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.207 -175.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 13.1 t -60.59 -33.03 72.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.792 0.33 . . . . 0.0 111.424 -175.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -82.67 -2.8 90.67 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.696 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 63.5 44.44 96.65 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.203 -178.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -115.02 126.51 54.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 118.0 0.9 . . . . 0.0 111.0 177.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.692 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.2 OUTLIER -134.7 119.65 29.24 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.568 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.475 ' OG1' HG23 ' A' ' 250' ' ' THR . 53.1 m -113.39 134.98 54.35 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.285 -0.26 . . . . 0.0 110.498 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.46 ' CG1' ' HB2' ' A' ' 301' ' ' ALA . 6.9 m -145.8 164.39 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.361 0.601 . . . . 0.0 110.547 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.445 ' O ' HG22 ' A' ' 298' ' ' THR . 19.7 m -119.99 138.54 53.43 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.421 173.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.522 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 4.1 mp -109.59 169.58 8.61 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.631 -175.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 C--N 1.326 -0.449 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -172.91 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.57 ' CG2' ' HB3' ' A' ' 233' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 121.227 0.537 . . . . 0.0 112.117 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -144.65 147.86 33.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.328 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -98.95 173.18 6.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.767 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 98.99 8.16 54.36 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.818 -0.706 . . . . 0.0 113.05 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.589 ' HB3' ' O ' ' A' ' 271' ' ' THR . 30.6 m-20 -92.81 -172.96 3.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.793 0.33 . . . . 0.0 111.795 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -112.12 142.71 44.24 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.665 -172.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 82.9 t -126.97 149.55 32.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.373 -178.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 50.7 m -147.98 158.86 44.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.921 0.391 . . . . 0.0 110.528 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 48.9 t -102.22 137.04 31.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.797 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.547 HG22 ' HE2' ' A' ' 269' ' ' LYS . 53.1 t . . . . . 0 C--N 1.332 -0.181 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.078 175.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.61 0 CA-C-O 121.201 0.334 . . . . 0.0 113.241 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.9 m -91.01 147.61 22.96 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.159 0.504 . . . . 0.0 111.434 -175.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 4.4 mp -138.34 176.01 9.07 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 168.138 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 33.0 m -135.92 161.79 34.64 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.634 0.254 . . . . 0.0 110.893 -170.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 59.3 t -118.09 126.09 74.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 176.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.456 ' HE2' HG21 ' A' ' 252' ' ' THR . 20.4 ttmm -108.67 -11.34 15.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.131 0.491 . . . . 0.0 111.126 -177.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.475 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 57.5 p -124.11 -166.83 1.55 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.476 -179.327 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -102.82 112.49 65.75 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -170.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -65.08 103.53 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.503 1.469 . . . . 0.0 111.154 175.399 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.3 t -103.01 120.22 40.25 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.509 0.671 . . . . 0.0 110.532 -177.057 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.428 ' HA ' ' CB ' ' A' ' 247' ' ' PHE . 21.3 t -77.26 123.17 33.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.848 -175.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 29.2 m -96.72 105.15 17.21 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.12 178.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -89.84 116.09 27.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.607 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.484 ' OD1' ' HG3' ' A' ' 242' ' ' LYS . 0.8 OUTLIER -122.71 76.14 1.32 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 176.547 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -84.3 -32.28 24.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.126 -160.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 38.8 t -65.39 -22.17 30.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 122.164 0.983 . . . . 0.0 108.529 173.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.484 ' HG3' ' OD1' ' A' ' 239' ' ' ASN . 43.4 mmtt -101.77 0.47 35.87 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.166 179.196 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 51.4 37.67 19.75 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.056 -178.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.9 m -119.17 127.32 53.2 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.009 178.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -125.17 112.11 16.06 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.079 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . 0.42 ' HB3' ' O ' ' A' ' 313' ' ' LEU . 18.2 mt-30 -130.79 -178.87 4.99 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.685 -175.276 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 313' ' ' LEU . 6.9 p90 -156.76 137.83 13.59 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.476 171.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 61.4 m -103.15 134.95 45.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.177 -173.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.409 ' HB ' HD11 ' A' ' 251' ' ' LEU . 0.5 OUTLIER -147.62 149.36 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.563 -179.839 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.551 HG23 ' OG1' ' A' ' 310' ' ' THR . 38.3 m -99.09 111.4 23.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 164.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.576 HD23 HG21 ' A' ' 339' ' ' VAL . 4.6 mp -104.3 168.06 9.35 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -172.751 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.456 HG21 ' HE2' ' A' ' 231' ' ' LYS . 0.7 OUTLIER -120.57 130.24 54.11 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.693 0.282 . . . . 0.0 110.367 177.467 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.422 ' N ' HG12 ' A' ' 309' ' ' VAL . . . -124.08 -143.15 6.15 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.944 -171.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -113.5 -171.33 1.86 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -173.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 256' ' ' ALA . 1.8 m -51.12 167.34 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -173.157 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 257' ' ' SER . . . -69.95 -175.78 0.99 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.177 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 67.6 m 80.6 9.15 1.21 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.794 176.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 94.4 t -119.52 94.5 3.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 170.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 22.6 m -74.6 89.56 2.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.42 -178.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 80.1 102.32 0.28 Allowed Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.623 -175.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.456 ' CE1' ' HB2' ' A' ' 303' ' ' SER . 10.6 m-85 -48.17 -59.11 3.66 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.673 0.749 . . . . 0.0 110.392 173.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 266' ' ' ASP . 89.3 mt -141.7 168.4 19.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.009 -175.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -131.63 -169.27 2.16 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.18 0.3 . . . . 0.0 111.006 -179.535 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -56.82 114.41 2.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.255 0.55 . . . . 0.0 111.652 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 112.75 -6.07 25.97 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.562 177.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . 0.547 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 64.6 m-20 -96.19 138.14 34.24 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 267' ' ' GLN . . . . . 0.554 ' HB2' HG11 ' A' ' 342' ' ' VAL . 30.5 mt-30 -108.94 159.76 16.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.636 0.732 . . . . 0.0 111.779 -173.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.06 -175.48 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.827 -179.29 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 340' ' ' SER . 23.9 tptt -120.9 104.56 9.93 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.834 174.419 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -95.29 120.71 35.99 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 120.942 0.401 . . . . 0.0 110.127 -175.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 54.8 m -110.6 89.25 2.98 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.767 178.352 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 . . . . . 0 C--N 1.323 -0.571 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.611 179.115 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 55.7 p . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -143.45 148.27 35.85 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 66.7 m -74.94 115.99 15.16 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.675 -179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -103.14 -179.95 4.1 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 177.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.593 ' HB ' ' O ' ' A' ' 314' ' ' SER . 90.7 m -139.82 133.8 30.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -175.1 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.57 HG13 HG21 ' A' ' 311' ' ' VAL . 50.7 t -78.64 135.91 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.715 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 5.1 m -108.62 -13.43 14.81 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -173.178 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -154.38 -178.66 7.29 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.172 -0.33 . . . . 0.0 110.916 -175.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.58 105.58 0.66 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.178 0.513 . . . . 0.0 110.447 178.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -95.41 100.43 12.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.499 -177.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.434 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 65.3 t30 -61.04 149.49 36.74 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -168.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.519 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 36.6 t -128.78 95.23 4.04 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 166.374 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -104.9 173.03 6.48 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.89 -179.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 8.5 t -58.25 -32.08 68.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.861 0.362 . . . . 0.0 111.472 -173.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -73.77 3.45 35.25 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.217 -177.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 66.27 41.85 94.46 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.739 178.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -116.84 139.08 51.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.901 0.35 . . . . 0.0 110.694 -178.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 251' ' ' LEU . 1.8 p -147.7 95.17 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.366 0.603 . . . . 0.0 111.352 179.186 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.551 ' OG1' HG23 ' A' ' 250' ' ' THR . 53.0 m -96.12 130.37 43.18 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 121.597 -0.689 . . . . 0.0 110.896 179.523 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.57 HG21 HG13 ' A' ' 297' ' ' VAL . 14.5 p -165.81 150.24 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.109 0.48 . . . . 0.0 110.424 175.216 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 25.0 m -93.69 145.49 24.52 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.632 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.526 ' HA ' ' O ' ' A' ' 296' ' ' THR . 5.1 mp -110.62 140.95 44.48 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.086 -175.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . 0.593 ' O ' ' HB ' ' A' ' 296' ' ' THR . 39.0 t . . . . . 0 C--N 1.32 -0.709 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.677 -176.14 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.232 0.156 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -127.43 134.83 49.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.92 0.39 . . . . 0.0 110.628 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -66.53 157.16 32.94 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.584 -175.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.38 3.12 5.75 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.401 178.21 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.11 166.85 10.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.222 0.534 . . . . 0.0 111.49 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -116.56 148.05 41.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.993 -179.048 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.576 HG21 HD23 ' A' ' 251' ' ' LEU . 70.7 t -130.38 150.59 34.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.809 0.338 . . . . 0.0 111.086 -172.573 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.503 ' HB2' ' HB3' ' A' ' 269' ' ' LYS . 30.0 m -150.05 177.77 9.57 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.318 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 39.3 t -113.56 142.58 25.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.554 HG11 ' HB2' ' A' ' 267' ' ' GLN . 9.9 p . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 121.053 0.454 . . . . 0.0 111.051 -175.095 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.7 0 CA-C-O 121.047 0.248 . . . . 0.0 112.942 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.1 m -105.94 147.84 28.33 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.975 0.417 . . . . 0.0 111.184 -174.466 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.9 mp -132.61 -178.66 5.04 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 167.152 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.48 ' HB ' ' OG1' ' A' ' 252' ' ' THR . 23.1 m -127.47 155.82 43.11 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 122.324 -0.235 . . . . 0.0 111.072 -173.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.497 HG23 ' CG2' ' A' ' 339' ' ' VAL . 0.9 OUTLIER -111.22 137.43 43.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.275 177.399 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.415 ' HE3' HG22 ' A' ' 250' ' ' THR . 59.3 mtmt -109.57 -26.92 9.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.769 174.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.451 ' O ' HG13 ' A' ' 230' ' ' VAL . 58.6 p -137.07 -179.7 5.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.546 ' HB3' ' HB ' ' A' ' 333' ' ' VAL . 17.9 mm-40 -116.57 157.01 46.92 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -166.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.466 ' HG3' ' CZ ' ' A' ' 293' ' ' PHE . 73.8 Cg_endo -73.05 104.24 1.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.076 2.517 . . . . 0.0 113.127 178.576 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.475 ' N ' ' HB2' ' A' ' 247' ' ' PHE . 10.1 t -157.11 110.44 2.57 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.659 170.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.768 ' O ' ' HB2' ' A' ' 246' ' ' GLN . 75.7 t -154.74 79.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.34 0.656 . . . . 0.0 109.559 165.814 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 26.0 m 81.44 92.73 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.536 0.684 . . . . 0.0 110.645 174.117 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -106.95 104.96 14.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.341 178.13 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -129.29 126.82 39.87 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -102.61 -43.0 5.74 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.622 -170.282 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 67.3 t -61.55 -26.9 40.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.39 0.614 . . . . 0.0 109.916 178.085 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -99.05 -4.77 31.66 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.874 -179.425 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 53.3 57.9 5.77 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.059 -177.051 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 23.7 m -138.51 111.14 7.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.458 -177.073 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -128.57 120.08 26.02 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.321 -177.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . 0.768 ' HB2' ' O ' ' A' ' 236' ' ' VAL . 47.3 mt-30 -128.57 163.36 25.18 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 173.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.526 ' HA ' ' N ' ' A' ' 236' ' ' VAL . 20.9 p90 -168.64 151.43 5.21 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 174.007 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.411 ' H ' HG23 ' A' ' 236' ' ' VAL . 50.0 m -113.97 138.54 50.21 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 31.6 t -137.91 139.71 42.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.526 -178.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.542 HG23 ' OG1' ' A' ' 310' ' ' THR . 15.8 m -102.09 113.74 27.25 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.617 ' HB2' HG13 ' A' ' 309' ' ' VAL . 4.9 mp -110.39 170.63 7.96 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.943 0.402 . . . . 0.0 110.027 -171.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.636 HG22 ' O ' ' A' ' 307' ' ' GLY . 0.0 OUTLIER -126.87 120.97 30.5 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.402 176.761 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.442 ' HA3' HD23 ' A' ' 228' ' ' LEU . . . -156.78 134.77 4.16 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.81 -0.709 . . . . 0.0 111.404 178.049 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -112.7 93.41 4.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.107 0.48 . . . . 0.0 112.179 -173.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 18.3 m -126.16 102.74 7.34 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 169.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -56.0 134.86 52.67 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -175.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 24.5 t 63.31 53.65 2.16 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.901 172.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.446 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 84.2 t -132.47 95.97 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.291 0.567 . . . . 0.0 110.377 175.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.5 m -75.97 86.31 2.89 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.567 0.698 . . . . 0.0 109.857 177.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 95.62 92.51 1.75 Allowed Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.251 -177.235 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.552 ' CD1' ' HB2' ' A' ' 303' ' ' SER . 3.6 m-85 -45.34 -58.79 3.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.786 0.803 . . . . 0.0 109.958 169.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 266' ' ' ASP . 75.8 mt -141.53 169.83 16.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.168 -1.378 . . . . 0.0 108.031 -175.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 96.0 mttt -137.68 -171.22 2.94 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 121.173 -0.211 . . . . 0.0 110.884 -179.386 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -54.11 113.95 1.43 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.261 0.553 . . . . 0.0 111.413 -179.061 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 113.03 -6.82 25.42 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.77 177.087 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 22.9 m-20 -90.37 136.03 33.31 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.722 -0.281 . . . . 0.0 110.262 179.049 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -107.15 142.28 37.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.5 0.667 . . . . 0.0 111.981 -174.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 295' ' ' ALA . 0.7 OUTLIER -126.09 164.04 26.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.569 179.006 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 294' ' ' THR . 0.0 OUTLIER -135.68 147.99 48.75 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.674 174.221 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -110.95 130.03 55.71 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -174.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 44.0 m -104.25 126.63 51.52 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 . . . . . 0 C--N 1.316 -0.885 0 CA-C-O 121.893 0.854 . . . . 0.0 113.184 -163.208 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 32.8 p . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . 0.466 ' CZ ' ' HG3' ' A' ' 234' ' ' PRO . 35.9 p90 -161.58 177.2 10.23 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.992 0.425 . . . . 0.0 111.403 -176.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 269' ' ' LYS . 53.8 m -124.06 132.67 53.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.508 -178.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . 0.485 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -114.97 -179.74 3.71 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.802 0.334 . . . . 0.0 111.249 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 96.1 m -143.67 121.64 12.06 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.569 0.699 . . . . 0.0 111.675 178.358 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.703 HG13 HG21 ' A' ' 311' ' ' VAL . 78.0 t -66.86 138.79 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.544 -178.04 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 312' ' ' THR . 6.0 t -121.4 6.54 10.13 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.108 -175.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -163.18 -167.03 1.37 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -72.46 113.8 9.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.246 0.546 . . . . 0.0 110.047 179.179 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -91.98 101.28 13.83 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.343 178.212 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -56.36 134.01 53.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.503 -0.772 . . . . 0.0 112.802 -169.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.552 ' HB2' ' CD1' ' A' ' 261' ' ' PHE . 30.5 t -128.23 111.39 13.36 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 120.913 0.387 . . . . 0.0 110.873 173.583 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.49 157.41 41.23 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 3.9 t -71.07 -10.14 59.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.009 -171.235 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -69.17 -15.05 69.41 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 173.004 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . 0.636 ' O ' HG22 ' A' ' 252' ' ' THR . . . 90.07 41.03 5.68 Favored Glycine 0 C--O 1.223 -0.558 0 C-N-CA 120.925 -0.655 . . . . 0.0 114.379 174.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -126.22 130.73 51.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.151 0.976 . . . . 0.0 111.427 178.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.617 HG13 ' HB2' ' A' ' 251' ' ' LEU . 0.8 OUTLIER -141.93 112.06 2.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.744 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.525 176.018 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.542 ' OG1' HG23 ' A' ' 250' ' ' THR . 99.0 m -110.15 129.47 55.7 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.491 -0.756 . . . . 0.0 110.618 177.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.703 HG21 HG13 ' A' ' 297' ' ' VAL . 2.6 p -151.72 144.38 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 121.141 0.496 . . . . 0.0 111.23 178.252 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.525 ' O ' HG22 ' A' ' 298' ' ' THR . 22.6 m -100.34 145.21 28.43 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.679 175.418 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 313' ' ' LEU . 1.3 mm? -121.44 129.81 53.21 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.484 -172.065 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 16.0 p . . . . . 0 C--N 1.316 -0.861 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.932 -174.762 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 233' ' ' GLN . 15.4 m . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -155.92 112.16 3.1 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.483 -174.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -74.64 143.71 44.18 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -171.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 131.51 11.55 2.16 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 120.787 -0.72 . . . . 0.0 114.231 175.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -76.72 174.48 10.4 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 117.498 0.649 . . . . 0.0 112.03 175.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -112.0 132.0 55.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.731 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.497 ' CG2' HG23 ' A' ' 230' ' ' VAL . 54.5 t -102.67 152.91 5.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.668 -169.498 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 23.2 t -157.45 177.16 11.75 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 174.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 46.6 t -112.52 138.59 41.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.65 0.262 . . . . 0.0 110.767 -174.04 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 269' ' ' LYS . 56.5 t . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.78 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.233 0 N-CA-C 113.526 0.17 . . . . 0.0 113.526 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 19.1 m -102.66 142.44 33.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.926 0.393 . . . . 0.0 110.886 -178.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.558 HD21 ' CE1' ' A' ' 261' ' ' PHE . 19.2 mt -144.39 176.61 9.24 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 42.7 m -135.97 160.23 39.26 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 122.27 -0.269 . . . . 0.0 110.485 -174.142 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.628 ' HB ' ' OD2' ' A' ' 337' ' ' ASP . 3.4 t -118.63 152.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 177.581 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.578 ' HE3' HG22 ' A' ' 250' ' ' THR . 53.1 pttt -130.38 14.43 5.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.857 0.36 . . . . 0.0 111.132 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.617 ' H ' HG12 ' A' ' 230' ' ' VAL . 24.1 p -151.73 -178.55 6.79 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -175.56 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.553 ' HB3' ' CG2' ' A' ' 333' ' ' VAL . 0.3 OUTLIER -115.79 129.46 25.14 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -174.28 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.49 105.79 1.32 Allowed 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.452 2.101 . . . . 0.0 112.243 -179.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 5.8 t -107.0 129.6 54.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.307 178.624 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.439 HG22 ' HB3' ' A' ' 247' ' ' PHE . 8.1 t -85.61 123.63 39.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.203 -173.054 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 49.2 m -82.17 96.66 7.89 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.048 173.145 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.75 109.07 13.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.511 -178.548 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.5 HD22 ' HA ' ' A' ' 239' ' ' ASN . 0.2 OUTLIER -121.0 81.2 1.74 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.419 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -85.11 -36.86 20.85 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.067 -164.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.03 -23.15 32.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.757 0.789 . . . . 0.0 109.162 174.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.409 ' HG3' ' OD1' ' A' ' 239' ' ' ASN . 13.4 mmmm -103.62 -6.76 21.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.262 -176.212 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 58.32 58.95 3.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.57 -177.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 41.7 m -145.53 128.63 16.61 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.372 176.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -129.14 100.4 5.61 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.199 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -133.97 144.18 48.62 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.498 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.439 ' HB3' HG22 ' A' ' 236' ' ' VAL . 41.7 p90 -120.11 136.59 54.54 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.644 -178.083 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 97.9 m -100.95 141.25 34.1 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -173.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.519 HG13 ' CD1' ' A' ' 251' ' ' LEU . 1.4 p -144.48 146.14 20.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.418 -177.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.578 HG22 ' HE3' ' A' ' 231' ' ' LYS . 4.9 m -107.84 124.95 50.84 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 174.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.56 HD23 HG21 ' A' ' 339' ' ' VAL . 3.9 mp -115.21 171.74 7.5 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.668 0.747 . . . . 0.0 110.926 -167.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.406 HG23 ' HD3' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -129.11 142.28 50.94 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.218 169.151 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -140.98 -144.54 4.45 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.007 -173.783 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.524 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -101.91 -173.54 2.37 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -176.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.581 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -70.83 -177.81 1.7 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.337 -171.635 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.581 ' H ' HG22 ' A' ' 255' ' ' THR . . . -67.32 -175.39 0.47 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.266 -178.599 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 50.7 m 80.59 6.22 1.53 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.002 0.921 . . . . 0.0 111.244 179.46 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.9 88.79 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.505 0.669 . . . . 0.0 109.411 171.377 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 62.9 m -89.09 103.68 16.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.953 179.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 83.22 79.44 1.03 Allowed Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.068 -176.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.638 ' CE1' ' HB2' ' A' ' 303' ' ' SER . 6.8 m-85 -45.32 -54.59 6.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.788 0.804 . . . . 0.0 109.932 170.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.5 pp -158.11 173.7 16.33 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.288 -1.323 . . . . 0.0 108.677 -175.021 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.543 ' HE2' ' OD2' ' A' ' 300' ' ' ASP . 94.4 mttt -136.29 -167.54 2.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.702 0.287 . . . . 0.0 111.54 -174.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -55.4 116.57 2.93 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.436 0.636 . . . . 0.0 111.446 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 115.08 -14.96 18.84 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.199 177.624 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -86.06 141.89 29.12 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.254 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -104.86 150.16 25.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.878 0.847 . . . . 0.0 112.668 -172.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.35 173.71 13.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.668 175.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.454 ' HE2' ' CB ' ' A' ' 340' ' ' SER . 0.0 OUTLIER -134.57 149.88 50.67 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 167.091 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . 0.512 ' O ' ' HA ' ' A' ' 292' ' ' SER . 55.4 m-85 -106.5 130.73 54.23 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.494 -175.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 45.6 m -107.16 88.34 2.71 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 171.387 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 121.424 0.631 . . . . 0.0 111.767 -172.3 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 17.8 p . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -111.63 147.39 35.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.856 0.36 . . . . 0.0 111.127 -174.212 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 269' ' ' LYS . 51.9 m -88.02 127.27 35.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.783 -179.21 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -120.23 179.13 4.38 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 95.3 m -136.97 130.65 31.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.534 0.683 . . . . 0.0 112.543 -177.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 299' ' ' ALA . 61.1 t -85.1 144.08 10.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.484 -178.359 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 0.6 OUTLIER -119.33 24.74 10.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.821 -174.993 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.557 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -166.83 173.34 9.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.763 0.316 . . . . 0.0 111.668 -177.346 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.543 ' OD2' ' HE2' ' A' ' 263' ' ' LYS . 2.3 m-20 -64.8 116.55 6.42 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.256 176.688 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -93.26 112.75 24.76 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.664 179.023 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.74 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 65.9 t30 -85.55 134.47 34.02 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -171.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.638 ' HB2' ' CE1' ' A' ' 261' ' ' PHE . 7.7 t -113.88 95.72 5.46 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 163.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -98.53 179.25 4.76 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.976 -178.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 20.5 m -57.07 -32.92 66.75 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -173.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -83.39 5.54 76.97 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.468 -176.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 64.49 42.69 97.42 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.864 -178.345 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -120.22 142.91 48.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.367 0.584 . . . . 0.0 111.682 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.74 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.2 OUTLIER -143.89 152.7 15.93 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.616 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.096 176.973 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.448 ' OG1' HG23 ' A' ' 250' ' ' THR . 95.5 m -149.72 120.04 7.34 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.692 -0.63 . . . . 0.0 110.619 178.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 35.4 m -145.87 160.88 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.41 0.624 . . . . 0.0 111.23 -177.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 23.7 m -114.75 140.93 48.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.582 176.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.52 126.52 54.47 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.367 -171.245 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 7.6 p . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.329 -176.118 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.553 ' CG2' ' HB3' ' A' ' 233' ' ' GLN . 2.6 m . . . . . 0 C--O 1.236 0.393 0 CA-C-O 121.381 0.61 . . . . 0.0 112.113 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -147.22 161.82 40.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.937 -177.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -65.96 173.09 3.18 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.507 0.504 . . . . 0.0 111.358 178.596 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 112.26 13.73 11.64 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -176.086 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.628 ' OD2' ' HB ' ' A' ' 230' ' ' VAL . 0.4 OUTLIER -96.29 146.68 24.51 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.742 0.782 . . . . 0.0 112.617 -173.885 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -144.08 163.56 33.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.779 178.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.56 HG21 HD23 ' A' ' 251' ' ' LEU . 74.7 t -125.24 143.03 40.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.227 0.537 . . . . 0.0 111.285 -169.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.454 ' CB ' ' HE2' ' A' ' 269' ' ' LYS . 20.0 m -147.51 127.21 13.38 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 172.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 19.1 t -76.04 143.12 13.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 120.867 0.365 . . . . 0.0 111.311 -173.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 53.4 t . . . . . 0 C--N 1.333 -0.15 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.471 176.969 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.565 0 CA-C-O 121.533 0.518 . . . . 0.0 114.083 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 5.3 m -67.28 145.35 55.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.435 0.636 . . . . 0.0 112.401 -173.077 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.431 HD22 HG11 ' A' ' 309' ' ' VAL . 1.3 mt -133.68 179.13 6.42 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.89 177.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 251' ' ' LEU . 48.1 m -139.08 158.84 43.46 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 122.303 -0.248 . . . . 0.0 110.498 -175.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 17.6 t -106.08 133.19 51.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 179.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -104.46 -39.05 6.56 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 178.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 63.5 p -118.77 -169.56 1.75 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.785 0.326 . . . . 0.0 110.489 -177.021 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.45 ' HB3' HG23 ' A' ' 333' ' ' VAL . 91.2 mt-30 -105.27 126.1 31.83 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.507 -169.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.646 ' HB3' ' CD2' ' A' ' 247' ' ' PHE . 23.7 Cg_exo -62.56 104.73 0.38 Allowed 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.687 2.258 . . . . 0.0 111.861 176.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.8 t -142.55 104.87 4.45 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.661 0.743 . . . . 0.0 112.187 -177.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.706 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.16 175.42 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.879 171.931 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . 0.602 ' H ' HG13 ' A' ' 236' ' ' VAL . 55.9 m -34.09 114.27 0.2 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -169.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -116.04 88.13 2.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.465 173.178 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -113.73 133.16 55.52 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -179.225 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -104.28 -40.39 6.13 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.621 -172.163 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.73 -29.77 46.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.516 0.674 . . . . 0.0 109.74 176.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.49 ' HA ' ' HE2' ' A' ' 242' ' ' LYS . 11.2 mmpt? -100.45 -3.43 30.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.084 -178.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 53.72 51.57 14.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 113.998 -1.456 . . . . 0.0 111.089 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.2 m -126.28 99.16 5.75 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.095 -175.239 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -116.44 108.42 16.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.071 0.462 . . . . 0.0 110.502 -177.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . 0.505 ' HB2' HG12 ' A' ' 236' ' ' VAL . 95.0 mt-30 -129.5 164.16 24.35 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.057 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.706 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 31.3 p90 -159.79 135.66 8.59 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.565 -0.454 . . . . 0.0 112.143 176.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 51.9 m -98.09 138.92 34.66 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.487 ' HB ' HD11 ' A' ' 251' ' ' LEU . 0.2 OUTLIER -142.7 150.83 17.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.765 -179.305 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.595 HG23 ' OG1' ' A' ' 310' ' ' THR . 96.2 m -104.38 117.45 34.21 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 167.488 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.582 ' HB2' HG13 ' A' ' 309' ' ' VAL . 4.0 mp -118.49 169.49 9.73 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.209 -170.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 307' ' ' GLY . 0.0 OUTLIER -110.4 141.72 43.09 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.279 176.114 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.417 ' HA2' HD23 ' A' ' 228' ' ' LEU . . . -138.34 -143.92 4.57 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.999 -178.653 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -109.96 -173.61 2.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.814 0.34 . . . . 0.0 111.877 -177.099 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.577 HG22 ' H ' ' A' ' 256' ' ' ALA . 2.2 m -67.04 173.68 3.55 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.388 -0.823 . . . . 0.0 112.877 -170.125 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.577 ' H ' HG22 ' A' ' 255' ' ' THR . . . -62.94 -175.34 0.09 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.861 0.864 . . . . 0.0 112.663 -178.785 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 31.3 t 81.53 6.4 1.2 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.95 0.9 . . . . 0.0 111.101 -178.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 64.4 t -125.32 90.54 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.545 0.688 . . . . 0.0 109.571 171.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 22.2 m -75.81 97.86 4.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.735 178.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 80.52 87.82 0.58 Allowed Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.495 -177.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.565 ' HB3' HD22 ' A' ' 262' ' ' LEU . 2.6 m-85 -44.6 -61.39 1.57 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.666 0.746 . . . . 0.0 110.143 170.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.565 HD22 ' HB3' ' A' ' 261' ' ' PHE . 2.9 mm? -135.22 166.01 24.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.405 -1.27 . . . . 0.0 108.483 179.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 98.2 mttt -134.74 -170.98 2.67 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 123.164 0.29 . . . . 0.0 110.822 178.022 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -59.51 117.28 4.7 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.112 0.482 . . . . 0.0 110.57 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 115.26 -14.93 18.36 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.514 177.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 28.5 m-20 -86.9 138.48 31.51 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -100.6 154.2 18.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.072 0.463 . . . . 0.0 110.319 -178.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 294' ' ' THR . 1.3 m -135.17 176.33 8.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.314 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.425 ' HE3' HG22 ' A' ' 342' ' ' VAL . 1.7 mptm? -122.8 139.99 53.41 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 171.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -137.68 136.76 37.72 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.803 174.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.631 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 29.7 m -110.14 88.54 2.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.428 -175.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.462 ' HA ' ' CG ' ' A' ' 337' ' ' ASP . 3.2 t-20 . . . . . 0 N--CA 1.467 0.384 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.205 176.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 10.3 p . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -153.3 168.87 24.58 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.248 0.547 . . . . 0.0 111.737 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 90.0 m -89.35 133.57 34.44 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.814 -172.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . 0.406 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -119.15 -170.43 1.92 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.963 175.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 16.9 m -139.01 131.82 29.19 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.58 0.705 . . . . 0.0 112.877 -177.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.639 HG13 HG21 ' A' ' 311' ' ' VAL . 55.1 t -82.42 142.09 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 114.207 -1.361 . . . . 0.0 109.488 179.155 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 41.5 p -129.19 18.44 5.98 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -173.576 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.409 ' HB3' HG23 ' A' ' 311' ' ' VAL . . . -167.59 177.95 5.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.394 0.14 . . . . 0.0 110.67 179.092 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.41 108.66 2.04 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.846 0.716 . . . . 0.0 109.556 178.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -92.67 100.91 13.33 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.275 0.56 . . . . 0.0 110.241 -177.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.449 ' OD1' ' HB3' ' A' ' 304' ' ' ASP . 9.0 t-20 -63.35 135.06 56.76 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -169.204 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.526 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 27.5 t -115.68 96.52 5.65 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 166.38 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . 0.449 ' HB3' ' OD1' ' A' ' 302' ' ' ASN . 0.4 OUTLIER -106.25 174.7 5.77 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.476 -176.864 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 20.3 m -60.67 -32.24 71.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.749 0.309 . . . . 0.0 111.589 -176.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -74.21 1.05 51.2 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.188 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . 0.465 ' O ' HG22 ' A' ' 252' ' ' THR . . . 63.91 40.68 98.56 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.309 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -114.16 127.77 56.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.695 0.284 . . . . 0.0 110.683 -179.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.582 HG13 ' HB2' ' A' ' 251' ' ' LEU . 2.7 p -131.97 101.06 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.392 0.615 . . . . 0.0 111.134 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.595 ' OG1' HG23 ' A' ' 250' ' ' THR . 54.3 m -104.03 126.63 51.3 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 121.95 -0.469 . . . . 0.0 110.864 -179.009 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.639 HG21 HG13 ' A' ' 297' ' ' VAL . 12.7 p -160.43 151.4 5.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.066 0.46 . . . . 0.0 110.237 175.37 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 48.4 m -92.4 148.9 21.75 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.307 178.449 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.502 ' HB2' ' CE2' ' A' ' 247' ' ' PHE . 5.7 mp -117.23 149.3 40.64 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.795 -179.076 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 36.8 m . . . . . 0 C--N 1.32 -0.713 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.74 -178.461 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.45 HG23 ' HB3' ' A' ' 233' ' ' GLN . 22.2 m . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -131.34 153.89 49.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.0 0.429 . . . . 0.0 110.638 -178.513 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -97.95 165.21 12.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.857 -179.079 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 103.5 12.17 31.46 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.344 175.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.631 ' HB3' ' O ' ' A' ' 271' ' ' THR . 23.8 m-20 -95.19 -178.77 4.57 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.021 0.438 . . . . 0.0 112.126 -178.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -104.73 153.92 20.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.61 -173.444 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.453 HG21 HD23 ' A' ' 251' ' ' LEU . 50.5 t -132.86 150.34 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.791 -176.367 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 31.6 t -144.85 171.34 14.57 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 175.318 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 32.2 t -118.29 160.28 18.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.669 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.425 HG22 ' HE3' ' A' ' 269' ' ' LYS . 94.3 t . . . . . 0 C--O 1.235 0.293 0 CA-C-N 118.212 0.46 . . . . 0.0 110.392 -179.582 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.964 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 20.3 m -129.74 131.49 46.3 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.738 0.304 . . . . 0.0 110.383 -173.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 2.2 mp -138.47 -177.3 4.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.122 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 95.3 m -143.74 156.14 44.42 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.997 -176.799 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.438 HG23 HG23 ' A' ' 339' ' ' VAL . 66.3 t -108.05 122.77 62.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.197 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -106.05 -6.28 18.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.106 0.479 . . . . 0.0 110.716 -175.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 17.5 p -130.25 -168.32 1.95 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.732 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.418 ' HA ' ' HD2' ' A' ' 234' ' ' PRO . 6.8 mt-30 -113.74 113.65 47.39 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -175.347 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 233' ' ' GLN . 18.3 Cg_endo -62.17 106.98 0.51 Allowed 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.894 2.396 . . . . 0.0 112.494 -179.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.0 t -149.37 118.44 6.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.533 0.682 . . . . 0.0 112.269 179.556 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.666 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -155.9 174.72 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.164 171.569 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . 0.497 ' H ' HG13 ' A' ' 236' ' ' VAL . 34.8 m -23.09 100.19 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.609 1.164 . . . . 0.0 113.525 -177.318 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.95 83.42 1.82 Allowed 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.408 174.158 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.423 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 35.7 t-20 -108.79 129.96 55.38 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.016 -178.326 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -102.46 -41.39 6.32 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.68 -170.519 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.8 -33.77 65.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.43 0.633 . . . . 0.0 109.944 178.1 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.492 ' HA ' ' HE2' ' A' ' 242' ' ' LYS . 10.8 mmpt? -88.77 -11.25 45.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.481 178.835 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 26.5 t70 58.1 69.19 0.75 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.277 -178.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.9 m -146.8 104.84 3.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.159 -177.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -123.33 106.33 10.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.783 -176.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . 0.564 ' HB2' HG12 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -124.03 161.92 24.53 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 171.551 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.666 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 35.2 p90 -149.09 134.82 18.78 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.67 174.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 46.5 m -98.8 137.49 37.32 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.428 ' HB ' ' CD1' ' A' ' 251' ' ' LEU . 0.2 OUTLIER -142.29 148.58 20.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.878 -178.946 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.6 HG23 ' OG1' ' A' ' 310' ' ' THR . 41.6 m -99.51 107.84 20.12 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 166.519 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.561 ' HB2' HG13 ' A' ' 309' ' ' VAL . 5.2 mp -102.82 167.97 9.53 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -170.685 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.19 144.13 43.69 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.813 175.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -142.82 -142.48 4.01 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.369 -173.144 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.414 ' H ' ' HZ ' ' A' ' 261' ' ' PHE . . . -113.37 -173.66 2.31 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -176.362 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.577 HG22 ' H ' ' A' ' 256' ' ' ALA . 1.8 m -70.9 174.0 6.69 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.185 -171.726 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.577 ' H ' HG22 ' A' ' 255' ' ' THR . . . -62.51 -177.46 0.14 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.495 0.718 . . . . 0.0 112.862 -177.17 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 23.1 t 80.83 10.93 0.95 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.185 0.994 . . . . 0.0 111.155 -176.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 40.4 t -124.33 94.06 2.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 169.705 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.2 m -67.65 88.89 0.24 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.515 -177.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 69.48 107.42 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.109 -174.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.414 ' HZ ' ' H ' ' A' ' 254' ' ' ALA . 15.1 m-85 -44.19 -57.35 3.49 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 117.243 0.521 . . . . 0.0 111.091 174.254 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.524 HD11 HG13 ' A' ' 341' ' ' VAL . 91.9 mt -147.83 146.81 29.26 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -177.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.514 ' HD2' ' N ' ' A' ' 263' ' ' LYS . 9.5 mptt -112.86 -166.45 1.08 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.033 0.444 . . . . 0.0 111.561 176.53 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -52.79 114.15 1.32 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.66 -175.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 114.2 -16.07 20.26 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.416 171.392 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.54 134.79 35.2 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.83 -177.014 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.19 145.94 24.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.24 -173.592 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.408 HG23 ' HB3' ' A' ' 295' ' ' ALA . 0.2 OUTLIER -125.33 165.3 22.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.744 179.97 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 340' ' ' SER . 0.8 OUTLIER -97.57 120.3 37.69 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 172.433 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -122.55 120.55 34.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.857 0.361 . . . . 0.0 110.085 -174.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 30.4 m -125.79 113.0 16.69 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.491 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 19.4 m120 . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.031 -177.584 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.449 -0.488 0 CA-C-O 120.739 0.304 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -118.96 174.99 5.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.046 0.45 . . . . 0.0 110.665 -178.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 67.9 m -109.22 117.91 35.35 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.852 178.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . 0.408 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -104.24 -175.85 2.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 -176.148 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 91.4 m -141.63 131.16 23.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.384 0.612 . . . . 0.0 112.282 -176.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.589 HG13 HG21 ' A' ' 311' ' ' VAL . 64.3 t -75.13 136.67 24.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.053 176.372 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 2.4 m -111.45 -9.04 14.24 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.97 -167.698 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -164.45 -168.9 1.63 Allowed 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.912 -0.492 . . . . 0.0 111.676 -177.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.16 151.71 35.1 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.77 0.795 . . . . 0.0 110.762 179.35 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -148.13 -178.38 6.26 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.315 -1.311 . . . . 0.0 109.433 -178.135 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -136.56 135.83 38.77 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -173.482 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.8 OUTLIER -112.94 95.62 5.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 161.618 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -99.88 175.49 5.76 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.662 -176.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 53.5 m -60.91 -31.39 70.9 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -177.027 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -78.55 -2.43 84.85 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.213 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 69.2 42.06 77.36 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.739 179.006 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -114.67 135.52 54.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.92 0.86 . . . . 0.0 110.856 175.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.561 HG13 ' HB2' ' A' ' 251' ' ' LEU . 2.3 p -136.51 105.29 4.41 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.507 -179.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.6 ' OG1' HG23 ' A' ' 250' ' ' THR . 90.7 m -102.82 129.84 49.62 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 121.664 -0.648 . . . . 0.0 111.365 -178.31 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.589 HG21 HG13 ' A' ' 297' ' ' VAL . 14.4 p -165.93 155.41 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.033 0.444 . . . . 0.0 110.237 174.303 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 52.4 m -96.64 149.32 21.93 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.453 -179.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.474 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.4 mp -117.21 136.62 52.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.542 -178.422 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.446 -173.915 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 25.9 m . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.873 0.368 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -132.64 144.7 50.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.5 -179.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -67.16 154.01 42.29 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.591 -178.49 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 117.25 6.1 13.98 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.201 -178.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -69.33 159.99 32.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.836 0.35 . . . . 0.0 111.162 -177.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -105.96 138.51 42.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.769 -176.235 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.48 HG21 HD23 ' A' ' 251' ' ' LEU . 77.2 t -128.09 145.1 35.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.137 0.494 . . . . 0.0 111.202 -175.436 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.536 ' HB2' ' HB3' ' A' ' 269' ' ' LYS . 36.5 m -145.02 175.54 10.15 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 172.206 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.524 HG13 HD11 ' A' ' 262' ' ' LEU . 98.7 t -116.09 122.3 69.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.917 0.389 . . . . 0.0 111.963 -174.667 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.428 173.563 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.701 0 N-CA-C 111.871 -0.492 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -115.72 140.11 49.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.178 0.513 . . . . 0.0 111.033 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -79.73 -22.23 43.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.26 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 100.76 12.65 36.89 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.4 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -111.74 115.7 3.94 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.17 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 26.4 m -152.21 98.93 2.47 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 2.2 mp -116.67 -176.66 3.01 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.615 -172.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 87.6 m -134.01 154.77 50.92 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.418 -176.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 41.1 t -93.87 107.26 19.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -90.49 -31.19 16.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.025 0.44 . . . . 0.0 111.194 -172.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 19.2 p -128.71 -168.45 1.92 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.194 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.61 ' HB3' HG23 ' A' ' 333' ' ' VAL . 64.9 mt-30 -108.08 122.02 41.96 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-O 120.887 0.375 . . . . 0.0 110.617 -171.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.77 106.78 2.32 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 123.014 2.476 . . . . 0.0 113.264 -176.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 236' ' ' VAL . 10.2 t -155.33 127.93 7.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.964 0.411 . . . . 0.0 111.911 176.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.652 HG12 ' HB2' ' A' ' 246' ' ' GLN . 0.9 OUTLIER -155.3 173.96 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.308 172.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.495 ' H ' HG13 ' A' ' 236' ' ' VAL . 57.1 m -20.38 112.04 0.02 OUTLIER 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.535 1.534 . . . . 0.0 114.207 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -115.61 100.85 8.35 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.087 174.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -135.61 131.52 35.94 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.129 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -98.82 -47.82 5.15 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.168 -170.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.68 -23.8 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.437 0.637 . . . . 0.0 110.078 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -100.61 1.07 40.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.296 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 51.0 50.61 18.78 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.324 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 14.7 m -122.31 101.08 7.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.336 -175.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -128.58 112.55 14.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.941 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . 0.652 ' HB2' HG12 ' A' ' 236' ' ' VAL . 50.6 mt-30 -138.75 164.62 29.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 175.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.632 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 36.8 p90 -147.02 134.64 21.01 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.244 171.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 38.6 m -100.34 137.79 38.29 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.68 143.96 22.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.317 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 18.3 m -91.22 113.37 25.61 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 160.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.575 ' HB2' HG13 ' A' ' 309' ' ' VAL . 5.1 mp -101.77 167.29 10.18 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -177.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.57 141.07 48.94 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.236 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -141.62 -143.37 4.23 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 121.227 -0.511 . . . . 0.0 111.937 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -112.15 -174.44 2.46 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -175.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.579 HG22 ' H ' ' A' ' 256' ' ' ALA . 3.0 m -67.86 173.55 4.35 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.417 -172.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.579 ' H ' HG22 ' A' ' 255' ' ' THR . . . -60.48 -176.17 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.818 0.847 . . . . 0.0 112.535 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 15.3 t 81.05 6.3 1.34 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.125 0.97 . . . . 0.0 110.619 -176.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 91.6 t -123.74 90.37 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 170.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.4 m -75.54 93.43 3.01 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.345 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 75.74 97.16 0.14 Allowed Glycine 0 N--CA 1.44 -1.068 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.068 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.658 ' HB3' HD13 ' A' ' 262' ' ' LEU . 28.5 m-85 -46.2 -58.75 3.38 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.652 0.739 . . . . 0.0 109.737 172.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.658 HD13 ' HB3' ' A' ' 261' ' ' PHE . 0.0 OUTLIER -151.88 171.32 17.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.807 177.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 37.9 mtmm -136.28 -166.84 1.95 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.696 0.284 . . . . 0.0 111.765 -174.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -53.46 118.87 4.19 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.397 0.618 . . . . 0.0 111.69 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 106.31 -12.15 43.82 Favored Glycine 0 C--N 1.316 -0.557 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.118 176.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . 0.453 ' CB ' ' HB2' ' A' ' 262' ' ' LEU . 40.9 m-20 -84.47 133.23 34.48 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -94.36 147.62 23.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.326 0.584 . . . . 0.0 111.149 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.5 OUTLIER -120.48 179.59 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.4 174.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.49 ' O ' ' HD3' ' A' ' 269' ' ' LYS . 12.8 tmtt? -134.51 102.55 5.35 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 174.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -112.51 143.77 43.11 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.534 -174.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.611 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 84.8 m -127.78 89.54 2.96 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.649 0.737 . . . . 0.0 110.297 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.446 ' HA ' ' CB ' ' A' ' 337' ' ' ASP . 2.4 t-20 -102.39 95.13 6.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.562 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . 0.566 ' HB ' ' OG1' ' A' ' 289' ' ' THR . 68.2 p -88.89 111.7 22.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.772 -171.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -85.21 115.94 23.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.815 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 41.1 t-105 -101.69 14.06 33.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.885 0.85 . . . . 0.0 109.503 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.0 47.08 0.96 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.932 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -101.96 -46.81 4.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.724 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -59.2 -47.65 84.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.247 -173.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -73.54 -33.44 64.71 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.386 -176.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 33.4 p -78.72 -34.0 46.26 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.908 0.385 . . . . 0.0 111.097 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -85.84 -10.08 55.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.497 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 62.43 11.46 4.64 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.822 0.849 . . . . 0.0 111.197 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -177.82 -171.6 0.31 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.57 -1.196 . . . . 0.0 107.953 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 8.6 mp 61.59 71.95 0.53 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -52.54 -36.74 56.24 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.186 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 14.1 m120 65.89 167.16 0.2 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.876 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -143.17 15.5 2.33 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.488 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -136.23 119.39 16.6 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.133 0.492 . . . . 0.0 110.438 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.566 ' OG1' ' HB ' ' A' ' 273' ' ' THR . 10.0 t -90.47 149.0 40.13 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.278 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . 0.452 ' HD2' ' OG1' ' A' ' 289' ' ' THR . 35.0 Cg_exo -35.28 -58.34 0.42 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.332 3.354 . . . . 0.0 114.516 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 289' ' ' THR . 68.9 mt 64.13 95.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.401 0.62 . . . . 0.0 110.737 -176.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.23 177.26 7.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.088 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -142.71 -135.81 0.1 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.512 -169.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 48.7 m -70.49 130.87 43.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.13 0.491 . . . . 0.0 112.031 -173.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -130.11 -169.49 2.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.029 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 54.5 m -139.85 132.63 29.09 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.497 HG13 HG21 ' A' ' 311' ' ' VAL . 64.4 t -82.16 139.89 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.33 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.38 9.64 13.4 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.493 -169.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -171.82 -172.28 0.99 Allowed 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 120.568 0.223 . . . . 0.0 111.509 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.42 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 4.4 m-20 -61.98 123.42 18.03 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.397 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.554 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -111.81 110.02 20.15 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.528 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.418 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 25.5 t-20 -80.0 132.29 35.98 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -166.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.543 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 12.8 t -106.75 95.97 6.12 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 164.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.63 -178.63 3.78 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.261 -175.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 23.3 t -60.76 -34.8 75.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.971 0.415 . . . . 0.0 111.368 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -81.9 -3.12 90.68 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.687 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 65.0 41.17 97.44 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.704 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.32 125.84 54.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.385 0.612 . . . . 0.0 109.852 175.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.575 HG13 ' HB2' ' A' ' 251' ' ' LEU . 2.0 p -127.07 94.08 2.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.946 -175.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 53.5 m -98.79 127.01 44.58 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.003 -0.435 . . . . 0.0 111.676 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.497 HG21 HG13 ' A' ' 297' ' ' VAL . 11.8 p -161.95 151.02 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 175.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 49.2 m -93.22 146.03 23.99 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.079 0.466 . . . . 0.0 110.339 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.49 ' HB2' ' CE2' ' A' ' 247' ' ' PHE . 5.7 mp -117.46 151.21 37.54 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.62 -175.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 2.8 p -100.32 135.6 41.5 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.589 173.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 116.89 -171.58 13.86 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -175.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 318' ' ' ILE . 1.5 m -157.71 170.09 9.52 Favored Pre-proline 0 N--CA 1.466 0.358 0 C-N-CA 122.985 0.514 . . . . 0.0 109.844 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.31 92.09 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.458 2.105 . . . . 0.0 110.693 169.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 316' ' ' VAL . 96.3 mt -80.95 146.69 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.528 -171.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 79.7 -13.55 0.94 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.179 0.991 . . . . 0.0 111.103 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -113.21 -62.06 1.65 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.263 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 32.1 p -88.07 52.56 2.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.449 0.642 . . . . 0.0 110.494 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 2.1 m -102.61 5.7 39.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.033 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -113.75 88.75 14.46 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.096 -174.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.42 -44.66 21.64 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 121.577 1.518 . . . . 0.0 111.165 173.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . 0.43 ' HB3' ' HB3' ' A' ' 328' ' ' SER . 13.7 mt-30 72.93 -41.37 0.5 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.753 171.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 75.73 -32.14 0.21 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.642 0.777 . . . . 0.0 112.509 172.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -111.04 -48.87 3.07 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' A' ' 325' ' ' GLN . 23.1 t -74.57 102.92 4.69 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.532 173.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 34.5 t -49.63 122.58 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.078 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 19.3 m -61.06 150.61 33.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.515 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.28 142.08 57.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.917 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -88.49 149.53 23.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.095 0.474 . . . . 0.0 110.444 -174.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.61 HG23 ' HB3' ' A' ' 233' ' ' GLN . 9.5 m -77.64 150.27 5.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.76 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -137.52 148.17 45.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.085 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -97.71 172.75 7.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.049 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 112.73 11.64 14.19 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.444 176.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.611 ' HB3' ' O ' ' A' ' 271' ' ' THR . 4.3 m-20 -104.36 -170.77 1.82 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -176.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -114.32 157.17 23.15 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.155 0.503 . . . . 0.0 111.926 -172.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 39.0 t -134.42 145.8 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.28 -176.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 35.9 t -142.62 176.45 9.03 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 50.9 t -119.04 126.58 75.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.966 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 9.7 p -112.06 4.75 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 121.499 0.666 . . . . 0.0 110.979 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -81.33 169.05 50.94 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.117 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 18.9 p -120.29 -82.05 0.64 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.07 0.462 . . . . 0.0 111.272 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.898 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.14 -179.793 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.816 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -59.69 121.58 11.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.17 0.509 . . . . 0.0 111.327 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.514 ' HB3' ' HB ' ' A' ' 341' ' ' VAL . 85.0 t80 -82.71 -28.2 30.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.785 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 96.55 -1.96 62.33 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.621 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -89.77 145.14 18.13 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.073 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 23.6 m -124.32 132.03 53.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.177 0.513 . . . . 0.0 110.18 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.644 HD22 HG11 ' A' ' 309' ' ' VAL . 5.5 mt -131.3 173.36 11.14 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.576 -175.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 31.6 m -141.9 156.08 45.5 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -174.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 54.7 t -117.14 127.96 74.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 122.418 -0.177 . . . . 0.0 110.964 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.475 ' NZ ' HG23 ' A' ' 252' ' ' THR . 31.1 mtmm -112.38 -14.9 13.23 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -177.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 75.2 p -120.44 -174.09 2.72 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.23 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -106.59 106.33 57.39 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -170.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.552 ' C ' ' HB2' ' A' ' 247' ' ' PHE . 55.5 Cg_endo -69.83 103.75 1.22 Allowed 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.567 2.178 . . . . 0.0 113.6 -174.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.531 ' O ' HG23 ' A' ' 236' ' ' VAL . 15.1 t -157.93 129.32 6.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.714 170.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.604 ' N ' ' HA ' ' A' ' 247' ' ' PHE . 2.9 t -155.94 114.49 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 C-N-CA 122.827 0.451 . . . . 0.0 110.69 172.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' A' ' 245' ' ' TYR . 23.7 m 64.57 93.65 0.06 Allowed 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.228 0.537 . . . . 0.0 111.649 176.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -109.55 84.44 1.92 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -132.52 129.06 38.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.218 -175.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.22 -35.01 7.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.78 -173.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 61.5 t -62.81 -29.56 47.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.497 0.665 . . . . 0.0 109.62 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.479 ' HA ' ' HE2' ' A' ' 242' ' ' LYS . 9.8 mmpt? -96.81 -12.46 23.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.881 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 60.7 59.92 2.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.001 -1.454 . . . . 0.0 110.55 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 36.8 m -143.93 106.27 4.4 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.151 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . 0.619 ' HA ' ' O ' ' A' ' 237' ' ' THR . 59.0 m-85 -129.07 118.17 22.07 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 236' ' ' VAL . 45.0 mt-30 -130.54 -179.16 5.12 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.604 ' HA ' ' N ' ' A' ' 236' ' ' VAL . 13.0 p90 -160.26 136.8 8.89 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.238 165.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.486 ' OG1' HG21 ' A' ' 236' ' ' VAL . 32.8 m -102.66 138.41 39.6 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.461 ' HB ' ' CD1' ' A' ' 251' ' ' LEU . 0.1 OUTLIER -144.92 151.15 15.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.712 -0.795 . . . . 0.0 112.11 -178.336 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.605 HG23 ' OG1' ' A' ' 310' ' ' THR . 91.7 m -103.14 104.85 15.04 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 168.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.616 ' HB2' HG13 ' A' ' 309' ' ' VAL . 5.1 mp -102.7 167.78 9.68 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -169.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.475 HG23 ' NZ ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -114.68 151.37 33.71 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.91 172.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -150.97 -142.67 3.57 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 121.197 -0.525 . . . . 0.0 111.907 -173.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.584 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -107.42 -174.59 2.57 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.561 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -69.48 -177.8 1.26 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.41 -172.043 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.561 ' H ' HG22 ' A' ' 255' ' ' THR . . . -64.39 -175.98 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.825 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 49.8 m 80.24 9.05 1.36 Allowed 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.489 0.716 . . . . 0.0 111.287 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 28.6 t -126.85 90.07 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 171.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.9 m -70.9 93.76 1.01 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.892 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 73.62 98.0 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.217 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.408 ' CE1' HD21 ' A' ' 228' ' ' LEU . 6.3 m-85 -44.99 -58.67 3.02 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.816 0.817 . . . . 0.0 109.824 171.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 266' ' ' ASP . 77.8 mt -140.78 169.15 18.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.31 -1.314 . . . . 0.0 109.051 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -133.25 -167.33 1.91 Allowed 'General case' 0 C--N 1.323 -0.554 0 O-C-N 123.079 0.237 . . . . 0.0 110.502 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -59.93 116.28 4.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.286 0.565 . . . . 0.0 111.171 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 111.7 -14.37 27.09 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.547 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . 0.518 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 37.3 m-20 -81.0 128.23 33.46 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.938 0.399 . . . . 0.0 110.292 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.97 150.93 22.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.449 0.642 . . . . 0.0 111.759 -173.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.444 HG12 HG22 ' A' ' 341' ' ' VAL . 1.3 m -131.38 171.71 17.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.276 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.505 ' HD2' HG13 ' A' ' 342' ' ' VAL . 0.0 OUTLIER -143.77 129.21 18.99 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.2 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.469 ' CB ' HG22 ' A' ' 339' ' ' VAL . 8.6 p90 -130.4 158.51 39.67 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.128 -174.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.687 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 93.2 m -108.7 86.89 2.37 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.163 -173.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -116.1 89.96 3.23 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 19.6 p -76.62 85.9 3.29 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.531 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -86.64 157.57 19.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.273 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.505 ' HA ' ' HB2' ' A' ' 279' ' ' GLN . 9.3 p-90 -158.23 81.16 0.84 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.047 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.609 ' HB2' ' OD1' ' A' ' 320' ' ' ASP . 2.9 mm? -107.38 -74.93 0.64 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.39 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . 0.532 ' OE1' ' HA ' ' A' ' 321' ' ' THR . 69.4 mt-30 -106.39 -56.1 2.24 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -174.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.586 ' HG3' ' O ' ' A' ' 320' ' ' ASP . 75.8 mt-30 -74.6 -59.85 2.55 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.546 0.689 . . . . 0.0 110.16 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.505 ' HB2' ' HA ' ' A' ' 275' ' ' TRP . 12.5 mm100 -70.76 9.3 0.69 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.46 -1.246 . . . . 0.0 113.38 -170.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.64 -45.21 8.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.81 0.338 . . . . 0.0 110.445 171.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -92.02 -37.25 12.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.056 0.455 . . . . 0.0 110.489 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 61.72 19.7 10.74 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.445 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.462 ' HB3' HD22 ' A' ' 284' ' ' LEU . . . 67.16 -57.02 0.43 Allowed 'General case' 0 CA--C 1.532 0.253 0 O-C-N 124.589 1.181 . . . . 0.0 112.163 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.462 HD22 ' HB3' ' A' ' 283' ' ' ALA . 1.1 mm? -106.11 -4.7 20.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.726 0.298 . . . . 0.0 110.596 -177.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 60.51 92.31 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.407 -172.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -96.71 -41.28 8.57 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.51 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 102.66 24.16 8.37 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.313 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -149.65 -171.39 3.88 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 120.945 0.402 . . . . 0.0 110.24 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.593 ' OG1' ' HD2' ' A' ' 290' ' ' PRO . 9.3 t -172.11 158.35 4.2 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . 0.593 ' HD2' ' OG1' ' A' ' 289' ' ' THR . 6.6 Cg_endo -49.45 118.34 3.6 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.835 2.357 . . . . 0.0 112.109 177.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 50.0 mm -75.59 -60.6 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.462 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 36.9 m -132.04 143.31 49.96 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.4 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -145.29 154.25 42.15 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.07 0.462 . . . . 0.0 110.439 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 86.7 m -89.31 134.75 33.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.87 -172.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . 0.414 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -129.03 -174.19 3.19 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 80.0 m -142.48 135.36 28.34 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.554 HG13 HG21 ' A' ' 311' ' ' VAL . 58.2 t -78.31 140.53 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.832 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 4.0 m -116.31 1.57 13.09 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -161.56 176.96 10.48 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.908 -0.495 . . . . 0.0 111.517 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.93 104.96 0.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.23 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -93.22 103.42 15.69 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.797 -174.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -61.0 135.07 57.68 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -171.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.07 97.49 6.25 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 162.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.4 174.11 6.85 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.715 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 42.5 m -57.05 -33.74 67.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -77.74 -3.05 83.1 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.449 -176.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . 0.584 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 72.73 41.26 50.68 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.246 -178.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -113.37 146.25 39.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.687 0.743 . . . . 0.0 110.909 174.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.644 HG11 HD22 ' A' ' 228' ' ' LEU . 2.2 p -145.56 102.19 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.414 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.605 ' OG1' HG23 ' A' ' 250' ' ' THR . 91.0 m -102.42 124.17 47.5 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.514 -0.741 . . . . 0.0 111.032 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.554 HG21 HG13 ' A' ' 297' ' ' VAL . 14.8 p -160.15 154.31 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.134 0.493 . . . . 0.0 110.213 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 47.0 m -97.87 152.39 19.24 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.65 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.486 HD13 ' CE1' ' A' ' 247' ' ' PHE . 5.7 mp -119.89 135.19 54.98 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.632 -177.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 27.7 p -122.51 151.43 41.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.807 0.337 . . . . 0.0 111.598 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 78.67 50.06 6.24 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.959 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -138.37 85.62 17.87 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 121.079 0.466 . . . . 0.0 111.425 -174.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -76.5 78.54 3.27 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.943 2.428 . . . . 0.0 112.444 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 11.0 mm -83.57 128.36 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.382 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -115.69 134.88 54.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.125 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.609 ' OD1' ' HB2' ' A' ' 276' ' ' LEU . 24.3 t70 -172.98 -38.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.358 174.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.532 ' HA ' ' OE1' ' A' ' 277' ' ' GLN . 0.0 OUTLIER -82.75 73.95 9.74 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.449 176.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 4.9 m -80.78 -23.04 39.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.555 0.693 . . . . 0.0 110.087 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -66.4 136.83 95.17 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.37 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.41 20.23 0.43 Allowed 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.81 1.674 . . . . 0.0 113.943 -174.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 74.44 -50.81 0.68 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.648 0.779 . . . . 0.0 112.912 173.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 65.07 22.72 12.38 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.478 0.656 . . . . 0.0 109.6 -174.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -176.87 159.77 1.78 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -173.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 20.4 m -75.85 90.44 2.93 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.398 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 23.7 t 64.85 103.48 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.984 -177.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 19.3 p -98.42 -69.41 0.76 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.182 -176.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -102.29 153.57 19.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.747 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -133.55 -177.33 4.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.321 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.427 HG22 ' N ' ' A' ' 334' ' ' GLU . 13.1 p -88.98 166.03 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . 0.427 ' N ' HG22 ' A' ' 333' ' ' VAL . 10.4 tp10 -119.87 147.81 44.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.978 0.418 . . . . 0.0 110.485 -175.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -85.85 173.5 9.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.213 -176.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 112.58 11.5 14.8 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.417 173.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.687 ' HB2' ' O ' ' A' ' 271' ' ' THR . 4.9 p-10 -91.05 179.87 5.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.998 0.428 . . . . 0.0 111.52 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -118.04 137.63 52.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.442 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.469 HG22 ' CB ' ' A' ' 270' ' ' PHE . 55.9 t -116.48 150.78 18.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.458 -172.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 41.9 m -146.73 173.22 12.57 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 172.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 224' ' ' PHE . 86.1 t -117.85 132.99 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -171.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.505 HG13 ' HD2' ' A' ' 269' ' ' LYS . 32.6 m -117.14 10.4 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 111.561 174.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . 0.406 ' H ' HG12 ' A' ' 341' ' ' VAL . . . -97.49 96.41 1.82 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.603 -177.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 8.5 p -127.07 -67.15 0.86 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.287 0.565 . . . . 0.0 109.742 175.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.947 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.955 177.503 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.56 0 N-CA-C 112.184 -0.366 . . . . 0.0 112.184 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -87.21 52.2 2.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.331 0.586 . . . . 0.0 110.631 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -82.46 46.51 1.06 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.779 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 67.12 36.68 90.74 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.054 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -41.23 115.51 0.75 Allowed Glycine 0 C--N 1.338 0.653 0 O-C-N 124.18 0.576 . . . . 0.0 113.167 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 21.2 m -107.53 142.66 37.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.04 0.448 . . . . 0.0 110.72 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.677 HD22 HG11 ' A' ' 309' ' ' VAL . 20.4 mt -143.03 175.93 9.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.269 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.569 ' O ' ' HB3' ' A' ' 251' ' ' LEU . 43.6 m -131.7 152.69 50.7 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.414 0.149 . . . . 0.0 110.615 -176.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.475 HG23 HG23 ' A' ' 339' ' ' VAL . 12.2 t -100.03 127.9 52.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 176.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -110.96 -29.1 8.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.373 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.459 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 72.7 p -119.87 -169.33 1.76 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.688 0.28 . . . . 0.0 110.732 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.64 ' HB3' ' HB ' ' A' ' 333' ' ' VAL . 85.1 mt-30 -112.76 125.68 29.52 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -172.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 233' ' ' GLN . 10.0 Cg_endo -92.71 106.39 0.19 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.337 2.691 . . . . 0.0 115.728 -168.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 236' ' ' VAL . 1.2 m -157.52 133.23 9.22 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 165.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.682 ' N ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -158.24 139.6 4.92 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.807 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 176.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 97.7 m 69.12 108.51 0.05 Allowed 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.494 0.718 . . . . 0.0 112.635 170.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.411 ' OH ' ' HD2' ' A' ' 319' ' ' TYR . 4.4 m-85 -116.31 99.81 7.46 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.437 175.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.53 88.31 2.79 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -83.63 -44.32 14.69 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.773 -163.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 22.8 t -66.47 -23.18 31.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.629 0.728 . . . . 0.0 109.145 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -99.87 -3.75 31.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.888 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 36.1 t70 57.39 68.85 0.8 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.35 -1.296 . . . . 0.0 111.729 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 24.4 t -152.9 119.76 5.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.513 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -129.6 128.51 42.83 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -121.8 -174.74 2.94 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.682 ' HA ' ' N ' ' A' ' 236' ' ' VAL . 1.8 p90 -156.71 125.74 5.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 174.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 52.9 m -95.41 142.29 27.96 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.485 HG13 HD11 ' A' ' 251' ' ' LEU . 7.3 p -144.07 137.92 24.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 119.786 -0.766 . . . . 0.0 112.391 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.459 ' HB ' ' CG2' ' A' ' 232' ' ' THR . 92.2 m -98.43 113.36 25.32 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 168.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.673 ' HB2' HG13 ' A' ' 309' ' ' VAL . 1.4 mp -107.85 168.68 9.1 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -175.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.76 139.4 41.24 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.187 172.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.464 ' HA2' HD23 ' A' ' 228' ' ' LEU . . . -141.86 -149.41 5.19 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.275 -175.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -96.25 -174.23 3.01 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 256' ' ' ALA . 2.8 m -77.01 175.73 9.31 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.021 -170.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.582 ' H ' HG22 ' A' ' 255' ' ' THR . . . -65.03 -176.39 0.28 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.446 0.698 . . . . 0.0 112.275 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 24.8 t 80.2 6.97 1.62 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.834 0.854 . . . . 0.0 110.517 -176.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 24.0 t -123.37 90.71 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 170.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 5.6 m -73.44 92.45 1.86 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.654 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.622 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 80.77 94.2 0.43 Allowed Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.958 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.487 ' CZ ' HD21 ' A' ' 228' ' ' LEU . 4.1 m-85 -43.5 -55.35 4.28 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 169.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.8 pp -165.51 173.85 10.55 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.568 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 60.3 mttp -143.23 -166.32 2.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.997 0.427 . . . . 0.0 111.836 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -53.54 122.74 10.38 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.162 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 109.92 -16.01 30.89 Favored Glycine 0 C--N 1.313 -0.718 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.7 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -84.35 139.43 32.28 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.587 ' HB2' HG11 ' A' ' 342' ' ' VAL . 27.5 mt-30 -107.91 151.92 25.13 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.389 0.614 . . . . 0.0 110.765 -178.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.4 OUTLIER -132.4 176.18 9.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.397 -179.24 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.405 ' HE2' HG23 ' A' ' 342' ' ' VAL . 3.2 mptp? -123.64 143.24 50.37 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 172.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.497 ' CE2' ' HB2' ' A' ' 295' ' ' ALA . 17.2 p90 -136.68 142.5 43.16 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 173.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 25.7 p -150.17 109.69 4.01 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.876 -174.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.561 HD22 ' HG3' ' A' ' 334' ' ' GLU . 24.1 p-10 -109.19 147.38 32.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.555 0.693 . . . . 0.0 111.802 -176.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 20.3 p -121.79 81.44 1.81 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.495 168.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -146.96 140.33 25.52 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.15 -172.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -86.43 121.73 29.39 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.327 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -78.93 102.46 8.28 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . 0.58 ' O ' ' HG2' ' A' ' 281' ' ' LYS . 96.7 mt-30 -56.49 -29.58 61.94 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -172.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -71.03 -45.15 64.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.125 0.488 . . . . 0.0 110.437 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.42 ' HG2' ' NE2' ' A' ' 332' ' ' GLN . 11.4 mm-40 -72.05 -36.81 69.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.986 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 34.4 p -69.01 -12.15 61.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.674 0.273 . . . . 0.0 111.562 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 277' ' ' GLN . 47.1 mmtm -63.45 -43.91 95.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.369 0.604 . . . . 0.0 109.378 171.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -84.51 -58.81 2.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.907 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 49.46 65.07 1.5 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.187 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 284' ' ' LEU . 3.1 mm? -107.81 -40.97 5.12 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.148 176.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -136.39 23.61 3.2 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.904 -175.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -93.57 -54.72 3.54 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.042 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 86.09 -64.55 4.03 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.241 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -162.42 -151.31 0.2 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 6.9 t -77.22 125.55 86.38 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-O 120.959 0.409 . . . . 0.0 110.294 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.69 141.64 24.93 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.521 2.147 . . . . 0.0 111.738 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 41.4 pt -89.08 132.16 34.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.047 0.451 . . . . 0.0 110.582 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.33 -165.85 1.34 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.004 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -161.71 -144.16 0.09 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 -168.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 56.0 m -74.77 137.04 41.71 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -175.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . 0.497 ' HB2' ' CE2' ' A' ' 270' ' ' PHE . . . -124.92 172.4 9.41 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 173.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 87.1 m -134.21 129.54 35.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.473 0.654 . . . . 0.0 112.474 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.596 HG12 ' H ' ' A' ' 299' ' ' ALA . 93.3 t -89.87 140.69 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.047 -177.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 1.9 m -125.06 23.86 7.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.009 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.596 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -156.29 -177.25 6.45 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.421 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 2.6 m-20 -76.83 165.57 24.52 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.775 -174.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.622 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -147.5 155.61 42.05 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.688 -175.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -128.99 133.1 47.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.263 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.529 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.8 OUTLIER -111.51 95.45 5.51 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 164.141 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.15 169.37 8.48 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.554 -0.459 . . . . 0.0 110.444 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 67.0 m -57.95 -30.3 65.87 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -76.85 7.51 34.17 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.622 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 59.89 41.88 97.94 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.219 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -121.78 117.98 27.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.316 0.558 . . . . 0.0 111.242 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.677 HG11 HD22 ' A' ' 228' ' ' LEU . 2.6 p -125.42 125.42 68.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.982 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 86.2 m -120.21 135.67 54.9 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 121.729 -0.607 . . . . 0.0 111.249 -177.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.548 ' CG1' ' HB2' ' A' ' 301' ' ' ALA . 6.6 m -146.76 165.21 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.143 0.497 . . . . 0.0 110.445 175.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 28.3 m -121.95 136.32 54.92 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.691 173.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 4.2 mp -112.8 158.93 19.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.999 -173.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 14.3 m -133.15 140.07 47.41 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.863 0.363 . . . . 0.0 111.561 -176.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 101.06 78.77 1.37 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.65 170.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 1.9 m -146.13 129.18 8.15 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 120.618 0.247 . . . . 0.0 110.695 173.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -81.67 48.43 2.85 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.65 2.233 . . . . 0.0 111.376 175.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.516 HG12 ' CD2' ' A' ' 319' ' ' TYR . 20.7 tt -83.97 133.46 29.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.952 -175.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.516 ' CD2' HG12 ' A' ' 318' ' ' ILE . 49.0 m-85 73.02 36.05 0.9 Allowed 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.028 176.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -76.05 -58.91 3.0 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.463 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 2.6 p -149.68 -155.22 0.61 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 23.9 m -99.58 -39.28 8.38 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.422 0.63 . . . . 0.0 109.761 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -137.65 68.24 51.96 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.511 -169.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -59.96 -67.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.171 1.914 . . . . 0.0 111.932 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . 0.42 ' O ' ' HB2' ' A' ' 326' ' ' TYR . 26.4 mm-40 -107.38 67.0 0.68 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 325' ' ' GLN . 69.8 m-85 73.25 -39.92 0.46 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.305 -176.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -172.28 114.81 0.32 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 170.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 9.3 m -144.15 111.11 5.75 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.769 -0.582 . . . . 0.0 111.277 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 5.5 t 58.76 42.22 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-O 121.907 0.86 . . . . 0.0 111.186 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 9.6 t -80.14 57.63 2.76 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 173.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -92.32 144.2 25.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.623 -173.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . 0.42 ' NE2' ' HG2' ' A' ' 279' ' ' GLN . 25.9 mp0 -121.85 123.0 40.73 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 168.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.64 ' HB ' ' HB3' ' A' ' 233' ' ' GLN . 28.8 m -44.8 107.34 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.991 0.901 . . . . 0.0 112.962 -168.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . 0.561 ' HG3' HD22 ' A' ' 272' ' ' ASN . 1.0 OUTLIER -109.19 145.74 35.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.402 -178.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -99.97 156.29 17.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.653 174.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 106.86 8.89 31.32 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.487 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.455 ' HB3' ' CG2' ' A' ' 230' ' ' VAL . 10.6 t70 -66.01 150.45 48.65 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.781 0.324 . . . . 0.0 110.854 178.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -98.52 112.64 24.61 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.475 HG23 HG23 ' A' ' 230' ' ' VAL . 57.4 t -97.09 148.85 5.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.387 0.613 . . . . 0.0 111.654 -170.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 65.5 m -143.67 171.58 13.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.762 173.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 343' ' ' GLY . 24.1 t -119.25 141.85 37.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.587 HG11 ' HB2' ' A' ' 267' ' ' GLN . 8.4 p -73.91 -28.41 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.085 0.469 . . . . 0.0 110.555 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . 0.582 ' H ' HG12 ' A' ' 341' ' ' VAL . . . 158.88 -174.87 35.92 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 17.6 p -102.17 -75.8 0.59 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.103 0.478 . . . . 0.0 110.55 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.033 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.725 178.051 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.817 0 N-CA-C 112.267 -0.333 . . . . 0.0 112.267 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -117.69 -78.32 0.58 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.505 0.193 . . . . 0.0 110.629 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -99.79 178.0 4.96 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 111.24 3.06 27.85 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.735 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -80.26 122.26 5.69 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.088 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 20.8 m -152.36 96.22 2.14 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 175.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.461 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 4.0 mp -122.73 -179.25 4.17 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.889 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 48.3 m -134.34 162.72 31.41 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.529 -175.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 94.4 t -108.24 130.88 60.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.497 ' HB2' HG23 ' A' ' 252' ' ' THR . 27.2 tptp -108.53 -15.21 14.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.874 0.369 . . . . 0.0 111.482 -173.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 20.6 p -138.44 -169.54 2.62 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.206 -173.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.458 ' HB3' ' HB ' ' A' ' 333' ' ' VAL . 74.7 mt-30 -105.02 118.24 56.6 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.248 -172.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.78 106.15 1.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.716 2.277 . . . . 0.0 111.997 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.438 ' OG1' ' HA ' ' A' ' 320' ' ' ASP . 10.9 t -154.88 124.06 6.33 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.575 -0.45 . . . . 0.0 112.095 -178.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.73 HG12 ' HB2' ' A' ' 246' ' ' GLN . 1.1 t -154.05 168.89 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.606 171.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.482 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 74.6 m -14.73 112.96 0.02 OUTLIER 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.725 1.61 . . . . 0.0 114.472 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -106.41 88.57 2.81 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 172.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -125.89 139.32 53.56 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.366 0.603 . . . . 0.0 110.236 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.22 -44.58 4.52 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.558 -173.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 63.1 t -61.04 -36.71 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.263 0.554 . . . . 0.0 110.167 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -88.14 -5.48 58.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.316 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 22.4 t70 50.91 67.45 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.036 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.5 m -144.75 100.89 3.58 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.589 -175.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -121.49 100.89 7.28 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . 0.73 ' HB2' HG12 ' A' ' 236' ' ' VAL . 80.0 mt-30 -127.6 178.97 5.76 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.629 -171.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.64 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 2.1 p90 -156.64 125.63 5.97 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 19.5 m -95.4 134.53 38.1 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.461 ' HB ' ' CD1' ' A' ' 251' ' ' LEU . 0.2 OUTLIER -141.95 146.71 22.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.676 -178.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.478 HG23 ' OG1' ' A' ' 310' ' ' THR . 95.2 m -96.69 112.79 24.4 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 164.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.599 ' HB2' HG13 ' A' ' 309' ' ' VAL . 5.3 mp -102.46 169.16 8.84 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -176.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.497 HG23 ' HB2' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -127.57 108.69 11.0 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.68 0.276 . . . . 0.0 111.628 -177.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.491 ' N ' HG12 ' A' ' 309' ' ' VAL . . . -147.39 135.81 5.8 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 177.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.421 ' HB2' ' HA2' ' A' ' 307' ' ' GLY . . . -108.34 93.98 4.82 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -172.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.483 ' HB ' ' OG ' ' A' ' 303' ' ' SER . 10.1 m -126.29 118.97 26.21 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 170.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -73.04 136.82 45.05 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 70.8 m 59.89 55.58 3.8 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.119 174.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.471 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 94.6 t -131.74 95.37 2.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.25 0.548 . . . . 0.0 109.858 174.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 27.4 m -74.15 97.63 2.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.143 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 71.23 99.7 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.844 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.51 ' CE2' ' HB2' ' A' ' 303' ' ' SER . 11.6 m-85 -48.02 -59.18 3.56 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.324 0.583 . . . . 0.0 110.34 170.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.424 HD11 HG13 ' A' ' 341' ' ' VAL . 61.3 mt -143.57 173.52 11.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.537 -173.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -130.7 -169.86 2.23 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.818 0.342 . . . . 0.0 111.172 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -57.95 114.05 2.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.563 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 111.14 -1.6 28.33 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.846 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . 0.409 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 13.0 m-20 -87.59 145.32 26.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.704 0.252 . . . . 0.0 110.556 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -102.23 149.23 24.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.48 0.657 . . . . 0.0 111.124 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.666 HG23 ' HB3' ' A' ' 295' ' ' ALA . 0.1 OUTLIER -132.22 174.33 13.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.542 178.357 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' A' ' 293' ' ' PHE . 5.6 mptp? -110.23 135.83 50.38 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 172.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.679 ' O ' ' HA ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -142.65 105.87 4.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.806 0.812 . . . . 0.0 110.566 178.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.588 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 31.4 m -81.15 86.06 6.24 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -108.97 86.5 2.29 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.93 -170.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 22.8 p -114.27 98.42 6.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.198 0.523 . . . . 0.0 112.26 -173.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -165.41 174.33 10.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.6 174.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 35.0 p-90 -144.14 151.91 40.2 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 177.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 82.5 mt -108.66 140.27 42.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.132 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -72.46 -10.4 59.74 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.127 0.489 . . . . 0.0 110.619 -178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -86.8 -51.97 5.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.298 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -66.84 -26.7 67.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.712 -174.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 17.7 p -59.96 -34.05 72.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.032 0.444 . . . . 0.0 111.179 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -82.15 -33.3 29.65 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.024 0.44 . . . . 0.0 110.008 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -66.64 -36.39 82.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.022 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 286' ' ' ASN . . . -99.33 28.42 4.55 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.359 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 8.3 mp 64.72 63.85 0.7 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.349 171.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 69.75 25.37 5.12 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.289 1.042 . . . . 0.0 110.319 173.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.648 ' O ' ' HB3' ' A' ' 283' ' ' ALA . 2.3 t30 -144.85 138.11 26.79 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.5 -1.682 . . . . 0.0 108.318 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -104.3 -128.54 6.3 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.463 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -167.34 124.9 1.23 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 93.9 m -147.73 116.35 4.2 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.774 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.51 127.54 18.55 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.432 2.088 . . . . 0.0 111.188 174.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 18.5 tt -63.08 -35.98 73.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.378 -172.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . 0.437 ' HB2' ' H ' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -162.95 -147.76 0.12 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 175.371 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . 0.679 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 2.2 p90 -109.77 88.36 2.73 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -166.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 92.3 m -151.63 112.03 4.15 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 122.061 -0.4 . . . . 0.0 110.975 175.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . 0.666 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -131.35 -177.1 4.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.555 0.217 . . . . 0.0 111.197 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 7.5 m -143.39 131.56 21.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.876 0.846 . . . . 0.0 113.061 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.552 HG13 HG21 ' A' ' 311' ' ' VAL . 63.2 t -76.75 141.55 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 113.551 -1.658 . . . . 0.0 111.135 -178.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 15.1 m -110.35 -14.23 14.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -176.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -162.03 -175.63 4.74 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 122.158 -0.339 . . . . 0.0 111.266 -177.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -59.15 113.99 2.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.029 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.45 ' HB2' ' HB ' ' A' ' 311' ' ' VAL . . . -94.87 101.5 13.3 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.476 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 309' ' ' VAL . 5.1 m-20 -58.55 127.3 31.49 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.708 -174.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.51 ' HB2' ' CE2' ' A' ' 261' ' ' PHE . 30.2 t -114.97 113.39 24.06 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 120.73 0.3 . . . . 0.0 111.267 172.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -127.16 152.21 47.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 170.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 10.8 t -74.72 -4.31 36.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.712 -172.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -68.63 -11.46 62.56 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 172.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . 0.421 ' HA2' ' HB2' ' A' ' 254' ' ' ALA . . . 92.55 37.12 5.93 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.067 -0.567 . . . . 0.0 113.384 176.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -125.81 141.9 51.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 117.225 0.513 . . . . 0.0 111.407 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 302' ' ' ASN . 1.6 p -152.24 100.37 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.16 174.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.478 ' OG1' HG23 ' A' ' 250' ' ' THR . 63.8 m -93.15 129.83 39.02 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.521 -0.737 . . . . 0.0 110.824 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.552 HG21 HG13 ' A' ' 297' ' ' VAL . 2.1 p -157.61 141.92 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 54.7 m -94.48 147.67 23.02 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.047 0.451 . . . . 0.0 110.122 175.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.441 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.0 mp -131.54 170.82 14.19 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.717 -174.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 246' ' ' GLN . 29.8 p -132.91 157.17 45.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.066 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 94.18 72.85 1.19 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.151 -0.547 . . . . 0.0 113.809 171.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.498 HG13 ' CE2' ' A' ' 247' ' ' PHE . 2.6 m -148.44 158.61 40.44 Favored Pre-proline 0 N--CA 1.466 0.342 0 CA-C-N 116.929 0.364 . . . . 0.0 111.462 177.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -96.8 47.01 0.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.086 2.524 . . . . 0.0 110.838 167.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 82.7 mt -118.45 122.38 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.193 -176.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -66.4 153.89 41.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.254 0.55 . . . . 0.0 111.857 -176.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.438 ' HA ' ' OG1' ' A' ' 235' ' ' THR . 13.0 p-10 -86.45 29.71 0.75 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.961 -173.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 20.6 p 45.78 42.05 8.3 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 173.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 7.3 p -118.1 100.41 7.52 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 175.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -150.11 159.36 35.49 Favored Pre-proline 0 C--N 1.312 -1.038 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.146 -169.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.532 ' HB2' ' CE1' ' A' ' 326' ' ' TYR . 84.6 Cg_endo -79.99 103.65 1.58 Allowed 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.297 1.998 . . . . 0.0 111.518 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -58.59 -67.46 0.36 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.791 -1.549 . . . . 0.0 111.271 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . 0.532 ' CE1' ' HB2' ' A' ' 324' ' ' PRO . 17.6 m-85 69.2 -45.96 0.56 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.677 0.791 . . . . 0.0 112.824 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -99.81 -76.87 0.54 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.671 0.272 . . . . 0.0 110.378 -174.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 10.2 p -163.05 -70.16 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.487 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 23.0 t -69.17 126.91 30.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.087 0.47 . . . . 0.0 110.587 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 12.1 m -87.0 160.61 18.58 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.61 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -73.05 111.57 8.29 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 174.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -123.03 153.18 40.18 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.995 0.426 . . . . 0.0 111.132 -169.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.493 HG12 ' H ' ' A' ' 334' ' ' GLU . 2.9 t -88.31 168.99 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.006 177.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . 0.493 ' H ' HG12 ' A' ' 333' ' ' VAL . 33.7 tt0 -115.11 134.83 54.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.683 0.277 . . . . 0.0 111.118 -174.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -97.85 173.06 7.27 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.674 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 117.73 1.97 17.14 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.432 -0.89 . . . . 0.0 113.879 170.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 271' ' ' THR . 10.7 p-10 -79.47 173.01 13.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.079 0.439 . . . . 0.0 111.484 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -110.84 148.7 31.85 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.255 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.562 HG21 HD23 ' A' ' 251' ' ' LEU . 73.9 t -127.28 150.74 33.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.841 0.353 . . . . 0.0 111.82 -169.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.539 ' HB3' ' HB2' ' A' ' 269' ' ' LYS . 31.0 t -151.74 178.03 9.79 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 175.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.424 HG13 HD11 ' A' ' 262' ' ' LEU . 58.9 t -119.19 144.03 28.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 122.338 -0.226 . . . . 0.0 110.971 -176.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 50.7 t -71.21 -47.01 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.073 0 CA-C-O 121.061 0.457 . . . . 0.0 110.037 174.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . 0.409 ' N ' HG12 ' A' ' 341' ' ' VAL . . . 126.38 174.73 13.92 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.008 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 13.2 p -132.85 -74.64 0.5 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.235 0.541 . . . . 0.0 110.288 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.809 177.932 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 63.26 18.98 11.4 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 122.97 0.508 . . . . 0.0 111.931 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.535 ' HD1' ' N ' ' A' ' 225' ' ' GLY . 0.5 OUTLIER -94.58 122.12 36.84 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -178.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.535 ' N ' ' HD1' ' A' ' 224' ' ' PHE . . . 85.59 28.96 28.19 Favored Glycine 0 CA--C 1.501 -0.84 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 176.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -49.9 114.49 2.44 Favored Glycine 0 N--CA 1.454 -0.109 0 CA-C-N 114.52 -0.84 . . . . 0.0 112.618 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 23.7 m -136.34 136.56 39.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.978 0.418 . . . . 0.0 110.705 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.511 ' HB2' ' CG1' ' A' ' 339' ' ' VAL . 1.2 mp -139.51 175.75 9.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.752 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 24.7 m -130.63 160.24 34.81 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.521 HG23 HG23 ' A' ' 339' ' ' VAL . 73.8 t -118.42 147.01 22.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 122.304 -0.248 . . . . 0.0 110.692 174.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -117.6 -19.02 9.56 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 39.6 p -124.7 -167.61 1.69 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.47 ' HB3' HG23 ' A' ' 333' ' ' VAL . 83.2 mt-30 -112.7 131.01 22.9 Favored Pre-proline 0 C--N 1.316 -0.881 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -173.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.412 ' HA ' HG22 ' A' ' 249' ' ' VAL . 35.2 Cg_endo -66.95 104.04 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.06 1.84 . . . . 0.0 111.545 177.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 5.0 t -154.91 116.86 4.16 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.416 0.627 . . . . 0.0 111.778 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.71 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.5 174.42 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 168.404 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.505 ' H ' HG13 ' A' ' 236' ' ' VAL . 66.9 m -37.62 110.03 0.11 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -174.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -112.18 83.96 1.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.042 170.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -110.96 132.86 53.85 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.39 -39.91 5.75 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.733 -170.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.45 -27.21 42.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.471 0.653 . . . . 0.0 109.938 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -96.33 -13.93 22.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.837 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 60.45 68.46 0.76 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.471 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 41.7 m -149.08 100.86 3.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.36 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -116.84 109.74 17.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.551 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . 0.452 ' HB2' HG12 ' A' ' 236' ' ' VAL . 0.5 OUTLIER -131.41 161.44 32.44 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 172.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.71 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 0.7 OUTLIER -160.12 133.67 7.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.471 0.176 . . . . 0.0 111.109 179.056 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 48.2 m -108.47 143.1 37.89 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 122.35 -0.218 . . . . 0.0 110.506 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.517 HG23 ' CD2' ' A' ' 313' ' ' LEU . 0.4 OUTLIER -146.09 148.36 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.923 178.612 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.593 HG23 ' OG1' ' A' ' 310' ' ' THR . 28.2 m -97.68 114.47 26.44 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 169.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 309' ' ' VAL . 4.9 mp -109.81 164.79 12.24 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 -175.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.83 140.42 52.95 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -135.22 -143.32 4.73 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.388 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.512 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -108.75 -176.5 3.06 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.981 0.419 . . . . 0.0 112.102 -177.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.597 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.6 OUTLIER -68.94 -179.54 1.51 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.146 -171.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.597 ' H ' HG22 ' A' ' 255' ' ' THR . . . -60.49 -177.39 0.07 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.233 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 46.9 m 79.48 6.19 2.01 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.734 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 10.9 t -124.29 89.51 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.799 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 171.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 11.6 m -73.22 98.38 2.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.831 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 61.84 98.82 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.842 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -43.1 -56.36 3.41 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.827 0.346 . . . . 0.0 111.139 173.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.54 167.08 23.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.928 -177.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.432 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 48.6 mtmt -137.25 -166.34 1.91 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -176.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -46.68 116.09 1.23 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.983 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.542 ' HA2' ' OH ' ' A' ' 319' ' ' TYR . . . 117.5 -10.53 14.45 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.092 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -101.96 138.6 38.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.951 0.405 . . . . 0.0 110.829 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.401 ' HB2' HG11 ' A' ' 342' ' ' VAL . 1.9 mp0 -107.24 153.43 22.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.32 0.581 . . . . 0.0 110.191 -176.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.624 HG23 ' HB3' ' A' ' 295' ' ' ALA . 1.7 m -133.97 168.2 24.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 176.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.32 135.27 32.03 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.067 170.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.608 ' HB3' ' HA ' ' A' ' 339' ' ' VAL . 35.1 p90 -147.64 167.39 24.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.83 -0.168 . . . . 0.0 111.21 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 1.8 t -158.24 119.06 3.4 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.379 0.609 . . . . 0.0 112.19 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.561 ' HB2' ' CA ' ' A' ' 337' ' ' ASP . 51.0 t30 -123.47 79.39 1.68 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 160.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 2.0 p -107.48 87.23 2.45 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.394 -173.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -85.79 114.55 22.83 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 175.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 6.1 p90 37.2 53.5 1.24 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 124.273 0.983 . . . . 0.0 112.98 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.37 153.46 29.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.616 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -74.42 -10.19 59.33 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-O 121.124 0.488 . . . . 0.0 110.858 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -88.34 -2.22 58.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.878 -172.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.431 ' OE1' ' HB ' ' A' ' 289' ' ' THR . 46.0 mt-30 -47.92 -67.91 0.23 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.588 176.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 16.6 p -118.85 -82.12 0.64 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.949 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -113.12 -70.97 0.78 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.984 0.421 . . . . 0.0 110.499 174.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -117.49 -24.43 7.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.021 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' A' ' 279' ' ' GLN . . . 53.96 82.21 0.09 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.47 -0.787 . . . . 0.0 112.344 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 6.7 mp -84.55 -39.56 18.64 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.608 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -110.36 101.27 10.01 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.766 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -83.16 147.75 27.87 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.292 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -153.95 -46.13 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -136.63 116.88 13.52 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 173.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.431 ' HB ' ' OE1' ' A' ' 279' ' ' GLN . 1.9 t -122.33 88.51 48.89 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 121.495 0.664 . . . . 0.0 111.267 -173.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . 0.402 ' O ' ' HB ' ' A' ' 291' ' ' ILE . 96.0 Cg_endo -95.89 -157.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.479 2.786 . . . . 0.0 112.499 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.402 ' HB ' ' O ' ' A' ' 290' ' ' PRO . 47.5 mm 75.86 120.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.576 0.703 . . . . 0.0 111.634 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 30.4 p -105.59 171.66 7.21 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.304 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -127.11 137.19 52.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.099 0.476 . . . . 0.0 110.101 175.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 85.7 m -82.45 136.32 34.95 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.886 -174.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . 0.624 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -114.85 177.04 4.79 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.877 176.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 7.2 m -141.02 114.14 8.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.457 0.646 . . . . 0.0 111.398 177.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 67.3 t -75.51 131.77 34.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.013 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 8.4 p -123.31 24.35 8.76 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.101 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -152.4 164.39 37.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.027 0.442 . . . . 0.0 111.983 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.432 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 2.3 m-20 -60.41 112.47 1.97 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.974 176.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -92.66 175.54 6.78 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.032 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.588 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 64.2 t30 -149.46 122.34 8.74 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -168.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.4 94.87 5.32 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 163.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . 0.429 ' HB3' HD21 ' A' ' 302' ' ' ASN . 2.2 p-10 -96.23 -178.53 4.35 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.005 -174.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 25.5 m -58.66 -33.06 69.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.871 0.367 . . . . 0.0 111.647 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -82.03 -5.8 89.41 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.146 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 67.47 42.46 89.04 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.114 -176.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -116.62 132.27 56.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.78 0.79 . . . . 0.0 111.343 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.588 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.5 OUTLIER -135.06 102.58 3.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.945 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.593 ' OG1' HG23 ' A' ' 250' ' ' THR . 95.3 m -107.66 113.89 27.49 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.774 -0.579 . . . . 0.0 110.533 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 27.5 m -143.06 157.6 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-O 121.545 0.688 . . . . 0.0 110.698 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 26.3 m -109.02 148.24 31.08 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.224 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.573 HD22 ' N ' ' A' ' 313' ' ' LEU . 0.8 OUTLIER -112.23 135.01 53.43 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.237 -176.145 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 41.5 m -147.02 145.63 29.78 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 119.738 -0.785 . . . . 0.0 112.621 -171.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 132.02 152.28 7.07 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.74 169.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.651 ' HB ' ' HD2' ' A' ' 317' ' ' PRO . 18.0 m -68.36 -179.8 0.55 Allowed Pre-proline 0 CA--C 1.54 0.594 0 CA-C-O 117.406 -1.283 . . . . 0.0 108.648 172.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.651 ' HD2' ' HB ' ' A' ' 316' ' ' VAL . 4.3 Cg_exo -30.71 106.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 123.056 2.504 . . . . 0.0 113.632 -169.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 11.7 pt -82.88 102.89 9.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.739 -164.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.542 ' OH ' ' HA2' ' A' ' 265' ' ' GLY . 44.3 m-85 57.39 24.99 10.76 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.535 173.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 52.6 32.31 11.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.563 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 41.1 p -83.98 -3.73 58.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.693 0.758 . . . . 0.0 109.48 174.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 1.2 t -137.37 128.03 26.96 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.883 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.544 ' HB3' ' HD3' ' A' ' 324' ' ' PRO . 4.2 t-20 -167.71 -46.98 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.004 -178.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 323' ' ' ASN . 4.8 Cg_exo -84.32 3.8 7.32 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.329 2.019 . . . . 0.0 110.857 173.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . 0.484 ' CA ' HE21 ' A' ' 325' ' ' GLN . 0.0 OUTLIER -64.9 -55.19 20.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.186 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 54.34 53.49 10.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.859 0.838 . . . . 0.0 108.841 -174.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -119.31 26.34 9.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.854 -172.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 5.8 m -84.12 53.1 2.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.636 0.731 . . . . 0.0 109.671 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 27.9 t -119.84 154.24 22.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.528 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 9.7 t -70.43 77.11 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.572 0.701 . . . . 0.0 109.263 175.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -80.0 144.84 32.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.504 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -89.23 107.64 19.17 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 233' ' ' GLN . 16.6 m -84.37 137.37 20.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.964 -175.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -115.41 152.14 33.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.566 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -90.61 126.04 35.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.24 -175.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 230' ' ' VAL . . . 129.38 13.13 2.39 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.083 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.561 ' CA ' ' HB2' ' A' ' 272' ' ' ASN . 3.0 m-20 -49.03 134.65 16.97 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.92 105.67 3.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.302 168.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.608 ' HA ' ' HB3' ' A' ' 270' ' ' PHE . 75.7 t -95.04 139.16 19.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.399 0.619 . . . . 0.0 111.888 -173.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 41.2 m -147.82 157.28 43.46 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.059 172.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.462 HG12 ' H ' ' A' ' 343' ' ' GLY . 20.8 t -87.76 151.24 3.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.401 HG11 ' HB2' ' A' ' 267' ' ' GLN . 8.9 p -69.14 -24.45 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.566 -176.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . 0.462 ' H ' HG12 ' A' ' 341' ' ' VAL . . . -141.04 -144.43 4.43 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.082 -0.58 . . . . 0.0 111.684 174.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 7.6 p -111.72 -53.27 2.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.423 0.63 . . . . 0.0 110.539 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.569 176.348 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.738 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -129.16 16.81 6.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.829 0.347 . . . . 0.0 111.498 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -81.42 -30.39 33.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.108 0.48 . . . . 0.0 110.627 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 80.78 26.83 52.75 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.073 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -73.52 159.3 53.09 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.719 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 8.3 m -79.15 140.03 37.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.811 0.338 . . . . 0.0 110.493 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.518 HD23 ' HA3' ' A' ' 253' ' ' GLY . 1.8 mp -132.7 177.41 7.64 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 252' ' ' THR . 82.0 m -128.75 159.95 34.06 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.636 0.255 . . . . 0.0 110.853 -174.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 41.8 t -110.05 138.39 38.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 43.3 tttm -111.34 -34.62 6.08 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.388 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 76.3 p -119.91 -169.46 1.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.523 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.532 ' HB3' HG13 ' A' ' 333' ' ' VAL . 87.4 mt-30 -112.37 120.8 40.62 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 120.512 0.196 . . . . 0.0 111.235 -167.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.661 ' HB3' ' CD1' ' A' ' 247' ' ' PHE . 88.9 Cg_exo -51.1 102.68 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.172 2.581 . . . . 0.0 113.313 175.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 236' ' ' VAL . 8.7 t -158.38 113.98 2.67 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 174.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.565 HG12 ' HB2' ' A' ' 246' ' ' GLN . 7.9 t -154.01 125.05 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 120.915 0.388 . . . . 0.0 110.889 169.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 26.5 m 48.15 89.53 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 123.82 0.848 . . . . 0.0 111.906 177.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -99.05 89.09 4.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.332 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -111.07 114.91 28.54 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 175.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -94.78 -50.39 5.17 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -168.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 49.0 t -65.45 -23.27 32.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.306 0.574 . . . . 0.0 110.129 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -96.02 -8.43 33.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.231 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 14.9 t70 55.41 69.61 0.72 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.955 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 17.8 m -145.2 105.11 4.02 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.819 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -129.84 122.43 28.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.847 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . 0.565 ' HB2' HG12 ' A' ' 236' ' ' VAL . 0.3 OUTLIER -120.73 -176.9 3.34 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 172.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.661 ' CD1' ' HB3' ' A' ' 234' ' ' PRO . 1.2 p90 -166.41 126.81 1.66 Allowed 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 119.969 -0.692 . . . . 0.0 112.793 174.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 37.2 m -99.75 131.25 45.85 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.403 HG22 ' HA ' ' A' ' 234' ' ' PRO . 19.4 t -138.67 141.9 35.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 119.609 -0.836 . . . . 0.0 112.111 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.441 HG23 ' OG1' ' A' ' 310' ' ' THR . 98.3 m -94.08 115.83 28.19 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.556 ' HB2' HG13 ' A' ' 309' ' ' VAL . 5.2 mp -104.18 166.27 10.51 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -177.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' A' ' 229' ' ' THR . 0.7 OUTLIER -134.88 99.81 4.41 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.802 0.334 . . . . 0.0 111.34 -176.203 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.518 ' HA3' HD23 ' A' ' 228' ' ' LEU . . . -137.59 140.26 11.14 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.304 -0.719 . . . . 0.0 111.304 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -110.93 92.75 4.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.092 0.472 . . . . 0.0 112.081 -172.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 38.7 m -125.82 106.77 9.92 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.273 171.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' A' ' 305' ' ' SER . . . -63.16 141.47 58.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -175.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 6.0 t 61.72 53.32 3.24 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.92 171.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 49.0 t -137.45 103.84 2.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.164 0.507 . . . . 0.0 110.009 174.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 36.2 m -79.11 87.75 4.86 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.401 0.619 . . . . 0.0 110.299 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 94.4 92.98 1.64 Allowed Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.384 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.743 ' CE1' ' HB3' ' A' ' 303' ' ' SER . 3.0 m-85 -45.2 -59.26 2.73 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.324 0.583 . . . . 0.0 111.557 172.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.76 HD11 ' HB2' ' A' ' 266' ' ' ASP . 2.8 tm? -166.8 140.51 3.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.679 -166.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -125.94 -171.2 2.33 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -51.89 131.49 31.06 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.084 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 122.32 -32.23 4.59 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.513 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . 0.76 ' HB2' HD11 ' A' ' 262' ' ' LEU . 9.5 m-20 -108.07 154.49 21.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.005 0.431 . . . . 0.0 110.449 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.534 ' HB2' HG11 ' A' ' 342' ' ' VAL . 10.7 mt-30 -115.04 161.97 17.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.43 0.633 . . . . 0.0 111.44 -173.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.61 HG23 ' HB3' ' A' ' 295' ' ' ALA . 0.4 OUTLIER -126.18 -175.46 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.205 178.297 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.454 ' HD2' ' C ' ' A' ' 269' ' ' LYS . 2.5 tmmm? -148.54 134.71 19.31 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -146.66 148.1 31.7 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 118.779 -1.169 . . . . 0.0 112.258 176.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 81.0 p -95.83 111.44 23.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.569 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.479 ' HA ' ' OD1' ' A' ' 337' ' ' ASP . 25.7 p-10 -104.22 153.73 20.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.027 0.442 . . . . 0.0 110.877 -176.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 32.9 p -122.99 159.95 27.29 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.718 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -126.44 113.24 16.58 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 173.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 31.6 p-90 -159.71 36.05 0.19 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.387 0.613 . . . . 0.0 110.404 174.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 92.1 mt -66.92 173.97 3.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.804 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . 0.464 ' O ' ' HG3' ' A' ' 281' ' ' LYS . 18.4 mp0 -55.93 -50.41 70.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.716 0.293 . . . . 0.0 111.186 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -68.25 -46.0 71.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.472 0.653 . . . . 0.0 110.283 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -57.84 -40.32 79.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.242 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 4.1 p -67.48 -26.51 66.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.808 0.337 . . . . 0.0 111.577 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 277' ' ' GLN . 28.2 mtpp -83.07 -31.13 27.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.932 0.396 . . . . 0.0 110.748 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -86.84 -13.84 43.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.573 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -84.89 148.05 26.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.981 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 284' ' ' LEU . 6.8 mp -100.49 0.15 39.03 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.605 176.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 66.88 104.46 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.928 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -93.75 -26.93 16.77 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.339 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 132.01 -41.57 1.49 Allowed Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.23 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.511 ' O ' ' HD3' ' A' ' 290' ' ' PRO . . . -158.71 154.09 25.78 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 99.0 m -111.52 85.55 5.98 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.917 175.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 288' ' ' ALA . 12.3 Cg_endo -92.24 60.05 0.77 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.351 2.701 . . . . 0.0 112.402 -177.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 49.0 mm -92.6 134.96 28.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.978 0.418 . . . . 0.0 109.949 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 32.2 m -140.05 142.74 36.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.115 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -161.05 162.29 31.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.472 0.653 . . . . 0.0 111.443 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 268' ' ' VAL . 98.1 m -88.86 127.15 35.62 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.607 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . 0.61 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -108.47 175.91 5.3 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 45.0 m -135.32 123.35 22.77 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.816 HG13 HG21 ' A' ' 311' ' ' VAL . 91.0 t -77.72 124.97 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.872 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 312' ' ' THR . 15.0 t -132.77 17.95 4.24 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.303 -170.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -152.78 -173.32 4.53 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.146 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -70.94 139.68 50.73 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.186 0.517 . . . . 0.0 109.717 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.575 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -136.17 167.6 20.96 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.742 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -140.25 157.6 45.32 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.091 -177.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.743 ' HB3' ' CE1' ' A' ' 261' ' ' PHE . 0.0 OUTLIER -139.18 96.01 3.04 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.422 174.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . 0.421 ' OD2' ' HB2' ' A' ' 308' ' ' ASP . 2.0 p-10 -108.7 153.65 23.14 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 171.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.522 ' HB3' ' HB2' ' A' ' 256' ' ' ALA . 0.1 OUTLIER -68.65 -7.61 34.79 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -171.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -75.31 -4.68 74.67 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 175.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 86.46 42.85 6.38 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.933 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.421 ' HB2' ' OD2' ' A' ' 304' ' ' ASP . 3.9 m-20 -125.21 137.05 54.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.69 0.745 . . . . 0.0 112.119 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 251' ' ' LEU . 1.2 p -154.97 106.33 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.175 174.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.441 ' OG1' HG23 ' A' ' 250' ' ' THR . 54.5 m -106.44 130.28 54.27 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 121.16 -0.962 . . . . 0.0 111.431 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.816 HG21 HG13 ' A' ' 297' ' ' VAL . 7.1 p -159.55 147.43 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.131 0.491 . . . . 0.0 110.549 174.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 52.8 m -86.31 150.1 24.58 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.06 174.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.529 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.2 mp -126.05 164.83 19.99 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.284 -177.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 15.9 m -131.03 134.26 46.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.754 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 89.67 104.15 1.12 Allowed Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.978 173.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.629 HG13 ' CE2' ' A' ' 247' ' ' PHE . 0.0 OUTLIER -127.09 143.59 47.52 Favored Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 122.208 0.203 . . . . 0.0 110.851 177.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.92 104.58 1.53 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.048 2.498 . . . . 0.0 111.673 174.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.667 HG22 ' H ' ' A' ' 319' ' ' TYR . 24.1 mm -97.11 178.51 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.845 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.667 ' H ' HG22 ' A' ' 318' ' ' ILE . 96.8 m-85 77.38 -46.2 0.47 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.976 0.91 . . . . 0.0 110.786 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 56.08 66.05 1.29 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.612 0.72 . . . . 0.0 110.329 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 23.6 p -99.69 11.18 39.88 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.279 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 23.3 m -101.09 -48.62 4.36 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.678 -175.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.575 ' HB3' ' HD3' ' A' ' 324' ' ' PRO . 31.7 t-20 -74.19 -55.94 2.78 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.749 -176.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 323' ' ' ASN . 3.3 Cg_exo -83.52 -6.87 10.81 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.292 1.994 . . . . 0.0 112.511 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 58.45 -77.63 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.781 0.832 . . . . 0.0 112.581 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -105.86 -17.33 14.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.154 -172.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -110.65 52.69 0.72 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.117 0.484 . . . . 0.0 110.239 -173.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 61.0 m -80.52 66.65 6.11 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.289 -177.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 38.5 t -64.35 138.17 23.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 174.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 16.0 m -56.97 106.16 0.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.175 0.512 . . . . 0.0 110.992 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . 0.538 ' HD2' ' O ' ' A' ' 331' ' ' ARG . 3.8 ppt_? -85.35 154.89 21.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.987 -177.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . 0.426 ' HA ' ' OE1' ' A' ' 332' ' ' GLN . 11.6 mm-40 -94.67 154.38 17.35 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 173.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.532 HG13 ' HB3' ' A' ' 233' ' ' GLN . 6.8 p -77.76 143.73 12.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.718 -177.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -118.59 144.41 46.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.685 -174.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -100.58 151.98 20.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.401 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 112.45 12.08 14.0 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.391 173.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.479 ' OD1' ' HA ' ' A' ' 272' ' ' ASN . 10.8 m-20 -71.73 168.92 16.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.056 0.455 . . . . 0.0 111.463 -177.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -98.97 122.36 42.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.535 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.482 HG21 HD23 ' A' ' 251' ' ' LEU . 49.6 t -100.79 145.36 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.248 0.547 . . . . 0.0 111.773 -172.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 53.7 m -151.22 179.07 8.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.186 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 343' ' ' GLY . 29.6 t -111.96 143.69 21.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -175.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.534 HG11 ' HB2' ' A' ' 267' ' ' GLN . 9.7 p -69.57 -24.33 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.976 0.417 . . . . 0.0 110.88 -175.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . 0.545 ' H ' HG12 ' A' ' 341' ' ' VAL . . . -87.46 87.01 1.53 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.768 178.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 70.4 p 61.42 117.33 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.788 1.235 . . . . 0.0 112.803 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -1.009 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.733 179.479 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.563 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -153.52 -81.68 0.09 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.629 0.215 . . . . 0.0 110.656 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.426 ' CG ' ' N ' ' A' ' 225' ' ' GLY . 24.3 t80 54.18 -157.51 0.19 Allowed 'General case' 0 CA--C 1.542 0.642 0 O-C-N 123.266 0.354 . . . . 0.0 110.068 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.426 ' N ' ' CG ' ' A' ' 224' ' ' PHE . . . 121.88 -31.24 5.03 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.239 177.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -118.11 137.24 12.91 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.857 -177.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 87.2 m -129.38 131.28 46.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 2.4 mp -136.87 -178.36 5.16 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 60.9 m -128.4 153.78 46.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.765 0.317 . . . . 0.0 111.532 -171.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.465 ' CG2' HG23 ' A' ' 339' ' ' VAL . 22.0 t -110.53 133.0 57.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.487 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -125.22 12.09 8.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.824 0.345 . . . . 0.0 111.591 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.4 p -144.61 -172.0 3.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.596 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.716 ' OE1' ' HB2' ' A' ' 335' ' ' ALA . 1.3 mm100 -114.03 134.39 22.17 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -174.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.476 ' HB3' ' CG ' ' A' ' 247' ' ' PHE . 28.4 Cg_exo -61.95 104.97 0.35 Allowed 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.224 1.95 . . . . 0.0 111.454 173.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.422 ' O ' HG23 ' A' ' 236' ' ' VAL . 5.8 t -156.02 103.86 2.24 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.675 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.75 173.41 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.139 0.575 . . . . 0.0 110.561 170.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.548 ' H ' HG13 ' A' ' 236' ' ' VAL . 45.5 m -23.13 115.76 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.467 1.507 . . . . 0.0 114.521 -174.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -111.91 83.58 1.81 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.759 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.482 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 4.5 t30 -103.34 99.65 9.5 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -175.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -86.5 -47.94 8.83 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -163.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 37.7 t -65.88 -23.26 31.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.7 0.762 . . . . 0.0 109.313 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.482 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 28.0 mmmt -93.75 -7.47 43.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.16 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 54.83 58.98 4.35 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.424 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 19.8 m -136.83 102.86 5.01 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.62 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -120.73 116.62 25.62 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . 0.479 ' HB2' HG12 ' A' ' 236' ' ' VAL . 22.5 mt-30 -133.61 158.74 42.43 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 177.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.675 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 3.6 p90 -140.83 138.66 34.17 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.101 172.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 54.3 m -97.25 135.89 38.54 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 42.3 t -142.43 141.61 27.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.715 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.481 HG23 ' OG1' ' A' ' 310' ' ' THR . 90.8 m -88.08 113.83 24.1 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 168.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 309' ' ' VAL . 4.9 mp -104.34 163.95 12.07 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -176.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.9 140.87 52.53 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -139.3 -143.07 4.35 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.289 -175.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -106.02 -174.51 2.55 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -174.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.587 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.6 OUTLIER -71.51 -178.54 2.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.733 -172.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.587 ' H ' HG22 ' A' ' 255' ' ' THR . . . -62.41 -176.9 0.12 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.123 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 15.6 t 80.77 7.5 1.32 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.991 0.917 . . . . 0.0 110.559 -175.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 21.2 t -126.25 89.52 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-O 121.562 0.696 . . . . 0.0 109.216 170.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 31.2 m -74.37 99.66 3.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.426 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 67.16 94.48 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.455 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -43.42 -59.32 2.18 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 111.427 174.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 266' ' ' ASP . 95.9 mt -148.49 162.68 39.13 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 9.6 mtpm? -137.22 -167.26 2.07 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.625 0.231 . . . . 0.0 111.625 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -53.33 113.32 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.273 0.558 . . . . 0.0 111.86 -175.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 109.93 -17.74 29.57 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.553 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 30.2 m-20 -77.52 144.81 37.38 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.63 ' HB2' HG11 ' A' ' 342' ' ' VAL . 35.4 mt-30 -111.98 154.57 25.1 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.619 0.723 . . . . 0.0 111.192 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 295' ' ' ALA . 0.0 OUTLIER -121.98 -176.65 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.623 178.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 340' ' ' SER . 16.8 tppt? -125.29 89.02 2.98 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.719 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.457 ' HB3' ' CE1' ' A' ' 293' ' ' PHE . 6.8 t80 -81.73 128.33 33.87 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -171.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 291' ' ' ILE . 85.7 m -119.25 87.4 2.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.046 0.45 . . . . 0.0 109.855 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' A' ' 291' ' ' ILE . 22.6 t-20 -93.66 152.51 18.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.222 -175.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 12.4 p -84.83 134.23 34.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.022 0.439 . . . . 0.0 110.711 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.418 ' HA ' ' HB ' ' A' ' 289' ' ' THR . 21.0 p90 -83.27 116.05 22.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.714 0.768 . . . . 0.0 110.839 -174.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 36.0 t90 -147.35 -22.23 0.39 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.367 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.11 23.68 3.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.781 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . 0.497 ' O ' ' HB2' ' A' ' 283' ' ' ALA . 90.2 mt-30 -83.88 -70.77 0.54 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.073 0.463 . . . . 0.0 110.433 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -95.39 -26.8 15.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.339 -174.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 -85.91 13.06 8.0 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.226 -173.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.75 -80.44 0.44 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.87 0.367 . . . . 0.0 111.793 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -111.43 -80.02 0.58 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.015 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -162.94 86.83 0.56 Allowed 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 277' ' ' GLN . . . -65.85 -77.29 0.07 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.925 -174.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 53.19 37.48 25.17 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -170.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 63.27 93.42 0.06 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.792 -177.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -146.4 -36.32 0.26 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.746 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -138.15 -130.16 2.77 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . 177.04 -174.9 0.12 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.367 0.604 . . . . 0.0 110.184 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.418 ' HB ' ' HA ' ' A' ' 274' ' ' TYR . 86.3 m -137.98 102.93 8.28 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 173.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . 0.438 ' O ' ' HB3' ' A' ' 272' ' ' ASN . 69.5 Cg_exo -40.72 104.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 124.163 3.242 . . . . 0.0 114.091 -171.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 271' ' ' THR . 13.4 tt -88.95 -26.81 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.138 -176.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 43.3 t -156.99 95.14 1.48 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.922 0.391 . . . . 0.0 110.001 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . 0.457 ' CE1' ' HB3' ' A' ' 270' ' ' PHE . 13.0 p90 -140.69 161.0 38.81 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 46.4 m -88.48 111.41 21.79 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.831 0.348 . . . . 0.0 110.551 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . 0.458 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -97.6 -178.16 4.04 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.583 ' O ' ' HA ' ' A' ' 313' ' ' LEU . 93.2 m -136.96 131.85 33.56 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -174.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.53 HG13 HG21 ' A' ' 311' ' ' VAL . 67.3 t -78.5 131.49 34.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.703 174.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 312' ' ' THR . 6.9 t -111.41 2.35 17.5 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.757 -0.777 . . . . 0.0 112.723 -167.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -170.55 -166.49 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.776 -178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.92 144.54 27.89 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.508 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -137.59 173.58 11.51 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.854 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.676 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 6.9 t30 -146.34 128.7 15.86 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -169.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.453 ' HB2' ' HB ' ' A' ' 258' ' ' VAL . 0.3 OUTLIER -117.87 95.12 4.78 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 165.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . 0.51 ' HB3' HD21 ' A' ' 302' ' ' ASN . 4.6 p-10 -104.04 -177.21 3.3 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.925 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 39.1 m -60.88 -30.98 70.48 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.708 0.289 . . . . 0.0 111.425 -177.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -77.61 0.94 68.54 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.207 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 56.32 41.58 87.52 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.408 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -116.38 127.89 55.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.696 0.748 . . . . 0.0 111.005 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.676 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.4 OUTLIER -135.34 104.45 4.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.344 -179.398 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.481 ' OG1' HG23 ' A' ' 250' ' ' THR . 94.6 m -105.35 121.09 43.16 Favored 'General case' 0 C--N 1.316 -0.858 0 O-C-N 121.865 -0.522 . . . . 0.0 110.776 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.53 HG21 HG13 ' A' ' 297' ' ' VAL . 7.7 p -157.65 150.26 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 121.089 0.471 . . . . 0.0 110.006 176.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 58.1 m -85.54 151.95 23.54 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.265 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' A' ' 296' ' ' THR . 5.9 mp -114.53 135.47 54.09 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.747 -177.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . 0.433 ' HA ' ' HG2' ' A' ' 246' ' ' GLN . 14.1 p -113.53 154.51 26.98 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -174.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 72.12 40.35 56.51 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.071 176.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 2.6 m -142.89 112.74 5.79 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-O 121.006 0.431 . . . . 0.0 111.637 -170.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -90.31 87.28 0.35 Allowed 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.048 2.499 . . . . 0.0 113.535 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 49.4 mt -128.16 101.6 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 120.791 0.329 . . . . 0.0 111.016 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.499 ' HE1' ' O ' ' A' ' 236' ' ' VAL . 1.1 m-85 -150.6 136.91 18.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.317 174.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -109.76 -48.17 3.25 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.711 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 69.4 p 47.74 56.82 6.64 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.159 0.584 . . . . 0.0 111.074 -174.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 10.4 m -89.63 -68.44 0.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.998 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.426 ' HA ' ' HB2' ' A' ' 331' ' ' ARG . 65.5 t30 29.24 78.61 0.27 Allowed Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -178.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.438 ' HB2' ' CD1' ' A' ' 326' ' ' TYR . 7.5 Cg_exo -74.12 -179.01 4.28 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.022 1.814 . . . . 0.0 111.06 175.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -102.04 26.45 7.59 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.86 -168.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . 0.438 ' CD1' ' HB2' ' A' ' 324' ' ' PRO . 81.9 m-85 -63.29 -55.97 20.33 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.249 178.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -139.97 -4.11 1.38 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.274 0.559 . . . . 0.0 110.357 176.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 9.5 t 60.65 52.47 4.46 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.984 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 2.5 t -92.34 17.51 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.615 0.721 . . . . 0.0 110.312 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 8.2 t 58.07 57.54 4.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.338 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . 0.426 ' HB2' ' HA ' ' A' ' 323' ' ' ASN . 30.8 mmt180 -67.77 115.2 7.05 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.296 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -131.51 -165.05 1.52 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -177.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.419 ' H ' HG23 ' A' ' 333' ' ' VAL . 13.2 t -44.44 154.07 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 O-C-N 123.759 0.662 . . . . 0.0 110.893 175.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -97.25 144.54 26.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.493 -165.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.716 ' HB2' ' OE1' ' A' ' 233' ' ' GLN . . . -98.84 172.24 7.56 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.878 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 96.71 9.92 55.9 Favored Glycine 0 CA--C 1.511 -0.205 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.086 171.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.478 ' HB2' ' HA ' ' A' ' 272' ' ' ASN . 12.5 p-10 -88.43 -176.11 5.21 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.831 0.348 . . . . 0.0 110.854 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -120.16 145.76 46.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.438 0.637 . . . . 0.0 111.803 -171.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 79.4 t -108.63 150.23 11.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.973 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.516 ' HB2' ' HB3' ' A' ' 269' ' ' LYS . 69.3 m -144.89 176.7 9.27 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 174.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 343' ' ' GLY . 44.6 t -117.94 140.39 41.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.63 HG11 ' HB2' ' A' ' 267' ' ' GLN . 5.3 p -69.75 -27.42 33.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 CA-C-O 120.83 0.348 . . . . 0.0 110.692 -175.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . 0.531 ' H ' HG12 ' A' ' 341' ' ' VAL . . . 172.67 -122.15 0.91 Allowed Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 3.5 p -142.24 -54.61 0.43 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.036 0.446 . . . . 0.0 110.563 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.931 -179.164 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 N-CA-C 112.035 -0.426 . . . . 0.0 112.035 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -148.42 117.18 6.67 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -89.64 20.87 3.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.757 -174.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 92.07 32.51 8.35 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.422 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -75.86 -141.96 1.06 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.369 -0.443 . . . . 0.0 112.341 177.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 19.3 m -75.04 143.86 43.29 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.958 0.408 . . . . 0.0 111.031 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.448 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.1 mp -135.21 -178.74 5.24 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 70.8 m -130.24 150.43 51.49 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.885 0.374 . . . . 0.0 111.894 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.81 106.68 19.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -93.09 -16.92 24.42 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.972 0.415 . . . . 0.0 111.207 -173.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 32.1 p -130.84 -169.15 2.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.757 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.517 ' HB3' HG23 ' A' ' 333' ' ' VAL . 70.6 mt-30 -105.61 120.49 49.15 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.048 -170.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.527 ' HA ' HG22 ' A' ' 249' ' ' VAL . 15.0 Cg_exo -66.5 105.61 0.93 Allowed 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.378 2.052 . . . . 0.0 111.618 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 8.0 t -154.67 121.84 5.61 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.66 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -155.14 174.02 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 166.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.532 ' H ' HG13 ' A' ' 236' ' ' VAL . 62.9 m -23.78 110.07 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.88 1.272 . . . . 0.0 114.226 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -103.69 108.87 20.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.487 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.424 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 5.3 t30 -122.79 94.82 4.4 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -83.45 -50.12 8.62 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.08 -162.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 40.3 t -62.49 -23.1 31.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.662 0.744 . . . . 0.0 109.688 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.424 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 13.9 mmmm -96.18 -7.44 35.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.033 -178.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 60.28 57.5 2.89 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.684 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 11.7 t -139.95 112.9 8.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.907 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -129.52 110.12 11.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.591 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . 0.657 ' HB2' HG12 ' A' ' 236' ' ' VAL . 0.7 OUTLIER -114.65 165.93 12.26 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 173.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.66 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 1.7 p90 -157.65 125.98 5.53 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 51.9 m -94.17 133.07 38.07 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.527 HG22 ' HA ' ' A' ' 234' ' ' PRO . 0.8 OUTLIER -141.12 142.92 28.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 119.182 -1.007 . . . . 0.0 112.231 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.518 HG23 ' OG1' ' A' ' 310' ' ' THR . 21.9 m -93.79 111.97 23.75 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 165.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.57 ' HB2' HG13 ' A' ' 309' ' ' VAL . 5.2 mp -102.92 167.81 9.61 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -176.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.24 140.51 51.07 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -141.64 -143.1 4.19 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.329 -174.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -109.42 -173.93 2.38 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -174.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 256' ' ' ALA . 3.3 m -66.58 174.76 2.64 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.369 -172.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 255' ' ' THR . . . -59.52 -175.38 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.047 0.939 . . . . 0.0 113.012 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 69.8 m 81.18 10.88 0.87 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.992 0.917 . . . . 0.0 111.556 -177.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 22.3 t -128.73 89.79 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 167.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 7.2 m -71.72 97.17 1.71 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.384 -177.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 69.01 98.89 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.021 -172.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -44.34 -60.25 2.02 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 117.108 0.454 . . . . 0.0 110.933 172.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.514 ' HB3' ' CB ' ' A' ' 266' ' ' ASP . 94.4 mt -148.21 166.08 29.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.545 -174.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 97.6 mttt -141.36 -166.68 2.24 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -52.04 113.6 1.06 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.362 0.601 . . . . 0.0 112.058 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 110.92 -17.31 27.44 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.054 177.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . 0.514 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 18.0 m-20 -82.58 146.15 29.33 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.42 145.55 45.13 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.607 0.718 . . . . 0.0 111.641 -174.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.609 HG23 ' HB3' ' A' ' 295' ' ' ALA . 0.2 OUTLIER -121.75 -178.97 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.038 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.502 ' HD3' ' C ' ' A' ' 269' ' ' LYS . 1.0 OUTLIER -126.77 139.36 53.18 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.544 ' CE1' ' HB2' ' A' ' 295' ' ' ALA . 8.1 p90 -146.48 157.46 43.75 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.644 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.541 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 5.6 t -137.38 95.89 3.16 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.955 176.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.42 ' HA ' ' CG ' ' A' ' 337' ' ' ASP . 4.0 m120 -95.34 113.73 25.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.551 177.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 19.1 p -91.74 79.88 5.34 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.398 0.618 . . . . 0.0 110.55 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -94.99 123.87 38.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.191 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -82.72 17.9 1.71 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.473 0.654 . . . . 0.0 110.511 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.47 12.39 2.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.701 -178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -107.85 -8.72 15.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.051 172.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.459 HE22 HD22 ' A' ' 284' ' ' LEU . 33.3 mm-40 -69.08 -81.38 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.039 0.447 . . . . 0.0 112.037 -171.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -79.52 -21.47 45.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.09 -173.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 39.4 p -67.54 -44.65 77.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.177 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -95.16 -74.09 0.56 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.0 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -138.73 -102.12 0.17 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -175.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -170.18 116.62 0.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.459 HD22 HE22 ' A' ' 278' ' ' GLN . 8.1 mp -101.74 -33.15 9.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.672 0.272 . . . . 0.0 110.584 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 68.53 -58.73 0.47 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.001 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -107.17 122.88 47.4 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.98 0.419 . . . . 0.0 110.068 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 93.24 123.07 3.42 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.04 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.61 ' O ' ' HB ' ' A' ' 289' ' ' THR . . . -67.1 -41.7 85.84 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.711 0.767 . . . . 0.0 109.484 177.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.61 ' HB ' ' O ' ' A' ' 288' ' ' ALA . 5.6 t 169.8 128.81 0.05 OUTLIER Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 113.487 -1.688 . . . . 0.0 109.99 173.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.96 46.25 2.11 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.763 2.308 . . . . 0.0 112.551 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.406 HG12 ' OG1' ' A' ' 289' ' ' THR . 36.3 mm -86.11 116.29 28.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.156 0.503 . . . . 0.0 111.208 -177.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 25.9 p -152.74 122.17 6.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.492 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -165.34 -171.05 2.04 Favored 'General case' 0 C--O 1.23 0.079 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.912 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 91.3 m -88.76 134.65 33.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.914 -173.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . 0.609 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -117.5 176.0 5.37 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 54.5 m -130.82 125.44 33.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.597 0.713 . . . . 0.0 112.877 -176.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.649 HG13 HG21 ' A' ' 311' ' ' VAL . 60.7 t -75.33 130.5 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.714 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 3.5 m -115.78 -1.59 12.6 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.276 -169.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -160.13 -166.33 1.67 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.085 -0.384 . . . . 0.0 111.138 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.43 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 3.3 m-20 -66.32 157.62 31.25 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.468 0.651 . . . . 0.0 110.229 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.458 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -149.23 177.44 9.64 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.595 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -144.62 137.09 26.45 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.211 -0.196 . . . . 0.0 111.297 -171.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.8 OUTLIER -118.99 95.08 4.67 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 163.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.95 177.46 4.85 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.946 -174.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 11.6 t -59.58 -32.41 70.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.898 0.38 . . . . 0.0 111.004 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -78.9 4.23 62.16 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.252 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 59.94 42.33 98.22 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.631 176.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -114.55 131.1 56.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.454 0.627 . . . . 0.0 110.528 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 251' ' ' LEU . 2.1 p -132.45 95.01 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.501 0.667 . . . . 0.0 111.062 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.518 ' OG1' HG23 ' A' ' 250' ' ' THR . 76.7 m -101.42 128.41 47.63 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 122.011 -0.431 . . . . 0.0 111.827 -176.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.649 HG21 HG13 ' A' ' 297' ' ' VAL . 7.3 p -162.21 150.72 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.981 174.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 52.0 m -86.87 146.41 26.21 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.989 0.423 . . . . 0.0 110.584 177.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.485 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.4 mp -120.99 159.04 26.44 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.58 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 17.5 m -138.48 127.75 24.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.179 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 100.7 94.18 2.16 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.607 -0.806 . . . . 0.0 114.007 172.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.414 HG13 ' CE2' ' A' ' 247' ' ' PHE . 0.5 OUTLIER -138.64 110.28 8.06 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 172.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.26 62.49 3.44 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.89 2.393 . . . . 0.0 112.377 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 41.0 pt -122.04 147.49 26.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.924 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -116.99 119.43 35.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.974 0.416 . . . . 0.0 111.211 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -93.51 20.87 6.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.744 176.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 20.3 p 50.57 -107.14 0.27 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.402 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 38.1 m -159.62 -63.95 0.07 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.418 ' CB ' ' HB2' ' A' ' 330' ' ' SER . 43.1 m-80 55.4 64.65 5.36 Favored Pre-proline 0 N--CA 1.469 0.477 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.637 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.563 ' HA ' ' O ' ' A' ' 328' ' ' SER . 71.5 Cg_endo -90.9 -165.8 0.18 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.482 2.122 . . . . 0.0 111.565 -177.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 66.53 -69.91 0.11 Allowed 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.94 0.775 . . . . 0.0 111.707 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -57.57 -47.93 80.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.422 -174.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -136.26 21.54 3.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.799 0.333 . . . . 0.0 110.415 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . 0.563 ' O ' ' HA ' ' A' ' 324' ' ' PRO . 41.1 m 67.8 -65.99 0.23 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.124 -176.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 10.6 t -136.91 104.65 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 172.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' SER . . . . . 0.418 ' HB2' ' CB ' ' A' ' 323' ' ' ASN . 9.1 m -90.18 58.23 4.02 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.351 0.596 . . . . 0.0 110.947 -173.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -96.37 112.85 24.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.726 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -123.25 109.55 14.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.819 0.342 . . . . 0.0 110.526 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.517 HG23 ' HB3' ' A' ' 233' ' ' GLN . 6.1 m -103.04 132.44 49.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.16 162.65 14.07 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.412 0.625 . . . . 0.0 111.627 -176.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -99.04 170.0 9.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.977 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 110.64 10.75 20.89 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.473 172.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.541 ' HB3' ' O ' ' A' ' 271' ' ' THR . 13.6 m-20 -96.27 -177.26 3.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.846 0.323 . . . . 0.0 111.778 -176.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -109.08 153.3 23.87 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -169.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.502 HG21 HD23 ' A' ' 251' ' ' LEU . 76.1 t -135.98 157.31 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.676 -175.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 5.6 t -156.97 179.73 9.02 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 172.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.498 HG13 HD11 ' A' ' 262' ' ' LEU . 69.2 t -115.88 133.08 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.126 0.489 . . . . 0.0 111.946 -175.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 71.8 t -96.39 -44.76 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.887 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 113.06 -126.67 7.57 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 111.396 -0.681 . . . . 0.0 111.396 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 4.6 p -134.5 -71.57 0.49 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.313 0.578 . . . . 0.0 110.068 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.881 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.578 176.916 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.69 ' N ' ' HG1' ' A' ' 227' ' ' THR . . . . . . . . 0 N--CA 1.481 1.655 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 63.23 -81.16 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.352 0.661 . . . . 0.0 112.06 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -88.11 -23.25 23.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.87 0.367 . . . . 0.0 110.66 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 129.78 -38.78 1.93 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.127 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -118.35 121.75 5.15 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.859 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.69 ' HG1' ' N ' ' A' ' 222' ' ' GLY . 10.3 m -135.38 136.01 41.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.782 0.325 . . . . 0.0 110.378 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.486 HD21 ' CE1' ' A' ' 261' ' ' PHE . 8.2 mt -147.88 174.68 11.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.267 -177.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 57.2 m -134.59 161.98 33.57 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 12.2 t -116.11 139.61 41.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.426 ' HD2' ' CG2' ' A' ' 252' ' ' THR . 38.0 tttt -120.17 -1.58 10.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.044 0.45 . . . . 0.0 111.117 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.462 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 19.8 p -139.33 -168.23 2.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.932 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -113.67 102.52 54.89 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -174.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 248' ' ' THR . 35.9 Cg_endo -66.99 105.72 1.02 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.216 1.944 . . . . 0.0 112.176 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 247' ' ' PHE . 12.0 t -113.03 144.51 42.48 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.319 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.492 ' HA ' ' HB3' ' A' ' 247' ' ' PHE . 28.9 t -80.81 122.99 36.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.03 -171.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 94.0 m -97.95 124.59 42.47 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.104 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -93.77 124.1 37.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.188 0.518 . . . . 0.0 110.987 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.47 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 20.5 t30 -127.04 70.85 1.3 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -86.06 -28.38 24.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.757 -161.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.46 -22.97 30.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 172.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.47 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 19.6 mmtp -101.05 -0.72 35.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.135 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 23.1 t70 50.82 52.66 14.49 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 113.999 -1.455 . . . . 0.0 111.3 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 24.2 m -140.25 128.96 23.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.423 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -109.47 110.84 22.07 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -118.37 176.65 5.14 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.111 -174.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.492 ' HB3' ' HA ' ' A' ' 236' ' ' VAL . 15.7 p90 -160.58 148.87 16.41 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.366 171.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 55.4 m -112.11 145.07 40.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.786 -168.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 9.9 p -154.08 142.8 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.462 ' HB ' ' CG2' ' A' ' 232' ' ' THR . 19.2 m -103.93 109.93 21.87 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 166.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.69 171.33 7.42 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.287 0.565 . . . . 0.0 109.695 -175.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.426 ' CG2' ' HD2' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -125.77 139.14 53.76 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.066 175.01 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -136.08 -143.72 4.73 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.025 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.532 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -101.75 -174.58 2.62 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.702 HG22 ' H ' ' A' ' 256' ' ' ALA . 2.1 m -73.69 -178.2 3.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.426 -173.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.702 ' H ' HG22 ' A' ' 255' ' ' THR . . . -59.19 -177.19 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.697 0.799 . . . . 0.0 112.868 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 33.8 t 80.89 7.63 1.26 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.077 0.951 . . . . 0.0 111.109 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 59.1 t -128.01 89.7 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 121.538 0.685 . . . . 0.0 109.512 171.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 87.0 m -76.94 98.75 5.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.48 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 68.23 89.64 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.493 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.671 ' HB3' HD22 ' A' ' 262' ' ' LEU . 8.2 m-85 -46.12 -59.58 2.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.538 0.685 . . . . 0.0 109.897 170.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.671 HD22 ' HB3' ' A' ' 261' ' ' PHE . 1.4 mm? -123.31 156.21 35.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.286 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 55.1 mtmt -132.81 -167.6 1.93 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 171.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -54.41 114.23 1.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.212 0.53 . . . . 0.0 111.386 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 106.57 -12.86 42.93 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.527 175.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . 0.477 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 8.7 m-20 -78.32 136.67 37.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.827 0.346 . . . . 0.0 110.32 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -110.95 141.69 44.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.715 0.769 . . . . 0.0 112.133 -171.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 294' ' ' THR . 2.4 m -118.58 169.94 8.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.43 176.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.32 135.11 19.96 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.463 ' CB ' ' HA ' ' A' ' 339' ' ' VAL . 31.0 p90 -147.03 159.96 42.95 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.06 -1.056 . . . . 0.0 112.664 -173.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 82.7 p -99.69 96.06 7.36 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.943 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -77.38 160.52 28.71 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.372 0.606 . . . . 0.0 110.877 -176.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . 0.485 HG23 ' HB3' ' A' ' 337' ' ' ASP . 1.0 OUTLIER -70.26 123.4 21.59 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.912 -173.505 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -134.58 162.44 32.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.995 170.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.631 ' O ' ' HG3' ' A' ' 278' ' ' GLN . 32.1 t-105 57.84 72.65 0.51 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.717 0.635 . . . . 0.0 109.296 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.02 14.9 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.227 -175.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . 0.428 ' H ' ' C ' ' A' ' 275' ' ' TRP . 41.7 mt-30 -93.02 -14.07 27.86 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 176.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 275' ' ' TRP . 63.5 mt-30 -63.49 -51.27 66.27 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.422 0.629 . . . . 0.0 110.208 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -67.12 -27.0 66.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.454 -175.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 1.8 p -91.57 -47.84 7.18 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -176.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -77.94 -32.12 51.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.932 0.396 . . . . 0.0 110.987 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 57.85 18.93 5.29 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.8 0.84 . . . . 0.0 112.072 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -145.88 -164.99 2.08 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.315 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 90.4 mt 67.49 27.79 7.83 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 123.611 0.569 . . . . 0.0 111.199 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 63.84 102.24 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.648 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -158.67 158.15 33.2 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.592 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 156.59 -32.98 0.58 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.63 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -137.64 103.96 5.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.706 0.289 . . . . 0.0 110.929 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.405 HG23 ' HB ' ' A' ' 271' ' ' THR . 11.7 t -65.38 134.0 95.55 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . 0.61 ' O ' HG12 ' A' ' 291' ' ' ILE . 49.7 Cg_endo -69.77 158.02 58.36 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.56 2.173 . . . . 0.0 112.824 -177.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 290' ' ' PRO . 7.9 pt 59.37 170.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.085 1.354 . . . . 0.0 113.186 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 20.1 m -154.2 164.63 38.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.888 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -134.56 145.3 48.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.032 0.444 . . . . 0.0 110.328 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 268' ' ' VAL . 91.2 m -90.32 131.17 36.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.157 -176.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -123.19 173.95 7.57 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.403 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 90.2 m -134.4 128.23 33.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.277 0.56 . . . . 0.0 112.456 -175.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 299' ' ' ALA . 40.2 t -86.42 139.6 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.812 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 312' ' ' THR . 15.0 t -111.5 11.44 21.35 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -176.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.616 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -153.23 177.56 10.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.847 0.356 . . . . 0.0 111.504 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.414 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 2.8 m-20 -67.95 114.55 6.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.3 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.531 ' HB3' ' H ' ' A' ' 262' ' ' LEU . . . -93.33 100.1 12.5 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.893 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.743 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 13.6 m120 -68.15 126.85 30.83 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -171.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.536 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 18.8 t -104.75 94.82 5.49 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 161.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.1 178.31 5.58 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.718 -175.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 6.3 t -61.18 -33.63 73.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.815 0.341 . . . . 0.0 111.198 -176.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -82.44 7.19 65.48 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.08 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 61.38 42.35 99.75 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.099 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -117.79 134.54 54.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 117.232 0.516 . . . . 0.0 111.082 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.743 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.1 OUTLIER -141.13 106.03 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.957 -178.003 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.451 ' OG1' HG23 ' A' ' 250' ' ' THR . 47.0 m -112.7 122.8 48.73 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.695 -0.628 . . . . 0.0 110.837 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 17.6 m -147.73 161.55 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-O 121.227 0.537 . . . . 0.0 110.895 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 298' ' ' THR . 15.5 m -113.73 138.24 50.51 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.478 172.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.415 HD13 ' CZ ' ' A' ' 247' ' ' PHE . 4.8 mp -103.26 149.28 24.86 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.609 -175.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 20.3 m -138.48 139.0 38.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.05 0.452 . . . . 0.0 111.845 -173.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 92.92 41.66 4.59 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.509 -0.768 . . . . 0.0 112.43 174.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 4.7 m -127.42 98.96 28.08 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.203 0.525 . . . . 0.0 111.042 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.06 48.83 2.37 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 123.003 2.469 . . . . 0.0 111.817 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.51 122.96 38.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.425 0.631 . . . . 0.0 109.62 -176.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.496 ' HB3' ' HB ' ' A' ' 322' ' ' THR . 29.1 m-85 -102.88 73.6 1.27 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.138 0.494 . . . . 0.0 110.533 -175.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.61 -50.04 75.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.628 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 14.5 p -101.79 -7.3 22.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.954 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' A' ' 319' ' ' TYR . 0.6 OUTLIER -101.02 -1.38 34.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.065 0.46 . . . . 0.0 110.889 -174.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.491 ' ND2' ' HB2' ' A' ' 319' ' ' TYR . 39.8 m-20 -124.43 74.36 61.22 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.567 176.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.459 ' HB3' ' HA ' ' A' ' 328' ' ' SER . 38.5 Cg_exo -58.64 -58.03 0.84 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.836 1.691 . . . . 0.0 111.707 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . 0.565 ' HA ' HE21 ' A' ' 325' ' ' GLN . 0.0 OUTLIER 63.67 -79.81 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.934 175.315 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -79.19 -36.95 39.42 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.469 -176.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -165.7 147.88 7.41 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -174.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . 0.459 ' HA ' ' HB3' ' A' ' 324' ' ' PRO . 50.6 m -77.9 76.88 4.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.372 0.606 . . . . 0.0 109.982 176.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 38.8 t -71.59 -49.38 46.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.331 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 11.5 p 44.07 55.78 5.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.518 0.675 . . . . 0.0 111.34 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -102.82 154.03 19.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.898 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -107.99 142.07 38.68 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 171.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 18.7 m -58.52 154.98 2.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.902 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -123.87 147.04 47.98 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.798 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -69.14 139.31 54.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.841 -0.163 . . . . 0.0 111.111 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.63 -2.1 6.48 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.932 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 271' ' ' THR . 7.3 p-10 -75.66 168.66 19.6 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.256 0.55 . . . . 0.0 111.292 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -104.36 131.11 52.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.516 -171.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 270' ' ' PHE . 73.8 t -108.44 146.9 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.131 -176.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -143.98 165.09 28.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.277 173.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 48.3 t -109.41 142.4 22.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.235 -176.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 53.2 t -73.16 -46.46 50.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 48.81 -123.77 11.2 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.972 176.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.419 ' HG1' ' H ' ' A' ' 345' ' ' ALA . 25.5 p 58.38 -66.33 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.26 1.424 . . . . 0.0 112.92 -178.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . 0.419 ' H ' ' HG1' ' A' ' 344' ' ' THR . . . . . . . . 0 C--O 1.25 1.1 0 C-N-CA 123.52 0.728 . . . . 0.0 111.288 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.83 134.47 34.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.537 0.169 . . . . 0.0 110.681 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 39.8 t80 68.85 -43.88 0.52 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.901 0.88 . . . . 0.0 112.584 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 100.65 6.11 53.08 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -56.3 126.36 40.58 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.128 -0.536 . . . . 0.0 112.208 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 41.5 m -136.75 101.5 4.62 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.974 0.416 . . . . 0.0 109.948 -177.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.456 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.4 mp -119.4 176.2 5.46 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 63.9 m -138.55 158.34 44.45 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 -174.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.4 HG13 HG11 ' A' ' 249' ' ' VAL . 89.6 t -110.11 106.66 21.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 250' ' ' THR . 17.1 ptmt -93.27 -12.65 29.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.968 0.414 . . . . 0.0 111.02 -174.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.454 HG23 ' HG3' ' A' ' 231' ' ' LYS . 31.8 p -123.79 -166.95 1.55 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.32 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -112.6 121.06 39.71 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.145 -172.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -70.76 113.35 3.51 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.976 2.451 . . . . 0.0 111.849 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 10.1 t -147.23 109.06 4.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.782 0.801 . . . . 0.0 112.784 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.7 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.48 174.39 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 164.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.545 ' H ' HG13 ' A' ' 236' ' ' VAL . 54.3 m -40.94 119.03 1.07 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -173.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -112.71 82.64 1.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 171.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -115.24 136.75 52.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -174.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.68 -45.12 4.29 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.566 -171.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.89 -27.94 43.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.31 0.576 . . . . 0.0 110.035 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -94.55 -7.37 41.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.832 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 56.53 61.48 2.66 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.309 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.8 t -144.43 95.62 2.74 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.575 0.702 . . . . 0.0 110.073 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -108.71 101.53 10.65 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.908 175.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . 0.621 ' HB2' HG12 ' A' ' 236' ' ' VAL . 71.6 mt-30 -130.04 156.36 44.62 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.7 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 15.6 p90 -157.47 136.88 11.99 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.588 0.232 . . . . 0.0 111.615 177.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.421 HG23 ' OG1' ' A' ' 312' ' ' THR . 32.8 m -101.02 133.5 45.42 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.494 ' HB ' HD11 ' A' ' 251' ' ' LEU . 0.3 OUTLIER -142.18 148.05 20.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.906 -176.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.548 HG23 ' OG1' ' A' ' 310' ' ' THR . 41.3 m -99.07 111.92 24.19 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.516 HD13 HG22 ' A' ' 311' ' ' VAL . 5.4 mp -106.15 167.83 9.54 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -172.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.402 HG23 ' HD2' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -114.41 148.63 37.42 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.839 174.431 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -144.94 -142.35 3.84 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -175.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.53 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -110.2 -174.19 2.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -68.59 -178.34 1.13 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.676 -170.436 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.547 ' H ' HG22 ' A' ' 255' ' ' THR . . . -67.5 -176.3 0.59 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.849 -177.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 22.7 t 81.03 7.99 1.17 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.491 0.716 . . . . 0.0 111.033 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 39.1 t -124.16 90.81 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 173.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 18.4 m -69.62 98.22 1.14 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.691 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 66.98 95.67 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.717 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -41.91 -56.43 2.75 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 172.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.3 pp -165.08 161.58 19.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.979 -0.1 . . . . 0.0 110.905 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.434 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 92.6 mttt -141.29 -165.91 2.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.722 0.296 . . . . 0.0 111.764 -175.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -49.46 117.95 2.48 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.769 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 113.84 -20.07 17.82 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.689 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -89.15 142.28 27.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.888 0.375 . . . . 0.0 110.191 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.469 HE21 ' HG2' ' A' ' 317' ' ' PRO . 39.8 mt-30 -112.02 153.25 27.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.343 0.592 . . . . 0.0 110.881 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -131.43 165.93 30.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.401 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.483 ' HD2' HG22 ' A' ' 342' ' ' VAL . 0.0 OUTLIER -119.3 150.37 40.24 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 169.537 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -149.06 143.27 25.95 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.25 168.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.41 ' HB ' ' OG ' ' A' ' 292' ' ' SER . 3.7 t -93.69 105.02 17.09 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.143 176.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.612 ' HA ' ' OD2' ' A' ' 337' ' ' ASP . 2.8 t-20 -91.26 130.02 37.18 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.321 -174.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 16.0 p -112.16 111.33 22.15 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.713 174.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -87.88 113.0 23.12 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.641 ' O ' ' HB2' ' A' ' 279' ' ' GLN . 18.2 p-90 -157.43 -45.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.558 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 7.3 mp 59.6 174.73 0.08 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.485 0.659 . . . . 0.0 111.298 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -87.08 -10.39 53.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.022 0.439 . . . . 0.0 110.699 -177.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -93.46 -47.43 6.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.136 -175.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.641 ' HB2' ' O ' ' A' ' 275' ' ' TRP . 15.7 mm100 -67.08 -29.45 69.23 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.239 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.708 ' HA ' ' O ' ' A' ' 283' ' ' ALA . 1.2 p -72.71 0.23 11.32 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -176.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -75.22 -36.69 61.34 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -98.07 -44.07 6.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.561 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.708 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . -103.42 107.68 18.61 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.953 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 72.0 mt -88.36 9.18 24.25 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -169.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -137.26 -70.14 0.45 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.748 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 62.38 67.46 0.72 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.734 0.646 . . . . 0.0 110.788 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -101.59 9.76 57.33 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.381 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -91.93 9.43 33.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.247 0.546 . . . . 0.0 110.417 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 15.2 t -67.61 145.2 98.13 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.791 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.95 111.63 0.96 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.861 2.374 . . . . 0.0 112.048 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.616 HG23 ' H ' ' A' ' 292' ' ' SER . 3.6 tp -45.2 -68.55 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -170.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . 0.616 ' H ' HG23 ' A' ' 291' ' ' ILE . 51.5 m -155.71 145.04 20.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 118.198 0.454 . . . . 0.0 110.415 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -150.04 166.74 28.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.869 0.366 . . . . 0.0 110.719 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 99.7 m -100.19 135.79 41.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.488 -173.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . 0.498 ' HA ' ' HD2' ' A' ' 317' ' ' PRO . . . -126.77 177.61 6.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.185 176.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 87.4 m -134.26 134.69 42.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.29 0.567 . . . . 0.0 112.203 -176.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 84.4 t -93.84 144.54 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.282 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 4.2 m -131.4 25.32 4.82 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.985 0.422 . . . . 0.0 111.803 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.44 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -147.46 171.06 16.11 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.838 -0.539 . . . . 0.0 112.157 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.434 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 28.7 m-20 -63.62 157.18 24.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.721 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.412 ' HB2' ' CG1' ' A' ' 311' ' ' VAL . . . -141.77 168.82 18.84 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.953 -175.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.498 ' OD1' ' HB3' ' A' ' 304' ' ' ASP . 28.1 t-20 -143.85 131.98 21.8 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.869 -174.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.416 ' HB2' ' HB ' ' A' ' 258' ' ' VAL . 0.5 OUTLIER -115.58 94.53 4.74 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 163.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . 0.498 ' HB3' ' OD1' ' A' ' 302' ' ' ASN . 0.8 OUTLIER -94.92 176.31 6.3 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.763 -177.117 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 15.5 m -58.22 -32.87 68.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.027 0.441 . . . . 0.0 111.533 -177.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -77.42 -7.59 87.03 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.085 -178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 73.19 43.29 39.88 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.498 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -115.83 138.07 51.5 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 117.963 0.881 . . . . 0.0 111.488 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.9 OUTLIER -141.34 111.01 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.805 179.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.548 ' OG1' HG23 ' A' ' 250' ' ' THR . 88.9 m -100.49 122.54 43.38 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.602 -0.686 . . . . 0.0 111.01 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.516 HG22 HD13 ' A' ' 251' ' ' LEU . 9.6 m -145.0 155.72 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.545 0.688 . . . . 0.0 111.409 177.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.421 ' OG1' HG23 ' A' ' 248' ' ' THR . 20.7 m -112.3 140.19 47.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.547 177.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.519 HD13 ' CE2' ' A' ' 247' ' ' PHE . 5.1 mp -113.86 138.1 50.75 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.853 -174.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 78.6 p -139.4 116.85 11.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.786 0.327 . . . . 0.0 110.466 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 101.9 136.15 9.12 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.442 ' HB ' HG23 ' A' ' 318' ' ' ILE . 3.9 m -119.3 89.61 40.36 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 121.303 0.573 . . . . 0.0 111.993 -176.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.498 ' HD2' ' HA ' ' A' ' 295' ' ' ALA . 5.4 Cg_exo -76.57 54.52 4.42 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.529 2.82 . . . . 0.0 111.122 173.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.442 HG23 ' HB ' ' A' ' 316' ' ' VAL . 17.2 pt -94.02 155.91 3.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.069 -173.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -103.48 51.9 0.78 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.448 0.642 . . . . 0.0 109.82 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -127.92 60.9 1.44 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.785 -176.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 55.9 p 63.51 110.93 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.683 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 18.8 m -84.05 -27.01 28.61 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.401 ' CG ' ' HD2' ' A' ' 324' ' ' PRO . 27.1 t-20 -89.56 147.95 39.08 Favored Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.149 173.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.401 ' HD2' ' CG ' ' A' ' 323' ' ' ASN . 73.2 Cg_endo -72.1 61.85 3.26 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.89 1.726 . . . . 0.0 112.61 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . 0.702 ' HA ' HE21 ' A' ' 325' ' ' GLN . 0.0 OUTLIER -90.51 32.03 0.99 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.937 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 66.47 97.31 0.05 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.869 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -154.99 -63.64 0.12 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.066 175.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 20.2 m 54.16 86.5 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.469 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 48.5 t -80.53 130.82 35.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 41.8 m -142.31 102.68 4.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.071 0.462 . . . . 0.0 111.518 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . 0.559 ' CZ ' HD21 ' A' ' 272' ' ' ASN . 3.9 tpm_? -87.11 112.78 22.25 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -91.71 -177.6 4.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 174.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 18.7 m -67.77 106.44 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.799 0.809 . . . . 0.0 111.138 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -164.44 132.25 3.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.81 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -99.41 158.05 16.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.69 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.36 -22.1 5.35 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.878 175.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.612 ' OD2' ' HA ' ' A' ' 272' ' ' ASN . 65.3 m-20 -56.34 141.14 42.88 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 117.226 0.513 . . . . 0.0 111.479 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -99.41 139.76 34.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.571 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 53.7 t -117.37 148.01 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -169.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 36.3 t -142.36 175.59 9.66 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 173.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.465 ' O ' ' HE2' ' A' ' 269' ' ' LYS . 40.0 t -118.66 146.07 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 O-C-N 122.265 -0.272 . . . . 0.0 110.602 -174.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.483 HG22 ' HD2' ' A' ' 269' ' ' LYS . 42.0 t -75.4 -40.79 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.709 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -128.5 -168.16 12.36 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.995 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -73.6 -44.84 56.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.884 0.373 . . . . 0.0 111.522 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.844 179.742 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.554 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -106.73 131.95 53.27 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -62.84 156.38 24.25 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.008 0.432 . . . . 0.0 111.364 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 106.48 17.49 12.27 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -172.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -59.42 121.51 26.98 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.078 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.8 m -94.71 134.9 36.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.916 0.388 . . . . 0.0 109.978 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.474 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 1.1 mp -134.02 176.04 8.94 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.438 ' HB ' ' OG1' ' A' ' 252' ' ' THR . 35.4 m -122.33 154.79 37.16 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.667 0.27 . . . . 0.0 110.728 -175.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.506 HG21 ' OD2' ' A' ' 337' ' ' ASP . 99.2 t -97.91 133.15 41.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.172 -177.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.557 ' HD3' HG22 ' A' ' 250' ' ' THR . 33.2 mtpt -109.37 -38.19 5.55 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 171.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.712 ' O ' HG13 ' A' ' 249' ' ' VAL . 70.9 p -141.0 160.87 39.15 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 172.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.551 ' CD ' ' HD2' ' A' ' 234' ' ' PRO . 6.0 mm100 -116.12 163.74 20.42 Favored Pre-proline 0 C--N 1.318 -0.772 0 C-N-CA 123.369 0.667 . . . . 0.0 110.075 -176.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.594 ' HB3' ' CD2' ' A' ' 247' ' ' PHE . 5.6 Cg_exo -38.47 109.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 124.824 3.683 . . . . 0.0 115.126 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.441 ' O ' HG23 ' A' ' 236' ' ' VAL . 9.0 t -155.25 92.42 1.42 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.368 0.604 . . . . 0.0 111.596 173.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.75 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -157.75 175.17 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.983 171.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.593 ' H ' HG13 ' A' ' 236' ' ' VAL . 60.7 m -37.28 119.14 0.67 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.811 1.244 . . . . 0.0 114.093 -171.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -108.11 83.91 1.86 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 174.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.454 HD22 ' HA ' ' A' ' 239' ' ' ASN . 0.2 OUTLIER -96.56 115.82 28.07 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -175.513 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -101.18 -42.76 6.23 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -166.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.11 -24.19 33.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.624 0.726 . . . . 0.0 109.405 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -98.32 -8.89 26.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.014 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 16.1 t70 53.1 57.23 6.51 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.442 -175.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.7 m -129.47 96.94 4.41 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.1 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -115.91 109.25 17.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.659 -173.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -126.92 153.47 45.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.75 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 35.2 p90 -148.33 140.73 24.3 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.541 -0.463 . . . . 0.0 111.187 174.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 85.2 m -97.85 143.82 28.06 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 122.19 -0.319 . . . . 0.0 110.287 -178.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.712 HG13 ' O ' ' A' ' 232' ' ' THR . 41.6 t -140.64 125.14 18.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.862 177.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.563 HG23 ' OG1' ' A' ' 310' ' ' THR . 41.5 m -90.85 129.62 36.89 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 173.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.535 HD23 HG11 ' A' ' 339' ' ' VAL . 4.4 mp -120.3 165.39 14.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.585 0.707 . . . . 0.0 110.438 -176.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.463 HG23 ' HD2' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -120.75 136.98 54.73 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.375 -0.83 . . . . 0.0 108.973 169.57 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -127.58 -143.53 5.75 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.011 -176.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -112.99 -173.23 2.21 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 256' ' ' ALA . 1.4 m -56.5 168.82 0.51 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.581 -171.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.478 ' H ' HG22 ' A' ' 255' ' ' THR . . . -66.48 -176.77 0.49 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.294 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 10.9 t 79.6 16.76 0.83 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.009 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 45.1 t -128.96 90.45 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.784 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 172.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 23.2 m -73.68 95.82 2.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.147 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 75.43 93.8 0.16 Allowed Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.358 -0.837 . . . . 0.0 113.067 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -42.63 -56.14 3.25 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 171.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -161.79 164.82 28.64 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -140.02 -166.96 2.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -50.48 123.38 8.61 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.752 0.787 . . . . 0.0 111.903 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 109.39 -21.97 25.43 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.737 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -87.52 139.54 30.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.879 0.371 . . . . 0.0 110.16 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -111.74 143.45 42.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.159 0.504 . . . . 0.0 111.197 -175.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.2 OUTLIER -116.26 179.62 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.277 174.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.556 ' HD2' ' C ' ' A' ' 269' ' ' LYS . 3.0 tmmm? -138.35 128.57 25.84 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -116.4 157.66 24.74 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.783 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.503 ' HA ' ' OG ' ' A' ' 292' ' ' SER . 41.4 p -136.92 98.23 3.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.507 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.451 ' HA ' ' CG ' ' A' ' 337' ' ' ASP . 25.5 p-10 -91.25 162.29 14.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.81 -173.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 9.7 p -83.78 171.34 13.24 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.464 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.575 ' HB2' ' H ' ' A' ' 289' ' ' THR . 45.5 t80 -79.94 113.73 18.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.417 0.627 . . . . 0.0 109.901 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.96 0.94 0.65 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.258 -177.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.453 ' HA ' ' HB2' ' A' ' 331' ' ' ARG . 3.9 mp -103.9 -163.01 0.94 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.401 -176.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -66.38 -72.13 0.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.956 0.408 . . . . 0.0 110.954 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -115.08 -80.96 0.6 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.0 0.429 . . . . 0.0 109.965 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.402 ' OE1' ' HB3' ' A' ' 284' ' ' LEU . 32.1 mt-30 -117.23 -63.08 1.49 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.91 175.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 18.9 p -110.91 -77.68 0.59 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.534 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -92.71 -78.28 0.42 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.076 -0.249 . . . . 0.0 111.364 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -138.39 -9.71 1.46 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 284' ' ' LEU . . . -132.02 -146.97 0.3 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -170.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.507 ' HB2' ' O ' ' A' ' 283' ' ' ALA . 52.7 mt 84.59 8.71 0.46 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.621 1.169 . . . . 0.0 111.963 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 71.24 -67.01 0.27 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 169.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -43.93 -47.91 8.49 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.458 0.911 . . . . 0.0 113.458 -167.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 79.86 30.96 41.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.227 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.668 ' O ' ' HD3' ' A' ' 290' ' ' PRO . . . -148.57 137.57 21.65 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.575 ' H ' ' HB2' ' A' ' 274' ' ' TYR . 17.3 m -107.85 86.43 3.03 Favored Pre-proline 0 C--N 1.317 -0.826 0 O-C-N 123.109 0.255 . . . . 0.0 110.624 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . 0.668 ' HD3' ' O ' ' A' ' 288' ' ' ALA . 76.9 Cg_endo -102.62 12.25 0.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.309 2.673 . . . . 0.0 112.913 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 10.4 tp -165.37 145.87 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.047 0.451 . . . . 0.0 111.157 -175.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . 0.503 ' OG ' ' HA ' ' A' ' 271' ' ' THR . 0.0 OUTLIER -142.73 -162.38 1.42 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.315 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -142.81 -150.47 0.31 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -172.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 35.1 m -74.93 144.97 43.0 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -168.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -126.86 159.28 34.39 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 165.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 93.1 m -122.77 119.43 30.61 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.801 -0.759 . . . . 0.0 112.381 -175.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 64.9 t -78.81 133.99 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.614 -177.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 3.4 m -129.38 24.65 5.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.307 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.411 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -151.07 166.85 29.5 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.208 0.527 . . . . 0.0 112.134 -175.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -65.86 115.82 6.37 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.244 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.523 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -93.29 170.25 9.76 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.629 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.643 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 9.5 t30 -149.02 131.75 15.97 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.59 -171.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -113.85 95.52 5.36 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 169.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . 0.596 ' HB3' HD21 ' A' ' 302' ' ' ASN . 0.8 OUTLIER -96.35 178.52 5.34 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.007 -176.652 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 23.2 t -59.9 -34.38 73.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.938 0.399 . . . . 0.0 111.207 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -83.88 4.01 83.9 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.857 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 64.35 43.17 97.23 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.797 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -113.18 133.9 54.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 118.116 0.958 . . . . 0.0 111.634 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.643 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.1 OUTLIER -137.84 119.55 18.08 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.974 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.009 178.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.563 ' OG1' HG23 ' A' ' 250' ' ' THR . 76.6 m -120.51 126.11 49.55 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.379 -0.826 . . . . 0.0 110.979 -178.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 30.7 m -138.2 163.47 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.638 0.732 . . . . 0.0 111.485 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 31.4 m -123.25 138.58 54.6 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.1 173.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 313' ' ' LEU . 1.3 mm? -106.68 124.46 49.64 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.014 -169.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 47.6 t -120.53 144.22 48.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.147 0.499 . . . . 0.0 111.813 -171.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 78.37 38.03 26.3 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.936 176.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.62 112.79 5.46 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-O 120.868 0.366 . . . . 0.0 110.842 -174.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.23 72.35 5.95 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.876 2.384 . . . . 0.0 113.598 -175.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.573 ' HB ' ' CE1' ' A' ' 247' ' ' PHE . 8.3 mm -103.5 128.53 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -71.95 113.03 8.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.846 -173.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -63.46 -62.71 1.5 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.842 174.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 38.6 p 45.36 27.26 0.35 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 27.3 m -119.6 -34.63 3.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.05 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.416 ' HB3' ' HD3' ' A' ' 324' ' ' PRO . 7.4 t30 -61.77 -48.15 90.2 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' A' ' 323' ' ' ASN . 20.0 Cg_exo -69.58 2.09 3.74 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.661 2.241 . . . . 0.0 113.104 -176.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -84.04 78.16 9.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.601 0.715 . . . . 0.0 109.427 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -101.75 -8.7 21.48 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.661 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -164.16 -49.84 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.9 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 13.2 m -85.54 68.52 10.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.847 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 15.2 t -79.62 113.46 19.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.57 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' SER . . . . . 0.433 ' H ' ' HG ' ' A' ' 330' ' ' SER . 4.0 p -117.24 -71.06 0.76 Allowed 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.815 -178.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . 0.603 ' HD3' ' H ' ' A' ' 331' ' ' ARG . 0.0 OUTLIER -103.37 145.74 29.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.64 0.257 . . . . 0.0 110.392 178.714 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -142.34 133.14 25.58 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.518 ' HB ' ' CB ' ' A' ' 233' ' ' GLN . 14.7 m -57.82 145.87 8.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 O-C-N 123.334 0.396 . . . . 0.0 110.383 175.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . 0.404 ' CD ' HD22 ' A' ' 272' ' ' ASN . 0.9 OUTLIER -108.93 129.8 55.43 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -163.02 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -100.26 115.82 30.81 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.003 -0.436 . . . . 0.0 111.975 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 129.05 12.06 2.7 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 119.554 -1.308 . . . . 0.0 114.82 170.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.506 ' OD2' HG21 ' A' ' 230' ' ' VAL . 3.9 p-10 -92.82 -148.74 0.25 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 117.548 0.674 . . . . 0.0 111.322 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -121.54 147.28 46.01 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -168.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.535 HG11 HD23 ' A' ' 251' ' ' LEU . 68.0 t -121.85 149.4 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.145 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.416 ' HB2' ' HE2' ' A' ' 269' ' ' LYS . 25.4 m -147.42 178.62 8.28 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 175.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 46.6 t -112.27 153.34 13.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 74.1 t -68.71 -63.38 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 118.012 0.369 . . . . 0.0 110.52 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 69.5 67.03 2.05 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.939 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.38 -45.27 18.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.565 0.698 . . . . 0.0 110.557 176.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.532 179.168 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.815 0 N-CA-C 111.721 -0.552 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 53.76 69.16 0.74 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.168 0.509 . . . . 0.0 110.362 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.43 ' CG ' ' N ' ' A' ' 225' ' ' GLY . 12.6 t80 61.42 -161.25 0.29 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.391 -173.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.43 ' N ' ' CG ' ' A' ' 224' ' ' PHE . . . 131.07 -8.56 5.71 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.674 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -65.3 113.29 5.7 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.23 -0.986 . . . . 0.0 111.454 176.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 11.3 m -143.33 139.3 30.02 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.8 HD22 HG11 ' A' ' 309' ' ' VAL . 18.4 mt -142.0 176.26 9.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 251' ' ' LEU . 8.3 t -140.5 166.39 24.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.738 0.304 . . . . 0.0 110.335 -178.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 15.1 t -117.88 134.26 62.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.4 -168.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -128.6 11.87 6.3 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.86 0.362 . . . . 0.0 111.528 176.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.448 HG21 ' HB ' ' A' ' 250' ' ' THR . 17.4 p -141.06 -174.46 4.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.221 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -114.24 116.23 44.52 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -176.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.547 ' HB2' ' CD1' ' A' ' 247' ' ' PHE . 73.4 Cg_endo -78.28 106.7 2.18 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.455 2.103 . . . . 0.0 113.361 -176.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.44 ' O ' HG23 ' A' ' 236' ' ' VAL . 9.1 t -155.98 127.1 7.03 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.179 174.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.742 ' O ' ' HB2' ' A' ' 246' ' ' GLN . 47.7 t -154.35 81.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.384 0.674 . . . . 0.0 109.623 170.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 236' ' ' VAL . 33.1 m 83.14 94.89 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.939 175.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -111.67 90.22 3.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.925 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -122.91 135.86 54.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.447 ' HB1' ' OD2' ' A' ' 320' ' ' ASP . . . -103.64 -49.79 3.59 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.876 -170.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 75.9 t -60.36 -31.39 48.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.504 0.668 . . . . 0.0 110.071 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -91.05 -6.51 53.74 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.575 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 36.0 t70 54.55 63.98 1.97 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.435 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.7 m -143.27 99.82 3.51 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.622 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -120.78 112.92 19.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.033 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . 0.742 ' HB2' ' O ' ' A' ' 236' ' ' VAL . 69.7 mt-30 -135.48 170.33 16.12 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.672 ' HA ' ' N ' ' A' ' 236' ' ' VAL . 26.5 p90 -166.8 142.17 4.3 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 176.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.476 ' H ' HG23 ' A' ' 236' ' ' VAL . 34.0 m -104.5 142.9 33.8 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.96 139.67 27.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.769 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.516 HG23 ' OG1' ' A' ' 310' ' ' THR . 53.0 m -103.61 105.45 15.69 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 170.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.841 ' HB2' HG13 ' A' ' 309' ' ' VAL . 0.4 OUTLIER -106.4 171.36 7.4 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.553 0.692 . . . . 0.0 109.651 -174.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 307' ' ' GLY . 0.0 OUTLIER -121.81 144.37 48.86 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.703 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -144.73 -142.6 3.89 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.362 -172.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.535 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -95.58 -176.8 3.86 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -172.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.539 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -81.66 -177.16 6.42 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.867 -171.342 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.539 ' H ' HG22 ' A' ' 255' ' ' THR . . . -61.7 -177.61 0.11 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.668 -177.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 95.6 p 66.9 17.89 10.57 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.086 1.354 . . . . 0.0 110.895 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.444 HG11 ' CE2' ' A' ' 261' ' ' PHE . 12.9 t -129.06 88.83 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 31.6 m -87.79 92.56 9.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.347 -177.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 86.76 86.46 1.08 Allowed Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.533 178.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.444 ' CE2' HG11 ' A' ' 258' ' ' VAL . 0.8 OUTLIER -48.63 -45.06 37.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.093 0.473 . . . . 0.0 110.04 170.405 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.487 ' HB2' ' CB ' ' A' ' 266' ' ' ASP . 2.1 pt? -162.42 168.55 21.88 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.055 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.453 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 97.2 mttt -137.78 -167.53 2.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.634 0.254 . . . . 0.0 111.584 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -56.64 118.97 5.38 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.363 0.602 . . . . 0.0 110.969 178.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 110.73 -16.49 28.5 Favored Glycine 0 C--N 1.313 -0.742 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.541 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . 0.487 ' CB ' ' HB2' ' A' ' 262' ' ' LEU . 37.0 m-20 -91.68 140.5 29.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.038 0.447 . . . . 0.0 110.09 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 296' ' ' THR . 2.2 mp0 -95.55 168.7 10.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.552 -178.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.1 OUTLIER -126.54 171.83 14.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.514 173.079 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.51 ' HB3' ' HB2' ' A' ' 340' ' ' SER . 16.6 tptm -134.47 89.11 2.51 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.379 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -114.2 159.81 19.7 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 119.189 -1.005 . . . . 0.0 111.098 -172.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.424 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 10.1 t -132.57 99.89 4.79 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.853 0.835 . . . . 0.0 110.246 -177.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -94.88 81.29 3.75 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.642 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . 0.442 ' HB ' ' CB ' ' A' ' 288' ' ' ALA . 48.9 p -67.87 105.91 2.12 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.557 -178.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -82.5 112.97 19.9 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.565 ' O ' ' HG3' ' A' ' 278' ' ' GLN . 15.6 t-105 174.44 71.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -176.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -83.23 25.86 0.68 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -169.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.68 -5.35 58.82 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 172.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.565 ' HG3' ' O ' ' A' ' 275' ' ' TRP . 39.0 mt-30 -58.14 -41.24 83.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.517 174.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -63.88 -31.39 72.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.482 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 11.9 p -93.52 -22.31 18.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.642 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -89.56 -42.22 11.55 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.262 -0.175 . . . . 0.0 111.147 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 68.19 -37.72 0.35 Allowed 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.597 1.159 . . . . 0.0 113.857 175.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -71.47 -18.67 62.29 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.201 0.524 . . . . 0.0 110.87 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 87.5 mt 61.5 28.18 17.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.798 171.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -76.86 -14.92 59.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.127 0.489 . . . . 0.0 109.807 174.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -83.14 153.54 24.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.505 175.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -103.49 -128.27 6.29 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.416 177.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.442 ' CB ' ' HB ' ' A' ' 273' ' ' THR . . . 176.36 -172.72 0.09 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -175.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.432 ' O ' HG22 ' A' ' 273' ' ' THR . 8.4 t -85.13 117.01 67.89 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.68 175.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.61 53.53 4.77 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.866 2.377 . . . . 0.0 113.238 -174.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 21.1 pt -85.94 114.89 26.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.228 0.537 . . . . 0.0 111.092 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 43.8 p -127.11 116.08 20.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.596 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -134.65 171.8 13.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.535 0.683 . . . . 0.0 112.368 -175.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 87.7 m -102.53 127.89 49.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.623 -1.172 . . . . 0.0 111.5 -172.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -127.37 -172.46 2.67 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 267' ' ' GLN . 73.7 m -134.35 135.84 42.99 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -175.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.605 HG12 ' H ' ' A' ' 299' ' ' ALA . 87.0 t -95.9 142.72 13.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.98 176.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 8.9 t -114.84 24.1 12.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.857 0.36 . . . . 0.0 111.742 -174.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.605 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -160.42 170.15 21.58 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.125 0.488 . . . . 0.0 112.029 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.453 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 5.2 m-20 -62.85 111.98 2.36 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.042 177.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.477 ' HB2' HG11 ' A' ' 311' ' ' VAL . . . -92.42 114.25 26.75 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.206 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.662 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 27.3 m-80 -88.46 138.02 31.81 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -170.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 57.7 m -124.24 99.97 6.47 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.827 157.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -98.99 -175.06 2.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.447 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 49.3 m -57.21 -32.46 66.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.705 0.288 . . . . 0.0 111.758 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -79.57 2.56 72.17 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.741 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 58.17 42.25 95.18 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.284 -177.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -114.75 142.06 47.02 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 117.727 0.764 . . . . 0.0 111.259 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.841 HG13 ' HB2' ' A' ' 251' ' ' LEU . 1.6 p -149.3 104.13 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.74 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.516 ' OG1' HG23 ' A' ' 250' ' ' THR . 55.4 m -113.28 124.78 53.3 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 121.576 -0.703 . . . . 0.0 110.916 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.477 HG11 ' HB2' ' A' ' 301' ' ' ALA . 22.0 m -147.48 164.27 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.1 0.476 . . . . 0.0 110.568 -178.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 31.4 m -116.47 145.54 43.22 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.055 0.455 . . . . 0.0 110.196 176.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.466 HD13 ' CE1' ' A' ' 247' ' ' PHE . 5.2 mp -120.99 152.18 38.87 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.093 -174.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 25.6 m -139.98 119.19 12.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.438 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 98.46 133.11 7.87 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.967 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 30.5 m -136.6 155.35 76.87 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.51 47.55 2.32 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.609 2.206 . . . . 0.0 112.339 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.518 HG21 HH12 ' A' ' 331' ' ' ARG . 80.9 mt -118.01 122.47 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -101.35 140.16 36.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.054 0.454 . . . . 0.0 110.727 -174.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.447 ' OD2' ' HB1' ' A' ' 240' ' ' ALA . 37.1 t70 -87.42 3.27 47.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.601 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 3.6 p -54.71 -60.74 2.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.074 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 8.7 m -102.34 -43.93 5.54 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.591 175.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.455 ' N ' ' HD3' ' A' ' 324' ' ' PRO . 7.5 t-20 44.97 56.06 14.4 Favored Pre-proline 0 N--CA 1.472 0.663 0 O-C-N 123.807 0.692 . . . . 0.0 111.649 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.455 ' HD3' ' N ' ' A' ' 323' ' ' ASN . 25.5 Cg_endo -98.39 26.36 0.19 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.311 2.674 . . . . 0.0 112.59 -175.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -77.2 77.67 3.74 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.868 -172.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 65.82 -61.54 0.26 Allowed 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.32 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -152.72 -27.18 0.16 Allowed 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.424 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 10.1 t 77.05 -51.71 0.56 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.143 175.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 26.2 t -75.72 -18.45 15.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.401 0.619 . . . . 0.0 110.623 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 15.5 m -110.67 35.54 3.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.175 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . 0.518 HH12 HG21 ' A' ' 318' ' ' ILE . 86.7 mtm180 -92.32 113.75 26.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.573 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -111.72 151.52 28.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.842 0.353 . . . . 0.0 110.285 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 25.6 m -116.51 163.01 14.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.302 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -137.96 163.56 31.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.921 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -86.29 159.73 19.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.855 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 110.01 8.35 25.88 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.655 -0.783 . . . . 0.0 114.09 173.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 271' ' ' THR . 14.9 m-20 -93.77 -172.85 2.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.437 0.618 . . . . 0.0 111.713 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -115.56 149.22 38.55 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.816 -172.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.546 HG21 HD22 ' A' ' 251' ' ' LEU . 55.6 t -128.9 147.29 33.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.866 -177.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.51 ' HB2' ' HB3' ' A' ' 269' ' ' LYS . 37.3 m -137.96 178.27 7.25 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.489 HG12 ' H ' ' A' ' 343' ' ' GLY . 21.1 t -118.0 147.79 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 120.942 0.401 . . . . 0.0 111.751 -171.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 342' ' ' VAL . 47.0 t -128.76 50.62 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 122.359 1.076 . . . . 0.0 108.353 173.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . 0.489 ' H ' HG12 ' A' ' 341' ' ' VAL . . . -53.87 148.27 18.31 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 114.203 -1.362 . . . . 0.0 113.036 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 21.2 p -105.35 -61.05 1.53 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.04 0.447 . . . . 0.0 111.067 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.505 -179.539 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.79 0 N-CA-C 112.218 -0.353 . . . . 0.0 112.218 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.7 91.0 5.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.829 0.347 . . . . 0.0 111.099 -177.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -64.2 -41.83 96.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.214 0.531 . . . . 0.0 110.628 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 77.27 29.55 56.12 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.001 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -90.98 -143.43 11.26 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.169 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 6.1 m -82.16 144.97 30.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.915 0.388 . . . . 0.0 111.08 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.438 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.0 mp -136.14 -177.25 4.62 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 172.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 41.4 m -131.72 153.79 49.69 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.885 0.374 . . . . 0.0 110.961 -173.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 14.3 t -101.09 130.71 50.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -111.99 -28.13 8.14 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.16 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 32.8 p -123.82 -167.82 1.69 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.991 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 45.6 mt-30 -109.59 121.63 41.72 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -175.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.61 ' O ' HG11 ' A' ' 333' ' ' VAL . 14.6 Cg_exo -68.1 105.39 1.18 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.556 2.17 . . . . 0.0 111.633 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 236' ' ' VAL . 9.8 t -154.26 123.47 6.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.727 0.775 . . . . 0.0 112.868 -177.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.663 HG12 ' HB2' ' A' ' 246' ' ' GLN . 2.1 t -154.18 175.23 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 170.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.515 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 87.4 m -39.93 116.12 0.61 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -108.36 83.5 1.79 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 172.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -110.29 138.54 46.54 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.96 -41.5 5.17 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.588 -172.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 44.4 t -61.71 -31.62 51.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.435 0.636 . . . . 0.0 109.732 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -95.14 -5.77 43.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.667 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 30.6 t70 53.01 51.11 16.47 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.367 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 22.5 m -127.9 97.56 4.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.474 -173.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -113.69 105.36 13.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.95 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . 0.663 ' HB2' HG12 ' A' ' 236' ' ' VAL . 86.8 mt-30 -129.71 152.99 48.61 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.882 -178.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.643 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 2.8 p90 -154.8 129.8 9.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.776 0.322 . . . . 0.0 111.842 176.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 37.0 m -103.26 141.83 35.23 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.618 ' HB ' HD11 ' A' ' 251' ' ' LEU . 0.2 OUTLIER -142.84 146.45 21.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 119.911 -0.716 . . . . 0.0 112.129 179.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.559 HG23 ' OG1' ' A' ' 310' ' ' THR . 57.8 m -101.22 111.43 23.64 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 163.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.618 HD11 ' HB ' ' A' ' 249' ' ' VAL . 3.3 mp -114.04 168.57 9.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -172.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.7 138.56 46.93 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.74 0.305 . . . . 0.0 110.517 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -133.05 -142.74 4.88 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -175.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.481 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -106.34 -177.73 3.45 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.332 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.581 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.3 OUTLIER -70.82 -177.32 1.56 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.39 -175.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.581 ' H ' HG22 ' A' ' 255' ' ' THR . . . -63.34 -176.65 0.16 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 122.999 0.52 . . . . 0.0 111.672 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 11.7 t 79.63 12.81 1.12 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.073 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 90.9 t -133.02 89.56 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-O 121.621 0.724 . . . . 0.0 109.565 171.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 12.4 m -79.45 97.46 6.4 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.624 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 79.78 93.45 0.37 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.744 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.664 ' CE1' ' HB2' ' A' ' 303' ' ' SER . 7.0 m-85 -53.37 -43.07 67.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.217 0.532 . . . . 0.0 110.469 169.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.486 ' HB2' ' CB ' ' A' ' 266' ' ' ASP . 4.1 pp -161.34 172.96 15.66 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.97 -176.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -129.84 -166.92 1.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.989 0.423 . . . . 0.0 111.48 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -60.93 118.19 6.4 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.193 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 109.83 -15.86 31.2 Favored Glycine 0 C--N 1.316 -0.543 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.444 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . 0.486 ' CB ' ' HB2' ' A' ' 262' ' ' LEU . 14.3 m-20 -75.29 134.88 40.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -97.96 151.78 19.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.74 0.781 . . . . 0.0 111.668 -176.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.506 HG23 ' HB3' ' A' ' 295' ' ' ALA . 1.7 m -125.38 172.31 13.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.795 177.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.16 133.17 21.36 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 169.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 338' ' ' ALA . 47.2 p90 -143.81 167.87 21.28 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.456 -174.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.608 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 13.9 t -133.67 123.92 25.83 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.329 0.585 . . . . 0.0 111.561 -175.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.572 ' O ' ' HA ' ' A' ' 290' ' ' PRO . 3.2 t-20 -88.45 109.23 19.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.249 173.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . 0.404 ' H ' ' CG ' ' A' ' 337' ' ' ASP . 11.5 p -118.26 81.07 1.62 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.434 0.635 . . . . 0.0 111.327 -173.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -142.57 -171.85 3.5 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.738 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 46.8 t-105 -131.56 77.77 1.79 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.129 0.49 . . . . 0.0 109.777 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -89.27 22.75 2.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.667 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . 0.565 ' HA ' HG23 ' A' ' 280' ' ' THR . 12.7 mp0 -60.91 -23.71 65.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.753 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -64.84 -29.37 70.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.368 0.604 . . . . 0.0 109.729 175.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -107.8 13.34 26.49 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.118 -176.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.565 HG23 ' HA ' ' A' ' 277' ' ' GLN . 35.3 p -80.45 12.85 2.75 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.683 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -76.58 -29.09 56.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.236 0.541 . . . . 0.0 109.555 176.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -79.48 -26.55 41.63 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.394 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -85.82 -173.9 4.85 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.75 172.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.402 ' N ' HD22 ' A' ' 284' ' ' LEU . 2.9 mm? -98.13 34.79 1.87 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.131 0.491 . . . . 0.0 110.112 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 57.26 96.65 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.236 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -128.88 159.09 36.9 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.897 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -123.11 -3.21 8.97 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.338 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -102.57 56.64 0.78 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.931 0.396 . . . . 0.0 110.878 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.475 ' HB ' ' HD3' ' A' ' 290' ' ' PRO . 70.0 m -68.73 -46.4 33.79 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.073 178.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 272' ' ' ASN . 23.4 Cg_exo -66.12 79.46 0.3 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 122.171 1.914 . . . . 0.0 112.437 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 9.7 tp -124.17 149.99 28.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.157 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . 0.442 ' HB3' ' HB ' ' A' ' 271' ' ' THR . 16.0 p -113.38 138.83 49.5 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 176.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -152.26 159.7 43.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.936 0.398 . . . . 0.0 111.085 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 96.4 m -90.88 129.36 36.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.054 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . 0.506 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -119.97 -178.66 3.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.164 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 96.9 m -142.63 128.41 19.35 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.476 0.655 . . . . 0.0 112.503 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 299' ' ' ALA . 39.2 t -94.41 147.54 5.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.019 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 15.1 t -110.15 17.27 21.15 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -173.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.521 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -165.95 176.95 7.41 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 4.5 m-20 -60.91 120.76 10.81 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.58 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.441 ' HA ' ' CG1' ' A' ' 311' ' ' VAL . . . -93.38 115.02 27.58 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.263 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -79.72 130.17 35.11 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -169.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.664 ' HB2' ' CE1' ' A' ' 261' ' ' PHE . 32.7 t -114.06 94.91 5.03 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 162.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -109.66 177.6 4.68 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.152 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 17.2 t -54.78 -33.17 61.08 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -77.05 6.11 44.54 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.625 -176.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 56.24 40.49 84.55 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.927 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -120.17 124.29 45.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.861 0.363 . . . . 0.0 110.544 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.611 HG13 ' HB2' ' A' ' 251' ' ' LEU . 2.6 p -125.05 94.48 2.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.643 0.735 . . . . 0.0 110.359 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.559 ' OG1' HG23 ' A' ' 250' ' ' THR . 56.7 m -102.44 117.26 34.34 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.064 -176.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.441 ' CG1' ' HA ' ' A' ' 301' ' ' ALA . 5.4 m -148.55 160.09 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.306 0.574 . . . . 0.0 110.717 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 26.5 m -110.36 141.62 43.15 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.389 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.481 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.0 mp -109.59 122.39 47.33 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.551 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 23.6 p -144.13 152.46 40.96 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.945 -170.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 82.25 32.52 28.37 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.792 174.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 2.9 m -127.17 84.06 64.42 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 121.189 0.518 . . . . 0.0 111.635 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.73 78.12 3.82 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.217 2.611 . . . . 0.0 110.506 174.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 6.4 tt -82.09 99.15 4.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.28 -172.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -123.14 70.43 1.03 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.026 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.449 ' OD1' ' HB2' ' A' ' 326' ' ' TYR . 14.0 t70 -65.61 -62.01 1.76 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.593 -177.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.46 HG21 HE21 ' A' ' 325' ' ' GLN . 1.1 p -139.03 138.91 37.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.1 0.476 . . . . 0.0 110.596 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.2 -18.44 42.64 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.733 0.778 . . . . 0.0 109.57 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -80.45 159.42 69.78 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.711 172.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.44 34.62 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.351 2.034 . . . . 0.0 113.793 -174.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . 0.46 HE21 HG21 ' A' ' 321' ' ' THR . 25.1 mt-30 -81.12 -63.42 1.41 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 174.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . 0.449 ' HB2' ' OD1' ' A' ' 320' ' ' ASP . 86.8 m-85 -137.75 72.98 1.42 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.534 0.683 . . . . 0.0 109.436 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -106.62 71.23 0.85 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.244 -175.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 16.0 m -73.18 6.43 2.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.174 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 59.4 t -75.66 -37.9 37.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.745 175.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 51.3 m -79.39 52.19 1.33 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.702 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -97.38 142.39 29.29 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.638 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -125.48 108.42 11.61 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.61 HG11 ' O ' ' A' ' 234' ' ' PRO . 21.8 m -73.33 137.52 23.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.871 -167.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -140.12 153.89 46.83 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.649 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -91.87 141.67 28.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.653 -0.248 . . . . 0.0 111.065 -175.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 115.87 9.3 12.48 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.672 175.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.608 ' HB3' ' O ' ' A' ' 271' ' ' THR . 49.6 m-20 -87.45 -169.14 2.48 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.349 0.574 . . . . 0.0 112.215 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 270' ' ' PHE . . . -110.94 148.06 33.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.605 -174.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 54.3 t -124.12 151.74 29.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.816 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 24.0 m -150.36 163.25 38.82 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 343' ' ' GLY . 48.8 t -117.34 138.41 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.611 0.243 . . . . 0.0 110.694 -176.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 71.3 t -69.82 -35.96 67.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.117 0.484 . . . . 0.0 109.953 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . 0.51 ' H ' HG12 ' A' ' 341' ' ' VAL . . . 90.15 -60.64 3.38 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.407 174.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 4.8 p -155.71 123.57 5.69 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.518 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.364 179.869 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.59 0 N-CA-C 111.974 -0.45 . . . . 0.0 111.974 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 68.13 97.71 0.06 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.381 0.61 . . . . 0.0 111.033 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -65.93 -47.93 73.08 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.948 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 85.76 -2.77 87.77 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.996 -176.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.638 ' O ' ' HA ' ' A' ' 340' ' ' SER . . . -55.74 125.65 37.49 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.343 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 17.8 m -92.87 132.11 37.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.907 0.384 . . . . 0.0 111.536 -175.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.445 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.3 mp -138.46 -177.21 4.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 96.8 m -138.45 156.02 47.93 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.321 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.516 HG23 HG23 ' A' ' 339' ' ' VAL . 69.9 t -103.1 126.38 57.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -109.7 -11.69 14.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.048 0.452 . . . . 0.0 110.951 -173.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.509 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 36.5 p -131.22 -167.04 1.79 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.375 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.583 HE21 ' HB2' ' A' ' 335' ' ' ALA . 1.3 mp0 -111.85 115.27 51.12 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -173.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 248' ' ' THR . 65.0 Cg_endo -78.54 105.01 1.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.216 1.944 . . . . 0.0 111.975 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.448 ' OG1' ' HB2' ' A' ' 331' ' ' ARG . 15.3 t -107.42 136.13 47.73 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.34 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.507 ' HA ' ' HB3' ' A' ' 247' ' ' PHE . 39.2 t -82.58 121.74 36.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.391 0.615 . . . . 0.0 111.788 -175.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 52.7 m -87.38 105.24 17.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.558 175.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -86.46 125.65 33.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.055 0.455 . . . . 0.0 110.801 -178.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.419 HD22 ' HA ' ' A' ' 239' ' ' ASN . 0.2 OUTLIER -138.75 77.68 1.64 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.476 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -83.04 -36.18 25.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.03 -163.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 39.5 t -68.15 -23.4 28.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.407 ' HG3' ' OD1' ' A' ' 239' ' ' ASN . 11.3 mmpt? -97.56 -2.8 40.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.432 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 56.18 46.14 21.97 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.119 -1.401 . . . . 0.0 112.143 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 35.3 t -132.55 125.45 30.56 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.416 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -128.88 102.17 6.41 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . 0.405 ' HG2' ' HA ' ' A' ' 314' ' ' SER . 77.5 mt-30 -130.8 159.1 38.31 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -178.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.507 ' HB3' ' HA ' ' A' ' 236' ' ' VAL . 8.1 p90 -137.58 137.54 38.64 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.873 178.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 85.2 m -105.18 143.55 33.19 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 -171.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.526 HG13 ' CD1' ' A' ' 251' ' ' LEU . 4.2 p -148.5 142.79 18.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.581 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.509 ' HB ' ' CG2' ' A' ' 232' ' ' THR . 57.4 m -99.11 126.88 44.96 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 167.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.526 ' CD1' HG13 ' A' ' 249' ' ' VAL . 4.8 mp -111.59 172.56 6.82 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.968 -173.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.52 145.74 47.65 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 169.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -145.39 -142.83 3.87 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.862 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.545 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -113.47 -174.41 2.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.853 0.358 . . . . 0.0 111.725 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.609 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.7 OUTLIER -70.43 -179.82 2.21 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.561 -170.603 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.609 ' H ' HG22 ' A' ' 255' ' ' THR . . . -63.93 -174.93 0.12 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.678 0.791 . . . . 0.0 112.256 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . 0.476 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 34.5 t 81.94 7.4 1.01 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.819 0.847 . . . . 0.0 111.172 -177.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.578 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 42.4 t -128.45 89.04 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.619 0 CA-C-O 121.615 0.721 . . . . 0.0 109.377 170.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 26.4 m -81.86 88.42 6.34 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.105 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 96.31 81.69 1.59 Allowed Glycine 0 N--CA 1.439 -1.115 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.347 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -47.05 -59.7 2.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.382 0.61 . . . . 0.0 110.194 168.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 300' ' ' ASP . 88.1 mt -137.65 169.63 17.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.907 -174.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -135.78 -167.64 2.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.641 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.61 114.29 3.86 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.792 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 116.06 -5.64 19.96 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.989 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -87.06 127.47 35.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.951 0.405 . . . . 0.0 110.696 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 296' ' ' THR . 2.0 mp0 -86.84 149.36 24.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.103 0.478 . . . . 0.0 110.748 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 294' ' ' THR . 1.1 m -120.9 172.54 7.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.261 174.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.569 ' HD3' ' C ' ' A' ' 269' ' ' LYS . 0.7 OUTLIER -131.62 124.84 30.77 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.307 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -146.78 160.41 42.29 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.052 176.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 292' ' ' SER . 14.9 t -122.4 134.01 54.62 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.708 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.728 ' HA ' ' OD1' ' A' ' 337' ' ' ASP . 4.5 t-20 -76.67 83.33 3.31 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.805 -174.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 337' ' ' ASP . 12.9 p -86.91 77.95 9.13 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.569 0.7 . . . . 0.0 110.042 175.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -166.03 133.26 2.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.301 177.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 23.6 m-90 -91.9 89.9 7.22 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 6.4 mp -68.28 167.98 13.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.405 0.621 . . . . 0.0 111.29 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -73.33 -4.13 31.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.608 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -64.15 -46.84 82.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.003 177.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -66.39 -26.33 67.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.633 -177.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 17.1 p -100.37 -56.85 2.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -173.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -86.27 -31.58 21.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.743 -172.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -101.62 -9.03 21.3 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.909 -0.317 . . . . 0.0 111.472 -173.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -153.06 172.69 16.48 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.974 0.416 . . . . 0.0 111.208 -177.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 93.1 mt -116.21 32.09 6.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.34 175.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -121.93 98.4 5.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.928 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -132.63 172.39 12.59 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.31 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 144.21 -79.34 0.25 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -128.44 -168.89 1.98 Allowed 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.9 t -159.28 77.66 2.99 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-O 121.941 0.877 . . . . 0.0 110.841 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -93.44 38.68 0.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.45 2.766 . . . . 0.0 112.326 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 24.1 mt -77.29 92.65 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.19 -178.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 271' ' ' THR . 4.4 m -107.84 127.55 53.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.165 -177.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -151.97 167.09 29.5 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.23 0.538 . . . . 0.0 111.697 -177.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 94.6 m -97.93 129.75 44.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.992 -176.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -121.95 -171.68 2.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.298 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 267' ' ' GLN . 23.4 m -141.17 129.11 21.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.555 HG12 ' H ' ' A' ' 299' ' ' ALA . 50.4 t -86.47 138.59 18.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.678 176.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 312' ' ' THR . 6.0 t -112.59 14.91 20.2 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.895 0.379 . . . . 0.0 111.988 -174.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.555 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -165.95 -178.56 4.77 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.849 0.357 . . . . 0.0 111.743 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 4.3 m-20 -68.13 145.87 53.97 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.514 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.439 ' HB2' HG11 ' A' ' 311' ' ' VAL . . . -121.44 127.62 51.31 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.818 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.607 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 63.7 t30 -90.06 123.17 33.7 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -171.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.578 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 8.9 t -100.73 95.09 6.42 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 163.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . 0.487 ' HB3' ' ND2' ' A' ' 302' ' ' ASN . 0.3 OUTLIER -96.64 175.03 6.53 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.888 -174.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 8.3 t -59.84 -33.34 71.64 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.698 0.285 . . . . 0.0 111.57 -176.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -80.68 -3.94 90.26 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.15 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 71.54 41.56 57.4 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.238 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -121.99 133.63 54.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.365 0.582 . . . . 0.0 111.247 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.2 OUTLIER -128.24 155.5 39.92 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.046 179.039 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.449 ' OG1' HG23 ' A' ' 250' ' ' THR . 55.1 m -147.98 125.74 11.89 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.584 -0.698 . . . . 0.0 110.932 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.439 HG11 ' HB2' ' A' ' 301' ' ' ALA . 18.7 m -148.1 159.31 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.592 0.711 . . . . 0.0 111.25 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.486 ' O ' HG22 ' A' ' 298' ' ' THR . 16.4 m -108.94 140.21 42.74 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.488 174.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 5.3 mp -105.27 122.45 45.97 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.719 -174.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . 0.405 ' HA ' ' HG2' ' A' ' 246' ' ' GLN . 16.6 p -96.79 125.77 41.47 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.94 -176.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 95.67 115.4 2.97 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.648 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 15.6 m -73.39 120.7 82.45 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-O 121.013 0.435 . . . . 0.0 110.541 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.8 47.66 2.39 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.977 2.451 . . . . 0.0 112.509 -177.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 7.5 pt -136.56 131.15 47.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.12 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.408 ' O ' ' HB3' ' A' ' 323' ' ' ASN . 97.1 m-85 -119.23 112.58 19.66 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.862 0.363 . . . . 0.0 111.022 -174.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.58 -10.34 17.92 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.171 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 9.3 p -66.49 -60.92 2.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.583 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 22.3 m -94.91 -25.02 16.73 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.313 0.578 . . . . 0.0 110.727 -177.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.408 ' HB3' ' O ' ' A' ' 319' ' ' TYR . 26.8 t30 -99.77 117.79 62.97 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.814 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.5 -13.3 22.66 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 121.134 1.223 . . . . 0.0 111.772 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 69.16 -60.36 0.46 Allowed 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.841 0.856 . . . . 0.0 112.072 176.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 57.04 34.58 25.15 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.747 0.784 . . . . 0.0 109.644 -173.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -171.41 120.03 0.48 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.886 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 35.1 m -66.87 116.26 7.54 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 20.9 t -48.64 116.47 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.134 -177.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 34.0 m -128.78 157.37 41.64 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.4 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . 0.448 ' HB2' ' OG1' ' A' ' 235' ' ' THR . 10.1 ptp180 -69.22 111.83 5.41 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.826 0.346 . . . . 0.0 110.687 -178.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -112.51 153.55 27.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.736 0.303 . . . . 0.0 110.362 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.513 ' HB ' ' HG2' ' A' ' 233' ' ' GLN . 15.5 m -118.63 118.54 58.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.362 176.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . 0.512 ' HG3' HD21 ' A' ' 272' ' ' ASN . 0.5 OUTLIER -140.8 112.88 7.79 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.178 0.513 . . . . 0.0 111.257 179.748 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.583 ' HB2' HE21 ' A' ' 233' ' ' GLN . . . -100.66 138.85 37.16 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.93 -0.481 . . . . 0.0 112.029 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.42 -10.25 6.49 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.667 171.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.728 ' OD1' ' HA ' ' A' ' 272' ' ' ASN . 2.9 m-20 -54.33 150.75 8.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.388 0.613 . . . . 0.0 112.642 -178.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -102.41 134.93 44.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.012 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.516 HG23 HG23 ' A' ' 230' ' ' VAL . 57.8 t -114.82 147.23 18.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.32 0.581 . . . . 0.0 112.248 -169.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 226' ' ' GLY . 9.0 t -144.44 172.36 13.06 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.882 172.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.41 HG11 HD21 ' A' ' 262' ' ' LEU . 95.3 t -119.76 127.13 75.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.644 0.259 . . . . 0.0 111.655 -173.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 85.6 t -91.24 -45.02 14.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.99 0.424 . . . . 0.0 110.367 175.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 93.6 -135.97 12.85 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.771 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 3.7 p -125.68 -69.72 0.77 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.654 0.264 . . . . 0.0 110.82 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.903 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.832 -179.228 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.602 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -109.59 24.74 12.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.999 0.428 . . . . 0.0 111.236 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -73.49 155.28 39.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.593 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 117.96 20.92 4.34 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.612 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -61.67 115.43 7.92 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.054 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 26.4 m -119.38 134.24 55.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.014 0.435 . . . . 0.0 109.964 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.504 HD23 ' CA ' ' A' ' 253' ' ' GLY . 9.7 mt -140.32 171.66 13.83 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.292 -174.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 62.6 m -136.68 165.94 24.73 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.583 HG21 ' HB2' ' A' ' 337' ' ' ASP . 70.9 t -117.22 132.24 67.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 O-C-N 122.078 -0.389 . . . . 0.0 110.287 176.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.41 ' HE3' HG21 ' A' ' 252' ' ' THR . 34.8 ttmt -120.62 11.88 11.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.51 0.671 . . . . 0.0 110.32 -177.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.442 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 7.5 p -139.33 -170.49 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.323 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.547 HE21 ' HA ' ' A' ' 334' ' ' GLU . 34.7 mt-30 -114.79 111.22 45.86 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -177.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.94 105.71 1.87 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.382 2.055 . . . . 0.0 113.048 -176.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 4.6 t -155.81 130.82 9.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.122 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.644 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -154.71 171.84 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 171.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.469 ' N ' ' CG1' ' A' ' 236' ' ' VAL . 38.5 m -12.36 113.37 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.75 1.62 . . . . 0.0 114.798 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.526 ' CE1' ' HG2' ' A' ' 317' ' ' PRO . 95.7 m-85 -115.45 84.04 2.03 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.332 173.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -122.97 133.21 54.38 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.15 -33.47 7.84 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -170.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.94 -28.82 45.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.581 0.705 . . . . 0.0 109.512 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.478 ' HA ' ' HE2' ' A' ' 242' ' ' LYS . 8.2 mmpt? -98.44 -9.14 25.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.06 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 61.48 40.51 13.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.234 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.9 m -113.03 95.73 5.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.026 -175.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . 0.47 ' CD2' ' HD1' ' A' ' 238' ' ' TYR . 4.8 m-85 -126.93 109.66 12.18 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 176.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . 0.553 ' HB2' HG12 ' A' ' 236' ' ' VAL . 70.6 mt-30 -136.94 173.16 12.0 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.644 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 4.7 p90 -154.14 134.8 13.59 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.369 -0.533 . . . . 0.0 112.374 176.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 59.3 m -99.34 139.17 35.38 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.512 HG13 ' HG ' ' A' ' 251' ' ' LEU . 5.5 p -142.75 142.3 26.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.501 -176.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.442 ' HB ' ' CG2' ' A' ' 232' ' ' THR . 38.9 m -99.36 103.97 15.82 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 166.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.613 HD11 HG22 ' A' ' 311' ' ' VAL . 0.4 OUTLIER -87.18 171.01 10.99 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.41 HG21 ' HE3' ' A' ' 231' ' ' LYS . 0.2 OUTLIER -128.53 141.46 51.37 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.025 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.504 ' CA ' HD23 ' A' ' 228' ' ' LEU . . . -146.76 -142.45 3.72 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.433 -174.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -106.28 -173.64 2.34 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.565 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -67.37 -179.31 1.0 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.408 -168.48 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.565 ' H ' HG22 ' A' ' 255' ' ' THR . . . -65.99 -175.33 0.3 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.352 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 49.2 m 80.2 17.31 0.68 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.908 0.883 . . . . 0.0 111.362 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 49.5 t -133.43 90.9 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 170.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 31.2 m -68.1 100.72 1.04 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.493 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 70.73 92.32 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.934 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -41.96 -59.69 1.64 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 169.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.472 ' H ' ' HB3' ' A' ' 301' ' ' ALA . 91.7 mt -146.68 163.21 36.64 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.673 0.273 . . . . 0.0 111.106 -174.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 49.4 mtmt -134.89 -167.88 2.07 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.632 177.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -63.58 120.78 12.4 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.353 0.597 . . . . 0.0 111.234 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 106.62 -3.95 36.82 Favored Glycine 0 C--N 1.316 -0.553 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.162 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . 0.422 ' HB3' HD22 ' A' ' 262' ' ' LEU . 66.3 m-20 -92.59 134.94 34.51 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -103.12 152.31 21.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.566 0.698 . . . . 0.0 111.869 -174.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.77 153.67 39.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.745 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 340' ' ' SER . 0.8 OUTLIER -86.2 94.9 9.42 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 166.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 293' ' ' PHE . 76.7 t80 -115.15 106.94 14.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.582 -165.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 292' ' ' SER . 89.4 m -88.29 94.96 10.0 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.922 -178.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.705 ' HA ' ' OD1' ' A' ' 337' ' ' ASP . 3.0 t-20 -90.22 84.95 6.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.448 0.642 . . . . 0.0 109.521 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 18.7 p -123.85 157.63 33.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.143 -178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.527 ' CE2' HG23 ' A' ' 321' ' ' THR . 53.0 m-85 -82.98 113.84 20.84 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -126.64 57.34 1.44 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.572 0.701 . . . . 0.0 111.075 -170.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.454 ' HB2' HG23 ' A' ' 280' ' ' THR . 97.7 mt -59.98 125.65 24.5 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 166.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -61.42 -24.61 66.64 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -161.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -115.11 -62.7 1.56 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.928 -174.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -62.13 -17.52 58.09 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -167.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.454 HG23 ' HB2' ' A' ' 276' ' ' LEU . 29.3 p -83.04 -78.1 0.22 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 118.484 0.584 . . . . 0.0 111.965 -176.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -79.19 -32.31 44.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.539 0.685 . . . . 0.0 110.764 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 67.77 16.49 9.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.241 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -127.86 107.46 9.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.767 176.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 68.3 mt -81.24 21.79 0.72 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.264 -174.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -110.8 -7.92 14.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.008 -177.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -132.48 78.67 1.81 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.816 0.341 . . . . 0.0 111.126 -175.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -81.7 54.57 4.82 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.301 178.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -146.49 128.63 15.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.78 0.324 . . . . 0.0 110.298 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.462 ' O ' HG21 ' A' ' 271' ' ' THR . 16.8 p -112.18 92.49 18.82 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.6 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -90.06 107.04 0.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.661 2.241 . . . . 0.0 112.953 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.481 HG23 ' H ' ' A' ' 292' ' ' SER . 4.7 tp -167.13 -58.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.194 176.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 271' ' ' THR . 15.0 m -127.91 138.57 52.7 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . 0.558 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 0.8 OUTLIER -162.54 86.03 0.57 Allowed 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 21.3 m -160.79 124.28 3.4 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.027 -0.42 . . . . 0.0 111.003 175.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -152.85 179.88 8.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.323 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 90.8 m -140.31 132.39 27.92 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.595 0.712 . . . . 0.0 112.304 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 299' ' ' ALA . 59.2 t -79.54 136.52 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 114.35 -1.296 . . . . 0.0 110.339 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 4.4 m -124.86 25.01 7.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.13 0.49 . . . . 0.0 111.086 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -166.62 178.26 6.11 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.401 ' O ' HG12 ' A' ' 311' ' ' VAL . 40.8 m-20 -66.96 165.88 14.69 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.563 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.521 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -144.87 171.27 14.67 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.82 -177.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.689 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 16.6 m120 -142.29 126.27 17.26 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 119.687 -0.197 . . . . 0.0 110.964 -173.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.7 OUTLIER -107.88 96.88 6.69 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 168.253 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.16 178.71 4.53 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.023 -176.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 10.8 t -61.76 -33.17 73.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.991 0.424 . . . . 0.0 111.044 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -81.7 1.76 85.09 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.897 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 61.51 42.01 99.68 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 121.016 -0.612 . . . . 0.0 113.704 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.83 132.67 55.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 118.06 0.93 . . . . 0.0 110.454 175.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.689 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.1 OUTLIER -138.23 109.44 5.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.807 -177.308 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 250' ' ' THR . 54.0 m -101.5 135.22 43.38 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.962 -0.461 . . . . 0.0 111.712 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.613 HG22 HD11 ' A' ' 251' ' ' LEU . 26.8 m -145.71 165.36 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 173.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 46.4 m -117.02 138.9 51.27 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 171.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 4.9 mp -112.25 141.59 45.77 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.736 -173.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 22.9 t -111.01 131.01 55.41 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.327 0.584 . . . . 0.0 109.851 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 132.93 155.97 7.99 Favored Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -174.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.409 ' HA ' ' HB3' ' A' ' 245' ' ' TYR . 16.1 m -66.98 116.97 41.16 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 120.932 0.396 . . . . 0.0 111.909 -173.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.595 ' HG3' ' CD2' ' A' ' 247' ' ' PHE . 62.2 Cg_exo -57.13 138.91 88.39 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.524 2.149 . . . . 0.0 110.663 171.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.674 ' H ' HD13 ' A' ' 318' ' ' ILE . 0.1 OUTLIER -102.01 111.24 31.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-O 121.374 0.607 . . . . 0.0 110.714 -168.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -77.62 115.01 17.03 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.83 -175.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.03 -13.58 62.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.088 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.527 HG23 ' CE2' ' A' ' 274' ' ' TYR . 1.2 p -75.72 52.58 0.68 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.938 176.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 323' ' ' ASN . 0.6 OUTLIER -112.2 87.88 2.68 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.629 0.728 . . . . 0.0 110.378 178.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.607 ' HB3' ' HD3' ' A' ' 324' ' ' PRO . 13.5 t-20 165.88 -53.72 0.0 OUTLIER Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 113.646 -1.616 . . . . 0.0 109.206 -175.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.607 ' HD3' ' HB3' ' A' ' 323' ' ' ASN . 23.5 Cg_endo -101.48 112.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 123.463 2.776 . . . . 0.0 111.356 176.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -71.96 -32.13 66.99 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.831 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 70.8 -65.19 0.35 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 124.201 0.938 . . . . 0.0 109.938 -177.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 177.58 -61.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 32.1 t -145.13 -129.67 0.08 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.39 -1.277 . . . . 0.0 107.963 175.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 24.2 t -83.88 119.66 33.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 31.5 m -123.79 -68.32 0.88 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.829 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -91.38 137.54 32.28 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 120.699 0.285 . . . . 0.0 110.748 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -118.24 169.91 9.32 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 26.7 m -76.14 131.86 34.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.341 0.591 . . . . 0.0 111.665 -176.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . 0.547 ' HA ' HE21 ' A' ' 233' ' ' GLN . 0.8 OUTLIER -112.66 -166.82 1.11 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.477 176.363 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -81.56 155.11 25.88 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.041 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 129.59 -8.35 6.18 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.054 -1.07 . . . . 0.0 113.444 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.705 ' OD1' ' HA ' ' A' ' 272' ' ' ASN . 4.1 m-20 -52.12 140.62 20.41 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.978 0.389 . . . . 0.0 110.784 174.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -100.56 132.65 45.84 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.503 ' CG1' ' HB2' ' A' ' 228' ' ' LEU . 93.2 t -120.69 140.18 45.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.479 0.657 . . . . 0.0 112.029 -171.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 269' ' ' LYS . 22.7 m -141.09 167.6 21.79 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 343' ' ' GLY . 47.8 t -116.24 140.62 37.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.693 0.282 . . . . 0.0 111.122 -175.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 76.8 t -81.24 -37.43 15.72 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.265 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . 0.429 ' N ' HG12 ' A' ' 341' ' ' VAL . . . -61.17 129.77 46.33 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.781 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 7.3 p -79.1 -61.15 2.1 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.4 0.619 . . . . 0.0 110.997 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.941 177.639 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 N-CA-C 112.176 -0.369 . . . . 0.0 112.176 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 68.8 -74.7 0.07 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.535 0.734 . . . . 0.0 111.982 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -80.17 132.45 35.9 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.729 0.299 . . . . 0.0 110.361 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.42 ' HA3' ' HB ' ' A' ' 341' ' ' VAL . . . 99.53 35.71 4.57 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -174.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -67.46 -176.7 9.36 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.258 -0.471 . . . . 0.0 113.438 -177.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 6.8 m -65.48 132.31 48.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.763 0.316 . . . . 0.0 111.246 -177.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.489 HD22 ' HA2' ' A' ' 253' ' ' GLY . 29.2 mt -137.16 -175.95 4.22 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -177.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 84.9 m -104.26 148.87 25.85 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -171.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 60.3 t -99.41 133.23 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.482 175.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.611 ' HE3' HG21 ' A' ' 252' ' ' THR . 22.9 mmtp -102.92 -41.29 6.19 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 121.138 -0.225 . . . . 0.0 110.906 175.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.454 ' O ' HG13 ' A' ' 249' ' ' VAL . 40.2 p -136.55 175.76 9.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.925 0.393 . . . . 0.0 110.781 177.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.534 ' H ' ' HB ' ' A' ' 333' ' ' VAL . 0.4 OUTLIER -115.68 156.19 46.55 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.986 -170.72 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.499 ' HD2' ' HG3' ' A' ' 233' ' ' GLN . 3.9 Cg_endo -45.48 107.43 0.11 Allowed 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 124.127 3.218 . . . . 0.0 113.473 175.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 65.2 m -152.77 94.77 1.92 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.069 0.461 . . . . 0.0 111.34 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.749 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -157.85 173.97 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 123.874 0.87 . . . . 0.0 109.1 168.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.534 ' H ' HG13 ' A' ' 236' ' ' VAL . 27.2 m -29.8 109.16 0.05 OUTLIER 'General case' 0 C--O 1.236 0.373 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -172.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -112.95 87.74 2.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.945 171.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -128.43 133.8 48.63 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -177.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -105.22 -42.85 5.16 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -169.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.93 -27.51 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.318 0.58 . . . . 0.0 109.963 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' A' ' 242' ' ' LYS . 27.9 mmmt -90.72 -12.63 36.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.805 178.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 60.84 66.67 0.89 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.131 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 55.6 m -150.76 99.03 2.68 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.571 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -120.13 102.21 8.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.949 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -135.42 160.25 39.03 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.749 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 27.2 p90 -148.17 139.84 23.76 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.07 174.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 53.5 m -99.81 136.7 39.33 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 232' ' ' THR . 99.2 t -137.92 141.39 38.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.841 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.544 HG23 ' OG1' ' A' ' 310' ' ' THR . 84.8 m -95.87 119.26 34.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 170.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.515 ' HB2' HG13 ' A' ' 309' ' ' VAL . 3.6 mp -115.33 163.02 16.3 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -176.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.611 HG21 ' HE3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -126.77 111.12 13.85 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 121.014 -0.275 . . . . 0.0 110.566 175.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.489 ' HA2' HD22 ' A' ' 228' ' ' LEU . . . -95.17 -147.27 22.36 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.034 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -109.46 -173.72 2.33 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 256' ' ' ALA . 3.1 m -58.84 167.31 1.61 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.801 -1.091 . . . . 0.0 113.476 -169.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.489 ' H ' HG22 ' A' ' 255' ' ' THR . . . -62.43 -176.56 0.11 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.819 -176.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 42.6 m 79.47 12.2 1.23 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.68 -176.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 23.8 t -125.44 94.78 2.87 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.2 m -77.3 94.2 4.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.099 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 74.02 93.15 0.13 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.491 178.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.66 ' CE1' ' HB3' ' A' ' 303' ' ' SER . 4.1 m-85 -44.4 -42.11 6.69 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 169.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 266' ' ' ASP . 1.0 OUTLIER -166.51 173.63 9.65 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.287 -173.005 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 63.8 mttm -142.65 -165.91 2.15 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.04 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -57.84 114.41 2.3 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.54 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 114.5 -16.21 19.49 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.932 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 262' ' ' LEU . 14.3 m-20 -78.83 126.42 30.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -93.29 150.01 20.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.711 0.767 . . . . 0.0 111.954 -176.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 341' ' ' VAL . 2.9 m -127.02 170.6 16.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.453 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.04 144.62 43.3 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 167.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.651 ' O ' ' HA ' ' A' ' 292' ' ' SER . 56.8 m-85 -110.99 129.34 55.92 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.332 -175.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 338' ' ' ALA . 81.3 p -95.16 88.16 5.1 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 166.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.696 ' O ' ' HA ' ' A' ' 291' ' ' ILE . 3.2 p-10 -122.96 164.22 18.92 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.355 -170.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 1.9 p -117.91 99.21 6.77 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.046 173.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.591 ' O ' HG23 ' A' ' 289' ' ' THR . 26.3 t80 -82.91 114.25 21.07 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -148.84 68.14 1.06 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.878 0.846 . . . . 0.0 109.394 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.403 ' HA ' ' HG2' ' A' ' 331' ' ' ARG . 8.6 mp -98.85 166.07 11.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.209 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . 0.58 ' O ' ' HG3' ' A' ' 281' ' ' LYS . 73.9 mt-30 -63.96 -16.61 61.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.604 -173.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -55.46 -39.79 70.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.442 0.639 . . . . 0.0 109.896 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -72.47 -48.46 40.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.068 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 29.5 p -71.45 -24.42 62.01 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -171.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.58 ' HG3' ' O ' ' A' ' 277' ' ' GLN . 96.9 mttt -60.98 -54.97 38.43 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.913 0.387 . . . . 0.0 110.798 177.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -84.04 -26.17 29.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.903 -177.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 62.15 22.28 13.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.094 175.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 80.2 mt -88.59 -34.25 17.39 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.977 0.418 . . . . 0.0 110.924 -177.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -124.91 90.28 3.22 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.321 0.581 . . . . 0.0 111.038 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -129.45 -3.72 4.85 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.691 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -85.65 -22.18 51.18 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.592 -176.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -128.2 120.71 27.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.977 0.418 . . . . 0.0 110.357 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.591 HG23 ' O ' ' A' ' 274' ' ' TYR . 17.5 m -99.83 117.72 63.03 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.068 178.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -52.43 115.79 2.43 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.824 2.349 . . . . 0.0 111.647 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.696 ' HA ' ' O ' ' A' ' 272' ' ' ASN . 33.9 pt -110.11 -17.27 8.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -172.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 71.2 m -153.5 139.17 17.88 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.886 -0.726 . . . . 0.0 112.774 -176.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -155.15 145.67 22.14 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 173.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 99.0 m -91.63 123.26 34.9 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.237 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -120.61 -176.18 3.18 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 121.173 -0.211 . . . . 0.0 110.625 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 94.1 m -141.32 130.06 22.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.327 0.584 . . . . 0.0 112.287 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.499 HG12 ' H ' ' A' ' 299' ' ' ALA . 59.6 t -83.63 145.79 7.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.752 177.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 2.3 m -123.46 24.02 8.76 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -173.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -167.71 -176.94 3.29 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 178.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.57 159.0 25.61 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.38 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.523 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -139.92 166.25 25.14 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.45 -177.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.541 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 18.2 m120 -136.51 122.22 19.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -174.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.66 ' HB3' ' CE1' ' A' ' 261' ' ' PHE . 0.0 OUTLIER -108.6 94.76 5.23 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 165.013 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.96 -170.56 1.86 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.022 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 10.1 t -60.03 -33.85 72.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.359 . . . . 0.0 111.418 -175.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -98.36 0.52 58.48 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 59.99 43.17 98.42 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 114.963 0.745 . . . . 0.0 114.963 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -88.34 110.19 20.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 119.557 1.679 . . . . 0.0 109.964 176.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.541 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 1.3 p -124.11 94.71 2.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.473 0.654 . . . . 0.0 111.394 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.544 ' OG1' HG23 ' A' ' 250' ' ' THR . 92.9 m -100.65 118.38 36.67 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.109 -0.369 . . . . 0.0 110.332 177.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.402 ' HB ' HG13 ' A' ' 297' ' ' VAL . 9.6 m -138.6 156.47 29.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.31 0.576 . . . . 0.0 110.795 178.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 44.9 m -108.32 133.69 52.18 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.137 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.428 ' HB2' ' CE2' ' A' ' 247' ' ' PHE . 5.2 mp -102.24 124.69 48.28 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.432 -174.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 14.6 m -125.72 144.92 50.41 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.803 0.335 . . . . 0.0 111.415 -173.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 77.24 60.65 2.81 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.365 176.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 18.6 m -113.34 136.41 21.87 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.625 0.25 . . . . 0.0 110.942 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -83.32 46.87 2.21 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.749 2.3 . . . . 0.0 112.083 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 83.3 mt -117.24 99.42 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.558 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -107.83 61.16 0.61 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.768 0.794 . . . . 0.0 110.02 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -91.7 -51.02 5.44 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.129 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 3.1 p -83.51 49.1 1.52 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.331 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . 0.597 ' O ' ' HD3' ' A' ' 324' ' ' PRO . 7.3 m -81.26 1.33 32.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.754 0.788 . . . . 0.0 110.003 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -101.51 94.03 3.86 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.419 178.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.597 ' HD3' ' O ' ' A' ' 322' ' ' THR . 5.8 Cg_exo -80.94 -168.49 0.64 Allowed 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.756 1.638 . . . . 0.0 111.541 173.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 69.02 -49.12 0.59 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.792 0.837 . . . . 0.0 112.028 -178.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -84.81 15.57 3.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.144 0.497 . . . . 0.0 111.051 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -109.09 23.7 14.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.05 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 7.1 t -78.59 56.52 1.83 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.152 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 41.0 t 65.81 119.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.613 0.72 . . . . 0.0 111.981 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 12.3 t -173.19 -72.37 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.075 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . 0.403 ' HG2' ' HA ' ' A' ' 276' ' ' LEU . 7.4 tpm_? -102.78 111.11 23.27 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 171.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -99.5 -168.89 1.67 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.534 ' HB ' ' H ' ' A' ' 233' ' ' GLN . 26.9 m -55.31 135.55 18.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.822 0.344 . . . . 0.0 111.059 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -115.56 111.72 21.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.547 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -79.71 164.0 24.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.799 0.333 . . . . 0.0 110.963 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.87 -16.09 5.86 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.89 176.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.53 ' CG ' ' HA ' ' A' ' 272' ' ' ASN . 70.6 m-20 -81.53 -177.7 6.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.837 0.351 . . . . 0.0 111.089 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . 0.475 ' HB3' ' OG1' ' A' ' 271' ' ' THR . . . -122.77 150.02 43.34 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.316 0.579 . . . . 0.0 111.736 -176.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 53.0 t -103.04 147.53 9.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.386 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 11.6 p -156.85 151.95 26.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.018 0.437 . . . . 0.0 111.21 173.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.559 HG12 ' H ' ' A' ' 343' ' ' GLY . 41.0 t -108.37 147.03 13.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.238 -176.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 54.5 t -77.95 -34.06 19.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-O 121.216 0.532 . . . . 0.0 110.044 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . 0.559 ' H ' HG12 ' A' ' 341' ' ' VAL . . . 114.1 -165.32 12.04 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.172 175.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.6 p -88.15 -51.66 5.66 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.337 0.589 . . . . 0.0 110.873 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.353 178.639 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.713 0 N-CA-C 111.819 -0.512 . . . . 0.0 111.819 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -130.38 137.42 49.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.84 0.352 . . . . 0.0 111.027 -176.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.27 -30.56 71.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.179 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 130.24 -45.79 1.12 Allowed Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -174.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.614 ' C ' ' HB3' ' A' ' 340' ' ' SER . . . -104.52 114.59 4.74 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 173.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.743 HG23 ' HB ' ' A' ' 339' ' ' VAL . 52.4 m -153.29 135.49 14.88 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.664 -0.315 . . . . 0.0 111.311 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.662 ' H ' ' HA ' ' A' ' 339' ' ' VAL . 3.2 mt -128.36 87.63 2.62 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.951 ' HA ' ' O ' ' A' ' 338' ' ' ALA . 1.2 m -83.64 133.85 34.81 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.345 -174.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.678 ' O ' ' HA2' ' A' ' 336' ' ' GLY . 39.3 t -82.68 158.52 3.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.916 -160.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.435 ' HG3' HG23 ' A' ' 232' ' ' THR . 16.8 ptmt -131.75 -12.26 3.38 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.161 175.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 335' ' ' ALA . 40.6 p -129.32 -166.97 1.72 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.475 0.31 . . . . 0.0 110.829 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 34.1 mt-30 -112.91 118.24 44.94 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -173.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.548 ' HA ' ' O ' ' A' ' 248' ' ' THR . 1.1 Cg_endo -75.44 107.58 2.51 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.88 2.387 . . . . 0.0 113.007 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 236' ' ' VAL . 19.4 m -155.39 131.07 9.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.408 177.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.653 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -154.93 175.91 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.245 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.575 ' H ' HG13 ' A' ' 236' ' ' VAL . 98.1 m -32.84 124.74 0.35 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.18 1.392 . . . . 0.0 114.578 -173.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -104.13 108.42 19.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.631 172.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.437 HD22 ' HA ' ' A' ' 239' ' ' ASN . 0.4 OUTLIER -114.01 91.45 3.64 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.215 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -88.16 -37.74 15.91 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.773 -161.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 40.0 t -64.69 -22.88 32.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -103.7 -0.67 29.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.14 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 24.6 t70 53.7 48.82 20.65 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.051 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 14.9 m -127.2 113.14 15.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.524 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -128.44 105.97 8.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -174.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . 0.535 ' HB2' HG12 ' A' ' 236' ' ' VAL . 2.0 mp0 -108.28 154.11 22.26 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.653 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 4.6 p90 -149.81 124.72 9.92 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.679 177.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 78.3 m -91.7 140.6 29.56 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.515 HG13 HD11 ' A' ' 251' ' ' LEU . 8.2 p -139.97 136.03 38.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 C-N-CA 119.848 -0.741 . . . . 0.0 112.354 -177.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.58 HG23 ' OG1' ' A' ' 310' ' ' THR . 94.0 m -96.99 115.85 28.16 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 168.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.515 HD11 HG13 ' A' ' 249' ' ' VAL . 1.0 OUTLIER -113.8 171.55 7.52 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.968 0.889 . . . . 0.0 110.463 -173.108 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.495 HG22 ' O ' ' A' ' 307' ' ' GLY . 0.0 OUTLIER -121.21 94.13 4.24 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.094 169.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.543 ' H ' HG12 ' A' ' 309' ' ' VAL . . . -120.52 135.12 10.7 Favored Glycine 0 CA--C 1.505 -0.58 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.705 -176.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -115.6 93.42 4.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -165.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.471 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 93.5 m -128.23 103.91 7.45 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.119 165.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.547 ' HA ' ' CB ' ' A' ' 305' ' ' SER . . . -50.57 130.69 24.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 35.9 m 57.76 58.56 3.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.64 -1.164 . . . . 0.0 113.108 168.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.43 ' HB ' ' OG ' ' A' ' 303' ' ' SER . 60.2 t -140.2 101.29 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-O 121.022 0.439 . . . . 0.0 110.249 174.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 33.6 m -71.44 86.99 0.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.407 0.623 . . . . 0.0 109.855 177.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 78.81 111.44 0.21 Allowed Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.569 -174.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.705 ' CE2' ' HB3' ' A' ' 303' ' ' SER . 57.3 m-85 -49.91 -61.27 2.23 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 121.85 0.833 . . . . 0.0 109.168 173.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 261' ' ' PHE . 73.6 mt -167.38 -179.93 4.7 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.336 -1.756 . . . . 0.0 106.603 -175.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -108.92 -169.8 1.55 Allowed 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -35.37 114.97 0.27 Allowed 'General case' 0 N--CA 1.464 0.238 0 O-C-N 124.181 0.925 . . . . 0.0 112.516 -177.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 131.92 -14.0 5.23 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.123 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . 0.501 ' OD1' ' HB2' ' A' ' 262' ' ' LEU . 80.8 m-20 -64.05 146.69 53.72 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 120.758 0.314 . . . . 0.0 110.207 175.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.14 174.49 6.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.447 -174.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.93 ' HA ' ' N ' ' A' ' 341' ' ' VAL . 34.8 m -151.89 142.63 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.805 -175.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.729 ' N ' HG23 ' A' ' 341' ' ' VAL . 0.0 OUTLIER -77.6 97.76 5.19 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 157.139 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.495 ' HA ' ' HB1' ' A' ' 338' ' ' ALA . 14.2 t80 -78.75 86.58 4.69 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.662 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 53.7 m -78.9 107.68 11.81 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.464 HD21 ' HB2' ' A' ' 334' ' ' GLU . 2.6 t-20 -124.31 95.38 4.52 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.237 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . 0.455 HG22 HG21 ' A' ' 289' ' ' THR . 1.3 p -70.67 93.26 0.92 Allowed 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 166.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.578 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 84.9 t80 -84.03 156.22 22.35 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.578 ' HB2' ' O ' ' A' ' 274' ' ' TYR . 85.2 m95 82.47 39.0 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 O-C-N 124.039 0.837 . . . . 0.0 111.051 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.617 ' HG ' ' CG ' ' A' ' 334' ' ' GLU . 12.2 mt -76.38 155.08 34.37 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.348 177.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -65.71 -77.99 0.06 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.817 0.341 . . . . 0.0 110.664 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -118.62 -82.65 0.64 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.935 0.398 . . . . 0.0 110.747 174.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -119.08 -73.12 0.66 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -176.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 3.2 p -105.1 -19.25 13.88 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -168.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -62.95 -31.5 72.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.783 0.325 . . . . 0.0 111.014 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.508 ' O ' ' HA ' ' A' ' 276' ' ' LEU . 78.7 mt-30 64.25 -68.49 0.1 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.523 1.129 . . . . 0.0 112.043 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -177.86 122.81 0.11 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.31 -173.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 89.1 mt -104.94 -30.41 9.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.04 0.448 . . . . 0.0 110.809 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -123.86 7.13 8.7 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.397 -178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -129.37 168.69 15.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.699 -177.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 160.31 102.88 0.18 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.006 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -154.99 83.58 1.08 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.922 0.392 . . . . 0.0 110.802 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.455 HG21 HG22 ' A' ' 273' ' ' THR . 8.9 t -135.26 142.21 40.76 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.16 45.1 0.91 Allowed 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.132 2.554 . . . . 0.0 113.496 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 62.8 mt 66.62 -77.08 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.55 0.74 . . . . 0.0 111.997 177.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 8.5 t -163.85 158.93 20.54 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -141.67 144.0 33.89 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 88.6 m -85.21 125.94 33.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.71 0.291 . . . . 0.0 111.503 -172.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -119.38 -179.5 3.88 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 84.9 m -136.14 138.15 41.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.428 0.632 . . . . 0.0 112.531 -174.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.598 HG12 ' H ' ' A' ' 299' ' ' ALA . 48.9 t -93.66 139.3 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.228 179.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 8.4 t -109.93 24.1 13.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.044 0.449 . . . . 0.0 111.5 -175.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.598 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -156.69 174.99 14.65 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.177 0.513 . . . . 0.0 112.087 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.97 113.13 2.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.709 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.46 ' HA ' ' CG1' ' A' ' 311' ' ' VAL . . . -93.18 106.86 18.77 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.059 -176.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.522 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 65.4 t30 -69.63 147.08 51.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.818 0.342 . . . . 0.0 111.532 -177.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.705 ' HB3' ' CE2' ' A' ' 261' ' ' PHE . 2.5 p -142.01 95.98 2.89 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.151 0.501 . . . . 0.0 110.517 171.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.58 151.87 21.83 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 172.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.547 ' CB ' ' HA ' ' A' ' 256' ' ' ALA . 0.3 OUTLIER -70.77 -12.31 61.47 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -171.639 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -71.16 -11.62 70.99 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 169.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . 0.495 ' O ' HG22 ' A' ' 252' ' ' THR . . . 75.77 41.36 28.86 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.784 -0.708 . . . . 0.0 113.869 174.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -125.55 111.18 14.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.034 0.917 . . . . 0.0 111.602 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.543 HG12 ' H ' ' A' ' 253' ' ' GLY . 0.6 OUTLIER -132.59 138.79 51.32 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.103 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.58 ' OG1' HG23 ' A' ' 250' ' ' THR . 94.7 m -123.17 126.34 46.82 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.129 -0.357 . . . . 0.0 110.305 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 301' ' ' ALA . 15.4 m -146.47 164.89 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.944 0.402 . . . . 0.0 110.156 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 56.8 m -114.3 139.43 49.44 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.128 0.489 . . . . 0.0 110.573 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.404 HD13 ' CE2' ' A' ' 247' ' ' PHE . 4.8 mp -105.28 150.34 25.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.853 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 34.1 t -135.87 129.4 32.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.16 0.505 . . . . 0.0 112.047 -174.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 125.04 -43.55 1.37 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.891 167.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 34.0 m -108.11 146.24 33.11 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-O 120.928 0.394 . . . . 0.0 111.963 -172.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -92.47 139.8 1.96 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.119 2.546 . . . . 0.0 113.363 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.635 ' H ' HD13 ' A' ' 318' ' ' ILE . 0.1 OUTLIER -94.22 125.21 46.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 172.212 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -82.81 72.93 9.88 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -167.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -81.28 -8.45 59.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.746 0.784 . . . . 0.0 109.028 170.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 2.4 p -87.93 24.61 1.74 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.375 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 15.1 m -84.89 -15.16 45.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.887 0.851 . . . . 0.0 108.885 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -81.22 147.12 59.91 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.418 174.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.429 ' O ' ' HB2' ' A' ' 325' ' ' GLN . 60.3 Cg_endo -70.63 -19.0 32.53 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.115 1.876 . . . . 0.0 113.242 -174.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . 0.52 ' O ' ' HB ' ' A' ' 329' ' ' VAL . 27.5 mt-30 73.5 -58.75 0.58 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.447 0.699 . . . . 0.0 111.864 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . 0.401 ' HB2' ' O ' ' A' ' 325' ' ' GLN . 47.2 m-85 72.29 -63.64 0.42 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.448 0.699 . . . . 0.0 110.135 -178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -175.94 -60.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.634 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 19.7 m -99.9 -15.93 18.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.849 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . 0.52 ' HB ' ' O ' ' A' ' 325' ' ' GLN . 49.1 t -81.19 134.29 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 62.0 m -148.82 144.89 27.26 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.728 0.299 . . . . 0.0 110.278 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . 0.477 ' HG2' ' OH ' ' A' ' 274' ' ' TYR . 17.9 tpt180 -102.39 149.85 23.94 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.072 178.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -111.49 152.12 27.82 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 173.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.471 HG12 ' HD2' ' A' ' 234' ' ' PRO . 23.5 t -68.07 150.44 10.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.203 -178.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . 0.617 ' CG ' ' HG ' ' A' ' 276' ' ' LEU . 0.7 OUTLIER -79.66 129.25 34.31 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -168.166 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 232' ' ' THR . . . -99.59 114.26 27.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.901 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . 0.678 ' HA2' ' O ' ' A' ' 230' ' ' VAL . . . 128.8 13.34 2.5 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 119.179 -1.486 . . . . 0.0 115.82 163.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.662 ' HB3' ' O ' ' A' ' 271' ' ' THR . 3.6 t0 -108.83 -67.34 0.98 Allowed 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -171.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . 0.951 ' O ' ' HA ' ' A' ' 229' ' ' THR . . . -51.11 178.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 116.917 2.191 . . . . 0.0 116.917 -156.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.743 ' HB ' HG23 ' A' ' 227' ' ' THR . 3.1 m -149.42 -164.77 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 CA-C-O 117.855 -1.069 . . . . 0.0 108.833 -168.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.614 ' HB3' ' C ' ' A' ' 226' ' ' GLY . 29.1 t -119.63 152.35 37.21 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 121.247 1.839 . . . . 0.0 114.404 -168.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.93 ' N ' ' HA ' ' A' ' 268' ' ' VAL . 53.3 t -124.83 58.03 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.827 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 164.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.445 HG23 ' OG ' ' A' ' 340' ' ' SER . 3.5 t -119.81 47.37 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 122.446 1.117 . . . . 0.0 108.094 175.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 113.96 129.89 4.97 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 113.758 -1.564 . . . . 0.0 110.417 -170.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 80.6 p 62.05 118.1 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.523 1.129 . . . . 0.0 112.151 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.128 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.642 -176.302 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.793 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.15 -31.71 58.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.58 0.229 . . . . 0.0 110.813 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -60.9 136.15 58.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.145 178.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 93.35 10.19 59.65 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -173.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -89.92 168.76 34.49 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.208 -178.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 27.5 m -141.43 135.12 30.01 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 8.9 mt -139.31 178.11 7.43 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.705 -176.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.8 m -124.27 154.91 39.53 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.826 0.346 . . . . 0.0 110.735 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 67.2 t -99.63 128.78 51.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.974 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 51.2 tttt -112.47 -28.09 8.0 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.929 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 27.1 p -139.38 -169.97 2.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.696 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 61.2 mt-30 -112.64 116.81 47.67 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -174.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.719 ' HA ' ' O ' ' A' ' 248' ' ' THR . 7.4 Cg_exo -72.58 104.81 1.78 Allowed 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.361 2.041 . . . . 0.0 112.722 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.9 t -154.26 131.92 11.44 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.028 0.442 . . . . 0.0 111.782 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.684 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.87 176.47 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 168.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.534 ' H ' HG13 ' A' ' 236' ' ' VAL . 91.6 m -37.17 111.0 0.14 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -176.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -97.45 84.04 3.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.221 173.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.508 ' OD1' ' HB2' ' A' ' 242' ' ' LYS . 0.8 OUTLIER -87.09 121.25 29.29 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -176.091 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -105.99 -56.92 2.11 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -164.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 32.8 t -64.66 -29.7 48.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.388 0.613 . . . . 0.0 109.57 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.508 ' HB2' ' OD1' ' A' ' 239' ' ' ASN . 27.6 mtpt -89.56 -16.92 29.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.754 178.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 68.54 70.67 0.3 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 114.495 -1.229 . . . . 0.0 112.617 174.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.4 t -154.03 96.5 1.97 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.384 0.612 . . . . 0.0 110.298 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 17.1 m-30 -103.85 108.22 19.44 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.32 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -112.84 149.34 33.23 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 173.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.684 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 1.3 p90 -160.17 139.82 11.17 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 121.339 -0.144 . . . . 0.0 110.819 177.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.719 ' O ' ' HA ' ' A' ' 234' ' ' PRO . 52.4 m -109.22 142.53 39.91 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.218 -0.193 . . . . 0.0 111.167 -174.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.97 131.35 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 121.466 0.651 . . . . 0.0 112.727 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 21.3 m -96.94 120.69 37.74 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 165.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.456 ' HB2' HG13 ' A' ' 309' ' ' VAL . 0.4 OUTLIER -116.47 171.54 7.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.242 0.544 . . . . 0.0 109.831 -175.725 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.01 147.68 46.39 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.364 172.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -148.45 -143.75 3.85 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.62 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.478 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -104.76 -174.47 2.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -176.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.617 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.5 OUTLIER -72.31 -177.91 2.32 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.49 -169.628 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.617 ' H ' HG22 ' A' ' 255' ' ' THR . . . -62.83 -176.89 0.13 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.451 0.701 . . . . 0.0 112.506 -178.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 68.3 m 80.32 16.31 0.71 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.838 0.855 . . . . 0.0 111.613 -177.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 61.8 t -135.34 94.76 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 171.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 4.3 m -72.05 92.27 1.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.622 -177.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 76.72 92.86 0.22 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.925 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' A' ' 303' ' ' SER . 3.2 m-85 -42.92 -53.5 4.67 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.775 0.321 . . . . 0.0 111.66 168.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 18.3 mt -141.29 147.01 37.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.308 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 57.8 mtmt -139.38 -169.39 2.66 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 123.249 0.343 . . . . 0.0 110.886 175.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -53.66 119.39 4.85 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.278 0.561 . . . . 0.0 111.411 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 107.25 -7.87 37.75 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.45 176.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -90.45 130.97 36.45 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -109.23 140.7 42.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.877 0.37 . . . . 0.0 110.686 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 295' ' ' ALA . 1.0 OUTLIER -122.24 171.41 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 121.305 0.574 . . . . 0.0 111.834 -178.399 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.401 ' C ' ' HD2' ' A' ' 269' ' ' LYS . 0.2 OUTLIER -131.42 129.64 41.51 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.887 179.18 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.439 ' O ' ' HA ' ' A' ' 292' ' ' SER . 47.5 m-85 -100.04 127.57 46.24 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.129 -0.357 . . . . 0.0 110.261 177.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.51 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 51.7 m -102.73 88.15 3.14 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 173.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.656 ' HA ' ' CB ' ' A' ' 337' ' ' ASP . 4.3 p-10 -91.08 155.58 18.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.071 -167.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 11.7 p -123.03 169.47 11.15 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.678 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -80.79 115.17 20.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.781 0.801 . . . . 0.0 110.985 -176.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 54.5 m95 -134.51 -22.39 1.71 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.22 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.516 ' HG ' ' OE1' ' A' ' 334' ' ' GLU . 97.0 mt -43.3 99.27 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 O-C-N 123.92 0.763 . . . . 0.0 112.753 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -78.26 -11.54 59.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.243 0.544 . . . . 0.0 109.675 175.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.416 ' H ' ' HG3' ' A' ' 278' ' ' GLN . 7.9 mt-30 -63.98 -28.59 69.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.052 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.451 ' OE1' ' HB2' ' A' ' 286' ' ' ASN . 15.6 mm100 -67.32 -6.77 20.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.532 -175.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 35.8 p -72.76 -37.53 67.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.097 0.475 . . . . 0.0 110.407 177.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -110.02 -62.45 1.51 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.021 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.4 ' HB3' ' CD2' ' A' ' 285' ' ' TYR . 21.7 mt-30 -95.38 63.89 2.59 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 122.072 0.939 . . . . 0.0 111.039 -172.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -86.21 5.52 33.8 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.088 -1.415 . . . . 0.0 110.524 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 42.0 mt -85.28 -24.82 27.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.166 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . 0.4 ' CD2' ' HB3' ' A' ' 282' ' ' GLN . 39.2 m-85 -80.7 -57.15 3.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.352 -178.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.451 ' HB2' ' OE1' ' A' ' 279' ' ' GLN . 81.1 m-20 -101.08 134.28 44.33 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.942 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -75.94 -45.36 16.59 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.492 175.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -176.1 159.68 2.14 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.0 t -54.89 142.58 54.85 Favored Pre-proline 0 C--N 1.32 -0.716 0 O-C-N 123.491 0.495 . . . . 0.0 109.731 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.16 -170.0 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.529 2.153 . . . . 0.0 112.833 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 40.6 mm -103.32 -65.4 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.475 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 52.0 m -159.72 129.94 5.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.139 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -135.77 150.59 49.54 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 121.018 0.437 . . . . 0.0 111.472 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 98.4 m -95.65 136.51 35.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.755 -173.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . 0.536 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -121.25 171.07 8.99 Favored 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 122.447 -0.158 . . . . 0.0 110.705 176.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 96.6 m -135.2 121.59 20.43 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.282 0.563 . . . . 0.0 112.168 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 59.5 t -79.36 139.96 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.333 -178.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 0.9 OUTLIER -130.62 24.24 5.07 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.017 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.552 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -162.14 179.83 7.64 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.436 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 5.6 m-20 -69.17 163.48 24.79 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.81 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.442 ' HB2' ' CG1' ' A' ' 311' ' ' VAL . . . -149.48 172.86 14.29 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.668 -174.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.662 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 16.8 m120 -138.28 122.71 18.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -175.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.483 ' HB3' ' CE1' ' A' ' 261' ' ' PHE . 0.6 OUTLIER -105.87 93.37 4.6 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 162.622 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.33 178.91 4.46 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.436 -0.505 . . . . 0.0 110.92 -173.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 17.7 m -57.65 -33.1 67.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.851 0.358 . . . . 0.0 111.649 -177.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -82.05 0.89 88.11 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.321 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 62.01 43.11 99.61 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.438 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -121.04 126.65 50.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.717 0.758 . . . . 0.0 110.855 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.662 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.3 OUTLIER -136.67 126.2 38.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.846 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -177.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 34.1 m -123.65 132.58 53.89 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.939 -0.475 . . . . 0.0 111.117 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.442 ' CG1' ' HB2' ' A' ' 301' ' ' ALA . 9.2 m -144.71 162.19 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.213 0.53 . . . . 0.0 110.418 176.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 21.0 m -117.01 142.21 47.26 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.48 0.657 . . . . 0.0 109.891 174.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 313' ' ' LEU . 0.5 OUTLIER -107.83 133.27 52.44 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.874 -173.591 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 46.7 t -137.93 138.37 38.92 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.532 -171.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.45 49.25 71.41 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 114.774 -1.103 . . . . 0.0 113.666 170.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 20.3 m -82.94 123.8 77.41 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 121.077 0.465 . . . . 0.0 110.644 177.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -82.46 64.33 8.2 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.919 2.413 . . . . 0.0 112.006 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 321' ' ' THR . 22.9 mm -94.31 99.89 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-O 121.352 0.596 . . . . 0.0 111.296 -176.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -114.53 -63.7 1.42 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.122 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -139.42 33.74 2.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -177.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.413 HG21 HD13 ' A' ' 318' ' ' ILE . 3.5 p -52.99 117.3 2.88 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.984 -175.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 2.8 m -95.26 -5.71 43.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.679 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.534 ' HB3' ' HD3' ' A' ' 324' ' ' PRO . 19.2 t-20 -56.81 -47.32 99.24 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.453 173.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' A' ' 323' ' ' ASN . 1.4 Cg_endo -86.94 -166.41 0.3 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.537 2.158 . . . . 0.0 111.096 173.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -87.98 58.74 4.97 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.542 0.687 . . . . 0.0 110.627 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 59.07 96.84 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 113.705 -1.589 . . . . 0.0 111.026 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . 0.535 HD21 ' HG2' ' A' ' 331' ' ' ARG . 25.7 t-20 -129.37 108.05 9.99 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 22.8 t -113.52 68.61 0.69 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 120.771 0.319 . . . . 0.0 110.596 -174.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 53.6 t 75.07 -42.21 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.634 175.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 16.5 m -66.86 82.02 0.11 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.318 0.58 . . . . 0.0 111.46 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . 0.535 ' HG2' HD21 ' A' ' 327' ' ' ASN . 81.4 mtt180 -103.75 113.02 26.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.277 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -89.19 122.17 32.21 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.47 HG11 ' O ' ' A' ' 234' ' ' PRO . 34.3 m -99.16 123.24 51.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.606 0.717 . . . . 0.0 111.867 -175.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . 0.516 ' OE1' ' HG ' ' A' ' 276' ' ' LEU . 2.6 pt-20 -146.88 145.72 29.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.967 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -99.29 142.97 30.08 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.676 -174.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 129.09 11.43 2.83 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.569 171.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.656 ' CB ' ' HA ' ' A' ' 272' ' ' ASN . 10.9 p-10 -104.4 -153.32 0.48 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.926 0.363 . . . . 0.0 111.093 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -126.23 139.24 53.49 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 121.207 0.527 . . . . 0.0 111.774 -173.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.434 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 75.1 t -103.08 145.44 12.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.657 -177.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 10.5 m -142.97 178.92 7.35 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 268' ' ' VAL . 60.5 t -117.58 141.54 35.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.673 0.273 . . . . 0.0 110.563 -175.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 72.1 t -97.02 -44.93 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.87 177.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -179.47 168.41 38.95 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.967 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 19.0 p -124.91 -68.81 0.83 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.396 0.617 . . . . 0.0 110.333 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.189 -0.91 . . . . 0.0 109.365 175.034 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 112.249 -0.34 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.435 ' O ' ' HA3' ' A' ' 343' ' ' GLY . . . -78.04 71.16 4.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.292 0.568 . . . . 0.0 111.183 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -99.08 161.66 13.5 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.567 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 105.11 6.27 39.7 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -176.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -76.49 117.52 5.0 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.771 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.9 m -127.9 141.34 51.58 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.821 0.343 . . . . 0.0 110.421 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.456 HD21 ' CE2' ' A' ' 261' ' ' PHE . 12.7 mt -143.08 175.19 10.05 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.985 -177.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 63.3 m -128.65 157.46 41.26 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.219 -176.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.501 HG21 ' OD2' ' A' ' 337' ' ' ASP . 92.6 t -99.13 138.67 22.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 120.622 0.249 . . . . 0.0 110.648 -177.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.415 ' HB3' HG22 ' A' ' 250' ' ' THR . 35.6 tptt -117.53 -34.7 4.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.547 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 53.9 p -137.04 -173.67 3.52 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.599 ' HG3' ' N ' ' A' ' 334' ' ' GLU . 24.3 mm-40 -115.57 155.96 46.69 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -168.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.481 ' HB3' ' CD1' ' A' ' 247' ' ' PHE . 28.3 Cg_endo -63.47 105.95 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.176 2.584 . . . . 0.0 111.985 174.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 236' ' ' VAL . 5.1 t -148.27 96.98 2.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.574 0.702 . . . . 0.0 111.741 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.736 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.73 174.01 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 168.217 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.497 ' H ' HG13 ' A' ' 236' ' ' VAL . 44.2 m -29.06 109.54 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -175.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -108.72 87.63 2.54 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 168.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.51 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 4.9 t30 -113.88 102.47 10.24 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.642 -174.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -84.51 -52.14 6.37 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -164.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 26.1 t -67.28 -23.59 30.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.411 0.624 . . . . 0.0 109.578 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.51 ' HG3' ' ND2' ' A' ' 239' ' ' ASN . 43.2 mmtt -89.88 -12.77 38.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.566 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 30.0 t70 63.37 69.65 0.56 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.183 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.2 m -149.5 106.86 3.61 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.879 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -125.29 102.76 7.59 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . 0.454 ' HB2' HG12 ' A' ' 236' ' ' VAL . 38.8 mt-30 -129.76 160.01 34.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.736 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 7.4 p90 -154.92 132.91 11.58 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.629 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 53.0 m -97.94 131.89 44.0 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 25.3 t -136.86 140.32 43.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.867 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.415 HG22 ' HB3' ' A' ' 231' ' ' LYS . 24.2 m -96.9 121.49 38.83 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 167.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.542 HD23 HG21 ' A' ' 339' ' ' VAL . 4.8 mp -110.24 167.37 10.24 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -123.54 140.63 52.81 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.415 ' HA2' HD23 ' A' ' 228' ' ' LEU . . . -142.11 -143.56 4.22 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.709 -174.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -102.63 -174.32 2.53 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.629 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.9 OUTLIER -72.18 -179.43 2.84 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.446 -169.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.629 ' H ' HG22 ' A' ' 255' ' ' THR . . . -61.22 -176.44 0.07 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.93 0.892 . . . . 0.0 112.898 -177.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 27.7 t 80.52 6.73 1.51 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.82 0.848 . . . . 0.0 110.922 -178.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 17.3 t -122.07 90.21 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 17.0 m -74.8 88.02 2.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.595 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 301' ' ' ALA . . . 83.44 91.48 0.69 Allowed Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.383 -178.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.456 ' CE2' HD21 ' A' ' 228' ' ' LEU . 4.1 m-85 -43.01 -60.09 1.76 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 170.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 63.9 mt -149.02 161.76 41.29 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.12 -172.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 85.6 mttt -142.92 -167.19 2.47 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.119 0.262 . . . . 0.0 111.138 175.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -49.63 116.68 1.87 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.276 0.56 . . . . 0.0 111.686 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 108.36 -5.14 33.39 Favored Glycine 0 C--N 1.316 -0.53 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.299 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -94.96 143.27 26.61 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.402 ' O ' HG12 ' A' ' 342' ' ' VAL . 23.0 mt-30 -114.06 152.7 30.63 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.551 0.691 . . . . 0.0 111.455 -176.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 294' ' ' THR . 0.3 OUTLIER -130.09 165.97 28.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.865 177.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 340' ' ' SER . 0.8 OUTLIER -122.64 87.45 2.75 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.1 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 339' ' ' VAL . 5.3 p90 -92.16 132.38 36.67 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.807 -175.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.606 ' O ' ' HB2' ' A' ' 337' ' ' ASP . 77.2 m -98.24 87.14 3.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.36 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -99.21 101.97 13.47 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.006 -177.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 3.0 p -77.01 80.91 3.54 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.616 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -91.22 113.0 25.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.434 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -174.07 53.62 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.525 HD12 ' O ' ' A' ' 332' ' ' GLN . 25.4 mt -91.11 91.14 8.13 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.587 -170.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -99.62 -71.99 0.68 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.155 -176.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -115.24 -81.34 0.61 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.04 0.448 . . . . 0.0 110.858 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -86.58 -22.95 25.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.308 -176.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 28.1 p -64.35 -17.51 63.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.871 0.367 . . . . 0.0 111.228 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.476 ' HG2' ' HB3' ' A' ' 276' ' ' LEU . 7.3 mtpm? -63.58 -28.34 69.87 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.076 0.465 . . . . 0.0 110.325 176.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -104.5 -9.44 18.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.599 -178.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -130.88 88.94 2.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.906 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.9 -3.2 27.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.253 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -77.87 -18.05 56.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.065 0.46 . . . . 0.0 109.876 177.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -116.95 132.39 56.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.247 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -160.95 -122.63 0.64 Allowed Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.658 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -174.0 39.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.083 0.468 . . . . 0.0 110.07 -177.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.2 t -165.82 88.84 0.91 Allowed Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.682 0.753 . . . . 0.0 110.916 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -89.78 45.82 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.011 2.474 . . . . 0.0 112.65 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 271' ' ' THR . 50.2 pt -119.82 171.59 7.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.227 -176.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 8.0 t -135.22 142.04 45.92 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.96 144.57 50.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.19 0.519 . . . . 0.0 111.014 -176.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 60.3 m -81.53 122.89 28.13 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.275 -176.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . 0.429 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -114.48 175.45 5.48 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 63.8 m -135.19 130.58 35.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.573 0.701 . . . . 0.0 112.808 -176.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 62.8 t -80.57 139.39 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.811 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 312' ' ' THR . 13.8 t -121.71 1.8 10.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.782 0.325 . . . . 0.0 111.399 -176.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -142.46 -177.12 5.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -173.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.422 ' O ' HG12 ' A' ' 311' ' ' VAL . 10.9 m-20 -71.51 164.65 25.43 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.121 -178.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.56 ' O ' ' HA2' ' A' ' 260' ' ' GLY . . . -149.58 156.08 41.36 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.316 -173.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.546 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 3.9 m-20 -129.17 126.88 40.2 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.624 -175.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.496 ' HB2' ' HB ' ' A' ' 258' ' ' VAL . 0.4 OUTLIER -111.24 95.5 5.56 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 163.966 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -102.16 178.2 4.67 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.646 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 50.4 m -60.21 -32.28 70.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.729 0.299 . . . . 0.0 111.697 -177.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -73.64 -8.83 77.62 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.175 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 70.61 42.39 63.11 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.511 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -118.43 136.01 54.02 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.734 0.767 . . . . 0.0 111.474 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.546 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.7 OUTLIER -142.92 110.31 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.804 -178.478 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 25.5 m -105.16 127.4 52.89 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.609 -0.682 . . . . 0.0 111.537 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.522 HG22 HD13 ' A' ' 251' ' ' LEU . 19.5 m -144.38 148.72 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.296 0.57 . . . . 0.0 111.014 175.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.517 ' O ' HG22 ' A' ' 298' ' ' THR . 50.0 m -97.22 146.78 24.77 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 172.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.483 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.1 mp -117.51 136.73 53.03 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.299 -176.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 38.1 m -133.66 129.45 36.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.494 -174.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 82.53 88.85 0.69 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.2 174.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 10.9 m -129.99 122.38 20.3 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 121.016 0.436 . . . . 0.0 110.821 176.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -87.28 56.61 3.14 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.888 2.392 . . . . 0.0 111.987 178.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 8.9 tt -82.74 99.06 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.538 0.685 . . . . 0.0 110.877 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -138.55 77.92 1.65 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.33 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -162.61 -51.74 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.11 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 38.1 p -112.84 39.42 2.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.276 0.56 . . . . 0.0 110.438 175.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 3.9 m -80.47 -68.02 0.72 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.628 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 61.97 95.08 0.05 OUTLIER Pre-proline 0 N--CA 1.474 0.747 0 O-C-N 123.621 0.575 . . . . 0.0 112.123 170.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -73.13 140.39 31.01 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.678 1.585 . . . . 0.0 110.568 175.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -84.61 18.94 2.13 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.947 -176.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 69.08 -67.06 0.23 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.584 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -97.82 -12.89 21.68 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.675 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 46.5 m 70.31 103.61 0.06 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.019 -174.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 3.4 t -88.51 20.35 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.554 0.692 . . . . 0.0 110.573 -174.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 20.0 m 56.22 45.78 22.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.964 178.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -81.27 112.39 18.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.782 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . 0.525 ' O ' HD12 ' A' ' 276' ' ' LEU . 79.2 mm-40 -98.3 154.3 17.91 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.447 ' HB ' ' OE1' ' A' ' 233' ' ' GLN . 0.8 OUTLIER -76.69 170.55 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.867 -179.072 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . 0.599 ' N ' ' HG3' ' A' ' 233' ' ' GLN . 10.8 tp10 -158.67 130.34 6.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.606 0.241 . . . . 0.0 110.7 -173.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -66.22 158.35 29.09 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.295 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 130.07 -1.24 5.8 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.673 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.606 ' HB2' ' O ' ' A' ' 271' ' ' THR . 10.3 p-10 -89.08 -171.3 3.22 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 122.333 0.253 . . . . 0.0 110.742 176.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -129.04 162.57 27.35 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -171.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.542 HG21 HD23 ' A' ' 251' ' ' LEU . 98.3 t -128.56 142.62 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.968 -175.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.486 ' HB3' ' HB2' ' A' ' 269' ' ' LYS . 33.7 t -127.63 165.17 20.48 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 170.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.59 HG12 ' H ' ' A' ' 343' ' ' GLY . 39.5 t -120.76 148.72 23.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 122.328 0.251 . . . . 0.0 110.386 -177.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.433 ' HB ' ' HE3' ' A' ' 269' ' ' LYS . 7.5 p -85.01 -31.28 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 121.025 0.44 . . . . 0.0 110.691 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . 0.59 ' H ' HG12 ' A' ' 341' ' ' VAL . . . 78.07 -110.38 3.02 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.996 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 17.4 p -122.4 -95.92 0.47 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.811 0.339 . . . . 0.0 111.063 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.493 -0.765 . . . . 0.0 110.096 179.5 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.648 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 71.58 147.61 0.08 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.633 0.73 . . . . 0.0 111.421 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.407 ' CG ' ' HA2' ' A' ' 343' ' ' GLY . 59.8 t80 -69.86 -21.5 63.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.277 -176.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 130.98 -35.87 2.37 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -65.43 115.49 7.71 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.283 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 27.1 m -111.05 141.06 45.04 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.456 HD21 ' CE2' ' A' ' 261' ' ' PHE . 8.6 mt -139.34 172.07 13.35 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.575 -173.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 40.3 m -128.0 152.74 47.56 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 -176.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.506 ' HB ' ' H ' ' A' ' 337' ' ' ASP . 61.3 t -94.08 108.16 20.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -95.49 -32.41 12.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.192 0.52 . . . . 0.0 110.888 -174.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.564 ' OG1' ' HB ' ' A' ' 250' ' ' THR . 61.6 p -129.09 -167.44 1.78 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.604 178.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.57 ' HB3' ' CG2' ' A' ' 333' ' ' VAL . 13.1 mt-30 -112.72 128.51 25.48 Favored Pre-proline 0 C--N 1.32 -0.702 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.61 -171.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.28 107.92 2.27 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.682 2.255 . . . . 0.0 112.739 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 13.5 t -112.54 147.47 36.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.007 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.408 HG11 ' CZ ' ' A' ' 238' ' ' TYR . 16.0 t -110.52 136.97 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -166.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 22.5 m -101.91 116.89 33.68 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 168.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.408 ' CZ ' HG11 ' A' ' 236' ' ' VAL . 43.1 m-85 -103.16 131.5 50.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.039 0.447 . . . . 0.0 111.87 -176.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.47 HD22 ' HA ' ' A' ' 239' ' ' ASN . 0.2 OUTLIER -142.1 88.66 2.12 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.508 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -88.79 -41.0 12.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.293 -162.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.3 -23.22 32.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.706 0.765 . . . . 0.0 109.037 175.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -94.69 -12.33 27.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.016 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 6.3 t70 60.73 57.93 2.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.713 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 21.4 m -146.5 115.64 6.99 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.929 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . 0.493 ' HB3' ' HA3' ' A' ' 315' ' ' GLY . 17.9 m-85 -120.29 133.56 55.44 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -143.33 126.72 16.73 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.522 ' CE1' ' HB2' ' A' ' 313' ' ' LEU . 18.7 p90 -130.17 133.33 46.52 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.429 174.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 92.9 m -104.52 142.19 35.06 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.988 -167.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 8.5 p -145.69 133.06 15.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.36 0.6 . . . . 0.0 112.294 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.564 ' HB ' ' OG1' ' A' ' 232' ' ' THR . 52.9 m -97.23 116.81 30.12 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 168.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.44 170.89 7.97 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.486 0.66 . . . . 0.0 109.893 -175.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.54 150.25 35.22 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.486 171.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.417 ' CA ' HD23 ' A' ' 228' ' ' LEU . . . -148.27 -144.12 3.92 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.53 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -106.39 -176.5 3.09 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -175.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.615 HG22 ' H ' ' A' ' 256' ' ' ALA . 1.3 m -68.42 178.99 1.77 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.519 -171.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.615 ' H ' HG22 ' A' ' 255' ' ' THR . . . -61.76 -176.14 0.08 Allowed 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.718 0.807 . . . . 0.0 112.323 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 28.9 t 81.07 6.83 1.28 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.835 0.854 . . . . 0.0 110.894 -178.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 40.1 t -126.03 89.96 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.463 0.649 . . . . 0.0 109.304 172.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 10.8 m -69.37 97.31 0.96 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.376 -178.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 68.21 99.46 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.494 -177.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.456 ' CE2' HD21 ' A' ' 228' ' ' LEU . 11.9 m-85 -43.23 -49.99 6.51 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.742 0.271 . . . . 0.0 111.371 170.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 266' ' ' ASP . 0.7 OUTLIER -166.08 166.16 17.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.677 -175.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.448 ' HG2' ' HA ' ' A' ' 300' ' ' ASP . 59.0 mtmt -140.79 -165.82 2.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.722 0.296 . . . . 0.0 111.685 -177.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 297' ' ' VAL . . . -51.91 118.27 3.31 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.448 0.642 . . . . 0.0 111.877 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 107.02 -10.3 40.24 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.975 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 344' ' ' THR . 38.7 m-20 -93.3 136.97 33.06 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -108.31 151.52 25.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.533 0.682 . . . . 0.0 112.313 -172.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 294' ' ' THR . 1.3 m -125.26 163.8 25.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.901 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.547 ' HE2' HG22 ' A' ' 342' ' ' VAL . 0.0 OUTLIER -135.13 126.91 29.22 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 169.223 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -144.71 163.71 33.19 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.909 -0.494 . . . . 0.0 110.906 -174.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.589 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 5.0 t -121.67 101.3 7.51 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.893 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -103.6 143.59 32.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.366 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . 0.473 HG22 ' HA ' ' A' ' 288' ' ' ALA . 1.8 p -74.76 81.53 2.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.479 0.657 . . . . 0.0 112.405 -176.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.403 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 38.5 m-85 -84.93 159.36 20.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.559 170.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.403 ' HB2' ' O ' ' A' ' 274' ' ' TYR . 7.0 m-90 72.39 -51.91 0.7 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.348 0.659 . . . . 0.0 110.887 -174.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 32.6 mt 69.36 -67.51 0.22 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.815 0.846 . . . . 0.0 113.174 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -81.15 -49.3 10.99 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -167.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 283' ' ' ALA . 27.0 mp0 -103.09 -80.49 0.52 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.531 0.681 . . . . 0.0 112.223 -173.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -66.88 14.72 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -169.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 1.1 p -73.12 -50.65 21.59 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.607 -0.683 . . . . 0.0 109.92 172.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 285' ' ' TYR . 74.2 mmtt -108.95 -68.43 0.92 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.023 174.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -134.81 -81.47 0.44 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.62 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 278' ' ' GLN . . . -154.12 -54.22 0.1 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.983 0.42 . . . . 0.0 110.527 177.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.21 13.3 25.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.093 0.473 . . . . 0.0 110.539 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . 0.436 ' O ' ' HB2' ' A' ' 281' ' ' LYS . 82.7 m-85 -130.11 106.46 8.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.922 -178.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -94.37 171.62 8.71 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.412 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 156.09 -101.49 0.21 Allowed Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 111.356 -0.697 . . . . 0.0 111.356 177.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.473 ' HA ' HG22 ' A' ' 273' ' ' THR . . . -149.2 140.92 23.55 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.844 0.354 . . . . 0.0 110.14 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 7.1 t -93.21 137.71 23.48 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.919 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.7 -0.15 9.85 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.579 2.186 . . . . 0.0 112.02 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 72.5 mt -72.17 124.67 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.429 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 42.8 m -116.35 143.74 45.16 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.19 145.43 51.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.967 0.413 . . . . 0.0 110.936 -175.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 87.1 m -90.02 131.07 36.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.798 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -129.63 -178.4 4.67 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 89.7 m -141.71 134.15 28.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.392 0.615 . . . . 0.0 112.385 -177.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.559 HG12 ' H ' ' A' ' 299' ' ' ALA . 94.9 t -86.32 146.01 6.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.719 -178.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 13.6 t -125.57 18.11 8.12 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.572 -175.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.559 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -154.58 -177.86 6.77 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.448 ' HA ' ' HG2' ' A' ' 263' ' ' LYS . 2.7 m-20 -69.78 163.0 26.72 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.168 -178.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.46 ' HB2' ' CG1' ' A' ' 311' ' ' VAL . . . -147.28 167.88 23.14 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.973 -178.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.692 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 21.0 m120 -142.59 128.97 20.04 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.469 -174.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.6 OUTLIER -109.48 94.97 5.31 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 163.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -101.62 -176.94 3.28 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.207 -175.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 13.1 t -60.59 -33.03 72.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.792 0.33 . . . . 0.0 111.424 -175.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -82.67 -2.8 90.67 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.696 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 63.5 44.44 96.65 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.203 -178.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -115.02 126.51 54.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 118.0 0.9 . . . . 0.0 111.0 177.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.692 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.2 OUTLIER -134.7 119.65 29.24 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.568 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.475 ' OG1' HG23 ' A' ' 250' ' ' THR . 53.1 m -113.39 134.98 54.35 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 122.285 -0.26 . . . . 0.0 110.498 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.46 ' CG1' ' HB2' ' A' ' 301' ' ' ALA . 6.9 m -145.8 164.39 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.361 0.601 . . . . 0.0 110.547 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.445 ' O ' HG22 ' A' ' 298' ' ' THR . 19.7 m -119.99 138.54 53.43 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.421 173.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.522 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 4.1 mp -109.59 169.58 8.61 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.631 -175.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . 0.604 ' O ' HG13 ' A' ' 316' ' ' VAL . 19.7 m -87.15 64.69 8.51 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -172.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.493 ' HA3' ' HB3' ' A' ' 245' ' ' TYR . . . 29.07 31.71 0.01 OUTLIER Glycine 0 N--CA 1.471 1.002 0 N-CA-C 118.046 1.978 . . . . 0.0 118.046 173.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 314' ' ' SER . 29.2 m -85.09 131.34 48.89 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 119.066 1.433 . . . . 0.0 110.816 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.72 134.15 31.73 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 122.422 2.081 . . . . 0.0 111.455 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.454 ' O ' HG12 ' A' ' 318' ' ' ILE . 0.2 OUTLIER -123.82 97.11 4.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.314 0.578 . . . . 0.0 110.191 -177.004 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 59.9 29.73 19.29 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.912 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -98.13 38.98 1.26 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.318 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 65.8 p 52.79 -159.5 0.13 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.985 -177.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 14.2 t -160.46 -175.99 5.33 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.46 ' N ' ' HD3' ' A' ' 324' ' ' PRO . 10.8 m120 57.79 57.95 7.11 Favored Pre-proline 0 C--N 1.318 -0.766 0 O-C-N 123.716 0.635 . . . . 0.0 111.17 -178.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.588 ' HA ' ' O ' ' A' ' 327' ' ' ASN . 16.5 Cg_exo -68.66 2.65 2.77 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.81 2.34 . . . . 0.0 113.354 -174.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -69.33 -54.98 11.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.996 0.427 . . . . 0.0 109.885 177.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -103.48 -15.67 15.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.036 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . 0.588 ' O ' ' HA ' ' A' ' 324' ' ' PRO . 13.1 t30 -111.73 67.53 0.65 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 14.6 m -84.64 70.3 10.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.65 -174.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 52.4 t -79.62 127.58 39.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.236 0.541 . . . . 0.0 110.904 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 17.1 t -96.4 111.02 23.26 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -68.35 123.54 21.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.413 -172.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -108.05 107.75 18.55 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 171.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.57 ' CG2' ' HB3' ' A' ' 233' ' ' GLN . 0.2 OUTLIER -91.72 170.63 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.227 0.537 . . . . 0.0 112.117 -173.833 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -144.65 147.86 33.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.328 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -98.95 173.18 6.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.767 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 98.99 8.16 54.36 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.818 -0.706 . . . . 0.0 113.05 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.589 ' HB3' ' O ' ' A' ' 271' ' ' THR . 30.6 m-20 -92.81 -172.96 3.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.793 0.33 . . . . 0.0 111.795 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -112.12 142.71 44.24 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.665 -172.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 228' ' ' LEU . 82.9 t -126.97 149.55 32.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.373 -178.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 50.7 m -147.98 158.86 44.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.921 0.391 . . . . 0.0 110.528 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 48.9 t -102.22 137.04 31.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.797 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.547 HG22 ' HE2' ' A' ' 269' ' ' LYS . 53.1 t -71.5 -42.26 72.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.078 175.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . 0.407 ' HA2' ' CG ' ' A' ' 224' ' ' PHE . . . 149.16 -79.58 0.21 Allowed Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 266' ' ' ASP . 4.1 p -143.48 -87.45 0.13 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.028 0.442 . . . . 0.0 110.281 176.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.367 -0.825 . . . . 0.0 109.819 179.124 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.672 0 N-CA-C 112.175 -0.37 . . . . 0.0 112.175 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -144.53 100.71 3.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.894 0.378 . . . . 0.0 110.798 178.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -76.5 162.59 27.68 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.905 177.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 119.7 -0.36 13.74 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.857 -177.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -74.97 -167.28 19.68 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.241 -179.182 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.9 m -91.01 147.61 22.96 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.159 0.504 . . . . 0.0 111.434 -175.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 4.4 mp -138.34 176.01 9.07 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 168.138 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 33.0 m -135.92 161.79 34.64 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.634 0.254 . . . . 0.0 110.893 -170.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 59.3 t -118.09 126.09 74.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 176.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.456 ' HE2' HG21 ' A' ' 252' ' ' THR . 20.4 ttmm -108.67 -11.34 15.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.131 0.491 . . . . 0.0 111.126 -177.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.475 ' CG2' ' HB ' ' A' ' 250' ' ' THR . 57.5 p -124.11 -166.83 1.55 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.476 -179.327 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -102.82 112.49 65.75 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -170.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -65.08 103.53 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.503 1.469 . . . . 0.0 111.154 175.399 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.3 t -103.01 120.22 40.25 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.509 0.671 . . . . 0.0 110.532 -177.057 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.428 ' HA ' ' CB ' ' A' ' 247' ' ' PHE . 21.3 t -77.26 123.17 33.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.848 -175.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 29.2 m -96.72 105.15 17.21 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.12 178.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -89.84 116.09 27.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.607 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.484 ' OD1' ' HG3' ' A' ' 242' ' ' LYS . 0.8 OUTLIER -122.71 76.14 1.32 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 176.547 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -84.3 -32.28 24.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.126 -160.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 38.8 t -65.39 -22.17 30.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 122.164 0.983 . . . . 0.0 108.529 173.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.484 ' HG3' ' OD1' ' A' ' 239' ' ' ASN . 43.4 mmtt -101.77 0.47 35.87 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.166 179.196 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 51.4 37.67 19.75 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.056 -178.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.9 m -119.17 127.32 53.2 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.009 178.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -125.17 112.11 16.06 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.079 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . 0.42 ' HB3' ' O ' ' A' ' 313' ' ' LEU . 18.2 mt-30 -130.79 -178.87 4.99 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.685 -175.276 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 313' ' ' LEU . 6.9 p90 -156.76 137.83 13.59 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.476 171.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 61.4 m -103.15 134.95 45.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.177 -173.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.409 ' HB ' HD11 ' A' ' 251' ' ' LEU . 0.5 OUTLIER -147.62 149.36 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.563 -179.839 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.551 HG23 ' OG1' ' A' ' 310' ' ' THR . 38.3 m -99.09 111.4 23.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 164.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.576 HD23 HG21 ' A' ' 339' ' ' VAL . 4.6 mp -104.3 168.06 9.35 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -172.751 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.456 HG21 ' HE2' ' A' ' 231' ' ' LYS . 0.7 OUTLIER -120.57 130.24 54.11 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.693 0.282 . . . . 0.0 110.367 177.467 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.422 ' N ' HG12 ' A' ' 309' ' ' VAL . . . -124.08 -143.15 6.15 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.944 -171.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -113.5 -171.33 1.86 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -173.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 256' ' ' ALA . 1.8 m -51.12 167.34 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -173.157 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 257' ' ' SER . . . -69.95 -175.78 0.99 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.177 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 67.6 m 80.6 9.15 1.21 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.794 176.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 94.4 t -119.52 94.5 3.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 170.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 22.6 m -74.6 89.56 2.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.42 -178.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 80.1 102.32 0.28 Allowed Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.623 -175.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.456 ' CE1' ' HB2' ' A' ' 303' ' ' SER . 10.6 m-85 -48.17 -59.11 3.66 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.673 0.749 . . . . 0.0 110.392 173.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 266' ' ' ASP . 89.3 mt -141.7 168.4 19.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.009 -175.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -131.63 -169.27 2.16 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.18 0.3 . . . . 0.0 111.006 -179.535 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -56.82 114.41 2.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.255 0.55 . . . . 0.0 111.652 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 112.75 -6.07 25.97 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.562 177.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . 0.547 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 64.6 m-20 -96.19 138.14 34.24 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.554 ' HB2' HG11 ' A' ' 342' ' ' VAL . 30.5 mt-30 -108.94 159.76 16.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.636 0.732 . . . . 0.0 111.779 -173.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.06 -175.48 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.827 -179.29 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 340' ' ' SER . 23.9 tptt -120.9 104.56 9.93 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.834 174.419 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -95.29 120.71 35.99 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 120.942 0.401 . . . . 0.0 110.127 -175.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 291' ' ' ILE . 54.8 m -110.6 89.25 2.98 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.767 178.352 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -75.12 142.98 43.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.611 179.115 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 36.4 p -114.13 121.35 43.52 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.498 -173.008 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -96.35 113.9 25.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.122 0.487 . . . . 0.0 109.959 173.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.419 ' CZ2' ' HA ' ' A' ' 288' ' ' ALA . 73.0 m95 -149.97 33.52 0.67 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.489 178.113 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 85.3 mt -81.66 179.69 7.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.941 -174.328 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -68.93 -5.02 18.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.093 0.473 . . . . 0.0 110.882 178.107 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -64.74 -13.96 56.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.883 175.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -57.28 -14.49 4.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.486 173.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 24.1 p -67.4 -33.85 76.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.262 0.553 . . . . 0.0 110.352 174.138 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -91.13 -29.04 17.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.937 177.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -105.48 48.79 0.83 Allowed 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.732 0.777 . . . . 0.0 109.255 178.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -69.19 86.23 0.39 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.526 -176.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 92.3 mt -115.17 32.37 6.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.432 -178.501 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 58.99 31.96 21.84 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.901 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.66 85.93 0.14 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.001 -177.185 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -83.74 -100.08 0.57 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.441 -178.007 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.43 ' C ' ' HD3' ' A' ' 290' ' ' PRO . . . -166.68 179.36 5.45 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.066 0.46 . . . . 0.0 109.931 -179.102 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 6.8 t -131.54 61.29 57.89 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.189 178.45 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . 0.43 ' HD3' ' C ' ' A' ' 288' ' ' ALA . 1.7 Cg_endo -81.6 65.93 8.6 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.295 2.663 . . . . 0.0 112.35 -173.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 271' ' ' THR . 20.5 pt -128.74 154.26 39.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.3 179.002 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 55.7 p -162.09 141.72 9.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.256 178.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -143.45 148.27 35.85 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 66.7 m -74.94 115.99 15.16 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.675 -179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -103.14 -179.95 4.1 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 177.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.593 ' HB ' ' O ' ' A' ' 314' ' ' SER . 90.7 m -139.82 133.8 30.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -175.1 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.57 HG13 HG21 ' A' ' 311' ' ' VAL . 50.7 t -78.64 135.91 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.715 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 5.1 m -108.62 -13.43 14.81 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -173.178 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -154.38 -178.66 7.29 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.172 -0.33 . . . . 0.0 110.916 -175.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.58 105.58 0.66 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.178 0.513 . . . . 0.0 110.447 178.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -95.41 100.43 12.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.499 -177.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.434 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 65.3 t30 -61.04 149.49 36.74 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -168.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.519 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 36.6 t -128.78 95.23 4.04 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 166.374 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -104.9 173.03 6.48 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.89 -179.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 8.5 t -58.25 -32.08 68.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.861 0.362 . . . . 0.0 111.472 -173.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -73.77 3.45 35.25 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.217 -177.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 66.27 41.85 94.46 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.739 178.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -116.84 139.08 51.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.901 0.35 . . . . 0.0 110.694 -178.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 251' ' ' LEU . 1.8 p -147.7 95.17 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.366 0.603 . . . . 0.0 111.352 179.186 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.551 ' OG1' HG23 ' A' ' 250' ' ' THR . 53.0 m -96.12 130.37 43.18 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 121.597 -0.689 . . . . 0.0 110.896 179.523 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.57 HG21 HG13 ' A' ' 297' ' ' VAL . 14.5 p -165.81 150.24 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.109 0.48 . . . . 0.0 110.424 175.216 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 25.0 m -93.69 145.49 24.52 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.632 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.526 ' HA ' ' O ' ' A' ' 296' ' ' THR . 5.1 mp -110.62 140.95 44.48 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.086 -175.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . 0.593 ' O ' ' HB ' ' A' ' 296' ' ' THR . 39.0 t -119.95 137.93 53.77 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.677 -176.14 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 93.18 85.57 1.58 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.946 175.17 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 6.5 m -127.71 114.88 20.86 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 121.136 0.493 . . . . 0.0 110.688 176.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.72 55.03 5.05 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.797 2.331 . . . . 0.0 112.641 -178.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 26.4 pt -107.39 111.3 35.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.145 0.497 . . . . 0.0 110.292 179.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -120.68 74.14 1.05 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.231 0.539 . . . . 0.0 111.935 -175.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -93.47 -20.64 20.1 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.586 0.708 . . . . 0.0 109.377 170.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 69.4 p 54.85 17.63 1.86 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.89 177.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 3.3 m -139.58 -62.9 0.52 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.438 ' N ' ' HD3' ' A' ' 324' ' ' PRO . 90.5 m-20 53.29 60.71 11.83 Favored Pre-proline 0 N--CA 1.473 0.717 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.953 176.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 328' ' ' SER . 1.5 Cg_endo -79.85 -75.86 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.346 2.031 . . . . 0.0 111.304 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 66.54 -71.52 0.09 Allowed 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.413 0.685 . . . . 0.0 111.576 177.073 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . 0.475 ' O ' ' HB3' ' A' ' 327' ' ' ASN . 4.0 m-85 -108.28 79.6 1.27 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.168 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 326' ' ' TYR . 37.7 t30 86.11 -69.95 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.101 178.042 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' A' ' 324' ' ' PRO . 19.1 p -168.94 -77.83 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.949 0.404 . . . . 0.0 111.442 174.282 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . 0.417 ' O ' ' HD3' ' A' ' 331' ' ' ARG . 28.6 t -87.3 -23.28 6.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.202 0.525 . . . . 0.0 110.819 -176.173 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 27.5 t -86.33 46.3 1.33 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.907 -178.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . 0.593 ' HD3' ' H ' ' A' ' 331' ' ' ARG . 0.0 OUTLIER -63.5 137.85 58.29 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.37 178.518 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -135.12 147.85 49.61 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -179.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 35.2 m -116.52 173.43 4.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.877 176.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -127.43 134.83 49.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.92 0.39 . . . . 0.0 110.628 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -66.53 157.16 32.94 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.584 -175.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 128.38 3.12 5.75 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.401 178.21 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.11 166.85 10.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.222 0.534 . . . . 0.0 111.49 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -116.56 148.05 41.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.993 -179.048 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.576 HG21 HD23 ' A' ' 251' ' ' LEU . 70.7 t -130.38 150.59 34.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.809 0.338 . . . . 0.0 111.086 -172.573 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.503 ' HB2' ' HB3' ' A' ' 269' ' ' LYS . 30.0 m -150.05 177.77 9.57 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.318 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 343' ' ' GLY . 39.3 t -113.56 142.58 25.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.554 HG11 ' HB2' ' A' ' 267' ' ' GLN . 9.9 p -69.46 -24.59 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 121.053 0.454 . . . . 0.0 111.051 -175.095 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . 0.521 ' H ' HG12 ' A' ' 341' ' ' VAL . . . 120.2 76.44 0.47 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.34 174.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 15.6 p -88.0 -55.78 3.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.193 0.521 . . . . 0.0 111.356 -178.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.288 178.26 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.761 0 N-CA-C 112.345 -0.302 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -88.75 -8.68 54.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.782 0.291 . . . . 0.0 111.36 -176.017 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -63.5 -17.13 62.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.182 0.515 . . . . 0.0 110.796 178.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 120.32 6.7 9.61 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.653 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -84.16 -143.76 5.95 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.942 179.297 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.1 m -105.94 147.84 28.33 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.975 0.417 . . . . 0.0 111.184 -174.466 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 3.9 mp -132.61 -178.66 5.04 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 167.152 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.48 ' HB ' ' OG1' ' A' ' 252' ' ' THR . 23.1 m -127.47 155.82 43.11 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 122.324 -0.235 . . . . 0.0 111.072 -173.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.497 HG23 ' CG2' ' A' ' 339' ' ' VAL . 0.9 OUTLIER -111.22 137.43 43.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.275 177.399 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.415 ' HE3' HG22 ' A' ' 250' ' ' THR . 59.3 mtmt -109.57 -26.92 9.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.769 174.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.451 ' O ' HG13 ' A' ' 230' ' ' VAL . 58.6 p -137.07 -179.7 5.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.546 ' HB3' ' HB ' ' A' ' 333' ' ' VAL . 17.9 mm-40 -116.57 157.01 46.92 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -166.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.466 ' HG3' ' CZ ' ' A' ' 293' ' ' PHE . 73.8 Cg_endo -73.05 104.24 1.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.076 2.517 . . . . 0.0 113.127 178.576 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.475 ' N ' ' HB2' ' A' ' 247' ' ' PHE . 10.1 t -157.11 110.44 2.57 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.659 170.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.768 ' O ' ' HB2' ' A' ' 246' ' ' GLN . 75.7 t -154.74 79.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.34 0.656 . . . . 0.0 109.559 165.814 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 26.0 m 81.44 92.73 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.536 0.684 . . . . 0.0 110.645 174.117 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -106.95 104.96 14.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.341 178.13 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -129.29 126.82 39.87 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -102.61 -43.0 5.74 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.622 -170.282 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 67.3 t -61.55 -26.9 40.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.39 0.614 . . . . 0.0 109.916 178.085 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -99.05 -4.77 31.66 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.874 -179.425 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 53.3 57.9 5.77 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.059 -177.051 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 23.7 m -138.51 111.14 7.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.458 -177.073 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -128.57 120.08 26.02 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.321 -177.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . 0.768 ' HB2' ' O ' ' A' ' 236' ' ' VAL . 47.3 mt-30 -128.57 163.36 25.18 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 173.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.526 ' HA ' ' N ' ' A' ' 236' ' ' VAL . 20.9 p90 -168.64 151.43 5.21 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 174.007 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.411 ' H ' HG23 ' A' ' 236' ' ' VAL . 50.0 m -113.97 138.54 50.21 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 31.6 t -137.91 139.71 42.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.526 -178.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.542 HG23 ' OG1' ' A' ' 310' ' ' THR . 15.8 m -102.09 113.74 27.25 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.617 ' HB2' HG13 ' A' ' 309' ' ' VAL . 4.9 mp -110.39 170.63 7.96 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.943 0.402 . . . . 0.0 110.027 -171.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.636 HG22 ' O ' ' A' ' 307' ' ' GLY . 0.0 OUTLIER -126.87 120.97 30.5 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.402 176.761 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.442 ' HA3' HD23 ' A' ' 228' ' ' LEU . . . -156.78 134.77 4.16 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.81 -0.709 . . . . 0.0 111.404 178.049 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -112.7 93.41 4.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.107 0.48 . . . . 0.0 112.179 -173.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 18.3 m -126.16 102.74 7.34 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 169.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -56.0 134.86 52.67 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -175.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 24.5 t 63.31 53.65 2.16 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.901 172.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.446 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 84.2 t -132.47 95.97 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.291 0.567 . . . . 0.0 110.377 175.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.5 m -75.97 86.31 2.89 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.567 0.698 . . . . 0.0 109.857 177.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 95.62 92.51 1.75 Allowed Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.251 -177.235 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.552 ' CD1' ' HB2' ' A' ' 303' ' ' SER . 3.6 m-85 -45.34 -58.79 3.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.786 0.803 . . . . 0.0 109.958 169.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 266' ' ' ASP . 75.8 mt -141.53 169.83 16.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.168 -1.378 . . . . 0.0 108.031 -175.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 96.0 mttt -137.68 -171.22 2.94 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 121.173 -0.211 . . . . 0.0 110.884 -179.386 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -54.11 113.95 1.43 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.261 0.553 . . . . 0.0 111.413 -179.061 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 113.03 -6.82 25.42 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.77 177.087 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 22.9 m-20 -90.37 136.03 33.31 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.722 -0.281 . . . . 0.0 110.262 179.049 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -107.15 142.28 37.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.5 0.667 . . . . 0.0 111.981 -174.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 295' ' ' ALA . 0.7 OUTLIER -126.09 164.04 26.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.569 179.006 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 294' ' ' THR . 0.0 OUTLIER -135.68 147.99 48.75 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.674 174.221 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -110.95 130.03 55.71 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -174.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 44.0 m -104.25 126.63 51.52 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.426 ' ND2' ' HB3' ' A' ' 274' ' ' TYR . 26.6 p-10 -107.28 147.59 30.04 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.893 0.854 . . . . 0.0 113.184 -163.208 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 20.0 p -100.89 96.03 7.01 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 162.007 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' A' ' 289' ' ' THR . 26.1 p90 -80.67 127.07 32.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.22 0.533 . . . . 0.0 110.899 -165.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.483 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 62.5 t-105 -166.01 -58.25 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.051 -174.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.573 HD23 ' HB2' ' A' ' 334' ' ' GLU . 17.2 mt 62.0 92.49 0.05 Allowed 'General case' 0 C--O 1.237 0.403 0 O-C-N 123.421 0.451 . . . . 0.0 111.419 -178.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . 0.445 ' HA ' ' OG1' ' A' ' 280' ' ' THR . 35.8 mt-30 -70.63 -19.31 62.83 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.818 0.342 . . . . 0.0 110.684 -176.338 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 282' ' ' GLN . 24.4 mt-30 -67.33 -38.49 84.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.238 178.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -81.67 -38.09 26.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.001 -178.275 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.445 ' OG1' ' HA ' ' A' ' 277' ' ' GLN . 8.2 p -78.38 -56.04 4.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.111 -175.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -108.56 -78.79 0.59 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 121.136 -0.226 . . . . 0.0 111.575 -175.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 278' ' ' GLN . 77.0 mm-40 -143.65 -69.55 0.32 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.128 0.49 . . . . 0.0 110.514 -176.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -174.51 -61.0 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.672 -179.04 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 89.4 mt 57.9 33.88 23.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.965 175.524 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 67.77 -70.21 0.13 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.274 0.629 . . . . 0.0 112.221 176.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.639 ' HA ' ' OE1' ' A' ' 334' ' ' GLU . 9.8 p30 -166.47 171.03 12.27 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -178.327 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 162.43 -25.29 0.22 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 119.746 -1.216 . . . . 0.0 113.562 177.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.483 ' HB1' ' HB3' ' A' ' 275' ' ' TRP . . . -127.96 -141.59 0.26 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.868 0.334 . . . . 0.0 110.789 -177.097 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.619 ' CG2' ' HB3' ' A' ' 337' ' ' ASP . 13.5 m -157.01 151.54 20.46 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 110.484 -0.191 . . . . 0.0 110.484 179.021 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . 0.404 ' HG3' ' HA ' ' A' ' 333' ' ' VAL . 2.7 Cg_exo -78.57 -77.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.468 2.112 . . . . 0.0 113.641 173.37 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 14.9 tt -139.61 159.3 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -166.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 32.8 p -85.66 135.45 33.77 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 176.206 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . 0.466 ' CZ ' ' HG3' ' A' ' 234' ' ' PRO . 35.9 p90 -161.58 177.2 10.23 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.992 0.425 . . . . 0.0 111.403 -176.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 269' ' ' LYS . 53.8 m -124.06 132.67 53.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.508 -178.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . 0.485 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -114.97 -179.74 3.71 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.802 0.334 . . . . 0.0 111.249 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 96.1 m -143.67 121.64 12.06 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.569 0.699 . . . . 0.0 111.675 178.358 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.703 HG13 HG21 ' A' ' 311' ' ' VAL . 78.0 t -66.86 138.79 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.544 -178.04 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 312' ' ' THR . 6.0 t -121.4 6.54 10.13 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.108 -175.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -163.18 -167.03 1.37 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -72.46 113.8 9.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.246 0.546 . . . . 0.0 110.047 179.179 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -91.98 101.28 13.83 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.343 178.212 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -56.36 134.01 53.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.503 -0.772 . . . . 0.0 112.802 -169.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.552 ' HB2' ' CD1' ' A' ' 261' ' ' PHE . 30.5 t -128.23 111.39 13.36 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 120.913 0.387 . . . . 0.0 110.873 173.583 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.49 157.41 41.23 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 3.9 t -71.07 -10.14 59.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.009 -171.235 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -69.17 -15.05 69.41 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 173.004 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . 0.636 ' O ' HG22 ' A' ' 252' ' ' THR . . . 90.07 41.03 5.68 Favored Glycine 0 C--O 1.223 -0.558 0 C-N-CA 120.925 -0.655 . . . . 0.0 114.379 174.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -126.22 130.73 51.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.151 0.976 . . . . 0.0 111.427 178.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.617 HG13 ' HB2' ' A' ' 251' ' ' LEU . 0.8 OUTLIER -141.93 112.06 2.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.744 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.525 176.018 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.542 ' OG1' HG23 ' A' ' 250' ' ' THR . 99.0 m -110.15 129.47 55.7 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.491 -0.756 . . . . 0.0 110.618 177.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.703 HG21 HG13 ' A' ' 297' ' ' VAL . 2.6 p -151.72 144.38 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 121.141 0.496 . . . . 0.0 111.23 178.252 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.525 ' O ' HG22 ' A' ' 298' ' ' THR . 22.6 m -100.34 145.21 28.43 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.679 175.418 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 313' ' ' LEU . 1.3 mm? -121.44 129.81 53.21 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.484 -172.065 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 16.0 p -144.47 151.14 38.75 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.932 -174.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 74.66 47.33 15.59 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.333 175.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 7.0 m -118.99 111.56 37.07 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 120.976 0.417 . . . . 0.0 111.284 -177.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -71.99 78.91 1.74 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.696 2.264 . . . . 0.0 111.075 174.356 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 6.9 tt -82.46 99.29 5.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.561 0.696 . . . . 0.0 110.758 -177.473 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -135.77 88.61 2.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.569 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -77.95 -65.3 0.99 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 40.8 p 39.18 39.4 0.41 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 179.244 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 24.6 m -138.31 -52.01 0.59 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.893 0.378 . . . . 0.0 110.882 179.037 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -71.65 -45.82 12.72 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.68 -19.22 36.76 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.031 1.821 . . . . 0.0 112.217 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 70.07 -60.74 0.48 Allowed 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.902 0.751 . . . . 0.0 111.895 178.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -74.89 -50.31 17.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.708 -177.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 43.0 t30 70.71 81.44 0.16 Allowed 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -178.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . 0.402 ' O ' ' HB ' ' A' ' 329' ' ' VAL . 19.1 m -71.77 -15.36 62.17 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.895 -170.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 328' ' ' SER . 66.0 t 75.46 143.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.198 177.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 68.7 p 51.4 62.09 2.89 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.587 0.755 . . . . 0.0 111.829 178.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -72.03 144.76 48.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.221 179.46 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . 0.405 ' O ' HD21 ' A' ' 276' ' ' LEU . 26.3 mp0 -88.22 149.56 23.78 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 175.545 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 233' ' ' GLN . 15.4 m -90.09 161.65 2.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.627 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . 0.639 ' OE1' ' HA ' ' A' ' 286' ' ' ASN . 6.1 tp10 -155.92 112.16 3.1 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.483 -174.133 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -74.64 143.71 44.18 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -171.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 131.51 11.55 2.16 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 120.787 -0.72 . . . . 0.0 114.231 175.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.619 ' HB3' ' CG2' ' A' ' 289' ' ' THR . 4.5 p-10 -76.72 174.48 10.4 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 117.498 0.649 . . . . 0.0 112.03 175.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -112.0 132.0 55.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.731 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.497 ' CG2' HG23 ' A' ' 230' ' ' VAL . 54.5 t -102.67 152.91 5.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.668 -169.498 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 23.2 t -157.45 177.16 11.75 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 174.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 46.6 t -112.52 138.59 41.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.65 0.262 . . . . 0.0 110.767 -174.04 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 269' ' ' LYS . 56.5 t -82.91 -36.69 13.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.78 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -57.45 -61.21 7.74 Favored Glycine 0 C--N 1.332 0.349 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.742 -179.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 2.0 p -78.56 -72.14 0.39 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.626 0.213 . . . . 0.0 111.299 179.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.445 -0.788 . . . . 0.0 111.497 179.527 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.847 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 68.11 -73.76 0.08 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.548 0.739 . . . . 0.0 112.198 179.035 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.434 ' C ' ' H ' ' A' ' 226' ' ' GLY . 0.4 OUTLIER -132.43 154.52 49.77 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 122.573 0.349 . . . . 0.0 110.207 -177.924 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 71.45 -20.49 0.77 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.641 174.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 224' ' ' PHE . . . -51.46 137.63 29.83 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.832 -0.223 . . . . 0.0 113.526 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 19.1 m -102.66 142.44 33.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.926 0.393 . . . . 0.0 110.886 -178.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.558 HD21 ' CE1' ' A' ' 261' ' ' PHE . 19.2 mt -144.39 176.61 9.24 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 42.7 m -135.97 160.23 39.26 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 122.27 -0.269 . . . . 0.0 110.485 -174.142 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.628 ' HB ' ' OD2' ' A' ' 337' ' ' ASP . 3.4 t -118.63 152.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 177.581 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.578 ' HE3' HG22 ' A' ' 250' ' ' THR . 53.1 pttt -130.38 14.43 5.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.857 0.36 . . . . 0.0 111.132 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.617 ' H ' HG12 ' A' ' 230' ' ' VAL . 24.1 p -151.73 -178.55 6.79 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -175.56 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.553 ' HB3' ' CG2' ' A' ' 333' ' ' VAL . 0.3 OUTLIER -115.79 129.46 25.14 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -174.28 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.49 105.79 1.32 Allowed 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.452 2.101 . . . . 0.0 112.243 -179.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 5.8 t -107.0 129.6 54.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.307 178.624 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.439 HG22 ' HB3' ' A' ' 247' ' ' PHE . 8.1 t -85.61 123.63 39.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.203 -173.054 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 49.2 m -82.17 96.66 7.89 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.048 173.145 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.75 109.07 13.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.511 -178.548 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.5 HD22 ' HA ' ' A' ' 239' ' ' ASN . 0.2 OUTLIER -121.0 81.2 1.74 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.419 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -85.11 -36.86 20.85 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.067 -164.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.03 -23.15 32.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.757 0.789 . . . . 0.0 109.162 174.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.409 ' HG3' ' OD1' ' A' ' 239' ' ' ASN . 13.4 mmmm -103.62 -6.76 21.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.262 -176.212 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 58.32 58.95 3.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.57 -177.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 41.7 m -145.53 128.63 16.61 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.372 176.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -129.14 100.4 5.61 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.199 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -133.97 144.18 48.62 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.498 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.439 ' HB3' HG22 ' A' ' 236' ' ' VAL . 41.7 p90 -120.11 136.59 54.54 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.644 -178.083 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 97.9 m -100.95 141.25 34.1 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -173.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.519 HG13 ' CD1' ' A' ' 251' ' ' LEU . 1.4 p -144.48 146.14 20.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.418 -177.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.578 HG22 ' HE3' ' A' ' 231' ' ' LYS . 4.9 m -107.84 124.95 50.84 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 174.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.56 HD23 HG21 ' A' ' 339' ' ' VAL . 3.9 mp -115.21 171.74 7.5 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.668 0.747 . . . . 0.0 110.926 -167.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.406 HG23 ' HD3' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -129.11 142.28 50.94 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.218 169.151 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -140.98 -144.54 4.45 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.007 -173.783 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.524 ' O ' ' HA2' ' A' ' 307' ' ' GLY . . . -101.91 -173.54 2.37 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -176.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.581 HG22 ' H ' ' A' ' 256' ' ' ALA . 0.2 OUTLIER -70.83 -177.81 1.7 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.337 -171.635 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.581 ' H ' HG22 ' A' ' 255' ' ' THR . . . -67.32 -175.39 0.47 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.266 -178.599 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 50.7 m 80.59 6.22 1.53 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.002 0.921 . . . . 0.0 111.244 179.46 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.9 88.79 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.505 0.669 . . . . 0.0 109.411 171.377 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 62.9 m -89.09 103.68 16.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.953 179.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 83.22 79.44 1.03 Allowed Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.068 -176.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.638 ' CE1' ' HB2' ' A' ' 303' ' ' SER . 6.8 m-85 -45.32 -54.59 6.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.788 0.804 . . . . 0.0 109.932 170.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.5 pp -158.11 173.7 16.33 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.288 -1.323 . . . . 0.0 108.677 -175.021 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.543 ' HE2' ' OD2' ' A' ' 300' ' ' ASP . 94.4 mttt -136.29 -167.54 2.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.702 0.287 . . . . 0.0 111.54 -174.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -55.4 116.57 2.93 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.436 0.636 . . . . 0.0 111.446 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 115.08 -14.96 18.84 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.199 177.624 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -86.06 141.89 29.12 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.254 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -104.86 150.16 25.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.878 0.847 . . . . 0.0 112.668 -172.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.35 173.71 13.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.668 175.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.454 ' HE2' ' CB ' ' A' ' 340' ' ' SER . 0.0 OUTLIER -134.57 149.88 50.67 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 167.091 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.512 ' O ' ' HA ' ' A' ' 292' ' ' SER . 55.4 m-85 -106.5 130.73 54.23 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.494 -175.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 45.6 m -107.16 88.34 2.71 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 171.387 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -122.65 144.59 49.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.424 0.631 . . . . 0.0 111.767 -172.3 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 31.5 p -97.91 109.81 22.5 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.665 173.459 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -83.16 113.38 20.6 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.012 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 41.6 t90 -141.42 92.74 2.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.329 0.585 . . . . 0.0 110.522 -172.685 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -115.68 130.06 56.71 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 175.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -57.21 -26.4 60.63 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -167.67 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -80.04 -44.13 20.66 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.524 0.678 . . . . 0.0 110.413 178.255 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -76.01 -24.8 55.29 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.583 -174.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 17.0 p -69.8 -15.11 63.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.974 0.416 . . . . 0.0 111.401 179.495 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -76.46 -7.71 55.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.4 178.32 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -82.71 66.29 8.25 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 122.263 1.03 . . . . 0.0 109.073 175.209 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -75.81 66.82 2.14 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.41 -1.723 . . . . 0.0 111.596 -175.544 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 78.2 mt -94.28 4.38 53.96 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.875 178.285 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 75.06 -42.57 0.49 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.149 179.257 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -84.73 65.01 8.87 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -172.26 36.73 0.15 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.934 -177.26 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -100.8 33.91 2.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.188 0.518 . . . . 0.0 110.657 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.417 ' N ' ' HD3' ' A' ' 290' ' ' PRO . 9.1 t 44.43 61.94 10.57 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 124.75 1.22 . . . . 0.0 113.776 178.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 289' ' ' THR . 83.9 Cg_endo -95.99 57.81 0.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.933 2.422 . . . . 0.0 110.951 173.313 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 37.4 pt -113.77 162.71 11.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.245 0.545 . . . . 0.0 112.343 -170.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 270' ' ' PHE . 17.8 p -167.35 100.15 0.51 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.28 177.25 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -111.63 147.39 35.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.856 0.36 . . . . 0.0 111.127 -174.212 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 269' ' ' LYS . 51.9 m -88.02 127.27 35.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.783 -179.21 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -120.23 179.13 4.38 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 95.3 m -136.97 130.65 31.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.534 0.683 . . . . 0.0 112.543 -177.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 299' ' ' ALA . 61.1 t -85.1 144.08 10.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.484 -178.359 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 0.6 OUTLIER -119.33 24.74 10.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.821 -174.993 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.557 ' H ' HG12 ' A' ' 297' ' ' VAL . . . -166.83 173.34 9.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.763 0.316 . . . . 0.0 111.668 -177.346 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.543 ' OD2' ' HE2' ' A' ' 263' ' ' LYS . 2.3 m-20 -64.8 116.55 6.42 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.256 176.688 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -93.26 112.75 24.76 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.664 179.023 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.74 ' O ' ' HB ' ' A' ' 309' ' ' VAL . 65.9 t30 -85.55 134.47 34.02 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -171.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.638 ' HB2' ' CE1' ' A' ' 261' ' ' PHE . 7.7 t -113.88 95.72 5.46 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 163.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -98.53 179.25 4.76 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.976 -178.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 20.5 m -57.07 -32.92 66.75 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -173.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -83.39 5.54 76.97 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.468 -176.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 254' ' ' ALA . . . 64.49 42.69 97.42 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.864 -178.345 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -120.22 142.91 48.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.367 0.584 . . . . 0.0 111.682 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.74 ' HB ' ' O ' ' A' ' 302' ' ' ASN . 0.2 OUTLIER -143.89 152.7 15.93 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.616 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.096 176.973 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.448 ' OG1' HG23 ' A' ' 250' ' ' THR . 95.5 m -149.72 120.04 7.34 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.692 -0.63 . . . . 0.0 110.619 178.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 35.4 m -145.87 160.88 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.41 0.624 . . . . 0.0 111.23 -177.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 23.7 m -114.75 140.93 48.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.582 176.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.52 126.52 54.47 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.367 -171.245 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 7.6 p -96.5 137.43 35.6 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.329 -176.118 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 92.95 153.62 30.41 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -176.811 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 3.9 m -114.4 86.19 11.88 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-O 121.126 0.488 . . . . 0.0 111.793 -177.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -83.44 47.68 2.43 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.757 2.305 . . . . 0.0 110.598 176.022 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.537 HD11 ' HB ' ' A' ' 322' ' ' THR . 10.3 tt -146.59 127.94 6.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.636 -174.495 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -113.4 -64.52 1.3 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.71 -174.493 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -121.3 -19.45 7.03 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.78 -173.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.9 p -56.85 -27.35 60.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.197 0.522 . . . . 0.0 111.464 -177.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . 0.537 ' HB ' HD11 ' A' ' 318' ' ' ILE . 2.4 m -153.1 128.68 10.03 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 167.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -156.45 138.62 10.21 Favored Pre-proline 0 C--N 1.307 -1.28 0 CA-C-N 115.428 -0.805 . . . . 0.0 108.849 -178.097 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.07 -15.46 23.22 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.368 1.378 . . . . 0.0 112.702 -177.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -82.07 69.56 8.8 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.928 0.87 . . . . 0.0 112.09 -175.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -100.65 -35.69 9.4 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 166.358 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -139.48 -52.71 0.54 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.283 170.195 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 32.9 t -153.98 -67.4 0.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.097 171.499 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 5.0 t -143.68 40.56 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 3.2 p -67.14 -68.25 0.39 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.519 -1.219 . . . . 0.0 112.689 -172.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . 0.561 ' NE ' ' HA ' ' A' ' 331' ' ' ARG . 3.8 mmp_? -100.5 149.97 23.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.74 0.305 . . . . 0.0 111.392 -175.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -127.93 -168.54 1.91 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.813 179.182 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.553 ' CG2' ' HB3' ' A' ' 233' ' ' GLN . 2.6 m -68.78 169.4 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.381 0.61 . . . . 0.0 112.113 -179.304 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -147.22 161.82 40.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.937 -177.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -65.96 173.09 3.18 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.507 0.504 . . . . 0.0 111.358 178.596 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 112.26 13.73 11.64 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -176.086 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.628 ' OD2' ' HB ' ' A' ' 230' ' ' VAL . 0.4 OUTLIER -96.29 146.68 24.51 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.742 0.782 . . . . 0.0 112.617 -173.885 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -144.08 163.56 33.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.779 178.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.56 HG21 HD23 ' A' ' 251' ' ' LEU . 74.7 t -125.24 143.03 40.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.227 0.537 . . . . 0.0 111.285 -169.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.454 ' CB ' ' HE2' ' A' ' 269' ' ' LYS . 20.0 m -147.51 127.21 13.38 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 172.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 19.1 t -76.04 143.12 13.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 120.867 0.365 . . . . 0.0 111.311 -173.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 53.4 t -87.43 -42.91 15.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.471 176.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 157.04 143.56 3.69 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.821 179.479 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 17.3 p -90.9 -80.87 0.33 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.953 0.406 . . . . 0.0 111.155 -178.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.526 -0.749 . . . . 0.0 110.291 -179.565 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.769 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.02 136.4 39.96 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 176.388 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -94.21 -21.0 19.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.191 0.52 . . . . 0.0 110.87 -177.435 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 106.03 34.82 3.11 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.139 -172.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -62.61 -170.04 1.1 Allowed Glycine 0 CA--C 1.523 0.565 0 CA-C-O 121.533 0.518 . . . . 0.0 114.083 177.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 5.3 m -67.28 145.35 55.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.435 0.636 . . . . 0.0 112.401 -173.077 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.431 HD22 HG11 ' A' ' 309' ' ' VAL . 1.3 mt -133.68 179.13 6.42 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.89 177.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 251' ' ' LEU . 48.1 m -139.08 158.84 43.46 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 122.303 -0.248 . . . . 0.0 110.498 -175.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 17.6 t -106.08 133.19 51.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 179.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -104.46 -39.05 6.56 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 178.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 63.5 p -118.77 -169.56 1.75 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.785 0.326 . . . . 0.0 110.489 -177.021 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.45 ' HB3' HG23 ' A' ' 333' ' ' VAL . 91.2 mt-30 -105.27 126.1 31.83 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.507 -169.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.646 ' HB3' ' CD2' ' A' ' 247' ' ' PHE . 23.7 Cg_exo -62.56 104.73 0.38 Allowed 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.687 2.258 . . . . 0.0 111.861 176.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.8 t -142.55 104.87 4.45 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.661 0.743 . . . . 0.0 112.187 -177.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.706 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -156.16 175.42 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.879 171.931 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.602 ' H ' HG13 ' A' ' 236' ' ' VAL . 55.9 m -34.09 114.27 0.2 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -169.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -116.04 88.13 2.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.465 173.178 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -113.73 133.16 55.52 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -179.225 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -104.28 -40.39 6.13 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.621 -172.163 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.73 -29.77 46.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.516 0.674 . . . . 0.0 109.74 176.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.49 ' HA ' ' HE2' ' A' ' 242' ' ' LYS . 11.2 mmpt? -100.45 -3.43 30.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.084 -178.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 53.72 51.57 14.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 113.998 -1.456 . . . . 0.0 111.089 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.2 m -126.28 99.16 5.75 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.095 -175.239 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -116.44 108.42 16.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.071 0.462 . . . . 0.0 110.502 -177.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . 0.505 ' HB2' HG12 ' A' ' 236' ' ' VAL . 95.0 mt-30 -129.5 164.16 24.35 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.057 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.706 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 31.3 p90 -159.79 135.66 8.59 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.565 -0.454 . . . . 0.0 112.143 176.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 51.9 m -98.09 138.92 34.66 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.487 ' HB ' HD11 ' A' ' 251' ' ' LEU . 0.2 OUTLIER -142.7 150.83 17.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.765 -179.305 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.595 HG23 ' OG1' ' A' ' 310' ' ' THR . 96.2 m -104.38 117.45 34.21 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 167.488 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.582 ' HB2' HG13 ' A' ' 309' ' ' VAL . 4.0 mp -118.49 169.49 9.73 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.209 -170.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 307' ' ' GLY . 0.0 OUTLIER -110.4 141.72 43.09 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.279 176.114 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.417 ' HA2' HD23 ' A' ' 228' ' ' LEU . . . -138.34 -143.92 4.57 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.999 -178.653 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -109.96 -173.61 2.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.814 0.34 . . . . 0.0 111.877 -177.099 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.577 HG22 ' H ' ' A' ' 256' ' ' ALA . 2.2 m -67.04 173.68 3.55 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.388 -0.823 . . . . 0.0 112.877 -170.125 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.577 ' H ' HG22 ' A' ' 255' ' ' THR . . . -62.94 -175.34 0.09 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.861 0.864 . . . . 0.0 112.663 -178.785 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 31.3 t 81.53 6.4 1.2 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.95 0.9 . . . . 0.0 111.101 -178.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 303' ' ' SER . 64.4 t -125.32 90.54 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.545 0.688 . . . . 0.0 109.571 171.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 22.2 m -75.81 97.86 4.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.735 178.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 80.52 87.82 0.58 Allowed Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.495 -177.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.565 ' HB3' HD22 ' A' ' 262' ' ' LEU . 2.6 m-85 -44.6 -61.39 1.57 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.666 0.746 . . . . 0.0 110.143 170.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.565 HD22 ' HB3' ' A' ' 261' ' ' PHE . 2.9 mm? -135.22 166.01 24.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.405 -1.27 . . . . 0.0 108.483 179.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 299' ' ' ALA . 98.2 mttt -134.74 -170.98 2.67 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 123.164 0.29 . . . . 0.0 110.822 178.022 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 298' ' ' THR . . . -59.51 117.28 4.7 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.112 0.482 . . . . 0.0 110.57 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 115.26 -14.93 18.36 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.514 177.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 28.5 m-20 -86.9 138.48 31.51 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -100.6 154.2 18.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.072 0.463 . . . . 0.0 110.319 -178.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 294' ' ' THR . 1.3 m -135.17 176.33 8.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.314 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.425 ' HE3' HG22 ' A' ' 342' ' ' VAL . 1.7 mptm? -122.8 139.99 53.41 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 171.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -137.68 136.76 37.72 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.803 174.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.631 ' O ' ' HB3' ' A' ' 337' ' ' ASP . 29.7 m -110.14 88.54 2.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.428 -175.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.462 ' HA ' ' CG ' ' A' ' 337' ' ' ASP . 3.2 t-20 -85.24 108.3 17.69 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.205 176.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 289' ' ' THR . 19.2 p -123.19 80.32 1.76 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.967 0.413 . . . . 0.0 111.473 -176.145 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -143.41 119.73 10.9 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.473 0.654 . . . . 0.0 111.042 177.091 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.421 ' CE2' HG22 ' A' ' 280' ' ' THR . 26.9 t90 -91.18 83.96 5.61 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.759 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 74.8 mt -82.0 172.03 13.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.608 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . 0.497 ' HA ' ' OE1' ' A' ' 277' ' ' GLN . 14.6 mm-40 -64.66 -50.42 67.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -176.179 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 61.2 mm-40 -68.9 -28.39 66.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.72 0.771 . . . . 0.0 109.752 178.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -79.63 0.73 28.94 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.369 -178.373 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.421 HG22 ' CE2' ' A' ' 275' ' ' TRP . 30.8 p -63.33 -34.81 78.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.04 0.448 . . . . 0.0 111.125 178.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -72.87 -12.4 60.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.034 -178.356 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.547 HE22 ' NE ' ' A' ' 331' ' ' ARG . 67.6 mt-30 -108.85 3.58 22.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.683 -177.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -63.92 115.02 4.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.282 178.252 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 6.5 mp -73.0 -44.4 61.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.108 -172.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -144.98 123.48 12.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.996 0.427 . . . . 0.0 111.009 -173.18 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 63.6 24.56 14.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.284 171.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 67.01 56.51 12.17 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.718 -178.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.508 ' C ' ' HD3' ' A' ' 290' ' ' PRO . . . -153.31 168.37 26.25 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.657 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 273' ' ' THR . 17.2 m -122.44 66.36 25.48 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.194 -179.259 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . 0.508 ' HD3' ' C ' ' A' ' 288' ' ' ALA . 57.9 Cg_endo -99.49 72.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.312 2.674 . . . . 0.0 112.794 -176.522 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.577 ' H ' HD13 ' A' ' 291' ' ' ILE . 0.2 OUTLIER -126.47 173.25 12.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.01 0.433 . . . . 0.0 111.292 -179.416 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 10.3 p -156.81 133.5 10.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.25 176.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -153.3 168.87 24.58 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.248 0.547 . . . . 0.0 111.737 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 268' ' ' VAL . 90.0 m -89.35 133.57 34.44 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.814 -172.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . 0.406 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -119.15 -170.43 1.92 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.963 175.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 16.9 m -139.01 131.82 29.19 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.58 0.705 . . . . 0.0 112.877 -177.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.639 HG13 HG21 ' A' ' 311' ' ' VAL . 55.1 t -82.42 142.09 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 114.207 -1.361 . . . . 0.0 109.488 179.155 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 264' ' ' ALA . 41.5 p -129.19 18.44 5.98 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -173.576 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.409 ' HB3' HG23 ' A' ' 311' ' ' VAL . . . -167.59 177.95 5.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.394 0.14 . . . . 0.0 110.67 179.092 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.41 108.66 2.04 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.846 0.716 . . . . 0.0 109.556 178.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -92.67 100.91 13.33 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.275 0.56 . . . . 0.0 110.241 -177.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.449 ' OD1' ' HB3' ' A' ' 304' ' ' ASP . 9.0 t-20 -63.35 135.06 56.76 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -169.204 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.526 ' HB3' ' HB ' ' A' ' 258' ' ' VAL . 27.5 t -115.68 96.52 5.65 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 166.38 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . 0.449 ' HB3' ' OD1' ' A' ' 302' ' ' ASN . 0.4 OUTLIER -106.25 174.7 5.77 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.476 -176.864 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 20.3 m -60.67 -32.24 71.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.749 0.309 . . . . 0.0 111.589 -176.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -74.21 1.05 51.2 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.188 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . 0.465 ' O ' HG22 ' A' ' 252' ' ' THR . . . 63.91 40.68 98.56 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.309 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -114.16 127.77 56.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.695 0.284 . . . . 0.0 110.683 -179.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.582 HG13 ' HB2' ' A' ' 251' ' ' LEU . 2.7 p -131.97 101.06 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.392 0.615 . . . . 0.0 111.134 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.595 ' OG1' HG23 ' A' ' 250' ' ' THR . 54.3 m -104.03 126.63 51.3 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 121.95 -0.469 . . . . 0.0 110.864 -179.009 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.639 HG21 HG13 ' A' ' 297' ' ' VAL . 12.7 p -160.43 151.4 5.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.066 0.46 . . . . 0.0 110.237 175.37 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 48.4 m -92.4 148.9 21.75 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.307 178.449 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.502 ' HB2' ' CE2' ' A' ' 247' ' ' PHE . 5.7 mp -117.23 149.3 40.64 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.795 -179.076 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 36.8 m -143.15 119.24 10.73 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.74 -178.461 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 97.03 113.77 3.08 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.553 179.133 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.436 HG23 HD12 ' A' ' 318' ' ' ILE . 0.2 OUTLIER -145.22 137.69 13.51 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.981 0.42 . . . . 0.0 110.799 177.559 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.45 66.24 8.8 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.827 2.351 . . . . 0.0 113.401 -177.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.576 ' H ' HD13 ' A' ' 318' ' ' ILE . 0.2 OUTLIER -110.97 143.27 21.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 173.624 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -105.99 -47.44 3.85 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.156 0.503 . . . . 0.0 110.45 -178.199 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 38.2 t70 62.21 15.33 7.43 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.038 171.378 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.41 ' O ' ' HD2' ' A' ' 324' ' ' PRO . 5.6 p 48.05 96.49 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.756 0.822 . . . . 0.0 111.965 -173.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.02 -7.22 59.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.297 0.57 . . . . 0.0 110.704 -174.468 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.586 ' HB3' ' HD3' ' A' ' 324' ' ' PRO . 44.3 t-20 -71.09 -53.4 8.37 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.114 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' A' ' 323' ' ' ASN . 9.7 Cg_endo -93.95 103.72 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.684 2.256 . . . . 0.0 111.187 177.279 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . 0.422 ' O ' ' HB2' ' A' ' 326' ' ' TYR . 12.9 mm100 -115.75 -64.55 1.3 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.645 -175.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 325' ' ' GLN . 51.2 m-85 73.74 -66.13 0.32 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.282 176.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -128.6 -17.22 4.14 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.57 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 23.9 m 71.42 -61.12 0.5 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.924 0.765 . . . . 0.0 111.247 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 58.9 t 70.44 135.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 121.26 0.552 . . . . 0.0 111.228 179.066 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 9.5 m -59.45 126.92 29.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.517 176.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . 0.547 ' NE ' HE22 ' A' ' 282' ' ' GLN . 0.0 OUTLIER -73.51 116.7 14.4 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.123 -174.658 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -96.83 116.7 29.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.307 0.575 . . . . 0.0 110.795 178.43 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.45 HG23 ' HB3' ' A' ' 233' ' ' GLN . 22.2 m -101.35 171.97 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.847 178.613 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -131.34 153.89 49.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.0 0.429 . . . . 0.0 110.638 -178.513 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -97.95 165.21 12.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.857 -179.079 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 103.5 12.17 31.46 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.344 175.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.631 ' HB3' ' O ' ' A' ' 271' ' ' THR . 23.8 m-20 -95.19 -178.77 4.57 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.021 0.438 . . . . 0.0 112.126 -178.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -104.73 153.92 20.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.61 -173.444 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.453 HG21 HD23 ' A' ' 251' ' ' LEU . 50.5 t -132.86 150.34 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.791 -176.367 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 31.6 t -144.85 171.34 14.57 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 175.318 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 32.2 t -118.29 160.28 18.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.669 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.425 HG22 ' HE3' ' A' ' 269' ' ' LYS . 94.3 t -67.86 -60.56 2.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 118.212 0.46 . . . . 0.0 110.392 -179.582 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 172.91 -115.78 0.58 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.385 179.209 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 12.9 p -86.46 -57.51 2.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.214 0.53 . . . . 0.0 111.451 -178.529 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.61 -179.316 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.724 0 N-CA-C 112.148 -0.381 . . . . 0.0 112.148 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.21 99.57 0.92 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.191 0.52 . . . . 0.0 111.399 -178.162 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -100.77 -13.46 18.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.061 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 122.44 -47.81 0.99 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -175.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -119.14 113.7 2.6 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 167.097 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 20.3 m -129.74 131.49 46.3 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.738 0.304 . . . . 0.0 110.383 -173.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 339' ' ' VAL . 2.2 mp -138.47 -177.3 4.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.122 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 95.3 m -143.74 156.14 44.42 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.997 -176.799 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.438 HG23 HG23 ' A' ' 339' ' ' VAL . 66.3 t -108.05 122.77 62.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.197 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -106.05 -6.28 18.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.106 0.479 . . . . 0.0 110.716 -175.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 17.5 p -130.25 -168.32 1.95 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.732 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.418 ' HA ' ' HD2' ' A' ' 234' ' ' PRO . 6.8 mt-30 -113.74 113.65 47.39 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -175.347 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 233' ' ' GLN . 18.3 Cg_endo -62.17 106.98 0.51 Allowed 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.894 2.396 . . . . 0.0 112.494 -179.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.0 t -149.37 118.44 6.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.533 0.682 . . . . 0.0 112.269 179.556 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.666 ' HB ' ' HA ' ' A' ' 247' ' ' PHE . 0.9 OUTLIER -155.9 174.72 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.164 171.569 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.497 ' H ' HG13 ' A' ' 236' ' ' VAL . 34.8 m -23.09 100.19 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.609 1.164 . . . . 0.0 113.525 -177.318 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.95 83.42 1.82 Allowed 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.408 174.158 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.423 ' ND2' ' HG3' ' A' ' 242' ' ' LYS . 35.7 t-20 -108.79 129.96 55.38 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.016 -178.326 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -102.46 -41.39 6.32 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.68 -170.519 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.8 -33.77 65.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.43 0.633 . . . . 0.0 109.944 178.1 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.492 ' HA ' ' HE2' ' A' ' 242' ' ' LYS . 10.8 mmpt? -88.77 -11.25 45.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.481 178.835 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 26.5 t70 58.1 69.19 0.75 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.277 -178.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.9 m -146.8 104.84 3.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.159 -177.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -123.33 106.33 10.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.783 -176.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . 0.564 ' HB2' HG12 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -124.03 161.92 24.53 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 171.551 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.666 ' HA ' ' HB ' ' A' ' 236' ' ' VAL . 35.2 p90 -149.09 134.82 18.78 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.67 174.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 312' ' ' THR . 46.5 m -98.8 137.49 37.32 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.428 ' HB ' ' CD1' ' A' ' 251' ' ' LEU . 0.2 OUTLIER -142.29 148.58 20.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.878 -178.946 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.6 HG23 ' OG1' ' A' ' 310' ' ' THR . 41.6 m -99.51 107.84 20.12 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 166.519 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.561 ' HB2' HG13 ' A' ' 309' ' ' VAL . 5.2 mp -102.82 167.97 9.53 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -170.685 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.19 144.13 43.69 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.813 175.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -142.82 -142.48 4.01 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.369 -173.144 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.414 ' H ' ' HZ ' ' A' ' 261' ' ' PHE . . . -113.37 -173.66 2.31 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -176.362 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.577 HG22 ' H ' ' A' ' 256' ' ' ALA . 1.8 m -70.9 174.0 6.69 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.185 -171.726 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.577 ' H ' HG22 ' A' ' 255' ' ' THR . . . -62.51 -177.46 0.14 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.495 0.718 . . . . 0.0 112.862 -177.17 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 23.1 t 80.83 10.93 0.95 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.185 0.994 . . . . 0.0 111.155 -176.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 303' ' ' SER . 40.4 t -124.33 94.06 2.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 169.705 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.2 m -67.65 88.89 0.24 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.515 -177.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 69.48 107.42 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.109 -174.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.414 ' HZ ' ' H ' ' A' ' 254' ' ' ALA . 15.1 m-85 -44.19 -57.35 3.49 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 117.243 0.521 . . . . 0.0 111.091 174.254 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.524 HD11 HG13 ' A' ' 341' ' ' VAL . 91.9 mt -147.83 146.81 29.26 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -177.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.514 ' HD2' ' N ' ' A' ' 263' ' ' LYS . 9.5 mptt -112.86 -166.45 1.08 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.033 0.444 . . . . 0.0 111.561 176.53 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -52.79 114.15 1.32 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.66 -175.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 114.2 -16.07 20.26 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.416 171.392 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . 0.537 ' HA ' HG23 ' A' ' 344' ' ' THR . 0.6 OUTLIER -82.54 134.79 35.2 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.83 -177.014 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.19 145.94 24.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.24 -173.592 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.408 HG23 ' HB3' ' A' ' 295' ' ' ALA . 0.2 OUTLIER -125.33 165.3 22.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.744 179.97 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 340' ' ' SER . 0.8 OUTLIER -97.57 120.3 37.69 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 172.433 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -122.55 120.55 34.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.857 0.361 . . . . 0.0 110.085 -174.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 30.4 m -125.79 113.0 16.69 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.491 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.634 ' O ' ' HA ' ' A' ' 290' ' ' PRO . 19.4 m120 -84.09 153.27 23.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.031 -177.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 21.4 p -91.95 162.94 14.19 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.676 175.53 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -84.61 142.71 29.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.217 0.532 . . . . 0.0 111.787 -176.168 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -155.02 -36.98 0.09 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.972 176.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 67.7 mt -72.41 77.0 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.981 176.497 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . 0.533 ' HA ' ' OG1' ' A' ' 280' ' ' THR . 51.9 mt-30 -63.83 -22.43 66.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.006 -173.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -60.24 -38.71 84.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.728 0.775 . . . . 0.0 109.642 176.267 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.515 ' HB3' ' O ' ' A' ' 287' ' ' GLY . 74.1 mm-40 -89.17 -41.38 12.28 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.418 -175.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.533 ' OG1' ' HA ' ' A' ' 277' ' ' GLN . 43.6 p -68.21 -25.62 65.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.979 0.418 . . . . 0.0 111.256 -177.373 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -91.07 -58.87 2.32 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.716 176.321 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -97.8 -75.43 0.55 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -173.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 51.17 79.67 0.09 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.276 0.56 . . . . 0.0 111.086 -171.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.8 -26.71 57.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.942 -178.4 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -110.42 -70.06 0.83 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.157 0.503 . . . . 0.0 109.735 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.424 ' OD1' ' HA ' ' A' ' 320' ' ' ASP . 6.3 p30 -169.5 143.16 2.74 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.707 177.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 279' ' ' GLN . . . 168.79 101.82 0.15 Allowed Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.892 -177.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -126.13 114.47 18.42 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.204 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.516 ' HB ' ' HD3' ' A' ' 290' ' ' PRO . 8.1 m -88.12 -52.94 0.38 Allowed Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.615 -178.644 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . 0.634 ' HA ' ' O ' ' A' ' 272' ' ' ASN . 72.6 Cg_endo -76.13 66.83 6.95 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.771 1.648 . . . . 0.0 112.08 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 14.3 pt -99.82 151.22 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.656 -177.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 12.2 p -111.86 90.52 3.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.227 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -118.96 174.99 5.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.046 0.45 . . . . 0.0 110.665 -178.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 67.9 m -109.22 117.91 35.35 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.852 178.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . 0.408 ' HB3' HG23 ' A' ' 268' ' ' VAL . . . -104.24 -175.85 2.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 -176.148 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 91.4 m -141.63 131.16 23.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.384 0.612 . . . . 0.0 112.282 -176.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.589 HG13 HG21 ' A' ' 311' ' ' VAL . 64.3 t -75.13 136.67 24.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.053 176.372 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 2.4 m -111.45 -9.04 14.24 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.97 -167.698 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 263' ' ' LYS . . . -164.45 -168.9 1.63 Allowed 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.912 -0.492 . . . . 0.0 111.676 -177.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.16 151.71 35.1 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.77 0.795 . . . . 0.0 110.762 179.35 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -148.13 -178.38 6.26 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.315 -1.311 . . . . 0.0 109.433 -178.135 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -136.56 135.83 38.77 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -173.482 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 256' ' ' ALA . 0.8 OUTLIER -112.94 95.62 5.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 161.618 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -99.88 175.49 5.76 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.662 -176.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 53.5 m -60.91 -31.39 70.9 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -177.027 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -78.55 -2.43 84.85 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.213 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 69.2 42.06 77.36 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.739 179.006 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -114.67 135.52 54.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.92 0.86 . . . . 0.0 110.856 175.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.561 HG13 ' HB2' ' A' ' 251' ' ' LEU . 2.3 p -136.51 105.29 4.41 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.507 -179.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.6 ' OG1' HG23 ' A' ' 250' ' ' THR . 90.7 m -102.82 129.84 49.62 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 121.664 -0.648 . . . . 0.0 111.365 -178.31 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.589 HG21 HG13 ' A' ' 297' ' ' VAL . 14.4 p -165.93 155.41 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.033 0.444 . . . . 0.0 110.237 174.303 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 248' ' ' THR . 52.4 m -96.64 149.32 21.93 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.453 -179.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.474 ' HB2' ' CE1' ' A' ' 247' ' ' PHE . 5.4 mp -117.21 136.62 52.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.542 -178.422 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 5.4 m -133.46 132.19 40.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.446 -173.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 94.64 80.21 1.49 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.971 175.276 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 12.4 m -134.95 134.72 22.03 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.763 0.316 . . . . 0.0 110.812 177.244 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -88.41 69.64 2.83 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.0 2.467 . . . . 0.0 113.182 -178.465 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.88 114.1 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 175.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -109.87 18.22 20.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.372 0.606 . . . . 0.0 110.319 -178.55 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.424 ' HA ' ' OD1' ' A' ' 286' ' ' ASN . 16.1 m-20 -87.85 32.18 0.75 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.043 176.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 12.5 p -80.96 32.54 0.32 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.412 -175.319 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 20.8 m -95.2 -22.13 18.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.176 0.513 . . . . 0.0 110.375 179.22 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.446 ' HB3' ' HD3' ' A' ' 324' ' ' PRO . 8.3 t30 -74.05 -48.27 6.12 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.767 176.897 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 327' ' ' ASN . 2.9 Cg_exo -80.72 14.43 2.04 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.756 2.304 . . . . 0.0 113.088 -177.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . 0.514 ' HA ' HE21 ' A' ' 325' ' ' GLN . 0.0 OUTLIER -59.79 -60.63 3.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.174 -178.741 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -88.84 -9.92 49.94 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.7 0.286 . . . . 0.0 111.354 -177.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 324' ' ' PRO . 25.8 t-20 -159.76 105.88 1.62 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.243 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 29.5 p -114.76 -0.64 13.47 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.66 178.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 55.5 t -104.79 -34.17 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.756 0.312 . . . . 0.0 111.713 -175.132 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 330' ' ' SER . . . . . . . . . . . . . 6.0 m -86.19 -60.26 2.06 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.121 0.486 . . . . 0.0 110.23 179.287 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -82.99 112.51 19.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.936 -178.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -140.42 -168.69 2.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.225 0.536 . . . . 0.0 110.877 -177.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 25.9 m -66.7 172.85 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.892 174.247 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -132.64 144.7 50.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.5 -179.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -67.16 154.01 42.29 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.591 -178.49 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 117.25 6.1 13.98 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.201 -178.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -69.33 159.99 32.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.836 0.35 . . . . 0.0 111.162 -177.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -105.96 138.51 42.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.769 -176.235 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.48 HG21 HD23 ' A' ' 251' ' ' LEU . 77.2 t -128.09 145.1 35.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.137 0.494 . . . . 0.0 111.202 -175.436 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.536 ' HB2' ' HB3' ' A' ' 269' ' ' LYS . 36.5 m -145.02 175.54 10.15 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 172.206 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.524 HG13 HD11 ' A' ' 262' ' ' LEU . 98.7 t -116.09 122.3 69.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.917 0.389 . . . . 0.0 111.963 -174.667 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 60.7 t -84.57 -41.1 15.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.428 173.563 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 96.05 -152.53 20.29 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.11 177.246 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.537 HG23 ' HA ' ' A' ' 266' ' ' ASP . 1.0 OUTLIER -142.61 -60.42 0.44 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.701 0.286 . . . . 0.0 110.299 177.509 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.106 -0.949 . . . . 0.0 111.423 179.037 . . . . . . . . 0 0 . 1 stop_ save_